<SEC-DOCUMENT>0001792044-22-000017.txt : 20220509
<SEC-HEADER>0001792044-22-000017.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509160616
ACCESSION NUMBER:		0001792044-22-000017
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		106
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viatris Inc
		CENTRAL INDEX KEY:			0001792044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				834364296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39695
		FILM NUMBER:		22904878

	BUSINESS ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		(724) 514-1465

	MAIL ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Upjohn Inc
		DATE OF NAME CHANGE:	20191023
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>vtrs-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:bf4cfb5a-529b-48e5-98f7-7a0c9b128563,g:c48d1c16-74b3-4c20-a8f8-3b8e11527314,d:288d0c78bfc143dbaf3ab9e5cd85c3ad--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:vtrs="http://www.viatris.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vtrs-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF80LTEtMS0xLTU4OTc5_5afbec66-6f73-45d9-bd56-da39197dfd24">0001792044</ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF83LTEtMS0xLTU4OTc5_9b5203b6-9f01-4436-b787-7ab78e735780">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF84LTEtMS0xLTU4OTc5_6a77005f-92e6-4aea-bdae-a61cc4440bb5">2022</ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF85LTEtMS0xLTU4OTc5_7452ef4d-3391-447e-81f1-5ec48f4849e8">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF8xMC0xLTEtMS01ODk3OQ_a84f5658-bbdc-4a44-a601-24402b07223d">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i32276e78cf4b4306ab1293b0c1151e0b_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTU_c0f2427b-1baa-41a5-bae1-4668a072522c">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i8a3a5f469f2a41ea9dba3560f618f489_D20220401-20220630" name="vtrs:DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTUzOTMxNjI3OTU3NDY_e1f2e313-6d28-4936-b405-9423e140767f">P2Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vtrs-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ibb3acc72c20e4e09b7934a67fa2aa217_I20220504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d2ff4971a6c4d628f7e2a84354fde90_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3da2991a25341b09ab36340008ea196_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib578d781d99c4f47885649d77583e23e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3915b76fc6ea48ff93b407a9221bd01f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie352cada5a604c7d8404347ba1732ca1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad7c661b920b42e4bb603f29ac39dd7f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0f234c800024956b447083ed4d02c3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e37563a7f3a4909b7dd02085a753d01_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i540972ea3b894aad8a249c7604f8d68d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b0cf057ebfd4957826fe40ac96ad443_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b8608f018ae44cfa0a49be1967faa7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f380484fc704f83a0342b6bdf44bebd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec90faf56074071843d5dff2b177e01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i067dee996df34e2f84a35524e9e8481c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93966d3931bb4b9a9d064377829d20d5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id369222933c4479abd90313ae11b86e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269ed4494e9b4057b6b5fd874978d0ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia304a43e569c442dabdb1c25c2e35832_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i949fd9a15d71419c9f66a4369a131379_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e4b05435485489b9e8b4fad080fe718_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f01433cbdfb450fa016216bdc117a8f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf18a35c07d4619b44d7c23d09f585e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff1f52f268c4433b7551e32308c1640_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41532774e5ff4f418b14c53f63cb7d8a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eaf90e86a23405aa9ca93eeeb3b40f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc0f9f8a1bf4a9a967c3233ef153a6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie72c892bc6534c14adab5d7152694449_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869a99efa4864d4490272885dbb4c20d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf75acc573ac4b3ea45a192607841887_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i758900e2e79742f39cd9b920398e128d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4d981978cc94683b97f4e364187100f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16129c8fa4c146e7b0efbdba33260113_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84ae372e0d4640afaf6ca7d236588eca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8dd750c9019453f8f3c004524321932_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if11d265b55994603936bcc00f3604ac6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">us-gaap:UnusualOrInfrequentItemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i86ba39e9fd3f4576a6e3ba8ea5af515d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e9f96c4bfdf4076a41b2f57ff65da66_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i292d6065b18c456da950161dc0ed5cdc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i955056f26f174344a59efe72d96b834c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba711be447b3478c996341536356cdf5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fe9d75ef6164e1aba47dd0b90e867b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a2e8d20544d4bc2a6e3f00cdd628190_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474b93c64de34a159cbfd01885dbf1f1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if294433954e94b85a607d271a2bd0aa8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491eb04d3a654f62b1752d08b7f0ac78_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7d16d65a7504e289ccdc9b0fe5363e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9174fff41b14aaca81b7b98168f76b6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd7dbc12b4304f5c84ac1ca236493c73_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f0d8fcddec412b8d97bd5a1419a982_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25e59d16c05e4059bb82ad3b1d4de7c2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibde6978e33374457b942a44020cb10ac_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d1621479f04da080f48af407080848_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2820f52c9a448be8acecbf9c082bfca_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc3684b9a82c4961986055887197e3e0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbaa3dc1ea00496aa8394b48d658329d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i748408c8afd2496db200ffab60f6309a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia11c96949c8246b1a6f02ad3e9a1b8ff_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a80de9958be4b8999ac5f83c006a04d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c27f0d85da4abe8f1080ed37fb7cc5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fb745d16ade49188c879e9695ef5f1f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcee3429c94d4f49a2cdae32dc34c903_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id284b62a1ee441a690f5d1dc632ff0f0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia59211776b6c4a7691d42c9ca7bf9112_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bb7352eee5c4e39a4037e1da189dcd5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9f9d84adfd04a3190bc51b5249c2bb3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e1cab044e074c6892720c7206be4d3e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1835a54addd6406c921c384df5914a3a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i135d47fb8e1749deb28406184113a7f3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9abec7680e7e486b9c3cba801e828c78_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52fa1580002c42d589ddb55c78697ff0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e79823554854c9994555c6c449804f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ffa584bf64441bfa32a52dfbd8ccd56_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id717ea1bde634a34a611f888a445e7bc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie24ff44d1ac94a97977bf67c683e1249_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3006593f3b0c4bff83619b0e08ba5ff4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b41aeba1a37461eb3d32c974467161a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib02f402791b04a8a848fabcaebd62823_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i158536bda5ef4607b007205257c61c21_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ede27cc7454699baf57d0d454a0244_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85796e832ed74154ae053fee7baad954_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad726170615b4ba3addd534151d713e8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48022c64e99b421c837601b663c4be1c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7b925316344a58a37be2388b7ffca1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9199b9cb6f924570befa8e11e3b7a86f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87788733377c4d97813f696f3baef142_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0b104192aa044c58ca3556d6141607c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84563bdbb5d44725a06b2c5fbc62e422_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4fea5e9149f40bfa10bc9bd2936bc6d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e58994728654ea6896d5c8702fe2b3b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0912a24a584447deb9f3b49a05227ef6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cfaa89f38c84069b2fa8d501cbd8580_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1daacd537079404ba5c511f26c26f483_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5583a6d8429e4a15a832e3cb417de6c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dca7477e77e4046b85ab1d82f7b0be9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i126834f952d14d5ba0e012629f9f51b8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2348a305e98341d6b3d64a25bd98d99f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08cd6d30ddde4135b38cb6b4509af6be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1403ea4a4ff462894d5f150c3fc0424_I20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300f9d815ab347b99f79dd4a94ef5112_D20201116-20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-16</xbrli:startDate><xbrli:endDate>2020-11-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b945f241fe546d3b6b6002a03ff26fc_I20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32276e78cf4b4306ab1293b0c1151e0b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d074444c7494355a757a9e0ab0d8ffd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd6d8a15669b44269a74dc8552c59bff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i172cb95ff1b1402d846fc493dacaeb9c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56b037f5e77a4f00aa5d7a3f375a6f96_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d97c12bd31b4009bd5259d649284b90_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f30854d5be84566bce9b02e6adf2bc7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf19978eee644aba94ea1363e7675424_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5151f58ea94c4939ae23348ce92f1b70_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie815b9c252a444bb82e640d926a75aaa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde1a85ed6e247a086a8aad3326c4e01_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d8d5eff296a4e6d8f34d3fd83d2fa04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4505670638054dd8bdc85765bd7b5bb5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67b06c877d5645eca6b4db2020388c0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02260e2d4d964332930fc8ba5cb79fd1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992fd5c4440f4ad69a507b4b2076605b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc828c926f7f4226bb0765da134ca177_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5a293effe2d476e8a82ca69b066c37a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e4d7d622da84b43bba3a6f1313667a9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf8ebd1f9f2b43aea75b756394d24cc8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia835a6c092bb43bdaabb4af69cf5c32b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd41d809933d449a9b51ef98b9a9d921_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5cf551f83c9439aa1d37ce9a597c5af_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bfda8fa6a3472ab6b18074c291d3ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id222bc967c45426a9e0cbe615268daea_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a3a5f469f2a41ea9dba3560f618f489_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad95ad3c0d504290a9510ac2d347f752_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286f6b049173419eb8a591dad67f9db8_D20220316-20220316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-16</xbrli:startDate><xbrli:endDate>2022-03-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2c8bb318051412cb62ce2064e9b0c5d_I20220505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa26d9c588c4182ac69aa58107614ff_D20220505-20220505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-05</xbrli:startDate><xbrli:endDate>2022-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ae763f13a34754b0fd888a4b714401_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb635dccb0e2485ba7f187b187e581b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f004bc05e4d45dcbf537fff903cba0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i752b23ca41c0414ca31a93d78f55cae9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e0a6768c4f4658ba5394068805bb7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb4bb3504c5e414bbca00d5745e6a325_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdf9310863c94efea7cc955d04dbeb08_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820840cef80c4d0abf74da03594e7239_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0854ccbdb6a48ee945effcd9ab00b5f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6f0a30fe8f420c8ddd936989792b64_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a2086ac5d6c416b8cc71c7c9d2219a7_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id333e02064fc4188b6fa4779c0cbfc27_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b9e3a7f9cd84f3382111f444d8fd22f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd36615fdc104e8db3c91f5da47da6f3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01f391ba0c104b98ac8794ec261fe166_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb1ec291d2a84558b24739819de98b81_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide2d1af249e641b2bbe8c69bb9739743_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i818820f897ea49ce9285f09c3e769eef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a466c9613234adb9f17ffade4f5a431_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d62cc2f2fbf44be90f3fd74e62058f7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i644ef34e48024030985c3c07b31dd73b_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cf43177df974a66a92ba7c52d11995c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafaccb0fcfc84110aeb682de67ac7598_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a75f125239e4b0dba35bc1553cb1180_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c6e60c0df4e41c9bebb8ff1ffb5fda7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61d256d33cc44601b273de07772fa27f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9c68f36a2124e6f86cc33905c166b9a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1428e3de2174baeb5d4ae097870b5b2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id49e7597eca549ac831d9ddf6e7f90c6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e1a767e23ce445bb33d791ad179db05_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c3c1a407b84d5394d09bf25fdf32eb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f95d2c71ab4e0fae07e7b6378dcf77_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aaa3d21b6224eb5a1c10a50ead809a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03b774597744b8b834dd7a887f814c2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc71de7a5d384a43a72d12d1445db364_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f3b4b5b39b34c1089e08a978b8bc67e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cfb365259e146c6bba35a35319a19c5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9478897d044e4bbb3db8f4e11cc304_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4601448e1f8540a6ba7701a19f013bd5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i168375750af04b89bb5edbe12849ea57_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="ia67acd3202fe49928ecd11cf6bb82d49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e25a7630854faa8b10ecbe7048f2c1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i185546023b6e445993a678e5d4722fff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc273f6b86c64387bac8a24acd1ec9cc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64717797560f4b29aaf331840961ba46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e7c0c2a027c4880bf99a89c7fb9f689_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3248c8cc8d1d4263a978a30127f1f7be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if30ad4912b2043e7b71727fd26678a9d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c2ac9f4fde4bc0a2f15e30264bf399_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20ba0871dd394cf28d8d432a947229c7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c57a318497434ea45fb2cedd9123a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6af29a91f22a4587acfbe0f78b537ef4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibde372d79c2146ddadac6aed84087ad7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d8094561c746b4943fe946808e87b4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i489b4bee565a43f1b5c420df05100124_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibddc3eacd6dd4edfae437c8842c62937_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i2666c0b7ccc347c8bdd95d798a089cf1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2315c69a559e4eae91ade095257f342e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24df969ffb85419eae1c0c148008a809_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1191c9e9a6448b388ec9d255cffdfa0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a60db9d80e0425e83e2738fe92d001c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6831aec7acf4e11b1bc17696acc3144_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ca1a79cd858475c8b6530e800e63398_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fdb2ff01ac847c19778cd87d74222f1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b01b262a9d74022bcf13a779fe76cca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i740a3710177c4f15a0f461ce34a65593_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9864394108cb4f43a773c02f1d88b974_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3710c0edc8c84beeb61925296b505b14_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic21bb23c7f724ec68483061e279115c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58199c3b9d0f49d7b609e6c79d1d2858_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia358047e46fc47289a9c1fc7e5a31fea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c9296c20f324c8fafc1080799a70da3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b4474a8a96541b39e3b1d4e792ff2c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id20f8c33191c4815bf929abe5e50121a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41a2e2ea84564d72a4afb25e8c4ec35c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb235bc6a0834cf8b1051570d9efcfd2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b19775d069f423880e9edef937484af_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbdf89a5e09043f89d464a52f1f1cbcf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia669f6d3e67f4786bbd8d4cfa62c4a11_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib21734e807cd4e47b6955ff0fcbecc9c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cf147b8a161451fa1f8ea341adcecb0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8a1b50cf22c46cba7f94a3405c8b929_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d8935dcf644389a84187c0bf9ec7f2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b41955007d149708ebff22ad2acdb2b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01bcaaa4b3194bcd9c8ab64e7e506f0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic47baa2563274d178d24b9c707cec448_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c37287ee4c4f9baecb393bab99f75a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a3013e3234d4648b00f091ea9483ca7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4740a19848394a6490ab4788151155ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b8800864c446e3bfb4396ac7251eba_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13cab697039642b0953eef067bf76e23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5318b8966de4c9ab5c12c99f7de2b32_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i677b7ff6d33c441eaf16aa67eb7dc18f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820b54ced26a43b8942c3d0dc474c2aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ffddd3ebd9249b282c2a947e3995e55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3240de2751ea4f6caf10457b795b3d54_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47a9183eea87483492bb05c98ca32541_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica31ae73f51947efba3f84f2f5e73f75_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f6d283f86b4446cade80f58f4010940_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c01cb8bf2d74226a4d1bb1d254e5e1d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c1042f293c4a6cb388f7e3e3500abc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4b6849d2bc41cab8e20fa6106f5c67_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64bab9ba75b1441cb4e430c740dd70d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i010e212468d14224aaf4661c0271995c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbb6f6a4865a4b13846c0311a8198fc1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3a6d2ba35574c48b54a634add899b86_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77480a5aa2164b569a9e91f030454ffb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1194fb7125fd48feb4af6f6c94758641_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77dc0798004d44c791a5bbb08b126c3e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebdd0591acbe4bef9892e17e437e510c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic828aa0199d948a4a260f04156670656_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia28510b5c71d4182aa49d69fb01fa474_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18b5d9e71fd45c2b8cb4bb900be2c8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9efa78417d2452cb7a8ab1ecd2e2f9b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5878664ac9f14f6b85a0598e1613ce8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb3906df3ad546cd8e29117ea61b2a8d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82800c514aa0452d855d2b15e4818734_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d46a4c2ea764c4ea5d63935feab31f1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i920805edb6bd4fc6b02db9ae904e4bce_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc4c1e487a74688ab81273067a97cf2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34906e61f9a74e3a9907c245d674475d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i730b6b0ebf854761bfab2a3d7849fe20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib033b18c10b54540877cb94c0a2c2d1b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616a7760ff9a412f95e120d328a13496_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic62d942e80a44f328ced46abd8385b8f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21352fc4b3034be49d25e0fe2cc81ea9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i235e89926eb74f3d88770caa518d54ab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77c67b48aac04b57a96558d5638e2069_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8760241a3c7746f88dfc82fd0dc38eb9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c88993426de4bfa82c2af5b9e9ed5cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3495d968dabe49db8632cd8419777821_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if209dd52df884edca3b342ed0f29e0ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i005465bb6d4141108265ad72c8d64c05_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1871f3ae6b044568aa7edef970da41e8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87954de7b4154d90921ac559950690e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i410da26a1bdf4849ad61862472be13bd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4393b7ef55d44b491ed13b410ae5f95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a2f21b97703441394122c32e24bae16_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59e61082e1f54d149a0319da03a3379f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a7f0dc2e5b0416aa4a0385ea9cf3510_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i674842c707794f4b9c18faf16d310ee6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a34081d5ebc44a2b5346da3d6b8808e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88e2860e30684408955db848202e3b35_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4808a45c314bcbb675ab9e037ae38d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i724052a3d05f4c35a5c6a00a2fea921f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d84cd5ad0974a9989194bfb8e273bb0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a475c2355f74134b164dcccd5dfb7d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbb10749b14e419a92f4ae26723a62ac_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaa95b408619484988378fae1c283bb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e4efee03b0b4da6844362cd1376dc49_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icab334cf12f3428e832773ef37592e11_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdcab6e29434459989a147cd7b7e7450_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f77a33b8832445ca8a138130657da67_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9ec6ac3b5374b0a8f1f65dd3c2855cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39206c4f1d9c4866a802fcd055a7e2a1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05c5629823074ba09faf3ca2ad8969a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb2326817a4c4b8aa31f1fcf83769a0a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aed418e17ea4186b695f6810d200726_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i177681bbc11b40ee9f75db3045c19e95_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5606c2ba35cb4d71b8656f287034dcec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13bcb00848b642c88bfcc2a3c877ede2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc8c69e7703a44399519315b43924c3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia40f39ee6378480184a30bc13c9e3594_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992ae6748a1644e29dc32186549f45e4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7473c049234582bd30c2c495ac8ba9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ad052255252472887637ab010a153d2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa54af0ed26448d9b6ab8f7c2c6167a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8245ebc2dc2948b69c11fb33e05f36b6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc759c1f2ebc440c8f306b8b1ca6b9f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07178dd71fc4b9d989a85d7e37587c8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ca82ad60f24969bc24380087f4af1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97cceb4d5127408091af840823fc721e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bf7ecce65c9422f8f5f4fe13d646c1e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a532fa1402b4fc68731b04ccee54724_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9319cb1e85a2470bbb378e5ce64d1b1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia55bbf8c4e19462595c29c8a377dea3e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7f17a49b80d45fab66d262a44deaace_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e368b781a74d6686679790d4bff5a8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia55ac01c2b07425bbe40921fb5981f21_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide8689d47bf04a43bf675d0763fad522_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4988c8f213a042118b4b5eaf9c7f1e82_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01b91695a1b4712b96033763cf44ccb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4771d8abfecc4e1e95bac68b8f627709_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a0f1e83bb0d410fbdd5481b44ffd1f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47a8319f4395450dbae6322e0e8646d3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide368397434c48e59036b17de6b68663_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2ded494c0c74830993e23285344ef34_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i879cd700e4194424af2d4d04eef590c5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i413aa6ce376641bdba0e00e871461952_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72e12d4aab9b464eb4d8ad17759e7f56_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib31b0884d24244149616a8b8da8525b4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i058f357ea23c4c98b73c618d1d854722_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03493d8105474aeb862abf63b7ef74a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78ad5902fd35439c8f4af1782d4c7515_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31e0fdd1fab64cb898debb3cb62f7b63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb76b00d31784891b8cb395e638378b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcbcb91759414078b56888757bdb9d8c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i557fd976de2e4b8c83c710c96321b9ba_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b30c4edf7ef407098a198c2ade53163_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b05065a6c98419eb5b6caba576c82bf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5db4cd0e0a14bd7b8ad825332acc3a2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id851527d609c4cc481afc6dd44e8b9c8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefe2b30097f544b791322bb2f629e462_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13e37fd7655a489ca62fce5309929cdc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfeddcfa49be4a9f9ca7273bb0bc0b2d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife06d4353ee146d29a89e17a68a9eb78_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibac83a8acaf741ca954ebb93d7b9c302_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bf21bcb23a34c3498a8a496b6117bb3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59b28feb2f7d45d7b83dc9fca6123f83_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156daef6d1e44bdbb6b3a817528d646d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib366aa410a2f41b6a5c4c31aaf520612_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69c1db3a5e434cf2b0bec2a19b9128b1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae9a8abb5cdb4a0988a591e31a0ac4e6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a0499bbe67f4f29816cc986f12548ee_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7c23dc951cc4e8989a77c2c56fbd5cc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf733ae3e5124ab199c7831a4facfe9e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf02807bb1474b44a231a8d6a3b86371_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa7571660234425ca582abda7db56793_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dbf52cc348a44cba02d8ba438c2c120_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10246c296fdb4978908586b17cec13ad_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41f4e43848544a8b3cd335d5ac9237e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1e5b4b8499b48638e60332fdcb0ebb0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1452feb5e534b13a92ff4d8dc1fd100_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea8b0cc4e1164b799a97e32fa53ec105_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81001995ccc476fb965e3e428336426_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i434ad84a039c49a7b73a32c66eff9799_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i939eb9ebbfc9436e9ef6a820918949ed_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6271454a81c6421fbe19f900527e1bbe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cd2df5979694abd9cfb33abc0ae4026_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib755013306ad4359a6aae01eb324d613_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58c46b4f27f41a69c77fc95bcc936c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c8958a092304f48b6c503090ac334f6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38aa3e44188c4557aa18bc19d33a2f00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaafdd9a3a724498080488d52b9b8e49a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:MultiDistrictLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef39d3d08a74324abe20f3b54b78a71_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cebc8f9c5ae49bab6671a9b180b170e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49cbe2fbefc424a92f99179077a1f8a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AmendedAnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>vtrs:state</xbrli:measure></xbrli:unit><xbrli:context id="i4c504afee4fe48c49e1b8ec64187b6b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="increase"><xbrli:measure>vtrs:increase</xbrli:measure></xbrli:unit><xbrli:context id="id8a766f58ff5477781e10e45ea959330_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:0.5pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form&#160;<ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTMz_4f9848c1-b099-438e-85f4-7aee237463ad">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTg4NzM2MzBlNTQyNDViZGI0MTIwZDFiMGZhZmQ1NmUvdGFibGVyYW5nZTo1ODg3MzYzMGU1NDI0NWJkYjQxMjBkMWIwZmFmZDU2ZV8wLTAtMS0xLTU4OTc5_ffe63faf-c93b-4d60-b494-112d9d5eed8e">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xMjQ_d1fc21a4-aeb7-4f63-b900-fe69df3d606e">March&#160;31, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6M2MxNWM5MjExZGE2NDI3YmIzMWU0M2ZmZWJlNmRlMmIvdGFibGVyYW5nZTozYzE1YzkyMTFkYTY0MjdiYjMxZTQzZmZlYmU2ZGUyYl8wLTAtMS0xLTU4OTc5_c5eb021e-ffa8-4f33-b393-76e330480892">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _____________to___________ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM0_45941027-5648-4e96-85eb-420fcc569d16">001-39695</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8yNDE_ec71c905-29ef-4bdf-b156-15f40ee4d6b1">VIATRIS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTM0ZWQ2ZjA4YjM0NDZmYWExNmZmM2E5MTNiNDBkZTYvdGFibGVyYW5nZTo1MzRlZDZmMDhiMzQ0NmZhYTE2ZmYzYTkxM2I0MGRlNl8wLTAtMS0xLTU4OTc5_991071ff-9c66-415f-95a8-a84d208352a4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTM0ZWQ2ZjA4YjM0NDZmYWExNmZmM2E5MTNiNDBkZTYvdGFibGVyYW5nZTo1MzRlZDZmMDhiMzQ0NmZhYTE2ZmYzYTkxM2I0MGRlNl8wLTItMS0xLTU4OTc5_1ed38cef-0794-4a11-ba65-b968ace624ee">83-4364296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM4_874ae838-7a4b-458a-a6fe-19ed23daeb19">1000 Mylan Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM5_c7130cf0-7973-4f24-9d85-8ccd96593ea3">Canonsburg</ix:nonNumeric>, <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM1_0587908a-b8e1-4e35-9730-6b3abc3e00e3">Pennsylvania</ix:nonNumeric> <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTQw_b1a5f400-ee5d-4321-b4a3-cf7af9108927">15317</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8zOTc_3f4d34f1-0791-4d46-9580-0443a94c913f">(724)</ix:nonNumeric> <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8zOTk_0db85f17-a85e-47a6-9b85-215033a4237d">514-1800</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of Each Class:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered:</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6MmVhYTQ0NDRmMWYwNDkyNWE4YmZlZGFiNjRlODdlNTcvdGFibGVyYW5nZToyZWFhNDQ0NGYxZjA0OTI1YThiZmVkYWI2NGU4N2U1N18yLTAtMS0xLTU4OTc5_090b311d-b68f-466a-abda-e1bfde3b2555">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6MmVhYTQ0NDRmMWYwNDkyNWE4YmZlZGFiNjRlODdlNTcvdGFibGVyYW5nZToyZWFhNDQ0NGYxZjA0OTI1YThiZmVkYWI2NGU4N2U1N18yLTItMS0xLTU4OTc5_f4193e49-37be-4a57-a0eb-5bcf25f15412">VTRS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6MmVhYTQ0NDRmMWYwNDkyNWE4YmZlZGFiNjRlODdlNTcvdGFibGVyYW5nZToyZWFhNDQ0NGYxZjA0OTI1YThiZmVkYWI2NGU4N2U1N18yLTQtMS0xLTU4OTc5_ea905c22-7be9-48da-a5a6-a7d8aa763464">The NASDAQ Stock Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM2_517b2236-e66a-4b44-aaec-7f9ea8e5cc61">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTMy_f9fa4a9d-e658-4200-8d3a-c74cd212e67c">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.606%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTQ4MWQ3ZGQ4MWYyNGUwNDk5OTkxMTI3ZTcwNTYzNzYvdGFibGVyYW5nZTo1NDgxZDdkZDgxZjI0ZTA0OTk5OTExMjdlNzA1NjM3Nl8wLTAtMS0xLTU5NDIw_17a888c9-a46c-4145-a957-2c7c2af4b86a">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTQ4MWQ3ZGQ4MWYyNGUwNDk5OTkxMTI3ZTcwNTYzNzYvdGFibGVyYW5nZTo1NDgxZDdkZDgxZjI0ZTA0OTk5OTExMjdlNzA1NjM3Nl8yLTYtMS0xLTU4OTc5_ed94347c-deb2-4344-bbca-807b2d02f4c6">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTQ4MWQ3ZGQ4MWYyNGUwNDk5OTkxMTI3ZTcwNTYzNzYvdGFibGVyYW5nZTo1NDgxZDdkZDgxZjI0ZTA0OTk5OTExMjdlNzA1NjM3Nl80LTYtMS0xLTU4OTc5_6e9d9aca-c854-4516-98fd-0feaaa858f0c">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="margin-top:1pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM3_129e3f92-e5a9-4f4f-90c6-9accc675873f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of common stock outstanding, par value $<ix:nonFraction unitRef="eurPerShare" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xODgx_4fb422e8-fffa-46f5-a612-dd3186c20807">0.01</ix:nonFraction> per share, of the registrant as of May&#160;4, 2022 was <ix:nonFraction unitRef="shares" contextRef="ibb3acc72c20e4e09b7934a67fa2aa217_I20220504" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTI2_ab7ed90d-c3b7-456f-a406-bd6d1e004145">1,212,326,908</ix:nonFraction>.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:2pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_4"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2022 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;I &#8212; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Financial Statements (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_19">Condensed Consolidated Statements of Operations&#160;&#8212; Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_19">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_22">Condensed Consolidated Statements of Comprehensive Earnings (Loss) &#8212; Three Months Ended March 31, 2022 and  2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_22">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_25">Condensed Consolidated Balance Sheets&#160;&#8212; March 31, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_25">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_31">Condensed Consolidated Statements of Equity&#160;&#8212; Three Months Ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_31">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_31"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_31">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_34">Condensed Consolidated Statements of Cash Flows&#160;&#8212; Three Months Ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_34">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_34"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_34">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_34">11</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_37">12</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_106">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_106">43</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_133">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_133">59</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_136">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_136">59</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;II &#8212; OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_142">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_142">60</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_145">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_145">60</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_151">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_151">60</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_154">SIGNATURES</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_154">61</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_10"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glossary of Defined Terms</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Unless the context requires otherwise, references to &#8220;Viatris,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; in this Form 10-Q (defined below) refer to Viatris Inc. and its subsidiaries. We also have used several other terms in this Form 10-Q, most of which are explained or defined below. Some amounts in this Form 10-Q may not add due to rounding.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003 LTIP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Form 10-K </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; annual report on Form 10-K for the fiscal year ended December 31, 2021, as amended </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP financial measure that the Company believes is appropriate to provide information to investors - EBITDA (defined below) is further adjusted for share-based compensation expense, litigation settlements, and other contingencies, net, restructuring and other special items</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AOCE</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive earnings</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APIs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active pharmaceutical ingredients </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARV</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antiretroviral medicines</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Limited</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics Limited, a majority owned subsidiary of Biocon</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics Transaction</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The pending transaction between Viatris and Biocon Biologics pursuant to which Viatris will contribute its biosimilars portfolio to Biocon Biologics </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The transaction agreement between Viatris and Biocon Biologics, dated  February 27, 2022, relating to the Biocon Biologics Transaction</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA Inc. and Biogen International GmbH, collectively </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination Agreement, dated as of July 29, 2019, as amended from time to time, among Viatris, Mylan, Pfizer and certain of their affiliates</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAT</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition Appeals Tribunal</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CJEU</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Court of Justice</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">clean energy investments</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Used to define the three equity method investments the Company has in limited liability companies that own refined coal production plants whose activities qualify for income tax credits under Section 45 of the Code</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition and Markets Authority</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Code</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The U.S. Internal Revenue Code of 1986, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combination</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refers to Mylan combining with Pfizer's Upjohn Business in a Reverse Morris Trust transaction to form Viatris on November 16, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper Program</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $1.65 billion unsecured commercial paper program entered into as of November 16, 2020 by Viatris, as issuer, Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V., as guarantors, and certain dealers from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novel coronavirus disease of 2019</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CP Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured, short-term commercial paper notes issued pursuant to the Commercial Paper Program</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DCGI</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drug Controller General of India</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations primarily in the following markets: North America and Europe</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer's distribution to Pfizer stockholders all the issued and outstanding shares of Upjohn Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DOJ</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Department of Justice</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;DRIP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dividend Reinvestment and Share Purchase Plan</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP financial measure that the Company believes is appropriate to provide information to investors - U.S. GAAP net earnings (loss) adjusted for net contribution attributable to equity method investments, income tax provision (benefit), interest expense and depreciation and amortization</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EDPA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. District Court for the Eastern District of Pennsylvania</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes, but is not limited to, our operations primarily in the following markets: Parts of Asia, the Middle East, South and Central America, Africa, and Eastern Europe</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning system</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Act </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Exchange Act of 1934, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FCA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial Conduct Authority in the U.K.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 10-Q</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This quarterly report on Form 10-Q for the quarterly period  ended March 31, 2022</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations primarily in the following markets: China, Taiwan and Hong Kong</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gx</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic drugs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter Partes review</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Internal Revenue Service</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS Ruling</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The private letter ruling issued by the IRS to Pfizer with respect to the Combination, dated as of March 17, 2020</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations in the following markets: Japan, Australia and New Zealand</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lilly</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eli Lilly and Company</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">maximum leverage ratio </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The maximum consolidated leverage ratio financial covenant requiring maintenance of a maximum ratio of consolidated total indebtedness as of the end of any quarter to consolidated EBITDA for the trailing four quarters as defined in the related credit agreements from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multidistrict litigation</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPI</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Pharmaceuticals Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan N.V. and its subsidiaries</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan II B.V., a company incorporated under the laws of the Netherlands and an indirect wholly owned subsidiary of Viatris, in which legacy Mylan merged with and into</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Inc. Euro Notes</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2.125% Senior Notes due 2025 issued by Mylan Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Inc. U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 4.200% Senior Notes due 2023, 3.125% Senior Notes due 2023, 4.550% Senior Notes due 2028, 5.400% Senior Notes due 2043 and 5.200% Senior Notes due 2048 issued by Mylan Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Securitization</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Securitization LLC</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The NASDAQ Stock Market</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New drug application</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NHS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Health Services</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Securitization Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The note securitization facility entered into in July 2021 for borrowings up to $200 million and expiring in August 2022</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over-the-counter</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc. 2020 Stock Incentive Plan</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmascience Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance awards</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTAB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Patent Trial and Appeal Board</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $400 million accounts receivable entered into in August 2020 and expiring in April 2025</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registered Upjohn Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 1.125% Senior Notes due 2022, 1.650% Senior Notes due 2025, 2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 originally issued on October 29, 2021 registered with the SEC in exchange for the corresponding Unregistered Upjohn U.S. Dollar Notes in a similar aggregate principal amount and with terms substantially identical to the corresponding Unregistered Upjohn U.S. Dollar Notes and fully and unconditionally guaranteed by Mylan Inc., Mylan II and Utah Acquisition Sub Inc.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">respiratory delivery platform</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer&#8217;s proprietary dry powder inhaler delivery platform</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">restricted stock awards</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company&#8217;s nonvested restricted stock and restricted stock unit awards, including PSUs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $4.0 billion revolving facility dated as of July 1, 2021, by and among Viatris, certain lenders and issuing banks from time to time party thereto and Bank of America, N.A., as administrative agent</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RICO</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Racketeer Influenced and Corrupt Organizations Act</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company's unvested restricted stock unit awards</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi-Aventis U.S., LLC</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Appreciation Rights</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SDNY</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. District Court for the Southern District of New York</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Act</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Act of 1933, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Upjohn U.S. Dollar Notes, the Utah U.S. Dollar Notes and the Mylan Inc. U.S. Dollar Notes, collectively</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer's transfer to Upjohn of substantially all the assets and liabilities comprising the Upjohn Business</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement between Viatris and Pfizer, dated as of July 29, 2019, as amended from time to time</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOFR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured overnight financial rate</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and SARs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teva Pharmaceutical Industries Ltd.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TSA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition service agreements</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting principles generally accepted in the U.S.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unregistered Upjohn U.S. Dollar Notes</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 1.125% Senior Notes due 2022, 1.650% Senior Notes due 2025, 2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 originally issued on June 22, 2020 by Upjohn Inc. (now Viatris Inc.) in a private offering exempt from the registration requirements of the Securities Act and fully and unconditionally guaranteed by Mylan Inc., Mylan II and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Inc., a wholly owned subsidiary of Pfizer prior to the Distribution, that combined with Mylan and was renamed Viatris Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Business</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer&#8217;s off-patent branded and generic established medicines business that, in connection with the Combination, was separated from Pfizer and combined with Mylan to form Viatris</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes denominated in U.S. dollars and originally issued by Upjohn Inc. or Viatris Inc. pursuant to an indenture dated June 22, 2020 and fully and unconditionally guaranteed by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Acquisition Sub</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Acquisition Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Viatris</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Euro Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2.250% Senior Notes due 2024 and 3.125% Senior Notes due 2028 issued by Utah Acquisition Sub Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 3.950% Senior Notes due 2026 and 5.250% Senior Notes due 2046 issued by Utah Acquisition Sub Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc., formerly known as Upjohn Inc. prior to the completion of the Combination</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">YEN Term Loan Facility</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The &#165;40 billion term loan agreement dated as of July 1, 2021, by and among Viatris, Mizuho Bank, Ltd. and MUFG Bank, Ltd., as administrative agent</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I&#160;&#8212; FINANCIAL INFORMATION</span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_16"></div><div><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions, except per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNC01LTEtMS01ODk3OQ_e818dee5-edca-4a32-97ab-67b0b665e6da">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNC03LTEtMS01ODk3OQ_423640aa-222e-4e82-b933-17a3231451fd">4,400.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2ff4971a6c4d628f7e2a84354fde90_D20220101-20220331" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNS01LTEtMS01ODk3OQ_dc6f9bf0-db68-4da5-b034-870a6e409914">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3da2991a25341b09ab36340008ea196_D20210101-20210331" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNS03LTEtMS01ODk3OQ_0f56dd3d-c987-45ba-baa4-784784735925">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNi01LTEtMS01ODk3OQ_0b87a6f7-77b6-4173-945c-badcfa15b5c2">4,191.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNi03LTEtMS01ODk3OQ_7b4af28f-98f4-43e3-815a-80abe0348762">4,430.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNy01LTEtMS01ODk3OQ_a2c3c2b9-52c8-4ce9-ba91-88b6c7f8cac0">2,420.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNy03LTEtMS01ODk3OQ_00007aa4-d359-4aab-9829-25172314e1ff">3,303.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfOC01LTEtMS01ODk3OQ_148b78c1-d381-4731-bc76-db6ff98721bc">1,771.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfOC03LTEtMS01ODk3OQ_6b85632b-c75c-4f80-a808-5add33338371">1,127.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTAtNS0xLTEtNTg5Nzk_8ec57e90-6986-4b8b-9428-eb11ceb20bba">142.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTAtNy0xLTEtNTg5Nzk_4692c6c2-9245-4ce5-ac38-dbb43d426cba">184.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTEtNS0xLTEtNTg5Nzk_6a799aec-4ad4-47cf-9532-f06b6518cd80">915.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTEtNy0xLTEtNTg5Nzk_ff69ea64-1dc0-48f6-a395-51cf683ca3e5">1,186.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTItNS0xLTEtNTg5Nzk_67a95c3d-aabc-4265-87c5-6466fa483280">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTItNy0xLTEtNTg5Nzk_548870cd-e61d-432d-aa3a-28d25345ac2a">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTMtNS0xLTEtNTg5Nzk_96a1f15d-32a0-4ab8-b8d8-21490b56da7e">1,063.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTMtNy0xLTEtNTg5Nzk_7bea4946-3ee3-4c45-b7c1-119f7ed2682e">1,393.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTQtNS0xLTEtNTg5Nzk_73298397-7c40-478e-98cf-05dca382e72a">707.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTQtNy0xLTEtNTg5Nzk_962311fc-721a-454c-b183-2a46507109b3">266.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTUtNS0xLTEtNTg5Nzk_c4a283a2-f07b-4738-9f96-ab506f950bab">146.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTUtNy0xLTEtNTg5Nzk_488521b0-298e-4a22-90ec-1f3c659752fe">169.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTYtNS0xLTEtNTg5Nzk_6b46cc81-983f-456c-a50c-c633adcf02fc">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTYtNy0xLTEtNTg5Nzk_bb6d1382-2543-4e77-9341-454fd4f9ac53">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTctNS0xLTEtNTg5Nzk_0607d6a5-833e-4673-af0b-4b1f9c16cf8c">527.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTctNy0xLTEtNTg5Nzk_2b06d101-7dc7-4d4c-9791-20b4bf9c7993">441.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTgtNS0xLTEtNTg5Nzk_a57eee3e-e528-4671-ae19-b18506c87183">128.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTgtNy0xLTEtNTg5Nzk_0141e36c-1ee3-44c4-9789-3b5ba16c972e">596.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTktNS0xLTEtNTg5Nzk_1aa781b6-2cfa-421d-a929-6c4442f5b385">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTktNy0xLTEtNTg5Nzk_1701f0f1-81f3-49f0-a843-430ea0281202">1,037.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjEtNS0xLTEtNTg5Nzk_a0a80fa8-134a-4fc4-862b-967b29b2aa16">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjEtNy0xLTEtNTg5Nzk_5b1bf627-345c-4a4a-9bbe-f2a754ab02a6">0.86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjItNS0xLTEtNTg5Nzk_33fafc8c-be6b-424b-ba1f-1a4d2420f0a5">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjItNy0xLTEtNTg5Nzk_2ecd9488-03aa-4e33-9be4-85bc38bed2fb">0.86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjQtNS0xLTEtNTg5Nzk_7287e534-3261-493a-92fb-58aeabe6399a">1,210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjQtNy0xLTEtNTg5Nzk_6f62822d-a6c6-44fe-95aa-3a3ed3ada22e">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjUtNS0xLTEtNTg5Nzk_6eb9b7f3-38d7-45f4-bc02-25a07fd00187">1,213.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjUtNy0xLTEtNTg5Nzk_3e92f14e-c50a-43b3-96dd-f169af598400">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div><span><br/></span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Earnings (Loss) </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMy01LTEtMS01ODk3OQ_1aa781b6-2cfa-421d-a929-6c4442f5b385">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMy03LTEtMS01ODk3OQ_1701f0f1-81f3-49f0-a843-430ea0281202">1,037.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, before tax:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNS01LTEtMS01ODk3OQ_106a6c7e-a32a-4304-b453-6a3c59816fd3">469.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNS03LTEtMS01ODk3OQ_5420e493-27f7-474d-b3b7-fea768103131">721.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized (loss) gain and prior service cost related to defined benefit plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNi01LTEtMS01ODk3OQ_9a604b8d-b1cc-44ac-b2a1-e7729573c4fa">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNi03LTEtMS01ODk3OQ_4a9bf70e-dcd6-47fe-865c-ad89c1be1ae3">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain on derivatives in cash flow hedging relationships</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib578d781d99c4f47885649d77583e23e_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNy01LTEtMS01ODk3OQ_5c8b6d4d-193f-47e5-ae70-81712beafb00">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3915b76fc6ea48ff93b407a9221bd01f_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNy03LTEtMS01ODk3OQ_6fb77c42-0a37-410e-be57-319e7081112b">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain on derivatives in net investment hedging relationships</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie352cada5a604c7d8404347ba1732ca1_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOC01LTEtMS01ODk3OQ_7ae5a9ad-f5ec-4153-bc0c-56748da56d74">201.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad7c661b920b42e4bb603f29ac39dd7f_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOC03LTEtMS01ODk3OQ_97148c31-f881-4554-ae21-67dec0d809c2">227.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOS01LTEtMS01ODk3OQ_6039bbea-f024-4fe5-a429-b345934215b8">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOS03LTEtMS01ODk3OQ_3b0a7ba5-9602-407b-b047-98cb539bb136">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, before tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTAtNS0xLTEtNTg5Nzk_c294e6f1-a34c-4ce5-a6f6-aec06836d8bd">272.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTAtNy0xLTEtNTg5Nzk_e95a98a1-f8d4-44b8-9266-de99d967f2e9">490.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTEtNS0xLTEtNTg5Nzk_c5f5ee1d-4cca-4f8c-8a53-fa405bf8e22e">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTEtNy0xLTEtNTg5Nzk_de72b97c-eb15-4500-90f5-39c697bd20ff">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTItNS0xLTEtNTg5Nzk_7a7128f6-7f3a-4fdc-95cd-5367b18470f1">316.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTItNy0xLTEtNTg5Nzk_60e08eae-b784-4732-b4ee-5bbb9b80f7b0">527.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTMtNS0xLTEtNTg5Nzk_b8270d0c-a451-47d9-b7d9-7ea09dccffff">82.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTMtNy0xLTEtNTg5Nzk_94a3c4d2-1fd2-4c56-bce7-e97cae580da3">1,565.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div><span><br/></span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited in millions, except share and per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">ASSETS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNC0xLTEtMS01ODk3OQ_b28ef41d-4c66-4290-b4f0-b292aae141e4">752.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNC0zLTEtMS01ODk3OQ_af007108-94f3-4f6a-bf4e-3be1967a731d">701.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNS0xLTEtMS01ODk3OQ_3ed3f340-b9a4-4a00-9bce-59a5fcc0ff28">4,093.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNS0zLTEtMS01ODk3OQ_2b049a5d-4827-4809-8ea5-3509fa2004cb">4,266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNi0xLTEtMS01ODk3OQ_110a1e15-af11-454f-8a0b-7ec43971f934">3,797.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNi0zLTEtMS01ODk3OQ_8245a4b1-d776-4b7b-9bd8-6317c2ebc859">3,977.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNy0xLTEtMS01ODk3OQ_204169c6-4ad7-489a-9c49-ad5f6a447c64">1,763.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNy0zLTEtMS01ODk3OQ_5ef458dd-cd51-47f4-9719-cd12f22a83ad">1,957.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0xLTEtMS02MzkzMg_0c29e7c8-27d3-4f02-bd00-654a92b49e84">1,337.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0zLTEtMS02MzkzOA_326f4d60-f592-46b6-9238-e047264d179c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0xLTEtMS01ODk3OQ_921682db-3a75-4590-8c43-7217fc8b146c">11,744.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0zLTEtMS01ODk3OQ_e9c16e79-4c9a-4431-b2f2-ab69416a98d6">10,902.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOS0xLTEtMS01ODk3OQ_0186bb33-a1ec-4a3a-845a-4702767d1a48">3,150.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOS0zLTEtMS01ODk3OQ_f45153cd-7f8e-4dad-bb20-3faa21350d84">3,188.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTAtMS0xLTEtNTg5Nzk_f3329e87-0a20-4bb3-bd3a-d2f63aac3d6c">25,251.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTAtMy0xLTEtNTg5Nzk_5a087041-c4a4-456a-ac5c-6303664e6ba4">26,134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTEtMS0xLTEtNTg5Nzk_f734a5cc-561c-41c2-a26b-ce3420adbf4c">10,978.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTEtMy0xLTEtNTg5Nzk_220e6ae1-80d7-4f8a-8c71-5a64b5cc58e2">12,113.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTItMS0xLTEtNTg5Nzk_4b1c0d24-101f-49a3-ad88-09bedc68d824">1,285.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTItMy0xLTEtNTg5Nzk_d8e83865-a356-4311-a1d1-bab1a741bbab">1,332.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTMtMS0xLTEtNTg5Nzk_4b41ce87-83d8-4040-9a60-c9987e38e2b2">1,056.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTMtMy0xLTEtNTg5Nzk_fbd55628-d875-4863-aa67-eeb16f279f31">1,170.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTQtMS0xLTEtNTg5Nzk_8e3679b3-a4ad-4c29-bd91-8a6a78a353a3">53,466.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTQtMy0xLTEtNTg5Nzk_55c48110-4720-4ab1-b8dc-e14ee3f29d2a">54,842.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTktMS0xLTEtNTg5Nzk_60366fe9-7880-4332-a43c-7c7a931a6702">1,499.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTktMy0xLTEtNTg5Nzk_2b7022e9-da47-43b4-aa41-83aaacde7509">1,657.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjAtMS0xLTEtNTg5Nzk_2851a404-ee95-430a-9095-9101e419f8af">655.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjAtMy0xLTEtNTg5Nzk_8924d811-c8b6-4d9f-95a3-0b6f7353574d">1,493.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjEtMS0xLTEtNTg5Nzk_b087bfd4-f17a-4973-ae99-5108c6ebbd52">177.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjEtMy0xLTEtNTg5Nzk_481ad3f3-b442-4766-9238-64c06e6d961d">236.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and other long-term obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjItMS0xLTEtNTg5Nzk_f5261288-3803-47b7-af5b-89bf378398b6">2,606.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjItMy0xLTEtNTg5Nzk_6b1e1a18-0ab9-42d0-99ad-5a999f0a2252">1,877.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMS0xLTEtNjM5Njc_6fe9c473-2b37-4a08-bd8c-92a50efa501d">277.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMy0xLTEtNjM5NzM_55b603ab-a482-474e-938a-39bf3fcd5adb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjMtMS0xLTEtNTg5Nzk_95d1751a-dc58-4423-9a68-93f011c7fe7a">4,426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjMtMy0xLTEtNTg5Nzk_631893f6-2821-4e96-88cc-2601f2eb72e8">4,619.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMS0xLTEtNTg5Nzk_1b18ea4d-da33-4582-b60f-aba67c254e50">9,642.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMy0xLTEtNTg5Nzk_d7fb8fb8-9056-45ff-a9ee-8b128f1dfaa2">9,884.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjUtMS0xLTEtNTg5Nzk_2ac6cd0b-7d75-406b-ac68-d6583f7b708f">18,762.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjUtMy0xLTEtNTg5Nzk_4dbb5c6f-aba5-4f10-a5c4-6828d7ead372">19,717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjYtMS0xLTEtNTg5Nzk_80c4ef80-5789-4cd2-ac7c-d6d5f0beabe1">2,729.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjYtMy0xLTEtNTg5Nzk_60b11b71-df64-44bb-9b6c-55b483d7b224">2,815.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjctMS0xLTEtNTg5Nzk_a11371ef-c0de-486e-9f27-8cf4cdaa7fa0">1,884.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjctMy0xLTEtNTg5Nzk_d89c92b4-3274-4bde-9f9c-feba20b64084">1,933.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjgtMS0xLTEtNTg5Nzk_5a96f327-2263-4be2-9ee2-5f35734d7837">33,019.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjgtMy0xLTEtNTg5Nzk_8aa5457b-9889-47cd-8f2a-63901321962c">34,350.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc. shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="eurPerShare" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8xMDk5NTExNjI3ODQ0_4fb422e8-fffa-46f5-a612-dd3186c20807">0.01</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8xMDk5NTExNjI3ODgz_985616b3-85ce-4f49-915c-183fb6af2f08">3,000,000,000</ix:nonFraction> shares authorized; shares issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i3e37563a7f3a4909b7dd02085a753d01_I20220331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8xOQ_4cec96ff-e853-434b-8d10-6ede83b07411">1,212,323,483</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i540972ea3b894aad8a249c7604f8d68d_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8yNg_3c07351c-e734-4239-9755-9520cd7ba674">1,209,507,463</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMS0xLTEtNTg5Nzk_a95f9d8c-e35a-498a-ad8b-c30108778362">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMy0xLTEtNTg5Nzk_63670ef2-cee3-4e9a-9399-5bcf4145320a">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzQtMS0xLTEtNTg5Nzk_a437f9c2-3e22-4fd6-8130-29bed16a5b39">18,555.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzQtMy0xLTEtNTg5Nzk_40eb7893-be88-4a74-8041-8f288e1d5d06">18,536.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzUtMS0xLTEtNTg5Nzk_c2079690-b552-4f05-857a-c83c77443687">3,941.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzUtMy0xLTEtNTg5Nzk_4a539680-a7df-4a48-a8f1-f7e36fa81854">3,688.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzYtMS0xLTEtNTg5Nzk_048114c8-2499-4833-a5ec-62e4e34afd5c">2,061.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzYtMy0xLTEtNTg5Nzk_c669d75d-c8d8-434c-ba3e-95612c2841a8">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDEtMS0xLTEtNTg5Nzk_5907062c-e2d9-40f8-ac0e-e0fd7f0f5ccd">20,447.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDEtMy0xLTEtNTg5Nzk_3bbda29b-0bf3-485e-96ba-accffcbcbbc4">20,492.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDMtMS0xLTEtNTg5Nzk_8835f971-10fc-4d38-bf42-c2b15909e1e6">53,466.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDMtMy0xLTEtNTg5Nzk_4955669a-1803-48c7-b6cf-c45ad020c912">54,842.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:15pt;padding-left:18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div><span><br/></span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions, except share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.675%"><tr><td style="width:1.0%"></td><td style="width:37.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i540972ea3b894aad8a249c7604f8d68d_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMS0xLTEtNTg5Nzk_3c07351c-e734-4239-9755-9520cd7ba674">1,209,507,463</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540972ea3b894aad8a249c7604f8d68d_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMy0xLTEtNTg5Nzk_16429b9c-1d62-4739-8fde-16bbd1ca7555">12.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b0cf057ebfd4957826fe40ac96ad443_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktNS0xLTEtNTg5Nzk_2940633c-70c7-4a41-b5dd-56443ea1618d">18,536.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8608f018ae44cfa0a49be1967faa7d_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktNy0xLTEtNTg5Nzk_59ee5dbc-327f-4cc1-a06c-3cbccf899da2">3,688.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f380484fc704f83a0342b6bdf44bebd_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktOS0xLTEtNTg5Nzk_e8049d50-a26e-452d-9aec-62bb70f0c528">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f380484fc704f83a0342b6bdf44bebd_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMTEtMS0xLTU4OTc5_dc274b9c-cb5b-480b-b0ad-2646c17b6472">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifec90faf56074071843d5dff2b177e01_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMTMtMS0xLTU4OTc5_14cdc7ab-aff8-4774-bd65-37e62bcd45c6">1,744.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMTctMS0xLTU4OTc5_3bbda29b-0bf3-485e-96ba-accffcbcbbc4">20,492.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjAtNy0xLTEtNTg5Nzk_1aa781b6-2cfa-421d-a929-6c4442f5b385">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjAtMTctMS0xLTU4OTc5_a5221870-c00a-4ec1-b8e1-3a17012e27f7">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i067dee996df34e2f84a35524e9e8481c_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjEtMTMtMS0xLTU4OTc5_4871eb77-93b5-4de9-a452-006da674b5c7">316.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjEtMTctMS0xLTU4OTc5_a4fcdca7-757a-46ad-b633-af79e22af574">316.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock and stock options exercised, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93966d3931bb4b9a9d064377829d20d5_D20220101-20220331" decimals="INF" name="vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItMS0xLTEtNTg5Nzk_f6101876-cc99-4103-a792-3bd24fca6f59">2,816,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93966d3931bb4b9a9d064377829d20d5_D20220101-20220331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItMy0xLTEtNTg5Nzk_49e27b0d-79eb-4720-a0c0-5c535d03ed0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id369222933c4479abd90313ae11b86e9_D20220101-20220331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItNS0xLTEtNTg5Nzk_aab4cf42-3878-46da-b03f-31cb349d78ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItMTctMS0xLTU4OTc5_f164c2dd-f4fc-4e7d-b5c8-31b672c67075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes related to the net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id369222933c4479abd90313ae11b86e9_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjMtNS0xLTEtNTg5Nzk_bedd7e58-c904-44fd-8811-c7c0bdcb7fd9">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjMtMTctMS0xLTU4OTc5_a98be003-b7c9-4da8-a873-2b01da48b9c0">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id369222933c4479abd90313ae11b86e9_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjQtNS0xLTEtNTg5Nzk_230c1424-629c-47c3-9811-b1e638b28097">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjQtMTctMS0xLTU4OTc5_9e70f1b1-613c-47d1-a045-2b6acde73ae5">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared, $0.12 per common share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i269ed4494e9b4057b6b5fd874978d0ee_D20220101-20220331" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjktNy0xLTEtNjAxMDg_80cd7c98-99e9-4038-9cdb-fa8d87ee0c56">146.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i269ed4494e9b4057b6b5fd874978d0ee_D20220101-20220331" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjktMTctMS0xLTYwMTA4_4f1ba383-a0e9-4d97-af8e-0cec53a7a951">146.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e37563a7f3a4909b7dd02085a753d01_I20220331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMS0xLTEtNTg5Nzk_4cec96ff-e853-434b-8d10-6ede83b07411">1,212,323,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e37563a7f3a4909b7dd02085a753d01_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMy0xLTEtNTg5Nzk_904694a5-e343-42a7-a756-d2c5655d5ec1">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia304a43e569c442dabdb1c25c2e35832_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtNS0xLTEtNTg5Nzk_02e54aab-c7fe-4a95-b528-30e4170e5a3a">18,555.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949fd9a15d71419c9f66a4369a131379_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtNy0xLTEtNTg5Nzk_152078c4-484a-43c3-bd1c-e55495027ddb">3,941.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e4b05435485489b9e8b4fad080fe718_I20220331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtOS0xLTEtNTg5Nzk_e90015fd-2477-44fb-9d15-f0c714663c73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4b05435485489b9e8b4fad080fe718_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMTEtMS0xLTU4OTc5_bbb3fafe-12d6-467c-b4ed-8dd09540469c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f01433cbdfb450fa016216bdc117a8f_I20220331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMTMtMS0xLTU4OTc5_d552e804-fc21-44d9-8292-e7a4e8ca4c90">2,061.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMTctMS0xLTU4OTc5_5907062c-e2d9-40f8-ac0e-e0fd7f0f5ccd">20,447.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.675%"><tr><td style="width:1.0%"></td><td style="width:37.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieaf18a35c07d4619b44d7c23d09f585e_I20201231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMS0xLTEtNTg5Nzk_bfe982ac-9d03-46d1-8a21-0fcdf8426872">1,206,895,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf18a35c07d4619b44d7c23d09f585e_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMy0xLTEtNTg5Nzk_4b410a4a-e4cb-4128-8c87-26bc9fe5aa1a">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff1f52f268c4433b7551e32308c1640_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtNS0xLTEtNTg5Nzk_31878032-b6d6-4ce6-9233-fcab9f647432">18,438.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41532774e5ff4f418b14c53f63cb7d8a_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtNy0xLTEtNTg5Nzk_b764cb99-182d-41cc-9bd3-56a37dc773e3">5,361.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3eaf90e86a23405aa9ca93eeeb3b40f6_I20201231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtOS0xLTEtNTg5Nzk_4c2aedbe-6ca7-4ecd-ade6-cb9bcb17e938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eaf90e86a23405aa9ca93eeeb3b40f6_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMTEtMS0xLTU4OTc5_845f4955-3a0e-4c43-8922-e32dcffca233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc0f9f8a1bf4a9a967c3233ef153a6d_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMTMtMS0xLTU4OTc5_121c1f94-cd26-454b-9ee0-e69fe29cc72a">858.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMTctMS0xLTU4OTc5_48df6aef-abaf-45fd-9e8b-9d2e063f268a">22,954.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTktNy0xLTEtNTg5Nzk_1701f0f1-81f3-49f0-a843-430ea0281202">1,037.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTktMTctMS0xLTU4OTc5_b904a2c6-5fa5-4730-a062-d04c05d481cb">1,037.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie72c892bc6534c14adab5d7152694449_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjAtMTMtMS0xLTU4OTc5_922c8c50-ab74-4043-9c7c-3de5e9a316be">527.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjAtMTctMS0xLTU4OTc5_8a0853a5-c1f5-4817-a905-e8e4fedf4bc3">527.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock and stock options exercised, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i869a99efa4864d4490272885dbb4c20d_D20210101-20210331" decimals="0" name="vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjEtMS0xLTEtNTg5Nzk_3154bc7f-76a0-4e2c-aaf4-8551d576aefa">1,635,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjEtNS0xLTEtNTg5Nzk_a19dc4cd-0d9b-41df-97b7-df10f947d6be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjEtMTctMS0xLTU4OTc5_d3367c21-54f2-4292-b700-99e1e7125aa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes related to the net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjItNS0xLTEtNTg5Nzk_d7e69553-b886-4d06-8cd7-1777af88975a">6.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjItMTctMS0xLTU4OTc5_7a13a112-075d-4205-97cb-9dadf6c7137f">6.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjMtNS0xLTEtNTg5Nzk_52774262-395f-4a5c-8a34-cf7484fce781">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjMtMTctMS0xLTU4OTc5_d5e4f772-24ff-44d3-8be6-15d1dbd72c96">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf75acc573ac4b3ea45a192607841887_I20210331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMS0xLTEtNTg5Nzk_857505a8-bfde-44a8-88df-3d272d3e49db">1,208,530,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf75acc573ac4b3ea45a192607841887_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMy0xLTEtNTg5Nzk_9fcca5ca-f683-496c-bd81-6ad410ae7b35">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i758900e2e79742f39cd9b920398e128d_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtNS0xLTEtNTg5Nzk_2f1fc305-4551-40eb-a6bd-04087a35404c">18,464.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4d981978cc94683b97f4e364187100f_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtNy0xLTEtNTg5Nzk_314bf3e2-29a9-4877-a5bf-db7e9dc1eade">4,323.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16129c8fa4c146e7b0efbdba33260113_I20210331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtOS0xLTEtNTg5Nzk_d2a6d1d7-cbd1-481f-aebb-778dc6f71821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16129c8fa4c146e7b0efbdba33260113_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMTEtMS0xLTU4OTc5_cb0842a5-770d-486b-a93a-dac9abb409a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84ae372e0d4640afaf6ca7d236588eca_I20210331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMTMtMS0xLTU4OTc5_fb90c38f-ae66-4e21-8062-e52904969199">1,385.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8dd750c9019453f8f3c004524321932_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMTctMS0xLTU4OTc5_3e2685a0-d62a-4bb7-a9d2-f9bdc42931b3">21,414.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div><span><br/></span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNC0xLTEtMS01ODk3OQ_1aa781b6-2cfa-421d-a929-6c4442f5b385">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNC0zLTEtMS01ODk3OQ_52c2cd04-8fdb-4468-ab28-642f067f9fc3">1,037.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNi0xLTEtMS01ODk3OQ_a252c4a9-dccc-4966-a6d3-78e37678d266">736.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNi0zLTEtMS01ODk3OQ_e4881907-72da-4648-970e-66b62e255431">1,422.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNy0xLTEtMS01ODk3OQ_75a24247-f26f-4a6a-809b-0da6e735475c">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNy0zLTEtMS01ODk3OQ_bc4c732d-5099-4afb-8210-c89938b17ce6">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOC0xLTEtMS01ODk3OQ_ffd373a9-916f-4bff-b14e-fe587611b582">52.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOC0zLTEtMS01ODk3OQ_6bc014d8-17b4-4d1f-84dc-f01326cac8cc">288.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOS0xLTEtMS01ODk3OQ_7b707fae-313c-4a18-a8f4-50ff29417a33">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOS0zLTEtMS01ODk3OQ_8a48cd19-891b-4058-a27f-a0af6e626740">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTAtMS0xLTEtNTg5Nzk_b7e47da9-2980-462a-b81f-b6e705ee5440">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTAtMy0xLTEtNTg5Nzk_c3c9ad56-5d1d-4ef7-8bcb-2086d8164cb1">33.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="vtrs:Changeinnoncashlitigationsettlementsnet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTEtMS0xLTEtNTg5Nzk_3afbb225-c599-400d-8fa1-0d5beb808a3c">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="vtrs:Changeinnoncashlitigationsettlementsnet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTEtMy0xLTEtNTg5Nzk_d3bf34e3-7c44-4cd5-ba0c-32f971fcdbfa">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTMtMS0xLTEtNTg5Nzk_c38094fe-a7dd-4445-8fef-af3c2b470f99">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTMtMy0xLTEtNTg5Nzk_8a3379ef-502f-48fe-bc06-c134d1eaaf0a">59.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTQtMS0xLTEtNTg5Nzk_3eed4b4d-969f-4586-b51c-f45451ab4fc5">69.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTQtMy0xLTEtNTg5Nzk_fa2e21e7-28b5-4a30-aace-5d5b06f373a5">203.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTUtMS0xLTEtNTg5Nzk_69e9e58f-03c6-437f-8407-fb239aaef269">30.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTUtMy0xLTEtNTg5Nzk_c56b1fc3-9042-4c18-af97-b6b0dcd06fdd">191.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTYtMS0xLTEtNTg5Nzk_ff5a109b-29ff-4eec-a5aa-a126820e30b5">67.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTYtMy0xLTEtNTg5Nzk_b5d59630-f812-4bd4-954b-92a79b035e1c">494.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTctMS0xLTEtNTg5Nzk_688eaf2a-4a3b-4938-80cb-fdddbfdc2116">132.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTctMy0xLTEtNTg5Nzk_2179d553-9ea3-42c9-b316-f04b9008132d">354.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTgtMS0xLTEtNTg5Nzk_44f59e37-3667-48a3-bccb-a3509513a61e">1,138.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTgtMy0xLTEtNTg5Nzk_d658c0af-12e3-404b-b276-3af433852025">848.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjAtMS0xLTEtNTg5Nzk_9eca6eae-744a-4572-b7ff-ba86bcd78068">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjAtMy0xLTEtNTg5Nzk_7be72ddb-f4d4-4a9f-95ec-39d664153bf0">277.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjEtMS0xLTEtNTg5Nzk_56eac795-3e8f-493d-b80a-d6b00ef8610c">64.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjEtMy0xLTEtNTg5Nzk_d3fb0dc9-19ec-422f-9c3a-eecfca71f1c5">49.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjItMS0xLTEtNTg5Nzk_dd837920-3718-4346-a717-3ae616156439">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjItMy0xLTEtNTg5Nzk_23dc572a-098b-47a6-a1b9-e5c06d7d3d84">12.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the sale of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjMtMS0xLTEtNTg5Nzk_3adbd4e3-03ee-49ee-9db1-ed2e39775681">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjMtMy0xLTEtNTg5Nzk_89845c50-4404-4b1f-aa2a-c6a2fcca4279">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for product rights and other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjQtMS0xLTEtNTg5Nzk_5fd24dd6-693a-4277-b119-d0b90239543b">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjQtMy0xLTEtNTg5Nzk_4773249e-3acf-4a62-b219-dff85ae9e9f5">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjUtMS0xLTEtNTg5Nzk_c0596ca5-8156-4176-9eb4-c34a224b67f6">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjUtMy0xLTEtNTg5Nzk_b6597861-073a-4799-9e2c-67b6babcc56d">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjYtMS0xLTEtNTg5Nzk_b274a2b9-07f7-4eeb-8a14-bab3aab10460">66.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjYtMy0xLTEtNTg5Nzk_814ac379-757c-4b71-a142-4af0aef6c962">236.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjgtMS0xLTEtNTg5Nzk_bdac8c78-b7fb-41fb-9c42-2499634d41cf">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjgtMy0xLTEtNTg5Nzk_6d2fd9f2-1d75-4d93-943e-11e8e7cdd257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjktMS0xLTEtNTg5Nzk_e441245a-d028-455a-bee6-c38fbcbd98ad">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjktMy0xLTEtNTg5Nzk_eca4287d-ba2a-4db5-a77e-23e04e431799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in short-term borrowings, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzEtMS0xLTEtNTg5Nzk_11191e4f-43a4-4f19-816a-4f9c9f565661">837.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzEtMy0xLTEtNTg5Nzk_37be0777-9a3a-4529-b971-5a290bf79310">1,063.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzItMS0xLTEtNTg5Nzk_a0ffb358-1941-4859-8825-fcc68d4db3ef">9.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzItMy0xLTEtNTg5Nzk_15a451fb-d35a-494b-914b-dc6d73a834ee">7.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzMtMS0xLTEtNTg5Nzk_b192c18e-57a8-4431-b9d0-542a59c987e4">15.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzMtMy0xLTEtNTg5Nzk_fdb40998-c1a6-41aa-814f-c6a999c07744">26.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzQtMS0xLTEtNTg5Nzk_64f84bfe-674b-403f-818c-7ea56817059a">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzQtMy0xLTEtNTg5Nzk_05e73e8c-6f1e-406d-b2f0-688f0c25c504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzUtMS0xLTEtNjQxOTU_0b079369-5a71-428f-8a25-02f4b7dbecfb">145.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzUtMy0xLTEtNjQxOTU_85f4a6f3-a591-4921-93ae-1291fa35774d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzYtMS0xLTEtNTg5Nzk_158adb76-03ac-4744-8a88-c88f9ba33dc9">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzYtMy0xLTEtNTg5Nzk_7b9a7c4b-4d62-4f3a-80ea-58f7a06c6127">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzctMS0xLTEtNTg5Nzk_a61ebf48-0335-4468-93c5-f02ab9ded29a">1,009.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzctMy0xLTEtNTg5Nzk_7d708256-bd4b-4305-842e-1dba35af232d">1,099.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect on cash of changes in exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzgtMS0xLTEtNTg5Nzk_efa328c1-d121-4b74-9a56-6d31b912d1eb">11.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzgtMy0xLTEtNTg5Nzk_afa7ff67-be1b-426b-ab30-1a2ac3ca6180">22.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzktMS0xLTEtNTg5Nzk_b343e1c5-11cc-4b3b-b804-b970aeb4eff3">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzktMy0xLTEtNTg5Nzk_270d227e-6592-4e06-8a28-41cb217d9bbf">36.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash &#8212; beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDAtMS0xLTEtNTg5Nzk_242d6296-f231-4210-9f17-ee8e3c459cee">706.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDAtMy0xLTEtNTg5Nzk_c5a28ff4-b313-44ee-a439-f62ed8c93d9d">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash &#8212; end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDEtMS0xLTEtNTg5Nzk_e646c6c1-d83e-490a-9be0-8b5dc46fd0d2">757.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8dd750c9019453f8f3c004524321932_I20210331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDEtMy0xLTEtNTg5Nzk_5f1abadc-5309-4f21-a978-61d10e300efe">813.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div><span><br/></span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_37"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">                                              </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div></div><div><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_40"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTM1NA_d88c2415-56e6-4da8-8b0a-786ccfc34867" continuedAt="i88044aa5724547a99ab161995d4f05cb" escape="true">General</ix:nonNumeric></span></div><ix:continuation id="i88044aa5724547a99ab161995d4f05cb"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTM1NQ_34579f3f-460b-4c9e-9af7-d37cd0df3680" escape="true">The accompanying unaudited condensed consolidated financial statements (&#8220;interim financial statements&#8221;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto in Viatris&#8217; 2021 Form&#160;10-K. The December&#160;31, 2021 condensed consolidated balance sheet was derived from audited financial statements. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Turkey Highly Inflationary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Under ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 830&#8221;), a highly inflationary economy is one that has cumulative inflation of approximately 100% or more over a three-year period. Effective April 1, 2022, we classified Turkey as highly inflationary. In accordance with ASC 830, starting with the second quarter of 2022, we will begin to use the U.S. dollar as our functional currency in Turkey, which historically utilized the Turkish lira as the functional currency. The impacted net sales for the three months ended March 31, 2022 and total assets at March 31, 2022 represented less than <ix:nonFraction unitRef="number" contextRef="if11d265b55994603936bcc00f3604ac6_D20220101-20220331" decimals="3" name="vtrs:PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTA5OTUxMTYzMjcxMw_139e664a-72c4-49f0-a28e-33a0550fb7c6"><ix:nonFraction unitRef="number" contextRef="if11d265b55994603936bcc00f3604ac6_D20220101-20220331" decimals="3" name="vtrs:PercentOfTotalAssetsImpactedHighInflationaryEconomy" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTA5OTUxMTYzMjcxMw_a7651d0e-9743-4541-80dd-72dce6e7f890">1</ix:nonFraction></ix:nonFraction>% of our consolidated net sales and total assets, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim results of operations, comprehensive earnings and cash flows for the three months ended March&#160;31, 2022 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period.</span></div></ix:continuation><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_43"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzI1Mg_0a6a04d4-dbb3-4f77-ae4b-ccbfba47238b" continuedAt="i12e0e703c6e64396a2ff75ef56754409" escape="true">Revenue Recognition and Accounts Receivable</ix:nonNumeric></span></div><ix:continuation id="i12e0e703c6e64396a2ff75ef56754409" continuedAt="ia4b6abd4854842bcb131b6b3ba77edd4"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the condensed consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash).</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#8217;s subsequent sales or usages occur. Such consideration is included in other revenues in the condensed consolidated statements of operations.</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzI1Mw_797a2695-5ed3-4f11-87da-bd96f8606ca0" continuedAt="i54a57cf77524492795f8fba533f850c5" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ba39e9fd3f4576a6e3ba8ea5af515d_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi0xLTEtMS01ODk3OQ_a753a315-d561-4817-b243-2a566135b279">1,298.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e9f96c4bfdf4076a41b2f57ff65da66_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi0zLTEtMS01ODk3OQ_19647209-762e-46f1-9f44-142ce5eabf16">569.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i292d6065b18c456da950161dc0ed5cdc_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi01LTEtMS01ODk3OQ_e9b2c4e3-a4de-4bde-a151-53c3940101f5">249.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i955056f26f174344a59efe72d96b834c_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi03LTEtMS01ODk3OQ_265c87d6-b359-4736-b6b8-bc52148491bb">436.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba711be447b3478c996341536356cdf5_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi05LTEtMS01ODk3OQ_1c9f1523-16c2-4261-98f7-1a343bdcfe68">2,554.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe9d75ef6164e1aba47dd0b90e867b5_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy0xLTEtMS01ODk3OQ_8c6c384a-1902-4609-a6cb-aabcb05c3ae0">364.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2e8d20544d4bc2a6e3f00cdd628190_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy0zLTEtMS01ODk3OQ_8eb61fcd-11f7-434b-8ce2-d71ac46df009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i474b93c64de34a159cbfd01885dbf1f1_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy01LTEtMS01ODk3OQ_599316d9-3aae-4e82-ba77-90fa52b93b97">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if294433954e94b85a607d271a2bd0aa8_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy03LTEtMS01ODk3OQ_fd413999-1d75-412e-8079-2abe44fce840">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491eb04d3a654f62b1752d08b7f0ac78_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy05LTEtMS01ODk3OQ_0725a791-2cc1-48bd-9e45-ce1c1cd69d8c">390.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d16d65a7504e289ccdc9b0fe5363e9_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC0xLTEtMS01ODk3OQ_d911439f-d7d8-4348-a3f1-c2048333e0bf">813.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9174fff41b14aaca81b7b98168f76b6_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC0zLTEtMS01ODk3OQ_f0f6881a-ba33-407b-ae90-3a11026a0001">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd7dbc12b4304f5c84ac1ca236493c73_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC01LTEtMS01ODk3OQ_76292799-813d-4c6c-9ba8-396e36f3aec9">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f0d8fcddec412b8d97bd5a1419a982_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC03LTEtMS01ODk3OQ_e0993c15-04a1-476e-98cd-eb3cdc8145c8">252.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e59d16c05e4059bb82ad3b1d4de7c2_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC05LTEtMS01ODk3OQ_01a75c56-ea8d-4f0c-a2ce-a5aed8f5c210">1,233.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS0xLTEtMS01ODk3OQ_f587dc67-a18a-4660-b386-f31166d0cf64">2,476.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS0zLTEtMS01ODk3OQ_18c9c919-92bc-4a34-b58f-6b44f1cdee49">573.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde6978e33374457b942a44020cb10ac_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS01LTEtMS01ODk3OQ_a70588b8-a4e4-4457-966d-93552a47166e">423.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS03LTEtMS01ODk3OQ_27d7685b-986a-4223-9574-ba172d170cfa">705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS05LTEtMS01ODk3OQ_e818dee5-edca-4a32-97ab-67b0b665e6da">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><ix:continuation id="ia4b6abd4854842bcb131b6b3ba77edd4" continuedAt="i4476e7560d6e442bbfa19fbbbe817bc0"><ix:continuation id="i54a57cf77524492795f8fba533f850c5" continuedAt="iaae68f2d40ac49c98d09ace26dd128b7"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d1621479f04da080f48af407080848_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi0xLTEtMS01ODk3OQ_c4b28317-390c-4fa8-b95a-3ac7b6a76566">1,403.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2820f52c9a448be8acecbf9c082bfca_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi0zLTEtMS01ODk3OQ_dbc5b6c5-15a1-4578-b3ca-9f5313b19259">590.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3684b9a82c4961986055887197e3e0_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi01LTEtMS01ODk3OQ_15f76ed7-0882-440e-a8cc-d19885bf1be2">284.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbaa3dc1ea00496aa8394b48d658329d_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi03LTEtMS01ODk3OQ_fd130db3-e70c-48af-a37d-d0fe6a71758d">446.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748408c8afd2496db200ffab60f6309a_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi05LTEtMS01ODk3OQ_a763e333-ecdb-4867-be30-b5406a2c0cb8">2,724.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c96949c8246b1a6f02ad3e9a1b8ff_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy0xLTEtMS01ODk3OQ_1b600170-a1d6-4b76-b4a8-28c83507dd64">312.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a80de9958be4b8999ac5f83c006a04d_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy0zLTEtMS01ODk3OQ_48cc1afd-aebf-4f93-a5fa-0ca064668cd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c27f0d85da4abe8f1080ed37fb7cc5_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy01LTEtMS01ODk3OQ_c5d7fd33-70b2-40bf-822c-3e8689005080">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb745d16ade49188c879e9695ef5f1f_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy03LTEtMS01ODk3OQ_7fbf7313-1381-4aec-893c-3733c746ad3d">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcee3429c94d4f49a2cdae32dc34c903_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy05LTEtMS01ODk3OQ_05f45a2f-e05a-4d5f-bc14-265cf3f5855c">328.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id284b62a1ee441a690f5d1dc632ff0f0_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC0xLTEtMS01ODk3OQ_1fffc320-e458-4b05-9b05-ea97d1ee2607">855.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia59211776b6c4a7691d42c9ca7bf9112_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC0zLTEtMS01ODk3OQ_210d47a4-a827-4e13-87cc-dfe4866dba5a">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb7352eee5c4e39a4037e1da189dcd5_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC01LTEtMS01ODk3OQ_a56230ce-09e0-4978-9574-c80f7e9e7fc4">189.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f9d84adfd04a3190bc51b5249c2bb3_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC03LTEtMS01ODk3OQ_26bbd377-70aa-4ff8-a8d4-319acd6b337e">300.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e1cab044e074c6892720c7206be4d3e_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC05LTEtMS01ODk3OQ_c14ba6f8-55c9-4e39-adfe-f1803297e0f5">1,346.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS0xLTEtMS01ODk3OQ_4d12581e-041a-4545-8231-bd618bdae72a">2,571.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS0zLTEtMS01ODk3OQ_3f3bc3a1-723f-4e44-a614-8af577ac723d">591.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS01LTEtMS01ODk3OQ_269d0470-e8b7-41f0-a76e-a7651433ddc1">481.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS03LTEtMS01ODk3OQ_651f7874-3c5f-4cf9-89d6-484197903b3b">754.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS05LTEtMS01ODk3OQ_423640aa-222e-4e82-b933-17a3231451fd">4,400.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2022 and 2021: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1835a54addd6406c921c384df5914a3a_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMy04LTEtMS01ODk3OQ_acf85fde-dd20-4b78-888d-30517b2b2090">440.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135d47fb8e1749deb28406184113a7f3_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMy0xMC0xLTEtNTg5Nzk_ddafa5e2-dae7-4418-a760-255ba3eb938e">464.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9abec7680e7e486b9c3cba801e828c78_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNC04LTEtMS01ODk3OQ_1be9da5b-0ccd-46d1-9da2-ae3bcb538833">207.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fa1580002c42d589ddb55c78697ff0_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNC0xMC0xLTEtNTg5Nzk_aa8dc921-2c6b-4722-b0fd-956a85bb71d7">227.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e79823554854c9994555c6c449804f0_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNS04LTEtMS01ODk3OQ_cf14d161-c866-47aa-bba6-8c8d62513a37">171.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffa584bf64441bfa32a52dfbd8ccd56_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNS0xMC0xLTEtNTg5Nzk_e0527d32-b2cf-43cf-b28f-3e2588485da2">187.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id717ea1bde634a34a611f888a445e7bc_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNi04LTEtMS01ODk3OQ_65813525-9b04-492d-a434-b1b35c80fcfe">129.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24ff44d1ac94a97977bf67c683e1249_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNi0xMC0xLTEtNTg5Nzk_af68e266-6903-4f74-8b2f-d1460c67d807">139.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3006593f3b0c4bff83619b0e08ba5ff4_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNy04LTEtMS01ODk3OQ_47122ba9-95ec-47d7-ac05-cf902aae68b7">88.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b41aeba1a37461eb3d32c974467161a_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNy0xMC0xLTEtNTg5Nzk_5bf99b48-cf3b-4722-9511-412eee67b7ac">103.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02f402791b04a8a848fabcaebd62823_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOC04LTEtMS01ODk3OQ_62492f3d-0927-493b-9386-e799d7ab7806">85.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i158536bda5ef4607b007205257c61c21_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOC0xMC0xLTEtNTg5Nzk_a6b5e384-23c7-4203-ab72-bf8a4ee497a6">89.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ede27cc7454699baf57d0d454a0244_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOS04LTEtMS01ODk3OQ_f40a7354-56bd-4878-adc1-e1e51e8f6b9e">77.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85796e832ed74154ae053fee7baad954_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOS0xMC0xLTEtNTg5Nzk_757f3826-e082-40e0-823f-ddd9b063c2d4">76.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad726170615b4ba3addd534151d713e8_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTEtMi0xLTEtNjU4ODc_d8ec241a-fd47-44e3-a961-53119d6d4a65">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48022c64e99b421c837601b663c4be1c_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTEtNC0xLTEtNjU4ODc_2f0c9e58-06eb-4ee4-8747-6856e47dc7b6">69.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c7b925316344a58a37be2388b7ffca1_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTAtOC0xLTEtNTg5Nzk_233670d7-7691-4d29-a95b-f87dfaf3ee80">73.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9199b9cb6f924570befa8e11e3b7a86f_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTAtMTAtMS0xLTU4OTc5_fcf4a49b-9381-4a5a-b919-f97cf050e220">76.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87788733377c4d97813f696f3baef142_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTItOC0xLTEtNTg5Nzk_2e74e5d1-8485-4d5e-a149-53f9e5dd240b">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b104192aa044c58ca3556d6141607c_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTItMTAtMS0xLTU4OTc5_e918d8ab-82f0-45c2-b3c8-d807901a15b4">57.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84563bdbb5d44725a06b2c5fbc62e422_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctMi0xLTEtNzAxMDk_537646ab-3acc-474e-b3d8-e1806012f890">44.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4fea5e9149f40bfa10bc9bd2936bc6d_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctNC0xLTEtNzAxMDk_e468ecaf-f9f8-4dbf-8d4e-f5c1570818eb">40.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e58994728654ea6896d5c8702fe2b3b_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctMi0xLTEtNjU4Nzk_4560cc25-67ea-4d76-b222-c2a2d2d1e588">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0912a24a584447deb9f3b49a05227ef6_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctNC0xLTEtNjU4Nzk_0f3dbafc-d3b5-4e00-a5fd-59be1951835b">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfaa89f38c84069b2fa8d501cbd8580_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTUtOC0xLTEtNTg5Nzk_385e6dc0-7a63-4969-b55b-97f79838104b">41.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1daacd537079404ba5c511f26c26f483_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTUtMTAtMS0xLTU4OTc5_f49ba4cc-0d5a-4dee-823d-d8d8632bdff0">45.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5583a6d8429e4a15a832e3cb417de6c1_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTYtOC0xLTEtNTg5Nzk_8417cb88-2750-4964-83ae-efeb6fbd80d5">40.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dca7477e77e4046b85ab1d82f7b0be9_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTYtMTAtMS0xLTU4OTc5_bca4f648-ae28-496a-8ab8-9744b4b87485">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2022 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i4476e7560d6e442bbfa19fbbbe817bc0"><ix:continuation id="iaae68f2d40ac49c98d09ace26dd128b7"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration and Accounts Receivable</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMy01LTEtMS01ODk3OQ_26438f67-4a14-4293-b3c7-99fa8c0ea51c">7,198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMy03LTEtMS01ODk3OQ_62b275cf-8d21-4a72-aaa6-04715e91d86c">7,567.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:Chargebacks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNS01LTEtMS01ODk3OQ_3616a8f5-d460-4c0a-bf14-7d67c6c7e760">1,584.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="vtrs:Chargebacks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNS03LTEtMS01ODk3OQ_0ac6579a-b460-4c56-a3f4-8a2bd6466e35">1,318.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:AccruedSalesAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNi01LTEtMS01ODk3OQ_3a83a365-7ad5-400a-b735-bb9cbc51a61a">1,205.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="vtrs:AccruedSalesAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNi03LTEtMS01ODk3OQ_2bbb5202-27d6-4be1-89b3-a3a3b7b6dead">1,568.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNy01LTEtMS01ODk3OQ_94fe3dad-909d-4e2c-9e07-268d58e5e4e8">82.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNy03LTEtMS01ODk3OQ_5da18840-207c-443e-9618-b4c1bdc53c36">113.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:Medicaidandothergovernmentalrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOC01LTEtMS01ODk3OQ_cdc712b3-edbe-44b8-9206-df13315e1f76">147.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="vtrs:Medicaidandothergovernmentalrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOC03LTEtMS01ODk3OQ_d6f4383a-258d-427b-97a7-69c908dde927">167.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:SalesRevenueGrosstonetadjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOS01LTEtMS01ODk3OQ_d66e2730-4425-48cd-8613-4a25f2b67da5">3,020.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="vtrs:SalesRevenueGrosstonetadjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOS03LTEtMS01ODk3OQ_2b8ac42a-79c6-403f-8b28-497faf6798f2">3,166.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMTAtNS0xLTEtNTg5Nzk_e818dee5-edca-4a32-97ab-67b0b665e6da">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMTAtNy0xLTEtNTg5Nzk_423640aa-222e-4e82-b933-17a3231451fd">4,400.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No significant revisions were made to the methodology used in determining these provisions or the nature of the provisions during the three months ended March&#160;31, 2022. <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzI1Nw_d92ddfbd-d7a9-4578-9196-622b7227a29f" continuedAt="ic68e543b76d4489aa17c2db0110851b9" escape="true">Such allowances were comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:</ix:nonNumeric></span></div><ix:continuation id="ic68e543b76d4489aa17c2db0110851b9"><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMS0xLTEtMS01ODk3OQ_ce93f761-e2ad-4565-963a-99b4616994ce">1,707.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMS0zLTEtMS01ODk3OQ_dedf1e17-de0f-409a-8a62-dc2c6c84525e">1,688.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMi0xLTEtMS01ODk3OQ_25fcebd5-0573-49ee-ac92-e59ac35e981a">1,095.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMi0zLTEtMS01ODk3OQ_7b325a47-1c11-4c36-aebc-ede242163130">1,362.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMy0xLTEtMS01ODk3OQ_f26e3fae-7af2-4186-b32f-11a92af7fb29">2,802.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMy0zLTEtMS01ODk3OQ_4e8b7f95-0f81-44a7-930c-64f962d9e829">3,050.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net was comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:76.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMS0xLTEtMS01ODk3OQ_94c2edb2-5113-442a-90c4-a059ffc19d6d">3,556.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMS0zLTEtMS01ODk3OQ_d249a635-91a2-4a75-89e7-4fa6202ac8b9">3,774.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMi0xLTEtMS01ODk3OQ_a0d7b22e-3cd0-4325-b86c-7d994515437a">537.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMi0zLTEtMS01ODk3OQ_5d2e8e84-8661-4eea-8ffb-a789822d86b3">492.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMy0xLTEtMS01ODk3OQ_3ed3f340-b9a4-4a00-9bce-59a5fcc0ff28">4,093.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMy0zLTEtMS01ODk3OQ_2b049a5d-4827-4809-8ea5-3509fa2004cb">4,266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Factoring Arrangements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzE0MA_9097eab6-fc9d-4846-a73e-e0702ec6d416">55.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i08cd6d30ddde4135b38cb6b4509af6be_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzE0Nw_f0259161-ebaa-478a-9e88-fcd0f6b5873b">29.6</ix:nonFraction> million of accounts receivable as of March&#160;31, 2022 and December&#160;31, 2021, respectively, under these factoring arrangements.</span></div></ix:continuation><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_46"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80Ni9mcmFnOjgzODc3M2I2NzBhMzQ2MmE5Mzk2ODk3Y2U2NjMzZDVkL3RleHRyZWdpb246ODM4NzczYjY3MGEzNDYyYTkzOTY4OTdjZTY2MzNkNWRfMjYxNA_99fcf2d0-11f1-4fa6-9311-a0adc940fc3d" continuedAt="ifaefbe0eb91c4e9bbf04bfb5545ed135" escape="true">Recent Accounting Pronouncements</ix:nonNumeric></span></div><ix:continuation id="ifaefbe0eb91c4e9bbf04bfb5545ed135" continuedAt="if1bad52156d44b7db54225711a80c958"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standard</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued Accounting Standards Update 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. We adopted the ASU prospectively on January 1, 2022. The additional annual disclosures required are not expected to have a material impact on our consolidated financial statements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if1bad52156d44b7db54225711a80c958">There were no other significant changes in new accounting standards from those disclosed in Viatris&#8217; 2021 Form 10-K. Refer to Viatris&#8217; 2021 Form 10-K for additional information.</ix:continuation></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_52"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjYyNA_7de22873-f716-4329-bd82-749cd8968147" continuedAt="i623e30ccbbcb4e93b51ef117d3d4687e" escape="true">Share-Based Incentive Plan</ix:nonNumeric></span></div><ix:continuation id="i623e30ccbbcb4e93b51ef117d3d4687e"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#8217; sole stockholder at such time, approved the Plan which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP, which had previously been approved by Mylan shareholders. The Plan and 2003 LTIP include (i) <ix:nonFraction unitRef="shares" contextRef="ia1403ea4a4ff462894d5f150c3fc0424_I20201116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTA5OTUxMTYzMTE5MA_f6647c8c-9320-4c50-a7f7-c4b4543ae69a">72,500,000</ix:nonFraction> shares of common stock authorized for grant pursuant to the Plan, which may include dividend payments payable in common stock on unvested shares granted under awards, (ii) <ix:nonFraction unitRef="shares" contextRef="i300f9d815ab347b99f79dd4a94ef5112_D20201116-20201116" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTA5OTUxMTYzMTIwMg_e1586451-48e2-4c94-a318-105613f06f0c">6,757,640</ix:nonFraction> shares of common stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) <ix:nonFraction unitRef="shares" contextRef="i1b945f241fe546d3b6b6002a03ff26fc_I20201116" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTA5OTUxMTYzMTIxMw_5add54e5-6d97-48a5-b39b-1caf5abc62c6">13,535,627</ix:nonFraction> shares of common stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTU_c0f2427b-1baa-41a5-bae1-4668a072522c">three</span> to <ix:nonNumeric contextRef="i4d074444c7494355a757a9e0ab0d8ffd_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTY_ce08e511-280a-467c-a3da-2d8afa767cfc">four years</ix:nonNumeric>, and generally expire in <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTc_03628b07-1c1b-44dc-a0fd-7956e1b998ac">ten years</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjYyMg_631645e5-63bf-4dbe-819e-cde36a331b82" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfMS0xLTEtMS01ODk3OQ_085d44f5-3ad2-4a21-8fdf-e0bb60903bdb">5,576,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfMS0zLTEtMS01ODk3OQ_f2806a32-fd80-446f-a94a-72b6cc85129d">37.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNC0xLTEtMS01ODk3OQ_c0bb99db-34b2-44d4-8bc1-ce5898b46eb1">450,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNC0zLTEtMS01ODk3OQ_b1a2889e-a519-49f0-baad-9efc216c9811">27.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNS0xLTEtMS01ODk3OQ_2b9f9590-78d9-482c-9032-974af756b763">5,126,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNS0zLTEtMS01ODk3OQ_f5be6b82-301c-4979-898c-b0525d4813c2">38.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNi0xLTEtMS01ODk3OQ_384192d6-f494-4274-ae7d-c8842d3c3110">5,077,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNi0zLTEtMS01ODk3OQ_1ad93f39-bdbf-420a-9644-14d7492e7953">38.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNy0xLTEtMS01ODk3OQ_faae0ae3-ce07-4125-92d1-79394fba3fba">4,831,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNy0zLTEtMS01ODk3OQ_44d2199f-af68-4bf3-9c47-4b9859d09277">39.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of <ix:nonNumeric contextRef="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTkyOA_2aec001c-3fd6-4b0c-8d8c-a6b97a514d73">4.7</ix:nonNumeric> years, <ix:nonNumeric contextRef="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTkzMg_839d914a-6e6a-4094-b9c3-bba67d27a3a8">4.6</ix:nonNumeric> years and <ix:nonNumeric contextRef="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTkzOQ_ca124633-0163-4b52-a298-fc45f312cd29">4.5</ix:nonNumeric> years, respectively. Also, at March&#160;31, 2022, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had no aggregate intrinsic value.</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjYwNQ_f71f2399-0389-4d56-b9f7-24f0864bd443" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs) as of March&#160;31, 2022 and the changes during the three months ended March&#160;31, 2022 are presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock&#160;Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair&#160;Value&#160;Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd6d8a15669b44269a74dc8552c59bff_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMS0xLTEtMS01ODk3OQ_8f47740d-574f-4610-9fd1-96ca6f274d40">16,858,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibd6d8a15669b44269a74dc8552c59bff_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMS0zLTEtMS01ODk3OQ_4df99e93-3f7e-4a2c-95d6-2987c0354a10">15.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMi0xLTEtMS01ODk3OQ_bb114cb4-5024-4a21-bc44-750f2ccc7692">16,635,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMi0zLTEtMS01ODk3OQ_4bf3f673-1a98-4776-ac68-256094934b94">10.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMy0xLTEtMS01ODk3OQ_95ba7d7f-d274-4f88-b144-0ca2e48e9092">3,517,219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMy0zLTEtMS01ODk3OQ_83ca2700-e9cc-4010-90ae-37670f8f45d7">17.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNC0xLTEtMS01ODk3OQ_118024e8-aba4-44b6-826c-1b8d8aed9ca4">229,241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNC0zLTEtMS01ODk3OQ_2b5fff6c-1560-498f-91ff-e51d5ca09020">13.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i172cb95ff1b1402d846fc493dacaeb9c_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNS0xLTEtMS01ODk3OQ_49211842-4925-4b85-9595-bab6830b93dd">29,747,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i172cb95ff1b1402d846fc493dacaeb9c_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNS0zLTEtMS01ODk3OQ_cb299974-c5bf-4262-b898-6520b0f606b2">12.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i56b037f5e77a4f00aa5d7a3f375a6f96_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjI1Nw_40220796-5100-471e-8d1f-25bb297e4905">272.7</ix:nonFraction> million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of <ix:nonNumeric contextRef="i1d97c12bd31b4009bd5259d649284b90_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjQ1OQ_fab41223-43ed-496e-92bf-803bd580efe9">2.0</ix:nonNumeric> years. The total intrinsic value of restricted stock units released during the three months ended March&#160;31, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i1d97c12bd31b4009bd5259d649284b90_D20220101-20220331" decimals="-5" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjU3OQ_554917a8-a5f8-4830-8df5-d47674028fd2">63.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f30854d5be84566bce9b02e6adf2bc7_D20210101-20210331" decimals="-5" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjU4Ng_2890ffe9-cf2a-438b-af3e-56fcafa3ee26">30.8</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_58"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMjA4NA_6eba9f6f-c875-4d49-8333-686f4d0e2d61" continuedAt="i4a7df219029b4c17b106ad730d46b652" escape="true">Pensions and Other Postretirement Benefits</ix:nonNumeric></span></div><ix:continuation id="i4a7df219029b4c17b106ad730d46b652"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMjA4OA_39e8d366-21eb-4abf-bc69-dcb53f61c4d7" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the three months ended March&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNC01LTEtMS01ODk3OQ_aceb58d3-cd8e-456e-904d-9e83ed2e368f">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNC03LTEtMS01ODk3OQ_d88a3b22-fce7-4a2b-8696-5454bbe59b93">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNS01LTEtMS01ODk3OQ_3a8d71eb-f7f4-403a-b649-0dfce52d8f58">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNS03LTEtMS01ODk3OQ_a1bc43b2-4dde-4f6d-af92-ab9b93ab694a">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNi01LTEtMS01ODk3OQ_0dc3eb50-3875-4f3a-8fb6-79920196476c">16.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNi03LTEtMS01ODk3OQ_75608d53-8a69-4cf3-80ac-b7fe662987c9">16.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNy01LTEtMS01ODk3OQ_8333c1de-af14-4130-9640-17b3ac848732">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNy03LTEtMS01ODk3OQ_053f9a32-3671-449d-95f6-2defe001e3f5">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOC01LTEtMS01ODk3OQ_c21f3540-4622-42f8-95dd-70bb38d94fab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOC03LTEtMS01ODk3OQ_67069601-f4c4-4afd-b066-2ff6df46958d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOS01LTEtMS01ODk3OQ_67f31304-bd06-4ed4-bb5e-56c783221be0">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOS03LTEtMS01ODk3OQ_1e1ae23a-7d87-4e73-af38-56064e83edcf">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is making the minimum mandatory contributions to its defined benefit pension plans in the U.S. and Puerto Rico for the 2022 plan year. The Company expects to make total benefit payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMTkwMg_8b3fa94b-9d32-42a2-8d03-3f22fb5c5159">118.0</ix:nonFraction> million from pension and other postretirement benefit plans in 2022. The Company anticipates making contributions to pension and other postretirement benefit plans of approximately $<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMjA3Ng_f96e179b-8b0a-4f7a-af40-bb8c76a7eec1">52.0</ix:nonFraction> million in 2022.</span></div></ix:continuation><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_61"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDE4_dfd6ded9-925e-4c3e-a210-2dff36cdcc95" continuedAt="i0f7b6d617e4d425fad15b0509ea584da" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="i0f7b6d617e4d425fad15b0509ea584da" continuedAt="i5464182772224003be3c423f2589c111"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected balance sheet components consist of the following:</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDUz_5ac0f066-66c8-47c7-9e9e-09a7a0043796" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMS0xLTEtMS01ODk3OQ_b28ef41d-4c66-4290-b4f0-b292aae141e4">752.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMS0zLTEtMS01ODk3OQ_af007108-94f3-4f6a-bf4e-3be1967a731d">701.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8dd750c9019453f8f3c004524321932_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMS01LTEtMS01ODk3OQ_a2bdd8aa-0e4b-4607-bb57-33830c7e4829">806.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMi0xLTEtMS01ODk3OQ_43dbdabc-01af-4695-9f00-133d05d0c362">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMi0zLTEtMS01ODk3OQ_23911ace-542e-4285-9cbd-806055d1a430">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8dd750c9019453f8f3c004524321932_I20210331" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMi01LTEtMS01ODk3OQ_70d8288f-d7c9-4786-902e-92793e54f11d">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMy0xLTEtMS01ODk3OQ_e646c6c1-d83e-490a-9be0-8b5dc46fd0d2">757.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMy0zLTEtMS01ODk3OQ_242d6296-f231-4210-9f17-ee8e3c459cee">706.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8dd750c9019453f8f3c004524321932_I20210331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMy01LTEtMS01ODk3OQ_f2106f92-ab38-462c-a95e-f3be76ad7d73">813.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDU3_daa6caf1-c048-4f15-aaec-b727c9b65c50" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMS0xLTEtMS01ODk3OQ_5aea8864-967c-442e-bc6e-5dbaf0664703">868.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMS0zLTEtMS01ODk3OQ_0ca5db1f-2f4e-4cd6-ba6b-26e6c0523759">922.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMi0xLTEtMS01ODk3OQ_8a3ac55f-d702-4891-8398-ac3b8c057552">767.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMi0zLTEtMS01ODk3OQ_94112ab8-65d7-4dca-a586-f8dca231e251">993.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMy0xLTEtMS01ODk3OQ_16aa14f0-46c2-4cea-af90-e126f5c3398d">2,161.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMy0zLTEtMS01ODk3OQ_993b2b2d-ec3b-4d7e-9e58-f3ebebac5ee6">2,062.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfNC0xLTEtMS01ODk3OQ_110a1e15-af11-454f-8a0b-7ec43971f934">3,797.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfNC0zLTEtMS01ODk3OQ_8245a4b1-d776-4b7b-9bd8-6317c2ebc859">3,977.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i5464182772224003be3c423f2589c111" continuedAt="ic4bef3328f3f4f61bed33d86219792ed"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDU1_ac5530f0-fff0-415a-b579-557b882326df" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMS0xLTEtMS01ODk3OQ_0bbe1ef0-9ef6-41dd-a341-d7a8f2dc7cbf">268.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMS0zLTEtMS01ODk3OQ_760260bb-95e9-44ff-a3ef-c988194d33a6">256.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5151f58ea94c4939ae23348ce92f1b70_I20220331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMy0xLTEtMS01ODk3OQ_14737803-a528-4d4b-beaf-837713a67cf1">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie815b9c252a444bb82e640d926a75aaa_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMy0zLTEtMS01ODk3OQ_7e68e83e-098d-443f-aca3-be7b7cbf8f0a">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNC0xLTEtMS01ODk3OQ_9289c09a-12b6-4714-ab6e-612cbb4f048c">202.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNC0zLTEtMS01ODk3OQ_aeb695a3-f99e-44a5-b595-5804b3c884c2">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNS0xLTEtMS01ODk3OQ_7751f758-da17-409d-a852-33660b11402e">48.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNS0zLTEtMS01ODk3OQ_85ad8ef6-06d8-4b1f-99e3-192c3d21947c">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNi0xLTEtMS01ODk3OQ_31e94884-3b7d-4974-b079-79fa9f81840c">1,208.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNi0zLTEtMS01ODk3OQ_844b1567-163e-4645-b4fa-5c7fd9cf70e4">1,467.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNy0xLTEtMS01ODk3OQ_204169c6-4ad7-489a-9c49-ad5f6a447c64">1,763.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNy0zLTEtMS01ODk3OQ_5ef458dd-cd51-47f4-9719-cd12f22a83ad">1,957.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items. </span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDUx_9285f43c-3ea9-430f-973d-d47e41d95602" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde1a85ed6e247a086a8aad3326c4e01_I20220331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMS0xLTEtMS01ODk3OQ_044aa6d8-e1fb-42cc-a405-32fce991a952">2,845.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d8d5eff296a4e6d8f34d3fd83d2fa04_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMS0zLTEtMS01ODk3OQ_7b3b2470-5ebf-47ec-9685-ef6b89bb88ec">3,054.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4505670638054dd8bdc85765bd7b5bb5_I20220331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMi0xLTEtMS01ODk3OQ_937f2f88-5ea4-4a37-b174-6875f5328d26">1,578.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b06c877d5645eca6b4db2020388c0f_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMi0zLTEtMS01ODk3OQ_82645fbe-57a3-4c2d-8dd2-fecbdfe0711a">1,808.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02260e2d4d964332930fc8ba5cb79fd1_I20220331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMy0xLTEtMS01ODk3OQ_ba8b4e1b-05f9-477a-8c78-2453c7f9b59a">541.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992fd5c4440f4ad69a507b4b2076605b_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMy0zLTEtMS01ODk3OQ_22174759-5612-446f-afb3-733021bac62e">588.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc828c926f7f4226bb0765da134ca177_I20220331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNC0xLTEtMS01ODk3OQ_1ba1bb17-c5cc-4bcd-8d12-38fa5a6c46db">126.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5a293effe2d476e8a82ca69b066c37a_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNC0zLTEtMS01ODk3OQ_367e26d4-94f4-4868-8a2a-7f1a7593e594">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNS0xLTEtMS01ODk3OQ_88e68608-7a96-459e-8f98-132e60688b6b">5,092.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNS0zLTEtMS01ODk3OQ_d86521da-d3bc-4406-b7c6-760f1d6e1054">5,589.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNi0xLTEtMS01ODk3OQ_3056b608-2e50-40ef-870c-72ac2bacd352">1,942.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNi0zLTEtMS01ODk3OQ_cb54dc1c-40b8-4b1b-9b17-7869e97981a9">2,400.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNy0xLTEtMS01ODk3OQ_0186bb33-a1ec-4a3a-845a-4702767d1a48">3,150.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNy0zLTEtMS01ODk3OQ_f45153cd-7f8e-4dad-bb20-3faa21350d84">3,188.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDYw_815b0a53-1e37-4552-8575-8f85088b00d1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMi0xLTEtMS01ODk3OQ_2642f3df-4d7e-401c-b017-bb5eec1774e5">281.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMi0zLTEtMS01ODk3OQ_e5fb9b65-d555-467c-8d86-9734bdd88431">290.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="vtrs:Otherlongtermassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMy0xLTEtMS01ODk3OQ_cbbad063-eb28-4319-8570-cf7b443d16e5">774.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="vtrs:Otherlongtermassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMy0zLTEtMS01ODk3OQ_79c268d5-fce0-401c-84b8-a0ed6fa5230f">879.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfNC0xLTEtMS01ODk3OQ_4b41ce87-83d8-4040-9a60-c9987e38e2b2">1,056.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfNC0zLTEtMS01ODk3OQ_fbd55628-d875-4863-aa67-eeb16f279f31">1,170.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDQ4_f990b80f-19c9-42aa-b019-f32ee2db76c2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMS0xLTEtMS01ODk3OQ_1a1f9275-2076-48eb-9efa-2bb167b03201">928.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMS0zLTEtMS01ODk3OQ_7cfb3531-ec13-4af6-821b-57c45ac86915">1,056.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMi0xLTEtMS01ODk3OQ_fa25d64a-dee1-4c5d-b6c0-8e6bfffc43b4">571.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMi0zLTEtMS01ODk3OQ_376e1186-bf9a-4da5-a3db-35afd6aaa81b">601.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMy0xLTEtMS01ODk3OQ_60366fe9-7880-4332-a43c-7c7a931a6702">1,499.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMy0zLTEtMS01ODk3OQ_2b7022e9-da47-43b4-aa41-83aaacde7509">1,657.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="ic4bef3328f3f4f61bed33d86219792ed"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDEy_83e3743e-743d-43cb-9ab8-19bdbaac3b01" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMS0xLTEtMS01ODk3OQ_25fcebd5-0573-49ee-ac92-e59ac35e981a">1,095.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMS0zLTEtMS01ODk3OQ_7b325a47-1c11-4c36-aebc-ede242163130">1,362.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMi0xLTEtMS01ODk3OQ_d73d96e7-9ebe-4afa-915d-8dd96823d745">694.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMi0zLTEtMS01ODk3OQ_6f08bb2e-a437-4741-9ff2-8cc16cd28db0">715.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMy0xLTEtMS01ODk3OQ_bda65a13-9b5c-46da-9499-65566d9da58d">567.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMy0zLTEtMS01ODk3OQ_60737995-3213-4c07-9850-6016f8d93d3c">741.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4d7d622da84b43bba3a6f1313667a9_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNC0xLTEtMS01ODk3OQ_b4653449-fd99-4abd-9a03-9dd65d7081b4">86.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8ebd1f9f2b43aea75b756394d24cc8_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNC0zLTEtMS01ODk3OQ_19cc38be-b9dc-4cc9-9687-25a0b3705075">66.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0xLTEtMS02MDYxMg_5b444113-c4fe-434f-ac8e-911f7aa8a154">171.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0zLTEtMS02MDYxOQ_79bcd3a2-58b8-4a9c-bec2-af173711450a">233.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0xLTEtMS01ODk3OQ_132c8fc6-a0bc-4687-998a-d5ea7c9affc6">228.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0zLTEtMS01ODk3OQ_5ca5e544-5565-4d8b-aa51-05e1efe0c910">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia835a6c092bb43bdaabb4af69cf5c32b_I20220331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNy0xLTEtMS01ODk3OQ_f58da765-0bf9-40c6-96b6-fc40fe76ac77">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd41d809933d449a9b51ef98b9a9d921_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNy0zLTEtMS01ODk3OQ_96c6dfb8-015c-42bf-9aea-85c409b73b5c">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOC0xLTEtMS01ODk3OQ_6faab031-6173-49ec-9f01-96e54a614dc4">98.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOC0zLTEtMS01ODk3OQ_15fc38ed-b066-4f75-82b5-9efe681d70be">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOS0xLTEtMS01ODk3OQ_33b7858e-e544-42c1-8453-8c593f544e31">89.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOS0zLTEtMS01ODk3OQ_c2d444d5-3022-4518-9821-5c000fddd0fc">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTAtMS0xLTEtNTg5Nzk_f9f45b18-c3a9-45a8-8194-d4072ff8ed60">1,388.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTAtMy0xLTEtNTg5Nzk_4c05ddc8-33d8-4031-83c2-ac50d2b782f5">1,254.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTEtMS0xLTEtNTg5Nzk_95d1751a-dc58-4423-9a68-93f011c7fe7a">4,426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTEtMy0xLTEtNTg5Nzk_631893f6-2821-4e96-88cc-2601f2eb72e8">4,619.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDM5_3d79c6ae-f726-4e5d-b1d7-896751b3cf66" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMS0xLTEtMS01ODk3OQ_a129d7c6-6503-485a-8b09-6dfe2f98564f">861.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMS0zLTEtMS01ODk3OQ_d695c183-ed5f-4415-8930-672d334dae0c">876.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cf551f83c9439aa1d37ce9a597c5af_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMi0xLTEtMS01ODk3OQ_becf76e4-0565-4f33-b72e-3071fe5839ca">112.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bfda8fa6a3472ab6b18074c291d3ba_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMi0zLTEtMS01ODk3OQ_fa38e2d6-6194-4346-9193-514603c8a255">133.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNC0xLTEtMS01ODk3OQ_f6fca34b-4b74-4715-85ce-5499fa2d3f7c">429.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNC0zLTEtMS01ODk3OQ_8853ee8f-d43f-4f3b-855d-7557a55ecb8d">426.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNS0xLTEtMS01ODk3OQ_5186ac18-1dee-4ee0-abd1-7cbff1d13f84">191.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNS0zLTEtMS01ODk3OQ_167a2ef8-6a79-46ac-af5f-cfb304294730">200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNi0xLTEtMS01ODk3OQ_1e72d8f1-4ee9-4647-a6ba-240f1c3a2923">51.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNi0zLTEtMS01ODk3OQ_ef2af271-5c09-4874-a4f6-a7005818c4ec">64.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNy0xLTEtMS01ODk3OQ_fac18d11-6245-4233-a235-9fe54b2b0504">238.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNy0zLTEtMS01ODk3OQ_725e32bb-d580-45d8-b7f5-40f598105d8d">232.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfOC0xLTEtMS01ODk3OQ_a11371ef-c0de-486e-9f27-8cf4cdaa7fa0">1,884.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfOC0zLTEtMS01ODk3OQ_d89c92b4-3274-4bde-9f9c-feba20b64084">1,933.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and liabilities held for sale</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2022, the Company entered into an agreement to contribute its biosimilars portfolio to Biocon Biologics. Under the terms of the Biocon Agreement, at closing Viatris will receive an up-front cash payment of $<ix:nonFraction unitRef="usd" contextRef="id222bc967c45426a9e0cbe615268daea_I20220630" decimals="-8" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTA5OTUxMTYzMTE2Mw_b63bc9f9-df9f-4357-8ed0-e4e61ed1909e">2.0</ix:nonFraction>&#160;billion, subject to certain adjustments, ownership of at least <ix:nonFraction unitRef="number" contextRef="i8a3a5f469f2a41ea9dba3560f618f489_D20220401-20220630" decimals="3" name="vtrs:DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTA5OTUxMTYzMTIwNA_c255f123-66bf-401f-9160-ca43c30be39d">12.9</ix:nonFraction>% of Biocon Biologics, on a fully diluted basis, in the form of convertible preferred equity which will have certain priority rights with respect to certain liquidity events, and $<ix:nonFraction unitRef="usd" contextRef="id222bc967c45426a9e0cbe615268daea_I20220630" decimals="-6" name="vtrs:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTA5OTUxMTYzMTE4NA_1e7fa35f-38e0-4945-aece-4d7988807271">335</ix:nonFraction>&#160;million as additional cash payments that are expected to be paid in 2024. Upon closing of the transaction, we expect to record a gain for the difference between the consideration received, including the fair value of the convertible preferred equity, and the carrying value of the biosimilars portfolio. The companies will also enter into a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTUzOTMxNjI3OTU3NDY_e1f2e313-6d28-4936-b405-9423e140767f">two</span>-year transition services agreement, subject to extension in certain circumstances, during which time Viatris will provide certain commercial and administrative services for an applicable service fee. The transaction is expected to close in the second half of 2022 and is subject to various closing conditions (including regulatory approvals).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities associated with the biosimilars portfolio were reclassified as held for sale in the condensed consolidated balance sheets as of March&#160;31, 2022. <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTUzOTMxNjI3OTU5MjM_56cbdbee-7a2c-481f-ac04-6be405f7d321" continuedAt="i6d6a82a557b8453cb4b82edb3214ac1c" escape="true">The amounts associated with the biosimilars portfolio classified as held for sale consisted of the following:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div><ix:continuation id="i6d6a82a557b8453cb4b82edb3214ac1c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMy0yLTEtMS02ODA0NQ_95ad3a2f-3081-4c08-9591-6d4d95a5fd51">136.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNC0yLTEtMS02ODA0NQ_04f7269c-eb92-450b-a9b2-a435b14cae3b">122.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNS0yLTEtMS03MTIyNQ_a96f170f-67fa-4295-bd83-6f7b9568bbd0">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNS0yLTEtMS02ODA0NQ_34fb1a16-58a2-451f-a06b-80a794e8b93a">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNi0yLTEtMS02ODA0NQ_6126324f-4af8-4cb3-8c62-e189342a4055">953.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNy0yLTEtMS02ODA0NQ_8dd6f902-f074-4a56-9031-4a7b27880cf0">105.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfOC0yLTEtMS02ODA0NQ_0c29e7c8-27d3-4f02-bd00-654a92b49e84">1,337.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMTEtMi0xLTEtNjgwNTg_bacfb0c2-56bc-404b-980e-079dfc1c0e48">95.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMTItMi0xLTEtNjgwNTg_24e9232e-d570-443d-b801-875c940e5c2c">182.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMTMtMi0xLTEtNjgwNTg_6fe9c473-2b37-4a08-bd8c-92a50efa501d">277.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, total revenues relating to the biosimilars portfolio expected to be contributed to Biocon Biologics during the second half of 2022 were approximately $<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTY0OTI2NzQ0NTYyNQ_bdc3245f-c8fa-47d8-b784-8104f608efea">169.1</ix:nonFraction>&#160;million.</span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_70"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfNzMz_da0e18f9-43fa-4347-8b92-5de7b60b1794" continuedAt="i3aa404e3cf69495f812958327c6a9777" escape="true">Equity Method Investments</ix:nonNumeric></span></div><ix:continuation id="i3aa404e3cf69495f812958327c6a9777" continuedAt="i352f9a83bee741b48b0162ac63eb116b"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The law that provides for IRC Section 45 tax credits expired during the year ended December 31, 2021 for all three clean energy investments and all of the clean energy investments have wound down operations. <ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfNzMy_3305e7e8-fc1e-4be0-a52b-a51fa570db20" continuedAt="i45e710f14b144d218d6e4ac37df23a30" escape="true">Summarized financial information, in the aggregate, for the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="ia835a6c092bb43bdaabb4af69cf5c32b_I20220331" decimals="INF" name="vtrs:Numberofequitymethodinvestments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfMTAy_591c70e0-8b34-4705-bf0b-916e95907e98">three</ix:nonFraction> equity method, clean energy investments on a <ix:nonFraction unitRef="number" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="2" name="vtrs:EquityMethodInvestmentsSummarizedFinancialDataBasis" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfMTUw_cf67537c-2246-4832-bb43-d9cd0faa2e56">100</ix:nonFraction>% basis for the three months ended March&#160;31, 2021 are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:continuation id="i45e710f14b144d218d6e4ac37df23a30"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.350%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfMy03LTEtMS01ODk3OQ_0d586028-e7ec-46c5-90dd-6f6b0c5a16b5">109.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfNC03LTEtMS01ODk3OQ_c9135dfd-5b2f-4fc5-a8c4-ca84a23dbacd">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating and non-operating expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfNS03LTEtMS01ODk3OQ_e7141dfd-21d2-413f-a46b-5e6fb17385a6">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfNi03LTEtMS01ODk3OQ_2e3f817a-4b01-45ab-b8d0-93217fa25479">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i352f9a83bee741b48b0162ac63eb116b">The Company&#8217;s net losses from its equity method investments included amortization expense related to the excess of the cost basis of the Company&#8217;s investment over the underlying assets of each individual investee. For the three months ended March&#160;31, 2021, the Company recognized net losses from equity method investments of $<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfNTA1_8a48cd19-891b-4058-a27f-a0af6e626740">17.9</ix:nonFraction> million, which were recognized as a component of other expense, net in the condensed consolidated statements of operations. The Company recognized the income tax credits and benefits from the clean energy investments as part of its provision for income taxes.</ix:continuation></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_73"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTc2Mw_7740daf7-5f80-4b4d-bffe-03574f360c10" continuedAt="if38d0834a83e43fe8c9e2323176492d1" escape="true">Earnings (Loss)&#160;per Share</ix:nonNumeric></span></div><ix:continuation id="if38d0834a83e43fe8c9e2323176492d1" continuedAt="i38dab09418234d12affac09ba3ea0f2b"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTc1Mg_097ead93-e650-4028-95bc-a641be1c29ab" escape="true">Basic earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTc1NA_a35e8435-bb27-407c-959a-2b58db678ebf" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNC01LTEtMS01ODk3OQ_1aa781b6-2cfa-421d-a929-6c4442f5b385">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNC03LTEtMS01ODk3OQ_1701f0f1-81f3-49f0-a843-430ea0281202">1,037.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNi01LTEtMS01ODk3OQ_7287e534-3261-493a-92fb-58aeabe6399a">1,210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNi03LTEtMS01ODk3OQ_6f62822d-a6c6-44fe-95aa-3a3ed3ada22e">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNy01LTEtMS01ODk3OQ_a0a80fa8-134a-4fc4-862b-967b29b2aa16">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNy03LTEtMS01ODk3OQ_5b1bf627-345c-4a4a-9bbe-f2a754ab02a6">0.86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTAtNS0xLTEtNTg5Nzk_1aa781b6-2cfa-421d-a929-6c4442f5b385">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTAtNy0xLTEtNTg5Nzk_1701f0f1-81f3-49f0-a843-430ea0281202">1,037.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTItNS0xLTEtNTg5Nzk_7287e534-3261-493a-92fb-58aeabe6399a">1,210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTItNy0xLTEtNTg5Nzk_6f62822d-a6c6-44fe-95aa-3a3ed3ada22e">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTMtNS0xLTEtNTg5Nzk_cfcbc739-befa-4343-ae95-55b7ed912aac">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTMtNy0xLTEtNTg5Nzk_210432ed-5c61-4e73-9025-c2c737218ada">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTQtNS0xLTEtNTg5Nzk_6eb9b7f3-38d7-45f4-bc02-25a07fd00187">1,213.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTQtNy0xLTEtNTg5Nzk_3e92f14e-c50a-43b3-96dd-f169af598400">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTUtNS0xLTEtNTg5Nzk_33fafc8c-be6b-424b-ba1f-1a4d2420f0a5">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTUtNy0xLTEtNTg5Nzk_2ecd9488-03aa-4e33-9be4-85bc38bed2fb">0.86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional stock awards and restricted stock awards were outstanding during the three months ended March&#160;31, 2022 and 2021, but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares at March&#160;31, 2022 include certain share-based compensation awards whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented <ix:nonFraction unitRef="shares" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTAwMQ_9e5709b4-1ab9-421a-b6f5-9aa238f1dc26">15.5</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTAxNQ_ae6c50c1-666c-436b-aa72-46e8e0683e6a">10.9</ix:nonFraction> million shares for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid a quarterly dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i286f6b049173419eb8a591dad67f9db8_D20220316-20220316" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDUxOQ_1af8de33-ed0f-455b-a552-15acb4bef112">0.12</ix:nonFraction> per share on the Company&#8217;s issued and outstanding common stock on March 16, 2022. On May 5, 2022, the Company&#8217;s Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2c8bb318051412cb62ce2064e9b0c5d_I20220505" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDUxMg_0c476a22-7f02-431f-bb9a-bf2b4a03ae6e"><ix:nonFraction unitRef="usdPerShare" contextRef="ibaa26d9c588c4182ac69aa58107614ff_D20220505-20220505" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDUxMg_5388a588-b574-40ed-ae01-cdba284c9a27">0.12</ix:nonFraction></ix:nonFraction> per share on the Company&#8217;s issued and outstanding common stock, which will be payable on June 16, 2022 to shareholders of record as of the close of business on May 24, 2022. The declaration and payment of future dividends to holders of the Company&#8217;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#8217;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2022, the Company announced that its Board of Directors had authorized a DRIP. The DRIP will allow shareholders to automatically reinvest all or a portion of the cash dividends paid on their shares of the Company&#8217;s common stock and to make certain additional optional cash investments in the Company&#8217;s common stock.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i38dab09418234d12affac09ba3ea0f2b">On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ic6ae763f13a34754b0fd888a4b714401_I20220228" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDQ5Nw_d007e3cf-ed09-46c0-8906-308e8a116984">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_76"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Goodwill and Intangible Assets</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODYy_f673b1bd-4499-4c6e-b366-a3f86844eb01" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2022 are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb635dccb0e2485ba7f187b187e581b3_I20211231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi0xLTEtMS01ODk3OQ_34cd31d9-54bf-402f-af40-4f8be4014d37">9,108.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f004bc05e4d45dcbf537fff903cba0a_I20211231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi0zLTEtMS01ODk3OQ_329ad2ab-042d-4afa-8e93-fd406244ee29">969.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752b23ca41c0414ca31a93d78f55cae9_I20211231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi01LTEtMS01ODk3OQ_c7f54027-549a-491b-aee9-9dac0dea401c">776.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e0a6768c4f4658ba5394068805bb7e_I20211231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi03LTEtMS01ODk3OQ_6c36c900-8d6f-421e-ac0a-9783c79ea96a">1,644.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi05LTEtMS01ODk3OQ_3e93911e-594a-464d-bb94-dd841b58209b">12,498.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb635dccb0e2485ba7f187b187e581b3_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy0xLTEtMS01ODk3OQ_0288da95-03e0-4261-8844-a30aae711937">385.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f004bc05e4d45dcbf537fff903cba0a_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy0zLTEtMS01ODk3OQ_0c07b1ba-1080-427b-a590-c6bc7a692db1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752b23ca41c0414ca31a93d78f55cae9_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy01LTEtMS01ODk3OQ_9f97ad81-0a09-4c8b-b1dc-3c5f3bc17cdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e0a6768c4f4658ba5394068805bb7e_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy03LTEtMS01ODk3OQ_b53a07b7-a823-4b3a-846e-e5e99aaff030">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy05LTEtMS01ODk3OQ_75379d2f-bb65-48a8-afd6-882da9ca003f">385.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb635dccb0e2485ba7f187b187e581b3_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC0xLTEtMS01ODk3OQ_41974709-cfa5-4692-9aba-f75933033f22">8,723.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f004bc05e4d45dcbf537fff903cba0a_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC0zLTEtMS01ODk3OQ_6c2a9331-231f-4a2b-a0f3-9c916f6c9a87">969.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752b23ca41c0414ca31a93d78f55cae9_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC01LTEtMS01ODk3OQ_8baa99f2-de5e-4bf2-92c9-18d2eac5e292">776.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e0a6768c4f4658ba5394068805bb7e_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC03LTEtMS01ODk3OQ_a900792b-b50b-46f6-9b62-0b8dec722eaa">1,644.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC05LTEtMS01ODk3OQ_220e6ae1-80d7-4f8a-8c71-5a64b5cc58e2">12,113.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS0xLTEtMS01ODk3OQ_cd28437e-4fb4-4079-ba1b-9af2f1793877">762.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS0zLTEtMS01ODk3OQ_fcb70ee6-2eac-4d10-9522-4f3ffcda5131">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS01LTEtMS01ODk3OQ_1fc0177b-2a8a-4256-b403-b4ab1bd4cc54">37.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS03LTEtMS01ODk3OQ_7d65a824-1b69-4dec-bc2f-b184b6ac5c53">151.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS05LTEtMS01ODk3OQ_d2dd022f-7ef8-44cd-a21c-d44946807337">953.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi0xLTEtMS01ODk3OQ_455ef652-55d0-4cb4-b89c-159d40d4c7f0">172.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi0zLTEtMS01ODk3OQ_eae99ca7-83d8-4cba-b278-4fe0e42148d3">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi01LTEtMS01ODk3OQ_ae94c2ba-f441-4033-949d-75093ebad28d">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi03LTEtMS01ODk3OQ_faf0d47b-5191-4c44-ba32-ef7f8f7a58b7">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi05LTEtMS01ODk3OQ_a0ebb16f-5ae6-4972-87fd-2a6d32251543">181.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy0xLTEtMS01ODk3OQ_8061c737-064b-482d-9c43-f4751d490d30">7,789.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy0zLTEtMS01ODk3OQ_b65947db-eeba-49b2-ba83-64b5b3aede13">967.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820840cef80c4d0abf74da03594e7239_I20220331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy01LTEtMS01ODk3OQ_10b7f972-ab9d-459c-ba2b-0508c3af6e3d">738.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy03LTEtMS01ODk3OQ_995543ed-7a9c-4266-9f31-99edfca74889">1,483.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy05LTEtMS01ODk3OQ_f734a5cc-561c-41c2-a26b-ce3420adbf4c">10,978.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS0xLTEtMS01ODk3OQ_070a6d14-d34d-40d9-8af3-b62c9bfe5f2e">8,174.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS0zLTEtMS01ODk3OQ_dd8a8e43-4398-47be-8e30-1542ba028afa">967.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820840cef80c4d0abf74da03594e7239_I20220331" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS01LTEtMS01ODk3OQ_604d627e-1e3a-4007-8663-929c96ab91fb">738.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS03LTEtMS01ODk3OQ_1dd65bbc-5ed9-487f-9fb1-5b903c5e4f7d">1,483.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS05LTEtMS01ODk3OQ_8548bdda-3f7e-47fd-933b-78ea9da92708">11,363.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtMS0xLTEtNTg5Nzk_a0fffcd7-7f12-4403-b287-f8c6fa35d6fa">385.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtMy0xLTEtNTg5Nzk_f1f4f2f2-1bf6-42e7-bd82-c8b373b89711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820840cef80c4d0abf74da03594e7239_I20220331" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtNS0xLTEtNTg5Nzk_688b428a-bf1e-4bbd-9dbc-63b72fe63d46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtNy0xLTEtNTg5Nzk_4dd5c43e-cf45-47a1-8073-95bb47c0e3ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtOS0xLTEtNTg5Nzk_6d64d8cf-2700-411e-850e-6504f0a43957">385.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtMS0xLTEtNTg5Nzk_2a9b8a6b-aaaf-4c10-af9b-44371734b31c">7,789.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtMy0xLTEtNTg5Nzk_342d2828-c2d3-45ce-addd-d15a3c477eed">967.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820840cef80c4d0abf74da03594e7239_I20220331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtNS0xLTEtNTg5Nzk_3d69dd2e-ab18-40fe-8652-2bcf99bfdafb">738.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtNy0xLTEtNTg5Nzk_814df981-b95c-43f9-95f1-7ad5842015e7">1,483.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtOS0xLTEtNTg5Nzk_f734a5cc-561c-41c2-a26b-ce3420adbf4c">10,978.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment annually on April 1st or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable. As a result of the Biocon Biologics Transaction (refer to Note 6 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Components </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information) and the decline in the Company&#8217;s share price during the first quarter of 2022, the Company performed an interim goodwill impairment test as of March 31, 2022. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its interim goodwill impairment test on a quantitative basis for its five reporting units, North America, Europe, Emerging Markets, JANZ, and Greater China. In estimating each reporting unit&#8217;s fair value, the Company performed an extensive valuation analysis, utilizing both income and market-based approaches. The determination of the fair value of the reporting units requires the Company to make significant estimates and assumptions that affect the reporting unit&#8217;s expected future cash flows. These estimates and assumptions, utilizing Level 3 inputs, primarily include, but are not limited to, market multiples, control premiums, the discount rate, terminal growth rates, operating income before depreciation and amortization, and capital expenditures forecasts. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the allocation of the Company&#8217;s total goodwill (prior to the reclassification of goodwill to assets held for sale) was as follows: North America $<ix:nonFraction unitRef="usd" contextRef="id0854ccbdb6a48ee945effcd9ab00b5f_I20220331" decimals="-7" name="vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk4NTc_3736ec28-816a-430e-b311-4bcec97a8bf8">3.61</ix:nonFraction>&#160;billion, Europe $<ix:nonFraction unitRef="usd" contextRef="i7d6f0a30fe8f420c8ddd936989792b64_I20220331" decimals="-7" name="vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk4NzI_648e775c-7be5-473c-a71a-f63e90ab875a">4.95</ix:nonFraction>&#160;billion, Emerging Markets $<ix:nonFraction unitRef="usd" contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331" decimals="-7" name="vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk4ODc_c9887667-f599-406c-81c0-f41feee0047b">1.64</ix:nonFraction>&#160;billion, JANZ $<ix:nonFraction unitRef="usd" contextRef="i820840cef80c4d0abf74da03594e7239_I20220331" decimals="-7" name="vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk5MDI_7ceeea54-1f91-41dc-92ee-dcbf201e8d0e">0.78</ix:nonFraction>&#160;billion and Greater China $<ix:nonFraction unitRef="usd" contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331" decimals="-7" name="vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk5MTc_f7861a0d-db7e-4e1f-b768-c63e64a6f2f7">0.97</ix:nonFraction>&#160;billion.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company determined that the fair value of the North America and Greater China reporting units was substantially in excess of the respective unit&#8217;s carrying value. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Europe reporting unit, the estimated fair value exceeded its carrying value by approximately $<ix:nonFraction unitRef="usd" contextRef="i7d6f0a30fe8f420c8ddd936989792b64_I20220331" decimals="-6" name="us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNjQ_e6482b07-90b4-425a-8597-575c704a889c">797</ix:nonFraction>&#160;million or <ix:nonFraction unitRef="number" contextRef="i7d6f0a30fe8f420c8ddd936989792b64_I20220331" decimals="3" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTc0MDY_80fdbe3c-cc3a-4737-93c8-83a5fe3e50fa">5.3</ix:nonFraction>% for the interim goodwill impairment test. As it relates to the income approach for the Europe reporting unit at March 31, 2022, the Company forecasted cash flows for the next <ix:nonNumeric contextRef="i6a2086ac5d6c416b8cc71c7c9d2219a7_D20220331-20220331" name="vtrs:GoodwillImpairmentMeasurementInputTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMzg0ODI5MDc3MjA3OQ_04e4264c-5543-4016-8562-73c4d4504c50">10</ix:nonNumeric> years. During the forecast period, the revenue compound annual growth rate was approximately <ix:nonFraction unitRef="number" contextRef="id333e02064fc4188b6fa4779c0cbfc27_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MTQ_88afee52-46b8-40e4-957b-d9ccedc31939">0.5</ix:nonFraction>%. A terminal year value was calculated with a negative <ix:nonFraction unitRef="number" contextRef="i4b9e3a7f9cd84f3382111f444d8fd22f_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MjA_c4ea711f-a29c-4dbc-867a-59966438f742">1.0</ix:nonFraction>% revenue growth rate applied. The discount rate utilized was <ix:nonFraction unitRef="number" contextRef="icd36615fdc104e8db3c91f5da47da6f3_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MjY_71baa09a-86e5-4aff-ac9c-7b7a7653e2ac">9.5</ix:nonFraction>% and the estimated tax rate was <ix:nonFraction unitRef="number" contextRef="i01f391ba0c104b98ac8794ec261fe166_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MzI_454b5883-6307-41b3-94ce-f1d96045f702">15.3</ix:nonFraction>%. Under the market-based approach, we utilized an estimated range of market multiples of <ix:nonFraction unitRef="number" contextRef="icb1ec291d2a84558b24739819de98b81_I20220331" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NDQ_481cc7cf-f3e3-4a67-95eb-4fbd53713953">7.5</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ide2d1af249e641b2bbe8c69bb9739743_I20220331" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1Mzk_192b9238-9f41-4aa8-9e58-fe5f7753f607">8.0</ix:nonFraction> times EBITDA plus a control premium of <ix:nonFraction unitRef="number" contextRef="i818820f897ea49ce9285f09c3e769eef_I20220331" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NDk_7723d6d6-c864-4eb6-b691-491bc3da6688">15.0</ix:nonFraction>%. If all other assumptions are held constant, a reduction in the terminal value growth rate by <ix:nonFraction unitRef="number" contextRef="i1a466c9613234adb9f17ffade4f5a431_I20220331" decimals="3" sign="-" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NjI_3da824df-9235-4b4b-ac7a-367b8063eae8">3.0</ix:nonFraction>% or an increase in discount rate by <ix:nonFraction unitRef="number" contextRef="i4d62cc2f2fbf44be90f3fd74e62058f7_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NTY_133a544d-1ee0-4e28-b493-853887ac3900">1.5</ix:nonFraction>% would result in an impairment charge for the Europe reporting unit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the JANZ reporting unit, the estimated fair value exceeded its carrying value by approximately $<ix:nonFraction unitRef="usd" contextRef="i820840cef80c4d0abf74da03594e7239_I20220331" decimals="-6" name="us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNzk_f2afed59-7a12-45d8-b627-4396b35f0d70">231</ix:nonFraction>&#160;million or <ix:nonFraction unitRef="number" contextRef="i820840cef80c4d0abf74da03594e7239_I20220331" decimals="3" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczOTY_49aaef40-b076-46c0-8492-457da185e72e">7.4</ix:nonFraction>% for the interim goodwill impairment test. As it relates to the income approach for the JANZ reporting unit at March 31, 2022, the Company forecasted cash flows for the next <ix:nonNumeric contextRef="i644ef34e48024030985c3c07b31dd73b_D20220331-20220331" name="vtrs:GoodwillImpairmentMeasurementInputTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMzg0ODI5MDc3MjA5NQ_4ec632a7-0ef9-4d28-94ca-d423fa069da1">10</ix:nonNumeric> years. During the forecast period, the revenue compound annual growth rate was approximately negative <ix:nonFraction unitRef="number" contextRef="i6cf43177df974a66a92ba7c52d11995c_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NzI_f9e1c67f-04af-4010-a30d-1aea033ac854">4.8</ix:nonFraction>%. A terminal year value was calculated assuming <ix:nonFraction unitRef="number" contextRef="iafaccb0fcfc84110aeb682de67ac7598_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNTA_77df67ce-bd5b-4381-84a4-b74de7326842">no</ix:nonFraction> revenue growth. The discount rate utilized was <ix:nonFraction unitRef="number" contextRef="i4a75f125239e4b0dba35bc1553cb1180_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczMjE_7be0a879-a015-4414-a1b1-67142f029f70">6.0</ix:nonFraction>% and the estimated tax rate was <ix:nonFraction unitRef="number" contextRef="i2c6e60c0df4e41c9bebb8ff1ffb5fda7_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczMjk_a76633c6-29d8-4eaa-82ce-ad68060d396c">30.4</ix:nonFraction>%. Under the market-based approach, we utilized an estimated market multiple of <ix:nonFraction unitRef="number" contextRef="i61d256d33cc44601b273de07772fa27f_I20220331" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczMzY_2e73d154-c526-4981-b245-cfed1e191b2d">6.0</ix:nonFraction> times EBITDA plus a control premium of <ix:nonFraction unitRef="number" contextRef="if9c68f36a2124e6f86cc33905c166b9a_I20220331" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNDE_436d22ee-7863-431f-8e4d-08df83ddb916">15.0</ix:nonFraction>%. If all other assumptions are held constant, a reduction in the terminal value growth rate by <ix:nonFraction unitRef="number" contextRef="ic1428e3de2174baeb5d4ae097870b5b2_I20220331" decimals="3" sign="-" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1Nzg_47254988-2f99-41dc-8155-54107e613290">3.5</ix:nonFraction>% or an increase in discount rate by <ix:nonFraction unitRef="number" contextRef="id49e7597eca549ac831d9ddf6e7f90c6_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1ODQ_1ba86cb7-b455-491c-8fc5-55798980b079">2.0</ix:nonFraction>% would result in an impairment charge for the JANZ reporting unit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Emerging Markets reporting unit, the estimated fair value exceeded its carrying value by approximately $<ix:nonFraction unitRef="usd" contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331" decimals="-6" name="us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2NzA_4de093a6-ba25-4283-84b2-5a8f67a6dc48">816</ix:nonFraction>&#160;million or <ix:nonFraction unitRef="number" contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331" decimals="3" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2OTA_afe6a223-ecdd-4c46-be12-db59f5a2608e">10.3</ix:nonFraction>% for the interim goodwill impairment test. As it relates to the income approach for the Emerging Markets reporting unit at March 31, 2022, the Company forecasted cash flows for the next <ix:nonNumeric contextRef="i5e1a767e23ce445bb33d791ad179db05_D20220331-20220331" name="vtrs:GoodwillImpairmentMeasurementInputTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMzg0ODI5MDc3MjExMQ_c18fb67f-4e17-4b48-ac64-60cc914ab520">10</ix:nonNumeric> years. During the forecast period, the revenue compound annual growth rate was approximately <ix:nonFraction unitRef="number" contextRef="i55c3c1a407b84d5394d09bf25fdf32eb_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MzY_de570d1c-5ce5-46a6-a4f2-97990d460ad3">1.6</ix:nonFraction>%. A terminal year value was calculated with a <ix:nonFraction unitRef="number" contextRef="ia6f95d2c71ab4e0fae07e7b6378dcf77_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2Mjk_cfa34f2b-85cb-41b1-ac70-027a0e2b3d9b">0.8</ix:nonFraction>% revenue growth rate applied. The discount rate utilized was <ix:nonFraction unitRef="number" contextRef="i3aaa3d21b6224eb5a1c10a50ead809a2_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MjI_d8d34f4f-3d00-4202-9c3a-a93c335d4063">10.5</ix:nonFraction>% and the estimated tax rate was <ix:nonFraction unitRef="number" contextRef="ib03b774597744b8b834dd7a887f814c2_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MTU_cea94134-22c5-4b44-9699-99c41995d573">18.4</ix:nonFraction>%. Under the market-based approach, we utilized an estimated market multiple of <ix:nonFraction unitRef="number" contextRef="idc71de7a5d384a43a72d12d1445db364_I20220331" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MTA_3f368b68-c1b8-4e71-9ce7-807e73e915c3">7.5</ix:nonFraction> times EBITDA plus a control premium of <ix:nonFraction unitRef="number" contextRef="if9c68f36a2124e6f86cc33905c166b9a_I20220331" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MDM_2537cfea-089a-47fb-ac84-89f4a73825f7">15.0</ix:nonFraction>%. If all other assumptions are held constant, a reduction in the terminal value growth rate by approximately <ix:nonFraction unitRef="number" contextRef="i8f3b4b5b39b34c1089e08a978b8bc67e_I20220331" decimals="3" sign="-" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1OTA_8780b4e4-21b2-4db3-a9e8-489171bc9942">8.5</ix:nonFraction>% or an increase in discount rate by <ix:nonFraction unitRef="number" contextRef="i8cfb365259e146c6bba35a35319a19c5_I20220331" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1OTc_8218ed49-d979-40cb-bee8-8f228e8a2e61">3.0</ix:nonFraction>% would result in an impairment charge for the Emerging Markets reporting unit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty involved in making these estimates, actual results could differ from those estimates. In addition, changes in underlying assumptions, especially as they relate to the key assumptions detailed, could have a significant impact on the fair value of the reporting units.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the completion of the interim goodwill impairment test, the Company allocated goodwill of $<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GoodwillTransfers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTY0OTI2NzUwMTM5OA_d2dd022f-7ef8-44cd-a21c-d44946807337">953</ix:nonFraction>&#160;million to its biosimilars portfolio using a relative fair value approach and then reclassified the amount to assets held for sale in conjunction with the Biocon Biologics Transaction.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODk2_7bb6c1c0-d35d-4c31-804e-f854e1e8ebe8" continuedAt="i00cc0cf607174733a026eec0f5be92ce" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following components at March&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica9478897d044e4bbb3db8f4e11cc304_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi0xLTEtMS01ODk3OQ_922602b4-ae6d-48a5-a49b-3b02c8857691">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi0zLTEtMS01ODk3OQ_129b77c3-b2c3-4d60-acaa-e1f7ee159fa6">38,550.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi01LTEtMS01ODk3OQ_cf406ef4-051e-46cd-bf89-8d5ca662b779">13,344.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi03LTEtMS01ODk3OQ_7f0397c4-0801-42eb-abd4-fe8ef8a79e02">25,206.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMy0zLTEtMS01ODk3OQ_b1f4428a-b6a9-47f6-8a1a-c0157e6e006b">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMy03LTEtMS01ODk3OQ_79a69b6c-c055-4b34-adee-f1cfe38c5dd5">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNC0zLTEtMS01ODk3OQ_3ef3db7a-535c-4077-99b0-4e410d71ad04">38,596.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNC01LTEtMS01ODk3OQ_55b7116e-4b87-4017-9139-5db212282436">13,344.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNC03LTEtMS01ODk3OQ_f3329e87-0a20-4bb3-bd3a-d2f63aac3d6c">25,251.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4601448e1f8540a6ba7701a19f013bd5_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi0xLTEtMS01ODk3OQ_8a974647-9760-4628-bfd1-2d566053396b">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi0zLTEtMS01ODk3OQ_18a61266-02c8-4309-80a4-2d865ce041d7">39,006.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi01LTEtMS01ODk3OQ_5c264941-d2a2-4c84-a297-0b51d470d831">12,918.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi03LTEtMS01ODk3OQ_c485e54d-ed74-4257-808b-923a42979d6b">26,087.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNy0zLTEtMS01ODk3OQ_7f7a2b7c-173d-4341-bfbe-b59cabcb882a">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNy03LTEtMS01ODk3OQ_74112713-e9e8-4007-ae04-cea8b873b750">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfOC0zLTEtMS01ODk3OQ_b99da3e3-c199-45db-bef8-dbd077427af2">39,052.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfOC01LTEtMS01ODk3OQ_e87ddef4-01ee-4b42-a3cd-5bfaa755ed32">12,918.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfOC03LTEtMS01ODk3OQ_5a087041-c4a4-456a-ac5c-6303664e6ba4">26,134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="i00cc0cf607174733a026eec0f5be92ce" continuedAt="i2d3d4b6e506e4db68b8a1948dd9db1d8">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"><ix:continuation id="i2d3d4b6e506e4db68b8a1948dd9db1d8">Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense, which is classified primarily within cost of sales in the condensed consolidated statements of operations for the three months ended March&#160;31, 2022 and 2021 totaled:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODgx_9c2edef5-e217-4b56-b946-3e11e4a6478a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfMy01LTEtMS01ODk3OQ_1dc11947-1205-45e4-9444-2574ff14343c">648.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfMy03LTEtMS01ODk3OQ_0a8b7518-a640-410b-87d0-b32593daa42d">684.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNC01LTEtMS01ODk3OQ_8bed7d9b-406e-45cb-a5ba-9deb075e8517">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNC03LTEtMS01ODk3OQ_4587b953-8b95-4eaf-ad9d-6c2ee7fd212f">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible asset amortization expense (including impairment charges)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNi01LTEtMS01ODk3OQ_140370b3-4d64-4597-9f41-544f74446827">648.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNi03LTEtMS01ODk3OQ_1298a1b1-dd5e-4bbb-9563-13979ef28280">767.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2021, the Company completed an agreement to divest a group of OTC products in the U.S. As a result of this transaction, the Company recognized an intangible asset impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTA5OTUxMTY2MTE2MQ_4587b953-8b95-4eaf-ad9d-6c2ee7fd212f">83.4</ix:nonFraction> million during the three months ended March 31, 2021. </span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODY2_6652d4f0-d280-46fe-af12-067dd774390a" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense over the remainder of 2022 and for the years ending December&#160;31, 2023 through 2026 is estimated to be as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:88.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfMS0xLTEtMS01ODk3OQ_43680767-9b69-4901-91e2-9782b4f99353">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfMi0xLTEtMS01ODk3OQ_bb73cbf7-5c50-432b-b242-c7aeb43c9aad">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfMy0xLTEtMS01ODk3OQ_9801dc15-1a4a-46a1-820b-cf7f5b9460a6">2,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfNC0xLTEtMS01ODk3OQ_2cd03095-0d73-4bf9-9c89-14fdcd8b088a">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfNS0xLTEtMS01ODk3OQ_1fa7b0a0-445d-411b-85ff-39367e221dc1">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_79"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"> Financial Instruments and Risk Management </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain financial risks relating to its ongoing business operations. The primary financial risks that are managed by using derivative instruments are foreign currency risk and interest rate risk.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage certain foreign currency risks, the Company enters into foreign exchange forward contracts to mitigate risk associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities. The foreign exchange forward contracts are measured at fair value and reported as current assets or current liabilities on the condensed consolidated balance sheets. Any gains or losses on the foreign exchange forward contracts are recognized in earnings in the period incurred in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also entered into forward contracts to hedge forecasted foreign currency denominated sales from certain international subsidiaries and a portion of forecasted intercompany inventory sales denominated in Euro, Japanese Yen and Chinese Renminbi for up to eighteen months. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities on the condensed consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are deferred in AOCE and are reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries by either borrowing directly in foreign currencies and designating all or a portion of the foreign currency debt as a hedge of the applicable net investment position or entering into foreign currency swaps that are designated as hedges of net investments. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated certain Euro and Yen borrowings as a hedge of its investment in certain Euro-functional and Yen-functional currency subsidiaries in order to manage foreign currency translation risk. Borrowings designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of AOCE until the sale or substantial liquidation of the underlying net investments. In addition, the Company manages the related foreign exchange risk of the Euro and Yen borrowings not designated as net investment hedges through certain Euro and Yen denominated financial assets and forward currency swaps. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the principal amounts of the Company&#8217;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges: </span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount Designated as a Net Investment Hedge</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i168375750af04b89bb5edbe12849ea57_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMi0yLTEtMS01ODk3OQ_c4ebebfd-ab85-4fbe-b649-1d2a34a58ff0">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i168375750af04b89bb5edbe12849ea57_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMi00LTEtMS01ODk3OQ_5ea78b87-80cf-414e-ab9f-ef9a95bb792b">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia67acd3202fe49928ecd11cf6bb82d49_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMi02LTEtMS01ODk3OQ_2759f9c8-b191-4c04-be27-8b1ca8aedec6">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Euro Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4e25a7630854faa8b10ecbe7048f2c1_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMy0yLTEtMS01ODk3OQ_cd5bff5d-0f4b-4581-b160-22f74814356b">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4e25a7630854faa8b10ecbe7048f2c1_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMy00LTEtMS01ODk3OQ_abd2f5a8-d5bf-4415-a61f-02fdaab3f82f">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i185546023b6e445993a678e5d4722fff_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMy02LTEtMS01ODk3OQ_8d7a7342-ed80-4a4d-87c7-dad89cf8fff2">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125% Euro Senior Notes due 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibc273f6b86c64387bac8a24acd1ec9cc_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNS0yLTEtMS01ODk3OQ_403244b4-5521-4fd2-a98b-f1f4a09031e3">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibc273f6b86c64387bac8a24acd1ec9cc_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNS00LTEtMS01ODk3OQ_00f670e2-154e-4702-ad4d-6ed732709fec">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i64717797560f4b29aaf331840961ba46_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNS02LTEtMS01ODk3OQ_b653f2fb-a4e5-46e6-b82a-5f9be2f3d899">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.816% Euro Senior Notes due 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5e7c0c2a027c4880bf99a89c7fb9f689_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNi0yLTEtMS01ODk3OQ_e3a7b6dc-d938-415a-860e-16db3a273137">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5e7c0c2a027c4880bf99a89c7fb9f689_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNi00LTEtMS01ODk3OQ_2c58c20f-1cb2-4cdb-940e-90283b4e7fd6">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3248c8cc8d1d4263a978a30127f1f7be_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNi02LTEtMS01ODk3OQ_0d8fddba-013c-488b-9cef-ca99b75c0b99">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if30ad4912b2043e7b71727fd26678a9d_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNy0yLTEtMS01ODk3OQ_5887e8f4-7a83-456c-9d53-9525fcdec688">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if30ad4912b2043e7b71727fd26678a9d_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNy00LTEtMS01ODk3OQ_28679b0d-12c9-4766-accc-c7d1f7a691f6">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2c2ac9f4fde4bc0a2f15e30264bf399_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNy02LTEtMS01ODk3OQ_b064aefb-5e43-40e6-8236-60008bd720f4">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362% Euro Senior Notes due 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ba0871dd394cf28d8d432a947229c7_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOC0yLTEtMS01ODk3OQ_ac96608b-12c3-4c93-aacb-f4b07729d0cc">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ba0871dd394cf28d8d432a947229c7_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOC00LTEtMS01ODk3OQ_48c083ec-dc76-4026-95ca-149e8c5348fa">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i29c57a318497434ea45fb2cedd9123a4_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOC02LTEtMS01ODk3OQ_861f533f-1267-4db9-bbfc-213a29bbc44b">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908% Euro Senior Notes due 2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6af29a91f22a4587acfbe0f78b537ef4_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOS0yLTEtMS01ODk3OQ_d31006c0-8505-4048-937e-18d8299433f2">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6af29a91f22a4587acfbe0f78b537ef4_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOS00LTEtMS01ODk3OQ_27ca8ebe-d274-47ab-81d5-e5c3d62fea62">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibde372d79c2146ddadac6aed84087ad7_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOS02LTEtMS01ODk3OQ_74d3569e-dd56-4e04-8557-60e5eede5587">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46d8094561c746b4943fe946808e87b4_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTEtMi0xLTEtNTg5Nzk_3e5aa6c5-c4b4-4bb6-aa4f-3baf50fc21d9">5,850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46d8094561c746b4943fe946808e87b4_I20220331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTEtNC0xLTEtNTg5Nzk_aa9954b8-6816-406c-94f7-d710576ae304">5,850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i489b4bee565a43f1b5c420df05100124_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTEtNi0xLTEtNTg5Nzk_5606a952-155c-4ada-8dd9-a7f97f271881">5,850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="ibddc3eacd6dd4edfae437c8842c62937_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTQtMi0xLTEtNjEyODc_8df65ca0-8510-4e65-a15c-3c58558f95e3">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="ibddc3eacd6dd4edfae437c8842c62937_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTQtNC0xLTEtNjEyODc_1692484f-52c2-4301-820c-a6a561085393">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i2666c0b7ccc347c8bdd95d798a089cf1_I20211231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTQtNi0xLTEtNjEyOTM_5a686b51-0c30-4269-8d15-1ba1a14cce55">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i46d8094561c746b4943fe946808e87b4_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTUtMi0xLTEtNjEyODc_8b5ae916-5b19-4a1d-866e-075375c1acda">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i46d8094561c746b4943fe946808e87b4_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTUtNC0xLTEtNjEyODc_aa97bd2c-efaa-4660-b40d-2628d9a0c08e">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i489b4bee565a43f1b5c420df05100124_I20211231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTUtNi0xLTEtNjEyOTM_002e4f28-857f-4dfe-a519-fbb098585ab5">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31,2022, the principal amount of the Company&#8217;s outstanding Yen borrowings and the notional amount of the Yen borrowings designated as net investment hedge was $<ix:nonFraction unitRef="usd" contextRef="i2315c69a559e4eae91ade095257f342e_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfMTA5OTUxMTYzNzYwMQ_b9973635-d010-4e7d-a6e1-2755ede463d5">328.7</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into interest rate swaps from time to time in order to manage interest rate risk associated with the Company&#8217;s fixed-rate and floating-rate debt. Interest rate swaps that meet specific accounting criteria are accounted for as fair value or cash flow hedges. All derivative instruments used to manage interest rate risk are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. For fair value hedges, the changes in the fair value of both the hedging instrument and the underlying debt obligations are included in interest expense. For cash flow hedges, the change in fair value of the hedging instrument is deferred through AOCE and is reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant loss from the failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. Certain derivative instrument contracts entered into by the Company are governed by master agreements, which contain credit-risk-related contingent features that would allow the counterparties to terminate the contracts early and request immediate payment should the Company trigger an event of default on other specified borrowings. The Company records all derivative instruments on a gross basis in the condensed consolidated balance sheets. Accordingly, there are no offsetting amounts that net assets against liabilities. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:nonNumeric contextRef="i24df969ffb85419eae1c0c148008a809_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTIzMw_de43511e-5195-414d-aa6f-dba2fba1be7d" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:33.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td></tr><tr style="height:15pt"><td colspan="24" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1191c9e9a6448b388ec9d255cffdfa0_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS0yLTEtMS01ODk3OQ_d5145f43-de94-4dab-9f9f-ec9cac8d25b4">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a60db9d80e0425e83e2738fe92d001c_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS0zLTEtMS01ODk3OQ_2872f80c-01a2-4790-a100-98c186fa24eb">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6831aec7acf4e11b1bc17696acc3144_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS02LTEtMS01ODk3OQ_813f417a-ff35-45e2-9055-70162d77c689">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ca1a79cd858475c8b6530e800e63398_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS03LTEtMS01ODk3OQ_d7ac49ae-ef9a-40f2-8eeb-9fc38c5f9434">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdb2ff01ac847c19778cd87d74222f1_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi0yLTEtMS01ODk3OQ_42140a32-8558-46d7-9b0f-c5eaa4d62350">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b01b262a9d74022bcf13a779fe76cca_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi0zLTEtMS01ODk3OQ_3b236cc1-8b03-4e08-954b-9fc9e674dbc3">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdb2ff01ac847c19778cd87d74222f1_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi02LTEtMS01ODk3OQ_5a3864cd-aa2a-4bbf-b909-9c98ccbd6219">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b01b262a9d74022bcf13a779fe76cca_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi03LTEtMS01ODk3OQ_275fb67c-a68a-4e6a-9bb3-2aa7acb4bca7">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740a3710177c4f15a0f461ce34a65593_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC0yLTEtMS01ODk3OQ_bdd73a3d-9997-41aa-9d9f-bb01fb595f10">138.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9864394108cb4f43a773c02f1d88b974_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC0zLTEtMS01ODk3OQ_2f2b9a93-4ecb-42b1-b145-0350d8cd342d">82.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3710c0edc8c84beeb61925296b505b14_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC02LTEtMS01ODk3OQ_2119fb9e-a105-423a-b84c-624826684dac">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21bb23c7f724ec68483061e279115c5_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC03LTEtMS01ODk3OQ_58c9dd1e-40b2-45b9-b282-6aaa8dd6b2cf">56.7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58199c3b9d0f49d7b609e6c79d1d2858_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS0yLTEtMS01ODk3OQ_ee7f6757-69fa-41c7-8751-11f91bba5ec8">138.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia358047e46fc47289a9c1fc7e5a31fea_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS0zLTEtMS01ODk3OQ_a989ac4a-8b1e-4062-97f7-c760f8d81cd6">82.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58199c3b9d0f49d7b609e6c79d1d2858_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS02LTEtMS01ODk3OQ_af8e80a8-2be4-4a17-a059-be3c00505bd8">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia358047e46fc47289a9c1fc7e5a31fea_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS03LTEtMS01ODk3OQ_fb484d22-b2b8-46c5-8d19-e140824dcd31">56.7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtMi0xLTEtNTg5Nzk_9289c09a-12b6-4714-ab6e-612cbb4f048c">202.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtMy0xLTEtNTg5Nzk_aeb695a3-f99e-44a5-b595-5804b3c884c2">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtNi0xLTEtNTg5Nzk_6faab031-6173-49ec-9f01-96e54a614dc4">98.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtNy0xLTEtNTg5Nzk_15fc38ed-b066-4f75-82b5-9efe681d70be">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in Earnings</span></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives</span></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Reclassified from AOCE into Earnings </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9296c20f324c8fafc1080799a70da3_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy00LTEtMS01ODk3OQ_14da197f-e543-44c5-bff7-a3598844500d">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4474a8a96541b39e3b1d4e792ff2c0_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy01LTEtMS01ODk3OQ_c53fb666-a9b4-46d4-940b-0fae693be27e">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20f8c33191c4815bf929abe5e50121a_D20220101-20220331" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy02LTEtMS01ODk3OQ_759e7500-89dd-44fb-bf80-c16dfc2c477a">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a2e2ea84564d72a4afb25e8c4ec35c_D20210101-20210331" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy03LTEtMS01ODk3OQ_1fa28ffe-77d0-43cc-9ecc-60599dfa4c0f">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb235bc6a0834cf8b1051570d9efcfd2_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC00LTEtMS01ODk3OQ_7a5f4359-1637-44ad-a412-90b172cfe470">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b19775d069f423880e9edef937484af_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC01LTEtMS01ODk3OQ_1c4fe6c5-9a53-4e7b-bb51-45421e0f47a4">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbdf89a5e09043f89d464a52f1f1cbcf_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC02LTEtMS01ODk3OQ_da1e3edf-376f-49b3-80fc-d346ef16cedb">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia669f6d3e67f4786bbd8d4cfa62c4a11_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC03LTEtMS01ODk3OQ_0cf51808-af3e-4101-a6ed-28f5b0ef4c39">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency borrowings and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21734e807cd4e47b6955ff0fcbecc9c_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTAtNC0xLTEtNTg5Nzk_e171c4c3-5df4-4598-a8cc-511a9a69f3f2">156.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf147b8a161451fa1f8ea341adcecb0_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTAtNS0xLTEtNTg5Nzk_98e67450-e702-4211-a7d2-43d12f6d9f15">258.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a1b50cf22c46cba7f94a3405c8b929_D20220101-20220331" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTItMi0xLTEtNTg5Nzk_51f9ec4a-c5d4-4791-aca2-cbe228146e00">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d8935dcf644389a84187c0bf9ec7f2_D20210101-20210331" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTItMy0xLTEtNTg5Nzk_5a0827b1-9b16-488c-9d93-00a4bd077ded">35.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtMi0xLTEtNTg5Nzk_e5da1ae8-28db-4ecd-b0d5-6c64d01a23ad">21.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtMy0xLTEtNTg5Nzk_2f32f952-12c2-4e3d-832d-45d811954a95">35.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNC0xLTEtNTg5Nzk_a27bf3a2-71c0-422f-b857-58cbba060e78">165.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNS0xLTEtNTg5Nzk_e3e45a50-0983-46c7-bb45-e24c41ce7ea3">263.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNi0xLTEtNTg5Nzk_ae1bd591-232a-4c17-8214-6ce029f41736"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNi0xLTEtNTg5Nzk_f9b543b1-a0b2-43a5-830b-28f1855153ee">13.1</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNy0xLTEtNTg5Nzk_f813d294-49b1-4fb9-9a66-9686a5f04c4b">5.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">At March&#160;31, 2022, the Company expects that approximately $<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfNDgzMA_5be172ef-8066-4ceb-acbc-2900ac8af3cc">22.0</ix:nonFraction> million of pre-tax net gains on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) recognized in earnings on derivatives.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) reclassified from AOCE into earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurement</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTI1NA_53626ca6-71a4-40f4-adba-5316694d30ca" continuedAt="i36faf20b3d5a4e3db8f91a4cb201ac76" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i36faf20b3d5a4e3db8f91a4cb201ac76"><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.</span></div></ix:continuation><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTI0Ng_28625908-2d77-4899-8b36-c624e5d4e700" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b41955007d149708ebff22ad2acdb2b_I20220331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNS0xLTEtMS01ODk3OQ_b48ab8be-64dc-4376-b273-92e5bad7f852">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bcaaa4b3194bcd9c8ab64e7e506f0f_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNS03LTEtMS01ODk3OQ_67c65d32-f7e4-4cd0-acb4-8c32eb2e23cc">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47baa2563274d178d24b9c707cec448_I20220331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNi0xLTEtMS01ODk3OQ_cf928877-d8a3-438b-ba56-8a7633b304ab">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c37287ee4c4f9baecb393bab99f75a_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNi03LTEtMS01ODk3OQ_361fddd7-c95a-4022-942d-77f1042a6a6f">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a3013e3234d4648b00f091ea9483ca7_I20220331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOC0xLTEtMS01ODk3OQ_89f0a016-7743-48e5-ae3a-ed34e89a4870">47.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4740a19848394a6490ab4788151155ac_I20211231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOC03LTEtMS01ODk3OQ_83e41551-7254-4056-a1cb-731583f12a70">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b8800864c446e3bfb4396ac7251eba_I20220331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOS0xLTEtMS01ODk3OQ_3156dad4-0107-471c-8b6a-b86bb3777a34">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13cab697039642b0953eef067bf76e23_I20211231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOS03LTEtMS01ODk3OQ_f5da12cc-e069-4d35-9888-ea3693c81781">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47baa2563274d178d24b9c707cec448_I20220331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTAtMS0xLTEtNTg5Nzk_827b089e-c09b-418c-af54-6d15e4a64e60">48.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c37287ee4c4f9baecb393bab99f75a_I20211231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTAtNy0xLTEtNTg5Nzk_34fc90e6-d37a-4c52-9604-73c7e9096e16">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5318b8966de4c9ab5c12c99f7de2b32_I20220331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTItMy0xLTEtNTg5Nzk_34703ac0-c560-4011-ab02-14c543db084a">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677b7ff6d33c441eaf16aa67eb7dc18f_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTItOS0xLTEtNTg5Nzk_c1a496f7-b678-4d56-88d4-f13a9ec5fc77">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820b54ced26a43b8942c3d0dc474c2aa_I20220331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTMtMy0xLTEtNTg5Nzk_c4cbe3bd-833a-4ed9-ba51-9e1fd5e4f36b">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffddd3ebd9249b282c2a947e3995e55_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTMtOS0xLTEtNTg5Nzk_8eb8dd84-e681-4608-bbc8-20bb87af6d10">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3240de2751ea4f6caf10457b795b3d54_I20220331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTQtMy0xLTEtNTg5Nzk_fdb8264c-59b5-4b21-b9f1-1f82b3337549">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a9183eea87483492bb05c98ca32541_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTQtOS0xLTEtNTg5Nzk_22527daa-1bfc-4516-b732-334ad32ebd26">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica31ae73f51947efba3f84f2f5e73f75_I20220331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTUtMy0xLTEtNTg5Nzk_c58429e9-8a2f-431f-803f-03a23eaa5b31">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f6d283f86b4446cade80f58f4010940_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTUtOS0xLTEtNTg5Nzk_04042840-1973-437f-9b04-d8e746273093">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c01cb8bf2d74226a4d1bb1d254e5e1d_I20220331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTYtMy0xLTEtNTg5Nzk_ffa530e0-3920-4465-b5d0-3aad398a3cc0">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c1042f293c4a6cb388f7e3e3500abc_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTYtOS0xLTEtNTg5Nzk_c4e73a00-1a11-475f-86ef-8e52ef6ddb89">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4b6849d2bc41cab8e20fa6106f5c67_I20220331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTctMy0xLTEtNTg5Nzk_c2b2761f-1cd0-4bfc-ac19-b4dbe14f4a27">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64bab9ba75b1441cb4e430c740dd70d0_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTctOS0xLTEtNTg5Nzk_ec0f1671-1834-4266-bca8-a4f696d3da8b">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010e212468d14224aaf4661c0271995c_I20220331" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTgtMy0xLTEtNTg5Nzk_2a333fce-3151-4993-8c0b-be367b46ad32">202.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbb6f6a4865a4b13846c0311a8198fc1_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTgtOS0xLTEtNTg5Nzk_70dd63bd-0ac8-4d94-9eba-0c6458a89464">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47baa2563274d178d24b9c707cec448_I20220331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtMS0xLTEtNTg5Nzk_8fda7d3f-dbf8-42b5-a537-9cd6b92ca1e4">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a6d2ba35574c48b54a634add899b86_I20220331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtMy0xLTEtNTg5Nzk_f494dcfa-3e7e-465e-8235-78d5c93b0dc5">239.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c37287ee4c4f9baecb393bab99f75a_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtNy0xLTEtNTg5Nzk_384e2751-abf5-44f0-92d1-06fa8016b12d">101.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77480a5aa2164b569a9e91f030454ffb_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtOS0xLTEtNTg5Nzk_a92f3e06-02ce-4e26-8579-b85c5baebed3">182.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010e212468d14224aaf4661c0271995c_I20220331" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjMtMy0xLTEtNTg5Nzk_29c13341-6360-486d-ba42-d97010b6d601">98.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbb6f6a4865a4b13846c0311a8198fc1_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjMtOS0xLTEtNTg5Nzk_dd693826-c4e4-4db1-8f65-4d1dc7976c41">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1194fb7125fd48feb4af6f6c94758641_I20220331" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjQtNS0xLTEtNTg5Nzk_984e1a37-8e8f-4b26-86cf-211429ce33c4">198.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjQtMTEtMS0xLTU4OTc5_84737019-6e41-4cb9-9f44-29150a846cf9">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a6d2ba35574c48b54a634add899b86_I20220331" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtMy0xLTEtNTg5Nzk_5837d294-b5f0-48eb-ae8e-8d7e04c60918">98.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77dc0798004d44c791a5bbb08b126c3e_I20220331" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtNS0xLTEtNTg5Nzk_0c462e3b-76bf-49b7-a3af-4d6935e8fb8f">198.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77480a5aa2164b569a9e91f030454ffb_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtOS0xLTEtNTg5Nzk_941d0c06-8803-40d7-b7a7-5257cd782646">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdd0591acbe4bef9892e17e437e510c_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtMTEtMS0xLTU4OTc5_227eb6dd-a973-46ba-8d6c-d69e4d78dad4">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities that utilize Level&#160;2 inputs, the Company utilizes both direct and indirect observable price quotes, including the LIBOR yield curve, foreign exchange forward prices and bank price quotes. Below is a summary of valuation techniques for Level&#160;1 and Level&#160;2 financial assets and liabilities:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at observable net asset value prices.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, exchange traded funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the active quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, marketable securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted stock prices from public exchanges at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the condensed consolidated statements of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale fixed income investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value, net of income taxes, are included in accumulated other comprehensive loss as a component of shareholders&#8217; equity.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign exchange derivative assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted forward foreign exchange prices and spot rates at the reporting date. Counterparties to these contracts are highly rated financial institutions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurement of contingent consideration is determined using Level 3 inputs. The Company&#8217;s contingent consideration represents a component of the total purchase consideration for Pfizer&#8217;s respiratory delivery platform and certain other acquisitions. The measurement is calculated using unobservable inputs based on the Company&#8217;s own assumptions primarily related to the probability and timing of future development and commercial milestones and future profit sharing payments which are discounted using a market rate of return. At March&#160;31, 2022 and December&#160;31, 2021, a discount rate of <ix:nonFraction unitRef="number" contextRef="ic828aa0199d948a4a260f04156670656_I20220331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfODU2Mg_ded1a51c-0d12-4617-857e-fd99acf0857c">8.0</ix:nonFraction>% was utilized in the valuations. Significant changes in unobservable inputs could result in material changes to the contingent consideration liability.</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTI0MQ_f172b321-5930-4a95-b28a-9ac599d6689c" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2021 to March&#160;31, 2022 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8ebd1f9f2b43aea75b756394d24cc8_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMS0xLTEtMS01ODk3OQ_19cc38be-b9dc-4cc9-9687-25a0b3705075">66.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bfda8fa6a3472ab6b18074c291d3ba_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMS0zLTEtMS01ODk3OQ_fa38e2d6-6194-4346-9193-514603c8a255">133.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMS01LTEtMS01ODk3OQ_84737019-6e41-4cb9-9f44-29150a846cf9">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMi0xLTEtMS01ODk3OQ_44290e85-9594-4ec9-8eb6-829304fa4d51">15.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMi0zLTEtMS01ODk3OQ_3fdfb97f-cd7a-42f6-a173-27bc7f79e584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMi01LTEtMS01ODk3OQ_e98f9685-33c6-4e4b-aabe-3d86b88f3cf7">15.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMy0xLTEtMS01ODk3OQ_e7ac55bf-3533-4679-9faf-2821fab41cde">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMy0zLTEtMS01ODk3OQ_f206365b-dadb-41f1-ad0a-00f19dc764cb">35.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMy01LTEtMS01ODk3OQ_d3811fd2-e5a6-4e61-b28f-0b0e1168ba66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331" decimals="-5" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNC0xLTEtMS01ODk3OQ_4a1b8895-9a85-4692-8c5d-bb1430c9133f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNC0zLTEtMS01ODk3OQ_3fa38f1c-8f50-4ad9-afc8-54e5155e0c2e">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNC01LTEtMS01ODk3OQ_91a6159a-8be0-4722-a702-2ca0b213c81c">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNS0xLTEtMS01ODk3OQ_6f078ad5-d22c-4b4b-b79e-d823b234d90f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNS0zLTEtMS01ODk3OQ_16e47fe8-8d48-47dc-9e17-b552c8be1c8d">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNS01LTEtMS01ODk3OQ_85c8c0c9-8e09-4b7f-b9b0-3b7d0b020640">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4d7d622da84b43bba3a6f1313667a9_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNi0xLTEtMS01ODk3OQ_b4653449-fd99-4abd-9a03-9dd65d7081b4">86.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cf551f83c9439aa1d37ce9a597c5af_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNi0zLTEtMS01ODk3OQ_becf76e4-0565-4f33-b72e-3071fe5839ca">112.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNi01LTEtMS01ODk3OQ_6c51a61f-7a36-4fba-b3b1-1ea3ef3c1281">198.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has not elected the fair value option for other financial assets and liabilities, any future transacted financial asset or liability will be evaluated for the fair value election.</span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_82"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Debt</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For additional information, see Note 10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in Viatris&#8217; 2021 Form 10-K.</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMTUzOTMxNjI4MDQ1MDM_eb2a2f26-0414-4d35-95c0-800ae5ce1d77" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfNDk_53a73b5b-5d7c-46eb-9816-8ce4276ea689">655.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-7" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfNTY_f6b5382f-6d11-4bc0-bfcf-d371d61c77c8">1.49</ix:nonFraction> billion of short-term borrowings as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28510b5c71d4182aa49d69fb01fa474_I20220331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMS0xLTEtMS01ODk3OQ_c0cd1191-7f76-4837-a41b-0bb12b561cc4">328.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18b5d9e71fd45c2b8cb4bb900be2c8a_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMS0zLTEtMS01ODk3OQ_7087f320-dad5-4208-9fa8-66f266ec8d92">1,173.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9efa78417d2452cb7a8ab1ecd2e2f9b_I20220331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMi0xLTEtMS01ODk3OQ_007e8f45-fb9c-4afa-9ffa-e86b3fe33efa">325.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5878664ac9f14f6b85a0598e1613ce8f_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMi0zLTEtMS01ODk3OQ_5577a311-e222-4b82-add0-0976468c7c47">318.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3906df3ad546cd8e29117ea61b2a8d_I20220331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNC0xLTEtMS01ODk3OQ_bb7d82f4-7f60-4506-adee-49f520cbe180">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82800c514aa0452d855d2b15e4818734_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNC0zLTEtMS01ODk3OQ_d9513f65-e1e9-4189-881d-a40ace4a03ec">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNS0xLTEtMS01ODk3OQ_2851a404-ee95-430a-9095-9101e419f8af">655.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNS0zLTEtMS01ODk3OQ_8924d811-c8b6-4d9f-95a3-0b6f7353574d">1,493.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables Facility </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $<ix:nonFraction unitRef="usd" contextRef="i0d46a4c2ea764c4ea5d63935feab31f1_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMTA5OTUxMTY0MDMyMw_5d7c5219-2938-4e08-b488-6fe846650128">400</ix:nonFraction>&#160;million Receivables Facility (the &#8220;Receivables Facility&#8221;), which originally was to expire on April 22, 2022. On April 22, 2022, the Company entered into an agreement to extend the expiration date of the Receivables Facility to April 22, 2025.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Receivables Facility, our subsidiary, MPI, sells certain accounts receivable to Mylan Securitization LLC (&#8220;Mylan Securitization&#8221;), a wholly-owned special purpose entity which in turn sells a percentage ownership interest in the receivables to financial institutions and commercial paper conduits sponsored by financial institutions. Mylan Securitization&#8217;s assets have been pledged to MUFG Bank, Ltd., as agent, in support of its obligations under the Receivables Facility. Any amounts outstanding under the facility are recorded as borrowings and the underlying receivables are included in accounts receivable, net, in the condensed consolidated balance sheets of the Company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Long-Term Debt</span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjgyMg_2720e1d3-6737-428c-8b76-04a3cea34786" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A summary of long-term debt is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate as of March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i920805edb6bd4fc6b02db9ae904e4bce_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC0xLTEtMS02MTM5Mg_02745604-ef2e-473c-82dd-074456346ae8">0.816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i920805edb6bd4fc6b02db9ae904e4bce_I20220331" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC0zLTEtMS02MTM5Mg_8d8fe292-d62b-45d1-860e-90a9c131de8d">831.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc4c1e487a74688ab81273067a97cf2_I20211231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC01LTEtMS02MTM5Mg_eb430ce3-0fff-4964-ac95-3171b07a8cb2">856.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34906e61f9a74e3a9907c245d674475d_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS0xLTEtMS02MTM5Mg_c21ac891-04c8-4eb6-ae50-c8a6e5bd801f">1.125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34906e61f9a74e3a9907c245d674475d_I20220331" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS0zLTEtMS02MTM5Mg_33b8e98e-a29c-4aca-9946-51fb6208f936">1,001.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i730b6b0ebf854761bfab2a3d7849fe20_I20211231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS01LTEtMS02MTM5Mg_2cecf390-d0df-44ef-b2b6-8cdc53f5d1be">1,002.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib033b18c10b54540877cb94c0a2c2d1b_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtMS0xLTEtNjM3NDY_ca665118-0291-4207-8e2a-48896c626215">3.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib033b18c10b54540877cb94c0a2c2d1b_I20220331" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtMy0xLTEtNjM3Mzc_db3fecac-ed2a-419f-a85b-45241de05848">762.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616a7760ff9a412f95e120d328a13496_I20211231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtNS0xLTEtNjM3Mzc_0d20540f-b0b3-45b8-bbdc-34836c5cd7cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3906df3ad546cd8e29117ea61b2a8d_I20220331" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC0zLTEtMS01ODk3OQ_46864064-e8ec-4969-a990-7f527a965c6d">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82800c514aa0452d855d2b15e4818734_I20211231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC01LTEtMS01ODk3OQ_f748a09f-5a1a-401a-be94-f679cbd341fd">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic62d942e80a44f328ced46abd8385b8f_I20220331" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS0zLTEtMS01ODk3OQ_5d14f4c6-456f-4286-8be0-7cf95baedf36">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21352fc4b3034be49d25e0fe2cc81ea9_I20211231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS01LTEtMS01ODk3OQ_c24ac254-4e42-4f96-a53c-29c190810a49">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtMy0xLTEtNTg5Nzk_8ef47949-136e-4fab-a864-fb05f59db110">2,595.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtNS0xLTEtNTg5Nzk_37d67222-ff87-4fc7-b7ca-cb000660c1c7">1,860.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i235e89926eb74f3d88770caa518d54ab_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTctMS0xLTEtNTg5Nzk_8bd9a7fd-5b0f-4791-99fd-62b33ed7041e">3.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235e89926eb74f3d88770caa518d54ab_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTctMy0xLTEtNTg5Nzk_ec682339-4442-4aef-b036-8dd577af6fa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c67b48aac04b57a96558d5638e2069_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTctNS0xLTEtNTg5Nzk_d4147e6a-7963-4a23-a150-2bdb4e9bc587">766.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8760241a3c7746f88dfc82fd0dc38eb9_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTgtMS0xLTEtNTg5Nzk_2b6658a4-ac3a-4cd6-9970-8442fa406a3e">4.200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8760241a3c7746f88dfc82fd0dc38eb9_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTgtMy0xLTEtNTg5Nzk_7e7edb77-0db9-4158-b02c-4cf7cea26c9a">499.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c88993426de4bfa82c2af5b9e9ed5cf_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTgtNS0xLTEtNTg5Nzk_0a72ff5d-15d7-4567-8e1e-c64a42727c82">499.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3495d968dabe49db8632cd8419777821_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTktMS0xLTEtNTg5Nzk_649007f3-5b31-44e4-8ac2-7713f2df8dba">2.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3495d968dabe49db8632cd8419777821_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTktMy0xLTEtNTg5Nzk_264d0fc7-a00a-4999-b898-96e267955dc6">1,105.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if209dd52df884edca3b342ed0f29e0ca_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTktNS0xLTEtNTg5Nzk_f004fb7b-5074-4dc6-8003-a8149db20090">1,135.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i005465bb6d4141108265ad72c8d64c05_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjAtMS0xLTEtNTg5Nzk_6df1b9b9-57e5-4c6c-b209-a2671277d192">1.023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1871f3ae6b044568aa7edef970da41e8_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjAtMy0xLTEtNTg5Nzk_fbf08c59-00cb-4cd3-b106-4e7d4e34cb65">846.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87954de7b4154d90921ac559950690e5_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjAtNS0xLTEtNTg5Nzk_2e3fb3a6-d543-45b5-9f5f-8a937fa4eb19">871.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i410da26a1bdf4849ad61862472be13bd_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjEtMS0xLTEtNTg5Nzk_d365b8a1-12fa-44c6-b037-555911e83723">2.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410da26a1bdf4849ad61862472be13bd_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjEtMy0xLTEtNTg5Nzk_25a6ab44-24c6-4944-9c2c-9a5490797010">552.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4393b7ef55d44b491ed13b410ae5f95_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjEtNS0xLTEtNTg5Nzk_a71c611d-6822-4e43-9269-2d588899afe1">567.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a2f21b97703441394122c32e24bae16_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjItMS0xLTEtNTg5Nzk_b259d13e-9843-4d5c-8d97-5066c73a8dbe">1.650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2f21b97703441394122c32e24bae16_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjItMy0xLTEtNTg5Nzk_7f7c44ac-1b62-4624-868a-44b285b48589">762.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e61082e1f54d149a0319da03a3379f_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjItNS0xLTEtNTg5Nzk_1cc79c47-ddaf-4d8c-8403-c5e6f948b6b5">763.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a7f0dc2e5b0416aa4a0385ea9cf3510_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjMtMS0xLTEtNTg5Nzk_45046356-6f51-41fb-afc4-56cd47a63798">3.950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a7f0dc2e5b0416aa4a0385ea9cf3510_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjMtMy0xLTEtNTg5Nzk_910ae1a7-134e-4bb7-806c-4ddbb01ee3ee">2,241.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674842c707794f4b9c18faf16d310ee6_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjMtNS0xLTEtNTg5Nzk_e6f5e9d7-b7b8-4de8-9972-e441e914776b">2,241.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a34081d5ebc44a2b5346da3d6b8808e_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjQtMS0xLTEtNTg5Nzk_7a4a3651-37a8-4d54-868f-77f6e7bd5961">1.362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e2860e30684408955db848202e3b35_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjQtMy0xLTEtNTg5Nzk_b6cc324d-16ab-4f51-9857-ba596e3657a4">984.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4808a45c314bcbb675ab9e037ae38d_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjQtNS0xLTEtNTg5Nzk_83a10f4b-9ec2-44fd-843c-98b60a312c26">1,013.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i724052a3d05f4c35a5c6a00a2fea921f_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjUtMS0xLTEtNTg5Nzk_53b1e480-8212-4545-85ff-e151bdbceff6">2.300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d84cd5ad0974a9989194bfb8e273bb0_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjUtMy0xLTEtNTg5Nzk_e05f98a8-c42b-4a75-a1be-41d1395be2d3">779.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a475c2355f74134b164dcccd5dfb7d7_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjUtNS0xLTEtNTg5Nzk_29027207-9c47-4947-ba4b-82912db44a8f">780.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icbb10749b14e419a92f4ae26723a62ac_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjYtMS0xLTEtNTg5Nzk_2313c9b4-8050-42b1-93b8-54d739dd2595">3.125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbb10749b14e419a92f4ae26723a62ac_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjYtMy0xLTEtNTg5Nzk_73a9af19-cd7f-4e30-b483-9434db97d39e">825.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa95b408619484988378fae1c283bb0_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjYtNS0xLTEtNTg5Nzk_8f0a5922-6c54-4c63-ad63-bae0ef8f0767">847.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e4efee03b0b4da6844362cd1376dc49_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjctMS0xLTEtNTg5Nzk_f8fe2525-3f67-463a-8b32-4989a499d848">4.550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab334cf12f3428e832773ef37592e11_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjctMy0xLTEtNTg5Nzk_ba530ee7-6cbd-46f0-b88f-24b8f974bdfa">748.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdcab6e29434459989a147cd7b7e7450_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjctNS0xLTEtNTg5Nzk_f0b77724-9fd1-4701-9892-35e7c48cb2b0">748.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f77a33b8832445ca8a138130657da67_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjgtMS0xLTEtNTg5Nzk_ffc536b8-e17c-4af2-97c9-5fec77496bf9">2.700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77a33b8832445ca8a138130657da67_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjgtMy0xLTEtNTg5Nzk_9bc08a28-98e3-4b69-9cb5-2e88e1537449">1,518.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ec6ac3b5374b0a8f1f65dd3c2855cb_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjgtNS0xLTEtNTg5Nzk_c1b2e25f-bb12-4092-a284-3c877438ccf5">1,520.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39206c4f1d9c4866a802fcd055a7e2a1_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjktMS0xLTEtNTg5Nzk_33310e16-6764-4fca-93cc-c9b3c9356f2e">1.908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39206c4f1d9c4866a802fcd055a7e2a1_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjktMy0xLTEtNTg5Nzk_101fbca4-21a2-46a2-9140-183e8392e717">1,502.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c5629823074ba09faf3ca2ad8969a0_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjktNS0xLTEtNTg5Nzk_7ecb4d3c-e5f2-4afb-b5d2-cf2f338ba417">1,546.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb2326817a4c4b8aa31f1fcf83769a0a_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzAtMS0xLTEtNTg5Nzk_62d1f761-c7f6-4899-9525-dc33f4b1a98e">3.850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb2326817a4c4b8aa31f1fcf83769a0a_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzAtMy0xLTEtNTg5Nzk_31056043-1a61-4df3-97c5-38abe04ddf0a">1,655.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aed418e17ea4186b695f6810d200726_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzAtNS0xLTEtNTg5Nzk_51066dee-93d4-49b5-b071-c2d392446030">1,657.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i177681bbc11b40ee9f75db3045c19e95_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzEtMS0xLTEtNTg5Nzk_e019597e-fbd9-4948-96be-f48639ac14fc">5.400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177681bbc11b40ee9f75db3045c19e95_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzEtMy0xLTEtNTg5Nzk_cde3fa14-907e-41bf-a810-28219afb53b4">497.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5606c2ba35cb4d71b8656f287034dcec_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzEtNS0xLTEtNTg5Nzk_e978dda8-19d6-42df-93ef-08b0b8ba3c4e">497.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2046 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> **</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13bcb00848b642c88bfcc2a3c877ede2_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzItMS0xLTEtNTg5Nzk_54f264c9-93c1-4022-aca0-acee652630ae">5.250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13bcb00848b642c88bfcc2a3c877ede2_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzItMy0xLTEtNTg5Nzk_dc937ceb-0376-45f0-8532-4ef4c909772e">999.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc8c69e7703a44399519315b43924c3c_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzItNS0xLTEtNTg5Nzk_363529cf-8295-41a6-8729-6feb184108fe">999.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia40f39ee6378480184a30bc13c9e3594_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzMtMS0xLTEtNTg5Nzk_945a1e95-758f-45f5-b75e-b18620e7c952">5.200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992ae6748a1644e29dc32186549f45e4_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzMtMy0xLTEtNTg5Nzk_076dd40e-f90e-464e-b1a1-0615d99833f7">747.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7473c049234582bd30c2c495ac8ba9_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzMtNS0xLTEtNTg5Nzk_cb0787b4-b9b7-4dd2-a070-28c084298ad3">747.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ad052255252472887637ab010a153d2_I20220331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzQtMS0xLTEtNTg5Nzk_a5185957-a5ef-4d66-8ca9-091838fa66eb">4.000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad052255252472887637ab010a153d2_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzQtMy0xLTEtNTg5Nzk_43cfe275-f9da-40bf-92d7-84d62d27d9e5">2,204.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa54af0ed26448d9b6ab8f7c2c6167a5_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzQtNS0xLTEtNTg5Nzk_7b0f72b2-dbe1-43e0-a877-070f3475cf63">2,205.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i920805edb6bd4fc6b02db9ae904e4bce_I20220331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtMy0xLTEtNjE1MjU_1d4c57d3-bd34-4d8c-af11-c8f3136bcf22">328.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc4c1e487a74688ab81273067a97cf2_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtNS0xLTEtNjE1MjU_84897a0f-296a-437e-b768-8b877f8362e3">347.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8245ebc2dc2948b69c11fb33e05f36b6_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzYtMy0xLTEtNTg5Nzk_3002a2e5-d327-483d-b131-20339192fec5">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc759c1f2ebc440c8f306b8b1ca6b9f3_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzYtNS0xLTEtNTg5Nzk_b2683d99-06d7-42e4-893e-80a6e2d0f7e6">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzctMy0xLTEtNTg5Nzk_62e33c4b-8c65-489f-893a-a09053d0b3d9">39.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzctNS0xLTEtNTg5Nzk_40902220-e800-4acd-8788-5a6312b95863">42.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtMy0xLTEtNTg5Nzk_2ac6cd0b-7d75-406b-ac68-d6583f7b708f">18,762.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtNS0xLTEtNTg5Nzk_4dbb5c6f-aba5-4f10-a5c4-6828d7ead372">19,717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfNDEw_6e432a2b-34f3-4bba-b7d1-25040e50a42d">45</ix:nonFraction> million. The fair value adjustment is being amortized to interest expense over the remaining term of the notes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Mylan Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Viatris Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Upjohn Finance B.V.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, the aggregate fair value of the Company&#8217;s outstanding notes was approximately $<ix:nonFraction unitRef="usd" contextRef="id07178dd71fc4b9d989a85d7e37587c8_I20220331" decimals="-7" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjQ0NQ_c54916d4-c9f4-4d3f-a6ac-53fc58f0a3a0">19.49</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i05ca82ad60f24969bc24380087f4af1b_I20211231" decimals="-7" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjQ1Mg_16cd6202-43e0-46b5-acf5-5083445cd88f">22.01</ix:nonFraction> billion, respectively. The fair values of the outstanding notes were valued at quoted market prices from broker or dealer quotations and were classified as Level 2 in the fair value hierarchy. </span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjg0MQ_89b06283-e374-4a05-8a4b-3d45da959292" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2022 were as follows for each of the periods ending December 31:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfMS0xLTEtMS01ODk3OQ_97802540-69c1-4694-9b3a-78ed97259057">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfMi0xLTEtMS01ODk3OQ_b429e63b-5160-4d10-a4fa-8b0656513dc7">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfMy0xLTEtMS01ODk3OQ_7e43cbc9-6b0f-40a4-97aa-6a108bb29c14">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNC0xLTEtMS01ODk3OQ_5bec0145-7350-496d-97e5-0e0515786117">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNS0xLTEtMS01ODk3OQ_2bf5498d-1d41-4270-a00e-3648400d1c27">2,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNi0xLTEtMS01ODk3OQ_2eca096c-4476-4d7f-9eee-89c587605244">11,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNy0xLTEtMS01ODk3OQ_f648acfa-3150-4b47-a43a-8b21b9f75371">20,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_88"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RleHRyZWdpb246YmY5NWM2YWU5NDc5NDc5NDg3NDhkZWRjN2I5NjRiNDBfMjYx_1bbbb5de-a249-4dd8-8f26-eec925f8ca26" continuedAt="i09596bd3ee824f428cfa3bc865003503" escape="true">Comprehensive Loss</ix:nonNumeric></span></div><ix:continuation id="i09596bd3ee824f428cfa3bc865003503" continuedAt="ia5610d7b335c4ef1819ffdd50026e83f"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RleHRyZWdpb246YmY5NWM2YWU5NDc5NDc5NDg3NDhkZWRjN2I5NjRiNDBfMjQ4_f5aeb5c8-21ed-413c-8bd9-86d2bedf32c0" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected on the condensed consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMi0xLTEtMS01ODk3OQ_799e393f-7f82-4fb3-9de9-9c6d046fe0f3">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMi0zLTEtMS01ODk3OQ_f3a0fb9c-24f5-4bb5-a096-8806fde1a6d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMy0xLTEtMS01ODk3OQ_b4a491d2-549d-4cbf-b6a7-1ac58f01137a">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMy0zLTEtMS01ODk3OQ_1e618b72-a3be-4772-bc9f-067f0cef15dd">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97cceb4d5127408091af840823fc721e_I20220331" decimals="-5" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNC0xLTEtMS01ODk3OQ_7104f422-8721-4cf9-8b86-221702a0853d">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf7ecce65c9422f8f5f4fe13d646c1e_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNC0zLTEtMS01ODk3OQ_f6926c51-f148-47eb-ad89-0241cf589969">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a532fa1402b4fc68731b04ccee54724_I20220331" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNS0xLTEtMS01ODk3OQ_4a5d5b8a-2069-4782-8135-824a8f33653c">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9319cb1e85a2470bbb378e5ce64d1b1f_I20211231" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNS0zLTEtMS01ODk3OQ_127863eb-26a5-46e2-bf64-07901eaddc42">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNi0xLTEtMS01ODk3OQ_b66156c7-f4eb-4a9f-b4ec-7a68b5d86b3b">2,271.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNi0zLTEtMS01ODk3OQ_ab32c992-fe19-4baa-bb83-905e6f3b5971">1,802.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNy0xLTEtMS01ODk3OQ_048114c8-2499-4833-a5ec-62e4e34afd5c">2,061.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNy0zLTEtMS01ODk3OQ_c669d75d-c8d8-434c-ba3e-95612c2841a8">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="ia5610d7b335c4ef1819ffdd50026e83f" continuedAt="i8a65a78e9c1e4bbcae0903ebcc026445"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RleHRyZWdpb246YmY5NWM2YWU5NDc5NDc5NDg3NDhkZWRjN2I5NjRiNDBfMjU0_940e9f16-fec8-40f6-8d37-072c72d48a45" continuedAt="i03a9df63cbbb438d8d903fa82b00de38" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.121%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf7ecce65c9422f8f5f4fe13d646c1e_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy01LTEtMS01ODk3OQ_f6926c51-f148-47eb-ad89-0241cf589969">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9319cb1e85a2470bbb378e5ce64d1b1f_I20211231" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy03LTEtMS01ODk3OQ_127863eb-26a5-46e2-bf64-07901eaddc42">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy05LTEtMS01ODk3OQ_f3a0fb9c-24f5-4bb5-a096-8806fde1a6d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy0xMS0xLTEtNTg5Nzk_1e618b72-a3be-4772-bc9f-067f0cef15dd">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy0xMy0xLTEtNTg5Nzk_ab32c992-fe19-4baa-bb83-905e6f3b5971">1,802.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy0xNS0xLTEtNTg5Nzk_c669d75d-c8d8-434c-ba3e-95612c2841a8">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia55bbf8c4e19462595c29c8a377dea3e_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC01LTEtMS01ODk3OQ_3a4f3611-ebc0-4aec-ac22-d7e237b1247f">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f17a49b80d45fab66d262a44deaace_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC03LTEtMS01ODk3OQ_1dfa3c6c-f5b5-45ea-850a-8f725a9c79a1">201.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC05LTEtMS01ODk3OQ_6039bbea-f024-4fe5-a429-b345934215b8">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5e368b781a74d6686679790d4bff5a8_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC0xMS0xLTEtNTg5Nzk_442dadc3-d326-4a45-839d-c8d02f94e7c5">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia55ac01c2b07425bbe40921fb5981f21_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC0xMy0xLTEtNTg5Nzk_d70e1c24-e597-4062-9bdc-eff28440c5fb">469.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i067dee996df34e2f84a35524e9e8481c_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC0xNS0xLTEtNTg5Nzk_cd556da9-5c98-469c-9566-b80eb8291636">259.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide8689d47bf04a43bf675d0763fad522_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNi0xLTEtMS01ODk3OQ_03f1304d-bfc5-4b2f-84f6-99e6b6154b95">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4988c8f213a042118b4b5eaf9c7f1e82_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNi01LTEtMS01ODk3OQ_ae114512-b672-43de-a4b1-3443ed4ab743">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib01b91695a1b4712b96033763cf44ccb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNi0xNS0xLTEtNTg5Nzk_48aa959b-d023-48b9-9650-571104e2518f">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4771d8abfecc4e1e95bac68b8f627709_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNy0zLTEtMS01ODk3OQ_badefa94-59ab-4470-a643-ef6308be8f47">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a0f1e83bb0d410fbdd5481b44ffd1f7_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNy01LTEtMS01ODk3OQ_dd3d1997-799d-4ed4-9798-61241530da5f">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a8319f4395450dbae6322e0e8646d3_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNy0xNS0xLTEtNTg5Nzk_0b607117-723b-44e3-8cb9-1be4050af9f0">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide368397434c48e59036b17de6b68663_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfOC0xMS0xLTEtNTg5Nzk_8be6eb86-b42f-4d27-afe5-20131ef591fc">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2ded494c0c74830993e23285344ef34_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfOC0xNS0xLTEtNTg5Nzk_9aff6804-8101-4713-8df2-029f7c02fddb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib578d781d99c4f47885649d77583e23e_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtNS0xLTEtNTg5Nzk_f37c9304-f45e-4c52-b01e-09d32d139a9f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f17a49b80d45fab66d262a44deaace_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtNy0xLTEtNTg5Nzk_1dfa3c6c-f5b5-45ea-850a-8f725a9c79a1">201.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtOS0xLTEtNTg5Nzk_6039bbea-f024-4fe5-a429-b345934215b8">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtMTEtMS0xLTU4OTc5_9a604b8d-b1cc-44ac-b2a1-e7729573c4fa">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia55ac01c2b07425bbe40921fb5981f21_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtMTMtMS0xLTU4OTc5_d70e1c24-e597-4062-9bdc-eff28440c5fb">469.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtMTUtMS0xLTU4OTc5_c294e6f1-a34c-4ce5-a6f6-aec06836d8bd">272.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia55bbf8c4e19462595c29c8a377dea3e_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtNS0xLTEtNTg5Nzk_61446dcf-8bf7-4269-9cb7-4493be9fb146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i879cd700e4194424af2d4d04eef590c5_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtNy0xLTEtNTg5Nzk_a8a326ea-f099-42df-8a00-e54af591bea9">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i413aa6ce376641bdba0e00e871461952_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtOS0xLTEtNTg5Nzk_3a2263d0-c164-4794-a656-788517fea7c7">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e12d4aab9b464eb4d8ad17759e7f56_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtMTEtMS0xLTU4OTc5_c3cfd737-01ea-4200-81ee-5f6fabac272a">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31b0884d24244149616a8b8da8525b4_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtMTMtMS0xLTU4OTc5_bcf845e7-81ea-4e88-9960-c42f44dff66c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2ded494c0c74830993e23285344ef34_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtMTUtMS0xLTU4OTc5_5a461c71-a815-4d5d-b21b-a882d6e061b6">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97cceb4d5127408091af840823fc721e_I20220331" decimals="-5" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtNS0xLTEtNTg5Nzk_7104f422-8721-4cf9-8b86-221702a0853d">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a532fa1402b4fc68731b04ccee54724_I20220331" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtNy0xLTEtNTg5Nzk_4a5d5b8a-2069-4782-8135-824a8f33653c">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtOS0xLTEtNTg5Nzk_799e393f-7f82-4fb3-9de9-9c6d046fe0f3">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtMTEtMS0xLTU4OTc5_b4a491d2-549d-4cbf-b6a7-1ac58f01137a">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtMTMtMS0xLTU4OTc5_b66156c7-f4eb-4a9f-b4ec-7a68b5d86b3b">2,271.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtMTUtMS0xLTU4OTc5_048114c8-2499-4833-a5ec-62e4e34afd5c">2,061.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-align:center"><ix:continuation id="i8a65a78e9c1e4bbcae0903ebcc026445"><ix:continuation id="i03a9df63cbbb438d8d903fa82b00de38"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.266%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i058f357ea23c4c98b73c618d1d854722_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy01LTEtMS01ODk3OQ_023e40f0-6aad-408b-a6ff-e3b1f37f1d0b">18.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03493d8105474aeb862abf63b7ef74a6_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy03LTEtMS01ODk3OQ_e2f4bc09-52f8-43f9-83f0-fb68f0ec6328">353.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ad5902fd35439c8f4af1782d4c7515_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy05LTEtMS01ODk3OQ_7db08ccd-69f2-4b64-939f-cea1dfdea12a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31e0fdd1fab64cb898debb3cb62f7b63_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy0xMS0xLTEtNTg5Nzk_929a03a6-330c-4f00-b9ce-e3ead167c124">26.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb76b00d31784891b8cb395e638378b8_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy0xMy0xLTEtNTg5Nzk_a87c67a3-47a6-4864-bc04-709e9de790ba">461.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc0f9f8a1bf4a9a967c3233ef153a6d_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy0xNS0xLTEtNTg5Nzk_4a4332fb-7389-46d3-a620-555824100628">858.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbcb91759414078b56888757bdb9d8c_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC01LTEtMS01ODk3OQ_cf510edf-5db8-42a9-ad50-e929b1f147c7">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i557fd976de2e4b8c83c710c96321b9ba_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC03LTEtMS01ODk3OQ_f862ea2a-84ad-467a-8fce-e85f89c58b31">227.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b30c4edf7ef407098a198c2ade53163_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC05LTEtMS01ODk3OQ_d92e9926-800c-4fe3-975b-cb26a135f73f">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b05065a6c98419eb5b6caba576c82bf_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC0xMS0xLTEtNTg5Nzk_f3d5538f-d75c-4391-8f84-2f25e09b67b7">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5db4cd0e0a14bd7b8ad825332acc3a2_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC0xMy0xLTEtNTg5Nzk_20c5edbc-7e78-455d-bff3-797fe174c235">721.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie72c892bc6534c14adab5d7152694449_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC0xNS0xLTEtNTg5Nzk_5eaf0b00-1141-4167-ba42-aa4da4aa04ea">485.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id851527d609c4cc481afc6dd44e8b9c8_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNi0xLTEtMS01ODk3OQ_6f44224b-ec28-4195-9eeb-4649393717e6">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id851527d609c4cc481afc6dd44e8b9c8_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNi01LTEtMS01ODk3OQ_1195b523-10f6-4690-94be-cc94fb53dc89">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefe2b30097f544b791322bb2f629e462_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNi0xNS0xLTEtNTg5Nzk_046a3605-2d5a-4b0d-8953-d7d8c4406ee6">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e37fd7655a489ca62fce5309929cdc_D20210101-20210331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNy0zLTEtMS01ODk3OQ_00ca6b46-189f-41c4-9c0d-115f932bd61e">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e37fd7655a489ca62fce5309929cdc_D20210101-20210331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNy01LTEtMS01ODk3OQ_26e850cc-1c5d-48a4-b247-687b76738ebe">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfeddcfa49be4a9f9ca7273bb0bc0b2d_D20210101-20210331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNy0xNS0xLTEtNTg5Nzk_6fb20e73-31cd-433b-a1f4-292b8093b1d4">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife06d4353ee146d29a89e17a68a9eb78_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOC0xMS0xLTEtNTg5Nzk_b4ac3255-0796-4fd2-b04c-140a39ef1638">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibac83a8acaf741ca954ebb93d7b9c302_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOC0xNS0xLTEtNTg5Nzk_a60f5b20-fb70-4150-b4b0-b5b6c6d8786c">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOS0xMS0xLTEtNTg5Nzk_67069601-f4c4-4afd-b066-2ff6df46958d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac83a8acaf741ca954ebb93d7b9c302_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOS0xNS0xLTEtNTg5Nzk_db57499e-2d60-4f9f-96ac-9d64ec2d397b">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf21bcb23a34c3498a8a496b6117bb3_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtNS0xLTEtNTg5Nzk_8914bb21-ad23-4258-9ce2-fad8d9ed167b">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b28feb2f7d45d7b83dc9fca6123f83_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtNy0xLTEtNTg5Nzk_376afe5d-123f-4e23-9bb3-ccc562c20fb6">227.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtOS0xLTEtNTg5Nzk_3b0a7ba5-9602-407b-b047-98cb539bb136">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife06d4353ee146d29a89e17a68a9eb78_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtMTEtMS0xLTU4OTc5_9a95c142-56a3-4afc-8c28-bbb4691abb28">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5db4cd0e0a14bd7b8ad825332acc3a2_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtMTMtMS0xLTU4OTc5_20c5edbc-7e78-455d-bff3-797fe174c235">721.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtMTUtMS0xLTU4OTc5_e95a98a1-f8d4-44b8-9266-de99d967f2e9">490.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbcb91759414078b56888757bdb9d8c_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtNS0xLTEtNTg5Nzk_8a195bf2-51b9-40d5-9582-1945165f14dc">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i557fd976de2e4b8c83c710c96321b9ba_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtNy0xLTEtNTg5Nzk_28655b04-48c0-4a08-a6af-10cb24b62031">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b30c4edf7ef407098a198c2ade53163_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtOS0xLTEtNTg5Nzk_7337bc2c-d54b-4087-9a11-1209d3a66f36">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b05065a6c98419eb5b6caba576c82bf_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtMTEtMS0xLTU4OTc5_66c4eb90-14b2-4a96-bf13-080dfa290c24">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156daef6d1e44bdbb6b3a817528d646d_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtMTMtMS0xLTU4OTc5_c6b758f7-81bf-403e-a8c2-0e0379ad60c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72c892bc6534c14adab5d7152694449_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtMTUtMS0xLTU4OTc5_d4e9ce75-bebd-47a1-9daf-3086f688912e">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib366aa410a2f41b6a5c4c31aaf520612_I20210331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtNS0xLTEtNTg5Nzk_661a33d8-84f5-4573-bc4b-00b9f67c04d2">15.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69c1db3a5e434cf2b0bec2a19b9128b1_I20210331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtNy0xLTEtNTg5Nzk_ea36044d-9c72-4bd6-9c2c-ccd13cf58b98">161.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9a8abb5cdb4a0988a591e31a0ac4e6_I20210331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtOS0xLTEtNTg5Nzk_5e4d9423-905c-4881-bdaa-c6b7a8a03510">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a0499bbe67f4f29816cc986f12548ee_I20210331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtMTEtMS0xLTU4OTc5_48194189-eb2b-4141-9351-f34338f7624d">26.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7c23dc951cc4e8989a77c2c56fbd5cc_I20210331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtMTMtMS0xLTU4OTc5_4b617cdb-455f-493b-86b0-414d0ad88dd3">1,182.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84ae372e0d4640afaf6ca7d236588eca_I20210331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtMTUtMS0xLTU4OTc5_b12dd0a6-97d1-48de-b099-0d915355c4ab">1,385.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_91"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RleHRyZWdpb246MmEyMzQ4NDlkZWI1NGUwMWFlOGU0MTliY2Q1YzkwZTdfMzgyMw_a6d9517b-44e9-4975-8984-a88df65f4678" continuedAt="ic5360088024046de813b3a1402ab8889" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="ic5360088024046de813b3a1402ab8889" continuedAt="i489427efc93c41e286100ea1a96e225d"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RleHRyZWdpb246MmEyMzQ4NDlkZWI1NGUwMWFlOGU0MTliY2Q1YzkwZTdfMzgwOQ_94f50d93-2b66-428d-8a7f-782f3d39d8d8" continuedAt="i1fba54196881422fb730ed45cbaec8e5" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of intangible assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i489427efc93c41e286100ea1a96e225d"><ix:continuation id="i1fba54196881422fb730ed45cbaec8e5"><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in the 2021 Form 10-K, and Note 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Form 10-Q.</span></div></ix:continuation><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RleHRyZWdpb246MmEyMzQ4NDlkZWI1NGUwMWFlOGU0MTliY2Q1YzkwZTdfMzgyMA_9bffa65b-363d-4ede-a72d-4f9e92762521" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS0yLTEtMS01ODk3OQ_8f4ac8f8-036a-43c9-85a4-0baf7a7db283">2,476.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS00LTEtMS01ODk3OQ_21506d4c-0871-4840-8325-931a2e9b8bf0">2,571.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS02LTEtMS01ODk3OQ_26931815-e4d1-4fb0-9ccb-a0cfb76cf952">1,211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS04LTEtMS01ODk3OQ_8d8da47d-9440-4c69-9139-2d5e288b769f">1,285.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi0yLTEtMS01ODk3OQ_ace86b96-3698-48da-839e-dbe070d359cd">573.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi00LTEtMS01ODk3OQ_777f02a0-3f91-41af-9620-9359ff8a9017">591.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi02LTEtMS01ODk3OQ_7080db4f-a663-4c84-8c5b-8c301a712834">417.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi04LTEtMS01ODk3OQ_86d5c2ea-dd6e-4110-9632-7c29f2132e6a">404.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde6978e33374457b942a44020cb10ac_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy0yLTEtMS01ODk3OQ_50c2e0b3-3d0e-4a3c-8511-d09f83a69998">423.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy00LTEtMS01ODk3OQ_9869fa50-7dfe-4ef8-b509-143f5e261422">481.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde6978e33374457b942a44020cb10ac_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy02LTEtMS01ODk3OQ_b789105f-83a1-4ddf-b1c2-05fc42ebad1d">174.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy04LTEtMS01ODk3OQ_7c354fc7-b6cc-4df0-b962-d53440fbcd2e">184.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC0yLTEtMS01ODk3OQ_2f3049e6-00b3-4abc-abd5-2651fd1dfea9">705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC00LTEtMS01ODk3OQ_1bf18e68-7e13-4793-9d9d-083bfac8da1f">754.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC02LTEtMS01ODk3OQ_32a287bc-0332-4584-a8f9-d6a8daa900d2">345.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC04LTEtMS01ODk3OQ_c10240ba-1d7c-469d-9788-8b5818ff6fca">337.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS0yLTEtMS01ODk3OQ_f5d9eaca-791a-4ae9-9f4c-8f6dc551ea53">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS00LTEtMS01ODk3OQ_08059515-2755-4688-85c2-a6820caa4c6b">4,400.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf733ae3e5124ab199c7831a4facfe9e_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS02LTEtMS01ODk3OQ_f4cb3b28-90c5-40cb-bd1b-a66d98f0b3a9">2,148.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf02807bb1474b44a231a8d6a3b86371_D20210101-20210331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS04LTEtMS01ODk3OQ_0d2440a7-f6d0-4d44-a0ae-aff4561d731c">2,211.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTItNi0xLTEtNTg5Nzk_335727f8-f3d3-4f1b-bc17-748d1bb3139d">648.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTItOC0xLTEtNTg5Nzk_de0da4db-b12f-4eaf-b273-c4d1420010c8">684.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTMtNi0xLTEtNTg5Nzk_e3547d09-f02c-4ad9-acec-f782c254530d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTMtOC0xLTEtNTg5Nzk_fc2f444c-2975-439e-878e-beccb913678b">83.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTQtNi0xLTEtNTg5Nzk_86c0d16d-4290-426f-aa9d-723bfdf0f925">142.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTQtOC0xLTEtNTg5Nzk_c36dd31c-abf5-4af5-9934-6306d8f27c03">184.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTUtNi0xLTEtNTg5Nzk_d429d997-8687-4a91-b5a4-290bcd5bef5d">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTUtOC0xLTEtNTg5Nzk_46cc2f69-842a-4c8b-9da7-731c79562ee0">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331" decimals="-5" name="vtrs:OtherOneTimeNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTYtNi0xLTEtNTg5Nzk_3247c51f-0fe2-440a-bf9d-e8fa53f8ffe1">185.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331" decimals="-5" name="vtrs:OtherOneTimeNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTYtOC0xLTEtNTg5Nzk_a07562fe-c866-462b-a1a3-30b8e9e26eeb">993.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dbf52cc348a44cba02d8ba438c2c120_D20220101-20220331" decimals="-5" name="vtrs:Corporatecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTctNi0xLTEtNTg5Nzk_f4615db1-4791-4096-87a1-7188b0da7d77">459.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10246c296fdb4978908586b17cec13ad_D20210101-20210331" decimals="-5" name="vtrs:Corporatecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTctOC0xLTEtNTg5Nzk_660a3822-981a-4f3d-9f02-4c00ad81e90c">509.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTgtNi0xLTEtNTg5Nzk_9d8ae75e-5d11-439f-a5ec-ac1dfb2d63f4">707.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTgtOC0xLTEtNTg5Nzk_cf5f30ac-a89e-4cef-9d28-21dfcca60f4f">266.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_94"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjIzOQ_83269d8b-e9a1-4744-9353-3b4ef768afe5" continuedAt="ie172d1a0d6ad4e8b99daf9eccdd362f7" escape="true">Restructuring</ix:nonNumeric></span></div><ix:continuation id="ie172d1a0d6ad4e8b99daf9eccdd362f7"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ia41f4e43848544a8b3cd335d5ac9237e_D20211001-20211231" decimals="-8" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTA5Mg_bf667adf-1ee0-4c60-b108-f1eda9e1e02d">1.4</ix:nonFraction>&#160;billion. Such charges are expected to include up to approximately $<ix:nonFraction unitRef="usd" contextRef="id1e5b4b8499b48638e60332fdcb0ebb0_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTE0OA_1ed1461e-0761-4160-b1b9-b399dcd47d2f">450</ix:nonFraction>&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ib1452feb5e534b13a92ff4d8dc1fd100_I20221231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTMyOQ_fe04cb78-40f3-49b2-8073-3d7060acc9d6">950</ix:nonFraction>&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and ongoing cost reduction initiatives are recorded in the period the Company commits to a restructuring or cost reduction plan, or executes specific actions contemplated by the plan and all criteria for liability recognition have been met. </span></div><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjI0NQ_06ed6afc-bcdc-4ee7-b374-44a6b5c389ce" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2021 to March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea8b0cc4e1164b799a97e32fa53ec105_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMS0xLTEtMS01ODk3OQ_86d88041-e7d7-49d3-adf7-3bb1d0971241">292.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81001995ccc476fb965e3e428336426_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMS0zLTEtMS01ODk3OQ_e96eafb8-812a-46e0-a12f-a99674fd41e1">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMS01LTEtMS01ODk3OQ_5019b163-d25d-4764-961f-6c0e5357a8a5">296.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMi0xLTEtMS01ODk3OQ_179ab792-8e9b-4750-a8dd-817db0b67863">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMi0zLTEtMS01ODk3OQ_ad699613-26fa-4c2a-ba53-a59401e29ee7">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMi01LTEtMS01ODk3OQ_2b4c3c8a-a959-4c90-bb30-4b66911cfcb0">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNC0xLTEtMS01ODk3OQ_3462988e-1878-41a8-a797-54a0170cf2d2">77.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNC0zLTEtMS01ODk3OQ_879a4e6e-9e5c-447b-bbab-44cccc2013f9">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNC01LTEtMS01ODk3OQ_2d9089a2-e51b-48b6-8c0f-2e8810b833e9">83.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNS0xLTEtMS01ODk3OQ_74bfaec0-fd2b-45de-a01d-b7a133639230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNS0zLTEtMS01ODk3OQ_107a730e-72d4-4354-9bd1-f360b65f910b">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNS01LTEtMS01ODk3OQ_ae3714f9-6f99-4887-86fb-c32d95da0a51">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNi0xLTEtMS01ODk3OQ_939df09e-4cc2-4674-b526-1a2ba76b7393">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNi0zLTEtMS01ODk3OQ_b2d8c550-0631-45f6-b712-05e02da789af">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNi01LTEtMS01ODk3OQ_3f8cf6d3-127e-4f72-a873-a67fa6b99f41">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434ad84a039c49a7b73a32c66eff9799_I20220331" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNy0xLTEtMS01ODk3OQ_040defd8-412d-4c82-b19d-123f0cd9d333">220.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i939eb9ebbfc9436e9ef6a820918949ed_I20220331" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNy0zLTEtMS01ODk3OQ_8d60aed8-50f2-4ddd-83a2-0432568f269a">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNy01LTEtMS01ODk3OQ_940f4eaf-0f2e-48a3-aa5f-370a30044ff7">223.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the three months ended March 31, 2022, total restructuring charges in Developed Markets, Emerging Markets, Greater China, JANZ, Emerging Markets and Corporate/Other were approximately $<ix:nonFraction unitRef="usd" contextRef="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjA1Ng_193901fa-8844-4d22-86ea-908933ab4dc0">12.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTY0OTI2NzQ0NDU2MA_f173888c-e025-44f0-a00b-f7d27a997e6e">2.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjA2MA_fe7437b8-c7b0-4d5d-81d7-1f4203756194">1.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjA2NA_e747b591-e28f-42d4-9d74-b55183f9cc0a">0.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6271454a81c6421fbe19f900527e1bbe_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTY0OTI2NzQ0NDU4MQ_bc595ea2-b4ee-4c43-bfca-167e33999e45">0.1</ix:nonFraction> million, respectively.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the condensed consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_97"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85Ny9mcmFnOmU2MzRhNzAxYzU1NzQ1ODI5ZGNhYjUwZWZlMGFjZDg3L3RleHRyZWdpb246ZTYzNGE3MDFjNTU3NDU4MjlkY2FiNTBlZmUwYWNkODdfMjIyMw_42a6fc01-6309-4085-9623-fd4b750bff5a" continuedAt="i9a90209be40b4b9687baf93f51a64822" escape="true">Licensing and Other Partner Agreements</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:continuation id="i9a90209be40b4b9687baf93f51a64822" continuedAt="i882ebc6b1b8b4d089d17f8f3d813ad08"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically enter into licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple, high-value generic biologic compounds, insulin analog products and respiratory products, among other complex products. Under these agreements, we have future potential milestone payments and co-development expenses payable to third parties as part of our licensing, development and co-development programs. Payments under these agreements generally become due and are payable upon the satisfaction or achievement of certain developmental, regulatory or commercial milestones or as development expenses are incurred on defined projects. Milestone payment obligations are uncertain, including the prediction of timing and the occurrence of events triggering a future obligation and are not reflected as liabilities in the condensed consolidated balance sheets, except for obligations reflected as acquisition related contingent consideration. Refer to Note 10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of contingent consideration. </span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i882ebc6b1b8b4d089d17f8f3d813ad08"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential maximum development milestones not accrued for at&#160;March&#160;31, 2022&#160;totaled approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i4cd2df5979694abd9cfb33abc0ae4026_D20220101-20220331" decimals="-5" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85Ny9mcmFnOmU2MzRhNzAxYzU1NzQ1ODI5ZGNhYjUwZWZlMGFjZDg3L3RleHRyZWdpb246ZTYzNGE3MDFjNTU3NDU4MjlkY2FiNTBlZmUwYWNkODdfMTQxMg_ba993d1a-09c7-46e4-a3ee-4885d8b66827">338</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the amounts that may be paid through the end of 2022 to be approximately $<ix:nonFraction unitRef="usd" contextRef="ib755013306ad4359a6aae01eb324d613_D20220101-20220331" decimals="-5" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85Ny9mcmFnOmU2MzRhNzAxYzU1NzQ1ODI5ZGNhYjUwZWZlMGFjZDg3L3RleHRyZWdpb246ZTYzNGE3MDFjNTU3NDU4MjlkY2FiNTBlZmUwYWNkODdfMTUwNg_93f8b913-5afa-46d3-a431-c7af08590ae9">10</ix:nonFraction> million. These agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. The amounts disclosed do not include sales-based milestones or royalty or profit share obligations on future sales of product as the timing and amount of future sales levels and costs to produce products subject to these obligations is not reasonably estimable. These sales-based milestones or royalty or profit share obligations may be significant depending upon the level of commercial sales for each product.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our licensing and other partner agreements as disclosed in our 2021 Form 10-K.</span></div></ix:continuation><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_100"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzQ1Nzc_224aac7b-038f-42f6-89ca-4a24136e1751" continuedAt="i9596eaf35b594bf098c5d802e7d9c073" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i9596eaf35b594bf098c5d802e7d9c073" continuedAt="i8294650555ca47549875fcade0d3385f"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Examinations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#8217;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#8217;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to ongoing IRS examinations. The years 2015 through 2019 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments or issued assessments to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law.  As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2020, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments for the years ended December 2009 to December 2019 and we have commenced litigation in the Australian Federal Court challenging that decision. A decision on our objection to the assessment for the year ended December 2020 is pending. The Company made a partial payment of $<ix:nonFraction unitRef="usd" contextRef="ib58c46b4f27f41a69c77fc95bcc936c7_D20210101-20211231" decimals="-5" name="vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMDk4ODk5_00fc4d4f-d65d-4f90-a852-3d50388a25aa">56.0</ix:nonFraction>&#160;million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="i3c8958a092304f48b6c503090ac334f6_D20220101-20220331" decimals="-5" name="vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMDk4OTE0_29f9eb04-6d59-4ab6-9374-e3bc875efb54">5.2</ix:nonFraction>&#160;million in 2022 in order to stay potential interest and penalties resulting from this litigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2015 concerning our tax position with respect to whether income earned by a Company entity not domiciled in France should be subject to French tax.  We have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. Some of these assessments remain in the audit phase where we are challenging them before the tax authorities while we are challenging some of the other assessments in the Indian tax courts.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i8294650555ca47549875fcade0d3385f"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a net reserve for uncertain tax positions of $<ix:nonFraction unitRef="usd" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="-5" name="vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMTAwMzM2_09fe02fd-685b-4851-b426-395d9c127b60">317.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231" decimals="-5" name="vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMTAwMzUy_cb938d81-14b5-4447-b282-fe636c885234">315.6</ix:nonFraction>&#160;million, including interest and penalties, in connection with its international audits at March 31, 2022 and December 31, 2021, respectively. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2020, with several state audits currently in progress. The Company&#8217;s major international taxing jurisdictions remain open from 2012 through 2020.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Court Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#8217;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS has appealed this decision.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Uncertainty in Income Taxes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a&#160;50%&#160;likelihood of being sustained.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_103"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with the Combination, the Company has generally assumed liability for, and control of, pending and threatened legal matters relating to the Upjohn Business &#8211; including certain matters initiated against Pfizer described below &#8211; and has agreed to indemnify Pfizer for liabilities arising out of such assumed legal matters. Pfizer, however, has agreed to retain various matters &#8211; including certain specified competition law matters &#8211; to the extent they arise from conduct during the pre-Distribution period and has agreed to indemnify the Company for liabilities arising out of such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#8217;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these governmental inquiries, investigations, proceedings and litigation matters with which the Company is involved are described below, and unless otherwise disclosed, the Company is unable to predict the outcome of the matter or to provide an estimate of the range of reasonably possible material losses. The Company records accruals for loss contingencies to the extent we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is also involved in other pending proceedings for which, in the opinion of the Company based upon facts and circumstances known at the time, either the likelihood of loss is remote or any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#8217;s business, financial position, results of operations, cash flows, ability to pay dividends and/or stock price. If and when any reasonably possible losses associated with the resolution of such other pending proceedings, in the opinion of the Company, become material, the Company will disclose such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal costs are recorded as incurred and are classified in SG&amp;A in the Company&#8217;s condensed consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EpiPen&#174; Auto-Injector Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and a former Mylan N.V. officer (collectively the &#8220;Mylan Defendants&#8221;) were named as defendants in indirect purchaser class actions relating to the pricing and/or marketing of the EpiPen&#174; Auto-Injector. The plaintiffs in these cases asserted violations of various federal and state antitrust and consumer protection laws, RICO as well as common law claims. Plaintiffs&#8217; seek monetary damages, attorneys&#8217; fees and costs. These lawsuits were filed in various federal and state courts and have either been dismissed or transferred into a MDL in the U.S. District Court for the District of Kansas and have been consolidated or centralized.  An antitrust class consisting of certain states was ultimately certified. On June 23, 2021, the Court granted &#8211; in substantial part &#8211; the Mylan Defendants&#8217; motion for summary judgment by dismissing certain antitrust claims and the RICO claims, which included RICO claims asserted against the former Mylan N.V. officer. The remaining antitrust theory concerns a patent settlement between Pfizer and Teva and other alleged actions regarding the launch of Teva&#8217;s generic epinephrine auto-injector. In February 2022, the parties reached an agreement to fully resolve this matter for $<ix:nonFraction unitRef="usd" contextRef="i38aa3e44188c4557aa18bc19d33a2f00_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2NjQ5NTY_494135b6-8ffe-4428-9c8f-c4cd1a023790">264</ix:nonFraction>&#160;million, which was accrued for during the year ended December 31, 2021. The settlement is subject to court approval and contains an express provision disclaiming and denying any wrongdoing or liability by the Mylan Defendants. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in a putative direct purchaser class action filed in the U.S. District Court for the District of Kansas relating to the pricing and/or marketing of the EpiPen&#174; Auto-Injector. On September 21, 2021, after Plaintiffs&#8217; then operative complaint was dismissed with an option to file a limited amended complaint, Plaintiffs filed an amended complaint asserting federal antitrust claims which are based on allegations that are similar to those in the indirect purchaser class actions discussed above. Plaintiffs&#8217; seek monetary damages, declaratory relief, attorneys&#8217; fees and costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in putative direct purchaser class actions filed in the U.S. District Court for the District of Minnesota relating to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracts with certain pharmacy benefit managers concerning EpiPen&#174; Auto-Injector. The plaintiffs claim that the alleged conduct resulted in the exclusion or restriction of competing products and the elimination of pricing constraints in violation of RICO and federal antitrust law. These actions have been consolidated. Plaintiffs&#8217; seek monetary damages, attorneys&#8217; fees and costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 24, 2017, Sanofi Aventis U.S., LLC (&#8220;Sanofi&#8221;) filed a lawsuit against the Company in the U.S. District Court for the District of New Jersey. This lawsuit has been transferred into the aforementioned MDL and alleges exclusive dealing and anti-competitive marketing practices in violation of the antitrust laws in connection with the sale and marketing of the EpiPen&#174; Auto-Injector. Sanofi seeks monetary damages, declaratory relief, attorneys&#8217; fees and costs. The Court granted the Company&#8217;s motion for summary judgment and dismissed Sanofi&#8217;s claims. Sanofi&#8217;s appeal is pending.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a total accrual of approximately $<ix:nonFraction unitRef="usd" contextRef="i3e4d7d622da84b43bba3a6f1313667a9_I20220331" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODU0NTQ_abc5b903-9fc0-4d59-8670-03d5e6a83991">269.0</ix:nonFraction> million related to these matters at March&#160;31, 2022, which is included in other current liabilities in the condensed consolidated balance sheets. Although it is reasonably possible that the Company may incur additional losses from these matters, any amount cannot be reasonably estimated at this time. In addition, the Company expects to incur additional legal and other professional service expenses associated with such matters in future periods and will recognize these expenses as services are received. The Company believes that the ultimate amount paid for these services and claims could have a material effect on the Company's business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price in future periods.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug Pricing Matters </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2015, the Company received a subpoena from the Antitrust Division of the DOJ seeking information relating to the marketing, pricing, and sale of certain of our generic products and any communications with competitors about such products. On September 8, 2016, the Company, as well as certain employees and a member of senior management, received subpoenas from the DOJ seeking similar information. Related search warrants also were executed.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2018, the Company received a civil investigative demand from the Civil Division of the DOJ seeking information relating to the pricing and sale of its generic drug products.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are fully cooperating with these investigations, which we believe are related to a broader industry-wide investigation of the generic pharmaceutical industry.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2016, the Company, along with other manufacturers, has been named as a defendant in lawsuits generally alleging anticompetitive conduct with respect to generic drugs. The lawsuits have been filed by plaintiffs, including putative classes of direct purchasers, indirect purchasers, and indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties. They allege harm under federal and state laws, including federal and state antitrust laws, state consumer protection laws and unjust enrichment claims. Some of the lawsuits also name as defendants the Company&#8217;s President, including allegations against him with respect to a single drug product, and one of the Company&#8217;s sales employees, including allegations against him with respect to certain generic drugs. The vast majority of the lawsuits have been consolidated in an MDL proceeding in the Eastern District of Pennsylvania (&#8220;EDPA&#8221;). Plaintiffs generally seek monetary damages, restitution, declaratory and injunctive relief, attorneys&#8217; fees and costs. The Court has ordered certain plaintiffs&#8217; complaints regarding two single-drug product cases to proceed as bellwethers. The Company is named in those plaintiffs&#8217; complaints that regard one of the two individual drug products. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorneys General Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2015, the Company received a subpoena and interrogatories from the Connecticut Office of the Attorney General seeking information relating to the marketing, pricing and sale of certain of the Company&#8217;s generic products and communications with competitors about such products. On December 14, 2016, attorneys general of certain states filed a complaint in the United States District Court for the District of Connecticut against several generic pharmaceutical drug manufacturers, including the Company, alleging anticompetitive conduct with respect to, among other things, a single drug product. The complaint has subsequently been amended, including on June 18, 2018, to add attorneys general alleging violations of federal and state antitrust laws, as well as violations of various states&#8217; consumer protection laws. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. The operative complaint includes attorneys general of <ix:nonFraction unitRef="number" contextRef="iaafdd9a3a724498080488d52b9b8e49a_I20220331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzk2Nzk_1c2b1cd8-baf5-4064-9729-a517a2dc7fa4">forty-six</ix:nonFraction> states, the District of Columbia and the Commonwealth of Puerto Rico. The Company is alleged to have engaged in anticompetitive conduct with respect to four generic drug products. The amended complaint also includes claims asserted by attorneys general of <ix:nonFraction unitRef="number" contextRef="ifef39d3d08a74324abe20f3b54b78a71_I20220331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzk5Mzg_2253653b-e742-4368-940c-9fee1dba937d">thirty-six</ix:nonFraction> states and the Commonwealth of Puerto Rico against certain individuals, including the Company&#8217;s President, with respect to a single drug product. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2019, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against various drug manufacturers and individuals, including the Company and one of its sales employees, alleging anticompetitive conduct with respect to additional generic drugs. On November 1, 2019, the complaint was amended, adding additional states as plaintiffs. The operative complaint is brought by attorneys general of <ix:nonFraction unitRef="number" contextRef="i2cebc8f9c5ae49bab6671a9b180b170e_I20220331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwNzI4_3a34002b-43e3-460b-b387-7ff30dc489d8">forty-seven</ix:nonFraction> states, certain territories and the District of Columbia. The amended complaint also includes claims asserted by attorneys general of <ix:nonFraction unitRef="number" contextRef="ic49cbe2fbefc424a92f99179077a1f8a_I20220331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwODY1_13b8fb13-4e32-4196-b956-922c8a5cc626">forty-two</ix:nonFraction> states and certain territories against several individuals, including a Company sales employee. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2020, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against drug manufacturers, including the Company, and individual defendants (none from the Company), alleging anticompetitive conduct with respect to additional generic drugs. On September 9, 2021, the complaint was amended, adding an additional state as a plaintiff. The operative complaint is brought by attorneys general of <ix:nonFraction unitRef="state" contextRef="iaafdd9a3a724498080488d52b9b8e49a_I20220331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2NzMwMTg_ff1313b2-dd95-4e28-a72e-8c5fa50b04a4">forty-six</ix:nonFraction> states, certain territories and the District of Columbia. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA and has been ordered to proceed as a bellwether.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Related Litigation </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purported class action complaints were filed in October 2016 against Mylan N.V. and Mylan Inc. (collectively &#8220;Mylan&#8221;), certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors and officers (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;) in the United States District Court for the Southern District of New York (&#8220;SDNY&#8221;) on behalf of certain purchasers of securities of Mylan on the NASDAQ. The complaints alleged that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the classification of their EpiPen&#174; Auto-Injector as a non-innovator drug for purposes of the Medicaid Drug Rebate Program. On March 20, 2017, a consolidated amended complaint was filed alleging substantially similar claims, but adding allegations that defendants made false or misleading statements and omissions of purportedly material fact in connection with allegedly anticompetitive conduct with respect to EpiPen&#174; Auto-Injector and certain generic drugs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operative complaint is the third amended consolidated complaint, which was filed on June 17, 2019, and contains the allegations as described above against Mylan, certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors, officers, and employees (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;). A class has been certified covering all persons or entities that purchased Mylan common stock between February 21, 2012 and May 24, 2019 excluding defendants, certain of the Company&#8217;s current directors and officers, former directors and officers of Mylan, members of their immediate families and their legal representatives, heirs, successors or assigns, and any entity in which defendants have or had a controlling interest. Plaintiffs seek damages and costs and expenses, including attorneys&#8217; fees and expert costs. A decision on Defendants&#8217; motion for summary judgment seeking to dismiss the case in its entirety and Plaintiffs&#8217; cross-motion for partial summary judgment as to portions of certain claims is pending.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2017, a similar lawsuit was filed in the Tel Aviv District Court (Economic Division) in Israel, which has been stayed pending a decision in the SDNY class action litigation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Abu Dhabi Investment Authority filed a complaint against Mylan in the SDNY asserting allegations pertaining to EpiPen&#174; Auto-Injector and certain generic drugs under the federal securities laws that overlap with those asserted in the third amended complaint identified above. The Abu Dhabi Investment Authority&#8217;s complaint seeks monetary damages as well as the plaintiff&#8217;s fees and costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2020, a putative class action complaint was filed by the Public Employees Retirement System of Mississippi, which was subsequently amended on November 13, 2020, against Mylan N.V., certain of Mylan N.V.&#8217;s former directors and officers, and an officer and director of the Company (collectively for the purposes of this paragraph, the &#8220;defendants&#8221;) in the U.S. District Court for the Western District of Pennsylvania on behalf of certain purchasers of securities of Mylan N.V. The amended complaint alleges that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the Morgantown manufacturing plant and inspections at the plant by the FDA. Plaintiff seeks certification of a class of purchasers of Mylan N.V. securities between February 16, 2016 and May 7, 2019. The complaint seeks monetary damages, as well as the plaintiff&#8217;s fees and costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2021, a complaint was filed by Skandia Mutual Life Ins. Co., Lansforsakringar AB, KBC Asset Management N.V., and GIC Private Limited, against the Company, certain of Mylan N.V.&#8217;s former directors and officers, a current director and officer of the Company, and current employees of the Company. The Complaint asserts claims which are based on allegations that are similar to those in the SDNY and the Western District of Pennsylvania complaints identified above.  Plaintiffs seek compensatory damages, costs and expenses and attorneys&#8217; fees.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and certain of its officers and directors were named as defendants in a putative class action lawsuit filed in the Court of Common Pleas of Allegheny County, Pennsylvania on behalf of former Mylan shareholders who received Company common stock in connection with the Combination.  A non-Viatris affiliated company and persons were also named as defendants.  The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 for purportedly failing to disclose or misrepresenting material information in the registration statement and related prospectus issued in connection with the Combination.  Plaintiffs seek monetary damages, reasonable costs and expenses, and certain other equitable and injunctive relief. </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioids</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with other manufacturers, distributors, pharmacies, pharmacy benefit managers, and individual healthcare providers is a defendant in more than <ix:nonFraction unitRef="number" contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331" decimals="0" name="vtrs:Numberofcases" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzE3NDg0_6e4215ec-739d-431c-ad1c-e074c2615495">1,000</ix:nonFraction> cases in the United States and Canada filed by various plaintiffs, including counties, cities and other local governmental entities, asserting civil claims related to sales, marketing and/or distribution practices with respect to prescription opioid products. In addition, lawsuits have been filed as putative class actions including on behalf of children with Neonatal Abstinence Syndrome due to alleged exposure to opioids.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lawsuits generally seek equitable relief and monetary damages (including punitive and/or exemplary damages) based on a variety of legal theories, including various statutory and/or common law claims, such as negligence, public nuisance and unjust enrichment. The vast majority of these lawsuits have been consolidated in an MDL in the U.S. District Court for the Northern District Court of Ohio.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, the Company is involved in a number of product liability lawsuits related to alleged personal injuries arising out of certain products manufactured/or distributed by the Company, including but not limited to those discussed below. Plaintiffs in these cases generally seek damages and other relief on various grounds for alleged personal injury and economic loss.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i4c504afee4fe48c49e1b8ec64187b6b1_I20220331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODU0MTY_fea8df04-c541-40ce-babd-99b4dc6066a6">75.3</ix:nonFraction> million as of March 31, 2022 for its product liability matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nitrosamines</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with numerous other manufacturers, retailers, and others, are parties to litigation relating to alleged trace amounts of nitrosamine impurities in certain products, including valsartan and ranitidine. The vast majority of these lawsuits in the United States are pending in two MDLs, namely an MDL pending in the United States District Court for the District of New Jersey concerning valsartan and an MDL pending in the United States District Court for the Southern District of Florida concerning ranitidine. The lawsuits against the Company in the MDLs include putative class actions seeking the refund of the purchase price and other economic and punitive damages allegedly sustained by consumers and end payors as well as individuals seeking compensatory and punitive damages for personal injuries allegedly caused by ingestion of the medications. Similar lawsuits pertaining to valsartan have been filed in other countries. Class certification motions are pending in the valsartan MDL. The Company has also received claims and inquiries related to these products, as well as requests to indemnify purchasers of the Company&#8217;s API and/ or finished dose forms of these products. The original master complaints concerning ranitidine were dismissed on December 31, 2020. The Company was not named as a defendant in the amended master complaints, though it was still named in certain short form personal injury complaints. The end-payor plaintiffs and certain of the plaintiffs named in the short form personal injury complaints in the ranitidine matter have filed appeals to the U.S. Court of Appeals for the Eleventh Circuit. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lipitor</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of individual and multi-plaintiff lawsuits have been filed against Pfizer in various federal and state courts alleging that the plaintiffs developed type 2 diabetes purportedly as a result of the ingestion of Lipitor. Plaintiffs seek compensatory and punitive damages. In February 2014, the federal actions were transferred for consolidated pre-trial proceedings to an MDL in the U.S. District Court for the District of South Carolina. Since 2016, certain cases in the MDL were remanded to certain state courts. In 2017, the District Court granted Pfizer&#8217;s motion for summary judgment, dismissing all of the cases pending in the MDL. In June 2018, this dismissal was affirmed by the U.S. Court of Appeals for the Fourth Circuit. The state court proceedings remain pending in various jurisdictions, including in California, Missouri, and New York. On January 27, 2021, the California Court granted Pfizer&#8217;s motion to exclude the opinions of plaintiffs&#8217; only general causation </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expert in connection with his opinions involving the three lowest doses of Lipitor (10, 20 and 40 mg). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s motion for summary judgment in connection with the 10, 20, and 40 mg plaintiffs was granted, resulting in their dismissal. On November 3, 2021, the Court granted the Company&#8217;s motion seeking the dismissal of the remaining cases involving the highest dose of Lipitor (80 mg).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Viagra</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since April 2016, an MDL has been pending in the U.S. District Court for the Northern District of California, in which plaintiffs allege that they developed melanoma and/or the exacerbation of melanoma purportedly as a result of the ingestion of Viagra. Additional cases filed against Eli Lilly and Company (&#8220;Lilly&#8221;) with respect to Cialis have also been consolidated in the MDL. Plaintiffs seek compensatory and punitive damages. In January 2020, the District Court granted Pfizer&#8217;s and Lilly&#8217;s motion to exclude all of plaintiffs&#8217; general causation opinions. As a result, in April 2020, the District Court entered summary judgment in favor of defendants and dismissed all of plaintiffs&#8217; claims. In April 2020, plaintiffs filed a notice of appeal in the U.S. Court of Appeals for the Ninth Circuit. The parties have reached a settlement in principle.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in a number of patent litigation lawsuits involving the validity and/or infringement of patents held by branded pharmaceutical manufacturers including but not limited to the matters described below. The Company uses its business judgment to decide to market and sell certain products, in each case based on its belief that the applicable patents are invalid and/or that its products do not infringe, notwithstanding the fact that allegations of patent infringement(s) or other potential third party rights have not been finally resolved by the courts. The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, a reasonable royalty on sales or damages measured by the profits lost by the patent owner. If there is a finding of willful infringement, damages may be increased up to <ix:nonFraction unitRef="increase" contextRef="i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331" decimals="INF" name="vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzI4MDI1_3c0a325b-d6f1-42a3-a48c-83410b88c0b3">three</ix:nonFraction> times. Moreover, because of the discount pricing typically involved with bioequivalent products, patented branded products generally realize a substantially higher profit margin than generic and biosimilar products. The Company also faces challenges to its patents, including suits in various jurisdictions pursuant to which generic drug manufacturers, payers, governments, or other parties are seeking damages for allegedly causing delay of generic entry. An adverse decision in any of these matters could have an adverse effect that is material to our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331" decimals="-5" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODUzODE_df945c8d-dcad-4790-9d33-6e878a563dfd">211.8</ix:nonFraction> million as of March 31, 2022 for its intellectual property matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dimethyl Fumarate</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2017, Biogen MA Inc. and Biogen International GmbH (collectively, &#8220;Biogen&#8221;) sued MPI in the U.S. District Court for the Northern District of West Virginia asserting that MPI&#8217;s abbreviated new drug application for dimethyl fumarate delayed-release capsules containing 120 mg and 240 mg of dimethyl fumarate (generic for Tecfidera&#174;) infringed six U.S. patents that Biogen had listed in the Orange Book: 6,509,376, 7,320,999, 7,619,001, 7,803,840, 8,759,393, and 8,399,514. All patents except for the &#8216;514 expired during the litigation and were dismissed from the case.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a trial involving only the &#8217;514 patent on June 18, 2020, the District Court issued a judgment finding all claims of the &#8217;514 patent invalid for lack of adequate written description. On appeal, the Federal Circuit affirmed the District Court&#8217;s judgment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biogen&#8217;s petition for rehearing was denied.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for Biogen to file a petition seeking review by the U.S. Supreme Court has not yet passed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2018, MPI filed an IPR petition challenging the &#8217;514 patent based only on obviousness. On February 5, 2020, the PTAB issued a final written decision finding the claims not obvious. MPI&#8217;s appeal of the PTAB decision is stayed pending resolution of any request by Biogen for U.S. Supreme Court review of the Federal Circuit&#8217;s affirmance of the District Court&#8217;s invalidity judgment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2020, the FDA approved MPI&#8217;s dimethyl fumarate delayed-release capsules, which MPI began selling on August 18, 2020.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lyrica - United Kingdom </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2014, Pfizer was involved in patent litigation in the English courts concerning the validity of its Lyrica pain use patent. In 2015, the High Court of Justice in London ordered that the NHS England issue guidance for prescribers and pharmacists directing the prescription and dispensing of Lyrica by brand when pregabalin was prescribed for the treatment of neuropathic pain and entered a preliminary injunction against certain Sandoz group companies preventing the sale of Sandoz&#8217;s full label pregabalin product. Pfizer undertook to compensate certain generic companies and NHS entities for losses caused by these orders, which remained in effect until patent expiration in July 2017. In November 2018, the U.K. Supreme Court ruled that all the relevant claims directed to neuropathic pain were invalid.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Reddy&#8217;s Laboratories filed a claim for monetary damages, interest, and costs in May 2020, followed by the Scottish Ministers and fourteen Scottish Health Boards (together, NHS Scotland) in July 2020. In September 2020, Teva, Sandoz, Ranbaxy, Actavis, and the Secretary of State for Health and Social Care, together with 32 other NHS entities (together, NHS England, Wales, Scotland and Northern Ireland) filed their claims. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he claims filed by Sandoz, Teva, Actavis, and Ranbaxy have been resolved. A trial on the remaining claims has been set for November 2023.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other legal proceedings including commercial, contractual, employment, or other similar matters that are considered normal to its business. The Company has approximately $<ix:nonFraction unitRef="usd" contextRef="id8a766f58ff5477781e10e45ea959330_I20220331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODUzNjM_b7a06f52-c4bf-44b0-aa87-526b2f015bdb">34.8</ix:nonFraction> million accrued related to these various other legal proceedings at March&#160;31, 2022.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_106"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_109"></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis addresses material changes in the financial condition and results of operations of Viatris Inc. and subsidiaries for the periods presented. Unless context requires otherwise, the &#8220;Company,&#8221; &#8220;Viatris,&#8221; &#8220;our&#8221; or &#8220;we&#8221; refer to Viatris Inc. and its subsidiaries. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis should be read in conjunction with the Consolidated Financial Statements, the related Notes to Consolidated Financial Statements and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in Viatris&#8217; 2021 Form 10-K, the unaudited interim financial statements and related Notes included in Part&#160;I&#160;&#8212; ITEM&#160;1 of this Form&#160;10-Q and our other SEC filings and public disclosures. The interim results of operations and comprehensive earnings (loss) for the three months ended March&#160;31, 2022, and cash flows for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form 10-Q contains &#8220;forward-looking statements&#8221;. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, statements about the Biocon Biologics Transaction, the Combination, the benefits and synergies of the Combination or our global restructuring program, future opportunities for the Company and its products and any other statements regarding the Company&#8217;s future operations, financial or operating results, capital allocation, dividend policy and payments, debt ratio and covenants, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, commitments, confidence in future results, efforts to create, enhance or otherwise unlock the value of our unique global platform, and other expectations and targets for future periods. Forward-looking statements may often be identified by the use of words such as &#8220;will&#8221;, &#8220;may&#8221;, &#8220;could&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, &#8220;project&#8221;, &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;forecast&#8221;, &#8220;potential&#8221;, &#8220;pipeline&#8221;, &#8220;intend&#8221;, &#8220;continue&#8221;, &#8220;target&#8221;, &#8220;seek&#8221; and variations of these words or comparable words. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the integration of Mylan and the Upjohn Business or the implementation of the Company&#8217;s global restructuring program being more difficult, time consuming or costly than expected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the pending Biocon Biologics Transaction may not achieve its intended benefits;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with the Combination or its global restructuring program within the expected timeframe or at all; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to successfully integrate Mylan and the Upjohn Business or implement its global restructuring program;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">operational or financial difficulties or losses associated with the Company&#8217;s reliance on agreements with Pfizer in connection with the Combination, including with respect to transition services; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to achieve all intended benefits of its strategic initiatives; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by the COVID-19 pandemic; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the Company&#8217;s failure to achieve expected or targeted future financial and operating performance and results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">actions and decisions of healthcare and pharmaceutical regulators;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in relevant laws and regulations, including but not limited to changes in tax, healthcare and pharmaceutical laws and regulations globally (including the impact of potential tax reform in the U.S.);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the ability to attract and retain key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the Company&#8217;s liquidity, capital resources and ability to obtain financing; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any regulatory, legal or other impediments to the Company&#8217;s ability to bring new products to market, including but not limited to &#8220;at-risk launches&#8221;; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">success of clinical trials and the Company&#8217;s or its partners&#8217; ability to execute on new product opportunities and develop, manufacture and commercialize products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any changes in or difficulties with the Company&#8217;s manufacturing facilities, including with respect to inspections, remediation and restructuring activities, supply chain or inventory or the ability to meet anticipated demand; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the scope, timing and outcome of any ongoing legal proceedings, including government inquiries or investigations, and the impact of any such proceedings on the Company; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any significant breach of data security or data privacy or disruptions to our information technology systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">risks associated with having significant operations globally; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the ability to protect intellectual property and preserve intellectual property rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">changes in third-party relationships; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the effect of any changes in the Company&#8217;s or its partners&#8217; customer and supplier relationships and customer purchasing patterns, including customer loss and business disruption being greater than expected following the Combination; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the impacts of competition, including decreases in sales or revenues as a result of the loss of market exclusivity for certain products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">changes in the economic and financial conditions of the Company or its partners; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">uncertainties regarding future demand, pricing and reimbursement for the Company&#8217;s products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">uncertainties and matters beyond the control of management, including but not limited to general political and economic conditions, inflation rates and global exchange rates; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with U.S. GAAP and related standards or on an adjusted basis.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detailed information on the risks and uncertainties associated with Viatris, see the risks described in Part I, Item 1A in the 2021 Form 10-K, and our other filings with the SEC. You can access Viatris&#8217; filings with the SEC through the SEC website at www.sec.gov or through our website, and Viatris strongly encourages you to do so. Viatris routinely posts information that may be important to investors on our website at investor.viatris.com, and we use this website address as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC&#8217;s Regulation Fair Disclosure (Reg FD). The contents of our website are not incorporated by reference in this Form 10-Q and shall not be deemed &#8220;filed&#8221; under the Securities Exchange Act of 1934, as amended. Viatris undertakes no obligation to update any statements herein for revisions or changes after the filing date of this Form 10-Q other than as required by law.</span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_112"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Company Overview</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is a global healthcare company formed in November 2020 whose mission is to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance. Improving the ability of patients to gain access to sustainable and high-quality healthcare is our relentless pursuit. One that rests on visionary thinking, determination and best-in-class capabilities that were strategically built to remove barriers across the health spectrum and advance access globally.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; seasoned management team is focused on ensuring that the Company is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers and other stakeholders. With a global workforce of approximately 37,000, the Company has industry leading commercial, R&amp;D, regulatory, manufacturing, legal and medical expertise complemented by a strong commitment to quality and unparalleled geographic footprint to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris&#8217; portfolio comprises more than 1,400 approved molecules across more than 10 major therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. The Company operates approximately 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Certain Market and Industry Factors</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global pharmaceutical industry is a highly competitive and highly regulated industry. As a result, we face a number of industry-specific factors and challenges, which can significantly impact our results.&#160;The following discussion highlights some of these key factors and market conditions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Generic products, particularly in the U.S., generally contribute most significantly to revenues and gross margins at the time of their launch, and even more so in periods of market exclusivity, or in periods of limited generic competition. As such, the timing of new product introductions can have a significant impact on the Company&#8217;s financial results. The entrance into the market of additional competition generally has a negative impact on the volume and pricing of the affected products. Additionally, pricing is often affected by factors outside of the Company&#8217;s control. Conversely, generic products generally experience less volatility over a longer period of time in Europe as compared to the U.S., primarily due to the role of government oversight of healthcare systems in the region.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For branded products, the majority of the product&#8217;s commercial value is usually realized during the period in which the product has market exclusivity. In the U.S.&#160;and some other countries, when market exclusivity expires and generic versions of a product are approved and marketed, there can often be very substantial and rapid declines in the branded product&#8217;s sales. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain markets in which we do business outside of the U.S. have undergone government-imposed price reductions, and further government-imposed price reductions are expected in the future. Such measures, along with the tender systems discussed below, are likely to have a negative impact on sales and gross profit in these markets. However, government initiatives in certain markets that appear to favor generic products could help to mitigate this unfavorable effect by increasing rates of generic substitution and penetration. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a number of markets in which we operate outside of the U.S. have implemented, or may implement, tender systems for generic pharmaceuticals in an effort to lower prices. Generally speaking, tender systems can have an unfavorable impact on sales and profitability. Under such tender systems, manufacturers submit bids that establish prices for generic pharmaceutical products. Upon winning the tender, the winning company will receive priority placement for a period of time. The tender system often results in companies underbidding one another by proposing low pricing in order to win the tender. The loss of a tender by a third party to whom we supply API can also have a negative impact on our sales and profitability. Sales continue to be negatively affected by the impact of tender systems in certain countries.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Reinvestment and Share Purchase Plan</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2022, the Company announced that its Board of Directors had authorized a DRIP. The DRIP will allow shareholders to automatically reinvest all or a portion of the cash dividends paid on their shares of the Company&#8217;s common stock and to make certain additional optional cash investments in the Company&#8217;s common stock.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Operations</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing conflict between Russia and Ukraine did not have a material impact on our business during the first quarter of 2022 and combined total revenues for both countries were less than 1% of consolidated total revenues during the three months ended March 31, 2022. However, trade controls, sanctions, supply chain and staffing challenges and other economic considerations related to the conflict have impacted our operations in these markets and may negatively impact our financial results in future periods. In addition, a significant escalation or expansion of the conflict&#8217;s current scope may have a negative impact on our operations and financial results in future periods. For a further discussion of the risks we encounter in our business, including the risks of conducting our business internationally, please refer to Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2021 Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 830&#8221;), a highly inflationary economy is one that has cumulative inflation of approximately 100% or more over a three-year period. Effective April 1, 2022, we classified Turkey as highly inflationary. In accordance with ASC 830, starting with the second quarter of 2022, we will begin to use the U.S. dollar as our functional currency in Turkey, which historically utilized the Turkish lira as the functional currency. The impacted net sales for the three months ended March 31, 2022 and total assets at March 31, 2022 represented less than 1% of our consolidated net sales and total assets, respectively.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biocon Biologics Agreement</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2022, the Company entered into an agreement to contribute its biosimilars portfolio to Biocon Biologics. Under the terms of the Biocon Agreement, at closing Viatris will receive an up-front cash payment of $2.0 billion, subject to certain adjustments, ownership of at least 12.9% of Biocon Biologics, on a fully diluted basis, in the form of convertible preferred equity which will have certain priority rights with respect to certain liquidity events, and $335 million as additional cash payments that are expected to be paid in 2024. Upon closing of the transaction, we expect to record a gain for the difference between the consideration received, including the fair value of the convertible preferred equity, and the carrying value of the biosimilars portfolio. The companies will also enter into a two-year transition services agreement, subject to extension in certain circumstances, during which time Viatris will provide certain commercial and administrative services for an applicable service fee. The transaction is expected to close in the second half of 2022 and is subject to various closing conditions (including regulatory approvals).</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0 billion of the Company&#8217;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cyclosporine Ophthalmic Emulsion</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2022, the Company announced that it had received approval from the FDA for its ANDA for Cyclosporine Ophthalmic Emulsion 0.05%, the first generic version of Allergan's Restasis&#174;. Cyclosporine Ophthalmic Emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca, also known as dry eye. The commercial launch of the product occurred in February 2022.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs. In addition, management believes the potential annual savings related to these committed restructuring activities to be up to approximately $900&#160;million once fully implemented, with most of these savings expected to improve operating cash flow.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of the Coronavirus Pandemic</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading global pharmaceutical company, Viatris is committed to continue doing its part in support of public health needs amid the evolving COVID-19 pandemic. The Company&#8217;s priorities remain protecting the health and safety of our workforce, continuing to produce critically needed medicines, deploying resources and expertise in the fight against COVID-19 through potential prevention and treatment efforts, supporting the communities in which we operate and maintaining the health of our overall business. As a result, many Viatris administrative offices continue operating under work from home protocols and some of our customer facing field personnel continue on a remote engagement model to ensure continued support for healthcare professionals, patient care and access to needed products. Additionally, all of our manufacturing facilities, and those of our key global partners, are currently operational and, at this time, we are not experiencing any significant disruptions. Current inventory levels, both ours and those in our distribution channel, remain in-line with normal levels.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global spread of COVID-19 has created and continues to create significant volatility, uncertainty and economic disruption affecting the markets we serve, including impacts on supply chain partners, third-party manufacturers, logistics providers and other vendors. The extent to which the COVID-19 pandemic will impact our business, operations and financial results in future periods will depend on numerous evolving factors that are beyond our control and that we may not be able to accurately predict, and could adversely impact our results of operations in future periods. Due to the Company&#8217;s ability to generate significant cash flows from operations, combined with our access to borrowing facilities and capital markets, we believe that we currently have, and will maintain, the ability to meet foreseeable liquidity needs. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_115"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below is a summary of the Company&#8217;s financial results for the three months ended March&#160;31, 2022 compared to the prior year period:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts and %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,191.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,037.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed discussion of the Company&#8217;s financial results can be found below in the section titled &#8220;Results of Operations.&#8221; As part of this discussion, we also report sales performance using the non-GAAP financial measures of &#8220;constant currency&#8221; net sales and total revenues. These measures provide information on the change in net sales and total revenues assuming that foreign currency exchange rates had not changed between the prior and current period. The comparisons presented at constant currency rates reflect comparative local currency sales at the prior year&#8217;s foreign exchange rates. We routinely evaluate our net sales and total revenues performance at constant currency so that sales results can be viewed without the impact of foreign currency exchange rates, thereby facilitating a period-to-period comparison of our operational activities, and believe that this presentation also provides useful information to investors for the same reason.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More information about non-GAAP measures used by the Company as part of this discussion, including adjusted cost of sales, adjusted gross margins, adjusted net earnings and adjusted EBITDA (all of which are defined below) can be found in &#8220;Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Results of Operations - Use of Non-GAAP Financial Measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_118"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_121"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March&#160;31, 2022 Compared to Three Months Ended March&#160;31, 2021</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:30.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 Currency Impact </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 Constant Currency Revenues</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency % Change </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,565.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated total revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,191.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Currency impact is shown as unfavorable (favorable).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The constant currency percentage change is derived by translating net sales or revenues for the current period at prior year comparative period exchange rates, and in doing so shows the percentage change from 2022 constant currency net sales or revenues to the corresponding amount in the prior year.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">For the three months ended March 31, 2022, other revenues in Developed Markets, JANZ, and Emerging Markets were approximately $6.3 million, $0.9 million, and $6.3 million, respectively.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Amounts exclude intersegment revenue which eliminates on a consolidated basis.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenues</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current quarter, Viatris reported total revenues of $4.19 billion, compared to $4.43 billion for the comparable prior year period, representing a decrease of $238.6 million, or 5%. Total revenues include both net sales and other revenues from third parties. Net sales for the current quarter were $4.18 billion, compared to $4.40 billion for the comparable prior year period, representing a decrease of $221.9 million, or 5%. Other revenues for the current quarter were $13.5 million, compared to $30.2 million for the comparable prior year period.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in total revenues and net sales was primarily driven by a decrease of approximately $169.7 million in net sales from existing products as a result of lower pricing and volumes, partially offset by approximately $120 million of new product sales. New product sales include new products launched in 2022 and the carryover impact of new products, including business development, launched within the last twelve months. The Company&#8217;s net sales were unfavorably impacted by the effect of foreign currency translation, primarily reflecting changes in the U.S. Dollar as compared to the currencies of subsidiaries in countries within the EU, Turkey, and Japan. The net unfavorable impact of foreign currency translation on net sales was approximately $170.3 million, or 4%. On a constant currency basis, the decrease in net sales was approximately $51.6 million, or 1% for the three months ended March&#160;31, 2022. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, a limited number of our products may represent a significant portion of our net sales, gross profit and net earnings. Generally, this is due to the timing of new product introductions and the amount, if any, of additional competition in the market. Our top ten products in terms of net sales, in the aggregate, represented approximately 35% for the three months ended March 31, 2022 and 2021. This percentage may fluctuate based upon the timing of new product launches, seasonality and the impact of competition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are derived from our four reporting segments: Developed Markets, Greater China, JANZ, and Emerging Markets. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Developed Markets Segment</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Developed Markets decreased by $95.5 million or 4% during the three months ended March&#160;31, 2022 when compared to the prior year period. Net sales within North America totaled approximately $1.12 billion and net sales within Europe totaled approximately $1.35 billion. This decrease was due primarily to the unfavorable impact of foreign currency translation, lower pricing and, to a lesser extent, lower volumes on net sales of existing products within the U.S., including Miacalcin&#174; and Perforomist&#174;, as a result of additional competition. These decreases were partially offset by new product sales, including Cyclosporine Ophthalmic Emulsion and Semglee&#174; in the U.S., and higher volumes of existing products in Europe. The unfavorable impact of foreign currency translation on current period net sales was approximately $89.1 million, or 4%. Constant currency net sales decreased by approximately $6.4 million, or less than 1% when compared to the prior year period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greater China Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Greater China decreased by $18.8 million or 3% for the three months ended March&#160;31, 2022 when compared to the prior year period. This decrease was the result of lower net sales of existing products, driven by lower volumes. Volumes on net sales of existing products were negatively impacted by competitive and other market conditions. The favorable impact of foreign currency translation was approximately $8.1 million, or 1%. Constant currency net sales decreased by approximately $26.9 million or 5% when compared to the prior year.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">JANZ Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from JANZ decreased by $58.1 million or 12% for the three months ended March&#160;31, 2022 when compared to the prior year. This decrease was primarily the result of the unfavorable impact of foreign currency translation, lower net sales of existing products mainly driven by lower pricing in Japan as a result of government price reductions and additional competition, and lower volumes on net sales of existing products in Australia. These decreases were partially offset by higher volumes on net sales of existing products in Japan, including for Celebrex&#174;. Foreign currency translation had an unfavorable impact of approximately $37.8 million, or 8%. Constant currency net sales decreased by approximately $20.3 million, or 4% when compared to the prior year period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emerging Markets Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Emerging Markets decreased by $49.5 million or 7% for the three months ended March&#160;31, 2022 when compared to the prior year period. This decrease was mainly driven by the unfavorable impact of foreign currency translation, lower volumes and, to a lesser extent, pricing for ARV products as a result of customer purchasing patterns and competitive market conditions. These decreases were partially offset by higher volumes in certain markets in Asia. The unfavorable impact of foreign currency translation was $51.5 million or 7%. Constant currency net sales increased by approximately $2.0 million, or less than 1%.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales and Gross Profit</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased from $3.30 billion for the three months ended March&#160;31, 2021 to $2.42 billion for the three months ended March&#160;31, 2022. Cost of sales was primarily impacted by purchase accounting related amortization of the fair value of step-up of acquired inventory of $476.4 million in the comparable prior year period, lower restructuring costs in the current period related to the 2020 restructuring program versus the comparable prior year period, and lower costs associated with other special items, which are described further in the section titled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Non-GAAP Financial Measures. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the three months ended March&#160;31, 2022 was $1.77 billion and gross margins were 42%. For the three months ended March&#160;31, 2021, gross profit was $1.13 billion and gross margins were 25%. This change is primarily related to the decrease in cost of sales. Adjusted gross margins were 59% for the three months ended March&#160;31, 2022, compared to 60% for the three months ended March&#160;31, 2021. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between cost of sales, as reported under U.S. GAAP, and adjusted cost of sales and adjusted gross margin for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. GAAP cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,303.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deduct:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting related amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted cost of sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,639.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Adjusted gross profit is calculated as total revenues less adjusted cost of sales. Adjusted gross margin is calculated as adjusted gross profit divided by total revenues.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research &amp; Development Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense for the three months ended March&#160;31, 2022 was $142.3 million, compared to $184.1 million for the comparable prior year period, a decrease of $41.8 million. This decrease was primarily due to lower costs for products under development and the impact of synergies.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General &amp; Administrative Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense for the current quarter was $915.3 million, compared to $1.19 billion for the comparable prior year period, a decrease of $271.2 million. The decrease was primarily due to lower restructuring costs of approximately $137.5 million related to the 2020 restructuring program and the impact of synergies. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Settlements and Other Contingencies, Net</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the losses/(gains) recognized in litigation settlements and other contingencies, net during the three months ended March&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:79.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration adjustment (primarily related to respiratory delivery platform)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total litigation settlements and other contingencies, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three months ended March&#160;31, 2022 totaled $146.2 million, compared to $169.0 million for the three months ended March&#160;31, 2021, a decrease of $22.8 million. The decrease is primarily due to the impact of debt repayments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Expense, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net includes losses from equity affiliates, foreign exchange gains and losses, expense (income) related to post-employment benefit plans and interest and dividend income. Other expense, net for the three months ended March 31, 2022 totaled $33.7 million, compared to $6.1 million for the three months ended March&#160;31, 2021. The increase was primarily driven by higher foreign exchange costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Provision</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, the Company recognized an income tax provision of $128.3 million, compared to $596.3 million for the comparable prior year period, a decrease of $468.0 million. The income tax provision for the three months ended March 31, 2021 was negatively impacted by the tax rates applied to the reversal of intercompany profit in inventory reserve which was recorded on the opening balance sheet as part of the Combination. This reserve eliminates the profit in inventory related to intercompany transactions and changes to this reserve occur as products are sold to third parties. Also impacting the current year income tax provision was the changing mix of income earned in jurisdictions with differing tax rates.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_127"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Measures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever the Company uses non-GAAP financial measures, we provide a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP financial measure. Investors and other readers are encouraged to review the related U.S. GAAP financial measures and the reconciliation of non-GAAP measures to their most directly comparable U.S. GAAP measure and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordance with U.S. GAAP. Additionally, since these are not measures determined in accordance with U.S. GAAP, non-GAAP financial measures have no standardized meaning across companies, or as prescribed by U.S. GAAP and, therefore, may not be comparable to the calculation of similar measures or measures with the same title used by other companies.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these measures internally for forecasting, budgeting, measuring its operating performance, and incentive-based awards. Primarily due to acquisitions and other significant events which may impact comparability of our periodic operating results, we believe that an evaluation of our ongoing operations (and comparisons of our current operations with historical and future operations) would be difficult if the disclosure of our financial results was limited to financial measures prepared only in accordance with U.S. GAAP. We believe that non-GAAP financial measures are useful supplemental information for our investors and when considered together with our U.S. GAAP financial measures and the reconciliation to the most directly comparable U.S. GAAP financial measure, provide a more complete understanding of the factors and trends affecting our operations. The financial performance of the Company is measured by senior management, in part, using adjusted metrics as described below, along with other performance metrics. The Company&#8217;s use of such non-GAAP measures is governed by an adjusted reporting policy maintained by the Company and such non-GAAP measures are reviewed in detail with the Audit Committee of the Board of Directors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Cost of Sales and Adjusted Gross Margin</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the non-GAAP financial measure &#8220;adjusted cost of sales&#8221; and the corresponding non-GAAP financial measure &#8220;adjusted gross margin.&#8221; The principal items excluded from adjusted cost of sales include restructuring, acquisition related and other special items and purchase accounting related amortization, which are described in greater detail below.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Net Earnings </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings is a non-GAAP financial measure and provides an alternative view of performance used by management. Management believes that, primarily due to acquisition activity and other significant events, an evaluation of the Company&#8217;s ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared only in accordance with U.S. GAAP. Management believes that adjusted net earnings is an important internal financial metric related to the ongoing operating performance of the Company, and is therefore useful to investors and that their understanding of our performance is enhanced by this measure. Actual internal and forecasted operating results and annual budgets used by management include adjusted net earnings.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EBITDA and Adjusted EBITDA </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBITDA and adjusted EBITDA are non-GAAP financial measures that the Company believes are appropriate to provide additional information to investors to demonstrate the Company&#8217;s ability to comply with financial debt covenants and assess the Company&#8217;s ability to incur additional indebtedness. The Company also believes that adjusted EBITDA better focuses management on the Company&#8217;s underlying operational results and true business performance and, is used, in part, for management&#8217;s incentive compensation. We calculate EBITDA as U.S. GAAP net earnings (loss) adjusted for net contribution attributable to equity method investments, income tax provision (benefit), interest expense and depreciation and amortization. EBITDA is further adjusted for share-based compensation expense, litigation settlements and other contingencies, net, and restructuring, acquisition related and other special items to determine adjusted EBITDA. These adjustments are generally permitted under our credit agreement in calculating adjusted EBITDA for determining compliance with our debt covenants.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant items excluded from adjusted cost of sales, adjusted net earnings, and adjusted EBITDA include:</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Accounting Amortization and Other Related Items</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing impact of certain amounts recorded in connection with acquisitions of both businesses and assets is excluded from adjusted cost of sales, adjusted net earnings, and adjusted EBITDA. These amounts include the amortization of intangible assets, inventory step-up, property, plant and equipment step-up, and intangible asset impairment charges, including for in-process research and development. For the acquisition of businesses accounted for under the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, these purchase accounting impacts are excluded regardless of the financing method used for the acquisitions, including the use of cash, long-term debt, the issuance of common stock, contingent consideration or any combination thereof.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upfront and Milestone-Related R&amp;D Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2022, upfront and milestone-related R&amp;D expenses related to collaboration and licensing arrangements are no longer excluded from adjusted net earnings and adjusted EBITDA. This change had no impact on the three months ended March&#160;31, 2022. For all prior periods presented, these expenses and payments were excluded from adjusted net earnings and adjusted EBITDA. Prior period adjusted net earnings and adjusted EBITDA have not been recast to reflect this change in policy because the excluded amount was approximately $0.5 million and is considered immaterial. </span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accretion of Contingent Consideration Liability and Other Fair Value Adjustments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of changes to the fair value of contingent consideration and accretion expense are excluded from adjusted net earnings and adjusted EBITDA because they are not indicative of the Company&#8217;s ongoing operations due to the variability of the amounts and the lack of predictability as to the occurrence and/or timing and management believes their exclusion is helpful to understanding the underlying, ongoing operational performance of the business.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is excluded from adjusted net earnings and adjusted EBITDA. Our share-based compensation programs have become increasingly weighted toward performance-based compensation, which leads to variability and to a lack of predictability as to the occurrence and/or timing of amounts incurred. As such, management believes the exclusion of such amounts on an ongoing basis is helpful to understanding the underlying operational performance of the business. </span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, Acquisition Related and Other Special Items</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs related to restructuring, acquisition and integration activities and other actions are excluded from adjusted cost of sales, adjusted net earnings and adjusted EBITDA, as applicable. These amounts include items such as: </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs related to formal restructuring programs and actions, including costs associated with facilities to be closed or divested, employee separation costs, impairment charges, accelerated depreciation, incremental manufacturing variances, equipment relocation costs, decommissioning and other restructuring related costs; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain acquisition related remediation and integration and planning costs, as well as other costs associated with acquisitions such as advisory and legal fees, certain financing related costs, certain reimbursements related to the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s obligation to reimburse Pfizer for certain financing and transaction related costs under the Business Combination Agreement and Separation and Distribution Agreement, certain other TSA related exit costs, and other business transformation and/or optimization initiatives, which are not part of a formal restructuring program, including employee separation and post-employment costs; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The pre-tax loss of the Company&#8217;s clean energy investments, whose activities qualify for income tax credits under the Code; only included in adjusted net earnings is the net tax effect of the entity&#8217;s activities;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other costs, incurred from time to time, related to certain special events or activities that lead to gains or losses, including, but not limited to, incremental manufacturing variances, asset write-downs, or liability adjustments;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain costs to further develop and optimize our global enterprise resource planning systems, operations and supply chain; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes related to uncertain tax positions and certain impacts related to the Combination are excluded from adjusted net earnings. In addition, tax adjustments to adjusted earnings are recorded to present items on an after-tax basis consistent with the presentation of adjusted net earnings.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has undertaken restructurings and other optimization initiatives of differing types, scope and amount during the covered periods and, therefore, these charges should not be considered non-recurring; however, management excludes these amounts from adjusted net earnings and adjusted EBITDA because it believes it is helpful to understanding the underlying, ongoing operational performance of the business.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Settlements, Net</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and gains related to legal matters, such as those discussed in Note 17 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part I, Item 1 of this Form 10-Q are generally excluded from adjusted net earnings and adjusted EBITDA. Normal, ongoing defense costs of the Company made in the normal course of our business are not excluded.</span></div><div style="margin-bottom:8pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of U.S. GAAP Net Earnings (Loss) to Adjusted Net Earnings </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between net earnings (loss) as reported under U.S. GAAP, and adjusted net earnings for the periods shown follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.172%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.898%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP net earnings (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,037.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting related amortization (primarily included in cost of sales)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (primarily amortization of premiums and discounts on long term debt)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clean energy investments pre-tax (gain) loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs (primarily included in SG&amp;A) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other special items included in:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of the above items and other income tax related items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (d)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items include the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Acquisition related costs consist primarily of transaction costs including legal and consulting fees and integration activities. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">For the three months ended March&#160;31, 2022, charges include approximately $13.1 million in cost of sales and approximately $3.7 million in SG&amp;A. Refer to Note 14 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part I, Item 1 of this Form 10-Q for additional information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">For the three months ended March&#160;31, 2022, charges include incremental manufacturing variances at plants in the 2020 restructuring program of approximately $31.3 million.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Adjusted for changes for uncertain tax positions and for certain impacts of the Combination. </span></div><div style="margin-bottom:8pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of U.S. GAAP Net Earnings (Loss) to EBITDA and Adjusted EBITDA</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a reconciliation of U.S. GAAP net earnings (loss) to EBITDA and adjusted EBITDA for the three months ended March&#160;31, 2022 compared to the prior year period:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP net earnings (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,037.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add / (deduct) adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net contribution attributable to equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, acquisition related and other special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes amortization of premiums and discounts on long-term debt.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes purchase accounting related amortization.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See items detailed in the Reconciliation of U.S. GAAP Net Earnings (Loss) to Adjusted Net Earnings.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_130"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of liquidity is net cash provided by operating activities, which was $1.14 billion for the three months ended March&#160;31, 2022. We believe that net cash provided by operating activities and available liquidity will continue to allow us to meet our needs for working capital, capital expenditures, interest and principal payments on debt obligations, and dividend payments. Nevertheless, our ability to satisfy our working capital requirements and debt service obligations, fund planned capital expenditures, or dividend payments, will substantially depend upon our future operating performance (which will be affected by prevailing economic conditions), and financial, business and other factors, some of which are beyond our control.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities increased by $289.7 million to $1.14 billion for the three months ended March&#160;31, 2022, as compared to net cash provided by operating activities of $848.8 million for the three months ended March&#160;31, 2021. Net cash provided by operating activities is derived from net earnings (loss) adjusted for non-cash operating items, gains and losses attributed to investing and financing activities and changes in operating assets and liabilities resulting from timing differences between the receipts and payments of cash, including changes in cash primarily reflecting the timing of cash collections from customers, payments to vendors and employees and tax payments in the ordinary course of business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in net cash provided by operating activities was principally due to lower payments for restructuring activities and other special items, and the impact of synergies, partially offset by the timing of cash payments and collections. </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $66.9 million for the three months ended March&#160;31, 2022, as compared to net cash provided by investing activities of $236.3 million for the three months ended March&#160;31, 2021, a net decrease of $303.2 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2022, significant items in investing activities included the following:</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital expenditures, primarily for equipment and facilities, totaling approximately $64.5 million. While there can be no assurance that current expectations will be realized, capital expenditures for the 2022 calendar year are expected to be approximately $525 million to $675 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2021, significant items in investing activities included the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash received from acquisitions, net totaling approximately $277.0 million related to additional target cash balances received from Pfizer subsequent to the closing of the Combination; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital expenditures, primarily for equipment and facilities, totaling approximately $49.5 million. </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $1.01 billion for the three months ended March&#160;31, 2022, as compared to $1.10 billion for the three months ended March&#160;31, 2021, a decrease of $90.8 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2022, significant items in financing activities included the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net repayments of short-term borrowings of $837.9 million; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash dividends paid of $145.1 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2021, significant items in financing activities included the following:</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net repayments of short-term borrowings of $1.06 billion.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Resources</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents totaled $752.4 million at March&#160;31, 2022, and the majority of these funds are held by our non-U.S. subsidiaries. The Company anticipates having sufficient liquidity, including existing borrowing capacity under the Revolving Facility, Commercial Paper Program and the Receivables Facility and the Note Securitization Facility combined with cash to be generated from operations, to fund foreseeable cash needs without requiring the repatriation of non-U.S. cash.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has access to $4.0 billion under the Revolving Facility which matures in July 2026. Up to $1.65 billion of the Revolving Facility may be used to support borrowings under our Commercial Paper Program. As of March&#160;31, 2022, the Company had $328.5 million outstanding under the Commercial Paper Program and did not have any borrowings outstanding under the Revolving Facility. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Revolving Facility, MPI, a wholly owned subsidiary of the Company, has access to $400 million under the Receivables Facility. On April 22, 2022, the Company entered into an agreement to extend the expiration date of the Receivables Facility to April 22, 2025. As of March&#160;31, 2022, the Company had $325.5 million outstanding under the Receivables Facility.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company entered into the Note Securitization Facility for borrowings up to $200 million, which was amended on July 1, 2021 to extend the term to August 2022. As of March&#160;31, 2022, the Company did not have any borrowings outstanding under the Note Securitization Facility. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. Borrowings outstanding under the Receivables Facility bear interest at the applicable base rate plus 0.775% and under the Note Securitization Facility at the relevant base rate plus 0.85% and are included as a component of short-term borrowings, while the accounts receivable securing these obligations remain as a component of accounts receivable, net, in our condensed consolidated balance sheets.  In addition, the agreements governing the Receivables Facility and Note Securitization Facility contain various customary affirmative and negative covenants, and customary default and termination provisions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $55.1 million and $29.6 million of accounts receivable as of March&#160;31, 2022 and December&#160;31, 2021 under these factoring arrangements, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding our dividends paid and declared, refer to Note 8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings (Loss) per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Part I, Item 1 of this Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuously evaluating the potential acquisition of products, as well as companies, as a strategic part of our future growth. Consequently, we may utilize current cash reserves or incur additional indebtedness to finance any such acquisitions, which could impact future liquidity. Also, on an ongoing basis, we review our operations including the evaluation of potential divestitures of products and businesses as part of our future strategy. Any divestitures could impact future liquidity. In addition, we plan to continue to explore various other ways to create, enhance or otherwise unlock the value of the Company&#8217;s unique global platform in order to create shareholder value.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt Maturity</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding our debt agreements and mandatory minimum repayments remaining on the outstanding notional amount of long-term debt at March&#160;31, 2022, refer to Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part I, Item 1 of this Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The YEN Term Loan Facility and the Revolving Facility contain customary affirmative covenants for facilities of this type, including among others, covenants pertaining to the delivery of financial statements, notices of default and certain material events, maintenance of corporate existence and rights, property, and insurance and compliance with laws, as well as customary negative covenants for facilities of this type, including limitations on the incurrence of subsidiary indebtedness, liens, mergers and certain other fundamental changes, investments and loans, acquisitions, transactions with affiliates, payments of dividends and other restricted payments and changes in our lines of business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is in compliance with its covenants at March&#160;31, 2022 and expects to remain in compliance for the next twelve months. </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris Inc. is the issuer of the Registered Upjohn Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Combination, Utah Acquisition Sub Inc. is the issuer of the Utah U.S. Dollar Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mylan Inc. is the issuer of the Mylan Inc. U.S. Dollar Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective obligations of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. as guarantors of the applicable series of Senior U.S. Dollar Notes are senior unsecured obligations of the applicable guarantor and rank </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pari passu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in right of payment with all of such guarantor&#8217;s existing and future senior unsecured obligations that are not expressly subordinated to such guarantor&#8217;s guarantee of the applicable series of Senior U.S. Dollar Notes, rank senior in right of payment to any future obligations of such guarantor that are expressly subordinated to such guarantor&#8217;s guarantee of the applicable series of Senior U.S. Dollar Notes, and are effectively subordinated to such guarantor&#8217;s existing and future secured obligations to the extent of the value of the collateral securing such obligations. Such obligations are structurally subordinated to all of the existing and future liabilities, including trade payables, of the existing and future subsidiaries of such guarantor that do not guarantee the applicable series of Senior U.S. Dollar Notes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantees by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. under the applicable series of Senior U.S. Dollar Notes will terminate under certain customary circumstances, each as described in the applicable indenture, including: (1) a sale or disposition of the applicable guarantor in a transaction that complies with the applicable indenture such that such guarantor ceases to be a subsidiary of the issuer of the applicable series of Senior U.S. Dollar Notes; (2) legal defeasance or covenant defeasance or if the issuer&#8217;s obligations under the applicable indenture are discharged; (3) with respect to the Utah U.S. Dollar Notes, the earlier to occur of (i) with respect to the guarantee provided by Mylan Inc., (x) the release of Utah Acquisition Sub Inc.&#8217;s guarantee under all applicable Mylan Inc. Debt (as defined in the applicable indenture) and (y) Mylan Inc. no longer having any obligations in respect of any Mylan Inc. Debt and (ii) with respect to the guarantee provided by Mylan II B.V., (x) the release of Mylan II B.V.&#8217;s guarantee under all applicable Triggering Indebtedness (as defined in the applicable indenture) and (y) the issuer and/or borrower of the applicable Triggering Indebtedness no longer having any obligations with respect to such Triggering Indebtedness; (4) with respect to the guarantees provided by Utah Acquisition Sub Inc. and Mylan II B.V. of the Mylan Inc. U.S. Dollar Notes, subject to certain exceptions set forth in the applicable indenture, such guarantor ceasing to be a guarantor or obligor in respect of any Triggering Indebtedness; and (5) with respect to the Registered Upjohn Notes, (a) upon the applicable guarantor no longer being an issuer or guarantor in respect of (i) Mylan Notes (as defined in the indenture governing the Registered Upjohn Notes) that have an aggregate principal amount in excess of $500.0 million or (ii) any Triggering Indebtedness; in each case, other than in respect of indebtedness or guarantees, as applicable, that are being concurrently released; or (b) upon receipt of the consent of holders of a majority of the aggregate principal amount of the outstanding notes of such series in accordance with the indenture governing the Registered Upjohn Notes.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantee obligations of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. under the Senior U.S. Dollar Notes are subject to certain limitations and terms similar to those applicable to other guarantees of similar instruments, including that (i) the guarantees are subject to fraudulent transfer and conveyance laws and (ii) each guarantee is limited in amount to an amount not to exceed the maximum amount that can be guaranteed by the applicable guarantor without rendering the guarantee, as it relates to such guarantor, voidable under applicable fraudulent transfer and conveyance laws or similar laws affecting the rights of creditors generally. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents unaudited summarized financial information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. on a combined basis as of and for the three months ended March&#160;31, 2022 and as of and for the year ended December&#160;31, 2021. All intercompany balances have been eliminated in consolidation. This unaudited combined summarized financial information is presented utilizing the equity method of accounting.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Combined Summarized Balance Sheet Information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,622.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,298.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,889.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,619.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,625.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Combined Summarized Income Statement Information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict. We have approximately&#160;$590.9 million&#160;accrued for legal contingencies at&#160;March&#160;31, 2022.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#8217;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Combination, Viatris entered into a TSA with Pfizer pursuant to which each party will provide certain limited transition services to the other party generally for an initial period of 24 months from the closing date of the Combination. In addition to the monthly service fees under the TSA, Viatris agreed to reimburse Pfizer for fifty percent of the costs, up to the first $380&#160;million incurred, to establish and wind down the TSA services. Viatris will be required to fully reimburse Pfizer for total costs in excess of $380&#160;million. The Company incurred approximately $16.6 million related to this provision of the TSA during the three months ended March&#160;31, 2022 and approximately $100.1 million during the period beginning on the closing date of the Combination and ended March&#160;31, 2022.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Application of Critical Accounting Policies</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to the Critical Accounting Policies disclosed in Viatris&#8217; 2021 Form 10-K. The following discussion supplements our Critical Accounting Policy for Acquisitions,&#160;Intangible Assets, Goodwill and Contingent Consideration&#160;as it relates to the annual goodwill impairment test performed as of March 31, 2022.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its interim goodwill impairment test on a quantitative basis for its five reporting units, North America, Europe, Emerging Markets, JANZ, and Greater China. In estimating each reporting unit&#8217;s fair value, the Company performed an extensive valuation analysis, utilizing both income and market-based approaches. The determination of the fair value of the reporting units requires the Company to make significant estimates and assumptions that affect the reporting unit&#8217;s expected future cash flows. These estimates and assumptions, utilizing Level 3 inputs, primarily include, but are not limited to, market multiples, control premiums, the discount rate, terminal growth rates, operating income before depreciation and amortization, and capital expenditures forecasts. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the allocation of the Company&#8217;s total goodwill (prior to the reclassification of goodwill to assets held for sale) was as follows: North America $3.61&#160;billion, Europe $4.95&#160;billion, Emerging Markets $1.64&#160;billion, JANZ $0.78&#160;billion and Greater China $0.97&#160;billion.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company determined that the fair value of the North America and Greater China reporting units was substantially in excess of the respective unit&#8217;s carrying value. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Europe reporting unit, the estimated fair value exceeded its carrying value by approximately $797&#160;million or 5.3% for the interim goodwill impairment test. As it relates to the income approach for the Europe reporting unit at March 31, 2022, the Company forecasted cash flows for the next 10 years. During the forecast period, the revenue compound annual growth rate was approximately 0.5%. A terminal year value was calculated with a negative 1.0% revenue growth rate applied. The discount rate utilized was 9.5% and the estimated tax rate was 15.3%. Under the market-based approach, we utilized an estimated range of market multiples of 7.5 to 8.0 times EBITDA plus a control premium of 15.0%. If all other assumptions are held constant, a reduction in the terminal value growth rate by 3.0% or an increase in discount rate by 1.5% would result in an impairment charge for the Europe reporting unit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the JANZ reporting unit, the estimated fair value exceeded its carrying value by approximately $231&#160;million or 7.4% for the interim goodwill impairment test. As it relates to the income approach for the JANZ reporting unit at March 31, 2022, the Company forecasted cash flows for the next 10 years. During the forecast period, the revenue compound annual growth rate was approximately negative 4.8%. A terminal year value was calculated assuming no revenue growth. The discount rate utilized was 6.0% and the estimated tax rate was 30.4%. Under the market-based approach, we utilized an estimated market multiple of 6.0 times EBITDA plus a control premium of 15.0%. If all other assumptions are held constant, a reduction in the terminal value growth rate by 3.5% or an increase in discount rate by 2.0% would result in an impairment charge for the JANZ reporting unit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Emerging Markets reporting unit, the estimated fair value exceeded its carrying value by approximately $816&#160;million or 10.3% for the interim goodwill impairment test. As it relates to the income approach for the Emerging Markets reporting unit at March 31, 2022, the Company forecasted cash flows for the next 10 years. During the forecast period, the revenue compound annual growth rate was approximately 1.6%. A terminal year value was calculated with a 0.8% revenue growth rate applied. The discount rate utilized was 10.5% and the estimated tax rate was 18.4%. Under the market-based approach, we utilized an estimated market multiple of 7.5 times EBITDA plus a control premium of 15.0%. If all other assumptions are held constant, a reduction in the terminal value growth rate by approximately 8.5% or an increase in discount rate by 3.0% would result in an impairment charge for the Emerging Markets reporting unit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty involved in making these estimates, actual results could differ from those estimates. In addition, changes in underlying assumptions, especially as they relate to the key assumptions detailed, could have a significant impact on the fair value of the reporting units.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_133"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the Company&#8217;s market risk, see &#8220;Item&#160;7A. Quantitative and Qualitative Disclosures about Market Risk&#8221; in Viatris&#8217; 2021 Form&#160;10-K.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_136"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of the Company&#8217;s management, including the Principal Executive Officer and the Principal Financial Officer, of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures as of March&#160;31, 2022. Based upon that evaluation, the Principal Executive Officer and the Principal Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were effective. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management identified the following change in the Company&#8217;s internal control over financial reporting (&#8220;ICFR&#8221;) that occurred during the quarter that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s ICFR. During the quarter ended March&#160;31, 2022, the Company continued to transition certain support services from Pfizer, as well as certain subsidiaries, to a new ERP system. The Company has modified and will continue to modify its internal controls relating to its business and financial processes throughout the transition period, which is expected through the end of calendar year 2022. While the Company believes that this new system and the related changes to internal controls will ultimately strengthen its ICFR, there are inherent risks in implementing any new ERP system and the Company will continue to evaluate and test control changes in order to provide certification as of its fiscal year ending December 31, 2022 on the effectiveness of its ICFR.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_139"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II&#160;&#8212; OTHER INFORMATION</span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_142"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding legal proceedings, refer to Note 17 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the accompanying Notes to interim financial statements in this Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_145"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in the Company&#8217;s risk factors from those disclosed in Viatris&#8217; 2021 Form 10-K.</span></div><div><span><br/></span></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_151"></div><div style="-sec-extract:summary;margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 6.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">EXHIBITS</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312522058054/d265304dex21.htm">2.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Transaction Agreement, dated as of February 27, 2022, by and among Biocon Biologics Limited and Viatris Inc., filed as Exhibit 2.1 to the Report on Form 8-K filed by Viatris Inc. with the SEC on February 28, 2022, and incorporated herein by reference.*</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204422000010/ex_22xvtrsx20211231x10-k.htm">22</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">List of subsidiary guarantors and issuers of guaranteed securities, filed as Exhibit 22 to the Form 10-K for the fiscal year ended December 31, 2021, and incorporated herein by reference.<br/></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_311xvtrsx20220331.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_312xvtrsx20220331.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_32xvtrsx20220331.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Definition Linkbase</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101). </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Annexes, schedules and/or exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Viatris agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.</span></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i288d0c78bfc143dbaf3ab9e5cd85c3ad_154"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i288d0c78bfc143dbaf3ab9e5cd85c3ad_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MICHAEL GOETTLER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Goettler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;9, 2022</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SANJEEV NARULA</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjeev Narula</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;9, 2022</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex_311xvtrsx20220331.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibcf9ecb4a9224c878b9cc1e3bb34ff2e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit&#160;31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Certification of Principal Executive Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Michael Goettler, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.&#160;I have reviewed this quarterly report on Form&#160;10-Q of Viatris Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; MICHAEL GOETTLER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael Goettler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; May&#160;9, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex_312xvtrsx20220331.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibbb94fe3d4ed41f48bd34f01ff492d6c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit&#160;31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Certification of Principal Financial Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Sanjeev Narula, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.&#160;I have reviewed this quarterly report on Form&#160;10-Q of Viatris Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.749%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.051%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; SANJEEV NARULA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanjeev Narula</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; May&#160;9, 2022</font></div><div style="margin-top:9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex_32xvtrsx20220331.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iba8da7866ce6492b92935be9bd2823aa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit&#160;32</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In connection with the Quarterly Report on Form&#160;10-Q of Viatris Inc. (the &#8220;Company&#8221;) for the period ended March&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to his knowledge&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.&#160;The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59;&#160;and</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.749%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.051%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; MICHAEL GOETTLER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael Goettler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; SANJEEV NARULA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanjeev Narula</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; May&#160;9, 2022</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The foregoing certification is being furnished in accordance with Securities and Exchange Commission Release No.&#160;34-47551 and shall not be considered filed as part of the Form&#160;10-Q.</font></div><div style="margin-top:9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>vtrs-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf4cfb5a-529b-48e5-98f7-7a0c9b128563,g:c48d1c16-74b3-4c20-a8f8-3b8e11527314-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vtrs="http://www.viatris.com/20220331" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.viatris.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.viatris.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfOperations" roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements Of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveLoss" roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements Of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements Of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="General" roleURI="http://www.viatris.com/role/General">
        <link:definition>2101101 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralPolicies" roleURI="http://www.viatris.com/role/GeneralPolicies">
        <link:definition>2202201 - Disclosure - General (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralDetails" roleURI="http://www.viatris.com/role/GeneralDetails">
        <link:definition>2403401 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivable" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable">
        <link:definition>2104102 - Disclosure - Revenue Recognition and Accounts Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableTables" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables">
        <link:definition>2305301 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableNarrativeDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails">
        <link:definition>2406402 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails">
        <link:definition>2407403 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails">
        <link:definition>2408404 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails">
        <link:definition>2409405 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingPronouncements" roleURI="http://www.viatris.com/role/RecentAccountingPronouncements">
        <link:definition>2110103 - Disclosure - Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" roleURI="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details">
        <link:definition>2411406 - Disclosure - Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactions" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactions">
        <link:definition>2112104 - Disclosure - Acquisitions and Other Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsTables" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables">
        <link:definition>2313302 - Disclosure - Acquisitions and Other Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsNarrativeDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails">
        <link:definition>2414407 - Disclosure - Acquisitions and Other Transactions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails">
        <link:definition>2415408 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails">
        <link:definition>2416409 - Disclosure - Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlan" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlan">
        <link:definition>2117105 - Disclosure - Share-Based Incentive Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanTables" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanTables">
        <link:definition>2318303 - Disclosure - Share-Based Incentive Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanNarrativeDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails">
        <link:definition>2419410 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanStockAwardsDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails">
        <link:definition>2420411 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails">
        <link:definition>2421412 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherPostretirementBenefits" roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefits">
        <link:definition>2122106 - Disclosure - Pensions and Other Postretirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherPostretirementBenefitsTables" roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables">
        <link:definition>2323304 - Disclosure - Pensions and Other Postretirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherPostretirementBenefitNarrativeDetails" roleURI="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails">
        <link:definition>2424413 - Disclosure - Pension and Other Postretirement Benefit (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
        <link:definition>2425414 - Disclosure - Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.viatris.com/role/BalanceSheetComponents">
        <link:definition>2126107 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.viatris.com/role/BalanceSheetComponentsTables">
        <link:definition>2327305 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails">
        <link:definition>2428415 - Disclosure - Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsInventoriesDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails">
        <link:definition>2429416 - Disclosure - Balance Sheet Components (Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2430417 - Disclosure - Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPropertyPlantandEquipmentDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails">
        <link:definition>2431418 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherAssetsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails">
        <link:definition>2432419 - Disclosure - Balance Sheet Components (Other Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTradeAccountsPayableDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails">
        <link:definition>2433420 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherCurrentLiabilitiesDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails">
        <link:definition>2434421 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherLongtermObligationsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails">
        <link:definition>2435422 - Disclosure - Balance Sheet Components (Other Long-term Obligations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails">
        <link:definition>2436423 - Disclosure - Balance Sheet Components - Assets and Liabilities Held For Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestments" roleURI="http://www.viatris.com/role/EquityMethodInvestments">
        <link:definition>2137108 - Disclosure - Equity Method Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsTables" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsTables">
        <link:definition>2338306 - Disclosure - Equity Method Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsNarrativeDetails" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails">
        <link:definition>2439424 - Disclosure - Equity Method Investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsIncomeStatementDetails" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails">
        <link:definition>2440425 - Disclosure - Equity Method Investments (Income Statement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShare" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShare">
        <link:definition>2141109 - Disclosure - Earnings (Loss) per Ordinary Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShareTables" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareTables">
        <link:definition>2342307 - Disclosure - Earnings (Loss) per Ordinary Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShareNarrativeDetails" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails">
        <link:definition>2443426 - Disclosure - Earnings (Loss) per Ordinary Share (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails">
        <link:definition>2444427 - Disclosure - Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssets">
        <link:definition>2145110 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>2346308 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>2447428 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails">
        <link:definition>2448429 - Disclosure - Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails">
        <link:definition>2449430 - Disclosure - Goodwill and Intangible Assets (Components of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsAmortizationExpenseDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails">
        <link:definition>2450431 - Disclosure - Goodwill and Intangible Assets (Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails">
        <link:definition>2451432 - Disclosure - Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagement" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement">
        <link:definition>2152111 - Disclosure - Financial Instruments and Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementTables" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables">
        <link:definition>2353309 - Disclosure - Financial Instruments and Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementNarrativeDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails">
        <link:definition>2454433 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails">
        <link:definition>2455434 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails">
        <link:definition>2456435 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails">
        <link:definition>2457436 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails">
        <link:definition>2458437 - Disclosure - Financial Instruments and Risk Management Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails">
        <link:definition>2459438 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationships (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails">
        <link:definition>2460439 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails">
        <link:definition>2461440 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations, Derivatives Not Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
        <link:definition>2462441 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails">
        <link:definition>2463442 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.viatris.com/role/Debt">
        <link:definition>2164112 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.viatris.com/role/DebtTables">
        <link:definition>2365310 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" roleURI="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails">
        <link:definition>2466443 - Disclosure - Debt (Receivables, Securitization Facility and Commercial Paper) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofLongTermDebtDetails" roleURI="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails">
        <link:definition>2467444 - Disclosure - Debt (Summary of Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" roleURI="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails">
        <link:definition>2468445 - Disclosure - Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtFairValueNarrativeDetails" roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails">
        <link:definition>2469446 - Disclosure - Debt (Fair Value) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtMinimumRepaymentsonOutstandingBorrowingsDetails" roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails">
        <link:definition>2470447 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarnings" roleURI="http://www.viatris.com/role/ComprehensiveEarnings">
        <link:definition>2171113 - Disclosure - Comprehensive Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsTables" roleURI="http://www.viatris.com/role/ComprehensiveEarningsTables">
        <link:definition>2372311 - Disclosure - Comprehensive Earnings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails">
        <link:definition>2473448 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails">
        <link:definition>2474449 - Disclosure - Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.viatris.com/role/SegmentInformation">
        <link:definition>2175114 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationPolicies" roleURI="http://www.viatris.com/role/SegmentInformationPolicies">
        <link:definition>2276202 - Disclosure - Segment Information (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.viatris.com/role/SegmentInformationTables">
        <link:definition>2377312 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.viatris.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2478450 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" roleURI="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails">
        <link:definition>2479451 - Disclosure - Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.viatris.com/role/Restructuring">
        <link:definition>2180115 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://www.viatris.com/role/RestructuringTables">
        <link:definition>2381313 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRestructuringChargesDetails" roleURI="http://www.viatris.com/role/RestructuringRestructuringChargesDetails">
        <link:definition>2482452 - Disclosure - Restructuring (Restructuring Charges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingAgreements" roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreements">
        <link:definition>1107116 - Statement - Collaboration and Licensing Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingAgreementsDetails" roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails">
        <link:definition>2483453 - Disclosure - Collaboration and Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.viatris.com/role/IncomeTaxes">
        <link:definition>2184117 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxesDisclosureDetails" roleURI="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails">
        <link:definition>2485454 - Disclosure - Income Taxes Income Taxes Disclosure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Litigation" roleURI="http://www.viatris.com/role/Litigation">
        <link:definition>2186118 - Disclosure - Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationLorazepamandClorazepateNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails">
        <link:definition>2487455 - Disclosure - Litigation (Lorazepam and Clorazepate) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationPricingandMedicaidLitigationNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails">
        <link:definition>2488456 - Disclosure - Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails">
        <link:definition>2489457 - Disclosure - Litigation (Modafinil Antitrust Litigation and FTC Inquiry) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationPioglitazoneNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails">
        <link:definition>2490458 - Disclosure - Litigation (Pioglitazone) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationShareholderClassActionDetails" roleURI="http://www.viatris.com/role/LitigationShareholderClassActionDetails">
        <link:definition>2491459 - Disclosure - Litigation (Shareholder Class Action) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" roleURI="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails">
        <link:definition>2492460 - Disclosure - Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationDrugPricingMattersDetails" roleURI="http://www.viatris.com/role/LitigationDrugPricingMattersDetails">
        <link:definition>2493461 - Disclosure - Litigation (Drug Pricing Matters) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationEuropeanCommissionProceedingsNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails">
        <link:definition>2494462 - Disclosure - Litigation (European Commission Proceedings) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails">
        <link:definition>2495463 - Disclosure - Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationProductLiabilityNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails">
        <link:definition>2496464 - Disclosure - Litigation (Product Liability) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationIntellectualPropertyNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails">
        <link:definition>2497465 - Disclosure - Litigation (Intellectual Property) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationOtherLitigationNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails">
        <link:definition>2498466 - Disclosure - Litigation (Other Litigation) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vtrs_ScheduleofothercurrentliabilitiesTable" abstract="true" name="ScheduleofothercurrentliabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_Medicaidandothergovernmentalrebates" abstract="false" name="Medicaidandothergovernmentalrebates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" abstract="true" name="ScheduleofOtherNoncurrentLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" abstract="true" name="SeniorNotesTwoThousandTwentyThree3.125PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" abstract="true" name="SeniorNotesTwoThousandEighteen3.0PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherLongTermDebtMember" abstract="true" name="OtherLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ProductLiabilityMember" abstract="true" name="ProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsReclassifications" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" abstract="false" name="ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_CreonMember" abstract="true" name="CreonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortyThreeMember" abstract="true" name="SeniorNotesTwoThousandFortyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NorthAmericaSegmentMember" abstract="true" name="NorthAmericaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AntitrustProceedingsMember" abstract="true" name="AntitrustProceedingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2024EuroSeniorNotesMember" abstract="true" name="A2024EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2020FloatingRateEuroNotesMember" abstract="true" name="A2020FloatingRateEuroNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" abstract="true" name="ScheduleofOtherNoncurrentLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" abstract="false" name="IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DevelopedMarketsSegmentMember" abstract="true" name="DevelopedMarketsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RevenuefromContractwithCustomerReturns" abstract="false" name="RevenuefromContractwithCustomerReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EUCommissionProceedingsPerindorprilMember" abstract="true" name="EUCommissionProceedingsPerindorprilMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" abstract="true" name="SeniorNotesTwoThousandTwentySix3.95PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EffexorMember" abstract="true" name="EffexorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EpiPenAutoInjectorCivilLitigationMember" abstract="true" name="EpiPenAutoInjectorCivilLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_IntangibleAssetsbyMajorClassLineItems" abstract="true" name="IntangibleAssetsbyMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_XalabrandsMember" abstract="true" name="XalabrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccruedSalesAllowances" abstract="false" name="AccruedSalesAllowances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ScheduleofActivityinContingentConsiderationRollForward" abstract="true" name="ScheduleofActivityinContingentConsiderationRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_LongTermIncentivePlan2003Member" abstract="true" name="LongTermIncentivePlan2003Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification" abstract="false" name="GoodWillAfterAmortizationExpenseBeforeReclassification" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BiosimilarsPortfolioMember" abstract="true" name="BiosimilarsPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GreaterChinaSegmentMember" abstract="true" name="GreaterChinaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy" abstract="false" name="PercentOfTotalAssetsImpactedHighInflationaryEconomy" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_ScheduleofothercurrentliabilitiesLineItems" abstract="true" name="ScheduleofothercurrentliabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_DymistaMember" abstract="true" name="DymistaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2028EuroSeniorNotesMember" abstract="true" name="A2028EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RestofWorldSegmentMember" abstract="true" name="RestofWorldSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MeasurementInputIncreaseInDiscountRateMember" abstract="true" name="MeasurementInputIncreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" abstract="false" name="Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_OtherCompaniesMember" abstract="true" name="OtherCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" abstract="true" name="A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2027SeniorNotesMember" abstract="true" name="A2027SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" abstract="false" name="ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vtrs_A2030SeniorNotesMember" abstract="true" name="A2030SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotes2021Member" abstract="true" name="SeniorNotes2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" abstract="false" name="AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" abstract="true" name="AmendedAnticompetitiveConductwithGenericDrugsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotes2022Member" abstract="true" name="SeniorNotes2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Otherlongtermassets" abstract="false" name="Otherlongtermassets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_PeriodDomain" abstract="true" name="PeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_CleanEnergyPartnershipsMember" abstract="true" name="CleanEnergyPartnershipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ReceivablesFacilityMember" abstract="true" name="ReceivablesFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" abstract="false" name="RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_MeasurementInputEstimatedTaxRateMember" abstract="true" name="MeasurementInputEstimatedTaxRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_TrailingFourQuartersMember" abstract="true" name="TrailingFourQuartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis" abstract="false" name="EquityMethodInvestmentsSummarizedFinancialDataBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandNineteenMember" abstract="true" name="SeniorNotesTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" abstract="true" name="SeniorNotesTwoThousandEighteen2.6PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortyEightMember" abstract="true" name="SeniorNotesTwoThousandFortyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" abstract="false" name="PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" abstract="false" name="NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_Changeinnoncashlitigationsettlementsnet" abstract="false" name="Changeinnoncashlitigationsettlementsnet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DefinedBenefitPlansNumberofFrozenPlans" abstract="false" name="DefinedBenefitPlansNumberofFrozenPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" abstract="true" name="MeasurementInputTerminalYearRevenueGrowthRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NorthAmericaBrandsMember" abstract="true" name="NorthAmericaBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Numberofstates" abstract="false" name="Numberofstates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" abstract="true" name="SeniorNotesTwoThousandTwenty3.75PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" abstract="true" name="MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_PfizerInc.Member" abstract="true" name="PfizerInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EpiPenAutoInjectorsMember" abstract="true" name="EpiPenAutoInjectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_YENTermLoanMember" abstract="true" name="YENTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2024EuroSeniorNotes1023Member" abstract="true" name="A2024EuroSeniorNotes1023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Chargebacks" abstract="false" name="Chargebacks" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_BusinessCombinationAbstract" abstract="true" name="BusinessCombinationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_A2027EuroSeniorNotesMember" abstract="true" name="A2027EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MultiDistrictLitigationMember" abstract="true" name="MultiDistrictLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ZoloftMember" abstract="true" name="ZoloftMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ViagraMember" abstract="true" name="ViagraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Corporatecosts" abstract="false" name="Corporatecosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyEightMember" abstract="true" name="SeniorNotesTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RevenuefromContractwithCustomerGross" abstract="false" name="RevenuefromContractwithCustomerGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_XanaxMember" abstract="true" name="XanaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NoteSecuritizationFacilityMember" abstract="true" name="NoteSecuritizationFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ComplexGXAndBiosimilarsMember" abstract="true" name="ComplexGXAndBiosimilarsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Developmentandsalesmilestonepayments" abstract="false" name="Developmentandsalesmilestonepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable" abstract="false" name="EquivalentPricePercentageOfPrincipalAmountRedeemable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" abstract="true" name="AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AmitizaMember" abstract="true" name="AmitizaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" abstract="true" name="SeniorNotesTwoThousandFortySix5.25PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SalesRevenueGrosstonetadjustments" abstract="false" name="SalesRevenueGrosstonetadjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EpiPenAutoInjectorLitigationMember" abstract="true" name="EpiPenAutoInjectorLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2048SeniorNotesMember" abstract="true" name="A2048SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" abstract="false" name="AccountsReceivableFacilityMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_BioconBiologicsMember" abstract="true" name="BioconBiologicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_PaymentsforBusinessSeparation" abstract="false" name="PaymentsforBusinessSeparation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_YupelriMember" abstract="true" name="YupelriMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_CurrentPortionofLongTermDebtMember" abstract="true" name="CurrentPortionofLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EpiPenIsraeliSecuritiesLitigationMember" abstract="true" name="EpiPenIsraeliSecuritiesLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_Numberofequitymethodinvestments" abstract="false" name="Numberofequitymethodinvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2022EuroSeniorNotesMember" abstract="true" name="A2022EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BalanceSheetComponentsAbstract" abstract="true" name="BalanceSheetComponentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_A2040SeniorNotesMember" abstract="true" name="A2040SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GenericsMember" abstract="true" name="GenericsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AnticompetitiveConductwithGenericDrugsMember" abstract="true" name="AnticompetitiveConductwithGenericDrugsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EUCommissionProceedingsCitalopramMember" abstract="true" name="EUCommissionProceedingsCitalopramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_LipitorMember" abstract="true" name="LipitorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" abstract="true" name="SeniorNotesTwoThousandTwentyOne3.15PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_CelebrexMember" abstract="true" name="CelebrexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" abstract="true" name="SeniorNotesTwoThousandNineteen2.50PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember" abstract="true" name="ModafinilAntitrustLitigationAndFtcInquiryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" abstract="false" name="RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_A2016SeniorRevolvingCreditFacilityMember" abstract="true" name="A2016SeniorRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherOneTimeNonoperatingExpense" abstract="false" name="OtherOneTimeNonoperatingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ProgramNameDomain" abstract="true" name="ProgramNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GoodwillImpairmentMeasurementInputTerm" abstract="false" name="GoodwillImpairmentMeasurementInputTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtrs_A2025EuroSeniorNotesMember" abstract="true" name="A2025EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationCARESActAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" abstract="true" name="SeniorNotesTwoThousandTwentyThree4.2PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2020RestructuringPlanMember" abstract="true" name="A2020RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" abstract="true" name="U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VariableConsiderationMember" abstract="true" name="VariableConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_UpjohnInc.Member" abstract="true" name="UpjohnInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EmergingMarketsSegmentMember" abstract="true" name="EmergingMarketsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherCurrentPortionofLongtermDebtMember" abstract="true" name="OtherCurrentPortionofLongtermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_PeriodAxis" abstract="true" name="PeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_BrandsMember" abstract="true" name="BrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_GoodwillImpairmentMeasurementInput" abstract="false" name="GoodwillImpairmentMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_Numberofcases" abstract="false" name="Numberofcases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_A2020EuroSeniorNotesMember" abstract="true" name="A2020EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NumberOfProducts" abstract="false" name="NumberOfProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_ProgramNameAxis" abstract="true" name="ProgramNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_A2032EuroSeniorNotesMember" abstract="true" name="A2032EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_InfluvacMember" abstract="true" name="InfluvacMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vtrs_NorvascMember" abstract="true" name="NorvascMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NorthAmericaGenericsMember" abstract="true" name="NorthAmericaGenericsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_LyricaMember" abstract="true" name="LyricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2050SeniorNotesMember" abstract="true" name="A2050SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_JapanAustraliaAndNewZealandSegmentMember" abstract="true" name="JapanAustraliaAndNewZealandSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>vtrs-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf4cfb5a-529b-48e5-98f7-7a0c9b128563,g:c48d1c16-74b3-4c20-a8f8-3b8e11527314-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfOperations"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_26600d17-1c66-4266-8a51-70b7fac885dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_84c6868c-5129-4c8f-9bee-1fe571d4696f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_26600d17-1c66-4266-8a51-70b7fac885dd" xlink:to="loc_us-gaap_OperatingIncomeLoss_84c6868c-5129-4c8f-9bee-1fe571d4696f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d073f371-2a1c-42d4-9bfe-a7201376eb83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_26600d17-1c66-4266-8a51-70b7fac885dd" xlink:to="loc_us-gaap_InterestExpense_d073f371-2a1c-42d4-9bfe-a7201376eb83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c915e675-5bae-4c45-9939-fb84ce573b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_26600d17-1c66-4266-8a51-70b7fac885dd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c915e675-5bae-4c45-9939-fb84ce573b9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_85a91ad7-6941-4f07-916b-0f22c686207c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_e1eab832-2b45-455d-a38c-2746aebb28f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_85a91ad7-6941-4f07-916b-0f22c686207c" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_e1eab832-2b45-455d-a38c-2746aebb28f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_329211cd-a306-4e9f-8c48-e50b06c06840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_85a91ad7-6941-4f07-916b-0f22c686207c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_329211cd-a306-4e9f-8c48-e50b06c06840" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a638199b-6649-4849-b8bb-a1a44d2ceca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_03b96eef-fb6d-4143-b2c1-63748d7dcaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a638199b-6649-4849-b8bb-a1a44d2ceca1" xlink:to="loc_us-gaap_GrossProfit_03b96eef-fb6d-4143-b2c1-63748d7dcaad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f296c276-4ca9-4b33-ba9f-9fbc7d578b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a638199b-6649-4849-b8bb-a1a44d2ceca1" xlink:to="loc_us-gaap_OperatingExpenses_f296c276-4ca9-4b33-ba9f-9fbc7d578b72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0378ee11-93e1-4168-aa21-053a06eaf0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bd5f2fd0-e20d-419b-9d11-f9c65c2c1cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0378ee11-93e1-4168-aa21-053a06eaf0d3" xlink:to="loc_us-gaap_Revenues_bd5f2fd0-e20d-419b-9d11-f9c65c2c1cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_99c0eaaf-b970-4300-9732-32e85d3533ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0378ee11-93e1-4168-aa21-053a06eaf0d3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_99c0eaaf-b970-4300-9732-32e85d3533ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_17aa03c9-7a27-48cf-adee-1c4886b82b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_19b22f2a-6931-43f9-a619-aff9031231e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_17aa03c9-7a27-48cf-adee-1c4886b82b1b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_19b22f2a-6931-43f9-a619-aff9031231e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_930988b6-b756-4c48-8e8a-23afacb86b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_17aa03c9-7a27-48cf-adee-1c4886b82b1b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_930988b6-b756-4c48-8e8a-23afacb86b9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8569688a-567a-418d-ac20-bdea2b3bb6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f041d5a2-b1b6-4273-ba08-5da1f64cf476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8569688a-567a-418d-ac20-bdea2b3bb6bb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f041d5a2-b1b6-4273-ba08-5da1f64cf476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bed05f99-9d51-4b3d-8c43-42cdd30d9816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8569688a-567a-418d-ac20-bdea2b3bb6bb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bed05f99-9d51-4b3d-8c43-42cdd30d9816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_b7eaef01-aa26-4703-bd28-826569e651ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8569688a-567a-418d-ac20-bdea2b3bb6bb" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_b7eaef01-aa26-4703-bd28-826569e651ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_28f43b16-78f4-48c8-b171-51941c1b5556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a51b630-753d-4232-b252-97622fb62a84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_28f43b16-78f4-48c8-b171-51941c1b5556" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a51b630-753d-4232-b252-97622fb62a84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3aeeec04-36ff-47d3-84a5-4a241d9380f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_28f43b16-78f4-48c8-b171-51941c1b5556" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3aeeec04-36ff-47d3-84a5-4a241d9380f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b1ccddb3-0ac5-4713-80cc-6056c4fba54f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_de70be78-ebff-499a-a3b1-000e93d79d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b1ccddb3-0ac5-4713-80cc-6056c4fba54f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_de70be78-ebff-499a-a3b1-000e93d79d53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ae9bfa94-9cdc-44a0-aee4-d6d24dca32e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b1ccddb3-0ac5-4713-80cc-6056c4fba54f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ae9bfa94-9cdc-44a0-aee4-d6d24dca32e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_64edfb55-f65c-4c97-833a-1147de035edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_766d72af-3359-4a7e-9e61-7f123ad510ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_64edfb55-f65c-4c97-833a-1147de035edd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_766d72af-3359-4a7e-9e61-7f123ad510ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_138c4657-c27b-4efa-b3af-b4a8a1573ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_64edfb55-f65c-4c97-833a-1147de035edd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_138c4657-c27b-4efa-b3af-b4a8a1573ad3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c9e80c5f-eef5-4740-bda3-131b982b22af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_64edfb55-f65c-4c97-833a-1147de035edd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c9e80c5f-eef5-4740-bda3-131b982b22af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_6b83b4fd-1be9-4b18-a163-dadadab5dcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_64edfb55-f65c-4c97-833a-1147de035edd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_6b83b4fd-1be9-4b18-a163-dadadab5dcf8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d574ef7a-0096-4757-9595-15fca2e39fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_90d94f39-e5e9-4c76-8ed1-06de04503b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d574ef7a-0096-4757-9595-15fca2e39fa0" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_90d94f39-e5e9-4c76-8ed1-06de04503b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_495e5aa0-309e-48bc-a47b-70cea50bfe14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d574ef7a-0096-4757-9595-15fca2e39fa0" xlink:to="loc_us-gaap_ShortTermBorrowings_495e5aa0-309e-48bc-a47b-70cea50bfe14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_759eb8bb-1936-4bf8-bcd2-e64d77023e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d574ef7a-0096-4757-9595-15fca2e39fa0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_759eb8bb-1936-4bf8-bcd2-e64d77023e76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3ed61f7e-efa3-422d-80fd-0a76b2021576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d574ef7a-0096-4757-9595-15fca2e39fa0" xlink:to="loc_us-gaap_LongTermDebtCurrent_3ed61f7e-efa3-422d-80fd-0a76b2021576" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a151dba0-dc6a-4bde-a57d-95d8c0447fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d574ef7a-0096-4757-9595-15fca2e39fa0" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a151dba0-dc6a-4bde-a57d-95d8c0447fa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a5c341f8-3b7a-4073-a586-d97422f07324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d574ef7a-0096-4757-9595-15fca2e39fa0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a5c341f8-3b7a-4073-a586-d97422f07324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7b75017f-009a-49b5-b4fd-506127e616a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_91a5d5e5-d9f7-482e-b68c-5fdea5a3cfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7b75017f-009a-49b5-b4fd-506127e616a8" xlink:to="loc_us-gaap_LiabilitiesCurrent_91a5d5e5-d9f7-482e-b68c-5fdea5a3cfe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_daf0a55c-7814-45e0-abc5-5e3f8c2b22f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7b75017f-009a-49b5-b4fd-506127e616a8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_daf0a55c-7814-45e0-abc5-5e3f8c2b22f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bdbccbe6-4c76-46e0-afb4-912204854da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7b75017f-009a-49b5-b4fd-506127e616a8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bdbccbe6-4c76-46e0-afb4-912204854da7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f8cfcd84-bc2c-4f87-8cb6-59ac7116fceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7b75017f-009a-49b5-b4fd-506127e616a8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f8cfcd84-bc2c-4f87-8cb6-59ac7116fceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c3d9e02-0a0c-4959-b55e-8a20158f11c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_016b5e9c-62ff-4e90-a147-7d1f3eae9202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c3d9e02-0a0c-4959-b55e-8a20158f11c4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_016b5e9c-62ff-4e90-a147-7d1f3eae9202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4ffd8f49-5c75-4f20-891a-ca146d4e4fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c3d9e02-0a0c-4959-b55e-8a20158f11c4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4ffd8f49-5c75-4f20-891a-ca146d4e4fbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_750fabd0-2f5e-4d45-8d97-924a62db8c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c3d9e02-0a0c-4959-b55e-8a20158f11c4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_750fabd0-2f5e-4d45-8d97-924a62db8c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3af6fd73-cd52-4c03-8f57-8123b4b9a51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c3d9e02-0a0c-4959-b55e-8a20158f11c4" xlink:to="loc_us-gaap_CommonStockValue_3af6fd73-cd52-4c03-8f57-8123b4b9a51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6907138e-cd56-4462-9d96-fc0f88bb4bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_33e54c1d-4f5c-4100-af86-4fac7f084f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6907138e-cd56-4462-9d96-fc0f88bb4bd1" xlink:to="loc_us-gaap_AssetsCurrent_33e54c1d-4f5c-4100-af86-4fac7f084f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f601b723-20ac-4357-b416-5cf6e7939ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6907138e-cd56-4462-9d96-fc0f88bb4bd1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f601b723-20ac-4357-b416-5cf6e7939ffc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9c81bbea-fefb-449b-a275-79353d189409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6907138e-cd56-4462-9d96-fc0f88bb4bd1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9c81bbea-fefb-449b-a275-79353d189409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0e3a3cb2-1f27-40a0-8e57-1774d619d5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6907138e-cd56-4462-9d96-fc0f88bb4bd1" xlink:to="loc_us-gaap_Goodwill_0e3a3cb2-1f27-40a0-8e57-1774d619d5ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_33676d23-daca-4654-85db-7b00b4463238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6907138e-cd56-4462-9d96-fc0f88bb4bd1" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_33676d23-daca-4654-85db-7b00b4463238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6e23bb2b-7a52-45ad-82f4-2dc7f31a0adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6907138e-cd56-4462-9d96-fc0f88bb4bd1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6e23bb2b-7a52-45ad-82f4-2dc7f31a0adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_68feac8a-8f09-4bbb-b763-7f7b87102007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_42079d58-82b0-44c5-809f-e37e3ff5991b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68feac8a-8f09-4bbb-b763-7f7b87102007" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_42079d58-82b0-44c5-809f-e37e3ff5991b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6bbf773e-cc0d-4d85-8aad-94db22bb3ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68feac8a-8f09-4bbb-b763-7f7b87102007" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6bbf773e-cc0d-4d85-8aad-94db22bb3ed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8d0a8e0-2767-49d1-bad3-3fbce27f7169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68feac8a-8f09-4bbb-b763-7f7b87102007" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8d0a8e0-2767-49d1-bad3-3fbce27f7169" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8050b27c-8c82-41cd-b1e9-1fe903690dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68feac8a-8f09-4bbb-b763-7f7b87102007" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8050b27c-8c82-41cd-b1e9-1fe903690dee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ec60081f-10ac-4079-9eaa-26bf4433c049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68feac8a-8f09-4bbb-b763-7f7b87102007" xlink:to="loc_us-gaap_InventoryNet_ec60081f-10ac-4079-9eaa-26bf4433c049" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6898d57-5d34-48e1-b484-6796b06c4c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c673578a-b25f-4c3b-bad5-9900a00f4bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6898d57-5d34-48e1-b484-6796b06c4c57" xlink:to="loc_us-gaap_Liabilities_c673578a-b25f-4c3b-bad5-9900a00f4bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1da43c63-f8ed-40c4-8862-573d9cdfc6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6898d57-5d34-48e1-b484-6796b06c4c57" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1da43c63-f8ed-40c4-8862-573d9cdfc6e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfCashFlows"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce98264b-85c5-41c1-bdb5-fe5eedb49199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_214a83bf-cb33-41b0-9483-9cc013083608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce98264b-85c5-41c1-bdb5-fe5eedb49199" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_214a83bf-cb33-41b0-9483-9cc013083608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5bdf8ac0-6062-4217-93dd-3972c172d0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce98264b-85c5-41c1-bdb5-fe5eedb49199" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5bdf8ac0-6062-4217-93dd-3972c172d0c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2eaeddc4-8957-4e83-9026-d9091dd0e2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce98264b-85c5-41c1-bdb5-fe5eedb49199" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2eaeddc4-8957-4e83-9026-d9091dd0e2c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c52d4ef-3cb3-40b6-8c40-84624a693705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce98264b-85c5-41c1-bdb5-fe5eedb49199" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c52d4ef-3cb3-40b6-8c40-84624a693705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_18d90175-2e1d-48b4-875a-de74c48d4b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_18d90175-2e1d-48b4-875a-de74c48d4b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_761f4201-ebe2-4fd4-99cc-8aa6b343861f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_761f4201-ebe2-4fd4-99cc-8aa6b343861f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_72fa1d01-8851-4c6d-95ba-5a4d09efbcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_72fa1d01-8851-4c6d-95ba-5a4d09efbcfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_5521ef18-5da8-4a78-af33-3c97a2f02be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_5521ef18-5da8-4a78-af33-3c97a2f02be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_003440b5-757b-45d0-9efe-2264639d0d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_003440b5-757b-45d0-9efe-2264639d0d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a37e0dc3-73c0-4418-b72c-243a0e0c0ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a37e0dc3-73c0-4418-b72c-243a0e0c0ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_25179352-4327-496f-a1ae-6dc91eda8be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_25179352-4327-496f-a1ae-6dc91eda8be0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_f7908967-4cf1-4c0e-a1c1-af9c62168bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f82c8-f41a-4588-87e9-ce63532e9333" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_f7908967-4cf1-4c0e-a1c1-af9c62168bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5edd42be-d411-4e1f-ae62-c4bf58f895f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ce9cee4c-20c0-4f5b-ad93-cef0f4ba33e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5edd42be-d411-4e1f-ae62-c4bf58f895f9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ce9cee4c-20c0-4f5b-ad93-cef0f4ba33e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_63988d21-a45e-4903-93f4-3f4b18738e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5edd42be-d411-4e1f-ae62-c4bf58f895f9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_63988d21-a45e-4903-93f4-3f4b18738e36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2072ff8f-a4b3-458a-a07c-17c779e6b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5edd42be-d411-4e1f-ae62-c4bf58f895f9" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2072ff8f-a4b3-458a-a07c-17c779e6b9a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ba0aaa3e-6ac2-47ff-b214-c22441d8f07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5edd42be-d411-4e1f-ae62-c4bf58f895f9" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ba0aaa3e-6ac2-47ff-b214-c22441d8f07d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bd696242-a4bf-4013-af38-d14bd3b19c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5edd42be-d411-4e1f-ae62-c4bf58f895f9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bd696242-a4bf-4013-af38-d14bd3b19c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_affaa19c-938a-471a-9a57-cd4001b6798f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5edd42be-d411-4e1f-ae62-c4bf58f895f9" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_affaa19c-938a-471a-9a57-cd4001b6798f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e133a8c4-8778-493b-a25f-0634c48a3b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e133a8c4-8778-493b-a25f-0634c48a3b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ad9a6274-f3f7-46b9-9031-dddf7ce3e06e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ad9a6274-f3f7-46b9-9031-dddf7ce3e06e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3358fc9b-9509-45b8-91ea-ea230f7e08f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_ShareBasedCompensation_3358fc9b-9509-45b8-91ea-ea230f7e08f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9b7b255d-1bd2-4a4a-b230-3271c0849ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9b7b255d-1bd2-4a4a-b230-3271c0849ebd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_eb50c74a-703a-4835-9baf-c3325909dde2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_eb50c74a-703a-4835-9baf-c3325909dde2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8af9f367-2ff8-4dc3-8849-6219cd1e23bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8af9f367-2ff8-4dc3-8849-6219cd1e23bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet_012af6a5-0476-45b7-8020-1c2cab96af1b" xlink:href="vtrs-20220331.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_vtrs_Changeinnoncashlitigationsettlementsnet_012af6a5-0476-45b7-8020-1c2cab96af1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_08a358ab-0689-4291-98ef-e88301d38059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_08a358ab-0689-4291-98ef-e88301d38059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ee2d35dc-32ed-41c7-afb4-53c394ceb02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ee2d35dc-32ed-41c7-afb4-53c394ceb02a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_dab12848-443e-46cd-b47c-d411f4e59f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_dab12848-443e-46cd-b47c-d411f4e59f42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6e75a3d2-204a-4466-950f-2bf531a7a1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6e75a3d2-204a-4466-950f-2bf531a7a1a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_dc92013a-56f1-4b8a-9b43-bda0c833e4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d559a99e-b117-404c-bfb1-83aee4831391" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_dc92013a-56f1-4b8a-9b43-bda0c833e4a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments_d95c3f34-d76d-4975-a144-3d275033bbf1" xlink:href="vtrs-20220331.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks_b3c9a0ec-0f62-452e-921b-e5a9d7946453" xlink:href="vtrs-20220331.xsd#vtrs_Chargebacks"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_d95c3f34-d76d-4975-a144-3d275033bbf1" xlink:to="loc_vtrs_Chargebacks_b3c9a0ec-0f62-452e-921b-e5a9d7946453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances_231e19f8-dba4-45b1-abc5-ad3bae561247" xlink:href="vtrs-20220331.xsd#vtrs_AccruedSalesAllowances"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_d95c3f34-d76d-4975-a144-3d275033bbf1" xlink:to="loc_vtrs_AccruedSalesAllowances_231e19f8-dba4-45b1-abc5-ad3bae561247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns_82f0df35-07f6-4a9e-a9f5-17f4e89cbf04" xlink:href="vtrs-20220331.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_d95c3f34-d76d-4975-a144-3d275033bbf1" xlink:to="loc_vtrs_RevenuefromContractwithCustomerReturns_82f0df35-07f6-4a9e-a9f5-17f4e89cbf04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates_7a57d11f-bd68-4efc-88e2-085188ac4152" xlink:href="vtrs-20220331.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_d95c3f34-d76d-4975-a144-3d275033bbf1" xlink:to="loc_vtrs_Medicaidandothergovernmentalrebates_7a57d11f-bd68-4efc-88e2-085188ac4152" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_58907c11-9c41-48ca-b91a-03ce0b8dab80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_1ba88a33-8367-4bae-8630-2101397cb1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_58907c11-9c41-48ca-b91a-03ce0b8dab80" xlink:to="loc_us-gaap_ReceivablesNetCurrent_1ba88a33-8367-4bae-8630-2101397cb1ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_1e3b30f3-ee67-4c2d-abd0-f84c089c1d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_58907c11-9c41-48ca-b91a-03ce0b8dab80" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_1e3b30f3-ee67-4c2d-abd0-f84c089c1d7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_6f3c4e33-454e-4b1f-8b8f-1b95319f8c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_9813ffd0-b92c-40ce-92e4-ba1875710acc" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_6f3c4e33-454e-4b1f-8b8f-1b95319f8c4c" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_9813ffd0-b92c-40ce-92e4-ba1875710acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c1684947-b8c3-49e2-b21d-dd013d404bda" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_6f3c4e33-454e-4b1f-8b8f-1b95319f8c4c" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c1684947-b8c3-49e2-b21d-dd013d404bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_95af7626-8df7-4c28-9fb2-ca7c17d6e339" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_6f3c4e33-454e-4b1f-8b8f-1b95319f8c4c" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_95af7626-8df7-4c28-9fb2-ca7c17d6e339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d6a8f036-245f-4292-b7dd-1c97b1e3ab68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_d6a8f036-245f-4292-b7dd-1c97b1e3ab68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f7f3160d-8fd7-4b3a-967c-15ad1c2ac408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f7f3160d-8fd7-4b3a-967c-15ad1c2ac408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_46b1b33f-7ea9-42fb-a17c-82012e72cb24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_46b1b33f-7ea9-42fb-a17c-82012e72cb24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_88dde2d8-a07d-4fac-a71b-1088010e8bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_88dde2d8-a07d-4fac-a71b-1088010e8bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2adccb0b-1a43-4359-a928-1ce47246a549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_Goodwill_2adccb0b-1a43-4359-a928-1ce47246a549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b5bdcfd3-7aa5-4c35-85a5-84fd56e933d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b5bdcfd3-7aa5-4c35-85a5-84fd56e933d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c24ed38f-d817-4ea1-b7d2-d03dec88af78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c24ed38f-d817-4ea1-b7d2-d03dec88af78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_59afe200-6aa0-4719-8298-d757b0c45d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_25e80d66-5667-4ffc-b537-e08e12958f76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_59afe200-6aa0-4719-8298-d757b0c45d21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_670beab5-f4da-4f0f-91c1-69c98a225fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e3b45362-b11d-4653-b102-133b24f03492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_670beab5-f4da-4f0f-91c1-69c98a225fce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e3b45362-b11d-4653-b102-133b24f03492" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_d857d354-3445-4dee-872b-7f25c9fa3845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_670beab5-f4da-4f0f-91c1-69c98a225fce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_d857d354-3445-4dee-872b-7f25c9fa3845" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_03ae1eb4-9ec8-4c02-b723-93143622e37a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_670beab5-f4da-4f0f-91c1-69c98a225fce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_03ae1eb4-9ec8-4c02-b723-93143622e37a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_2e74db8a-15b0-40c5-9818-e5830ff911a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_670beab5-f4da-4f0f-91c1-69c98a225fce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_2e74db8a-15b0-40c5-9818-e5830ff911a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c4abc221-ff81-45ff-86de-c15c17d15402" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_fb1dda11-3732-483d-a5ad-5a7e1f8162c0" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c4abc221-ff81-45ff-86de-c15c17d15402" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_fb1dda11-3732-483d-a5ad-5a7e1f8162c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_31cfe09e-15ce-4381-bb29-41867d8cbf2a" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c4abc221-ff81-45ff-86de-c15c17d15402" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_31cfe09e-15ce-4381-bb29-41867d8cbf2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_3c413a35-0e88-4ef7-969f-f51da653d479" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c4abc221-ff81-45ff-86de-c15c17d15402" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_3c413a35-0e88-4ef7-969f-f51da653d479" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d5917e4f-94fa-45cb-92cf-45d682b69756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e7ca2a55-11aa-4018-97b7-7dbbff2b2fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d5917e4f-94fa-45cb-92cf-45d682b69756" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e7ca2a55-11aa-4018-97b7-7dbbff2b2fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8adaa6ad-ff74-49a3-9ad7-a8fe8403c696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d5917e4f-94fa-45cb-92cf-45d682b69756" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8adaa6ad-ff74-49a3-9ad7-a8fe8403c696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9e1a1d80-9ca2-4891-9d27-379e7af5e5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d5917e4f-94fa-45cb-92cf-45d682b69756" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9e1a1d80-9ca2-4891-9d27-379e7af5e5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_fd7d74c4-51a5-404d-b6a5-849d93a23e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d5917e4f-94fa-45cb-92cf-45d682b69756" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_fd7d74c4-51a5-404d-b6a5-849d93a23e9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1d5e85eb-2fc1-44d5-834f-2af4d3883c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d5917e4f-94fa-45cb-92cf-45d682b69756" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1d5e85eb-2fc1-44d5-834f-2af4d3883c09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4afbcd2-e13d-456c-9bf9-f8ffcf4b3356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4816461-0a4e-4ea0-b109-851d8c7527d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4afbcd2-e13d-456c-9bf9-f8ffcf4b3356" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4816461-0a4e-4ea0-b109-851d8c7527d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_152c4372-8a2b-4244-ba43-de4522d7725f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4afbcd2-e13d-456c-9bf9-f8ffcf4b3356" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_152c4372-8a2b-4244-ba43-de4522d7725f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c3864128-6a43-4acc-a54c-e3402db338be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9c2225d6-a91c-4661-b8b5-cfe4638c3f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c3864128-6a43-4acc-a54c-e3402db338be" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9c2225d6-a91c-4661-b8b5-cfe4638c3f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_00abc80f-431b-442c-92f5-643533389c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c3864128-6a43-4acc-a54c-e3402db338be" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_00abc80f-431b-442c-92f5-643533389c19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_e4ae2c8f-57a0-4621-85e9-2abdcfc3d647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c3864128-6a43-4acc-a54c-e3402db338be" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_e4ae2c8f-57a0-4621-85e9-2abdcfc3d647" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d1bc70d-c5ca-409f-9018-ae3c83496a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_fea7b052-b4c7-4d8c-930e-6ffa90e928f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d1bc70d-c5ca-409f-9018-ae3c83496a52" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_fea7b052-b4c7-4d8c-930e-6ffa90e928f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_60dbe120-9268-42de-a67d-b2ee7f440fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d1bc70d-c5ca-409f-9018-ae3c83496a52" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_60dbe120-9268-42de-a67d-b2ee7f440fc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cd86e47c-e060-4303-bf84-204514bd939a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d1bc70d-c5ca-409f-9018-ae3c83496a52" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cd86e47c-e060-4303-bf84-204514bd939a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_36d0dafc-6aab-4b0d-9797-f9d670d0d953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d1bc70d-c5ca-409f-9018-ae3c83496a52" xlink:to="loc_us-gaap_TradingSecurities_36d0dafc-6aab-4b0d-9797-f9d670d0d953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d4e5be17-8d83-48ef-a4d5-bf08bf504922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d1bc70d-c5ca-409f-9018-ae3c83496a52" xlink:to="loc_us-gaap_OtherAssetsCurrent_d4e5be17-8d83-48ef-a4d5-bf08bf504922" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f8d5e999-ab23-410c-b2c3-7e2939c6bf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7d979f1a-1719-4506-80c6-4bb577768ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f8d5e999-ab23-410c-b2c3-7e2939c6bf4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7d979f1a-1719-4506-80c6-4bb577768ea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a0d4c095-1b9c-42a7-9a13-fb7ef07cb319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f8d5e999-ab23-410c-b2c3-7e2939c6bf4e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a0d4c095-1b9c-42a7-9a13-fb7ef07cb319" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0515b217-c948-49e8-a31e-37ec7d53032f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_edcdc930-eccb-4aa9-90b9-b868a2ca7905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_0515b217-c948-49e8-a31e-37ec7d53032f" xlink:to="loc_us-gaap_EquityMethodInvestments_edcdc930-eccb-4aa9-90b9-b868a2ca7905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_73756a63-5901-430b-a530-0afe10a19d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_0515b217-c948-49e8-a31e-37ec7d53032f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_73756a63-5901-430b-a530-0afe10a19d60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets_06f9c9fd-810b-4929-9bd6-e670087407cb" xlink:href="vtrs-20220331.xsd#vtrs_Otherlongtermassets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_0515b217-c948-49e8-a31e-37ec7d53032f" xlink:to="loc_vtrs_Otherlongtermassets_06f9c9fd-810b-4929-9bd6-e670087407cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsTradeAccountsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_1debb3d2-e9b9-4db6-86ba-a2f824bb8eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_982e4c14-da4c-459b-b5cf-10bb0a2304d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_1debb3d2-e9b9-4db6-86ba-a2f824bb8eca" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_982e4c14-da4c-459b-b5cf-10bb0a2304d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_466f683d-eea8-44cc-ae02-043dafe53277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_1debb3d2-e9b9-4db6-86ba-a2f824bb8eca" xlink:to="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_466f683d-eea8-44cc-ae02-043dafe53277" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a0d9d95-a820-4e33-a7f9-455da66871db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9c180c94-00b3-451e-bf46-f59436103b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a0d9d95-a820-4e33-a7f9-455da66871db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9c180c94-00b3-451e-bf46-f59436103b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_231e38b3-5f30-4209-afb0-282cc430d7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a0d9d95-a820-4e33-a7f9-455da66871db" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_231e38b3-5f30-4209-afb0-282cc430d7c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1b8afecf-b378-4d4e-89bf-42fcd64f52c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_69ecf5c4-4329-4f35-a4c7-356e7699ab99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Goodwill_1b8afecf-b378-4d4e-89bf-42fcd64f52c3" xlink:to="loc_us-gaap_GoodwillGross_69ecf5c4-4329-4f35-a4c7-356e7699ab99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1e63487f-7da9-490a-b3dc-38ae83ad136d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Goodwill_1b8afecf-b378-4d4e-89bf-42fcd64f52c3" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1e63487f-7da9-490a-b3dc-38ae83ad136d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f2c072bc-ddbe-4cff-ac31-2ebbef77af53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4173bd27-06a1-4203-b80b-3cf58e80e67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f2c072bc-ddbe-4cff-ac31-2ebbef77af53" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4173bd27-06a1-4203-b80b-3cf58e80e67d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_242df5c9-c192-4824-be61-8cfe6bc4f906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f2c072bc-ddbe-4cff-ac31-2ebbef77af53" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_242df5c9-c192-4824-be61-8cfe6bc4f906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c59421d-8fed-4251-a1af-cc48d225b3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f3d51d3e-951e-4529-8886-9ebe87640f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c59421d-8fed-4251-a1af-cc48d225b3e9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f3d51d3e-951e-4529-8886-9ebe87640f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b8e306f9-78c9-4653-a17b-e297bada2d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c59421d-8fed-4251-a1af-cc48d225b3e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b8e306f9-78c9-4653-a17b-e297bada2d67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_638ba2d5-4a00-41f5-b8bd-c3e318c7da48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_41e5794c-5d19-465a-8736-657db33baaab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_638ba2d5-4a00-41f5-b8bd-c3e318c7da48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_41e5794c-5d19-465a-8736-657db33baaab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cca26696-8cef-46e9-b2e1-d00e11a713a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_638ba2d5-4a00-41f5-b8bd-c3e318c7da48" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cca26696-8cef-46e9-b2e1-d00e11a713a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_d91cd5f2-99b7-4d6e-8606-e68af471e224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2b26d13e-a572-40fc-99c7-f3e241315bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentForAmortization_d91cd5f2-99b7-4d6e-8606-e68af471e224" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2b26d13e-a572-40fc-99c7-f3e241315bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ce493243-11dc-4bfe-a29c-20717403c794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentForAmortization_d91cd5f2-99b7-4d6e-8606-e68af471e224" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ce493243-11dc-4bfe-a29c-20717403c794" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtMinimumRepaymentsonOutstandingBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6e1af46d-4ab9-4bff-b1fd-6563a45945b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_774605ad-1b08-4a9a-a813-c2e9a4a30d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6e1af46d-4ab9-4bff-b1fd-6563a45945b8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_774605ad-1b08-4a9a-a813-c2e9a4a30d7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b1ee8ccd-a83e-4c7f-8c8c-21192598b115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6e1af46d-4ab9-4bff-b1fd-6563a45945b8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b1ee8ccd-a83e-4c7f-8c8c-21192598b115" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_bce60b3c-0809-4e96-b35a-22f7cc2b3457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6e1af46d-4ab9-4bff-b1fd-6563a45945b8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_bce60b3c-0809-4e96-b35a-22f7cc2b3457" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4b20222c-1c59-4b1d-a04c-902877bac39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6e1af46d-4ab9-4bff-b1fd-6563a45945b8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4b20222c-1c59-4b1d-a04c-902877bac39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6fb34f28-29b7-4920-8e8c-b4047d816e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6e1af46d-4ab9-4bff-b1fd-6563a45945b8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6fb34f28-29b7-4920-8e8c-b4047d816e76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_df273420-5fcf-41b7-84cf-30e20b41f1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6e1af46d-4ab9-4bff-b1fd-6563a45945b8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_df273420-5fcf-41b7-84cf-30e20b41f1e4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>vtrs-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf4cfb5a-529b-48e5-98f7-7a0c9b128563,g:c48d1c16-74b3-4c20-a8f8-3b8e11527314-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfOperations"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended" id="i47e162ed6c4b4f49a52f001ddfd913b3_CondensedConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23173a61-edef-49b5-a79c-aeea5825ed91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23173a61-edef-49b5-a79c-aeea5825ed91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_abb8fdb2-0498-4cc5-8476-839115fb69c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_Revenues_abb8fdb2-0498-4cc5-8476-839115fb69c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_26c1d56d-9d7d-457a-b460-6dacf32e21c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_26c1d56d-9d7d-457a-b460-6dacf32e21c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4404a77f-27bd-4398-b220-bdc3c24cf1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_GrossProfit_4404a77f-27bd-4398-b220-bdc3c24cf1d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b2088230-e9fe-4805-937c-1576529479ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b2088230-e9fe-4805-937c-1576529479ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7da1ea0c-7d7e-4b3c-8f10-e8ec9ebb05cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7da1ea0c-7d7e-4b3c-8f10-e8ec9ebb05cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_cd4eda9b-db03-4217-bc42-5d80d33b26e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_cd4eda9b-db03-4217-bc42-5d80d33b26e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ded6d5d4-9873-40e0-9f0e-a9698ed639df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_OperatingExpenses_ded6d5d4-9873-40e0-9f0e-a9698ed639df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6753b5c1-be97-444d-8d4c-a8aae76d9e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_OperatingIncomeLoss_6753b5c1-be97-444d-8d4c-a8aae76d9e8b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ed2a9e04-f666-490b-8aef-bb89dd0430e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_InterestExpense_ed2a9e04-f666-490b-8aef-bb89dd0430e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0bf91610-953f-44f5-9ab5-a044a4a00f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0bf91610-953f-44f5-9ab5-a044a4a00f72" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9a444ec-9b4a-41c7-b3c6-bbd5b0e8f231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9a444ec-9b4a-41c7-b3c6-bbd5b0e8f231" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bae6a5ef-4ff6-4da1-854d-6e810a76df35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bae6a5ef-4ff6-4da1-854d-6e810a76df35" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_75feb260-ea79-4016-a64d-23fd56218402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_75feb260-ea79-4016-a64d-23fd56218402" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4e19a11d-5085-429f-9ed3-544e7638d840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:to="loc_us-gaap_EarningsPerShareBasic_4e19a11d-5085-429f-9ed3-544e7638d840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_afacfd37-77f1-4aa2-8cdf-9e027ae1e952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_afacfd37-77f1-4aa2-8cdf-9e027ae1e952" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3afe4e3b-1d4b-46be-b382-88a2284fd8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3afe4e3b-1d4b-46be-b382-88a2284fd8cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_612cfa9a-bedf-4afe-805a-aa0f55658f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_612cfa9a-bedf-4afe-805a-aa0f55658f41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_5af6dbe2-d2ee-43a7-bc3d-cf842a3c7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_5af6dbe2-d2ee-43a7-bc3d-cf842a3c7c88" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_441eb3f8-8fd6-4863-b55c-1e9c508f7845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_StatementTable_441eb3f8-8fd6-4863-b55c-1e9c508f7845" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28b63958-2762-4e0d-95ad-979f5be70969" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_441eb3f8-8fd6-4863-b55c-1e9c508f7845" xlink:to="loc_srt_ProductOrServiceAxis_28b63958-2762-4e0d-95ad-979f5be70969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_28b63958-2762-4e0d-95ad-979f5be70969_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_28b63958-2762-4e0d-95ad-979f5be70969" xlink:to="loc_srt_ProductsAndServicesDomain_28b63958-2762-4e0d-95ad-979f5be70969_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c9e6cedb-a96f-430e-89cf-2d10b786ceac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_28b63958-2762-4e0d-95ad-979f5be70969" xlink:to="loc_srt_ProductsAndServicesDomain_c9e6cedb-a96f-430e-89cf-2d10b786ceac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_76615ede-19d1-46fe-9b5e-2b1e37afbb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c9e6cedb-a96f-430e-89cf-2d10b786ceac" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_76615ede-19d1-46fe-9b5e-2b1e37afbb8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended" id="i3280d502901647a7891464bb13464bbe_CondensedConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5ec0aa99-9b5f-44eb-addd-8169a8c4fe4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5ec0aa99-9b5f-44eb-addd-8169a8c4fe4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_3eaf3c0c-280b-445d-bcaf-221828250877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_3eaf3c0c-280b-445d-bcaf-221828250877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_49f9c595-f6fe-4a85-9349-38144b0e9114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_49f9c595-f6fe-4a85-9349-38144b0e9114" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_dfa3c833-b886-44ae-a212-b3f42fc7686b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_dfa3c833-b886-44ae-a212-b3f42fc7686b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ab49cd0a-a009-4f13-9ea7-994fc76142c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ab49cd0a-a009-4f13-9ea7-994fc76142c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_b3b037a9-c0b9-40cc-8196-4b68381bcf20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_b3b037a9-c0b9-40cc-8196-4b68381bcf20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf8fd308-3a26-41d8-8ade-150b961fc319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf8fd308-3a26-41d8-8ade-150b961fc319" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_21d0b1a6-d10b-4864-890d-c3864901196e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_21d0b1a6-d10b-4864-890d-c3864901196e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_544463b8-ec18-4f26-9a86-f52ba3ab3613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_544463b8-ec18-4f26-9a86-f52ba3ab3613" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_53978c45-3339-4b2e-9be4-835b041100c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_StatementTable_53978c45-3339-4b2e-9be4-835b041100c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6384712f-be22-45e6-8adb-cf6f61c1004f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_53978c45-3339-4b2e-9be4-835b041100c8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6384712f-be22-45e6-8adb-cf6f61c1004f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6384712f-be22-45e6-8adb-cf6f61c1004f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6384712f-be22-45e6-8adb-cf6f61c1004f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6384712f-be22-45e6-8adb-cf6f61c1004f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6384712f-be22-45e6-8adb-cf6f61c1004f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2e1aa328-6f8b-4306-9d25-6fdbdee66901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:to="loc_us-gaap_CashFlowHedgingMember_2e1aa328-6f8b-4306-9d25-6fdbdee66901" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_b047a4f1-cf24-4c6e-a2b1-1c3a0993a5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_b047a4f1-cf24-4c6e-a2b1-1c3a0993a5d5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ie440f5e573944b3e95893c93885219cd_CondensedConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_933ad64a-ce01-4033-98b5-dceafacecf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_933ad64a-ce01-4033-98b5-dceafacecf2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8b3e49db-bbf6-4088-aa23-bb59797bf2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8b3e49db-bbf6-4088-aa23-bb59797bf2e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4edd9cd4-4ccf-4a24-a11e-eedd06187ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:to="loc_us-gaap_TreasuryStockShares_4edd9cd4-4ccf-4a24-a11e-eedd06187ab1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_14f4921f-35dc-4c26-ac00-886f700d6ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:to="loc_us-gaap_StatementTable_14f4921f-35dc-4c26-ac00-886f700d6ffc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08d68a5f-6b79-48d8-9732-7e7b96252eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_14f4921f-35dc-4c26-ac00-886f700d6ffc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08d68a5f-6b79-48d8-9732-7e7b96252eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08d68a5f-6b79-48d8-9732-7e7b96252eba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08d68a5f-6b79-48d8-9732-7e7b96252eba" xlink:to="loc_us-gaap_EquityComponentDomain_08d68a5f-6b79-48d8-9732-7e7b96252eba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d7525bca-46cd-4928-88db-e923d0e87b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08d68a5f-6b79-48d8-9732-7e7b96252eba" xlink:to="loc_us-gaap_EquityComponentDomain_d7525bca-46cd-4928-88db-e923d0e87b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d5f70cec-8888-4cc4-8349-1cace23ef14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d7525bca-46cd-4928-88db-e923d0e87b3b" xlink:to="loc_us-gaap_CommonStockMember_d5f70cec-8888-4cc4-8349-1cace23ef14c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="extended" id="if444cdc49c9c44df990c66d911d9f405_ConsolidatedStatementsofEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aeb25887-53a2-4794-9e86-55974dda15fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aeb25887-53a2-4794-9e86-55974dda15fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_106449f5-65de-43a2-8eea-77a11f804776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_SharesIssued_106449f5-65de-43a2-8eea-77a11f804776" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_40d74c79-bbdb-48e1-8024-572777fea249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_TreasuryStockShares_40d74c79-bbdb-48e1-8024-572777fea249" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a479c734-fd3c-4c37-857b-1d16a3d3fff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a479c734-fd3c-4c37-857b-1d16a3d3fff4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c97eea45-eac3-4750-b316-add5fd8e920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c97eea45-eac3-4750-b316-add5fd8e920a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_1b239381-feb2-48e0-aa41-6eaa34b1be4f" xlink:href="vtrs-20220331.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_1b239381-feb2-48e0-aa41-6eaa34b1be4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_b96a8096-4a71-4106-a40a-276e4ff11659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_b96a8096-4a71-4106-a40a-276e4ff11659" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_5546da16-6481-4e03-8117-f214f1f04302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_5546da16-6481-4e03-8117-f214f1f04302" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4092670e-17a1-42a1-a4a7-96894a524040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4092670e-17a1-42a1-a4a7-96894a524040" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e18b2506-943e-4901-9da2-90fc2e2e4299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e85485cd-b146-4ddd-8bd3-823bf6524f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_9db50d78-b05f-43f0-b2fb-465a73032da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ad7a551c-eda5-471d-8ef7-7d66371577b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:to="loc_us-gaap_DividendsCommonStockCash_ad7a551c-eda5-471d-8ef7-7d66371577b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_af8e74f5-0047-4ce5-b30b-022d027c062a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:to="loc_us-gaap_StatementTable_af8e74f5-0047-4ce5-b30b-022d027c062a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_af8e74f5-0047-4ce5-b30b-022d027c062a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8" xlink:to="loc_us-gaap_EquityComponentDomain_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8" xlink:to="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a9e0b112-03cd-4891-af4a-797c7ce9a0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_CommonStockMember_a9e0b112-03cd-4891-af4a-797c7ce9a0dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_466a1529-803f-42aa-a00e-496807f12907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_466a1529-803f-42aa-a00e-496807f12907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_96d65ba3-254e-4d1a-b2fa-d3d9a74788c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_RetainedEarningsMember_96d65ba3-254e-4d1a-b2fa-d3d9a74788c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4183f2ae-0a6c-4518-b613-221631fa6cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_TreasuryStockMember_4183f2ae-0a6c-4518-b613-221631fa6cf7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_924c41d9-0d6e-4565-b73b-77787ff92462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_924c41d9-0d6e-4565-b73b-77787ff92462" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GeneralDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GeneralDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GeneralDetails" xlink:type="extended" id="i63bcbe42656a445f8e2980c93f1188f2_GeneralDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy_7c3bfacf-768e-48eb-8e0d-5aafdee41753" xlink:href="vtrs-20220331.xsd#vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:to="loc_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy_7c3bfacf-768e-48eb-8e0d-5aafdee41753" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy_5d8cd280-f2fb-4738-85a2-3e066ba53a6a" xlink:href="vtrs-20220331.xsd#vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:to="loc_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy_5d8cd280-f2fb-4738-85a2-3e066ba53a6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_694f9a9f-a338-4f6e-84b1-7194d2ba0484" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:to="loc_srt_StatementGeographicalAxis_694f9a9f-a338-4f6e-84b1-7194d2ba0484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_694f9a9f-a338-4f6e-84b1-7194d2ba0484_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_694f9a9f-a338-4f6e-84b1-7194d2ba0484" xlink:to="loc_srt_SegmentGeographicalDomain_694f9a9f-a338-4f6e-84b1-7194d2ba0484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ae737178-326a-4b7e-aed9-c181996bbb6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_694f9a9f-a338-4f6e-84b1-7194d2ba0484" xlink:to="loc_srt_SegmentGeographicalDomain_ae737178-326a-4b7e-aed9-c181996bbb6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR_f1930e04-1bec-4f93-8cef-f6362ed5eb51" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_TR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ae737178-326a-4b7e-aed9-c181996bbb6e" xlink:to="loc_country_TR_f1930e04-1bec-4f93-8cef-f6362ed5eb51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_baa74b99-f819-426c-a5a6-52d7077dbe60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_baa74b99-f819-426c-a5a6-52d7077dbe60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_baa74b99-f819-426c-a5a6-52d7077dbe60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_baa74b99-f819-426c-a5a6-52d7077dbe60" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_baa74b99-f819-426c-a5a6-52d7077dbe60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_41e8ede9-350b-4662-b3f9-be1df5e8ca56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_baa74b99-f819-426c-a5a6-52d7077dbe60" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_41e8ede9-350b-4662-b3f9-be1df5e8ca56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemMember_c25394b8-68d4-4087-9613-5041639301b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_41e8ede9-350b-4662-b3f9-be1df5e8ca56" xlink:to="loc_us-gaap_UnusualOrInfrequentItemMember_c25394b8-68d4-4087-9613-5041639301b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="extended" id="idb11ea93d2334cb593decf14b3c7ecd4_RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8a05c078-447f-4724-809c-c55586e18755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c69f525-1fb0-4b41-8f6f-1201c14169f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a05c078-447f-4724-809c-c55586e18755" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c69f525-1fb0-4b41-8f6f-1201c14169f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a05c078-447f-4724-809c-c55586e18755" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:to="loc_srt_ConsolidationItemsAxis_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7" xlink:to="loc_srt_ConsolidationItemsDomain_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_342ac7a5-3243-4c58-8e7e-fec69af4b645" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7" xlink:to="loc_srt_ConsolidationItemsDomain_342ac7a5-3243-4c58-8e7e-fec69af4b645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_94fccd11-8131-4b75-b11f-ccd9576bdbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_342ac7a5-3243-4c58-8e7e-fec69af4b645" xlink:to="loc_us-gaap_OperatingSegmentsMember_94fccd11-8131-4b75-b11f-ccd9576bdbf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1c3a9a74-05dd-46f9-9f95-fd1d0885b593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1c3a9a74-05dd-46f9-9f95-fd1d0885b593" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1c3a9a74-05dd-46f9-9f95-fd1d0885b593_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c3a9a74-05dd-46f9-9f95-fd1d0885b593" xlink:to="loc_us-gaap_SegmentDomain_1c3a9a74-05dd-46f9-9f95-fd1d0885b593_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c3a9a74-05dd-46f9-9f95-fd1d0885b593" xlink:to="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_845eeb99-ad7c-42cb-9d7b-41262a97bdaf" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_845eeb99-ad7c-42cb-9d7b-41262a97bdaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_1648fff3-9b2a-419b-85ff-bbc85a62e275" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_GreaterChinaSegmentMember_1648fff3-9b2a-419b-85ff-bbc85a62e275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_0f180bf6-da4b-43c1-b109-47b8637a0763" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_0f180bf6-da4b-43c1-b109-47b8637a0763" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_364548ee-aa72-4fc9-a746-d19551a110e2" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_364548ee-aa72-4fc9-a746-d19551a110e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_86a9af97-6e15-4b7d-aeb7-1934da42255a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:to="loc_srt_ProductOrServiceAxis_86a9af97-6e15-4b7d-aeb7-1934da42255a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_86a9af97-6e15-4b7d-aeb7-1934da42255a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_86a9af97-6e15-4b7d-aeb7-1934da42255a" xlink:to="loc_srt_ProductsAndServicesDomain_86a9af97-6e15-4b7d-aeb7-1934da42255a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_86a9af97-6e15-4b7d-aeb7-1934da42255a" xlink:to="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_7029222d-e214-4c9f-9009-34c4306434cc" xlink:href="vtrs-20220331.xsd#vtrs_BrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_BrandsMember_7029222d-e214-4c9f-9009-34c4306434cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_dc179698-2fe9-4064-b7ee-37442f35b71f" xlink:href="vtrs-20220331.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_dc179698-2fe9-4064-b7ee-37442f35b71f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_7b7136df-0403-4e26-93a1-77b0d2775bc0" xlink:href="vtrs-20220331.xsd#vtrs_GenericsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_GenericsMember_7b7136df-0403-4e26-93a1-77b0d2775bc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember_0cbb72f4-fe2f-4416-931d-5f3561c6c44f" xlink:href="vtrs-20220331.xsd#vtrs_LipitorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_LipitorMember_0cbb72f4-fe2f-4416-931d-5f3561c6c44f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember_db084fd8-ec5b-468b-8673-56cf773859dc" xlink:href="vtrs-20220331.xsd#vtrs_NorvascMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_NorvascMember_db084fd8-ec5b-468b-8673-56cf773859dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember_ab8cc800-c985-4221-ae44-2edc2b900a8d" xlink:href="vtrs-20220331.xsd#vtrs_LyricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_LyricaMember_ab8cc800-c985-4221-ae44-2edc2b900a8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember_ed0721db-26e0-44e6-9fa7-1d996a060fa1" xlink:href="vtrs-20220331.xsd#vtrs_ViagraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_ViagraMember_ed0721db-26e0-44e6-9fa7-1d996a060fa1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember_d564f296-4138-4281-931e-0682ec80ff99" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_EpiPenAutoInjectorsMember_d564f296-4138-4281-931e-0682ec80ff99" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember_3e40e07f-40b7-4935-8ce5-9b59d47f05b4" xlink:href="vtrs-20220331.xsd#vtrs_CelebrexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_CelebrexMember_3e40e07f-40b7-4935-8ce5-9b59d47f05b4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember_241a2be5-b6b1-474e-aa12-bccb7fa2ca41" xlink:href="vtrs-20220331.xsd#vtrs_EffexorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_EffexorMember_241a2be5-b6b1-474e-aa12-bccb7fa2ca41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember_fd90fd84-10e1-4f15-ab5f-32c9f58d80ef" xlink:href="vtrs-20220331.xsd#vtrs_ZoloftMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_ZoloftMember_fd90fd84-10e1-4f15-ab5f-32c9f58d80ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember_97592e80-c635-4bf4-b936-018583ddab9b" xlink:href="vtrs-20220331.xsd#vtrs_CreonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_CreonMember_97592e80-c635-4bf4-b936-018583ddab9b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember_8a4c2ea3-59ce-4bab-a9ed-bbd3d483b709" xlink:href="vtrs-20220331.xsd#vtrs_XalabrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_XalabrandsMember_8a4c2ea3-59ce-4bab-a9ed-bbd3d483b709" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember_e3087d92-25b6-448c-aec5-1319658092d3" xlink:href="vtrs-20220331.xsd#vtrs_AmitizaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_AmitizaMember_e3087d92-25b6-448c-aec5-1319658092d3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember_a151a935-e795-4e84-8140-57260f099bb0" xlink:href="vtrs-20220331.xsd#vtrs_XanaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_XanaxMember_a151a935-e795-4e84-8140-57260f099bb0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember_f0c1ab5b-a637-4df5-8fe9-69bc6d03a86f" xlink:href="vtrs-20220331.xsd#vtrs_DymistaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_DymistaMember_f0c1ab5b-a637-4df5-8fe9-69bc6d03a86f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember_8ae0e725-f86e-4097-9c83-e6a63502cb40" xlink:href="vtrs-20220331.xsd#vtrs_YupelriMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_YupelriMember_8ae0e725-f86e-4097-9c83-e6a63502cb40" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InfluvacMember_c12445c4-c46e-449a-a0ae-46fee22c5856" xlink:href="vtrs-20220331.xsd#vtrs_InfluvacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_InfluvacMember_c12445c4-c46e-449a-a0ae-46fee22c5856" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended" id="ib96f08e80114458183b771dde18590c2_RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7dfbb24e-3e61-4cfe-bd88-cc1aaa379739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7dfbb24e-3e61-4cfe-bd88-cc1aaa379739" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_35ae51cb-8e9f-40b3-af2c-8e1eb0ba844c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_35ae51cb-8e9f-40b3-af2c-8e1eb0ba844c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_29ac00c5-8335-4fef-984a-cace6387b027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_29ac00c5-8335-4fef-984a-cace6387b027" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_664ed0bf-33fd-4f0c-a64b-b35059164a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_664ed0bf-33fd-4f0c-a64b-b35059164a07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_de65efc0-1106-480f-82e5-dc5013c00a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_664ed0bf-33fd-4f0c-a64b-b35059164a07" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_de65efc0-1106-480f-82e5-dc5013c00a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_de65efc0-1106-480f-82e5-dc5013c00a44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_de65efc0-1106-480f-82e5-dc5013c00a44" xlink:to="loc_us-gaap_ReceivableTypeDomain_de65efc0-1106-480f-82e5-dc5013c00a44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_9a3ffc32-c92c-48d7-a19a-8b39896912f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_de65efc0-1106-480f-82e5-dc5013c00a44" xlink:to="loc_us-gaap_ReceivableTypeDomain_9a3ffc32-c92c-48d7-a19a-8b39896912f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_962cd5d3-21af-47b0-8c1a-d5c1562bc270" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_9a3ffc32-c92c-48d7-a19a-8b39896912f5" xlink:to="loc_vtrs_VariableConsiderationMember_962cd5d3-21af-47b0-8c1a-d5c1562bc270" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="extended" id="ibd9afd2ee6b24fbcb7cba9d06a4692f6_RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_834ef14a-3566-4c8c-bf91-9779d1836250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_834ef14a-3566-4c8c-bf91-9779d1836250" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c776875e-d163-4d6c-81ff-26f04c295fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c776875e-d163-4d6c-81ff-26f04c295fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b26ad617-ec08-41ee-b754-095cc6ffee64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b26ad617-ec08-41ee-b754-095cc6ffee64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e6645cff-32b7-419f-89ba-fab4db629ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_Revenues_e6645cff-32b7-419f-89ba-fab4db629ff8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08ae9630-b3b1-42e3-8062-55ef64b2b7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08ae9630-b3b1-42e3-8062-55ef64b2b7b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_a48393b6-de49-492e-8285-2d95505f37af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_a48393b6-de49-492e-8285-2d95505f37af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_005bf9ce-b794-420d-be96-7dc838935a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_005bf9ce-b794-420d-be96-7dc838935a45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_64fd3252-4ec1-434b-b22f-6ae72f1c8da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_64fd3252-4ec1-434b-b22f-6ae72f1c8da8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_85271c03-d958-446b-aacf-e34a6fdca758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_85271c03-d958-446b-aacf-e34a6fdca758" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3729ad6-0d07-4311-8ef1-9cc4f31aac37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_85271c03-d958-446b-aacf-e34a6fdca758" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3729ad6-0d07-4311-8ef1-9cc4f31aac37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b3729ad6-0d07-4311-8ef1-9cc4f31aac37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3729ad6-0d07-4311-8ef1-9cc4f31aac37" xlink:to="loc_us-gaap_EquityComponentDomain_b3729ad6-0d07-4311-8ef1-9cc4f31aac37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb5ec6ae-ffab-4709-a131-3a869bb4dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3729ad6-0d07-4311-8ef1-9cc4f31aac37" xlink:to="loc_us-gaap_EquityComponentDomain_eb5ec6ae-ffab-4709-a131-3a869bb4dbcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_067d392b-9a52-43e5-8efe-eb0375965a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb5ec6ae-ffab-4709-a131-3a869bb4dbcf" xlink:to="loc_us-gaap_RetainedEarningsMember_067d392b-9a52-43e5-8efe-eb0375965a80" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="extended" id="i71850e5871ad4192b222dfab73ba3fb0_AcquisitionsandOtherTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfProducts_a71111eb-abba-4939-9f1e-3385a9a452c6" xlink:href="vtrs-20220331.xsd#vtrs_NumberOfProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_vtrs_NumberOfProducts_a71111eb-abba-4939-9f1e-3385a9a452c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_28e629d7-4790-409e-a65b-cf46d242d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_28e629d7-4790-409e-a65b-cf46d242d831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1c457736-899e-4bb7-9790-be4180aada8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1c457736-899e-4bb7-9790-be4180aada8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsforBusinessSeparation_c36a4476-f9dd-4841-a3a9-55da9774c2a9" xlink:href="vtrs-20220331.xsd#vtrs_PaymentsforBusinessSeparation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_vtrs_PaymentsforBusinessSeparation_c36a4476-f9dd-4841-a3a9-55da9774c2a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2bddf59e-367e-404a-85cb-ea6b3db9fded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2bddf59e-367e-404a-85cb-ea6b3db9fded" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_20524d47-62a9-4bdf-9996-2367d6426378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_20524d47-62a9-4bdf-9996-2367d6426378" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_06a519dd-ac00-4b12-a5f3-e8715f100e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_06a519dd-ac00-4b12-a5f3-e8715f100e56" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dffe229e-a0d9-45fc-82e6-0cacd7ea2288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dffe229e-a0d9-45fc-82e6-0cacd7ea2288" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_16d95b79-f429-409e-b25c-1dd222a65718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_16d95b79-f429-409e-b25c-1dd222a65718" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2fd276b6-cc11-4f8f-95d0-c3b8128b7769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2fd276b6-cc11-4f8f-95d0-c3b8128b7769" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a5a685df-b2d4-4131-805a-68df60d5921d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a5a685df-b2d4-4131-805a-68df60d5921d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_93b36685-054c-4801-9c9f-3a2a1bb6ed36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_Goodwill_93b36685-054c-4801-9c9f-3a2a1bb6ed36" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_13d60f20-53eb-46ae-b1ee-e559b6faa34a" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_13d60f20-53eb-46ae-b1ee-e559b6faa34a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4cd0e480-6c11-4cb3-baea-eb15158acb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4cd0e480-6c11-4cb3-baea-eb15158acb72" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6689a57d-48da-4254-ba35-2a5f0a05f200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6689a57d-48da-4254-ba35-2a5f0a05f200" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_6ef60b63-3ab8-48c1-b74d-f05cc64d166c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_6ef60b63-3ab8-48c1-b74d-f05cc64d166c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_7d7c4ef5-3bd5-40b9-bf51-9aaf7a63822e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_7d7c4ef5-3bd5-40b9-bf51-9aaf7a63822e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_2c09e330-81ba-4e01-8c29-97ddab5b1c66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_OwnershipAxis_2c09e330-81ba-4e01-8c29-97ddab5b1c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2c09e330-81ba-4e01-8c29-97ddab5b1c66_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_2c09e330-81ba-4e01-8c29-97ddab5b1c66" xlink:to="loc_srt_OwnershipDomain_2c09e330-81ba-4e01-8c29-97ddab5b1c66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_77072540-f84c-4251-83d7-4a5b0be4fbe4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_2c09e330-81ba-4e01-8c29-97ddab5b1c66" xlink:to="loc_srt_OwnershipDomain_77072540-f84c-4251-83d7-4a5b0be4fbe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_6ece6a21-a611-4825-a435-17c273938f47" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_77072540-f84c-4251-83d7-4a5b0be4fbe4" xlink:to="loc_vtrs_UpjohnInc.Member_6ece6a21-a611-4825-a435-17c273938f47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c13d60b6-b139-4c6a-b708-800d4b92eae7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_ProductOrServiceAxis_c13d60b6-b139-4c6a-b708-800d4b92eae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c13d60b6-b139-4c6a-b708-800d4b92eae7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c13d60b6-b139-4c6a-b708-800d4b92eae7" xlink:to="loc_srt_ProductsAndServicesDomain_c13d60b6-b139-4c6a-b708-800d4b92eae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8cfff1e6-db79-42d4-849b-d830a65a047b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c13d60b6-b139-4c6a-b708-800d4b92eae7" xlink:to="loc_srt_ProductsAndServicesDomain_8cfff1e6-db79-42d4-849b-d830a65a047b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_e68a2b3e-6c90-4af9-b104-84eafa65d247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8cfff1e6-db79-42d4-849b-d830a65a047b" xlink:to="loc_us-gaap_ProductMember_e68a2b3e-6c90-4af9-b104-84eafa65d247" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b8537d01-d715-4e8b-8c9d-65a39d7d35d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_CounterpartyNameAxis_b8537d01-d715-4e8b-8c9d-65a39d7d35d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8537d01-d715-4e8b-8c9d-65a39d7d35d2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b8537d01-d715-4e8b-8c9d-65a39d7d35d2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8537d01-d715-4e8b-8c9d-65a39d7d35d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4d96c4f-89d7-4bfb-b51a-595e4b789b07" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b8537d01-d715-4e8b-8c9d-65a39d7d35d2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4d96c4f-89d7-4bfb-b51a-595e4b789b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_f534b680-6af4-4cec-bc58-dcb693b84c7e" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4d96c4f-89d7-4bfb-b51a-595e4b789b07" xlink:to="loc_vtrs_UpjohnInc.Member_f534b680-6af4-4cec-bc58-dcb693b84c7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e8f06b9c-8c48-4d6c-8aaa-55f04785d43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e8f06b9c-8c48-4d6c-8aaa-55f04785d43a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_f82204d1-02c9-490b-b86d-580b1558790a" xlink:href="vtrs-20220331.xsd#vtrs_PfizerInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e8f06b9c-8c48-4d6c-8aaa-55f04785d43a" xlink:to="loc_vtrs_PfizerInc.Member_f82204d1-02c9-490b-b86d-580b1558790a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_412e8093-3246-430e-ae82-92479deed9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_412e8093-3246-430e-ae82-92479deed9f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412e8093-3246-430e-ae82-92479deed9f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_412e8093-3246-430e-ae82-92479deed9f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_412e8093-3246-430e-ae82-92479deed9f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2845e8df-93bb-4f52-baeb-4dad4c6eef76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_412e8093-3246-430e-ae82-92479deed9f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2845e8df-93bb-4f52-baeb-4dad4c6eef76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_e2982eab-99b8-4f3b-a683-615b7fa42c9b" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2845e8df-93bb-4f52-baeb-4dad4c6eef76" xlink:to="loc_vtrs_UpjohnInc.Member_e2982eab-99b8-4f3b-a683-615b7fa42c9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_933805be-6901-4bff-93db-cb493c5e60f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_933805be-6901-4bff-93db-cb493c5e60f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_933805be-6901-4bff-93db-cb493c5e60f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_933805be-6901-4bff-93db-cb493c5e60f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_933805be-6901-4bff-93db-cb493c5e60f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_933805be-6901-4bff-93db-cb493c5e60f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_a1f9c4c6-6831-49fa-9c08-dbf8bf0cb78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_a1f9c4c6-6831-49fa-9c08-dbf8bf0cb78a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_4f9032f7-82b0-49b1-8636-9a286308ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:to="loc_us-gaap_BuildingMember_4f9032f7-82b0-49b1-8636-9a286308ab62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_587cc655-5744-4c9d-9587-723ff51078fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_587cc655-5744-4c9d-9587-723ff51078fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5191f922-d373-402f-98a1-3264c627fc49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_RangeAxis_5191f922-d373-402f-98a1-3264c627fc49" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5191f922-d373-402f-98a1-3264c627fc49_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5191f922-d373-402f-98a1-3264c627fc49" xlink:to="loc_srt_RangeMember_5191f922-d373-402f-98a1-3264c627fc49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5191f922-d373-402f-98a1-3264c627fc49" xlink:to="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e46b3d41-28fc-4ac7-a166-76bf7b0dfeee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:to="loc_srt_MinimumMember_e46b3d41-28fc-4ac7-a166-76bf7b0dfeee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2c83669-2bd4-499f-8c13-0581a78f69e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:to="loc_srt_MaximumMember_a2c83669-2bd4-499f-8c13-0581a78f69e1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended" id="i110c8a5daadf46f5996338646aa04e4c_AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_601197e1-1e6f-428e-8ea0-c38436f7d5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_601197e1-1e6f-428e-8ea0-c38436f7d5f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0f4085d5-1a32-456a-a905-484dfe37e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0f4085d5-1a32-456a-a905-484dfe37e8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4c53c594-98d3-4971-8286-6ddd9b330a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4c53c594-98d3-4971-8286-6ddd9b330a6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ebae8ca7-4bc7-46ce-917e-860ef2d74680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ebae8ca7-4bc7-46ce-917e-860ef2d74680" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_bc45c4a3-dff2-40be-afdc-01e979c2bfd6" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_bc45c4a3-dff2-40be-afdc-01e979c2bfd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8dd2d825-0a7c-4782-bca1-52499266b7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_Goodwill_8dd2d825-0a7c-4782-bca1-52499266b7cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_69e09548-3219-47ff-8e4c-32fd56028ac2" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_69e09548-3219-47ff-8e4c-32fd56028ac2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_a5161c8c-35d3-4c8f-8db3-580fc8645be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_a5161c8c-35d3-4c8f-8db3-580fc8645be3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4fca4c7b-85ea-4d32-a81d-c3f201736356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4fca4c7b-85ea-4d32-a81d-c3f201736356" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_cb595b12-c9f9-4645-a25a-09fad6f410da" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_cb595b12-c9f9-4645-a25a-09fad6f410da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_938a9a91-cf18-4683-b5bd-c39e7f003d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_938a9a91-cf18-4683-b5bd-c39e7f003d5c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b71ed8e8-f44f-498a-8d86-bb0d9a6a97e0" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b71ed8e8-f44f-498a-8d86-bb0d9a6a97e0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b2ce57e6-f496-4d45-a6a7-a6de70cc3127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b2ce57e6-f496-4d45-a6a7-a6de70cc3127" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_88b0fbff-cd63-4b43-941a-ec075574dd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_88b0fbff-cd63-4b43-941a-ec075574dd96" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fcb766b0-23e2-41ff-a9b8-cdd15bbe83e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fcb766b0-23e2-41ff-a9b8-cdd15bbe83e5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_7224374e-376b-447a-ba8a-e0c88546277a" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_7224374e-376b-447a-ba8a-e0c88546277a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_b1ba47f5-34dc-4055-b903-0ed9e24a857c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_b1ba47f5-34dc-4055-b903-0ed9e24a857c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0655ea82-6a40-4267-aa0d-fac94ce76bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0655ea82-6a40-4267-aa0d-fac94ce76bf2" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_c697c0e4-7b0c-490d-a26d-b9b4ad03ed52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_c697c0e4-7b0c-490d-a26d-b9b4ad03ed52" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_d140d0af-0acb-4bc4-8510-78e69f38a6f6" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_d140d0af-0acb-4bc4-8510-78e69f38a6f6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b0c2a535-6798-4380-a610-6b3fd80cb256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b0c2a535-6798-4380-a610-6b3fd80cb256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b0c2a535-6798-4380-a610-6b3fd80cb256_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b0c2a535-6798-4380-a610-6b3fd80cb256" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b0c2a535-6798-4380-a610-6b3fd80cb256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b0c2a535-6798-4380-a610-6b3fd80cb256" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_23433d13-1f9e-49da-b719-a50e3e16909c" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:to="loc_vtrs_UpjohnInc.Member_23433d13-1f9e-49da-b719-a50e3e16909c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7da2a6d5-76ff-43ba-9bcf-f0cbed0397a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7da2a6d5-76ff-43ba-9bcf-f0cbed0397a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:to="loc_srt_CounterpartyNameAxis_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c71d9ec-6b26-4d37-a1bd-77bc0f5d3bfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c71d9ec-6b26-4d37-a1bd-77bc0f5d3bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_19baccc5-e57c-49c2-8925-132b0ca4539d" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c71d9ec-6b26-4d37-a1bd-77bc0f5d3bfb" xlink:to="loc_vtrs_UpjohnInc.Member_19baccc5-e57c-49c2-8925-132b0ca4539d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cef78a1d-41b4-4833-918f-6a217b8302fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cef78a1d-41b4-4833-918f-6a217b8302fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_cef78a1d-41b4-4833-918f-6a217b8302fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cef78a1d-41b4-4833-918f-6a217b8302fc" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_cef78a1d-41b4-4833-918f-6a217b8302fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_4aac9795-b5d6-4537-a356-c257b3e5cefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cef78a1d-41b4-4833-918f-6a217b8302fc" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_4aac9795-b5d6-4537-a356-c257b3e5cefa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_a9c701c2-a169-4864-8aad-a2bdcc685a52" xlink:href="vtrs-20220331.xsd#vtrs_PfizerInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_4aac9795-b5d6-4537-a356-c257b3e5cefa" xlink:to="loc_vtrs_PfizerInc.Member_a9c701c2-a169-4864-8aad-a2bdcc685a52" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="extended" id="i9200be47f10d4eaebb3193fd152025d1_AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_24c62443-0329-480b-a581-8cc84c861bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_24c62443-0329-480b-a581-8cc84c861bc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f4cb845d-141a-41f9-b115-f6c4bee5b67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f4cb845d-141a-41f9-b115-f6c4bee5b67f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_facbfe1d-1dd1-488f-9003-788747f79736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_facbfe1d-1dd1-488f-9003-788747f79736" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_c64ba92d-4ff0-44fc-b6b9-dc00d67be9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_c64ba92d-4ff0-44fc-b6b9-dc00d67be9f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_d60c551b-826b-40c0-8e36-e0f08d0e57ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_d60c551b-826b-40c0-8e36-e0f08d0e57ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_d8e8c6bf-4cdc-45ff-a3c0-61f57adf8b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_d8e8c6bf-4cdc-45ff-a3c0-61f57adf8b61" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e878b97-23bf-4885-ad7b-9e0822d1e709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e878b97-23bf-4885-ad7b-9e0822d1e709" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3158704d-bd66-473f-923f-376db852cd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e878b97-23bf-4885-ad7b-9e0822d1e709" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3158704d-bd66-473f-923f-376db852cd14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3158704d-bd66-473f-923f-376db852cd14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3158704d-bd66-473f-923f-376db852cd14" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3158704d-bd66-473f-923f-376db852cd14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb2427a5-0a1c-4aff-a445-e8cd4542410e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3158704d-bd66-473f-923f-376db852cd14" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb2427a5-0a1c-4aff-a445-e8cd4542410e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_e8d63d13-56ae-4606-b924-1c6cc954cb9e" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb2427a5-0a1c-4aff-a445-e8cd4542410e" xlink:to="loc_vtrs_UpjohnInc.Member_e8d63d13-56ae-4606-b924-1c6cc954cb9e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ShareBasedIncentivePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="extended" id="id1d04fae76cd47f4bb642ae1daf31e21_ShareBasedIncentivePlanNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_67c91f58-c3f3-4dd0-8e02-cd1b76bf2def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_67c91f58-c3f3-4dd0-8e02-cd1b76bf2def" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_52ea217f-b419-46cd-84b3-26bff3de1fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_52ea217f-b419-46cd-84b3-26bff3de1fec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b5afdf1c-2b32-45f1-8270-b635c700c61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b5afdf1c-2b32-45f1-8270-b635c700c61a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_fac3d6dd-82ec-4647-a9a1-6c1a0e6f25c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_fac3d6dd-82ec-4647-a9a1-6c1a0e6f25c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d1cbdf4b-9267-4d3c-80a5-8338f2f9e3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d1cbdf4b-9267-4d3c-80a5-8338f2f9e3f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_26961540-00da-4520-9b35-52402e0de430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_26961540-00da-4520-9b35-52402e0de430" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a18d8e34-87ff-4382-9f68-f22bf27ee916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a18d8e34-87ff-4382-9f68-f22bf27ee916" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_66152099-41d7-4b58-942a-8b28a9029416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_66152099-41d7-4b58-942a-8b28a9029416" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ad488b91-2b24-46c2-bf4a-eb6726c0c30d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ad488b91-2b24-46c2-bf4a-eb6726c0c30d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_03749c7a-a7c1-4f73-bcb6-b692a3b7bd94" xlink:href="vtrs-20220331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_03749c7a-a7c1-4f73-bcb6-b692a3b7bd94" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a6d9995-4cf3-4dbb-8392-7a8809e5104d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a6d9995-4cf3-4dbb-8392-7a8809e5104d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_324badf0-cfc3-41c1-a480-71350012ef84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_324badf0-cfc3-41c1-a480-71350012ef84" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0c1c288c-46b3-46fc-a5bf-f5ed363f025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0c1c288c-46b3-46fc-a5bf-f5ed363f025c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_ee4b7090-c68f-44b2-abc1-75b54e44d520" xlink:href="vtrs-20220331.xsd#vtrs_ProgramNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_vtrs_ProgramNameAxis_ee4b7090-c68f-44b2-abc1-75b54e44d520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_ee4b7090-c68f-44b2-abc1-75b54e44d520_default" xlink:href="vtrs-20220331.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_ProgramNameAxis_ee4b7090-c68f-44b2-abc1-75b54e44d520" xlink:to="loc_vtrs_ProgramNameDomain_ee4b7090-c68f-44b2-abc1-75b54e44d520_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_bddd8bd2-f885-47df-8a74-365e08815d88" xlink:href="vtrs-20220331.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_ProgramNameAxis_ee4b7090-c68f-44b2-abc1-75b54e44d520" xlink:to="loc_vtrs_ProgramNameDomain_bddd8bd2-f885-47df-8a74-365e08815d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4b6958f3-21f0-46bc-a898-fa0e479c9d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_us-gaap_PlanNameAxis_4b6958f3-21f0-46bc-a898-fa0e479c9d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4b6958f3-21f0-46bc-a898-fa0e479c9d20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4b6958f3-21f0-46bc-a898-fa0e479c9d20" xlink:to="loc_us-gaap_PlanNameDomain_4b6958f3-21f0-46bc-a898-fa0e479c9d20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4b6958f3-21f0-46bc-a898-fa0e479c9d20" xlink:to="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_14e601fa-c78e-4273-bbe2-b5972356feab" xlink:href="vtrs-20220331.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_14e601fa-c78e-4273-bbe2-b5972356feab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_2d53385e-ffd1-4bb7-add5-62c1d26dee0a" xlink:href="vtrs-20220331.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:to="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_2d53385e-ffd1-4bb7-add5-62c1d26dee0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78732f9b-0be3-4cde-ba56-b009f089b530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_us-gaap_AwardTypeAxis_78732f9b-0be3-4cde-ba56-b009f089b530" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78732f9b-0be3-4cde-ba56-b009f089b530_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_78732f9b-0be3-4cde-ba56-b009f089b530" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78732f9b-0be3-4cde-ba56-b009f089b530_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b77d520c-afa4-47c9-a5f5-e50dcc5c8b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_78732f9b-0be3-4cde-ba56-b009f089b530" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b77d520c-afa4-47c9-a5f5-e50dcc5c8b56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_321fd9e9-b761-42a1-a135-75a1ad202cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b77d520c-afa4-47c9-a5f5-e50dcc5c8b56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_321fd9e9-b761-42a1-a135-75a1ad202cf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_srt_RangeAxis_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059" xlink:to="loc_srt_RangeMember_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059" xlink:to="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a91e830-97f1-427a-9287-2551ee42bf90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:to="loc_srt_MinimumMember_4a91e830-97f1-427a-9287-2551ee42bf90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08d38710-9709-4db1-ae08-8239ee8a3fc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:to="loc_srt_MaximumMember_08d38710-9709-4db1-ae08-8239ee8a3fc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5da23b5a-3bc7-4925-aa9d-0a179f60b731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5da23b5a-3bc7-4925-aa9d-0a179f60b731" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da23b5a-3bc7-4925-aa9d-0a179f60b731_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5da23b5a-3bc7-4925-aa9d-0a179f60b731" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da23b5a-3bc7-4925-aa9d-0a179f60b731_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0220f187-04ff-4f04-8fd5-4a8446c0c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5da23b5a-3bc7-4925-aa9d-0a179f60b731" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0220f187-04ff-4f04-8fd5-4a8446c0c12f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="extended" id="if596788f7dac413299257ec5baabce2b_ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_52a57e56-c3d1-4b91-be7b-f4976397fc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_52a57e56-c3d1-4b91-be7b-f4976397fc7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eeeb82db-7b1c-4fca-bd04-adaa019f6ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eeeb82db-7b1c-4fca-bd04-adaa019f6ee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_161dbff9-5e07-447d-98de-8458e8123262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_161dbff9-5e07-447d-98de-8458e8123262" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4ec2ae86-9f86-4654-82c8-aea314ac79a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4ec2ae86-9f86-4654-82c8-aea314ac79a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3da75ca-3844-43cf-96bd-790c8dceac2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3da75ca-3844-43cf-96bd-790c8dceac2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9cc6483b-56e0-47f7-88f3-652dc081d570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9cc6483b-56e0-47f7-88f3-652dc081d570" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25295cca-bbb0-4afa-a281-3a96d8f9faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25295cca-bbb0-4afa-a281-3a96d8f9faa2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_409e5da9-ebba-4ca0-8662-08d8cad40cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_409e5da9-ebba-4ca0-8662-08d8cad40cf0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c70a362d-3f59-4895-b486-65e2dfa01487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c70a362d-3f59-4895-b486-65e2dfa01487" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e261a634-49d2-4e4f-b05f-77fdf6c04361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c6efab6-e3de-4898-be02-81cd76d6fff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19a3082a-3470-42fa-8a67-90dbcfc62c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_52a57e56-c3d1-4b91-be7b-f4976397fc7c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19a3082a-3470-42fa-8a67-90dbcfc62c22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19a3082a-3470-42fa-8a67-90dbcfc62c22" xlink:to="loc_us-gaap_AwardTypeAxis_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3449849-e5b3-45b7-a8e9-b92861b6a523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3449849-e5b3-45b7-a8e9-b92861b6a523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_11983d75-d741-4c61-bcc4-d08f7881f06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3449849-e5b3-45b7-a8e9-b92861b6a523" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_11983d75-d741-4c61-bcc4-d08f7881f06d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#PensionandOtherPostretirementBenefitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="extended" id="i6cbccd022ece494d910d911a06f99c08_PensionandOtherPostretirementBenefitNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlansNumberofFrozenPlans_6c11c8c4-ecca-4a35-86cf-d739f0df2b26" xlink:href="vtrs-20220331.xsd#vtrs_DefinedBenefitPlansNumberofFrozenPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:to="loc_vtrs_DefinedBenefitPlansNumberofFrozenPlans_6c11c8c4-ecca-4a35-86cf-d739f0df2b26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_01028af9-4777-4f3f-8a5d-8b2d1502b93e" xlink:href="vtrs-20220331.xsd#vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:to="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_01028af9-4777-4f3f-8a5d-8b2d1502b93e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_dff5d866-4efb-4f6a-bf03-81a70933eb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_dff5d866-4efb-4f6a-bf03-81a70933eb0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9f788519-3203-4565-8650-9f611bd111c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9f788519-3203-4565-8650-9f611bd111c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_036d40c9-7a9d-45e2-b24a-719d428ead49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9f788519-3203-4565-8650-9f611bd111c9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_036d40c9-7a9d-45e2-b24a-719d428ead49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_036d40c9-7a9d-45e2-b24a-719d428ead49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_036d40c9-7a9d-45e2-b24a-719d428ead49" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_036d40c9-7a9d-45e2-b24a-719d428ead49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a60eb2b8-8fe3-49ec-aca5-32f9d360ca60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_036d40c9-7a9d-45e2-b24a-719d428ead49" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a60eb2b8-8fe3-49ec-aca5-32f9d360ca60" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended" id="i3fe7a21c745246aa863fd1357b510e28_PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_382d8593-289d-487a-b828-5f21bf65cc30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_382d8593-289d-487a-b828-5f21bf65cc30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f5ccf31b-550f-45f7-9674-17d9b7558c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f5ccf31b-550f-45f7-9674-17d9b7558c02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a438168c-b3ae-48eb-87b3-3cb3c6d6a2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a438168c-b3ae-48eb-87b3-3cb3c6d6a2d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_bfa38a76-26ee-4e1e-acf7-caf21a4aca80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_bfa38a76-26ee-4e1e-acf7-caf21a4aca80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e9571d4c-a219-43b4-a526-ae1d332b6537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e9571d4c-a219-43b4-a526-ae1d332b6537" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7aca5aba-dd14-4850-8bea-b50da95c111f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7aca5aba-dd14-4850-8bea-b50da95c111f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3bf86f24-2395-482e-af0c-0e583f20ae4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3bf86f24-2395-482e-af0c-0e583f20ae4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3bf86f24-2395-482e-af0c-0e583f20ae4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3bf86f24-2395-482e-af0c-0e583f20ae4a" xlink:to="loc_us-gaap_EquityComponentDomain_3bf86f24-2395-482e-af0c-0e583f20ae4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d2256b6-cde3-405f-9a92-ab692983008d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3bf86f24-2395-482e-af0c-0e583f20ae4a" xlink:to="loc_us-gaap_EquityComponentDomain_3d2256b6-cde3-405f-9a92-ab692983008d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3031b7c0-3eb7-4131-8399-ba9972bc2326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d2256b6-cde3-405f-9a92-ab692983008d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3031b7c0-3eb7-4131-8399-ba9972bc2326" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fb547af5-fb9e-42d6-99b6-f7f55567ab84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fb547af5-fb9e-42d6-99b6-f7f55567ab84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_d34126f2-c38e-4099-97f8-00743a2740ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fb547af5-fb9e-42d6-99b6-f7f55567ab84" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_d34126f2-c38e-4099-97f8-00743a2740ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_04e68ba5-ce71-47e4-bf34-4a6a0f75948e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_04e68ba5-ce71-47e4-bf34-4a6a0f75948e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_04e68ba5-ce71-47e4-bf34-4a6a0f75948e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_04e68ba5-ce71-47e4-bf34-4a6a0f75948e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_04e68ba5-ce71-47e4-bf34-4a6a0f75948e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4eae565a-687f-476c-9baa-f350ae61a373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_04e68ba5-ce71-47e4-bf34-4a6a0f75948e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4eae565a-687f-476c-9baa-f350ae61a373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e28c6f4a-cd43-4566-b6db-f8cfd6773244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4eae565a-687f-476c-9baa-f350ae61a373" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e28c6f4a-cd43-4566-b6db-f8cfd6773244" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended" id="ib60a9bc404434309954d28301c149106_BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2fd4c5b7-4ef3-40a4-a8e8-570bd89de841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2fd4c5b7-4ef3-40a4-a8e8-570bd89de841" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16f98d8f-2668-45a6-8a0a-48c970f1d25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16f98d8f-2668-45a6-8a0a-48c970f1d25d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6ab366e9-4481-4bc2-b404-6e013fd32638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6ab366e9-4481-4bc2-b404-6e013fd32638" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_f133f27e-27ac-40fd-8f2c-8f7609848447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_TradingSecurities_f133f27e-27ac-40fd-8f2c-8f7609848447" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_705f2774-a8df-4dca-8692-ec3893f482be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_OtherAssetsCurrent_705f2774-a8df-4dca-8692-ec3893f482be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_84d53366-1be6-4902-8b66-93730b6245a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_84d53366-1be6-4902-8b66-93730b6245a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_56ebe897-35ed-4277-91d8-da3b2db362f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_56ebe897-35ed-4277-91d8-da3b2db362f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_56ebe897-35ed-4277-91d8-da3b2db362f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_56ebe897-35ed-4277-91d8-da3b2db362f3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_56ebe897-35ed-4277-91d8-da3b2db362f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_74339951-27ee-4214-9789-edc2c766e0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_56ebe897-35ed-4277-91d8-da3b2db362f3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_74339951-27ee-4214-9789-edc2c766e0b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_fb7fefaf-e918-4809-9fa8-fb4825e25c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_74339951-27ee-4214-9789-edc2c766e0b2" xlink:to="loc_us-gaap_DebtSecuritiesMember_fb7fefaf-e918-4809-9fa8-fb4825e25c90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_47e7d9e4-7927-43b0-b98e-59d62ff9e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_47e7d9e4-7927-43b0-b98e-59d62ff9e98a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_47e7d9e4-7927-43b0-b98e-59d62ff9e98a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_47e7d9e4-7927-43b0-b98e-59d62ff9e98a" xlink:to="loc_us-gaap_ReceivableTypeDomain_47e7d9e4-7927-43b0-b98e-59d62ff9e98a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ea63effb-9933-4898-b273-30edeb67f346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_47e7d9e4-7927-43b0-b98e-59d62ff9e98a" xlink:to="loc_us-gaap_ReceivableTypeDomain_ea63effb-9933-4898-b273-30edeb67f346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_c07aeeee-4e95-4213-90ce-9b35ddc9e6e3" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_ea63effb-9933-4898-b273-30edeb67f346" xlink:to="loc_vtrs_VariableConsiderationMember_c07aeeee-4e95-4213-90ce-9b35ddc9e6e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8d059e7b-cae0-49df-afa5-60bbdd8351bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8d059e7b-cae0-49df-afa5-60bbdd8351bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8d059e7b-cae0-49df-afa5-60bbdd8351bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d059e7b-cae0-49df-afa5-60bbdd8351bc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8d059e7b-cae0-49df-afa5-60bbdd8351bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5f1eb0b4-54fe-4e5a-8eee-df51b73339fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d059e7b-cae0-49df-afa5-60bbdd8351bc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5f1eb0b4-54fe-4e5a-8eee-df51b73339fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b86a9bcb-8b99-4d47-bfb0-f221ed0bf923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5f1eb0b4-54fe-4e5a-8eee-df51b73339fe" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b86a9bcb-8b99-4d47-bfb0-f221ed0bf923" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17dd30b1-1fc7-4728-821a-acd642701a88" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17dd30b1-1fc7-4728-821a-acd642701a88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_17dd30b1-1fc7-4728-821a-acd642701a88_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17dd30b1-1fc7-4728-821a-acd642701a88" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_17dd30b1-1fc7-4728-821a-acd642701a88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_50dbdc38-c410-47c7-860e-cb6ad3f19687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17dd30b1-1fc7-4728-821a-acd642701a88" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_50dbdc38-c410-47c7-860e-cb6ad3f19687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_4fc31c4c-72a1-4a02-b009-87eb05a1e48c" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_50dbdc38-c410-47c7-860e-cb6ad3f19687" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_4fc31c4c-72a1-4a02-b009-87eb05a1e48c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended" id="i04d358376016454fb0835f11a1a5b7a9_BalanceSheetComponentsPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_db5b26fb-ead9-4292-b8e1-b96f1c11b01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_db5b26fb-ead9-4292-b8e1-b96f1c11b01f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_05361681-e306-4f5c-8293-e0534c376ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_05361681-e306-4f5c-8293-e0534c376ca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_28572d69-c780-4d93-88b1-9646fa70761e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_28572d69-c780-4d93-88b1-9646fa70761e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_618c5088-7b1b-47c7-83d4-8b8d1c96380b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_618c5088-7b1b-47c7-83d4-8b8d1c96380b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_618c5088-7b1b-47c7-83d4-8b8d1c96380b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a022b74e-119d-4f9e-a4b4-6c769ed38711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a022b74e-119d-4f9e-a4b4-6c769ed38711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_afffc8ef-77ac-40ba-a5a5-20c87711ec8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_afffc8ef-77ac-40ba-a5a5-20c87711ec8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_4da0f53b-6e97-453d-815f-ff1ee6cac24b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_ConstructionInProgressMember_4da0f53b-6e97-453d-815f-ff1ee6cac24b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_98dcb9eb-3da6-45d4-b5da-94d7ead7b87b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_98dcb9eb-3da6-45d4-b5da-94d7ead7b87b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended" id="i8c37dbdd224c457a81d903f2bd816470_BalanceSheetComponentsOtherCurrentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_de4a8a92-a798-4176-a349-822e0aa0e8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_de4a8a92-a798-4176-a349-822e0aa0e8dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_6d0af42d-10a3-49a7-b500-96ed4b642fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_LitigationReserveCurrent_6d0af42d-10a3-49a7-b500-96ed4b642fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_88e81d2c-a579-4044-9111-a8577143db68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_88e81d2c-a579-4044-9111-a8577143db68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2fbc9ef4-1918-4b0c-be13-cdf5c20d3657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2fbc9ef4-1918-4b0c-be13-cdf5c20d3657" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_ba644f2a-dd9f-49f4-b21b-65504cadfe59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_RestructuringReserveCurrent_ba644f2a-dd9f-49f4-b21b-65504cadfe59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_ed85c144-095c-42a4-a3f2-ae9e57b7c239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_InterestPayableCurrent_ed85c144-095c-42a4-a3f2-ae9e57b7c239" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2c8c56a2-b8c2-4f2d-b144-4160eac2b48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2c8c56a2-b8c2-4f2d-b144-4160eac2b48c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_86483072-6b70-4eda-bce3-c701d4c01329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_86483072-6b70-4eda-bce3-c701d4c01329" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2622e3e6-e397-4335-87b7-3c373051fe05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2622e3e6-e397-4335-87b7-3c373051fe05" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_25926b2c-050e-4c89-bf46-1e67e135b21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_25926b2c-050e-4c89-bf46-1e67e135b21a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_4e725a79-31f6-4543-a482-9f702059a566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_4e725a79-31f6-4543-a482-9f702059a566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4e725a79-31f6-4543-a482-9f702059a566_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_4e725a79-31f6-4543-a482-9f702059a566" xlink:to="loc_us-gaap_ReceivableTypeDomain_4e725a79-31f6-4543-a482-9f702059a566_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_727d8b71-9dc2-469c-bc22-b8f0d429cd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_4e725a79-31f6-4543-a482-9f702059a566" xlink:to="loc_us-gaap_ReceivableTypeDomain_727d8b71-9dc2-469c-bc22-b8f0d429cd68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_8ffab555-88fa-4791-921d-a200ea3b84fa" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_727d8b71-9dc2-469c-bc22-b8f0d429cd68" xlink:to="loc_vtrs_VariableConsiderationMember_8ffab555-88fa-4791-921d-a200ea3b84fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6939fecf-81e7-4f07-9bcc-8a45184cb890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6939fecf-81e7-4f07-9bcc-8a45184cb890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_172545cc-fd32-4666-82f8-fc42720a117a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6939fecf-81e7-4f07-9bcc-8a45184cb890" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_172545cc-fd32-4666-82f8-fc42720a117a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_115b4f8e-ba2d-4348-8394-321bf538f56a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_115b4f8e-ba2d-4348-8394-321bf538f56a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_115b4f8e-ba2d-4348-8394-321bf538f56a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_115b4f8e-ba2d-4348-8394-321bf538f56a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_115b4f8e-ba2d-4348-8394-321bf538f56a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_963d6ca9-c07f-4e91-b87f-31ee80bbf647" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_115b4f8e-ba2d-4348-8394-321bf538f56a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_963d6ca9-c07f-4e91-b87f-31ee80bbf647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_ed194346-0db6-46fc-b4e4-39c1293aefd4" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_963d6ca9-c07f-4e91-b87f-31ee80bbf647" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_ed194346-0db6-46fc-b4e4-39c1293aefd4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsOtherLongtermObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="extended" id="i8a7590b12e7b47d9b37556e810592c05_BalanceSheetComponentsOtherLongtermObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_3f3e68b6-5820-4c13-aa6b-fb835def8f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_3f3e68b6-5820-4c13-aa6b-fb835def8f1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14adba2a-c491-486d-b78b-8d6265dd1774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14adba2a-c491-486d-b78b-8d6265dd1774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_c7a52c65-bdc1-45f9-aac8-2d57b9238d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_c7a52c65-bdc1-45f9-aac8-2d57b9238d4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87dcc578-db98-470e-9062-575670cf274d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87dcc578-db98-470e-9062-575670cf274d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_8337cb6a-342a-4326-b82a-e31295a354b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_8337cb6a-342a-4326-b82a-e31295a354b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_31142fce-e25f-4f65-9852-9e85fb9a0d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_31142fce-e25f-4f65-9852-9e85fb9a0d5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f5fe8436-ef42-486d-ab95-a2e1d8f69faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f5fe8436-ef42-486d-ab95-a2e1d8f69faa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_940fcd71-2c4a-4ce2-92d9-3258922a9023" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_940fcd71-2c4a-4ce2-92d9-3258922a9023" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_423cdc1f-530e-410d-af28-05f28c94d49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_940fcd71-2c4a-4ce2-92d9-3258922a9023" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_423cdc1f-530e-410d-af28-05f28c94d49a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_423cdc1f-530e-410d-af28-05f28c94d49a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_423cdc1f-530e-410d-af28-05f28c94d49a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_423cdc1f-530e-410d-af28-05f28c94d49a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e9c31404-307e-4284-90f9-d4b4b4cbc4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_423cdc1f-530e-410d-af28-05f28c94d49a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e9c31404-307e-4284-90f9-d4b4b4cbc4fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c0b6115c-7bc8-401b-93ab-c662e2ff5686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e9c31404-307e-4284-90f9-d4b4b4cbc4fa" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c0b6115c-7bc8-401b-93ab-c662e2ff5686" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended" id="i52ba68b5dec44c79a3460ff2b592dc05_BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_d0adf78f-4bf7-46ea-9d24-8684f9afdb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_d0adf78f-4bf7-46ea-9d24-8684f9afdb5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership_50515561-8423-45bc-a3ef-37172cb5b12e" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership_50515561-8423-45bc-a3ef-37172cb5b12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh_3441a70d-662e-4fea-bc57-8d10c3d86386" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh_3441a70d-662e-4fea-bc57-8d10c3d86386" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement_3c062af9-e6cc-4998-a626-c21b5c42b399" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement_3c062af9-e6cc-4998-a626-c21b5c42b399" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_03ab970e-8a6f-49a7-9523-79d929ba2c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_03ab970e-8a6f-49a7-9523-79d929ba2c86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0773015d-26a4-4e72-ada5-e58d49b41011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0773015d-26a4-4e72-ada5-e58d49b41011" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7d23537-5358-441d-91df-35c65163cb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7d23537-5358-441d-91df-35c65163cb62" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_6ca982d8-2540-4503-96e2-eb07d5174480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_6ca982d8-2540-4503-96e2-eb07d5174480" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_adbf8ee6-ed9b-485b-91f6-2a293edbe836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_adbf8ee6-ed9b-485b-91f6-2a293edbe836" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_23a79afb-31ea-401e-b153-5fe09f62cb93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_23a79afb-31ea-401e-b153-5fe09f62cb93" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_585a2274-587f-4cb4-bb6b-b66b8b4c4b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_585a2274-587f-4cb4-bb6b-b66b8b4c4b02" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_eba76d00-9415-4997-8f29-743e4c80a06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_eba76d00-9415-4997-8f29-743e4c80a06c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_59f0ff4f-b7b5-45e1-bf59-31f8607bdbda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_59f0ff4f-b7b5-45e1-bf59-31f8607bdbda" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_36ac4115-0d75-4964-8f13-55ad4e42f4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_36ac4115-0d75-4964-8f13-55ad4e42f4d5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fd41869a-b1fb-4a94-86b1-7510730df1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fd41869a-b1fb-4a94-86b1-7510730df1a0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_af0b7245-b547-4e9c-82ce-fd5a17b0077b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_af0b7245-b547-4e9c-82ce-fd5a17b0077b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_af0b7245-b547-4e9c-82ce-fd5a17b0077b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_af0b7245-b547-4e9c-82ce-fd5a17b0077b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_af0b7245-b547-4e9c-82ce-fd5a17b0077b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ee906132-d32f-4ac1-a293-6a90f5448a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_af0b7245-b547-4e9c-82ce-fd5a17b0077b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ee906132-d32f-4ac1-a293-6a90f5448a19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_4df3f64c-a0dd-4b48-afb5-b5f6205def14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ee906132-d32f-4ac1-a293-6a90f5448a19" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_4df3f64c-a0dd-4b48-afb5-b5f6205def14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e87d23ef-7497-4de9-a42a-50ed55d5186a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_srt_StatementScenarioAxis_e87d23ef-7497-4de9-a42a-50ed55d5186a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e87d23ef-7497-4de9-a42a-50ed55d5186a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_e87d23ef-7497-4de9-a42a-50ed55d5186a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e87d23ef-7497-4de9-a42a-50ed55d5186a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1de6de15-7248-4382-ad68-a56a94d4bb91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_e87d23ef-7497-4de9-a42a-50ed55d5186a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1de6de15-7248-4382-ad68-a56a94d4bb91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_ee286e24-7334-4d65-96cb-15f3b94e804f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1de6de15-7248-4382-ad68-a56a94d4bb91" xlink:to="loc_srt_ScenarioForecastMember_ee286e24-7334-4d65-96cb-15f3b94e804f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b89e0222-c4dc-4771-8811-52f61b47a770" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_srt_CounterpartyNameAxis_b89e0222-c4dc-4771-8811-52f61b47a770" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b89e0222-c4dc-4771-8811-52f61b47a770_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b89e0222-c4dc-4771-8811-52f61b47a770" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b89e0222-c4dc-4771-8811-52f61b47a770_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_56d57477-419b-47b4-91a6-9f5b520a3a04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b89e0222-c4dc-4771-8811-52f61b47a770" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_56d57477-419b-47b4-91a6-9f5b520a3a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_4b21e006-b375-4f95-a606-d200d5b7fcb2" xlink:href="vtrs-20220331.xsd#vtrs_BioconBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_56d57477-419b-47b4-91a6-9f5b520a3a04" xlink:to="loc_vtrs_BioconBiologicsMember_4b21e006-b375-4f95-a606-d200d5b7fcb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_063f9c18-ca09-4e3d-b825-3b56ce022b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_063f9c18-ca09-4e3d-b825-3b56ce022b23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_063f9c18-ca09-4e3d-b825-3b56ce022b23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_063f9c18-ca09-4e3d-b825-3b56ce022b23" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_063f9c18-ca09-4e3d-b825-3b56ce022b23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_325d9556-5001-45db-aad0-bf0850507f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_063f9c18-ca09-4e3d-b825-3b56ce022b23" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_325d9556-5001-45db-aad0-bf0850507f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BiosimilarsPortfolioMember_61408658-b9f4-40c8-a30a-6fd27b970500" xlink:href="vtrs-20220331.xsd#vtrs_BiosimilarsPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_325d9556-5001-45db-aad0-bf0850507f68" xlink:to="loc_vtrs_BiosimilarsPortfolioMember_61408658-b9f4-40c8-a30a-6fd27b970500" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_128d29ee-be06-4201-9704-0c594311cdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_128d29ee-be06-4201-9704-0c594311cdb1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_128d29ee-be06-4201-9704-0c594311cdb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_128d29ee-be06-4201-9704-0c594311cdb1" xlink:to="loc_us-gaap_ReceivableTypeDomain_128d29ee-be06-4201-9704-0c594311cdb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_54a95024-f179-49e5-8194-2367c0ce3b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_128d29ee-be06-4201-9704-0c594311cdb1" xlink:to="loc_us-gaap_ReceivableTypeDomain_54a95024-f179-49e5-8194-2367c0ce3b87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_205bd9cb-af9e-4de2-b6c6-c9048bf42214" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_54a95024-f179-49e5-8194-2367c0ce3b87" xlink:to="loc_vtrs_VariableConsiderationMember_205bd9cb-af9e-4de2-b6c6-c9048bf42214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_67fb9d53-811d-48be-a835-a43fedced6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_67fb9d53-811d-48be-a835-a43fedced6c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_67fb9d53-811d-48be-a835-a43fedced6c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_67fb9d53-811d-48be-a835-a43fedced6c2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_67fb9d53-811d-48be-a835-a43fedced6c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_959cd392-f8f9-444f-9f9f-0c47cd33e60b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_67fb9d53-811d-48be-a835-a43fedced6c2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_959cd392-f8f9-444f-9f9f-0c47cd33e60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_755540e4-e3b8-433b-b09d-730cf7e7db66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_959cd392-f8f9-444f-9f9f-0c47cd33e60b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_755540e4-e3b8-433b-b09d-730cf7e7db66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05904b4b-a7a5-451c-b1b9-078089d81d09" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05904b4b-a7a5-451c-b1b9-078089d81d09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_05904b4b-a7a5-451c-b1b9-078089d81d09_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05904b4b-a7a5-451c-b1b9-078089d81d09" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_05904b4b-a7a5-451c-b1b9-078089d81d09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5f281e39-7eaa-4a32-a7da-7324260007b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05904b4b-a7a5-451c-b1b9-078089d81d09" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5f281e39-7eaa-4a32-a7da-7324260007b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_14cee8df-1f6a-457b-bf25-b67ce7504b3e" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f281e39-7eaa-4a32-a7da-7324260007b9" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_14cee8df-1f6a-457b-bf25-b67ce7504b3e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EquityMethodInvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="extended" id="i31209b1b8f394a76b021c6cfca141ffa_EquityMethodInvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofequitymethodinvestments_2d65f032-eeda-4589-83af-e678a4926327" xlink:href="vtrs-20220331.xsd#vtrs_Numberofequitymethodinvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:to="loc_vtrs_Numberofequitymethodinvestments_2d65f032-eeda-4589-83af-e678a4926327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis_709fd5df-7761-49a1-835d-a449379ff3ae" xlink:href="vtrs-20220331.xsd#vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:to="loc_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis_709fd5df-7761-49a1-835d-a449379ff3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_73d351d5-115b-48f5-8995-f7346479f865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_73d351d5-115b-48f5-8995-f7346479f865" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff14ae19-1f43-43f3-a0d9-b662f2c1f8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff14ae19-1f43-43f3-a0d9-b662f2c1f8d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a33dff6b-057b-491a-ac3a-84e514771eb5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff14ae19-1f43-43f3-a0d9-b662f2c1f8d8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a33dff6b-057b-491a-ac3a-84e514771eb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a33dff6b-057b-491a-ac3a-84e514771eb5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a33dff6b-057b-491a-ac3a-84e514771eb5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a33dff6b-057b-491a-ac3a-84e514771eb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a8c29d42-219e-422e-b606-1adb1ff172c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a33dff6b-057b-491a-ac3a-84e514771eb5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a8c29d42-219e-422e-b606-1adb1ff172c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_7c126b4f-2315-40f4-a3aa-3fd506c04007" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a8c29d42-219e-422e-b606-1adb1ff172c9" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_7c126b4f-2315-40f4-a3aa-3fd506c04007" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EquityMethodInvestmentsIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="extended" id="ieb3583c8f4dc47028075b41ca4cd2991_EquityMethodInvestmentsIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_09bc6875-7203-4ef6-9770-22f509eb1e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_Revenues_09bc6875-7203-4ef6-9770-22f509eb1e26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_42a805b9-b4e1-49ba-8272-92a077799f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_GrossProfit_42a805b9-b4e1-49ba-8272-92a077799f58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f228658-bd00-4968-a717-a03d36e02b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f228658-bd00-4968-a717-a03d36e02b59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5a64a4c1-4cb6-481e-91f6-b017717a25b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_ProfitLoss_5a64a4c1-4cb6-481e-91f6-b017717a25b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_436e55c2-7f7c-460d-81c9-2b9a673a2b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_436e55c2-7f7c-460d-81c9-2b9a673a2b41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5a43904d-2c5b-4de3-b69b-bf90c714244a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_436e55c2-7f7c-460d-81c9-2b9a673a2b41" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5a43904d-2c5b-4de3-b69b-bf90c714244a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5a43904d-2c5b-4de3-b69b-bf90c714244a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a43904d-2c5b-4de3-b69b-bf90c714244a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5a43904d-2c5b-4de3-b69b-bf90c714244a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7e72c2ef-745e-406c-9424-c7a52dc6d6ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a43904d-2c5b-4de3-b69b-bf90c714244a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7e72c2ef-745e-406c-9424-c7a52dc6d6ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember_0d30f632-7cb6-4101-bc82-f070c2a0f47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7e72c2ef-745e-406c-9424-c7a52dc6d6ab" xlink:to="loc_us-gaap_ConsolidatedEntityExcludingVieMember_0d30f632-7cb6-4101-bc82-f070c2a0f47a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EarningsLossperOrdinaryShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails" xlink:type="extended" id="i008217e92cb047f3b5f5657de005ee17_EarningsLossperOrdinaryShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6051690e-7c0e-496e-bf3e-c7ece55133dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6051690e-7c0e-496e-bf3e-c7ece55133dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1a0b8b9a-1424-4971-975f-e57a8c6349a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1a0b8b9a-1424-4971-975f-e57a8c6349a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_d5f9315f-9821-494c-823b-81f7254213bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_Dividends_d5f9315f-9821-494c-823b-81f7254213bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_e1b2bcfa-380d-49ae-8cdf-b99f70a90d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_e1b2bcfa-380d-49ae-8cdf-b99f70a90d0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1fede50f-11a1-46b0-9c25-33bdc5eed8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1fede50f-11a1-46b0-9c25-33bdc5eed8e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_bcc1df24-7927-4de9-9afe-36aadd1124dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_bcc1df24-7927-4de9-9afe-36aadd1124dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_dd3f1e39-7379-4b25-b038-417ec8b1fb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_dd3f1e39-7379-4b25-b038-417ec8b1fb6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_57e273c1-353b-4d12-a9c2-fc43c0553892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_57e273c1-353b-4d12-a9c2-fc43c0553892" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_57e273c1-353b-4d12-a9c2-fc43c0553892" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fe2b63f8-2f5f-4434-a22d-462e910f8d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fe2b63f8-2f5f-4434-a22d-462e910f8d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_889a40e3-869c-43ed-885f-a4e70b88ce45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fe2b63f8-2f5f-4434-a22d-462e910f8d6c" xlink:to="loc_us-gaap_SubsequentEventMember_889a40e3-869c-43ed-885f-a4e70b88ce45" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i6dafc67bc1784cf48033614655ba1b0b_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_209ba12c-55a5-4148-900f-f39444e05fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_209ba12c-55a5-4148-900f-f39444e05fba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c6481977-16cc-4664-a9e2-6a85821078c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c6481977-16cc-4664-a9e2-6a85821078c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_8d5f9cdc-26d4-41d1-a359-9df3a93b6277" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_8d5f9cdc-26d4-41d1-a359-9df3a93b6277" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b8918dce-88bb-4eac-82a1-6ea7d470ae6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b8918dce-88bb-4eac-82a1-6ea7d470ae6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6fc9a251-626e-4149-9da2-85fe985d6786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_Goodwill_6fc9a251-626e-4149-9da2-85fe985d6786" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_b8f7b48e-a778-4ade-8181-cb483d73615c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_b8f7b48e-a778-4ade-8181-cb483d73615c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_e52de30d-5355-45e5-89f0-de65f1fd9b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_e52de30d-5355-45e5-89f0-de65f1fd9b45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_70c49a53-aaf7-4f16-9e49-81e55b5c7c76" xlink:href="vtrs-20220331.xsd#vtrs_GoodwillImpairmentMeasurementInputTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_70c49a53-aaf7-4f16-9e49-81e55b5c7c76" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInput_45904693-1543-4cc0-889b-957ba3179d36" xlink:href="vtrs-20220331.xsd#vtrs_GoodwillImpairmentMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInput_45904693-1543-4cc0-889b-957ba3179d36" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification_f80318ca-bc58-46f2-afb0-b8fec15929d5" xlink:href="vtrs-20220331.xsd#vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification_f80318ca-bc58-46f2-afb0-b8fec15929d5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_6f746ccf-ab23-425c-a9b7-da24edc33956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_ReportingUnitAxis_6f746ccf-ab23-425c-a9b7-da24edc33956" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6f746ccf-ab23-425c-a9b7-da24edc33956_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_6f746ccf-ab23-425c-a9b7-da24edc33956" xlink:to="loc_us-gaap_ReportingUnitDomain_6f746ccf-ab23-425c-a9b7-da24edc33956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_6f746ccf-ab23-425c-a9b7-da24edc33956" xlink:to="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_df91975d-5648-4a42-a0ae-ce7f68a57f29" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_RestofWorldSegmentMember_df91975d-5648-4a42-a0ae-ce7f68a57f29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_d74560c6-7786-4a53-b612-f323c1c99451" xlink:href="vtrs-20220331.xsd#vtrs_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_EuropeSegmentMember_d74560c6-7786-4a53-b612-f323c1c99451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaBrandsMember_064fbb61-65fe-4043-87b7-819621e2bd17" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_NorthAmericaBrandsMember_064fbb61-65fe-4043-87b7-819621e2bd17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember_c0fc8b8d-597f-4e70-beea-c90060c69e10" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_NorthAmericaGenericsMember_c0fc8b8d-597f-4e70-beea-c90060c69e10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_srt_ConsolidationItemsAxis_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08" xlink:to="loc_srt_ConsolidationItemsDomain_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f1eefe89-d356-4858-8152-f193223baba3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08" xlink:to="loc_srt_ConsolidationItemsDomain_f1eefe89-d356-4858-8152-f193223baba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_f5a78c2e-6be2-487c-a3bb-b96a7cc99070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f1eefe89-d356-4858-8152-f193223baba3" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_f5a78c2e-6be2-487c-a3bb-b96a7cc99070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5e001d93-6b83-4c42-a78e-93c82fc5b6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5e001d93-6b83-4c42-a78e-93c82fc5b6a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9d0c9801-c78e-4f39-af2e-56b2247a3f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5e001d93-6b83-4c42-a78e-93c82fc5b6a3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9d0c9801-c78e-4f39-af2e-56b2247a3f3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_srt_RangeAxis_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28" xlink:to="loc_srt_RangeMember_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28" xlink:to="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9a312572-c7e3-4c4e-94bd-f03cf5f2f572" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:to="loc_srt_MinimumMember_9a312572-c7e3-4c4e-94bd-f03cf5f2f572" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a45eee2d-0df6-499d-9f3c-0bc9a8ba6b51" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:to="loc_srt_MaximumMember_a45eee2d-0df6-499d-9f3c-0bc9a8ba6b51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_142d96e0-a737-419f-b5e9-446f74abb00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_142d96e0-a737-419f-b5e9-446f74abb00e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_142d96e0-a737-419f-b5e9-446f74abb00e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_142d96e0-a737-419f-b5e9-446f74abb00e" xlink:to="loc_us-gaap_SegmentDomain_142d96e0-a737-419f-b5e9-446f74abb00e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_142d96e0-a737-419f-b5e9-446f74abb00e" xlink:to="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember_9174da0e-856f-47fa-a0a6-52896751b796" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_NorthAmericaGenericsMember_9174da0e-856f-47fa-a0a6-52896751b796" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaBrandsMember_e3950b6b-fdd4-417d-b6bd-c9b75a14bd69" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_NorthAmericaBrandsMember_e3950b6b-fdd4-417d-b6bd-c9b75a14bd69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_9294d01e-d297-4b6c-8662-c9f2753d8054" xlink:href="vtrs-20220331.xsd#vtrs_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_EuropeSegmentMember_9294d01e-d297-4b6c-8662-c9f2753d8054" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_702c4d93-942c-4c96-8dc2-5f17eba1804d" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_RestofWorldSegmentMember_702c4d93-942c-4c96-8dc2-5f17eba1804d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember_670e012d-ae8c-4796-b329-d09be52dcbae" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_NorthAmericaSegmentMember_670e012d-ae8c-4796-b329-d09be52dcbae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_80337de9-786b-4096-9360-6190027915bc" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_80337de9-786b-4096-9360-6190027915bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_b24b55fd-7c32-4585-ab3d-d120b837f294" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_b24b55fd-7c32-4585-ab3d-d120b837f294" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_c5290a6e-6d96-48fd-afbd-8bea07620118" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_GreaterChinaSegmentMember_c5290a6e-6d96-48fd-afbd-8bea07620118" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_197b79f9-0d32-413f-bc66-b9b1ce3b9ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_ValuationTechniqueAxis_197b79f9-0d32-413f-bc66-b9b1ce3b9ced" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_197b79f9-0d32-413f-bc66-b9b1ce3b9ced_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_197b79f9-0d32-413f-bc66-b9b1ce3b9ced" xlink:to="loc_us-gaap_ValuationTechniqueDomain_197b79f9-0d32-413f-bc66-b9b1ce3b9ced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_e3d1e30b-3f84-4683-a789-c912787f20ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_197b79f9-0d32-413f-bc66-b9b1ce3b9ced" xlink:to="loc_us-gaap_ValuationTechniqueDomain_e3d1e30b-3f84-4683-a789-c912787f20ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_bc25a10e-0b1a-4bf6-a038-5b75c2ffb1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_e3d1e30b-3f84-4683-a789-c912787f20ef" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_bc25a10e-0b1a-4bf6-a038-5b75c2ffb1d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_c2c42ceb-1720-4edb-a9d8-45f01c073b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_c2c42ceb-1720-4edb-a9d8-45f01c073b5c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c2c42ceb-1720-4edb-a9d8-45f01c073b5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_c2c42ceb-1720-4edb-a9d8-45f01c073b5c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c2c42ceb-1720-4edb-a9d8-45f01c073b5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_c2c42ceb-1720-4edb-a9d8-45f01c073b5c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7e617175-4d31-46b1-aba3-af50edae978b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7e617175-4d31-46b1-aba3-af50edae978b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_c67b358e-e5f7-44e9-b0f8-d6d59ee0aac1" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_c67b358e-e5f7-44e9-b0f8-d6d59ee0aac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputEstimatedTaxRateMember_4454b6e3-6d04-41c3-9aec-2573a564b69a" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputEstimatedTaxRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputEstimatedTaxRateMember_4454b6e3-6d04-41c3-9aec-2573a564b69a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputEbitdaMultipleMember_d8e6ed21-0bd8-4943-8f8d-2f5b35642591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputEbitdaMultipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputEbitdaMultipleMember_d8e6ed21-0bd8-4943-8f8d-2f5b35642591" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputControlPremiumMember_7c7cd7cc-2e31-4183-b5ee-553954b7ba28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputControlPremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputControlPremiumMember_7c7cd7cc-2e31-4183-b5ee-553954b7ba28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_e77f0825-4930-4990-a91f-5848e6b0e7f6" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_e77f0825-4930-4990-a91f-5848e6b0e7f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_0a99be00-d57f-44a3-bec0-3d25e7e7e63d" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputIncreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_0a99be00-d57f-44a3-bec0-3d25e7e7e63d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_6e5c8c94-385d-445b-bd7d-dc68ba4ac860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_6e5c8c94-385d-445b-bd7d-dc68ba4ac860" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="i28648b37136b4f45b030359932718d94_GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c71f7402-524e-41e9-aea3-11a05e72f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_c71f7402-524e-41e9-aea3-11a05e72f9c8" xlink:to="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_10828f91-1ae7-4bff-beaf-d0d130328971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillGross_10828f91-1ae7-4bff-beaf-d0d130328971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_83325cb9-b7a4-47e4-bf1c-6417266ef92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_83325cb9-b7a4-47e4-bf1c-6417266ef92e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7bc5786e-b862-43fe-b8e1-1716f7bbc067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7bc5786e-b862-43fe-b8e1-1716f7bbc067" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d248cc2e-4876-41ee-aadd-5a6ddf779ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_Goodwill_d248cc2e-4876-41ee-aadd-5a6ddf779ecf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3e5f59e6-0dbb-4b4e-8818-e5d8eaa1036e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_29b69b90-f547-44d5-a432-53efb0ded0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4c0ee23d-fa17-42cc-a87e-215ab8ada46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_98d2e6b6-d700-4f98-b3b0-adc0d0c5e101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillTransfers_98d2e6b6-d700-4f98-b3b0-adc0d0c5e101" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_342ff002-3534-4fc7-aac0-4a494307580b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_c71f7402-524e-41e9-aea3-11a05e72f9c8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_342ff002-3534-4fc7-aac0-4a494307580b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e2bf0c35-6bfc-44b9-a1b7-a5202b327895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_342ff002-3534-4fc7-aac0-4a494307580b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e2bf0c35-6bfc-44b9-a1b7-a5202b327895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e2bf0c35-6bfc-44b9-a1b7-a5202b327895_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2bf0c35-6bfc-44b9-a1b7-a5202b327895" xlink:to="loc_us-gaap_SegmentDomain_e2bf0c35-6bfc-44b9-a1b7-a5202b327895_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2bf0c35-6bfc-44b9-a1b7-a5202b327895" xlink:to="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_e753612b-ceab-4802-a2e7-48a85f91dca4" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_e753612b-ceab-4802-a2e7-48a85f91dca4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_bc97b981-ed89-4af7-80c4-e8a65eda3fec" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_GreaterChinaSegmentMember_bc97b981-ed89-4af7-80c4-e8a65eda3fec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_e740f477-f927-4ddd-ac48-cca2046bd70c" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_e740f477-f927-4ddd-ac48-cca2046bd70c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_10e3ab6a-af93-491b-a99a-978167f9c499" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_10e3ab6a-af93-491b-a99a-978167f9c499" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended" id="i3b7df02a3816462ca96ce9cf9483daea_GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:href="vtrs-20220331.xsd#vtrs_IntangibleAssetsbyMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6b4791a1-62ad-4e84-ba76-dfcc73759e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6b4791a1-62ad-4e84-ba76-dfcc73759e3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_682d15b5-d77b-4164-b11b-2d896440e036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_682d15b5-d77b-4164-b11b-2d896440e036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0651d0f9-ba27-47d2-8c9f-9aecdfe6341d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0651d0f9-ba27-47d2-8c9f-9aecdfe6341d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_614c936d-f95c-4284-90e9-fc54782eae0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_614c936d-f95c-4284-90e9-fc54782eae0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94bdcfe7-45c9-4373-a2e6-efac5d6d73e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94bdcfe7-45c9-4373-a2e6-efac5d6d73e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3418395e-300f-4dcd-8f7b-9934256043bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3418395e-300f-4dcd-8f7b-9934256043bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d9781b2d-1f06-4a89-be07-972b4f1c9c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d9781b2d-1f06-4a89-be07-972b4f1c9c33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e767e678-a1a5-4765-97c8-249df1d8c4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e767e678-a1a5-4765-97c8-249df1d8c4df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_0f4c120e-9e78-4309-bdb0-88e760027080" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_0f4c120e-9e78-4309-bdb0-88e760027080" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f7538f8-e1ea-4136-9dca-987485fe7c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_0f4c120e-9e78-4309-bdb0-88e760027080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f7538f8-e1ea-4136-9dca-987485fe7c23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f7538f8-e1ea-4136-9dca-987485fe7c23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f7538f8-e1ea-4136-9dca-987485fe7c23" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f7538f8-e1ea-4136-9dca-987485fe7c23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aab95ab0-e44d-45c3-a780-632415700f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f7538f8-e1ea-4136-9dca-987485fe7c23" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aab95ab0-e44d-45c3-a780-632415700f30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_ebe7ee12-716e-4611-95ac-77a2fb8b11b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aab95ab0-e44d-45c3-a780-632415700f30" xlink:to="loc_us-gaap_PatentsMember_ebe7ee12-716e-4611-95ac-77a2fb8b11b9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementTables"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="extended" id="i4bb5b32ea2364948a81d682be0f3c093_FinancialInstrumentsandRiskManagementTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8c55cda2-860d-472a-9a80-08651bad12a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8c55cda2-860d-472a-9a80-08651bad12a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f4fd5511-c607-4b22-94f4-c51b3d921cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f4fd5511-c607-4b22-94f4-c51b3d921cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_b81091d6-2c2b-4e7d-aa50-6adff742f833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_b81091d6-2c2b-4e7d-aa50-6adff742f833" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_271b4d29-d3aa-4ed7-a53e-659bbc2ff487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_271b4d29-d3aa-4ed7-a53e-659bbc2ff487" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7940fb7c-9c51-40e6-bd99-7558b9d3aec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:to="loc_us-gaap_HedgingDesignationAxis_7940fb7c-9c51-40e6-bd99-7558b9d3aec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7940fb7c-9c51-40e6-bd99-7558b9d3aec6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7940fb7c-9c51-40e6-bd99-7558b9d3aec6" xlink:to="loc_us-gaap_HedgingDesignationDomain_7940fb7c-9c51-40e6-bd99-7558b9d3aec6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7940fb7c-9c51-40e6-bd99-7558b9d3aec6" xlink:to="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d22f285-85b4-46c8-bfaf-9c691f4bcc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d22f285-85b4-46c8-bfaf-9c691f4bcc3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ac5b51b1-573f-40de-87b0-bac98396d4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:to="loc_us-gaap_NondesignatedMember_ac5b51b1-573f-40de-87b0-bac98396d4e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49d09f95-7ee3-45b9-95c1-1f29798ec2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49d09f95-7ee3-45b9-95c1-1f29798ec2c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_49d09f95-7ee3-45b9-95c1-1f29798ec2c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49d09f95-7ee3-45b9-95c1-1f29798ec2c8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_49d09f95-7ee3-45b9-95c1-1f29798ec2c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49d09f95-7ee3-45b9-95c1-1f29798ec2c8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_2e6da396-2edc-4d5c-8392-401eefe5593b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:to="loc_us-gaap_FairValueHedgingMember_2e6da396-2edc-4d5c-8392-401eefe5593b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_26411812-2023-4d36-96ff-aef81fe759da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:to="loc_us-gaap_CashFlowHedgingMember_26411812-2023-4d36-96ff-aef81fe759da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c3206869-68b1-47c2-900e-23143d90b6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c3206869-68b1-47c2-900e-23143d90b6c9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="extended" id="i89f7b5376828477894ebc94c4640b208_FinancialInstrumentsandRiskManagementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_6d42449b-32bf-4608-bf2d-3a776fb81a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_6d42449b-32bf-4608-bf2d-3a776fb81a9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65ab7d9b-78dc-4e27-90c2-205dcc285687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65ab7d9b-78dc-4e27-90c2-205dcc285687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_31c1921e-5b6f-4471-a46d-c3d693ae826b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_31c1921e-5b6f-4471-a46d-c3d693ae826b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dd225753-30c1-4c9b-8fb0-d3c1bccf51a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_LongTermDebt_dd225753-30c1-4c9b-8fb0-d3c1bccf51a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a60b66b4-53db-4560-b02b-39b3a89a4997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a60b66b4-53db-4560-b02b-39b3a89a4997" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_11d9be2e-8b3b-4883-8391-80c9ddef0bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_11d9be2e-8b3b-4883-8391-80c9ddef0bfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_286852a3-d7ab-49ab-856f-878152b0064f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_11d9be2e-8b3b-4883-8391-80c9ddef0bfc" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_286852a3-d7ab-49ab-856f-878152b0064f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2e2b6e1a-d667-47d1-8486-c93a5c38e57c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2e2b6e1a-d667-47d1-8486-c93a5c38e57c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2e2b6e1a-d667-47d1-8486-c93a5c38e57c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2e2b6e1a-d667-47d1-8486-c93a5c38e57c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2e2b6e1a-d667-47d1-8486-c93a5c38e57c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2e2b6e1a-d667-47d1-8486-c93a5c38e57c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d5c22495-d12a-4f59-b3a4-57e159287758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d5c22495-d12a-4f59-b3a4-57e159287758" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fec85f24-324c-4dbd-b982-59ff7e9ef72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:to="loc_us-gaap_InterestRateSwapMember_fec85f24-324c-4dbd-b982-59ff7e9ef72e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_25e2c246-bc07-45b4-8318-a2e7ccb552a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_25e2c246-bc07-45b4-8318-a2e7ccb552a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_a2faa629-66bd-475c-b5c7-b47013622c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_25e2c246-bc07-45b4-8318-a2e7ccb552a3" xlink:to="loc_us-gaap_OtherExpenseMember_a2faa629-66bd-475c-b5c7-b47013622c24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7fe46988-67dd-483d-8b63-a0b3f6b918f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_DebtInstrumentAxis_7fe46988-67dd-483d-8b63-a0b3f6b918f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7fe46988-67dd-483d-8b63-a0b3f6b918f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7fe46988-67dd-483d-8b63-a0b3f6b918f4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7fe46988-67dd-483d-8b63-a0b3f6b918f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7fe46988-67dd-483d-8b63-a0b3f6b918f4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_50350493-2fc8-40b9-8971-6af3911bd58f" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_50350493-2fc8-40b9-8971-6af3911bd58f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_fbed62b1-8774-4a82-9fca-3def80c4e3dc" xlink:href="vtrs-20220331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_fbed62b1-8774-4a82-9fca-3def80c4e3dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_c9212e31-00d3-47bc-821d-a0e8c83673ae" xlink:href="vtrs-20220331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_c9212e31-00d3-47bc-821d-a0e8c83673ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_aa430441-de5b-4de5-8746-c4d626c1ceaf" xlink:href="vtrs-20220331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_aa430441-de5b-4de5-8746-c4d626c1ceaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_262d0936-c96f-4c96-9bf6-d76fb646380f" xlink:href="vtrs-20220331.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_262d0936-c96f-4c96-9bf6-d76fb646380f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_4849522f-7f90-4960-b726-68819bcf6ac3" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_4849522f-7f90-4960-b726-68819bcf6ac3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_339197e3-e5aa-4568-815a-b380597513a5" xlink:href="vtrs-20220331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_339197e3-e5aa-4568-815a-b380597513a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_b5e0cfbf-2be2-4f36-ab46-3c6f2c0d8837" xlink:href="vtrs-20220331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_b5e0cfbf-2be2-4f36-ab46-3c6f2c0d8837" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_e7cf9c4e-e5ca-4edb-8ab6-9759592f0bbd" xlink:href="vtrs-20220331.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_e7cf9c4e-e5ca-4edb-8ab6-9759592f0bbd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_a58b1eb1-7a55-4f65-b745-ca289f9dd208" xlink:href="vtrs-20220331.xsd#vtrs_YENTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_YENTermLoanMember_a58b1eb1-7a55-4f65-b745-ca289f9dd208" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5360fc7f-d286-4828-b80b-38e5e3467eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5360fc7f-d286-4828-b80b-38e5e3467eed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5360fc7f-d286-4828-b80b-38e5e3467eed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5360fc7f-d286-4828-b80b-38e5e3467eed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5360fc7f-d286-4828-b80b-38e5e3467eed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5360fc7f-d286-4828-b80b-38e5e3467eed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_2582d3a8-b9d1-41c2-ac4c-fe622d3b0227" xlink:href="vtrs-20220331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:to="loc_vtrs_ContingentConsiderationMember_2582d3a8-b9d1-41c2-ac4c-fe622d3b0227" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_68bd01b7-f87b-4b38-be2b-e771d75f9784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_68bd01b7-f87b-4b38-be2b-e771d75f9784" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_620576d9-cec8-490d-8ed4-24a9f3241cba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_srt_RangeAxis_620576d9-cec8-490d-8ed4-24a9f3241cba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_620576d9-cec8-490d-8ed4-24a9f3241cba_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_620576d9-cec8-490d-8ed4-24a9f3241cba" xlink:to="loc_srt_RangeMember_620576d9-cec8-490d-8ed4-24a9f3241cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_620576d9-cec8-490d-8ed4-24a9f3241cba" xlink:to="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c4974efd-94bd-46af-958d-deae15a7d063" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:to="loc_srt_MinimumMember_c4974efd-94bd-46af-958d-deae15a7d063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7a443f93-ae7a-4e93-94b4-5afb1e3024bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:to="loc_srt_MaximumMember_7a443f93-ae7a-4e93-94b4-5afb1e3024bf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="extended" id="i393779553e804809aa9f5f28fac3b6b6_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2d05284f-fe0b-4bcb-bcd4-bfe94689914a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2d05284f-fe0b-4bcb-bcd4-bfe94689914a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_99791e36-c146-41f5-b89a-cc50865b5cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_99791e36-c146-41f5-b89a-cc50865b5cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e1c29d0e-5301-4174-ad56-8fca3223af79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e1c29d0e-5301-4174-ad56-8fca3223af79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d210abfe-8735-4993-972d-ac7760a50146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:to="loc_us-gaap_HedgingDesignationAxis_d210abfe-8735-4993-972d-ac7760a50146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d210abfe-8735-4993-972d-ac7760a50146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d210abfe-8735-4993-972d-ac7760a50146" xlink:to="loc_us-gaap_HedgingDesignationDomain_d210abfe-8735-4993-972d-ac7760a50146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d210abfe-8735-4993-972d-ac7760a50146" xlink:to="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1dd81b9a-3c2c-4698-8b33-1d8250ce6a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1dd81b9a-3c2c-4698-8b33-1d8250ce6a48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_86f19fc7-e603-495b-a007-d4bbf5a689fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:to="loc_us-gaap_NondesignatedMember_86f19fc7-e603-495b-a007-d4bbf5a689fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_60ccf5fa-4292-4114-9437-ffc170f4bba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_60ccf5fa-4292-4114-9437-ffc170f4bba3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_60ccf5fa-4292-4114-9437-ffc170f4bba3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_60ccf5fa-4292-4114-9437-ffc170f4bba3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_60ccf5fa-4292-4114-9437-ffc170f4bba3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_60ccf5fa-4292-4114-9437-ffc170f4bba3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_23b0e7b5-f546-46d7-8566-e678e4d38e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_23b0e7b5-f546-46d7-8566-e678e4d38e3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_596a638d-5c3c-42ca-b490-9578571abf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_596a638d-5c3c-42ca-b490-9578571abf3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_67c581c8-e032-4b93-b3c3-9f0302c7c108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_67c581c8-e032-4b93-b3c3-9f0302c7c108" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_67c581c8-e032-4b93-b3c3-9f0302c7c108_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_67c581c8-e032-4b93-b3c3-9f0302c7c108" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_67c581c8-e032-4b93-b3c3-9f0302c7c108_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_67c581c8-e032-4b93-b3c3-9f0302c7c108" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e16faf3a-cf95-4ff2-b80c-ea173d38521b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:to="loc_us-gaap_InterestRateSwapMember_e16faf3a-cf95-4ff2-b80c-ea173d38521b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f890a383-d934-4d7c-9695-a201d193d0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f890a383-d934-4d7c-9695-a201d193d0e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5934ca48-ede6-47f5-86d0-0ac166301a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5934ca48-ede6-47f5-86d0-0ac166301a93" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="extended" id="i30ebfdb352f7407b930b567241a9c0e8_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d4cce358-0e94-499d-9844-fc1cab3df7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d4cce358-0e94-499d-9844-fc1cab3df7eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1a94fc66-5428-4031-af87-f0d675eccb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1a94fc66-5428-4031-af87-f0d675eccb98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0f340875-4b17-4f9f-b5d9-80050aa51545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:to="loc_us-gaap_HedgingDesignationAxis_0f340875-4b17-4f9f-b5d9-80050aa51545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0f340875-4b17-4f9f-b5d9-80050aa51545_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0f340875-4b17-4f9f-b5d9-80050aa51545" xlink:to="loc_us-gaap_HedgingDesignationDomain_0f340875-4b17-4f9f-b5d9-80050aa51545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0025359a-3d44-46df-827e-cfa9b271ea62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0f340875-4b17-4f9f-b5d9-80050aa51545" xlink:to="loc_us-gaap_HedgingDesignationDomain_0025359a-3d44-46df-827e-cfa9b271ea62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1a95c91f-553b-4e25-8840-67bc2675129f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0025359a-3d44-46df-827e-cfa9b271ea62" xlink:to="loc_us-gaap_NondesignatedMember_1a95c91f-553b-4e25-8840-67bc2675129f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_148a189a-a56e-4e73-977d-a615d16229c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_148a189a-a56e-4e73-977d-a615d16229c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_148a189a-a56e-4e73-977d-a615d16229c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_148a189a-a56e-4e73-977d-a615d16229c9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_148a189a-a56e-4e73-977d-a615d16229c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_148a189a-a56e-4e73-977d-a615d16229c9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a3ff5ade-9f90-4f28-bc3c-0cae3cd7793a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a3ff5ade-9f90-4f28-bc3c-0cae3cd7793a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_76d8fe56-0ad3-4ecd-a665-c9187131d7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_76d8fe56-0ad3-4ecd-a665-c9187131d7ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_547e47bf-67ac-4881-867b-118ce5f50dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_547e47bf-67ac-4881-867b-118ce5f50dd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_547e47bf-67ac-4881-867b-118ce5f50dd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_547e47bf-67ac-4881-867b-118ce5f50dd0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_547e47bf-67ac-4881-867b-118ce5f50dd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cd929680-193e-4cc5-b8a8-42e5070aa99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_547e47bf-67ac-4881-867b-118ce5f50dd0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cd929680-193e-4cc5-b8a8-42e5070aa99c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b5391c50-c149-4519-859b-b2c8b196bbed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cd929680-193e-4cc5-b8a8-42e5070aa99c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b5391c50-c149-4519-859b-b2c8b196bbed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="extended" id="i758419e598ee476f996593d0338e1972_FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_45b2835b-5263-4395-a146-449a2dab0d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_45b2835b-5263-4395-a146-449a2dab0d8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_872f78fe-7dae-4593-a736-f465774b24ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_872f78fe-7dae-4593-a736-f465774b24ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_34962b0e-5593-46fe-a73b-2c57529c9afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_34962b0e-5593-46fe-a73b-2c57529c9afb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_34962b0e-5593-46fe-a73b-2c57529c9afb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_34962b0e-5593-46fe-a73b-2c57529c9afb" xlink:to="loc_us-gaap_HedgingRelationshipDomain_34962b0e-5593-46fe-a73b-2c57529c9afb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cc26c737-042d-414b-b83b-d712f83ff9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_34962b0e-5593-46fe-a73b-2c57529c9afb" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cc26c737-042d-414b-b83b-d712f83ff9ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d5bef8c8-2120-4fe5-afaf-6110186d4e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cc26c737-042d-414b-b83b-d712f83ff9ed" xlink:to="loc_us-gaap_FairValueHedgingMember_d5bef8c8-2120-4fe5-afaf-6110186d4e80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e8e2d8db-2f83-4076-a36a-68e88b3f649d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e8e2d8db-2f83-4076-a36a-68e88b3f649d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ba15b36e-2b3e-421e-b3f5-622484ddd9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e8e2d8db-2f83-4076-a36a-68e88b3f649d" xlink:to="loc_us-gaap_InterestExpenseMember_ba15b36e-2b3e-421e-b3f5-622484ddd9cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_976ef58c-21e5-4152-abbc-f5c9342f82d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_976ef58c-21e5-4152-abbc-f5c9342f82d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_976ef58c-21e5-4152-abbc-f5c9342f82d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_976ef58c-21e5-4152-abbc-f5c9342f82d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_976ef58c-21e5-4152-abbc-f5c9342f82d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_976ef58c-21e5-4152-abbc-f5c9342f82d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_edaea5c5-11dd-4633-8b35-c7f8b5730ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:to="loc_us-gaap_InterestRateSwapMember_edaea5c5-11dd-4633-8b35-c7f8b5730ab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_aeb8b5d2-f906-4dc7-98eb-b541c45a9926" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_aeb8b5d2-f906-4dc7-98eb-b541c45a9926" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails" xlink:type="extended" id="idc7001d2ee1e48f9814af846999910fe_FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_64f33cc1-dfba-40ab-afb7-2528fe15e149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_7f7eaa1f-0827-49f0-9566-1e76d4519c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_64f33cc1-dfba-40ab-afb7-2528fe15e149" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_7f7eaa1f-0827-49f0-9566-1e76d4519c4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_64f33cc1-dfba-40ab-afb7-2528fe15e149" xlink:to="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fef68d5-f5fc-4e09-8d1d-cfd179665e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fef68d5-f5fc-4e09-8d1d-cfd179665e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2fef68d5-f5fc-4e09-8d1d-cfd179665e44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fef68d5-f5fc-4e09-8d1d-cfd179665e44" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2fef68d5-f5fc-4e09-8d1d-cfd179665e44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_198e1665-3de4-4fe1-8052-21b726cc70d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fef68d5-f5fc-4e09-8d1d-cfd179665e44" xlink:to="loc_us-gaap_HedgingRelationshipDomain_198e1665-3de4-4fe1-8052-21b726cc70d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_30a258c8-069e-431e-8774-d5e0811fe752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_198e1665-3de4-4fe1-8052-21b726cc70d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_30a258c8-069e-431e-8774-d5e0811fe752" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cee36fb1-a272-4c93-b742-dfb261790e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cee36fb1-a272-4c93-b742-dfb261790e28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cee36fb1-a272-4c93-b742-dfb261790e28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cee36fb1-a272-4c93-b742-dfb261790e28" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cee36fb1-a272-4c93-b742-dfb261790e28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cee36fb1-a272-4c93-b742-dfb261790e28" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_102fe1bf-be6f-4578-881b-7435fb716f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:to="loc_us-gaap_ForeignExchangeContractMember_102fe1bf-be6f-4578-881b-7435fb716f93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6aa3c0e3-ba72-466c-825b-b085eb9f7d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:to="loc_us-gaap_InterestRateSwapMember_6aa3c0e3-ba72-466c-825b-b085eb9f7d10" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails" xlink:type="extended" id="i5b4fde13f9784913a2ef94ede4e783b5_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5a381130-a512-4d27-a2bb-da31df93898f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_4cde35da-cf31-40ef-8a9a-5cf3434883ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5a381130-a512-4d27-a2bb-da31df93898f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_4cde35da-cf31-40ef-8a9a-5cf3434883ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5a381130-a512-4d27-a2bb-da31df93898f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fb1a647d-08e1-4a06-950f-380a98c0066b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fb1a647d-08e1-4a06-950f-380a98c0066b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb1a647d-08e1-4a06-950f-380a98c0066b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fb1a647d-08e1-4a06-950f-380a98c0066b" xlink:to="loc_us-gaap_EquityComponentDomain_fb1a647d-08e1-4a06-950f-380a98c0066b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3a69ef6a-5f93-46a4-a38b-fccf2181b478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fb1a647d-08e1-4a06-950f-380a98c0066b" xlink:to="loc_us-gaap_EquityComponentDomain_3a69ef6a-5f93-46a4-a38b-fccf2181b478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2be0ea44-a536-42ca-9138-6b663057ad17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3a69ef6a-5f93-46a4-a38b-fccf2181b478" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2be0ea44-a536-42ca-9138-6b663057ad17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b4af5da-6a4a-4486-9a18-195316634333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b4af5da-6a4a-4486-9a18-195316634333" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6b4af5da-6a4a-4486-9a18-195316634333_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b4af5da-6a4a-4486-9a18-195316634333" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6b4af5da-6a4a-4486-9a18-195316634333_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_18953019-bd17-4ee0-9a2a-8ea1f1ce74bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b4af5da-6a4a-4486-9a18-195316634333" xlink:to="loc_us-gaap_HedgingRelationshipDomain_18953019-bd17-4ee0-9a2a-8ea1f1ce74bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_10868d52-9cb9-4b9d-bcb4-fcf28ce88c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_18953019-bd17-4ee0-9a2a-8ea1f1ce74bb" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_10868d52-9cb9-4b9d-bcb4-fcf28ce88c14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5beae9-100b-4659-bc1e-19fff036635b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5beae9-100b-4659-bc1e-19fff036635b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c5beae9-100b-4659-bc1e-19fff036635b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5beae9-100b-4659-bc1e-19fff036635b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c5beae9-100b-4659-bc1e-19fff036635b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a2c50ea2-aba3-4f71-b399-8cedf57ed11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5beae9-100b-4659-bc1e-19fff036635b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a2c50ea2-aba3-4f71-b399-8cedf57ed11c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_48787ce0-f3ab-44fc-90c7-632d46d2923f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a2c50ea2-aba3-4f71-b399-8cedf57ed11c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_48787ce0-f3ab-44fc-90c7-632d46d2923f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended" id="id9ca19b3bc2146a8b7ea117b45372dd5_FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5b9bf5ec-5ec7-47fe-8a05-cf603637dbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5b9bf5ec-5ec7-47fe-8a05-cf603637dbc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_2083e7ca-66e5-4193-bc81-3d5e783e0a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_2083e7ca-66e5-4193-bc81-3d5e783e0a8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0df7277c-6eca-4df8-91b1-6560b923d91f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0df7277c-6eca-4df8-91b1-6560b923d91f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_a0c92e9d-6b92-4959-9c11-2885c6adc7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_a0c92e9d-6b92-4959-9c11-2885c6adc7d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_3299d71a-e890-4f20-9e80-50892fa61645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_3299d71a-e890-4f20-9e80-50892fa61645" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7b5ea8ba-c3e9-4c13-981a-fc999759e9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7b5ea8ba-c3e9-4c13-981a-fc999759e9bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6628f35a-5bfb-461f-b6cf-bb260e95a00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6628f35a-5bfb-461f-b6cf-bb260e95a00b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_93abbf16-54d8-472b-b2df-d42ea9118cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_93abbf16-54d8-472b-b2df-d42ea9118cb8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ffbd8bb-8d84-4a61-bb81-528e04cbba31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ffbd8bb-8d84-4a61-bb81-528e04cbba31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3ffbd8bb-8d84-4a61-bb81-528e04cbba31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ffbd8bb-8d84-4a61-bb81-528e04cbba31" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3ffbd8bb-8d84-4a61-bb81-528e04cbba31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ffbd8bb-8d84-4a61-bb81-528e04cbba31" xlink:to="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1ae9296b-484e-4127-b028-9dda4b721a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:to="loc_us-gaap_CashFlowHedgingMember_1ae9296b-484e-4127-b028-9dda4b721a53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9d35f4ba-74f6-4684-8705-7b5a471dbdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9d35f4ba-74f6-4684-8705-7b5a471dbdb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c39fd706-e900-4c01-92cd-39f648bb7284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c39fd706-e900-4c01-92cd-39f648bb7284" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c39fd706-e900-4c01-92cd-39f648bb7284_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c39fd706-e900-4c01-92cd-39f648bb7284" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c39fd706-e900-4c01-92cd-39f648bb7284_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c39fd706-e900-4c01-92cd-39f648bb7284" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b3af5bb5-8720-4202-a965-6749437cfada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b3af5bb5-8720-4202-a965-6749437cfada" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9e263310-66c5-4096-bbf3-3b0e6cacd79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:to="loc_us-gaap_InterestRateSwapMember_9e263310-66c5-4096-bbf3-3b0e6cacd79b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ece1ea20-31bc-4308-b74a-71c809d8d008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ece1ea20-31bc-4308-b74a-71c809d8d008" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ece1ea20-31bc-4308-b74a-71c809d8d008_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ece1ea20-31bc-4308-b74a-71c809d8d008" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ece1ea20-31bc-4308-b74a-71c809d8d008_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ece1ea20-31bc-4308-b74a-71c809d8d008" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_461fa7cb-defc-4501-ba2b-5f50e1e64a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:to="loc_us-gaap_SalesMember_461fa7cb-defc-4501-ba2b-5f50e1e64a53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_b8ba5d4c-2ed4-453b-a74e-1396938d2b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:to="loc_us-gaap_InterestExpenseMember_b8ba5d4c-2ed4-453b-a74e-1396938d2b8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_36eb5a16-118a-473a-9b49-3ee08a650716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:to="loc_us-gaap_OtherExpenseMember_36eb5a16-118a-473a-9b49-3ee08a650716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_167eba2d-3196-4df8-88e2-ca1bcb7266a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_ValuationTechniqueAxis_167eba2d-3196-4df8-88e2-ca1bcb7266a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_167eba2d-3196-4df8-88e2-ca1bcb7266a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_167eba2d-3196-4df8-88e2-ca1bcb7266a6" xlink:to="loc_us-gaap_ValuationTechniqueDomain_167eba2d-3196-4df8-88e2-ca1bcb7266a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_ee4da984-c600-4efd-bdf1-8e36323e5502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_167eba2d-3196-4df8-88e2-ca1bcb7266a6" xlink:to="loc_us-gaap_ValuationTechniqueDomain_ee4da984-c600-4efd-bdf1-8e36323e5502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_720690c2-5b1b-42ea-be8f-df42dc3a2b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_720690c2-5b1b-42ea-be8f-df42dc3a2b9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_720690c2-5b1b-42ea-be8f-df42dc3a2b9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_720690c2-5b1b-42ea-be8f-df42dc3a2b9a" xlink:to="loc_us-gaap_EquityComponentDomain_720690c2-5b1b-42ea-be8f-df42dc3a2b9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5810cb09-62a1-47f3-9663-f2912e13f7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_720690c2-5b1b-42ea-be8f-df42dc3a2b9a" xlink:to="loc_us-gaap_EquityComponentDomain_5810cb09-62a1-47f3-9663-f2912e13f7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e9026e76-2f82-43d2-985e-efa9105b01f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5810cb09-62a1-47f3-9663-f2912e13f7e6" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e9026e76-2f82-43d2-985e-efa9105b01f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="icf7a7e278f15437ea2f5c8c97fc2a7da_FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e3f385a-4a94-4fe3-8239-a02b57bfaea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_116bb504-cc03-4f8c-a862-8d055dd66b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e3f385a-4a94-4fe3-8239-a02b57bfaea9" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_116bb504-cc03-4f8c-a862-8d055dd66b9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e3f385a-4a94-4fe3-8239-a02b57bfaea9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7988068c-aa66-4ef9-a95d-48b9f521e04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7988068c-aa66-4ef9-a95d-48b9f521e04d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7988068c-aa66-4ef9-a95d-48b9f521e04d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7988068c-aa66-4ef9-a95d-48b9f521e04d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7988068c-aa66-4ef9-a95d-48b9f521e04d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ccce201d-ef0e-44ac-992d-551b791b8835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7988068c-aa66-4ef9-a95d-48b9f521e04d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ccce201d-ef0e-44ac-992d-551b791b8835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b0d45c1d-9899-42cd-9dd4-898d4a158f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ccce201d-ef0e-44ac-992d-551b791b8835" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b0d45c1d-9899-42cd-9dd4-898d4a158f67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f8fad1b3-3703-4297-9bf0-4b9623a0d827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f8fad1b3-3703-4297-9bf0-4b9623a0d827" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f8fad1b3-3703-4297-9bf0-4b9623a0d827_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f8fad1b3-3703-4297-9bf0-4b9623a0d827" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f8fad1b3-3703-4297-9bf0-4b9623a0d827_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_11f3cf27-1e94-427b-a944-5901bb796057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f8fad1b3-3703-4297-9bf0-4b9623a0d827" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_11f3cf27-1e94-427b-a944-5901bb796057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_080c8f06-34b1-4cf9-b7a6-a24404971904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_11f3cf27-1e94-427b-a944-5901bb796057" xlink:to="loc_us-gaap_OtherExpenseMember_080c8f06-34b1-4cf9-b7a6-a24404971904" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended" id="i665c9ff1a8e940328f303b7bd7cc8af4_FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cebf1eb6-b42e-44e4-8eaa-6caf3c7897ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cebf1eb6-b42e-44e4-8eaa-6caf3c7897ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_0f52180e-9102-4e59-8c62-f529304f73cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_TradingSecurities_0f52180e-9102-4e59-8c62-f529304f73cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d4b1b19-21af-43b3-a2fc-ba4de0536752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d4b1b19-21af-43b3-a2fc-ba4de0536752" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e60f3c9e-c8a4-4c86-ae0f-f882be5a91a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e60f3c9e-c8a4-4c86-ae0f-f882be5a91a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e996ad7a-2b5a-472d-a5b6-6099a26a3848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_DerivativeAssets_e996ad7a-2b5a-472d-a5b6-6099a26a3848" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_450d0192-af06-4172-b394-487378575574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_450d0192-af06-4172-b394-487378575574" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_37a6403d-f92b-498a-922e-faf7b8426d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_37a6403d-f92b-498a-922e-faf7b8426d31" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_24055013-b72f-4fa4-a625-31a4b5953d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_24055013-b72f-4fa4-a625-31a4b5953d6d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_7f3b972b-65ec-4228-810d-c3fa9f10539b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_7f3b972b-65ec-4228-810d-c3fa9f10539b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_eea11353-14cc-4ebe-bdab-5be98c26556d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_eea11353-14cc-4ebe-bdab-5be98c26556d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b90a1f6d-77dd-4484-817d-7648e3d62595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b90a1f6d-77dd-4484-817d-7648e3d62595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b90a1f6d-77dd-4484-817d-7648e3d62595_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b90a1f6d-77dd-4484-817d-7648e3d62595" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b90a1f6d-77dd-4484-817d-7648e3d62595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18b6e182-14b4-40ee-a70d-5627d4335015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b90a1f6d-77dd-4484-817d-7648e3d62595" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18b6e182-14b4-40ee-a70d-5627d4335015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f033c35b-ff9d-4559-9643-d76f633611cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_18b6e182-14b4-40ee-a70d-5627d4335015" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f033c35b-ff9d-4559-9643-d76f633611cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d5d38e46-9dd2-4991-a0ef-cee4a253d261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_HedgingDesignationAxis_d5d38e46-9dd2-4991-a0ef-cee4a253d261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d5d38e46-9dd2-4991-a0ef-cee4a253d261_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5d38e46-9dd2-4991-a0ef-cee4a253d261" xlink:to="loc_us-gaap_HedgingDesignationDomain_d5d38e46-9dd2-4991-a0ef-cee4a253d261_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b46b9a55-afe0-4066-a11b-cca52e68dec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5d38e46-9dd2-4991-a0ef-cee4a253d261" xlink:to="loc_us-gaap_HedgingDesignationDomain_b46b9a55-afe0-4066-a11b-cca52e68dec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a97db846-0d5f-4598-b20b-e18e75ef4d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b46b9a55-afe0-4066-a11b-cca52e68dec1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a97db846-0d5f-4598-b20b-e18e75ef4d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_55cb9a3b-d227-4f65-a4c8-f65d8e04392c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_55cb9a3b-d227-4f65-a4c8-f65d8e04392c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55cb9a3b-d227-4f65-a4c8-f65d8e04392c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_55cb9a3b-d227-4f65-a4c8-f65d8e04392c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55cb9a3b-d227-4f65-a4c8-f65d8e04392c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_55cb9a3b-d227-4f65-a4c8-f65d8e04392c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7408a979-81e7-4030-b03c-a265d6aa40a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7408a979-81e7-4030-b03c-a265d6aa40a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1cf85cd0-6461-4c31-9df5-11ec4bfbd4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1cf85cd0-6461-4c31-9df5-11ec4bfbd4bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9e9bf64e-1e3d-4eda-b95f-ec510380200b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9e9bf64e-1e3d-4eda-b95f-ec510380200b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_05421c79-28e5-4c0e-a476-656078be1464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_05421c79-28e5-4c0e-a476-656078be1464" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05421c79-28e5-4c0e-a476-656078be1464_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_05421c79-28e5-4c0e-a476-656078be1464" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05421c79-28e5-4c0e-a476-656078be1464_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_05421c79-28e5-4c0e-a476-656078be1464" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_cd0fda51-caff-4e16-a507-fe522ca54e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_MoneyMarketFundsMember_cd0fda51-caff-4e16-a507-fe522ca54e2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_aa8bd4c7-967d-4d20-83d4-c14c8a4b1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_aa8bd4c7-967d-4d20-83d4-c14c8a4b1e22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_9a893ed8-4187-4973-9ca5-4e242f1b0cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_9a893ed8-4187-4973-9ca5-4e242f1b0cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_c26b8d6c-77d7-432f-9fac-d4eb643c49fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_c26b8d6c-77d7-432f-9fac-d4eb643c49fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_a9ece3a7-2f78-455b-8a19-eddf4f6e3183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_a9ece3a7-2f78-455b-8a19-eddf4f6e3183" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_33951f1b-c329-4305-9b89-f632397f8b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_33951f1b-c329-4305-9b89-f632397f8b3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_e0839c09-c6d8-4065-b27b-5c51aed04cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_e0839c09-c6d8-4065-b27b-5c51aed04cfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9b736ba7-e59b-465d-8bd3-758b85e2e1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_CommonStockMember_9b736ba7-e59b-465d-8bd3-758b85e2e1f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e4da8708-685d-43da-9d44-09a579e8fb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_InterestRateSwapMember_e4da8708-685d-43da-9d44-09a579e8fb89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_75fef593-5197-4f5c-a9fd-383f42ebf5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_75fef593-5197-4f5c-a9fd-383f42ebf5a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_75fef593-5197-4f5c-a9fd-383f42ebf5a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_75fef593-5197-4f5c-a9fd-383f42ebf5a2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_75fef593-5197-4f5c-a9fd-383f42ebf5a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_75fef593-5197-4f5c-a9fd-383f42ebf5a2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7e76afa0-cfdc-4f7e-af06-41f4feea9ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7e76afa0-cfdc-4f7e-af06-41f4feea9ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2aef646d-45ea-4d9e-b44b-a73069d896a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:to="loc_us-gaap_InterestRateSwapMember_2aef646d-45ea-4d9e-b44b-a73069d896a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_9dfe119e-7400-48e9-9ebc-676e332155e2" xlink:href="vtrs-20220331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:to="loc_vtrs_ContingentConsiderationMember_9dfe119e-7400-48e9-9ebc-676e332155e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6d5a044b-f01d-4a11-b386-2c1605406bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6d5a044b-f01d-4a11-b386-2c1605406bc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6d5a044b-f01d-4a11-b386-2c1605406bc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d5a044b-f01d-4a11-b386-2c1605406bc7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6d5a044b-f01d-4a11-b386-2c1605406bc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d5a044b-f01d-4a11-b386-2c1605406bc7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6291af7f-23fa-4866-a3bb-0d129df21bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:to="loc_us-gaap_InterestRateSwapMember_6291af7f-23fa-4866-a3bb-0d129df21bc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7a3d777d-1780-425b-9d92-232a848ab6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7a3d777d-1780-425b-9d92-232a848ab6f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="extended" id="ibf09a923a36c4e17b49ef21e32fa6ffd_FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a8afc38-aca1-444e-a229-d43eb5d1cb37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a8afc38-aca1-444e-a229-d43eb5d1cb37" xlink:to="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_85307196-836f-4f0c-aca5-03f5ae93039a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_85307196-836f-4f0c-aca5-03f5ae93039a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_e7ce3409-ee4f-4034-b65a-b3d518381b2a" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_e7ce3409-ee4f-4034-b65a-b3d518381b2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_6ddd6274-77f2-4649-b8d0-75e033d241a0" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_6ddd6274-77f2-4649-b8d0-75e033d241a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_46e288e5-bb76-4c4e-8a9a-f3a6b94069c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_us-gaap_AccretionExpense_46e288e5-bb76-4c4e-8a9a-f3a6b94069c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_020c0294-6d1b-4495-979e-1e94b587aeed" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_020c0294-6d1b-4495-979e-1e94b587aeed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cd590968-780c-4f5f-8309-e6d7af47f537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_93e90bb4-42a1-4766-bf99-5f509b98271a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a8afc38-aca1-444e-a229-d43eb5d1cb37" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_93e90bb4-42a1-4766-bf99-5f509b98271a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_af5834eb-0a10-4836-84c5-3bdc5c441964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_93e90bb4-42a1-4766-bf99-5f509b98271a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_af5834eb-0a10-4836-84c5-3bdc5c441964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_af5834eb-0a10-4836-84c5-3bdc5c441964_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_af5834eb-0a10-4836-84c5-3bdc5c441964" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_af5834eb-0a10-4836-84c5-3bdc5c441964_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_af5834eb-0a10-4836-84c5-3bdc5c441964" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e6560cc5-8919-4c20-b4a2-5689d1c7e0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e6560cc5-8919-4c20-b4a2-5689d1c7e0ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab7a3269-4170-4364-9737-44274bd906b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab7a3269-4170-4364-9737-44274bd906b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="extended" id="i1d1b4d434c994cdab378cf584adcb7b1_DebtReceivablesSecuritizationFacilityandCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_f4412363-9d0a-4ee5-8d75-61ea779c72be" xlink:href="vtrs-20220331.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_f4412363-9d0a-4ee5-8d75-61ea779c72be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4b3881e8-6a4a-4409-8296-162cc8e7944f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4b3881e8-6a4a-4409-8296-162cc8e7944f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a55db9f-60f8-4901-894f-aa69cf455441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a55db9f-60f8-4901-894f-aa69cf455441" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_be055afd-78fc-4f01-90bc-d2b671dcf328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_us-gaap_ShortTermBorrowings_be055afd-78fc-4f01-90bc-d2b671dcf328" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75649326-825b-4d5c-8e4b-09b09270d696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_DebtInstrumentAxis_75649326-825b-4d5c-8e4b-09b09270d696" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75649326-825b-4d5c-8e4b-09b09270d696_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_75649326-825b-4d5c-8e4b-09b09270d696" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75649326-825b-4d5c-8e4b-09b09270d696_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_75649326-825b-4d5c-8e4b-09b09270d696" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_96dcc8ad-0dcf-4686-b774-2d0f256c7c4b" xlink:href="vtrs-20220331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_96dcc8ad-0dcf-4686-b774-2d0f256c7c4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0fe837a5-c304-4d51-95ea-ae83e76bf3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:to="loc_us-gaap_CommercialPaperMember_0fe837a5-c304-4d51-95ea-ae83e76bf3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_9b535735-7bd9-49e7-a05f-129af99b71d3" xlink:href="vtrs-20220331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:to="loc_vtrs_ReceivablesFacilityMember_9b535735-7bd9-49e7-a05f-129af99b71d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d40252c0-aad5-4220-887e-289c95e5f933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_VariableRateAxis_d40252c0-aad5-4220-887e-289c95e5f933" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d40252c0-aad5-4220-887e-289c95e5f933_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d40252c0-aad5-4220-887e-289c95e5f933" xlink:to="loc_us-gaap_VariableRateDomain_d40252c0-aad5-4220-887e-289c95e5f933_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0ba1e32b-6458-42d3-932d-ff2cdc877a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d40252c0-aad5-4220-887e-289c95e5f933" xlink:to="loc_us-gaap_VariableRateDomain_0ba1e32b-6458-42d3-932d-ff2cdc877a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_00680ab1-e3c0-4683-a225-c22650aec0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_0ba1e32b-6458-42d3-932d-ff2cdc877a57" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_00680ab1-e3c0-4683-a225-c22650aec0d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44fb6b9b-ac60-4d29-9fdc-221dfad258b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_srt_RangeAxis_44fb6b9b-ac60-4d29-9fdc-221dfad258b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44fb6b9b-ac60-4d29-9fdc-221dfad258b2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_44fb6b9b-ac60-4d29-9fdc-221dfad258b2" xlink:to="loc_srt_RangeMember_44fb6b9b-ac60-4d29-9fdc-221dfad258b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_44fb6b9b-ac60-4d29-9fdc-221dfad258b2" xlink:to="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3afe6104-dc02-429b-ba2a-cbea84e126b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:to="loc_srt_MinimumMember_3afe6104-dc02-429b-ba2a-cbea84e126b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e7bff1a0-cdbd-48b5-8ade-f12c0e82e1cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:to="loc_srt_MaximumMember_e7bff1a0-cdbd-48b5-8ade-f12c0e82e1cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_d43794a7-4505-416a-acb1-03ef7f49c5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_d43794a7-4505-416a-acb1-03ef7f49c5d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d43794a7-4505-416a-acb1-03ef7f49c5d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d43794a7-4505-416a-acb1-03ef7f49c5d9" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d43794a7-4505-416a-acb1-03ef7f49c5d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d43794a7-4505-416a-acb1-03ef7f49c5d9" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_26609683-9a22-49bf-a3ea-e93f20126e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:to="loc_us-gaap_CommercialPaperMember_26609683-9a22-49bf-a3ea-e93f20126e09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_c3d331cd-82c9-4202-86b9-dcb292d5208d" xlink:href="vtrs-20220331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:to="loc_vtrs_ReceivablesFacilityMember_c3d331cd-82c9-4202-86b9-dcb292d5208d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_3b1eac18-b7aa-4378-bcb8-9a03589d936d" xlink:href="vtrs-20220331.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_3b1eac18-b7aa-4378-bcb8-9a03589d936d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_00f7476a-8ce8-4a57-a88b-fabf344bf078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_00f7476a-8ce8-4a57-a88b-fabf344bf078" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_00f7476a-8ce8-4a57-a88b-fabf344bf078_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_00f7476a-8ce8-4a57-a88b-fabf344bf078" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_00f7476a-8ce8-4a57-a88b-fabf344bf078_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d8480614-83dd-4036-bc5c-b9d53d24122f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_00f7476a-8ce8-4a57-a88b-fabf344bf078" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d8480614-83dd-4036-bc5c-b9d53d24122f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ee8b6e16-c304-4235-a7ec-06ef63ffe271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d8480614-83dd-4036-bc5c-b9d53d24122f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ee8b6e16-c304-4235-a7ec-06ef63ffe271" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtSummaryofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="extended" id="idd25b8002f164bfd9edbe0dd4d02e437_DebtSummaryofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_84ac10e0-715c-4893-9bfb-0b7faeeae93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_84ac10e0-715c-4893-9bfb-0b7faeeae93d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d493080b-6343-42fd-b6f7-4446e50e9327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_DebtCurrent_d493080b-6343-42fd-b6f7-4446e50e9327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9eaeb8a-a609-40cf-8ce5-6d236f206b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_LongTermDebt_b9eaeb8a-a609-40cf-8ce5-6d236f206b76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_c6d8d0f4-557e-4a96-bdce-2586b9e66331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_c6d8d0f4-557e-4a96-bdce-2586b9e66331" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0f309e9c-e61d-4f68-aa3b-45248c6eeb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0f309e9c-e61d-4f68-aa3b-45248c6eeb50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable_2545a672-db54-4cb9-86f6-d07e6f694996" xlink:href="vtrs-20220331.xsd#vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable_2545a672-db54-4cb9-86f6-d07e6f694996" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f57be9c0-04bf-46ef-86e3-015124d5dcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f57be9c0-04bf-46ef-86e3-015124d5dcd1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_a49d4d65-8550-4c07-a61c-f4fa0c113e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_a49d4d65-8550-4c07-a61c-f4fa0c113e09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_d562c7f3-72c1-4dac-9581-7f278acf1104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_d562c7f3-72c1-4dac-9581-7f278acf1104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d562c7f3-72c1-4dac-9581-7f278acf1104_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d562c7f3-72c1-4dac-9581-7f278acf1104" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d562c7f3-72c1-4dac-9581-7f278acf1104_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1dc95c60-4086-43f3-ab0d-4ed13f2adef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d562c7f3-72c1-4dac-9581-7f278acf1104" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1dc95c60-4086-43f3-ab0d-4ed13f2adef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c1d89dd0-ff18-49eb-b4a7-7316c3f328a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1dc95c60-4086-43f3-ab0d-4ed13f2adef8" xlink:to="loc_us-gaap_SeniorNotesMember_c1d89dd0-ff18-49eb-b4a7-7316c3f328a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ed9c2b2-f95a-43ff-a565-8387b0187c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ed9c2b2-f95a-43ff-a565-8387b0187c7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ed9c2b2-f95a-43ff-a565-8387b0187c7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ed9c2b2-f95a-43ff-a565-8387b0187c7b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ed9c2b2-f95a-43ff-a565-8387b0187c7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ed9c2b2-f95a-43ff-a565-8387b0187c7b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5601cb96-39ad-4062-8c61-29d6346ccc6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:to="loc_us-gaap_SeniorNotesMember_5601cb96-39ad-4062-8c61-29d6346ccc6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_37babb0e-2eec-4715-81f4-3269928d3b28" xlink:href="vtrs-20220331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:to="loc_vtrs_OtherLongTermDebtMember_37babb0e-2eec-4715-81f4-3269928d3b28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember_079d1f38-df87-44de-aac3-be9403519d66" xlink:href="vtrs-20220331.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:to="loc_vtrs_CurrentPortionofLongTermDebtMember_079d1f38-df87-44de-aac3-be9403519d66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1cdad835-759f-49c5-a23f-00844892a492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:to="loc_us-gaap_DebtInstrumentAxis_1cdad835-759f-49c5-a23f-00844892a492" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1cdad835-759f-49c5-a23f-00844892a492_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1cdad835-759f-49c5-a23f-00844892a492" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1cdad835-759f-49c5-a23f-00844892a492_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1cdad835-759f-49c5-a23f-00844892a492" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_fc016d98-2e4b-44c5-91c0-2982893740c5" xlink:href="vtrs-20220331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_fc016d98-2e4b-44c5-91c0-2982893740c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a6065ad8-04b0-4bf7-bd1f-12b1674931da" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a6065ad8-04b0-4bf7-bd1f-12b1674931da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_1d20fd1b-f7f4-4125-9804-fd475dda3429" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_1d20fd1b-f7f4-4125-9804-fd475dda3429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_3f73a716-e003-494d-8b1d-c0fe5f1479bb" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_3f73a716-e003-494d-8b1d-c0fe5f1479bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember_507923c4-d043-4548-8ace-b6eae12a68d9" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteenMember_507923c4-d043-4548-8ace-b6eae12a68d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_a3178ec3-fdcc-4c9e-b322-4e5e19e9c1dc" xlink:href="vtrs-20220331.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_a3178ec3-fdcc-4c9e-b322-4e5e19e9c1dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_b3f81235-9419-4d51-a3e6-43927d014f98" xlink:href="vtrs-20220331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_b3f81235-9419-4d51-a3e6-43927d014f98" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_40896a4b-9cd2-4852-b88b-b3585107ad92" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_40896a4b-9cd2-4852-b88b-b3585107ad92" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_5de61bb2-e1be-4db9-81d4-a58598c0f0ee" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_5de61bb2-e1be-4db9-81d4-a58598c0f0ee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_00903098-9cb6-4b6d-b558-c5be97b2ea26" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_00903098-9cb6-4b6d-b558-c5be97b2ea26" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_86e8b90f-89d5-448a-a80d-a9615c66f790" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_86e8b90f-89d5-448a-a80d-a9615c66f790" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_22110405-2fc6-4889-b8a5-a7c9373019fb" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_22110405-2fc6-4889-b8a5-a7c9373019fb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_133b2378-f69f-40c4-804b-b0e8b041ceb4" xlink:href="vtrs-20220331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_133b2378-f69f-40c4-804b-b0e8b041ceb4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_8ced343d-ff40-48a3-bc47-5e9301bb47eb" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_8ced343d-ff40-48a3-bc47-5e9301bb47eb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_92d7988b-6afa-4d64-a769-dc7b411df97c" xlink:href="vtrs-20220331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_92d7988b-6afa-4d64-a769-dc7b411df97c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_8015d0c9-7d33-45f8-a2e3-045e355093c9" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_8015d0c9-7d33-45f8-a2e3-045e355093c9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_fbec4848-d30b-4635-b79a-c0ff00b0ef2d" xlink:href="vtrs-20220331.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2028SeniorNotesMember_fbec4848-d30b-4635-b79a-c0ff00b0ef2d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_a9e0d762-990f-4c97-a2be-ec3895423b20" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_a9e0d762-990f-4c97-a2be-ec3895423b20" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_be685bbd-1416-42af-9cd5-1491d5f78eba" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_be685bbd-1416-42af-9cd5-1491d5f78eba" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_84f41c73-9ed3-47cb-8509-001e518cd25b" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_84f41c73-9ed3-47cb-8509-001e518cd25b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_14a840d6-2bbf-45b1-bccc-97115aa13bb9" xlink:href="vtrs-20220331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_OtherLongTermDebtMember_14a840d6-2bbf-45b1-bccc-97115aa13bb9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_2b55217f-0f2b-416d-bb87-4bc2adc4eb6e" xlink:href="vtrs-20220331.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2048SeniorNotesMember_2b55217f-0f2b-416d-bb87-4bc2adc4eb6e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2021Member_929ae468-c752-457d-af25-88eae22b7bfb" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotes2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotes2021Member_929ae468-c752-457d-af25-88eae22b7bfb" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_b3bceeaf-a9df-4afd-a0ec-eaf3ac9e0dda" xlink:href="vtrs-20220331.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_b3bceeaf-a9df-4afd-a0ec-eaf3ac9e0dda" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2022Member_22f45ad8-ff51-4773-a24a-1fbfe1e2b29f" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotes2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotes2022Member_22f45ad8-ff51-4773-a24a-1fbfe1e2b29f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_eb0d6e45-9f5d-45cf-83f1-fca642d7b94c" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_eb0d6e45-9f5d-45cf-83f1-fca642d7b94c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_fc93d65b-6d65-4cfd-ae32-a9f585a291fd" xlink:href="vtrs-20220331.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2025SeniorNotesMember_fc93d65b-6d65-4cfd-ae32-a9f585a291fd" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_bcd22ac2-7300-4fe1-aae6-ae424dbf23fc" xlink:href="vtrs-20220331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_bcd22ac2-7300-4fe1-aae6-ae424dbf23fc" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_2d28fc8d-39fe-4087-80ee-fad5deffec97" xlink:href="vtrs-20220331.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2027SeniorNotesMember_2d28fc8d-39fe-4087-80ee-fad5deffec97" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_433f8307-c5cd-4d72-adc2-d011b8537946" xlink:href="vtrs-20220331.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2030SeniorNotesMember_433f8307-c5cd-4d72-adc2-d011b8537946" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_307aa8e0-c1b4-4e72-9ec2-e2994c05035c" xlink:href="vtrs-20220331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_307aa8e0-c1b4-4e72-9ec2-e2994c05035c" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_81cfc5e1-cfc9-4ea5-8e2e-dc2603f9f536" xlink:href="vtrs-20220331.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2040SeniorNotesMember_81cfc5e1-cfc9-4ea5-8e2e-dc2603f9f536" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_9eedca2d-4eba-4b81-ab09-67ad9d94ba86" xlink:href="vtrs-20220331.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2050SeniorNotesMember_9eedca2d-4eba-4b81-ab09-67ad9d94ba86" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TermLoanMember_26d097b5-dae4-462a-bddc-fe1716506409" xlink:href="vtrs-20220331.xsd#vtrs_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_TermLoanMember_26d097b5-dae4-462a-bddc-fe1716506409" xlink:type="arc" order="33"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" xlink:type="extended" id="iab3cf738ecdf462482d340ff83979e84_Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_136946c6-c73f-4c76-894d-17007dee0258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_136946c6-c73f-4c76-894d-17007dee0258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_aec35874-3347-46bc-90c7-9f394c324b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_DebtCurrent_aec35874-3347-46bc-90c7-9f394c324b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9120dd9b-23d3-47e7-875c-0ec88510b9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9120dd9b-23d3-47e7-875c-0ec88510b9ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCovenantTerms_89b86475-66a5-49e5-99a7-32404a6b3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCovenantTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_LineOfCreditFacilityCovenantTerms_89b86475-66a5-49e5-99a7-32404a6b3c39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d7606fd9-9afc-4da4-b5b3-c48f4a832290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d7606fd9-9afc-4da4-b5b3-c48f4a832290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d7606fd9-9afc-4da4-b5b3-c48f4a832290_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d7606fd9-9afc-4da4-b5b3-c48f4a832290" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d7606fd9-9afc-4da4-b5b3-c48f4a832290_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ebd540e6-8902-400c-90fc-bf62e5455f60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d7606fd9-9afc-4da4-b5b3-c48f4a832290" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ebd540e6-8902-400c-90fc-bf62e5455f60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_495438e6-3dca-4eba-9a1c-4c67ea1bd450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ebd540e6-8902-400c-90fc-bf62e5455f60" xlink:to="loc_us-gaap_LineOfCreditMember_495438e6-3dca-4eba-9a1c-4c67ea1bd450" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_57b90639-0bd1-4be8-a35b-70f73792eced" xlink:href="vtrs-20220331.xsd#vtrs_PeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:to="loc_vtrs_PeriodAxis_57b90639-0bd1-4be8-a35b-70f73792eced" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_57b90639-0bd1-4be8-a35b-70f73792eced_default" xlink:href="vtrs-20220331.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_PeriodAxis_57b90639-0bd1-4be8-a35b-70f73792eced" xlink:to="loc_vtrs_PeriodDomain_57b90639-0bd1-4be8-a35b-70f73792eced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_fd9d3996-b366-4afe-8d99-2b427769ccea" xlink:href="vtrs-20220331.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_PeriodAxis_57b90639-0bd1-4be8-a35b-70f73792eced" xlink:to="loc_vtrs_PeriodDomain_fd9d3996-b366-4afe-8d99-2b427769ccea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TrailingFourQuartersMember_c9dad856-44ce-41aa-8dae-a4da313540b1" xlink:href="vtrs-20220331.xsd#vtrs_TrailingFourQuartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_PeriodDomain_fd9d3996-b366-4afe-8d99-2b427769ccea" xlink:to="loc_vtrs_TrailingFourQuartersMember_c9dad856-44ce-41aa-8dae-a4da313540b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_73125d51-8246-465b-b650-59ef45ec9ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:to="loc_us-gaap_DebtInstrumentAxis_73125d51-8246-465b-b650-59ef45ec9ab7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_73125d51-8246-465b-b650-59ef45ec9ab7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_73125d51-8246-465b-b650-59ef45ec9ab7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_73125d51-8246-465b-b650-59ef45ec9ab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9fdeb08a-3e70-4126-9ab8-bf1c797f918b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_73125d51-8246-465b-b650-59ef45ec9ab7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9fdeb08a-3e70-4126-9ab8-bf1c797f918b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_c599d175-b474-4d37-8bbc-65d027d0164b" xlink:href="vtrs-20220331.xsd#vtrs_A2016SeniorRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9fdeb08a-3e70-4126-9ab8-bf1c797f918b" xlink:to="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_c599d175-b474-4d37-8bbc-65d027d0164b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtFairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="extended" id="i1efa1cfe8c8a485ab1df529c55e606e4_DebtFairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2312a634-1e49-4179-a884-2776862313a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_783590f2-582a-40f1-9db6-28f98333c70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2312a634-1e49-4179-a884-2776862313a3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_783590f2-582a-40f1-9db6-28f98333c70a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3bc1882c-e476-4912-8afe-e8316d99dc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2312a634-1e49-4179-a884-2776862313a3" xlink:to="loc_us-gaap_DebtInstrumentTable_3bc1882c-e476-4912-8afe-e8316d99dc33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b1bf002d-02eb-40b0-bc22-01d3d7c36606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3bc1882c-e476-4912-8afe-e8316d99dc33" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b1bf002d-02eb-40b0-bc22-01d3d7c36606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b1bf002d-02eb-40b0-bc22-01d3d7c36606_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b1bf002d-02eb-40b0-bc22-01d3d7c36606" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b1bf002d-02eb-40b0-bc22-01d3d7c36606_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c295ab0a-2b58-4a6e-a957-7c5d948464bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b1bf002d-02eb-40b0-bc22-01d3d7c36606" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c295ab0a-2b58-4a6e-a957-7c5d948464bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d1191c9c-0235-4d65-849b-4c40ef34e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c295ab0a-2b58-4a6e-a957-7c5d948464bb" xlink:to="loc_us-gaap_SeniorNotesMember_d1191c9c-0235-4d65-849b-4c40ef34e7b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="ib91f55debcbe49fb89e28ec12952a2b4_ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1b6e9478-029c-4af8-9d20-b7dd5c14b7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1b6e9478-029c-4af8-9d20-b7dd5c14b7af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_690678fd-d15b-467e-9550-42c26413debc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_690678fd-d15b-467e-9550-42c26413debc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1a3f1b13-07c0-4122-8758-7a53aa7a3642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1a3f1b13-07c0-4122-8758-7a53aa7a3642" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_de714ddd-b746-4238-b709-bd0e2aa632af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_de714ddd-b746-4238-b709-bd0e2aa632af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_e446cfa8-23d2-4843-b1fc-0e2369c7a846" xlink:href="vtrs-20220331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_e446cfa8-23d2-4843-b1fc-0e2369c7a846" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_9e14b921-4d28-4236-9f52-838f78334358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_9e14b921-4d28-4236-9f52-838f78334358" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d166a9de-fcdb-4165-ba20-04e6e7e32111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d166a9de-fcdb-4165-ba20-04e6e7e32111" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_ec29d2c6-7474-45f5-a525-0b5a8dfbae87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_ec29d2c6-7474-45f5-a525-0b5a8dfbae87" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_15a7cf16-ef55-45d3-a33e-e8953769b41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_15a7cf16-ef55-45d3-a33e-e8953769b41f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_e2723303-4b71-4336-9dbd-7b61afb369aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_e2723303-4b71-4336-9dbd-7b61afb369aa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_7114f21d-7569-4c6e-8142-ddb64def460f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_7114f21d-7569-4c6e-8142-ddb64def460f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_5ecaa4ba-8903-4bc0-880b-5082a78cd040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_5ecaa4ba-8903-4bc0-880b-5082a78cd040" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_be6f781a-bc16-459e-abeb-1ec69910f853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_be6f781a-bc16-459e-abeb-1ec69910f853" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e78f5009-f219-47d4-852f-1a6427a6cb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_InterestExpense_e78f5009-f219-47d4-852f-1a6427a6cb57" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2eb395c3-d411-4a8c-a932-5f0bf83f66e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2eb395c3-d411-4a8c-a932-5f0bf83f66e6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_85fa4f53-09fb-4ff9-9842-2b784da3d270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_85fa4f53-09fb-4ff9-9842-2b784da3d270" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_621b4289-e588-45c7-85c6-9cf0ec65c416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_621b4289-e588-45c7-85c6-9cf0ec65c416" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dd68d7ef-0ee5-485d-95da-02f934833ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dd68d7ef-0ee5-485d-95da-02f934833ec5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_dd68d7ef-0ee5-485d-95da-02f934833ec5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dd68d7ef-0ee5-485d-95da-02f934833ec5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_dd68d7ef-0ee5-485d-95da-02f934833ec5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3d4b1c4b-d596-4d52-b6b8-738f3fed669d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dd68d7ef-0ee5-485d-95da-02f934833ec5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3d4b1c4b-d596-4d52-b6b8-738f3fed669d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_16e60c36-bc8d-4a84-b345-5b79d4449c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3d4b1c4b-d596-4d52-b6b8-738f3fed669d" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_16e60c36-bc8d-4a84-b345-5b79d4449c5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4a9a702c-4af6-4370-9604-53d8de5c696e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4a9a702c-4af6-4370-9604-53d8de5c696e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a9a702c-4af6-4370-9604-53d8de5c696e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4a9a702c-4af6-4370-9604-53d8de5c696e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a9a702c-4af6-4370-9604-53d8de5c696e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4a9a702c-4af6-4370-9604-53d8de5c696e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e12215c8-c4f3-4ea1-8fe3-055aca447219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e12215c8-c4f3-4ea1-8fe3-055aca447219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d156b725-b2a9-440c-bacb-1fa0d1b0a769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:to="loc_us-gaap_InterestRateSwapMember_d156b725-b2a9-440c-bacb-1fa0d1b0a769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_905415c8-5f79-4d1e-be3b-531cf6c5edab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_srt_ConsolidatedEntitiesAxis_905415c8-5f79-4d1e-be3b-531cf6c5edab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_905415c8-5f79-4d1e-be3b-531cf6c5edab_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_905415c8-5f79-4d1e-be3b-531cf6c5edab" xlink:to="loc_srt_ConsolidatedEntitiesDomain_905415c8-5f79-4d1e-be3b-531cf6c5edab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4e8ff338-154c-49d7-8ed8-7a640e806db6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_905415c8-5f79-4d1e-be3b-531cf6c5edab" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4e8ff338-154c-49d7-8ed8-7a640e806db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_1c58e2b2-b4fa-421b-afba-cdb254cc9c12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_4e8ff338-154c-49d7-8ed8-7a640e806db6" xlink:to="loc_srt_ParentCompanyMember_1c58e2b2-b4fa-421b-afba-cdb254cc9c12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f93d3494-1c5c-4977-ad80-e7af1a46cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f93d3494-1c5c-4977-ad80-e7af1a46cad6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_f93d3494-1c5c-4977-ad80-e7af1a46cad6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f93d3494-1c5c-4977-ad80-e7af1a46cad6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_f93d3494-1c5c-4977-ad80-e7af1a46cad6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c48b55c1-37d2-478b-9c4a-ed4527e0cae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f93d3494-1c5c-4977-ad80-e7af1a46cad6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c48b55c1-37d2-478b-9c4a-ed4527e0cae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_cc1d798a-fe95-42b5-b9e8-b0f5dcbc2dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c48b55c1-37d2-478b-9c4a-ed4527e0cae7" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_cc1d798a-fe95-42b5-b9e8-b0f5dcbc2dca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cc544d3-2d5f-462f-bc38-e749eabf2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cc544d3-2d5f-462f-bc38-e749eabf2f7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cc544d3-2d5f-462f-bc38-e749eabf2f7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cc544d3-2d5f-462f-bc38-e749eabf2f7d" xlink:to="loc_us-gaap_EquityComponentDomain_9cc544d3-2d5f-462f-bc38-e749eabf2f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cc544d3-2d5f-462f-bc38-e749eabf2f7d" xlink:to="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bf53a561-cc75-4b2e-90c0-2a2dc982fc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bf53a561-cc75-4b2e-90c0-2a2dc982fc72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_45d9bb76-30f5-43d8-97e9-cf670ea5b85b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_45d9bb76-30f5-43d8-97e9-cf670ea5b85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_32e0f89f-5e87-45d8-9094-639d3c059b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_32e0f89f-5e87-45d8-9094-639d3c059b0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_30842786-1584-45f1-997e-2d30c2c0079d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_30842786-1584-45f1-997e-2d30c2c0079d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6617dc0c-74d4-4bdd-963b-87dd320759f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6617dc0c-74d4-4bdd-963b-87dd320759f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a43007b1-7499-4dc7-ba47-0c66aa079090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a43007b1-7499-4dc7-ba47-0c66aa079090" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a43007b1-7499-4dc7-ba47-0c66aa079090_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a43007b1-7499-4dc7-ba47-0c66aa079090" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a43007b1-7499-4dc7-ba47-0c66aa079090_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a43007b1-7499-4dc7-ba47-0c66aa079090" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_036caaef-7611-4167-8503-d1fb176a54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:to="loc_us-gaap_CashFlowHedgingMember_036caaef-7611-4167-8503-d1fb176a54a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a0f7c104-fe96-4533-a91a-98c398924ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a0f7c104-fe96-4533-a91a-98c398924ac7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="extended" id="ib0da9412ee9642899b8dc464a3f7840b_ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_668b0703-046b-41f1-860e-9e1f278a3665" xlink:href="vtrs-20220331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_668b0703-046b-41f1-860e-9e1f278a3665" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_7a289458-a359-483b-ac6b-2b0a809e4b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_7a289458-a359-483b-ac6b-2b0a809e4b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ef8b0b6f-16fc-4d7f-b649-a72c7426c975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ef8b0b6f-16fc-4d7f-b649-a72c7426c975" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c5429a52-442f-4bdf-bd8a-838a1693da31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c5429a52-442f-4bdf-bd8a-838a1693da31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3666b1f7-bcb0-4f28-b91d-4afdf58d87bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3666b1f7-bcb0-4f28-b91d-4afdf58d87bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_10800ddd-be0b-443a-b9d0-54af8eba4f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_10800ddd-be0b-443a-b9d0-54af8eba4f47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_0aaa7114-3cf4-4e7b-8ce5-9b13392ed4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_0aaa7114-3cf4-4e7b-8ce5-9b13392ed4ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d60bbe93-e36c-46cd-9e5a-5f7eb5835178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d60bbe93-e36c-46cd-9e5a-5f7eb5835178" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a5a6b9fe-7123-4189-ba6d-ef8f03e040e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_InterestExpense_a5a6b9fe-7123-4189-ba6d-ef8f03e040e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_4b10a909-c63d-4f9f-8aa3-03496f633ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_4b10a909-c63d-4f9f-8aa3-03496f633ee5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_04102e84-ab69-4c40-99d8-59011f2ca367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_04102e84-ab69-4c40-99d8-59011f2ca367" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_032f938a-a9bc-4f19-8729-65ea7fbb23b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_032f938a-a9bc-4f19-8729-65ea7fbb23b6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_34e96fc4-6ab5-42f3-88f6-9628b419abcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_34e96fc4-6ab5-42f3-88f6-9628b419abcb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_e734135d-d8ff-4058-addc-0c9975356afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_e734135d-d8ff-4058-addc-0c9975356afa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_3563030d-27fb-4ea2-9903-9db4091a2dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_3563030d-27fb-4ea2-9903-9db4091a2dd5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_188dff58-e222-4c5e-80ce-b80f6fadf963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_188dff58-e222-4c5e-80ce-b80f6fadf963" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_839fca35-e7a8-4c88-a1cf-d129524f0390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_839fca35-e7a8-4c88-a1cf-d129524f0390" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c3a8c43e-bbd7-40ca-98d0-75b311979b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c3a8c43e-bbd7-40ca-98d0-75b311979b6e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_095ece77-39dc-4db0-b374-5f1743ae2b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e24ae32d-6c3f-49d1-9b9d-c061748c52d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e2b4e376-8fbd-4b8f-b903-7a9f245509c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_bcc42e01-0799-48f1-b8ab-617c20a6d22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_97d464d6-e9e8-4a69-82ef-a48e1b8d7acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_d16cee81-2d71-43ad-9c02-1c08e1bba0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_d16cee81-2d71-43ad-9c02-1c08e1bba0ba" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_30b46b6b-6b11-4f5d-9c62-f471cb40891c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_30b46b6b-6b11-4f5d-9c62-f471cb40891c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_30b46b6b-6b11-4f5d-9c62-f471cb40891c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_30b46b6b-6b11-4f5d-9c62-f471cb40891c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_30b46b6b-6b11-4f5d-9c62-f471cb40891c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0633d80c-5999-400d-a111-f4c23255f2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_30b46b6b-6b11-4f5d-9c62-f471cb40891c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0633d80c-5999-400d-a111-f4c23255f2d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_01dbfdbf-02ba-49e7-8c38-9351697c1154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0633d80c-5999-400d-a111-f4c23255f2d6" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_01dbfdbf-02ba-49e7-8c38-9351697c1154" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4e401240-0686-498d-b6f5-d392659442ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4e401240-0686-498d-b6f5-d392659442ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4e401240-0686-498d-b6f5-d392659442ee_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4e401240-0686-498d-b6f5-d392659442ee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4e401240-0686-498d-b6f5-d392659442ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_19539f15-1652-4e27-a398-d105cf65877a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4e401240-0686-498d-b6f5-d392659442ee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_19539f15-1652-4e27-a398-d105cf65877a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_a7a8b03c-ed94-4d98-9340-a82bcff7dbf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_19539f15-1652-4e27-a398-d105cf65877a" xlink:to="loc_srt_ParentCompanyMember_a7a8b03c-ed94-4d98-9340-a82bcff7dbf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c5bc7b56-590f-44c6-b712-5c1ad48ffc26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c5bc7b56-590f-44c6-b712-5c1ad48ffc26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c5bc7b56-590f-44c6-b712-5c1ad48ffc26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c5bc7b56-590f-44c6-b712-5c1ad48ffc26" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c5bc7b56-590f-44c6-b712-5c1ad48ffc26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c5bc7b56-590f-44c6-b712-5c1ad48ffc26" xlink:to="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7f59dbee-2c14-40e8-b9b2-b1ae759f069e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:to="loc_us-gaap_CashFlowHedgingMember_7f59dbee-2c14-40e8-b9b2-b1ae759f069e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d979928e-4a8f-4248-8937-41262889c3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d979928e-4a8f-4248-8937-41262889c3f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_45a0746f-5b5a-4c06-bb0d-462dd039f6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_45a0746f-5b5a-4c06-bb0d-462dd039f6fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_45a0746f-5b5a-4c06-bb0d-462dd039f6fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_45a0746f-5b5a-4c06-bb0d-462dd039f6fb" xlink:to="loc_us-gaap_EquityComponentDomain_45a0746f-5b5a-4c06-bb0d-462dd039f6fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_45a0746f-5b5a-4c06-bb0d-462dd039f6fb" xlink:to="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_22c31e72-7f9f-4a4c-97c8-affecaa2948f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_22c31e72-7f9f-4a4c-97c8-affecaa2948f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_819e58cb-be4c-4bc7-b467-698dd8bb26b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_819e58cb-be4c-4bc7-b467-698dd8bb26b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7035b02f-017c-4fc0-b691-f39bf2a047f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7035b02f-017c-4fc0-b691-f39bf2a047f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e1d37bf1-6aa8-47e6-be86-b8ac5da71aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e1d37bf1-6aa8-47e6-be86-b8ac5da71aaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52f45619-0909-4815-a428-10f1e2068667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52f45619-0909-4815-a428-10f1e2068667" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d6a43d9d-21db-41ef-b6bd-d4511a98c587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d6a43d9d-21db-41ef-b6bd-d4511a98c587" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d6a43d9d-21db-41ef-b6bd-d4511a98c587_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d6a43d9d-21db-41ef-b6bd-d4511a98c587" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d6a43d9d-21db-41ef-b6bd-d4511a98c587_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_40236701-c250-406f-923a-a7fa675f7451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d6a43d9d-21db-41ef-b6bd-d4511a98c587" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_40236701-c250-406f-923a-a7fa675f7451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_6ebab497-e79f-4881-a223-2462e69eaec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_40236701-c250-406f-923a-a7fa675f7451" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_6ebab497-e79f-4881-a223-2462e69eaec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_86deaac9-c664-4c47-b96e-5fbdde9bf695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_86deaac9-c664-4c47-b96e-5fbdde9bf695" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_86deaac9-c664-4c47-b96e-5fbdde9bf695_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_86deaac9-c664-4c47-b96e-5fbdde9bf695" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_86deaac9-c664-4c47-b96e-5fbdde9bf695_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_86deaac9-c664-4c47-b96e-5fbdde9bf695" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_77a81fb8-619c-4c34-9076-75d319bd12ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_77a81fb8-619c-4c34-9076-75d319bd12ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_22c8f035-3bdb-402b-93ef-52bab0acdd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:to="loc_us-gaap_InterestRateSwapMember_22c8f035-3bdb-402b-93ef-52bab0acdd96" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="i776df9659ee447af92871dbb4724e5db_SegmentInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_187af759-44b9-44bb-963b-1c038f6fdbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_28525541-d8f2-4d49-bbd0-402a6d0156bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_187af759-44b9-44bb-963b-1c038f6fdbb9" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_28525541-d8f2-4d49-bbd0-402a6d0156bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_187af759-44b9-44bb-963b-1c038f6fdbb9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7148a8b7-7324-4b50-879d-04426b9d9b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7148a8b7-7324-4b50-879d-04426b9d9b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7148a8b7-7324-4b50-879d-04426b9d9b7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7148a8b7-7324-4b50-879d-04426b9d9b7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7148a8b7-7324-4b50-879d-04426b9d9b7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_447dc8f9-e4ac-4596-9140-b0f46d0e2902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7148a8b7-7324-4b50-879d-04426b9d9b7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_447dc8f9-e4ac-4596-9140-b0f46d0e2902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_fc5f2541-fcfb-46b0-a41b-97a59e1ae0d6" xlink:href="vtrs-20220331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_447dc8f9-e4ac-4596-9140-b0f46d0e2902" xlink:to="loc_vtrs_ContingentConsiderationMember_fc5f2541-fcfb-46b0-a41b-97a59e1ae0d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c209261b-eee7-4c08-8a73-d8fbfdb94e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c209261b-eee7-4c08-8a73-d8fbfdb94e23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c209261b-eee7-4c08-8a73-d8fbfdb94e23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c209261b-eee7-4c08-8a73-d8fbfdb94e23" xlink:to="loc_us-gaap_SegmentDomain_c209261b-eee7-4c08-8a73-d8fbfdb94e23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c209261b-eee7-4c08-8a73-d8fbfdb94e23" xlink:to="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_197581c4-2265-48a3-92c6-d69b6846522c" xlink:href="vtrs-20220331.xsd#vtrs_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:to="loc_vtrs_EuropeSegmentMember_197581c4-2265-48a3-92c6-d69b6846522c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_f4b08cc5-da74-41f4-961d-0a9e52971817" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:to="loc_vtrs_RestofWorldSegmentMember_f4b08cc5-da74-41f4-961d-0a9e52971817" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="extended" id="i8a0f123544b14d6b9b7bcf9c47460add_SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_18a1f205-9738-4889-a32d-5652b451aae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_18a1f205-9738-4889-a32d-5652b451aae6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90716c8f-98c5-4091-a09e-da5ef7c0d1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_Revenues_90716c8f-98c5-4091-a09e-da5ef7c0d1ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7496d70d-fc71-4244-a3de-d18f7d065a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7496d70d-fc71-4244-a3de-d18f7d065a99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b0343b84-c541-4f88-b84b-711dae20fdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b0343b84-c541-4f88-b84b-711dae20fdc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f1861ede-3895-41fb-873f-8a8fb5891a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f1861ede-3895-41fb-873f-8a8fb5891a38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts_24f7863b-7ac3-4334-ba55-d5dd50036ff3" xlink:href="vtrs-20220331.xsd#vtrs_Corporatecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_vtrs_Corporatecosts_24f7863b-7ac3-4334-ba55-d5dd50036ff3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_ab2f869c-7523-4d89-a17a-d4d039e25d55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_ab2f869c-7523-4d89-a17a-d4d039e25d55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9d84f1f2-3ae4-43b1-9b55-9237935d0592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_OperatingIncomeLoss_9d84f1f2-3ae4-43b1-9b55-9237935d0592" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense_c13543ad-5cbd-47a1-ab74-14dc2fa76a87" xlink:href="vtrs-20220331.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_vtrs_OtherOneTimeNonoperatingExpense_c13543ad-5cbd-47a1-ab74-14dc2fa76a87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_08e217f8-a18f-4430-9194-8656cb7933ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:to="loc_srt_ProductOrServiceAxis_08e217f8-a18f-4430-9194-8656cb7933ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_08e217f8-a18f-4430-9194-8656cb7933ff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_08e217f8-a18f-4430-9194-8656cb7933ff" xlink:to="loc_srt_ProductsAndServicesDomain_08e217f8-a18f-4430-9194-8656cb7933ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3a0c7dfb-534c-4039-a211-df9312bdfa4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_08e217f8-a18f-4430-9194-8656cb7933ff" xlink:to="loc_srt_ProductsAndServicesDomain_3a0c7dfb-534c-4039-a211-df9312bdfa4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_d14d392a-9c84-4cfc-a2fb-9cc78dd879e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3a0c7dfb-534c-4039-a211-df9312bdfa4d" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_d14d392a-9c84-4cfc-a2fb-9cc78dd879e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_352378b8-7bb7-4cb1-89d5-0ebb80c31224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_352378b8-7bb7-4cb1-89d5-0ebb80c31224" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_352378b8-7bb7-4cb1-89d5-0ebb80c31224_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_352378b8-7bb7-4cb1-89d5-0ebb80c31224" xlink:to="loc_us-gaap_SegmentDomain_352378b8-7bb7-4cb1-89d5-0ebb80c31224_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_352378b8-7bb7-4cb1-89d5-0ebb80c31224" xlink:to="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_4558315a-60ed-4b0f-aaa9-2fdfb5dd2497" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_RestofWorldSegmentMember_4558315a-60ed-4b0f-aaa9-2fdfb5dd2497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_4ebfc797-0483-49b3-ae90-37767c411b95" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_4ebfc797-0483-49b3-ae90-37767c411b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_c0d1dfe0-ee9b-45ef-ae24-f601470a4561" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_GreaterChinaSegmentMember_c0d1dfe0-ee9b-45ef-ae24-f601470a4561" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_d1b3f31b-0c4a-4a9b-a38e-85cd11cfb296" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_d1b3f31b-0c4a-4a9b-a38e-85cd11cfb296" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_347c435c-9f53-41aa-aaa0-6699c7cfffce" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_347c435c-9f53-41aa-aaa0-6699c7cfffce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_354bf728-f3ee-4c22-9a68-b13796638ff3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:to="loc_srt_ConsolidationItemsAxis_354bf728-f3ee-4c22-9a68-b13796638ff3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_354bf728-f3ee-4c22-9a68-b13796638ff3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_354bf728-f3ee-4c22-9a68-b13796638ff3" xlink:to="loc_srt_ConsolidationItemsDomain_354bf728-f3ee-4c22-9a68-b13796638ff3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_354bf728-f3ee-4c22-9a68-b13796638ff3" xlink:to="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_67f55cf2-0a0d-405e-86a0-32f47fbd8efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:to="loc_us-gaap_OperatingSegmentsMember_67f55cf2-0a0d-405e-86a0-32f47fbd8efd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_75018b2d-855f-4d79-bd04-16fbaf2f78d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_75018b2d-855f-4d79-bd04-16fbaf2f78d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_783c19cf-23ef-4ab1-bb17-74f9833618c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:to="loc_us-gaap_CorporateNonSegmentMember_783c19cf-23ef-4ab1-bb17-74f9833618c4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RestructuringRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="extended" id="ia88f0e6494ee46c0b1f953e81d925030_RestructuringRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_24aa6dab-695d-4623-bf05-518edb1eeb52" xlink:href="vtrs-20220331.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_24aa6dab-695d-4623-bf05-518edb1eeb52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4af4d7e7-9256-43fa-bb9a-6f94e3b50fb0" xlink:href="vtrs-20220331.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4af4d7e7-9256-43fa-bb9a-6f94e3b50fb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_45c03da5-f4b7-4ce3-a282-e6fcacdaebbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_45c03da5-f4b7-4ce3-a282-e6fcacdaebbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fc483d5a-778c-4efa-957b-6c6cf718ae38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fc483d5a-778c-4efa-957b-6c6cf718ae38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_c1cc51b8-67a4-42c8-9a97-0a782fd1904d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_c1cc51b8-67a4-42c8-9a97-0a782fd1904d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_733f3422-41eb-402c-8426-82e7bb07d903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringReserve_733f3422-41eb-402c-8426-82e7bb07d903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_64143829-b7d5-4cc6-b02d-b34b0194520d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringCharges_64143829-b7d5-4cc6-b02d-b34b0194520d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_fd2d11f8-05dc-48ac-837d-e28c4d5178f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_PaymentsForRestructuring_fd2d11f8-05dc-48ac-837d-e28c4d5178f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a27d854d-b6a7-4dbe-b5ef-6d083ed297a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a27d854d-b6a7-4dbe-b5ef-6d083ed297a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_e64afca0-acc2-43f4-aa4d-17a370ec97bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_e64afca0-acc2-43f4-aa4d-17a370ec97bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_fdde4409-5122-4ea7-b20f-fdf89d838155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_703a5c65-df1b-4afb-8e13-35ba89e64205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_703a5c65-df1b-4afb-8e13-35ba89e64205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_703a5c65-df1b-4afb-8e13-35ba89e64205_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_703a5c65-df1b-4afb-8e13-35ba89e64205" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_703a5c65-df1b-4afb-8e13-35ba89e64205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_703a5c65-df1b-4afb-8e13-35ba89e64205" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_754429e5-9b86-45db-b37e-18de5fabf6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_754429e5-9b86-45db-b37e-18de5fabf6c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_6b7bd544-d13c-4aa0-8739-1fe24220f3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:to="loc_us-gaap_OtherRestructuringMember_6b7bd544-d13c-4aa0-8739-1fe24220f3fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b9e27bec-ff57-440e-b984-c92d6e56c3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b9e27bec-ff57-440e-b984-c92d6e56c3db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b9e27bec-ff57-440e-b984-c92d6e56c3db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b9e27bec-ff57-440e-b984-c92d6e56c3db" xlink:to="loc_us-gaap_SegmentDomain_b9e27bec-ff57-440e-b984-c92d6e56c3db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b9e27bec-ff57-440e-b984-c92d6e56c3db" xlink:to="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_a399370c-d5cb-435e-900c-e2eadfabbf7c" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_a399370c-d5cb-435e-900c-e2eadfabbf7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_ad15e26d-d2f2-40e3-ab88-046b7e70a115" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_GreaterChinaSegmentMember_ad15e26d-d2f2-40e3-ab88-046b7e70a115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3fbc8c49-7366-426f-8219-7dd4de49881e" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3fbc8c49-7366-426f-8219-7dd4de49881e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_00b8408f-bf3b-41a8-9fd1-cc7a4136d840" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_00b8408f-bf3b-41a8-9fd1-cc7a4136d840" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_1e54c943-b4a7-453d-8518-877a4d25f343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_us-gaap_CorporateAndOtherMember_1e54c943-b4a7-453d-8518-877a4d25f343" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b759a50f-7de4-4334-8c94-d95e8601e061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_srt_RangeAxis_b759a50f-7de4-4334-8c94-d95e8601e061" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b759a50f-7de4-4334-8c94-d95e8601e061_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b759a50f-7de4-4334-8c94-d95e8601e061" xlink:to="loc_srt_RangeMember_b759a50f-7de4-4334-8c94-d95e8601e061_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b759a50f-7de4-4334-8c94-d95e8601e061" xlink:to="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_827ffc79-7ffb-4d1f-bd41-ceaed0ea3361" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:to="loc_srt_MinimumMember_827ffc79-7ffb-4d1f-bd41-ceaed0ea3361" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_41e6966f-b38a-499b-ac6e-da2b16b4a4fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:to="loc_srt_MaximumMember_41e6966f-b38a-499b-ac6e-da2b16b4a4fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0f76278a-0ccd-45bc-b58f-b025fdcda293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_us-gaap_RestructuringPlanAxis_0f76278a-0ccd-45bc-b58f-b025fdcda293" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0f76278a-0ccd-45bc-b58f-b025fdcda293_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_0f76278a-0ccd-45bc-b58f-b025fdcda293" xlink:to="loc_us-gaap_RestructuringPlanDomain_0f76278a-0ccd-45bc-b58f-b025fdcda293_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cf3dd219-b6a2-496d-8e23-8906ea0110aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_0f76278a-0ccd-45bc-b58f-b025fdcda293" xlink:to="loc_us-gaap_RestructuringPlanDomain_cf3dd219-b6a2-496d-8e23-8906ea0110aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember_50940e48-a54c-49f3-9102-9587aa87f663" xlink:href="vtrs-20220331.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cf3dd219-b6a2-496d-8e23-8906ea0110aa" xlink:to="loc_vtrs_A2020RestructuringPlanMember_50940e48-a54c-49f3-9102-9587aa87f663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_48279b38-ca6e-4e0d-abd0-18e9243f794b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_srt_StatementScenarioAxis_48279b38-ca6e-4e0d-abd0-18e9243f794b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_48279b38-ca6e-4e0d-abd0-18e9243f794b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_48279b38-ca6e-4e0d-abd0-18e9243f794b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_48279b38-ca6e-4e0d-abd0-18e9243f794b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3bda708d-3ff4-4234-bc42-75dab3d10a5f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_48279b38-ca6e-4e0d-abd0-18e9243f794b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3bda708d-3ff4-4234-bc42-75dab3d10a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_21ee6aa6-b805-48ac-9381-32c158a65730" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3bda708d-3ff4-4234-bc42-75dab3d10a5f" xlink:to="loc_srt_ScenarioForecastMember_21ee6aa6-b805-48ac-9381-32c158a65730" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CollaborationandLicensingAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="extended" id="ib36668acb33145deb1616f3c50ad66cb_CollaborationandLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c332a810-1128-4beb-a1a9-98ede9e84f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments_821b9d3a-efc0-4438-8f37-87d131702b6d" xlink:href="vtrs-20220331.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c332a810-1128-4beb-a1a9-98ede9e84f65" xlink:to="loc_vtrs_Developmentandsalesmilestonepayments_821b9d3a-efc0-4438-8f37-87d131702b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c332a810-1128-4beb-a1a9-98ede9e84f65" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f03065fc-a3e6-4dbd-a3e7-435ee7756f31" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:to="loc_srt_RangeAxis_f03065fc-a3e6-4dbd-a3e7-435ee7756f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f03065fc-a3e6-4dbd-a3e7-435ee7756f31_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f03065fc-a3e6-4dbd-a3e7-435ee7756f31" xlink:to="loc_srt_RangeMember_f03065fc-a3e6-4dbd-a3e7-435ee7756f31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed32d906-7408-4ea6-8a22-5de15530e10b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f03065fc-a3e6-4dbd-a3e7-435ee7756f31" xlink:to="loc_srt_RangeMember_ed32d906-7408-4ea6-8a22-5de15530e10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c6e40fd1-35c8-4f7e-9476-e9ad62dc68c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ed32d906-7408-4ea6-8a22-5de15530e10b" xlink:to="loc_srt_MaximumMember_c6e40fd1-35c8-4f7e-9476-e9ad62dc68c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_feb183bf-b7bb-4057-8b16-b07596b3fc05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:to="loc_us-gaap_TypeOfArrangementAxis_feb183bf-b7bb-4057-8b16-b07596b3fc05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_feb183bf-b7bb-4057-8b16-b07596b3fc05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_feb183bf-b7bb-4057-8b16-b07596b3fc05" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_feb183bf-b7bb-4057-8b16-b07596b3fc05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f2dcc6d-60f3-4803-a609-03573a8114c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_feb183bf-b7bb-4057-8b16-b07596b3fc05" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f2dcc6d-60f3-4803-a609-03573a8114c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_f7147200-d8b2-4f59-ad4a-e2a6012ad3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f2dcc6d-60f3-4803-a609-03573a8114c3" xlink:to="loc_us-gaap_CollaborativeArrangementMember_f7147200-d8b2-4f59-ad4a-e2a6012ad3f7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#IncomeTaxesIncomeTaxesDisclosureDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="extended" id="idf452d18ba854207b5405825b8bd2375_IncomeTaxesIncomeTaxesDisclosureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount_5809048c-0036-48cd-8011-31abfa00e782" xlink:href="vtrs-20220331.xsd#vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount_5809048c-0036-48cd-8011-31abfa00e782" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_6a4e1b57-6e69-46ec-8556-3fa160a9ffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_6a4e1b57-6e69-46ec-8556-3fa160a9ffd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_9569b657-1dc2-4231-bab0-d7e03e885342" xlink:href="vtrs-20220331.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_9569b657-1dc2-4231-bab0-d7e03e885342" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_1ad9d740-4ff3-4d17-a97d-ed7a7f4c1044" xlink:href="vtrs-20220331.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_1ad9d740-4ff3-4d17-a97d-ed7a7f4c1044" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eccda2b3-8c70-42fe-9410-6ec8045238f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:to="loc_srt_StatementScenarioAxis_eccda2b3-8c70-42fe-9410-6ec8045238f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eccda2b3-8c70-42fe-9410-6ec8045238f1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_eccda2b3-8c70-42fe-9410-6ec8045238f1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eccda2b3-8c70-42fe-9410-6ec8045238f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5d5249e3-ff7d-444a-855f-ebbd71fb655b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_eccda2b3-8c70-42fe-9410-6ec8045238f1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5d5249e3-ff7d-444a-855f-ebbd71fb655b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_43204abc-ae8f-4810-9968-9dbc5b929e53" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5d5249e3-ff7d-444a-855f-ebbd71fb655b" xlink:to="loc_srt_ScenarioForecastMember_43204abc-ae8f-4810-9968-9dbc5b929e53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_68e231fc-ef7e-4568-90c1-8c64197b34df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_68e231fc-ef7e-4568-90c1-8c64197b34df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_68e231fc-ef7e-4568-90c1-8c64197b34df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_68e231fc-ef7e-4568-90c1-8c64197b34df" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_68e231fc-ef7e-4568-90c1-8c64197b34df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_97fa1c46-9393-4be9-84a5-5b87bc5e7b18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_68e231fc-ef7e-4568-90c1-8c64197b34df" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_97fa1c46-9393-4be9-84a5-5b87bc5e7b18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_22038f66-aacd-4b61-8dc9-a68d1113417d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_97fa1c46-9393-4be9-84a5-5b87bc5e7b18" xlink:to="loc_us-gaap_ForeignCountryMember_22038f66-aacd-4b61-8dc9-a68d1113417d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_c195b8e0-a411-48f8-b96b-9eaabc1b9244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_c195b8e0-a411-48f8-b96b-9eaabc1b9244" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_c195b8e0-a411-48f8-b96b-9eaabc1b9244_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_c195b8e0-a411-48f8-b96b-9eaabc1b9244" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_c195b8e0-a411-48f8-b96b-9eaabc1b9244_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe47f062-39db-47c3-a2f0-871487ae9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_c195b8e0-a411-48f8-b96b-9eaabc1b9244" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe47f062-39db-47c3-a2f0-871487ae9cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_82170bac-eff6-4c4b-8ccd-243db1c75e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe47f062-39db-47c3-a2f0-871487ae9cbc" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_82170bac-eff6-4c4b-8ccd-243db1c75e80" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationLorazepamandClorazepateNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="extended" id="i0c803b62a1234f26baece6e974c832ee_LitigationLorazepamandClorazepateNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c791240e-e4fd-4c8a-a7e2-ec6221bc6f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c791240e-e4fd-4c8a-a7e2-ec6221bc6f99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_1e9ffecf-4690-4f87-9afd-e90fee3defec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_1e9ffecf-4690-4f87-9afd-e90fee3defec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:to="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7cc6ab12-0149-4b0b-a557-b2e57f87ba01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:to="loc_srt_LitigationCaseAxis_7cc6ab12-0149-4b0b-a557-b2e57f87ba01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7cc6ab12-0149-4b0b-a557-b2e57f87ba01_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7cc6ab12-0149-4b0b-a557-b2e57f87ba01" xlink:to="loc_srt_LitigationCaseTypeDomain_7cc6ab12-0149-4b0b-a557-b2e57f87ba01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1821d693-3b6c-4255-b1a9-765a229fcfc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7cc6ab12-0149-4b0b-a557-b2e57f87ba01" xlink:to="loc_srt_LitigationCaseTypeDomain_1821d693-3b6c-4255-b1a9-765a229fcfc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9715b7fc-3a43-4589-84ab-fd18f0d9e16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9715b7fc-3a43-4589-84ab-fd18f0d9e16f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9715b7fc-3a43-4589-84ab-fd18f0d9e16f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9715b7fc-3a43-4589-84ab-fd18f0d9e16f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9715b7fc-3a43-4589-84ab-fd18f0d9e16f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d11322c7-5931-49f4-a757-0a9f789eda3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9715b7fc-3a43-4589-84ab-fd18f0d9e16f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d11322c7-5931-49f4-a757-0a9f789eda3f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationPricingandMedicaidLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="extended" id="ie22c816dd63e42b8a59657b6c57d59dc_LitigationPricingandMedicaidLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2d875fc7-8440-4f2d-b21a-bd5472ab4218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c38172d3-60af-47ad-be98-7a84fdd63501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2d875fc7-8440-4f2d-b21a-bd5472ab4218" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c38172d3-60af-47ad-be98-7a84fdd63501" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_2d875fc7-8440-4f2d-b21a-bd5472ab4218" xlink:to="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_642e8fff-2be3-4450-8e90-bf81b5f80228" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:to="loc_srt_LitigationCaseAxis_642e8fff-2be3-4450-8e90-bf81b5f80228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_642e8fff-2be3-4450-8e90-bf81b5f80228_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_642e8fff-2be3-4450-8e90-bf81b5f80228" xlink:to="loc_srt_LitigationCaseTypeDomain_642e8fff-2be3-4450-8e90-bf81b5f80228_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e45b3d5a-8a1d-4346-909d-93d26128b23c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_642e8fff-2be3-4450-8e90-bf81b5f80228" xlink:to="loc_srt_LitigationCaseTypeDomain_e45b3d5a-8a1d-4346-909d-93d26128b23c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3c996fa0-a34d-4707-9b50-4ed63b201835" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:to="loc_dei_LegalEntityAxis_3c996fa0-a34d-4707-9b50-4ed63b201835" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3c996fa0-a34d-4707-9b50-4ed63b201835_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3c996fa0-a34d-4707-9b50-4ed63b201835" xlink:to="loc_dei_EntityDomain_3c996fa0-a34d-4707-9b50-4ed63b201835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1760eebc-325c-4ed0-8f95-bf9754ef649a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3c996fa0-a34d-4707-9b50-4ed63b201835" xlink:to="loc_dei_EntityDomain_1760eebc-325c-4ed0-8f95-bf9754ef649a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_33ac9246-967e-4b38-87a7-21fa8f1982ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_33ac9246-967e-4b38-87a7-21fa8f1982ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_33ac9246-967e-4b38-87a7-21fa8f1982ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_33ac9246-967e-4b38-87a7-21fa8f1982ef" xlink:to="loc_us-gaap_LossContingencyNatureDomain_33ac9246-967e-4b38-87a7-21fa8f1982ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_94223a6d-5af0-4d8f-94c2-de81285495e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_33ac9246-967e-4b38-87a7-21fa8f1982ef" xlink:to="loc_us-gaap_LossContingencyNatureDomain_94223a6d-5af0-4d8f-94c2-de81285495e0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="extended" id="i96c25da08b9f43e8adf2ccf98f28e7c1_LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_348244e5-07e8-4822-b517-55c005d4b985" xlink:href="vtrs-20220331.xsd#vtrs_Numberofstates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_vtrs_Numberofstates_348244e5-07e8-4822-b517-55c005d4b985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_69402232-d926-4a61-87fa-9e6c1790c663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_69402232-d926-4a61-87fa-9e6c1790c663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_adf6493f-b903-4cb6-8247-2eb9a5ce102f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_adf6493f-b903-4cb6-8247-2eb9a5ce102f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_58a07f80-8336-4842-8019-4a86fc657670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_58a07f80-8336-4842-8019-4a86fc657670" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_50a0d1d3-4058-4f25-a271-3244f83ca59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_50a0d1d3-4058-4f25-a271-3244f83ca59f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_50a0d1d3-4058-4f25-a271-3244f83ca59f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_50a0d1d3-4058-4f25-a271-3244f83ca59f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_50a0d1d3-4058-4f25-a271-3244f83ca59f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2fb025e4-7206-4961-8b91-2405da5a321f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_50a0d1d3-4058-4f25-a271-3244f83ca59f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2fb025e4-7206-4961-8b91-2405da5a321f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e7445d39-1f68-429b-bdca-176d20db7db8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:to="loc_srt_LitigationCaseAxis_e7445d39-1f68-429b-bdca-176d20db7db8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e7445d39-1f68-429b-bdca-176d20db7db8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_e7445d39-1f68-429b-bdca-176d20db7db8" xlink:to="loc_srt_LitigationCaseTypeDomain_e7445d39-1f68-429b-bdca-176d20db7db8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d115eb79-efff-4701-a6ef-f1fc63191b97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_e7445d39-1f68-429b-bdca-176d20db7db8" xlink:to="loc_srt_LitigationCaseTypeDomain_d115eb79-efff-4701-a6ef-f1fc63191b97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember_548ec014-c455-42ff-84e9-81402282dbb6" xlink:href="vtrs-20220331.xsd#vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_d115eb79-efff-4701-a6ef-f1fc63191b97" xlink:to="loc_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember_548ec014-c455-42ff-84e9-81402282dbb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_00c88334-b6c4-4bab-ad98-1d0d9846b0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_00c88334-b6c4-4bab-ad98-1d0d9846b0f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_00c88334-b6c4-4bab-ad98-1d0d9846b0f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_00c88334-b6c4-4bab-ad98-1d0d9846b0f9" xlink:to="loc_us-gaap_LossContingencyNatureDomain_00c88334-b6c4-4bab-ad98-1d0d9846b0f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dc587a6a-94d8-4626-9925-4b7c426bf23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_00c88334-b6c4-4bab-ad98-1d0d9846b0f9" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dc587a6a-94d8-4626-9925-4b7c426bf23d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_41521fdd-99f4-4bb7-aeb2-623a5ce20081" xlink:href="vtrs-20220331.xsd#vtrs_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_dc587a6a-94d8-4626-9925-4b7c426bf23d" xlink:to="loc_vtrs_OtherCompaniesMember_41521fdd-99f4-4bb7-aeb2-623a5ce20081" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="extended" id="ibe80a9adf41f472e8577cedf5cd44b86_LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_609f3253-0942-4e1a-82fa-da280e46a291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_609f3253-0942-4e1a-82fa-da280e46a291" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_87047d9d-f14b-4ca7-83b3-da7309a9ec87" xlink:href="vtrs-20220331.xsd#vtrs_Numberofstates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:to="loc_vtrs_Numberofstates_87047d9d-f14b-4ca7-83b3-da7309a9ec87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_eccae072-0d11-402b-bcce-a34eeac74e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:to="loc_us-gaap_LitigationReserve_eccae072-0d11-402b-bcce-a34eeac74e47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:to="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_26040c91-1dc3-497d-90b4-99cad08a1b19" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:to="loc_srt_LitigationCaseAxis_26040c91-1dc3-497d-90b4-99cad08a1b19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_26040c91-1dc3-497d-90b4-99cad08a1b19_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_26040c91-1dc3-497d-90b4-99cad08a1b19" xlink:to="loc_srt_LitigationCaseTypeDomain_26040c91-1dc3-497d-90b4-99cad08a1b19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_26040c91-1dc3-497d-90b4-99cad08a1b19" xlink:to="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorCivilLitigationMember_1a551727-ce75-4a00-bb70-dfabe98ece02" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorCivilLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:to="loc_vtrs_EpiPenAutoInjectorCivilLitigationMember_1a551727-ce75-4a00-bb70-dfabe98ece02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorLitigationMember_469c9cd3-18f3-4ab3-b121-520dc7edacdb" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:to="loc_vtrs_EpiPenAutoInjectorLitigationMember_469c9cd3-18f3-4ab3-b121-520dc7edacdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3700caf8-d528-4c91-a08b-57c0296816a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3700caf8-d528-4c91-a08b-57c0296816a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3700caf8-d528-4c91-a08b-57c0296816a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3700caf8-d528-4c91-a08b-57c0296816a4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3700caf8-d528-4c91-a08b-57c0296816a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0bedc68e-3045-46d8-a5f2-abdcdb4f3ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3700caf8-d528-4c91-a08b-57c0296816a4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0bedc68e-3045-46d8-a5f2-abdcdb4f3ff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f7b4b481-7ff4-4775-9605-c31f03457711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0bedc68e-3045-46d8-a5f2-abdcdb4f3ff6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f7b4b481-7ff4-4775-9605-c31f03457711" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationDrugPricingMattersDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="extended" id="ia43549a60f5a422b9ee2a48ea4daf26e_LitigationDrugPricingMattersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_22c2296b-db37-4f08-8916-714880ff268a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_932fd972-8954-4f04-84f1-47b85c929d24" xlink:href="vtrs-20220331.xsd#vtrs_Numberofstates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_22c2296b-db37-4f08-8916-714880ff268a" xlink:to="loc_vtrs_Numberofstates_932fd972-8954-4f04-84f1-47b85c929d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d15b3b98-f073-445e-9344-ea900f9059ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_22c2296b-db37-4f08-8916-714880ff268a" xlink:to="loc_us-gaap_LossContingenciesTable_d15b3b98-f073-445e-9344-ea900f9059ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1293e7ea-e534-4d4f-bf37-06fa0f2a642d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d15b3b98-f073-445e-9344-ea900f9059ee" xlink:to="loc_srt_LitigationCaseAxis_1293e7ea-e534-4d4f-bf37-06fa0f2a642d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1293e7ea-e534-4d4f-bf37-06fa0f2a642d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_1293e7ea-e534-4d4f-bf37-06fa0f2a642d" xlink:to="loc_srt_LitigationCaseTypeDomain_1293e7ea-e534-4d4f-bf37-06fa0f2a642d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_1293e7ea-e534-4d4f-bf37-06fa0f2a642d" xlink:to="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember_54975a95-215c-4242-8646-082a3b1747fd" xlink:href="vtrs-20220331.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_MultiDistrictLitigationMember_54975a95-215c-4242-8646-082a3b1747fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_d01624ae-6ae6-4e2f-bc61-2bf8c1f4f6ca" xlink:href="vtrs-20220331.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_d01624ae-6ae6-4e2f-bc61-2bf8c1f4f6ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_91a54946-2e7a-4e65-8881-3ee6c93afc20" xlink:href="vtrs-20220331.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_91a54946-2e7a-4e65-8881-3ee6c93afc20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_a5b25622-2979-4115-ad16-75748f4b4811" xlink:href="vtrs-20220331.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_a5b25622-2979-4115-ad16-75748f4b4811" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationEuropeanCommissionProceedingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="extended" id="i396d3edd5c22400e8b27535a207e4159_LitigationEuropeanCommissionProceedingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_434d1199-9f6b-48c2-b582-1ede8080e25c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_434d1199-9f6b-48c2-b582-1ede8080e25c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_d83c1c79-9dc7-43e6-8059-cf6ee06027d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_d83c1c79-9dc7-43e6-8059-cf6ee06027d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_328d67d9-6598-457f-ba62-a6c09322a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_328d67d9-6598-457f-ba62-a6c09322a5bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_338751d3-96f7-40c7-9bcf-38ba4d45204f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_338751d3-96f7-40c7-9bcf-38ba4d45204f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0ed45935-05af-4228-8e6a-ce102dff35f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:to="loc_srt_LitigationCaseAxis_0ed45935-05af-4228-8e6a-ce102dff35f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0ed45935-05af-4228-8e6a-ce102dff35f4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_0ed45935-05af-4228-8e6a-ce102dff35f4" xlink:to="loc_srt_LitigationCaseTypeDomain_0ed45935-05af-4228-8e6a-ce102dff35f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_0ed45935-05af-4228-8e6a-ce102dff35f4" xlink:to="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsPerindorprilMember_a616f736-ea1a-4bfe-bfc2-d477628fa16e" xlink:href="vtrs-20220331.xsd#vtrs_EUCommissionProceedingsPerindorprilMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:to="loc_vtrs_EUCommissionProceedingsPerindorprilMember_a616f736-ea1a-4bfe-bfc2-d477628fa16e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsCitalopramMember_5cb1d3b7-b149-4f74-ae7d-4d43d60d747c" xlink:href="vtrs-20220331.xsd#vtrs_EUCommissionProceedingsCitalopramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:to="loc_vtrs_EUCommissionProceedingsCitalopramMember_5cb1d3b7-b149-4f74-ae7d-4d43d60d747c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_023f0a49-a5f6-4714-9ea8-4a4c619c9906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_023f0a49-a5f6-4714-9ea8-4a4c619c9906" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_023f0a49-a5f6-4714-9ea8-4a4c619c9906_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_023f0a49-a5f6-4714-9ea8-4a4c619c9906" xlink:to="loc_us-gaap_LossContingencyNatureDomain_023f0a49-a5f6-4714-9ea8-4a4c619c9906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_a1418f29-77ba-4eef-928d-aa2448fb5a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_023f0a49-a5f6-4714-9ea8-4a4c619c9906" xlink:to="loc_us-gaap_LossContingencyNatureDomain_a1418f29-77ba-4eef-928d-aa2448fb5a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AntitrustProceedingsMember_7914bb46-8e4b-4abd-a6f1-97bc48590f91" xlink:href="vtrs-20220331.xsd#vtrs_AntitrustProceedingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_a1418f29-77ba-4eef-928d-aa2448fb5a04" xlink:to="loc_vtrs_AntitrustProceedingsMember_7914bb46-8e4b-4abd-a6f1-97bc48590f91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0b969290-9528-4e01-b32c-efe102775eb6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0b969290-9528-4e01-b32c-efe102775eb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0b969290-9528-4e01-b32c-efe102775eb6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0b969290-9528-4e01-b32c-efe102775eb6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0b969290-9528-4e01-b32c-efe102775eb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0b969290-9528-4e01-b32c-efe102775eb6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_db21dafc-0ba9-4995-92a7-386f7b762ae7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:to="loc_srt_SubsidiariesMember_db21dafc-0ba9-4995-92a7-386f7b762ae7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_9edb055b-032a-4b6b-bc17-32d9e20ce102" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:to="loc_srt_ParentCompanyMember_9edb055b-032a-4b6b-bc17-32d9e20ce102" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="extended" id="i5dcc4f6af840438caff11db40c68ae7e_LitigationUKCompetitionandMarketsAuthorityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f5abb7ca-536f-4c3d-9931-67c4b11b2953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_51765cdb-860b-453c-a790-bc1361911509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f5abb7ca-536f-4c3d-9931-67c4b11b2953" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_51765cdb-860b-453c-a790-bc1361911509" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f5abb7ca-536f-4c3d-9931-67c4b11b2953" xlink:to="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_80ae2177-b253-4afd-a092-ec73215ad3c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:to="loc_srt_LitigationCaseAxis_80ae2177-b253-4afd-a092-ec73215ad3c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_80ae2177-b253-4afd-a092-ec73215ad3c4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_80ae2177-b253-4afd-a092-ec73215ad3c4" xlink:to="loc_srt_LitigationCaseTypeDomain_80ae2177-b253-4afd-a092-ec73215ad3c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5af91b33-6d1d-4185-9725-e3f8b1312ab9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_80ae2177-b253-4afd-a092-ec73215ad3c4" xlink:to="loc_srt_LitigationCaseTypeDomain_5af91b33-6d1d-4185-9725-e3f8b1312ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_89336ef5-e047-437d-88a7-b8ade7048864" xlink:href="vtrs-20220331.xsd#vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_5af91b33-6d1d-4185-9725-e3f8b1312ab9" xlink:to="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_89336ef5-e047-437d-88a7-b8ade7048864" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_73521016-47a2-4238-a8fb-32c4304d56fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_73521016-47a2-4238-a8fb-32c4304d56fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_73521016-47a2-4238-a8fb-32c4304d56fa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_73521016-47a2-4238-a8fb-32c4304d56fa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_73521016-47a2-4238-a8fb-32c4304d56fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_960ec0fd-cb51-4d3b-aaa9-d919ca404afe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_73521016-47a2-4238-a8fb-32c4304d56fa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_960ec0fd-cb51-4d3b-aaa9-d919ca404afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_0411ea3b-b8f1-4b38-a639-c0595555b92f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_960ec0fd-cb51-4d3b-aaa9-d919ca404afe" xlink:to="loc_srt_ParentCompanyMember_0411ea3b-b8f1-4b38-a639-c0595555b92f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationProductLiabilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="extended" id="i0c5fa2982db04475bdecd93195295456_LitigationProductLiabilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0a9009f1-46de-4de1-bc5c-fa591ec3d7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0386405c-36d0-491b-92a2-2348817484eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a9009f1-46de-4de1-bc5c-fa591ec3d7cc" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0386405c-36d0-491b-92a2-2348817484eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_61ae4e1e-5fdd-4f96-a834-13173230bf60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a9009f1-46de-4de1-bc5c-fa591ec3d7cc" xlink:to="loc_us-gaap_LossContingenciesTable_61ae4e1e-5fdd-4f96-a834-13173230bf60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_644cc8be-b235-420e-a33f-150211b5bd00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_61ae4e1e-5fdd-4f96-a834-13173230bf60" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_644cc8be-b235-420e-a33f-150211b5bd00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_644cc8be-b235-420e-a33f-150211b5bd00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_644cc8be-b235-420e-a33f-150211b5bd00" xlink:to="loc_us-gaap_LossContingencyNatureDomain_644cc8be-b235-420e-a33f-150211b5bd00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e4c39b3e-f11c-474e-8c84-e26a4ad244d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_644cc8be-b235-420e-a33f-150211b5bd00" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e4c39b3e-f11c-474e-8c84-e26a4ad244d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_eaa1885f-3abe-48da-bc54-0a4d96fd91d4" xlink:href="vtrs-20220331.xsd#vtrs_ProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e4c39b3e-f11c-474e-8c84-e26a4ad244d2" xlink:to="loc_vtrs_ProductLiabilityMember_eaa1885f-3abe-48da-bc54-0a4d96fd91d4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationIntellectualPropertyNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="extended" id="i8b079f4ea2784ecf8db7106d466dec7c_LitigationIntellectualPropertyNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_461be15b-7293-4f8e-88a5-104edda8e434" xlink:href="vtrs-20220331.xsd#vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:to="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_461be15b-7293-4f8e-88a5-104edda8e434" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_7ad58ec9-2b03-492d-93e0-66cb48856bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_7ad58ec9-2b03-492d-93e0-66cb48856bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0b2f1ce3-0411-4196-9228-934b11d94e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:to="loc_us-gaap_LossContingenciesTable_0b2f1ce3-0411-4196-9228-934b11d94e64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_57264fcc-d031-4b63-b682-2c17c853df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0b2f1ce3-0411-4196-9228-934b11d94e64" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_57264fcc-d031-4b63-b682-2c17c853df1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_57264fcc-d031-4b63-b682-2c17c853df1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_57264fcc-d031-4b63-b682-2c17c853df1c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_57264fcc-d031-4b63-b682-2c17c853df1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_3007ea14-ce9b-4b69-8448-373b52406f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_57264fcc-d031-4b63-b682-2c17c853df1c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_3007ea14-ce9b-4b69-8448-373b52406f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3c107fde-e1ec-4176-8463-7fbd9a65b122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_3007ea14-ce9b-4b69-8448-373b52406f50" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3c107fde-e1ec-4176-8463-7fbd9a65b122" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationOtherLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="extended" id="i3ad677754c784bc78d6cb61dfeaf8260_LitigationOtherLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_82e7fc98-391e-46b4-975f-c561d215b265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_82e7fc98-391e-46b4-975f-c561d215b265" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases_53674ff8-8cb9-48ed-aa54-b6adab92b96d" xlink:href="vtrs-20220331.xsd#vtrs_Numberofcases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:to="loc_vtrs_Numberofcases_53674ff8-8cb9-48ed-aa54-b6adab92b96d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_31794540-6092-4f82-93bd-afca65b52209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_31794540-6092-4f82-93bd-afca65b52209" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:to="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:to="loc_srt_LitigationCaseAxis_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d" xlink:to="loc_srt_LitigationCaseTypeDomain_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_dc97c1a9-b5ee-4810-a40b-431170a47a0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d" xlink:to="loc_srt_LitigationCaseTypeDomain_dc97c1a9-b5ee-4810-a40b-431170a47a0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenIsraeliSecuritiesLitigationMember_2b4226c6-ed76-4448-9c94-9699e011744f" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenIsraeliSecuritiesLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dc97c1a9-b5ee-4810-a40b-431170a47a0f" xlink:to="loc_vtrs_EpiPenIsraeliSecuritiesLitigationMember_2b4226c6-ed76-4448-9c94-9699e011744f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_2305ac79-4327-44c7-8002-e193dd09bce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_2305ac79-4327-44c7-8002-e193dd09bce3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_2305ac79-4327-44c7-8002-e193dd09bce3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_2305ac79-4327-44c7-8002-e193dd09bce3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_2305ac79-4327-44c7-8002-e193dd09bce3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_60845b0a-95a2-4edb-9e6b-0a74e6759869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_2305ac79-4327-44c7-8002-e193dd09bce3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_60845b0a-95a2-4edb-9e6b-0a74e6759869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_c1e8eef8-5962-4025-aa10-b03ee9c85d9b" xlink:href="vtrs-20220331.xsd#vtrs_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_60845b0a-95a2-4edb-9e6b-0a74e6759869" xlink:to="loc_vtrs_OtherMember_c1e8eef8-5962-4025-aa10-b03ee9c85d9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>vtrs-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf4cfb5a-529b-48e5-98f7-7a0c9b128563,g:c48d1c16-74b3-4c20-a8f8-3b8e11527314-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_dff81bf7-9922-4b7d-b6c9-266c6e968555_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_8a4da077-68db-4277-ae5c-efa65a95eda9_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorthAmericaGenericsMember_a1463eb1-6013-4e74-a863-4ea43e21ace3_terseLabel_en-US" xlink:label="lab_vtrs_NorthAmericaGenericsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Generics</link:label>
    <link:label id="lab_vtrs_NorthAmericaGenericsMember_label_en-US" xlink:label="lab_vtrs_NorthAmericaGenericsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Generics [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaGenericsMember_documentation_en-US" xlink:label="lab_vtrs_NorthAmericaGenericsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Generics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorthAmericaGenericsMember" xlink:to="lab_vtrs_NorthAmericaGenericsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bbedec52-c0ac-44dd-a8d5-c9c7b816c5f7_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, released</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_fc646905-4c7f-469c-a29a-dd53309002ae_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_fb5c91da-aea1-428a-a0d2-d1d590f380c7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes related to the net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_label_en-US" xlink:label="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:to="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_9620a382-8ac1-4598-b1d5-b6a8a8a09486_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_538fc4a8-abe1-4e22-be2f-b5ca421937e3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3d7a4360-29ee-4d21-8a73-dfd811d2b66a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_fb62c553-f370-4b0f-9268-fd1abe4eaf05_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_307910a1-2a5b-4916-804b-eabccbe55476_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5e18a75f-38a3-488a-9a30-536c57c9b4db_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fcaea190-1565-4b57-897b-ca6581611ab4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_YupelriMember_63bd3e08-0521-43ec-8429-39b42a44e687_terseLabel_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174;</link:label>
    <link:label id="lab_vtrs_YupelriMember_label_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174; [Member]</link:label>
    <link:label id="lab_vtrs_YupelriMember_documentation_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember" xlink:href="vtrs-20220331.xsd#vtrs_YupelriMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_YupelriMember" xlink:to="lab_vtrs_YupelriMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cb7c4e17-ad20-4a45-a940-349a4f580d01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_2f454060-8e67-40da-979f-3edaeef5c67a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_14466d4b-91a1-40c7-bebe-f71ff81b9cd1_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c4977c1-0694-4418-b1ba-698b79123b21_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab258775-6853-4552-9940-8c593f13c221_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_d125c011-9411-4a49-9dbc-fcbb9cc5f098_terseLabel_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_label_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_documentation_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:href="vtrs-20220331.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:to="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_116cc062-8e0c-4355-9d52-2fec0f683321_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6a9fae39-1f9f-4814-b3ac-08e61a3db5ba_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_fe4560dc-0c60-4ae2-abfc-e8b5aab5b14c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative liabilities</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_7c6d4c34-75bb-46b8-a912-b45cde2165a1_terseLabel_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2032EuroSeniorNotesMember" xlink:to="lab_vtrs_A2032EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_6506f5c6-8e24-461d-b8f2-3839f9f88f0a_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2043 Senior Notes (5.400% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortyThree [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand forty three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherCompaniesMember_707c725c-1e88-450c-9b99-c35dcbca4403_terseLabel_en-US" xlink:label="lab_vtrs_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other drug manufacturers</link:label>
    <link:label id="lab_vtrs_OtherCompaniesMember_label_en-US" xlink:label="lab_vtrs_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Companies [Member]</link:label>
    <link:label id="lab_vtrs_OtherCompaniesMember_documentation_en-US" xlink:label="lab_vtrs_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember" xlink:href="vtrs-20220331.xsd#vtrs_OtherCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherCompaniesMember" xlink:to="lab_vtrs_OtherCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_5296793e-c436-410d-9e9c-46e00b831b21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging Relationships</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy_c99e0b9e-7910-47be-969b-5ce0206c2695_terseLabel_en-US" xlink:label="lab_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Total Assets Impacted, High Inflationary Economy</link:label>
    <link:label id="lab_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy_label_en-US" xlink:label="lab_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Total Assets Impacted, High Inflationary Economy</link:label>
    <link:label id="lab_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy_documentation_en-US" xlink:label="lab_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Total Assets Impacted, High Inflationary Economy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy" xlink:href="vtrs-20220331.xsd#vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy" xlink:to="lab_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_76ed8b73-7c1b-40de-b78c-04d82ba013b9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c44f576c-901d-4092-b9d6-ad19344ac1c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_eaf225c5-9c9e-4a46-a9d6-fc54c98a81e3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_47330579-54c4-4530-9711-9e468d7fd242_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f25337f5-6c27-4625-9f60-08c0d15cbe1d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DefinedBenefitPlansNumberofFrozenPlans_9d9873ed-ea58-402f-9b8e-2e8d3c8e9d87_terseLabel_en-US" xlink:label="lab_vtrs_DefinedBenefitPlansNumberofFrozenPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans, Number of Frozen Plans</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlansNumberofFrozenPlans_label_en-US" xlink:label="lab_vtrs_DefinedBenefitPlansNumberofFrozenPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans, Number of Frozen Plans</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlansNumberofFrozenPlans_documentation_en-US" xlink:label="lab_vtrs_DefinedBenefitPlansNumberofFrozenPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans, Number of Frozen Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlansNumberofFrozenPlans" xlink:href="vtrs-20220331.xsd#vtrs_DefinedBenefitPlansNumberofFrozenPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DefinedBenefitPlansNumberofFrozenPlans" xlink:to="lab_vtrs_DefinedBenefitPlansNumberofFrozenPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_604fec6a-3701-4870-932a-bee83360e1a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_117cb3f1-46e5-43e7-8ebf-0b52ef5aabb0_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_efab5755-f708-44f8-a9fd-78ca2abfe5e5_terseLabel_en-US" xlink:label="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</link:label>
    <link:label id="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_label_en-US" xlink:label="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</link:label>
    <link:label id="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_documentation_en-US" xlink:label="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:href="vtrs-20220331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:to="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f567a8dd-be6a-4041-8e36-54103ac280e4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c5c975e8-a42e-4261-8a6b-9a5053c388e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProgramNameAxis_2b3f42ed-5c30-4820-8d61-60b79854b41a_terseLabel_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Axis]</link:label>
    <link:label id="lab_vtrs_ProgramNameAxis_label_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Axis]</link:label>
    <link:label id="lab_vtrs_ProgramNameAxis_documentation_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis" xlink:href="vtrs-20220331.xsd#vtrs_ProgramNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProgramNameAxis" xlink:to="lab_vtrs_ProgramNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c931c7d6-e10d-439d-b4d8-f4e934a4fd35_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f8dd7442-db87-4aaa-8ef1-dd21fa1d14ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_004d22a1-5f72-44f2-a6b6-9e695cb32093_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain_e0b92e10-aeb5-49b3-8057-2508dea5cc90_terseLabel_en-US" xlink:label="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity Type of Counterparty [Domain]</link:label>
    <link:label id="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain_label_en-US" xlink:label="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity Type of Counterparty [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:to="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_d4d20ffd-929d-4690-ae59-05b2b4c33240_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorthAmericaSegmentMember_50b51e2a-da84-466e-b42b-1660582c82dd_terseLabel_en-US" xlink:label="lab_vtrs_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment</link:label>
    <link:label id="lab_vtrs_NorthAmericaSegmentMember_label_en-US" xlink:label="lab_vtrs_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaSegmentMember_documentation_en-US" xlink:label="lab_vtrs_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorthAmericaSegmentMember" xlink:to="lab_vtrs_NorthAmericaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_ef35b8a9-9513-4d23-9b11-09ebb2365225_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3586d5dc-2e3c-4f2f-bf01-a5d309a9707c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0a29b30a-fddd-4edb-8185-27edf9889c29_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh_ff0aad6e-5757-4a51-a487-1374977286d6_terseLabel_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional cash payments to be received</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh_label_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh_documentation_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" xlink:to="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3c63fb9a-89bd-4a7f-b010-ce3663a301ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_185d592f-fd2b-4d52-931e-693abd0ee7b0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_1c2f15d0-6b97-49d7-8ff6-d55d9d52beeb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity of Counterparty, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity of Counterparty, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_a68610e6-7281-474f-8cec-ae403ea596fc_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment issued</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_dad13cba-e37f-4cc0-ae27-bb401664fe75_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3a2d5221-6893-4942-b1b0-9f29b29b40d0_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_44bd26eb-9380-4361-8956-c6dbb8cc4884_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_c7c5beea-38b0-4ef3-a1c9-997adc737d0c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_d5fb195d-cae2-4d1e-9ca1-d04313044690_terseLabel_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020EuroSeniorNotesMember" xlink:to="lab_vtrs_A2020EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_3ae26c8d-08e1-4a5e-bb36-c202e60ada4b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_2a2168c0-4116-4dd4-afba-d53fc8f7db08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale fixed income investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_824c5ba6-55c1-443b-afff-ed75651d0755_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_UpjohnInc.Member_ea7a3c32-088a-4fc9-923d-1434708acf7a_terseLabel_en-US" xlink:label="lab_vtrs_UpjohnInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Inc.</link:label>
    <link:label id="lab_vtrs_UpjohnInc.Member_label_en-US" xlink:label="lab_vtrs_UpjohnInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Inc. [Member]</link:label>
    <link:label id="lab_vtrs_UpjohnInc.Member_documentation_en-US" xlink:label="lab_vtrs_UpjohnInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_UpjohnInc.Member" xlink:to="lab_vtrs_UpjohnInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6cb153cc-0999-4833-9c02-1fc42f770600_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_cc3e8086-2be6-435a-9806-e5a73dfd1e0e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputEstimatedTaxRateMember_145d03ea-be21-4001-990e-738cdbc7740c_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Estimated Tax Rate</link:label>
    <link:label id="lab_vtrs_MeasurementInputEstimatedTaxRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Estimated Tax Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputEstimatedTaxRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Estimated Tax Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputEstimatedTaxRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:to="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_9e035b66-9bbb-455a-a445-a4311150bf33_terseLabel_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_label_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan [Member]</link:label>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_documentation_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember" xlink:href="vtrs-20220331.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020RestructuringPlanMember" xlink:to="lab_vtrs_A2020RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_fd609004-d157-43ae-b566-bc4edf3a6e8e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5eaf02fc-765b-4c9d-9422-20f17594d103_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share attributable to Viatris Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_3ed8b8a4-0542-4244-bd40-03d6b767a9ec_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInputTerm_a98f04fc-3e7b-452a-94c1-ab1daa411d09_terseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input, Term</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInputTerm_label_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input, Term</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInputTerm_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:href="vtrs-20220331.xsd#vtrs_GoodwillImpairmentMeasurementInputTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:to="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c4f2cf90-0b8f-4169-95bf-2d90b0241ded_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, nonvested beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c50cda4c-deac-4763-a368-e5009e046298_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, nonvested end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5327dfaa-8a21-4fcd-8462-3b15fed0d0bb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_9bba6ac8-a1e7-4b1f-ac5e-8afab36038fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance expense</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_ca71fe83-e40b-4584-bb82-3df454aa0490_terseLabel_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt</link:label>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_label_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt [Member]</link:label>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_documentation_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:href="vtrs-20220331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:to="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_09a3c0e1-2a2c-446c-949c-a4a470ab1e26_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_6d1ce407-3093-4c77-8be1-dc69d893a6c8_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_ce885605-636e-4095-bdb6-a22d9c8aa37f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_0bbf3f03-2b94-44fd-a65d-2a4e7178b679_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_363734db-f228-47df-bb32-586fd5abd3ba_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefit liabilities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_66dcc417-a1bc-4f08-beee-fd695bfb1ac7_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Terminal Year Revenue Growth Rate</link:label>
    <link:label id="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Terminal Year Revenue Growth Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Terminal Year Revenue Growth Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:to="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_fb1f3bf2-c76b-4fa8-b824-b18a7d632a9c_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_308cfbe4-cc28-40e5-bdf2-5a88878bb391_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_c64c6a65-b77b-404b-8aca-78c01c8aea75_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_8badb129-7844-4b82-8889-ec3ac947596a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationAbstract_label_en-US" xlink:label="lab_vtrs_BusinessCombinationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination [Abstract]</link:label>
    <link:label id="lab_vtrs_BusinessCombinationAbstract_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationAbstract" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationAbstract" xlink:to="lab_vtrs_BusinessCombinationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_73da60cb-2802-4b56-92e1-90e6f11657b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PeriodDomain_fc27a356-b6d7-4f2d-9245-84c07880ea24_terseLabel_en-US" xlink:label="lab_vtrs_PeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Domain]</link:label>
    <link:label id="lab_vtrs_PeriodDomain_label_en-US" xlink:label="lab_vtrs_PeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Domain]</link:label>
    <link:label id="lab_vtrs_PeriodDomain_documentation_en-US" xlink:label="lab_vtrs_PeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain" xlink:href="vtrs-20220331.xsd#vtrs_PeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PeriodDomain" xlink:to="lab_vtrs_PeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_63f204af-097c-432f-b744-5974950b894d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other payables</link:label>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_e0981272-dd44-4296-8334-89a781c9e262_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TermLoanMember_ce2ef4eb-90db-45a6-a4e5-c545e3c7b4e0_terseLabel_en-US" xlink:label="lab_vtrs_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_vtrs_TermLoanMember_label_en-US" xlink:label="lab_vtrs_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_vtrs_TermLoanMember_documentation_en-US" xlink:label="lab_vtrs_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TermLoanMember" xlink:href="vtrs-20220331.xsd#vtrs_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TermLoanMember" xlink:to="lab_vtrs_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6d06165d-d201-408e-b093-7759bf7c4f13_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_617ac0d1-6105-474d-9562-ae4f60f0c9b2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_2dcbd3a3-1aba-41f2-a856-3b78a42eb8c1_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_34365038-b531-4925-ad42-8b729a873ec7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f734facf-85c3-4f52-aa58-c333bc818992_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6b62c958-f7f5-44d9-a118-a6d0d12721b3_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_15a1dd4f-5abf-4169-8776-9c8773307f6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_0d411687-f6b8-48af-bd24-c0ef5a81cf79_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_label_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block]</link:label>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_documentation_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:to="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8511a4dc-fb64-498f-8e1d-ee09e6e9d964_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_ba101958-2228-452e-a0a7-1d2b5b5217b4_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b82c411c-c92b-4eca-89a0-50c51143fe64_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_b94af474-6f35-44f3-877c-76460940455a_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2d9f5615-4d3b-421e-ab35-3bb10f5539a5_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_27c6e284-ec98-44ca-bd37-3ab03a7f46a4_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f91b4a83-1df9-477e-adaa-72456d784660_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ac75b74-a5c1-4be9-b142-6cd7b3593aa8_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofequitymethodinvestments_295a01ff-5ea5-4907-810a-b4e7f31c6b62_terseLabel_en-US" xlink:label="lab_vtrs_Numberofequitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity method investments</link:label>
    <link:label id="lab_vtrs_Numberofequitymethodinvestments_label_en-US" xlink:label="lab_vtrs_Numberofequitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity method investments</link:label>
    <link:label id="lab_vtrs_Numberofequitymethodinvestments_documentation_en-US" xlink:label="lab_vtrs_Numberofequitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity method investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofequitymethodinvestments" xlink:href="vtrs-20220331.xsd#vtrs_Numberofequitymethodinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofequitymethodinvestments" xlink:to="lab_vtrs_Numberofequitymethodinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_c064dedb-6c9a-4b4a-bb17-192e05ae394d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0cecb35f-c83b-411e-a551-5aa1724101ac_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_0ec04bdc-fe05-4365-871a-66c971841f8a_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes (3.950% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentySix3.95Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes 3.950%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_04b44958-e2cd-4ea3-b61a-25d339145ed0_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_d90f2b6b-0d32-476a-a964-2b5712459219_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_5214f9f6-afe1-4a5e-ab2d-4e18c9214ebd_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0886d741-36e1-43ef-a042-d0d0fa3276df_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_95580e9c-daf1-4d2f-b23e-c2c603d522d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized net actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e1e328d7-59bf-469d-9730-98585d7cd0da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_44e8ce12-9e42-4e5f-a46e-52a4ff8a1e0a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8c30dbd4-0960-461a-a952-6b767f819201_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related items, including contingencies</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_b603a809-8754-48b9-ab61-b2daa8809410_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_ff4419db-b87b-4ce8-b91b-27d36a32458c_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan Laboratories Limited</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_067b84a5-f05c-44d5-99ae-345a493b3ef9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteenMember_7a183131-8ec9-4c89-b544-6cec181cb2aa_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes (2.550% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteenMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandNineteen [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteenMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand nineteen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_68971d85-346f-4761-9b57-623834468c1f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ordinary Shares, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BioconBiologicsMember_4f789180-64fa-498a-ae7b-197cacaa86d9_terseLabel_en-US" xlink:label="lab_vtrs_BioconBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biocon Biologics</link:label>
    <link:label id="lab_vtrs_BioconBiologicsMember_label_en-US" xlink:label="lab_vtrs_BioconBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biocon Biologics [Member]</link:label>
    <link:label id="lab_vtrs_BioconBiologicsMember_documentation_en-US" xlink:label="lab_vtrs_BioconBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biocon Biologics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember" xlink:href="vtrs-20220331.xsd#vtrs_BioconBiologicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BioconBiologicsMember" xlink:to="lab_vtrs_BioconBiologicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_957223f0-72c0-4f19-b849-38f0a7c0fbdf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_2a25ccc4-29aa-473b-add4-7d4cbfe46357_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_d607b1d3-0805-4afb-ab4b-ff1932d9a7d7_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotes2022Member_32f2745a-0332-4b9a-a8b5-b2437a750b13_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022</link:label>
    <link:label id="lab_vtrs_SeniorNotes2022Member_label_en-US" xlink:label="lab_vtrs_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotes2022Member_documentation_en-US" xlink:label="lab_vtrs_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2022Member" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotes2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotes2022Member" xlink:to="lab_vtrs_SeniorNotes2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_975201c6-de75-468f-92ad-986529e4f255_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a48a28bb-da52-439f-a9ce-0cbfc185b0e7_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_43b1e318-5be4-4781-888e-26b1d7f768e1_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_f69c29f8-0df8-4799-b455-30ea90c0f51c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_dacddde0-a741-4cfa-b3fc-bd48438720eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_d3296fc4-b1b2-4d36-bade-a222059725d5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_61117352-cbf6-48ec-9fd5-f19892d8d2d4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_bc775689-b348-4364-a765-801a9a697fca_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d28d8c52-49d3-4b48-a345-64039a5bb383_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for stock awards outstanding, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4c9d32f7-efbb-4cae-b240-0ea7f591c90e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_3a7ba1ca-f8de-4980-9a05-8a23dba72ab1_terseLabel_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components [Abstract]</link:label>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_label_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components [Abstract]</link:label>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_documentation_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract" xlink:href="vtrs-20220331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract" xlink:to="lab_vtrs_BalanceSheetComponentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_62dd8158-0007-4d49-ac56-e7337c93d075_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_de9c39bb-9c9e-444b-a624-425437fc0c52_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_5738f21a-a3c8-446e-bcdd-a3f3af2229f3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_304c3aea-5d50-4d1b-8581-3e8e1bf4188b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ae9f85b3-6ebb-4a32-8588-965b65621f71_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, nonvested beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a674e9b8-ff6d-402d-8d64-32a835361edb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, nonvested end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_9e8b259f-2a41-4c8c-8bcf-63a1de53180c_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccruedSalesAllowances_c28747ca-5d30-400a-9f47-e99218e39717_negatedNetLabel_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates, promotional programs and other sales allowances</link:label>
    <link:label id="lab_vtrs_AccruedSalesAllowances_label_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Allowances</link:label>
    <link:label id="lab_vtrs_AccruedSalesAllowances_documentation_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances" xlink:href="vtrs-20220331.xsd#vtrs_AccruedSalesAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccruedSalesAllowances" xlink:to="lab_vtrs_AccruedSalesAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_17c4f62e-6683-46ef-8ab3-4ea0efab3fc9_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Senior Notes (3.750% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Twenty - 3.75 Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Twenty - 3.75 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_7ea3187f-17a5-43eb-aadf-1ffe6d06f5ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Other Transactions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_4b0f6b07-9e20-4e5a-85cf-e850bc57b270_negatedLabel_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_label_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Returns</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_documentation_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns" xlink:href="vtrs-20220331.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RevenuefromContractwithCustomerReturns" xlink:to="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership_9e8aa3eb-47e3-4a20-8c86-cc9a0a12caca_terseLabel_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent ownership after transaction</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership_label_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership_documentation_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" xlink:to="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_05c67ed2-c0e5-4813-88eb-6bef1546f208_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_5db7462c-efe3-4645-b3e1-4f7766c36066_terseLabel_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2027SeniorNotesMember" xlink:to="lab_vtrs_A2027SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_94cf6ff6-cf3c-47d9-820c-c5a5c2beea09_terseLabel_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2024EuroSeniorNotesMember" xlink:to="lab_vtrs_A2024EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_cbb510a7-e55c-4581-b908-29a339e0852f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_62765578-1d77-4082-a7e3-a041bf1ee765_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_bb1ac92f-c2bf-4a9f-9f73-7f8781eb6242_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e1c892cb-2ca4-4d4f-8952-be6078885286_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_2c015adb-4428-43ba-aa7e-857d61e670c8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_825df76e-662b-4938-b5a4-ab1fcf3cc904_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_1f357342-62d6-464f-92e0-e8be75596393_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_11acb229-56a0-49e4-bb4b-71ad157dff1b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement_e0ecdf45-ea28-441c-b903-a9cd60d44b05_terseLabel_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of transition services agreement</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement_label_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement_documentation_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" xlink:to="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_be86e8b9-7773-4480-a622-46bbf271eeec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_32020977-e6a6-4e5f-8ab6-9fe314f493f3_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_977d1fa0-8308-4206-a5c3-603d060e650b_terseLabel_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_label_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_documentation_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember" xlink:href="vtrs-20220331.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MultiDistrictLitigationMember" xlink:to="lab_vtrs_MultiDistrictLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotes2021Member_97198632-e1c5-473b-8799-d8a96b1d049e_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotes2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2021</link:label>
    <link:label id="lab_vtrs_SeniorNotes2021Member_label_en-US" xlink:label="lab_vtrs_SeniorNotes2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2021 [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotes2021Member_documentation_en-US" xlink:label="lab_vtrs_SeniorNotes2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2021Member" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotes2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotes2021Member" xlink:to="lab_vtrs_SeniorNotes2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1cee367a-2fd0-4c20-846d-ad877c695dc3_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_21ac442d-af6b-4c22-8f57-a08e215dc49a_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_78a716d4-2a25-40ea-a567-ac2b7df9aabb_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_b9b2ea83-024f-4d89-b51f-ce108e8a426c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_92dd959f-481d-4c8b-900a-246c1c7f290a_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3ae25b9-c860-48bc-83a8-16eef61c63c0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Goods, Net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_c58456d2-4e21-489f-bb64-497fbc8b1f02_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:to="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_212ea283-7d60-4868-9ae6-3b8732964bca_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Corporatecosts_c75844c5-e51b-440f-abee-cf31668a12ad_terseLabel_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:label id="lab_vtrs_Corporatecosts_label_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:label id="lab_vtrs_Corporatecosts_documentation_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts" xlink:href="vtrs-20220331.xsd#vtrs_Corporatecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Corporatecosts" xlink:to="lab_vtrs_Corporatecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidatedEntityExcludingVieMember_3d4d8542-4843-47b4-9f8e-172621f9da02_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entity</link:label>
    <link:label id="lab_us-gaap_ConsolidatedEntityExcludingVieMember_label_en-US" xlink:label="lab_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entity, Excluding VIE [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:to="lab_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3f02afb5-5832-4251-ae3b-1a2c6946c2d9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_6df4c007-7960-42f2-965a-11cea7eae928_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9936e559-92a9-4e05-a400-c4c35b170ab8_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_7035f79c-560d-4ee7-863c-c7948c7d33d3_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_86b665ad-db11-452c-b0b3-9208f3281cc4_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_6a19d78c-4248-487d-9879-6c085102197d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestofWorldSegmentMember_49bbd500-2f32-4a2a-8224-0d80c05e5ca9_terseLabel_en-US" xlink:label="lab_vtrs_RestofWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JANZ</link:label>
    <link:label id="lab_vtrs_RestofWorldSegmentMember_label_en-US" xlink:label="lab_vtrs_RestofWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World Segment [Member]</link:label>
    <link:label id="lab_vtrs_RestofWorldSegmentMember_documentation_en-US" xlink:label="lab_vtrs_RestofWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestofWorldSegmentMember" xlink:to="lab_vtrs_RestofWorldSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_aba08899-1df8-4f6a-8046-d341580b4f3f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_a2ab3bdc-1f9e-45d8-8ef5-f72b41f2d13b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d1aa6085-cc54-45d0-93e4-230092abf6eb_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b7ee4bf7-cf0b-4943-b67e-21102bb7896f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_8704a794-f3d8-41a0-8750-369979b7ac2d_terseLabel_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023%</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_label_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023% [Member]</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_documentation_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2024EuroSeniorNotes1023Member" xlink:to="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TrailingFourQuartersMember_56efd24a-9b21-4af4-b7e4-e8e1cb7c5148_terseLabel_en-US" xlink:label="lab_vtrs_TrailingFourQuartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing Four Quarters [Member]</link:label>
    <link:label id="lab_vtrs_TrailingFourQuartersMember_label_en-US" xlink:label="lab_vtrs_TrailingFourQuartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing Four Quarters [Member]</link:label>
    <link:label id="lab_vtrs_TrailingFourQuartersMember_documentation_en-US" xlink:label="lab_vtrs_TrailingFourQuartersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing Four Quarters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TrailingFourQuartersMember" xlink:href="vtrs-20220331.xsd#vtrs_TrailingFourQuartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TrailingFourQuartersMember" xlink:to="lab_vtrs_TrailingFourQuartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_72eab076-dd6e-44ad-8774-6222128e4ca8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b893cdeb-0bad-4253-9799-fd0ba3071b1f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_23410289-5f17-417a-91de-e001f19d32e9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d6019d92-8a9d-4766-9f6c-7971f09225be_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_d7cd9720-3115-44ab-895b-53c3dd9aaf49_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_08f64fd1-ae4f-4a42-aaa4-03b0e618d968_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_51410fae-00ef-4bfa-8c07-8887dac64329_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gains (losses) on derivatives, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_56de33ad-fe29-4187-8574-9030da6eacab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_313c0a7a-0ee1-4fe4-9839-63c7e3bb6cb7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_fa8cd627-38db-4980-b775-0ab3380d69c6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GenericsMember_598a7246-9522-4148-9566-c31e4f1045cc_terseLabel_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:label id="lab_vtrs_GenericsMember_label_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics [Member]</link:label>
    <link:label id="lab_vtrs_GenericsMember_documentation_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember" xlink:href="vtrs-20220331.xsd#vtrs_GenericsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GenericsMember" xlink:to="lab_vtrs_GenericsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_39b8dccb-1795-43e7-8d7e-1e5754165643_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_81533aca-385b-4d66-ab27-69c3684800f1_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_10758261-64e9-49de-8abc-0e6d29778ce9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension, Postretirement and Supplemental Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3f7b019e-162d-4e1c-888b-996ba9945516_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for product rights and other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_3d9d6543-0ced-482b-89c7-4b112a9ff704_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6b818f86-0d18-48ad-9fb0-866fa0cc6975_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1e94fc43-0706-445c-be9d-d5a200b79554_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_0b3df4c8-447c-47e4-afaf-9eb3c7bb63df_terseLabel_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2028EuroSeniorNotesMember" xlink:to="lab_vtrs_A2028EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c68664c1-0b8f-41df-b575-ba7a67f9177d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_b34273df-f6fb-4b4e-bffc-346a5bbe967c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_9e0c59ee-1ef3-4e0f-af26-423e23875f3c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_8d2cbf74-0184-4529-a35b-28d0390426b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_679d4595-4703-485e-a0f7-d705add90703_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6300e6d9-94b2-4aee-8377-fa5a4f31237d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_8d20daa7-5535-42c6-b1ef-469c8fffdb9a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_bdd5feea-1b05-4c05-a0e2-4ffb8b0b3918_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8904ecbf-68ee-439a-b68d-1e835cd71754_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_87d175cb-435c-4154-9497-8fffd6f1d5a1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_302581ee-50dc-4574-9fa5-3b411f32b248_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97148041-0381-4017-8ba2-7d47ec2c6b62_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1eda33d9-8078-4d33-9266-455e5133c154_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viatris Inc. shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofstates_132e4fe8-5f56-4b74-9929-cbadc73131f6_terseLabel_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_vtrs_Numberofstates_label_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_vtrs_Numberofstates_documentation_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates" xlink:href="vtrs-20220331.xsd#vtrs_Numberofstates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofstates" xlink:to="lab_vtrs_Numberofstates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_0498ed77-ea2d-4d45-9956-9d6498eaa5e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_bb81f60a-bc1e-4e95-be0f-4c6636018410_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c674f57a-48ee-4825-b3ba-216921d7881f_totalLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_157b0162-2638-4541-bc0d-0e981a74d8d6_terseLabel_en-US" xlink:label="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Competition and Markets Authority Proceedings Paroxetine</link:label>
    <link:label id="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_label_en-US" xlink:label="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Competition and Markets Authority Proceedings Paroxetine [Member]</link:label>
    <link:label id="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_documentation_en-US" xlink:label="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Competition and Markets Authority Proceedings Paroxetine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:href="vtrs-20220331.xsd#vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:to="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f1b9c951-20aa-4aec-aa35-1a490bb33f7d_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_32bd46f9-4385-4ffa-86c5-93479fb52b69_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0084d86f-221b-4190-9706-a8c758fcf340_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a238935e-c49b-49cb-90c9-392918e83af1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_2c09ee26-832a-4345-913b-bbaf4ddedb8b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segment</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_40c210df-1e23-4d56-8bd5-7d604a8cfe20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_6fa4e09a-021a-4c01-950a-e7fab84fd611_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9b02f183-45a7-45c6-a433-85f1f2623493_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_6022eb40-852d-411e-888d-c39e67bf6254_terseLabel_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_label_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_documentation_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:href="vtrs-20220331.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:to="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_bee09240-89ec-4c8b-9f09-67172ca4eb6e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_b0fa0708-3bbd-4e0d-ae8a-fc57abf48e8d_verboseLabel_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_label_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt [Member]</link:label>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_documentation_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember" xlink:href="vtrs-20220331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherLongTermDebtMember" xlink:to="lab_vtrs_OtherLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_868f03b2-0e3b-4b88-9ba6-8cdc15f21fe2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8996043c-f4a2-4131-a6d3-7755922388ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_beb75ff2-0c8e-4f15-9b40-7df9b7d1e2bf_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_60137bd5-e649-4d50-832d-4a4637aafd4d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_25056ae0-ce18-446e-95c8-0992e62eca8b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_6a27a588-94d0-4f3c-91b0-3440759e146b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_38a80903-aaf4-4fb6-8934-0882a1b5279e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f46e4921-7db6-450f-a348-f132eaec3024_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b5da9a8f-ed93-4b79-98ea-fc84797066e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_67cb546c-d8a2-43b4-8a1c-2b69e6d585f7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_7a3e4166-a365-4172-b95c-84348169b1b3_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4ff64d1b-df4e-4801-92b8-7b34abce781b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_571eb061-55a8-4181-935c-fd60e6897247_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma_efccc883-3169-46e8-ad7a-b929abc3a3dd_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma_label_en-US" xlink:label="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Basic Shares Outstanding, Pro Forma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_a33a7bc2-3185-45ec-ba11-86a865f9dec0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_c9e0042c-18b0-4de8-b339-224ba0f137df_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_8f1039ac-95d8-4237-bf6b-40e4cb3ec9e5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_2525f9a7-65b1-4ee9-82f4-42155e615fd1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ddd81cc6-b535-4961-8a47-eb82cbdea94d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_6dcbaba5-b02c-407c-9331-b7d699f827e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_647f5783-de2a-4d95-a240-402b98607ee1_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_63e850f8-6709-4862-adeb-6adafc029276_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_7cf00fd5-e990-40b7-9cf5-01e51e1873c3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt and other long-term obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef128ad2-1843-4f16-9c30-55c4d77ed75a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_cc413142-cdc8-46cb-97b6-4740c5787b9a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LyricaMember_44f9b8db-8e93-4539-855a-9558cf273de7_terseLabel_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174;</link:label>
    <link:label id="lab_vtrs_LyricaMember_label_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174; [Member]</link:label>
    <link:label id="lab_vtrs_LyricaMember_documentation_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember" xlink:href="vtrs-20220331.xsd#vtrs_LyricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LyricaMember" xlink:to="lab_vtrs_LyricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_9d07b90a-c984-4756-905d-3cecf772313e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PfizerInc.Member_6c0eefda-18ed-4dcc-b0fc-21d7c45c2680_terseLabel_en-US" xlink:label="lab_vtrs_PfizerInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Inc.</link:label>
    <link:label id="lab_vtrs_PfizerInc.Member_label_en-US" xlink:label="lab_vtrs_PfizerInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Inc. [Member]</link:label>
    <link:label id="lab_vtrs_PfizerInc.Member_documentation_en-US" xlink:label="lab_vtrs_PfizerInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member" xlink:href="vtrs-20220331.xsd#vtrs_PfizerInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PfizerInc.Member" xlink:to="lab_vtrs_PfizerInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4bc00a1d-6e35-48d3-ad0f-4c495d10c90c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0279077a-90e9-4675-8a2b-b0c6e6b7394a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9065df99-6ff6-4963-bec0-8f1d8bdac965_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f413862d-f763-4129-963f-6e5f85c96172_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCovenantTerms_0bcb618a-a053-4351-b673-68e07ea3b757_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCovenantTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCovenantTerms_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCovenantTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCovenantTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCovenantTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCovenantTerms" xlink:to="lab_us-gaap_LineOfCreditFacilityCovenantTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0a224d7a-539d-4721-9907-8d91ca758991_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_5b71a8f5-317e-432b-a327-0e4daea42968_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_8c08715b-feef-47dd-8d2e-8d705e8711d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ZoloftMember_122eaa7c-769e-41bd-9489-f52b51d8ad00_terseLabel_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174;</link:label>
    <link:label id="lab_vtrs_ZoloftMember_label_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174; [Member]</link:label>
    <link:label id="lab_vtrs_ZoloftMember_documentation_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember" xlink:href="vtrs-20220331.xsd#vtrs_ZoloftMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ZoloftMember" xlink:to="lab_vtrs_ZoloftMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_3c07d043-52b0-4a00-8146-6f3d69a3e508_terseLabel_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2040SeniorNotesMember" xlink:to="lab_vtrs_A2040SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_34068b11-1317-4c94-9d6b-1829782f4e91_negatedLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_d4347cb1-162a-4e6c-8d31-5f5c77f69733_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_b71b1220-5ad9-4ef2-96a0-165150964ec8_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:to="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_d15c2790-d787-4f16-8b73-7dd79fc9ca39_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable_67e9ee0f-68b7-4969-8424-217a8eb195bc_terseLabel_en-US" xlink:label="lab_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equivalent percentage of redeemed amount</link:label>
    <link:label id="lab_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable_label_en-US" xlink:label="lab_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equivalent Price Percentage Of Principal Amount Redeemable</link:label>
    <link:label id="lab_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable_documentation_en-US" xlink:label="lab_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage price equivalent at which long-term debt principal amount is redeemable prior to a specified date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable" xlink:href="vtrs-20220331.xsd#vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable" xlink:to="lab_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_f9f797ba-2672-4e09-8502-c8ece546ca3f_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_90057182-6a3c-4947-8283-e0ba0039402d_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_a3acf057-af2c-4d8c-8f9b-b382e0ec459d_terseLabel_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2025SeniorNotesMember" xlink:to="lab_vtrs_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_bbbcf1fd-958e-495b-9163-113bb6070983_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_3ad9f5c6-d4e2-4f99-ae73-4c86ff2081c1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-term Revenue Growth Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-term Revenue Growth Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:to="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_327742ad-dc46-4823-a7df-e2207f8a789b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb9184fa-ebcb-482d-a496-df5ecccaba08_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and non-operating expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4825ea55-4c88-406b-8340-f3221963e793_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_e2300fae-3c18-4d43-8316-1ec2f0337c08_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_d6bee74f-8668-4c4a-b5ff-36060e45de34_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_7d0b65cf-507a-4be8-ab36-1552fbaa9bd5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2153c41c-2bf1-45c9-8405-bacc28d3e8f6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, estimated useful life, in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TR_f6fe2662-7c32-47d5-9bd8-07ba50372278_terseLabel_en-US" xlink:label="lab_country_TR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TURKEY</link:label>
    <link:label id="lab_country_TR_label_en-US" xlink:label="lab_country_TR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TURKEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_TR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TR" xlink:to="lab_country_TR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_21a59f1a-ac0b-420a-ae35-5fc194418dd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V.</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_3d2450ab-300e-4721-a192-559c80c80f2e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AntitrustProceedingsMember_59e9bc58-1391-4b23-bc47-7376b42e8f8a_terseLabel_en-US" xlink:label="lab_vtrs_AntitrustProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust Proceedings</link:label>
    <link:label id="lab_vtrs_AntitrustProceedingsMember_label_en-US" xlink:label="lab_vtrs_AntitrustProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust Proceedings [Member]</link:label>
    <link:label id="lab_vtrs_AntitrustProceedingsMember_documentation_en-US" xlink:label="lab_vtrs_AntitrustProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust proceedings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AntitrustProceedingsMember" xlink:href="vtrs-20220331.xsd#vtrs_AntitrustProceedingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AntitrustProceedingsMember" xlink:to="lab_vtrs_AntitrustProceedingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_51df3060-7de9-4fdf-b4ac-10ea10d0e474_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e5bd76f7-b7b5-411f-82bd-606e487c414e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_fa7d31ba-9b0f-492c-9625-388ff5c58729_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_d3271842-bb91-4f01-b2c3-36908beccd29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_025dc37d-5ea9-4de5-b16f-bd7b6c836444_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_88a2bbd5-b26c-42b4-8beb-b1a8eb1310fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:to="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_dab3399e-b9e1-4473-b766-9d6d144e642a_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4120d2ab-69d6-4280-a669-b8c4f0787ff3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss) attributable to Viatris Inc. common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4bea7b0c-946e-46b8-9ffc-43ffdb56b48d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c2f29282-3578-4366-acab-d05be2438732_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a5004459-c840-4023-96ad-9376cb49ff77_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_2a5530cb-a167-4d4e-9962-203971e2620b_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value loss</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_07fd4bc8-0690-46b3-b803-ca058b6d237c_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d51ff3d9-f629-4ed4-9068-ced9067a03f6_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated percentage rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_e41f25ff-779f-4791-821c-49e3e3614374_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_328e6b3e-f721-4221-802c-b5f8772a4b3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3e4b2102-4d5b-4bf9-8f2d-6a6f7f122bb3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_547e46a6-1ac6-47a7-8830-20a059216f33_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_15e88813-b2f9-4197-a0ec-148920a237b8_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd156ac-21ea-4a76-9324-a0f68e679ecf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_631d78b3-fdc7-4684-96e0-77ee7a70ec2e_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_label_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncash litigation settlements, net</link:label>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_documentation_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncash litigation settlements, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:href="vtrs-20220331.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:to="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2809d1e0-b2ca-4f5e-92d1-1331883f2b05_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_2a6e89ae-ca1c-4ffa-8059-5b0cbaac4f2b_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Senior Notes (4.200% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyThree4.2Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand twenty three - 4.2 percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_bb9c31c6-1823-4d61-a755-3af02109bb76_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_9d5c6b06-3e2e-4875-96e2-2535de2121ee_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_761c159d-3f5c-40ac-97aa-d133cdac77ec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of terminated interest rate swaps</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2b962a2e-55e9-443c-a723-b66fec982e58_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_0402ef12-20ea-49bf-8d9b-4f9a3cfddc6e_negatedTotalLabel_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_label_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_documentation_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments" xlink:href="vtrs-20220331.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments" xlink:to="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_514091c0-3088-4a0f-9b24-2fdb9e3e03b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_94543b92-4653-47c2-802a-558fc2288114_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b83bae5e-5b46-45a6-9f26-5f3939ecd59a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_0da19ed4-c904-4642-ae65-025b98d7bc3c_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_2cc7fd79-d17d-409a-ae6b-5e3e83f70358_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_be631c0f-64f6-4115-9702-df932f4d74e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service costs</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_653a1d91-cd70-447e-b844-9762470e6762_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f86fb742-5ea1-446c-b6bc-6426a9c7f42d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_a84d3692-89e7-4b72-8261-cd628bfba708_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes (2.500% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandNineteen2.50Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes (2.500%)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ContingentConsiderationMember_91b1eaf4-68d1-42bf-8a78-ce92f1377711_terseLabel_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_vtrs_ContingentConsiderationMember_label_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_vtrs_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember" xlink:href="vtrs-20220331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ContingentConsiderationMember" xlink:to="lab_vtrs_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2b10fd82-8d51-400e-b95a-ccb9166e1f7c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_d93ec359-ac20-48c4-be08-ef3a9cd6fef4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment subject to certain adjustments</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_204e8d21-4cab-4747-9f7d-9a130388c1e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option award vesting period, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VariableConsiderationMember_cc5f0590-7d90-41a2-9b76-aa12213af2f5_terseLabel_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration</link:label>
    <link:label id="lab_vtrs_VariableConsiderationMember_label_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationMember_documentation_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VariableConsiderationMember" xlink:to="lab_vtrs_VariableConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_1ea09be1-63ed-4c32-9eee-f5cc4c180d3f_terseLabel_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2030SeniorNotesMember" xlink:to="lab_vtrs_A2030SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_70856e6c-2844-4505-9ff2-8d7bf2964c89_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_3554ccc6-e223-47cf-bc68-289b5dc146fc_terseLabel_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange traded funds</link:label>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_label_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Traded Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExchangeTradedFundsMember" xlink:to="lab_us-gaap_ExchangeTradedFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_d690fc1f-e6c1-4f69-88d2-2820ec813096_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock and Restricted Stock Unit Awards Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PeriodAxis_ef3a737f-e44f-4577-a794-2468fd3a4a2f_terseLabel_en-US" xlink:label="lab_vtrs_PeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Axis]</link:label>
    <link:label id="lab_vtrs_PeriodAxis_label_en-US" xlink:label="lab_vtrs_PeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Axis]</link:label>
    <link:label id="lab_vtrs_PeriodAxis_documentation_en-US" xlink:label="lab_vtrs_PeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis" xlink:href="vtrs-20220331.xsd#vtrs_PeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PeriodAxis" xlink:to="lab_vtrs_PeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_1d7ac0a7-8d3e-4bfe-9805-16f32cf6aaf4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_eb2e9422-1772-4b3c-bf1e-54f177fce251_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_0834ea22-d75b-45fc-9486-0eb98d16fb4c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_35a3078f-0be3-4877-84e5-f6822b631ebd_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal and professional accruals, including litigation accruals</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAbstract_80c1672b-dd5d-43da-8f53-4e47da9833fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_27234344-33d8-478f-9476-78173d380dc9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d2bb8019-139b-4d89-9d0e-6a0e65c55ea1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_fb411227-aca6-45c9-9252-90ed0096c17e_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_a92df612-2fd3-4aa9-95bc-f37a125bec94_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale and collection of receivables</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_1dcd59e9-3378-42b8-95e1-21abb790eb19_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7b751cd0-58cb-4367-9e0f-1aec11c0ef67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_3a98e984-0aa8-4d37-a0ae-90e29d6308e4_terseLabel_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars</link:label>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_label_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars [Member]</link:label>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_documentation_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember" xlink:href="vtrs-20220331.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ComplexGXAndBiosimilarsMember" xlink:to="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_267c0811-dfbc-4569-9d1d-a199b5adb51e_terseLabel_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets</link:label>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_label_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets Segment [Member]</link:label>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_documentation_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EmergingMarketsSegmentMember" xlink:to="lab_vtrs_EmergingMarketsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_764ad999-e53b-4386-8904-c189b0ceca7e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_b0286d11-36d2-4443-99cf-acf781d83c1e_terseLabel_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China</link:label>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_label_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China Segment [Member]</link:label>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_documentation_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GreaterChinaSegmentMember" xlink:to="lab_vtrs_GreaterChinaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_418b6744-7544-4255-b7df-96cf7cb44268_terseLabel_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Facility</link:label>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_label_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Facility [Member]</link:label>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_documentation_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember" xlink:href="vtrs-20220331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReceivablesFacilityMember" xlink:to="lab_vtrs_ReceivablesFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b9d12b9f-c3b4-4b44-b2a7-5c8ea2e841bb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_6534996a-9173-42a4-bc87-2b0b025be2cc_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_label_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_documentation_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates" xlink:href="vtrs-20220331.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Medicaidandothergovernmentalrebates" xlink:to="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_063a4d4f-1775-4208-8a00-0fde04be23bc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_27fb7465-f3b7-469c-bf73-877da010e4e4_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_a50ae92b-7ba4-4052-a131-25b326263305_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_f58333e1-52fd-4fb1-b751-31ab8ca6ded8_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c9b6cea1-7018-498c-943d-481a84899abe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_2ab1887a-336c-4c35-bb94-0548ae3b4e76_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_5b13b986-fe24-4dd2-a20b-3aed470ce599_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to Viatris Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c6e8af01-caf9-4f2d-aa36-7cfb04fe4e5a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_e489269a-0779-4ee2-a0f5-5c5a3eecdbbe_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis_ee2898d7-8603-4864-af2c-563d4d26c699_terseLabel_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments summarized financial data basis</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis_label_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments Summarized Financial Data Basis</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis_documentation_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments Summarized Financial Data Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis" xlink:href="vtrs-20220331.xsd#vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis" xlink:to="lab_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_3545f4aa-5962-44af-b98a-938f635cabb5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_175c4adf-379c-4794-bd7d-d5db83d8dc6f_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_caa89427-0750-4ade-9f66-2837f1f0fbe4_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_24ff15c1-0b9a-4de6-a7e5-85cde2c34be3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_fc95d302-4d7f-4cbe-b825-56631b702332_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_6683a0b8-0870-4b7b-9831-a111088d706f_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency borrowings and forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_afbf9b07-75b2-4c3a-9bd6-176dc04abc27_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2022EuroSeniorNotesMember_050283dc-7aec-470d-90fb-f49ce31378ab_terseLabel_en-US" xlink:label="lab_vtrs_A2022EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2022EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2022EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2022EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2022EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2022EuroSeniorNotesMember" xlink:to="lab_vtrs_A2022EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_44a828ee-8081-4a63-8e43-b63a5d871eca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_cd231f18-663f-4e5a-8353-8146a9e2f24a_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_2fd41480-4475-4acf-b868-dc3110a538b0_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and technologies</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5320f8fe-c0bb-4f2b-ad1a-c93cf3b7f18a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e4cf9729-8bb4-4beb-9945-6ca5f7a3ab92_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_f4f416e3-499c-4616-9f50-574c068d7808_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_5f613feb-af0c-418e-85a2-9391033b0477_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_20ec4cee-eb08-497a-a6fc-99f8389d5f5a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_a9cea641-6e6b-46c2-8ed9-2f1f84840a87_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_10e6c1af-d434-418f-a444-887c5e58814e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DymistaMember_73d4f285-feca-41b7-8095-9185002002e4_terseLabel_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174;</link:label>
    <link:label id="lab_vtrs_DymistaMember_label_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174; [Member]</link:label>
    <link:label id="lab_vtrs_DymistaMember_documentation_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember" xlink:href="vtrs-20220331.xsd#vtrs_DymistaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DymistaMember" xlink:to="lab_vtrs_DymistaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_bbc7e82a-a963-4bcf-ab4e-df14a9dad460_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_1b834060-6431-4a0d-b21c-fd736f80bb0b_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_50be2529-3d51-44d1-868e-ba8c707a1856_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_d6757da6-eaf1-4781-a6c7-d95fa81b78a6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount_3abc5a31-2bb1-4e93-827f-f6512725f7dc_terseLabel_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected reduction to tax expense by CARES Act</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount_label_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, CARES Act, Amount</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount_documentation_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, CARES Act, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount" xlink:href="vtrs-20220331.xsd#vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount" xlink:to="lab_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_51a586c8-164b-451f-bb07-817f00c47dda_terseLabel_en-US" xlink:label="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans, estimated benefit payments, in current fiscal year</link:label>
    <link:label id="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_label_en-US" xlink:label="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans, estimated benefit payments, in current fiscal year</link:label>
    <link:label id="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_documentation_en-US" xlink:label="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans, estimated benefit payments, in current fiscal year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:href="vtrs-20220331.xsd#vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:to="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_a146912c-23c2-4b1a-ad39-49c8821adc3d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_5fcc7836-c028-403b-bad3-131b22746ab0_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1028d04e-ab63-41d0-a50e-bac4f75e2276_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_8c9ebbb5-fb8f-4d6a-8287-cf762877d597_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c976b9d4-7eb9-436a-967e-e2b4dccb5705_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_ed9f34a2-b1a5-4876-8e37-10c0aa76015b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7f0dadeb-f488-4a38-bfd0-3bded69347ea_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da29eb78-5c22-497a-9d49-5e645bdf86e9_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total dilutive shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_6011d70e-a464-4be6-a7d7-d718c07ea274_totalLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible asset amortization expense (including impairment charges)</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_53a8f091-e6dc-472e-9a8c-533b1fa722ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c7406d5f-e2cb-4bfe-b772-dc2af10eeea6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_db905324-4749-460b-8caf-bba56ad13e58_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_14c8adb0-a818-4f20-8d8f-52524f950c25_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_631dfc13-81fc-45e9-b863-12154ab8a6e7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_de4b4918-0f14-4eaa-840a-1717649f07ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_ca79664f-157d-4857-8cd8-dddf0a1909e1_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Notes (2.600% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 2.6 Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 2.6% [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_def6c706-a7b1-461f-a3c8-fb70b430ab32_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInput_5275e5e6-afa6-4a52-83ca-a57b760fa5a9_negatedTerseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInput_label_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInput_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInput" xlink:href="vtrs-20220331.xsd#vtrs_GoodwillImpairmentMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairmentMeasurementInput" xlink:to="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020FloatingRateEuroNotesMember_89f8afe1-e82f-4d2e-a471-ab8db5e3b41e_terseLabel_en-US" xlink:label="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Floating Rate Euro Notes</link:label>
    <link:label id="lab_vtrs_A2020FloatingRateEuroNotesMember_label_en-US" xlink:label="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Floating Rate Euro Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2020FloatingRateEuroNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Floating Rate Euro Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020FloatingRateEuroNotesMember" xlink:to="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_2af804f7-42ad-4e64-bf60-e026ec22a401_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d745e44-2b4a-4de0-9e5c-0ebf4d9fe56a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_647905a1-e69d-4066-b67f-b7f032d51c29_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_a0e1c476-6599-4f61-96a7-088e4363b20f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_ccda3a9d-5b37-49fe-93fc-62e4610ba124_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine3_ce79570a-8735-4b51-bd7c-d858d110eaa0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine3_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3" xlink:to="lab_dei_EntityAddressAddressLine3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e40c126b-ba44-4eba-a41b-874b10ee3fa4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_3b0a18e6-cc7c-4b57-bb42-173634d7a951_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:to="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5561580f-20d2-47d2-9188-04b979581d70_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_01330edd-b06d-4d5a-8a48-c0c916c389e9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_36f682b6-5790-46d0-94a0-c9199f9627b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0c378bbc-8f33-4b0d-be6a-cc885065ddfc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_970f21d5-7452-4f6c-9ab8-dbb9691fa0b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_0f077811-3d8f-4fdb-8b8a-baa128a97109_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_11d707e1-ea8c-4563-aee1-beea1aad62ba_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_ad090dc9-d45c-4223-ba95-b25f2a843dd7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_49fa3991-ec1b-4bde-8a61-1bb8d4c2e25b_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_e1e0d042-3d0f-44be-83c5-56a9b3f6e3d0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_58bb8b0d-1f04-4717-bddd-65afb3b9a3f6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_81028068-2099-4fdc-9dca-0506ee33d6bd_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_58c60d81-1c5a-4d43-be65-1c2f67402d25_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Risk Management</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_90e139fe-e3f0-418a-9f68-9b65de2bc213_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of defendants</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:to="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_edb315ea-308a-4ec0-bc65-bb0e559df4b3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_cca367da-4c49-4645-b65b-18247b7d4be8_terseLabel_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive Plan 2003</link:label>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_label_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan 2003 [Member]</link:label>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_documentation_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive 2003 Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member" xlink:href="vtrs-20220331.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LongTermIncentivePlan2003Member" xlink:to="lab_vtrs_LongTermIncentivePlan2003Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy_5b89cef6-aad3-45e4-852e-53438dff9ea6_terseLabel_en-US" xlink:label="lab_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Net Sales Impacted, High Inflationary Economy</link:label>
    <link:label id="lab_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy_label_en-US" xlink:label="lab_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Consolidated Net Sales Impacted, High Inflationary Economy</link:label>
    <link:label id="lab_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy_documentation_en-US" xlink:label="lab_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Consolidated Net Sales Impacted, High Inflationary Economy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" xlink:href="vtrs-20220331.xsd#vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" xlink:to="lab_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_62c0a32b-33e0-4e47-b2e9-081829276b90_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_66512efb-6baf-4511-abf2-d6d5785d219e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b4170fd1-bc08-4ae2-b6df-546d13ec010c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation expense, net of estimated forfeitures</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification_d77ae28f-243c-475d-ad45-7533db16e7e5_terseLabel_en-US" xlink:label="lab_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Good will, After Amortization Expense, Before Reclassification</link:label>
    <link:label id="lab_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification_label_en-US" xlink:label="lab_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Good will, After Amortization Expense, Before Reclassification</link:label>
    <link:label id="lab_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification_documentation_en-US" xlink:label="lab_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Good will, After Amortization Expense, Before Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification" xlink:href="vtrs-20220331.xsd#vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification" xlink:to="lab_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f9209662-f612-4239-938b-f2fc24b322b4_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_52a8660d-57f5-435c-ac36-8b0ca54860e7_terseLabel_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_label_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_documentation_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:href="vtrs-20220331.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:to="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b21c85fb-c3ba-4651-8a23-8348c529cb6b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e5e496f2-ec34-4850-b541-cb7158d919b4_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net book value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_ea3525b7-2776-4627-826e-5091a1b2f0e9_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_5b4bf950-f4b3-46cb-b228-32c7d23f6bc4_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d09c7fc9-aba7-4681-ac32-92205d545108_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_c903ac14-558a-45ef-9a1d-29a2eb0ec2da_totalLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember_f69d356f-ce44-4f0b-ad8f-52ded42ff9b5_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Increase in Discount Rate</link:label>
    <link:label id="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Increase in Discount Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Increase in Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputIncreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:to="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_89aa7418-75a1-4cd1-bb6b-5bed1ae3803a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_0876732f-3e86-47ff-b058-b26c36dbac39_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_0f10ac35-1681-498b-8738-29f6e6ec444e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_4127e02c-6b5a-4669-ada6-f80b63d8dce5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c353130e-4231-441f-bb14-65ce53ecddf0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2a25f593-e5f7-468c-9d1a-a3510a5be4ae_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ed12d5b6-0939-4bc7-9aba-2792584bc6d1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_99789a61-d9d0-4297-b23c-ee7ed694a241_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for stock awards vested and expected to vest, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_XalabrandsMember_4c98a301-6209-49cb-be00-271f9ec5c836_terseLabel_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands</link:label>
    <link:label id="lab_vtrs_XalabrandsMember_label_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands [Member]</link:label>
    <link:label id="lab_vtrs_XalabrandsMember_documentation_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember" xlink:href="vtrs-20220331.xsd#vtrs_XalabrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_XalabrandsMember" xlink:to="lab_vtrs_XalabrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_8f2769bc-f2fb-4da9-99e8-4c3f2cb26bfa_terseLabel_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office</link:label>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_label_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AustralianTaxationOfficeMember" xlink:to="lab_us-gaap_AustralianTaxationOfficeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_d67f544d-fd34-42e2-9fc1-b4abfa713a43_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_5fc415b2-6672-44e3-a6d1-3d5bc45095c3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0d06251e-6aa1-49fa-a06a-4347334fca37_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_6d6fb72b-b4ad-40c5-a795-1a25ce98de9d_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and other noncurrent obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_9155c270-4d21-42a6-8250-88628a36269e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_cb7bce6f-aa8b-4fe3-8401-ccb66724512d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share Policy</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_85d9a752-56fa-4b01-9fbc-eb0a4fb6eb89_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db02aae8-67e9-4536-9902-cd9381585a59_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_59784304-c720-4666-b003-89818a18ae17_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_6cfba387-80f2-4846-af72-238b413f3f39_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and employee benefit liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_e0733374-cbbb-46cc-b9b0-8bdb08ec9bc8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_62cab958-668a-4f25-85e7-fd191a69b0f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7f09a977-c896-4a69-97fb-31341d142f5d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d2c9577b-764a-41f6-9c72-6a8f10fe4764_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EUCommissionProceedingsPerindorprilMember_6e91ed75-f7ce-4cd1-9399-3a4730c2a2f5_terseLabel_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Commission Proceedings - Perindorpril</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsPerindorprilMember_label_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Perindorpril [Member]</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsPerindorprilMember_documentation_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Perindorpril</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:href="vtrs-20220331.xsd#vtrs_EUCommissionProceedingsPerindorprilMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:to="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fb8b96ef-7606-4f4d-9e33-a4a80aac4a80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Repayments on Outstanding Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_bcdf8d0d-6199-4fb4-8114-4dce28cbba7e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Policy</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_889df24a-a4cb-4498-889e-c52801718bef_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_fde13e41-ea33-453f-8781-cbb9b006152f_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Senior Notes (3.125% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyThree3.125Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand twenty three - 3.125 percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_ede2f93b-5f22-4a86-b25c-2c965015b56c_terseLabel_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</link:label>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_label_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:href="vtrs-20220331.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:to="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_1107d26f-067d-4061-acbb-8be53a37f97d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_4b092203-9f8c-4159-b3ec-1bdcfea154b7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_24b4d99c-3310-4196-bce5-690673b42ff7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_410767a8-3ea3-4bb6-ae7e-798a19eafc1d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ae97d328-3557-4188-8b6f-7cb3ab160af6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_dbf68713-5414-4bb6-af7a-6a572529debb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_f370cb71-bf65-44b3-a46b-5a32dcae2bd7_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0f5be4a9-17fe-447b-a94c-a948fd7fcc06_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_ac17572c-0693-4cb1-95ba-6a57cee09b2e_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes (3.150% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyOne3.15Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes 3.15%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4b2f4645-3bc7-4d11-bcbc-ee63e6e578c2_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_3813a414-ce2a-41de-a2f9-effe0f43fecd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_1b9a3d30-c575-4873-85fa-3936cabce5e6_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ViagraMember_3338effb-8326-4f87-a778-4e4b1f51c426_terseLabel_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174;</link:label>
    <link:label id="lab_vtrs_ViagraMember_label_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174; [Member]</link:label>
    <link:label id="lab_vtrs_ViagraMember_documentation_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember" xlink:href="vtrs-20220331.xsd#vtrs_ViagraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ViagraMember" xlink:to="lab_vtrs_ViagraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_9a7b2098-2967-418d-b8db-68659b824091_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_label_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:to="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75775411-5b89-471c-8c7c-5b557c78462c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_d2f39f30-42db-44be-a47a-4a2c75d99c3a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_ef028f35-160d-4723-a965-1e7c1db65549_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of financing fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CleanEnergyPartnershipsMember_9e32bad8-2d3c-4271-8715-781c4ff5a128_terseLabel_en-US" xlink:label="lab_vtrs_CleanEnergyPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean Energy Partnerships [Member]</link:label>
    <link:label id="lab_vtrs_CleanEnergyPartnershipsMember_94adca24-195d-42a3-a2d7-27e383a440d2_verboseLabel_en-US" xlink:label="lab_vtrs_CleanEnergyPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean energy investments</link:label>
    <link:label id="lab_vtrs_CleanEnergyPartnershipsMember_label_en-US" xlink:label="lab_vtrs_CleanEnergyPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean Energy Partnerships [Member]</link:label>
    <link:label id="lab_vtrs_CleanEnergyPartnershipsMember_documentation_en-US" xlink:label="lab_vtrs_CleanEnergyPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean Energy Partnerships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CleanEnergyPartnershipsMember" xlink:to="lab_vtrs_CleanEnergyPartnershipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_43081bba-5b55-458b-be65-e580fbac289e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_515eb9c1-d535-4bc3-9fb0-b76dc7cc1c71_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_becad1c5-43a2-43ee-b248-f25586bd42ea_terseLabel_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_label_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_documentation_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EpiPenAutoInjectorsMember" xlink:to="lab_vtrs_EpiPenAutoInjectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3282c6f3-7dc9-4d30-a78b-d51d6d920b08_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_70469246-6070-4efe-9e3b-05e1369200f7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_8af2804b-5c0e-484b-b899-111b07061424_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_29ff8b06-37e4-48e8-b549-842680edf14b_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_1d73c2f1-00e2-4325-bb5c-06c59af869a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_dc92e466-d976-4507-aae9-773c25502412_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_d16ff32a-2f39-4443-bdb1-ae566de7f15f_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b9065842-bd95-457c-844f-ed692a35cd24_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_b6af9757-1bd1-4e17-be6f-bddd9598ab99_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment losses, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ecf144dd-ecf0-4651-93e8-3b891d737c04_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment losses, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6529c943-0df8-495a-9780-ce9294d5fc74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_5881deb1-45a3-403a-97bb-81ad4da4e3f8_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciling items:</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_41f0c021-ed3b-4d05-b442-cc32e09c1664_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_30ce648c-aaa2-4a40-9f84-00ce024a14aa_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0c493821-5d57-4f25-9acd-1a265183ed58_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_84752edf-4cbf-4402-9be0-9979df1429ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c956085e-9a0e-46b9-982a-fcb5571d80b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a5aa8bd1-bb07-4c96-a82e-9856ab340b30_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_da7ee9bc-57b9-43ae-a805-f697d67d79b1_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_2ec01143-1f45-477d-8f18-49e8a6043f9c_terseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable securitization facility maximum borrowing capacity</link:label>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Facility Maximum Borrowing Capacity</link:label>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable facility maximum borrowing capacity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:href="vtrs-20220331.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:to="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_3980f87c-d1c6-4269-acb8-c9a53388254d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_0333be80-cd17-4fc0-8442-dfe18d5d275d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_1fc8637f-ff78-4f41-98a1-a884623eaa76_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_25e6ec46-80b4-4ecb-83f8-cee76ea6b666_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_47920e71-44e4-4333-aea7-76d2de49d223_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_100b9c67-4a2d-4ef8-ae46-04041b208b1f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8785ab5-68ec-4b34-90d3-2a403df432b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_073d2485-b6a1-404c-8294-95dba5e08e29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_47dccbd5-1413-4e47-be00-adc379a84689_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_73909188-f756-472f-9c0f-942863892f8d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyTable_6f149e99-2636-44bb-b90b-3443704c42f8_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty [Table]</link:label>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyTable_label_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable" xlink:to="lab_us-gaap_UnusualRiskOrUncertaintyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_8ab58667-d96a-4d2f-8f3e-c4e76eeed0d0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9d127ca6-3ecb-490b-a355-83976efdfdfb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_259b9446-f98d-4142-bae5-ff3d36a28265_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_48ef521c-f4b7-4a6e-90d3-36c25163d8da_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:to="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_32574738-43ef-40f9-8491-984d5e061ac3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1a07d940-c6de-4fa8-846d-c3a248f97b90_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares reserved for issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_1e22675e-7a66-4d73-8777-365533ad6be9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofcases_cb8b86ed-1275-400a-b064-baaef0e9725b_terseLabel_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_vtrs_Numberofcases_label_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_vtrs_Numberofcases_documentation_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases" xlink:href="vtrs-20220331.xsd#vtrs_Numberofcases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofcases" xlink:to="lab_vtrs_Numberofcases" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_8cda16ec-1eee-4068-8375-8df895c9d442_terseLabel_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JANZ</link:label>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_label_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia and New Zealand Segment [Member]</link:label>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_documentation_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia and New Zealand Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:to="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_557b809e-0264-4931-b310-8e020cce444a_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_label_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:to="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_904123ee-e85f-4bcf-a882-f25d5cc2ee7d_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_e0852cee-8a92-4ea6-b5d0-15807c68f211_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_292c96c6-4661-4267-8fb5-dc71d62d7cfc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_d2cf32d2-a2ed-495e-a52c-c5b3513dff1d_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_1c772a26-a13f-4d29-b34f-864e9af4bf8e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at recurring fair value measurement</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f4e8331c-8ac8-4109-9bd5-49b9a81de783_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f8d1f2a3-5edf-4fa0-b90c-fa38aa8872fb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4b8b1d85-88be-43fe-b3a7-70e748c47a0f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_60838d88-e21f-4dd2-8a62-245f35b8d13e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e11dffb9-b1e6-4bca-9084-3f5e0d78ef59_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyEightMember_d87927ed-a057-43f8-830c-546b3bcf8ebf_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes (5.200%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyEightMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortyEight [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyEightMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortyEight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_c1f596c6-1ff5-4058-bccd-ef791e64be42_terseLabel_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Euro Senior Notes due 2025</link:label>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2025EuroSeniorNotesMember" xlink:to="lab_vtrs_A2025EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_8b9fe493-e5df-405a-8248-51ad177d006e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_90e20998-989c-4629-a3dd-daa5f792b263_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e93dbfd5-ef9a-45df-a098-31a4f9843815_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative assets</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_6c6cba7f-5a2c-470e-93b3-912783e0240b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_1be0d2be-7547-45c5-b0e9-c0b42f5014d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_4cd26fd0-cc86-4793-9406-a38857e29fbb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_36e12e57-ab71-45c1-b55b-6ddbcfdd320c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0ec4accb-959b-4944-bb21-c78e49b895ed_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eb384663-90bb-4494-9535-92f46c4da34e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_6f74eb19-91cc-413d-8238-7589cc471f76_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_7eb6e9f4-a39c-4b55-9cf6-3c2d9b6e0794_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_6efafe96-9866-46d1-9132-816c994e9c8a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_bdc0ac58-df01-4388-b453-152be1c9160c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_da4a1f9f-3e99-4b71-abce-1fc59117af67_terseLabel_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility</link:label>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_label_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility [Member]</link:label>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_documentation_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember" xlink:href="vtrs-20220331.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NoteSecuritizationFacilityMember" xlink:to="lab_vtrs_NoteSecuritizationFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_69878d3f-fe99-41c7-8007-3a4bf92368b4_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_c93819de-097f-46bc-b7e9-85365d43aaa7_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross loss</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_af33e4f6-a539-4b5b-a516-28e57d74aed6_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on cash of changes in exchange rates</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember_294bcfe8-75d0-4be6-88df-a081bbc094be_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyEight [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyEight [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyEight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_2ed61b19-7d71-4ca2-8906-eab23768c739_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ffd09510-c6b0-486b-9bbf-028242002466_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_388ce9d4-611d-444b-9859-a2736437803f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_f4c7c65a-7b93-469f-b5d1-ee56f1454480_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_InfluvacMember_b408fb74-7b70-4097-a297-37485121e655_terseLabel_en-US" xlink:label="lab_vtrs_InfluvacMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influvac &#174;</link:label>
    <link:label id="lab_vtrs_InfluvacMember_label_en-US" xlink:label="lab_vtrs_InfluvacMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influvac &#174; [Member]</link:label>
    <link:label id="lab_vtrs_InfluvacMember_documentation_en-US" xlink:label="lab_vtrs_InfluvacMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influvac &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InfluvacMember" xlink:href="vtrs-20220331.xsd#vtrs_InfluvacMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_InfluvacMember" xlink:to="lab_vtrs_InfluvacMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_185bc924-46bb-4b5c-a3aa-97b349e9d38b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f2f15434-b166-4834-a06b-4bd5bf4bdbbf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss) before reclassifications, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_c2bb9e34-293c-4785-b87c-bb1f9a1b8763_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorthAmericaBrandsMember_abca3244-a19c-4fbe-8489-ec954b0fbc45_terseLabel_en-US" xlink:label="lab_vtrs_NorthAmericaBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Brands</link:label>
    <link:label id="lab_vtrs_NorthAmericaBrandsMember_label_en-US" xlink:label="lab_vtrs_NorthAmericaBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Brands [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaBrandsMember_documentation_en-US" xlink:label="lab_vtrs_NorthAmericaBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaBrandsMember" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorthAmericaBrandsMember" xlink:to="lab_vtrs_NorthAmericaBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0da7a83a-750d-476a-815f-0b6985cc09cc_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ad7a5567-992f-437e-b56c-e66a8368539e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions, net</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_556e4b31-218e-4f34-9c00-0c9f42756078_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0ebe0d0f-2ac1-4434-b422-bcffed158a1f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_f5fc2204-e0d6-40eb-8a4a-edcab56aa173_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Exit Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_b45a1f5a-1291-4b8a-96da-2242dcb7c1ae_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b38087b3-9832-4c5e-be65-b03948eb0faa_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Incentive Plan</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_bb5f476b-e624-4bea-ba82-7dad9b022f16_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_2fb3d295-f157-4fc7-a5b5-72d6b5932abd_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6dd5cb34-97ef-48e1-98dd-664b503891d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain on marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2c0edda8-83f6-452d-8f8b-b0561d4eacc7_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on marketable securities, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d3567cbe-2649-4478-8ea5-e698954d4084_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on marketable securities, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_4cbed192-8462-4429-b2b3-402fd9abd178_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of other current liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:to="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_51506bec-068d-4f42-b2ef-bec2dc76b89c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_56aafe44-b555-42de-9464-5925aec6e1c4_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting Policy</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4fb6794d-a1f2-4f1d-88b5-1bb37ad83d9a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06e85daa-790d-4bb9-be9c-aa78b50aa4a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bfc574f2-f245-45a1-8d09-40b26ff7471e_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_049a73a8-1bb4-45c4-b035-11557f508a93_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_fdd10495-69d9-4244-ad4a-fb7653f8e455_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_bf7238e6-484a-4d0a-ae99-2b9ad73f8e17_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_56284a00-91ed-47c7-ba3c-65cc3d9d3ea7_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_4a0ed7c1-b2a3-4c1a-9762-2bf24024c3fb_terseLabel_en-US" xlink:label="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_label_en-US" xlink:label="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Weighted Average Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:to="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5914f6f9-f7ae-486b-8673-33e3c8d77671_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_465e51e9-fa8c-40a0-b872-102446edea1e_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_41e83f16-170e-4422-a13a-b6f079962a6c_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_7aeec60b-814d-4c35-9c44-57c34559c18d_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyLineItems_034c9b85-a620-4b4d-826f-e65425a902eb_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty [Line Items]</link:label>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyLineItems_label_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyLineItems" xlink:to="lab_us-gaap_UnusualRiskOrUncertaintyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_8dc787f8-20d3-49a1-b500-f899354425e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a83342b1-5c98-450a-ab68-ddcb80489e7f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_4a8cc5c9-263a-4c74-806d-b24904a66adb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_a2f1f3e4-5bf3-4baa-b3b8-27e058c38e5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_4f4f6ed7-036c-42ea-9017-97298f883a69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_84e70a69-e6c7-4aef-85f3-f464614ff2b6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_d3aa95be-d2ba-4c11-a48f-1ca9a27db59c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_283175ad-c606-4f68-bce4-fdebf5e79974_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_cd03c542-6f02-4b8f-8436-12be75043b95_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Notes (3.000% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 3.0 Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 3.0 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_b3db0079-b824-41c5-a73b-8be4ca60d063_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_1edd651a-921b-4a4e-8419-9eef5fe79a89_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_8129cd66-f4d1-4c36-b57b-369c6ccdaad3_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7e447760-7045-400a-92a4-da508720eb44_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_266c293d-cf3e-4cec-9819-bc651eddc653_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Reduction in Terminal Year Revenue Growth Rate</link:label>
    <link:label id="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Reduction in Terminal Year Revenue Growth Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:to="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_b6276d50-d722-41bb-96d9-e5366e48ffa6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5d1bee97-895f-4e79-88c8-1790c0511cdb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0736932a-81fd-4a8c-bb35-5564e1505fba_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a2355954-0934-4cbb-9851-c022ce01287a_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8f506f1c-cfde-4261-9276-fc8d8df5e88f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_7b682ed4-302e-49ac-b00d-d364cbbda08a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_60494912-5635-4464-bfb4-340cb2f0548a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fa397730-72f8-4f79-87dd-6fbbd93ddcfc_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_d38ea3c6-ebf8-4fc4-a54d-ba57677a65a5_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2046 Senior Notes (5.250% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortySix5.25Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2046 Senior Note (5.250%)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_fdc2381f-a701-41e6-8920-1e63d99bcb18_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7c01a828-7cd2-4923-8a56-2d36290007c1_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_defc98f9-ff37-4db4-bbb9-50bc7fb48a22_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_7e641f5d-bfff-4d38-a32e-9740f7785506_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_617b0e61-cb39-4341-b5ae-865c764ea663_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments, clean energy investments</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_2dc4ec75-0ab1-43b9-9cdd-05441bcf034c_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ae10d66a-b58d-4945-8606-59a9eb599569_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0dab83f8-8fb3-4880-90f4-bc2a74423e1f_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b131ec12-b587-49a7-a0b7-5e2680acf380_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_f3b4fbe4-5c5b-4153-987a-20df8256f65b_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_label_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_documentation_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:to="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_264a0bf3-d53f-4e6b-87e5-061800862d85_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_ea9341e5-5110-4e64-ba69-3bec0a065e55_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CreonMember_a35c8444-4771-4096-ac52-c9dc499bc22c_terseLabel_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174;</link:label>
    <link:label id="lab_vtrs_CreonMember_label_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174; [Member]</link:label>
    <link:label id="lab_vtrs_CreonMember_documentation_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember" xlink:href="vtrs-20220331.xsd#vtrs_CreonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CreonMember" xlink:to="lab_vtrs_CreonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8b2af6d1-a696-4e6a-bb95-3509ed4d7b5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized (loss) gain and prior service cost related to defined benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_0faffaca-4a00-48e3-b0cc-d8a87b84b6be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_83f63c09-f1c9-445c-ac3a-f8205c75bc65_negatedNetLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized gain and prior service cost related to defined benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d2901377-3cd3-441c-9348-ebeb0e2938ca_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EpiPenAutoInjectorCivilLitigationMember_51f508f9-eec0-4bf0-9d85-561f92c1fea1_terseLabel_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto Injector Civil Litigation [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorCivilLitigationMember_label_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto Injector Civil Litigation [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorCivilLitigationMember_documentation_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto Injector Civil Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorCivilLitigationMember" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorCivilLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EpiPenAutoInjectorCivilLitigationMember" xlink:to="lab_vtrs_EpiPenAutoInjectorCivilLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_1dd0728d-081b-42b6-bd66-ef1786007703_terseLabel_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion of Long-Term Debt</link:label>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_label_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion of Long-Term Debt [Member]</link:label>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_documentation_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember" xlink:href="vtrs-20220331.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CurrentPortionofLongTermDebtMember" xlink:to="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0be8cb2e-8d5a-437c-a194-bbcf88bb9ca4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_2c0e779e-b58f-424f-9f66-0508de9c2a61_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_63861980-fef1-47c8-b033-eaa30fda65b2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_cea6efe7-2697-4efd-bfbe-721e8b2a69f0_verboseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_d3c3d66c-0a0a-496f-b834-6599e3c1b61e_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_637546cc-bceb-4150-9ec9-e8dc701368a4_terseLabel_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2050SeniorNotesMember" xlink:to="lab_vtrs_A2050SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_63a6903c-6b68-40b1-9b83-79f0edc22fa0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_9b8a84d4-d482-483e-815f-75658417dc10_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_38cfb6c2-da16-49c6-8633-197305173dfd_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_6fe205fd-c490-4ad4-9647-d21edabdcb12_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c11e1120-f635-45db-9398-4a3f5b738963_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_a8225916-4793-4a0a-b295-c8f92b87680b_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case Type [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_955769e6-689f-4c1b-94c7-86688fe8c574_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option award expiration period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_6bd8b4a9-bbfa-4ddb-9933-a93e1db64351_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Merger Related Costs, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:to="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_6567b765-1def-475d-b7e3-7feb4a912f69_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_83b393a9-8602-446a-a299-69982753e35c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d00f1623-c047-4319-9802-04a3fa4e8b00_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filler Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_e227e1ff-5ce4-4024-bf6e-852a6d39d99b_terseLabel_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets</link:label>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_label_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets Segment [Member]</link:label>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_documentation_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DevelopedMarketsSegmentMember" xlink:to="lab_vtrs_DevelopedMarketsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_fc707551-dd0e-4d33-9767-b6555fd53b4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_d79199e9-1a74-4fd7-b806-d06ce57d3874_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember_aabb5c01-d646-4028-8dd6-5ca2f54ac171_terseLabel_en-US" xlink:label="lab_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modafinil Antitrust Litigation and FTC Inquiry</link:label>
    <link:label id="lab_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember_label_en-US" xlink:label="lab_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modafinil Antitrust Litigation and FTC Inquiry [Member]</link:label>
    <link:label id="lab_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember_documentation_en-US" xlink:label="lab_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modafinil Antitrust Litigation and FTC Inquiry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember" xlink:href="vtrs-20220331.xsd#vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember" xlink:to="lab_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CelebrexMember_b819b980-06db-433a-ade8-9d96e540e287_terseLabel_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174;</link:label>
    <link:label id="lab_vtrs_CelebrexMember_label_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174; [Member]</link:label>
    <link:label id="lab_vtrs_CelebrexMember_documentation_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember" xlink:href="vtrs-20220331.xsd#vtrs_CelebrexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CelebrexMember" xlink:to="lab_vtrs_CelebrexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_c45c35ad-ef97-4f33-b048-e5d4af7180a4_terseLabel_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2028SeniorNotesMember" xlink:to="lab_vtrs_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f2376d91-6f07-4d4b-b2eb-bf53782b3211_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionExpense_c2d31d1d-4e39-49aa-baf2-ef64174d2d1a_terseLabel_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion expense</link:label>
    <link:label id="lab_us-gaap_AccretionExpense_label_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionExpense" xlink:to="lab_us-gaap_AccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_89a642c2-cca6-4458-a5cd-1f1d22330ca4_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_b10d8b83-28e3-446c-8b66-e5d9a3d4083f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_de1dd685-100d-4549-92f4-375fb56ee980_terseLabel_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_label_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_documentation_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:href="vtrs-20220331.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:to="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b625615c-3156-4ed3-a246-0c984ff4c1bc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e919bdc7-f43b-4feb-b353-ea62644dded6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62664e68-9a38-43af-bdd4-45631b0b68d1_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_067f6166-36c9-43ea-8127-1546f6d854d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1b0ff265-f423-42a6-b070-adde6e2781fa_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_87ecee76-787e-4e3b-968a-29dbcb02ab9c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7022c883-d9b3-4993-b56a-e63c9272e368_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemMember_42a6eef6-f14f-4592-8a58-c3fc86b56636_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemMember_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemMember" xlink:to="lab_us-gaap_UnusualOrInfrequentItemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f347a228-86a2-45d4-9976-0a23d03a69c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_790bc9ae-50c1-4464-ad69-bc1d07a314dd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_491ecbae-f513-416c-8a36-724c58df33d2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9bda0027-121b-4a07-95cc-3c05420aa93d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_1ac3a379-e01b-4d3e-9131-ecf70bfdffa6_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8a7403a9-ccec-42a4-a06f-edcd29e0fec3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Segment Information to Total Consolidated Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_54eb8202-422b-4a11-b8e1-f42103d57e41_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d896f5b5-de04-4fa5-a147-b3c12bb1418d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_af1c0e11-4785-4358-9942-a0d5f13095db_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EUCommissionProceedingsCitalopramMember_98438a28-bdb3-422c-ae69-03d54746b31d_terseLabel_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Union Commission Proceedings - Citalopram</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsCitalopramMember_label_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Citalopram [Member]</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsCitalopramMember_documentation_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Citalopram</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsCitalopramMember" xlink:href="vtrs-20220331.xsd#vtrs_EUCommissionProceedingsCitalopramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EUCommissionProceedingsCitalopramMember" xlink:to="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_e6a35a85-4d83-474d-b032-c84ad6884613_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Reclassifications</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Reclassifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f83fbdd4-3e8f-40b8-b04a-96e49a36b2f5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BiosimilarsPortfolioMember_054da137-78b1-4a09-96e1-c7e76ceb4b7f_terseLabel_en-US" xlink:label="lab_vtrs_BiosimilarsPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosimilars Portfolio</link:label>
    <link:label id="lab_vtrs_BiosimilarsPortfolioMember_label_en-US" xlink:label="lab_vtrs_BiosimilarsPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosimilars Portfolio [Member]</link:label>
    <link:label id="lab_vtrs_BiosimilarsPortfolioMember_documentation_en-US" xlink:label="lab_vtrs_BiosimilarsPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosimilars Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BiosimilarsPortfolioMember" xlink:href="vtrs-20220331.xsd#vtrs_BiosimilarsPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BiosimilarsPortfolioMember" xlink:to="lab_vtrs_BiosimilarsPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ec0e7073-b23f-437f-9110-d089c667ad92_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_bd1e2f8c-79cd-4dbf-8389-e02b2188ddae_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_42a89d3f-b9a6-4146-811c-a22c2847bd5c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets (excluding inventories and net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_288e3e9c-f1f0-43bd-8e97-e911c0fb6060_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_YENTermLoanMember_69b3a7e8-c504-4238-a4d6-c779c472b406_terseLabel_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan</link:label>
    <link:label id="lab_vtrs_YENTermLoanMember_label_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan [Member]</link:label>
    <link:label id="lab_vtrs_YENTermLoanMember_documentation_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember" xlink:href="vtrs-20220331.xsd#vtrs_YENTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_YENTermLoanMember" xlink:to="lab_vtrs_YENTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0f7abc04-d46d-43c2-a77c-34ebe412ba39_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_fdd330ee-950f-455f-ae4d-1748c6a182fa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Chargebacks_46682016-07eb-4ccc-9d95-562cf6abe317_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:label id="lab_vtrs_Chargebacks_label_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:label id="lab_vtrs_Chargebacks_documentation_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks" xlink:href="vtrs-20220331.xsd#vtrs_Chargebacks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Chargebacks" xlink:to="lab_vtrs_Chargebacks" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3909f0b1-2409-4c9f-a108-a2b6cd33ae40_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_82f0269f-493d-4299-8501-ab01f67c19f3_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_266bf42e-c3a4-495b-90ac-517afb2bea25_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue of biosimilars portfolio</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_ec9de1d7-2ec3-446e-960d-511291d5bea5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_d9b800fb-4a99-4a73-988a-ad1ff3758e44_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_847ff07b-a8b6-4f73-888e-d3ba4078ed20_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_afc57f50-b733-4ed8-84d0-b8585cf5f55b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_02f39830-1817-40a2-991f-7459a5202478_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_eb8544be-3ce3-4fd7-9850-8de6deeb6098_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_96a34f34-82e6-468c-8c40-b72c9d853f16_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a9a7d121-c096-4dc7-a1bc-c8f001d6b59e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProgramNameDomain_f987ce91-e117-43f3-bf58-1de30e3ec8d5_terseLabel_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Domain]</link:label>
    <link:label id="lab_vtrs_ProgramNameDomain_label_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Domain]</link:label>
    <link:label id="lab_vtrs_ProgramNameDomain_documentation_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Program Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain" xlink:href="vtrs-20220331.xsd#vtrs_ProgramNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProgramNameDomain" xlink:to="lab_vtrs_ProgramNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_21442932-970a-4943-b0e9-0193ff6ca996_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_56ae27f6-8dfa-425e-b7c0-4efd607033c4_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_061606d7-0936-41fe-bb4e-52ba54ba6ea0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_95f7a5d7-0581-433e-957a-168c515e2c94_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_2da0372e-3fef-470e-b4b5-2ad927b49a4d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EpiPenAutoInjectorLitigationMember_3a8a5171-917c-4afb-83b6-16a7fcdb7dc0_terseLabel_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto-Injector Litigation</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorLitigationMember_label_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto-Injector Litigation [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorLitigationMember_documentation_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto-Injector Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorLitigationMember" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EpiPenAutoInjectorLitigationMember" xlink:to="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_fed33fdd-f334-4b04-b7d3-169ec65ac8dc_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_af223a4e-468c-49bc-bfb1-a6e40b4c75f2_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_6e90bd85-b5bd-406b-886a-9d41ff66218c_verboseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan N.V.</link:label>
    <link:label id="lab_srt_ParentCompanyMember_802a1083-6f4e-4b46-a9bb-fcd930aee3db_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_ce9d352f-f41f-435a-a348-569b86fcd74b_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_2c5e2c41-9f09-4752-a7b1-a272fb8faf54_negatedLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b47a34a5-01de-47eb-83d4-d497cb0b3792_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_1e922395-0b21-4048-830c-ba9631ac98e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Otherlongtermassets_a9b13d50-c752-4be0-b324-1c7480d343e9_terseLabel_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_vtrs_Otherlongtermassets_label_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_vtrs_Otherlongtermassets_documentation_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets" xlink:href="vtrs-20220331.xsd#vtrs_Otherlongtermassets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Otherlongtermassets" xlink:to="lab_vtrs_Otherlongtermassets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d4151f28-c5f4-4f4b-9e7b-81fb15086b77_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_3c0e51db-7072-4cb2-9a8d-b81bbf501ff2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_d5b51ea0-f724-43e6-a806-5f4d3021ce6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition And Accounts Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_65b6bc14-1daa-41c0-b657-1e18cb2d2fe0_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e00aab2e-b3bf-4c9c-9cde-77b8868d6897_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a9ec5d0a-f19b-44c8-bf10-7d0c5b02d1ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_31bca841-336c-4fcf-b30f-4e4a6c2c8366_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_cb563349-b0e6-4f3a-a729-847a4f513373_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_2bd4d4a2-6df7-4f71-844d-df656082d6da_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c6efe61b-5a12-41e8-a8e0-6d41366a35a4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f852e6a2-daf9-4e5b-ad6b-1fc64bb95020_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d84db216-5a77-4677-8a0d-89cabf1cd3ee_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_84dba542-b450-485e-a9d4-74ce9053f4b0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per ordinary share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_fdefc104-8eb2-4ba9-b9d0-09558a5cd1d6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_c211ffc8-b555-4063-b18e-322a7e81ca85_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_5c63b2bc-1e84-4f1e-8dd9-2b21e073d1c4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages to be paid</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_a9d738fe-4218-4c2f-813b-2930e3da4cc8_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_cfd318f1-dec3-473e-86fb-f8e26f34ea11_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_XanaxMember_74a02cf9-99eb-43bc-96cd-8326231fc901_terseLabel_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174;</link:label>
    <link:label id="lab_vtrs_XanaxMember_label_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174; [Member]</link:label>
    <link:label id="lab_vtrs_XanaxMember_documentation_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember" xlink:href="vtrs-20220331.xsd#vtrs_XanaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_XanaxMember" xlink:to="lab_vtrs_XanaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3bca88dc-2ad6-46ee-907b-0ca43bd94e41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_3c713369-dea9-460c-a1b1-2c5590034524_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac628a37-cd8c-4427-a898-5aa9f143d516_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b48192d2-ccaa-432c-8e74-5e8804156c67_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net book value, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_8283f803-0b02-4a0a-af79-c5f98c0ccb90_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_07f63724-0e14-49c7-81b1-bbf86c5f38f4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_3193d2cd-560e-4d0c-bab9-a232d24587cb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_ba026314-e1fd-4eb8-bd5c-5bbd69caa25e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_34bd8866-f8e1-4d10-b2ad-6324a7424757_terseLabel_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of stock-based awards exercised and restricted stock units converted</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_label_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_documentation_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:href="vtrs-20220331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:to="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_e70e0a92-2b63-4ca5-843f-590cd9c9a3f7_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_4047be4a-44c5-4feb-ad21-a935fb24d393_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term obligations</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_998b7145-f6b1-40ed-9d1d-23ff96da7b1c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_f0c394d0-93ab-40b4-b681-941a9bb620af_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6c42d3c0-62ca-405f-b588-8ca877055642_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_dbe1acb6-8ad8-4911-ba6a-9ca85f01bf60_terseLabel_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2027EuroSeniorNotesMember" xlink:to="lab_vtrs_A2027EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6fde86bb-3dba-4b91-8cd2-b7e70c5fcfaf_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputControlPremiumMember_afd0ceb9-5b81-4b09-a846-195716efcc39_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputControlPremiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Control Premium</link:label>
    <link:label id="lab_us-gaap_MeasurementInputControlPremiumMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputControlPremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Control Premium [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputControlPremiumMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputControlPremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputControlPremiumMember" xlink:to="lab_us-gaap_MeasurementInputControlPremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_c32cfea2-e41a-4d30-8cfa-ba2f2d392773_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of times damages may be increased in cases of willful infringement</link:label>
    <link:label id="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_label_en-US" xlink:label="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of times damages may be increased in cases of willful infringement</link:label>
    <link:label id="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_documentation_en-US" xlink:label="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of times damages may be increased in cases of willful infringement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:href="vtrs-20220331.xsd#vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:to="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_f383b9e5-b91d-43c5-95b1-a28575229d42_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Liabilities Carried at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a53833dd-78fa-426c-8c12-fed18b426a7a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_163de9ec-ed1d-40d9-bcb7-db2570bbe38d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_66c28d6f-5a69-4570-a1f2-6c232b567f6a_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_8b238909-2842-4a3b-ae9d-d53832cddb9e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_9b38c334-f672-4bea-8663-a2fd20816f57_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:to="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_0e805662-073b-45dd-bddd-3a5c73e99b2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring - employee related</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_25b320ef-ac66-4183-a9d3-1f4bf0b8101e_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_eb1c824a-5f8e-4e44-ab55-6be09abf13a1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated employer contributions in current year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_a9837ca8-9601-4ab3-89c0-751ce8207137_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_0b7d6bc3-4e87-4ec8-9c44-61b4b349dfec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ac2bcf26-b8f3-4915-a07e-90e874c55034_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_dff61074-df9c-4a89-83b9-c5d388ded387_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Revenues</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmitizaMember_f19a50d3-0ed2-44bc-8f06-8aaa94b47ba9_terseLabel_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174;</link:label>
    <link:label id="lab_vtrs_AmitizaMember_label_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174; [Member]</link:label>
    <link:label id="lab_vtrs_AmitizaMember_documentation_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember" xlink:href="vtrs-20220331.xsd#vtrs_AmitizaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmitizaMember" xlink:to="lab_vtrs_AmitizaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_98fa0a3d-9e9c-4d7b-a06d-558c6eb77963_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9f530847-082d-498d-9ec5-eb1aae4c2786_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0d9a7e0a-d27d-4a01-b2ab-2908120a9333_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_ac936aa1-1f94-4ccd-a0da-81e0682d9288_terseLabel_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_label_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_documentation_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments" xlink:href="vtrs-20220331.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Developmentandsalesmilestonepayments" xlink:to="lab_vtrs_Developmentandsalesmilestonepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7fc7dc2d-a650-4918-90f2-796adee2d6e3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4beed17d-aec2-44d9-826f-c4ea6f1c8e43_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term obligations</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7a4a2290-92c5-4e89-91cb-1ee5c5d4f41e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c78824a9-d5b7-4b54-9982-b093159b3598_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_a9c7cde0-b2cb-461f-bcb9-ca42ffc5e634_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_2979ab7d-7831-48c2-b4b2-c8e875fb32d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_741af536-00ee-4360-894a-05951920b1cc_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_a5eb645c-ab2a-49ab-b6f5-0240ba55908f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_cc7bfe2f-644d-4168-b9ec-1eb503bfb365_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_fddc0e12-cc8a-44d1-bad4-468d3fcad655_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a20ae84d-a21d-4898-beab-9aa6c21d9a32_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of shares withheld</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IntangibleAssetsbyMajorClassLineItems_f0d0eabf-2885-4085-95fc-688ce65a8ca4_terseLabel_en-US" xlink:label="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_vtrs_IntangibleAssetsbyMajorClassLineItems_label_en-US" xlink:label="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_vtrs_IntangibleAssetsbyMajorClassLineItems_documentation_en-US" xlink:label="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets by Major Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:href="vtrs-20220331.xsd#vtrs_IntangibleAssetsbyMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:to="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_87606165-c5cd-458d-929a-a51b17c561d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_ce00a0c3-8b35-49a4-8034-187ba6a06922_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_26cf6cfc-76b2-45b8-9185-8cfc0454079a_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_12f79069-1cfe-4bc3-a5d5-05681ff8fda0_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LipitorMember_3a53c453-679a-4569-bfe3-111c4fc55e1a_terseLabel_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor</link:label>
    <link:label id="lab_vtrs_LipitorMember_label_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor &#174; [Member]</link:label>
    <link:label id="lab_vtrs_LipitorMember_documentation_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember" xlink:href="vtrs-20220331.xsd#vtrs_LipitorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LipitorMember" xlink:to="lab_vtrs_LipitorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_af39402e-8955-49fa-a84f-0cc122191878_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_c2bc51c4-4f86-4d98-b6f1-f4284169c325_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EpiPenIsraeliSecuritiesLitigationMember_fd8f6ec6-4e0a-4d39-8cca-4597f5424e80_terseLabel_en-US" xlink:label="lab_vtrs_EpiPenIsraeliSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Israeli Securities Litigation [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenIsraeliSecuritiesLitigationMember_label_en-US" xlink:label="lab_vtrs_EpiPenIsraeliSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Israeli Securities Litigation [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenIsraeliSecuritiesLitigationMember_documentation_en-US" xlink:label="lab_vtrs_EpiPenIsraeliSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Israeli Securities Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenIsraeliSecuritiesLitigationMember" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenIsraeliSecuritiesLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EpiPenIsraeliSecuritiesLitigationMember" xlink:to="lab_vtrs_EpiPenIsraeliSecuritiesLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_75fa02fc-6d79-4291-98f6-c3f3915ba8be_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_24774bd5-5b98-425c-9a65-9b05a822099b_terseLabel_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_label_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_documentation_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:href="vtrs-20220331.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:to="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e7bff746-f31d-44a8-a5c1-27276bd92a40_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for stock awards exercisable, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_05a7e541-4ac8-4e09-841e-f54e07678a55_terseLabel_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Facilities to be Eliminated</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_label_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Facilities to be Eliminated</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_documentation_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Facilities to be Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:href="vtrs-20220331.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:to="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_26b1f0c1-bbe2-42f1-a4e1-528b1f9bac9a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherMember_57957ace-24a4-42e4-b050-2cbcf4e4090f_verboseLabel_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Litigation</link:label>
    <link:label id="lab_vtrs_OtherMember_label_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_vtrs_OtherMember_documentation_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember" xlink:href="vtrs-20220331.xsd#vtrs_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherMember" xlink:to="lab_vtrs_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_95343f69-9c06-4341-914a-17a79b584a3b_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_57cbf923-ad70-40ca-afc6-b9db4bfbb813_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BrandsMember_1caf44ba-439d-4744-a5ae-39d740a06892_terseLabel_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands</link:label>
    <link:label id="lab_vtrs_BrandsMember_label_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands [Member]</link:label>
    <link:label id="lab_vtrs_BrandsMember_documentation_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember" xlink:href="vtrs-20220331.xsd#vtrs_BrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BrandsMember" xlink:to="lab_vtrs_BrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_bd2cd7d9-aded-448c-b80c-8cda8b82fb11_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd4a6d4d-3a5c-4dae-bc67-d5ccc6ad2695_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2470e54-3c0f-4982-8aae-7529c524cdd6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eecc7c28-1bba-4683-bcda-5da1aed376cb_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_e264a521-b09f-451c-a584-5f46b749d18f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_510c2681-c474-448e-a35a-ac475b586f8e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea11100c-496d-43d8-a09b-c4e87bb2d87e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputEbitdaMultipleMember_73945fef-f08b-452a-841b-3269480df980_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, EBITDA Multiple</link:label>
    <link:label id="lab_us-gaap_MeasurementInputEbitdaMultipleMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, EBITDA Multiple [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputEbitdaMultipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:to="lab_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_cc715f3d-a974-42f9-a3ad-c2643d3795b6_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7beae3ac-02c8-4649-a67c-197a5b253389_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f0454ed6-01c5-4b67-af41-dba5bf30fb7c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_8c1bcf53-8751-4ce7-b5ec-ba48e34a9bfb_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, original cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfProducts_3a92a00e-a9b1-47ce-bdb2-a490cb96020a_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_vtrs_NumberOfProducts_label_en-US" xlink:label="lab_vtrs_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_vtrs_NumberOfProducts_documentation_en-US" xlink:label="lab_vtrs_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfProducts" xlink:href="vtrs-20220331.xsd#vtrs_NumberOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfProducts" xlink:to="lab_vtrs_NumberOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7491919e-7266-48ba-b5cb-a8957775557c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0579d2b2-b0ac-4724-babe-2d157aa74ba6_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8ff8db54-fccf-4ce8-a0c0-a3fcf1cbc5ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fbce42d1-218b-4bcd-a67f-9a28c4c6849d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_98072c27-7b35-4830-a869-094b29d0e2dd_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_2fa39366-b823-49a5-9d00-0ed5c21e0fb9_negatedTerseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3cfd9acb-a1ae-474c-804e-90de21e41c2e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0272cefb-61aa-476a-ad72-b1448cb047da_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_1f9b4c7b-3a18-4579-9804-3fd5df17bb4f_terseLabel_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_label_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_documentation_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:href="vtrs-20220331.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:to="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_d3c1d6b3-1194-4e0f-a6a5-7f7022cd6d7d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_2fff9078-6714-40eb-bdd6-53a5df3590df_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_90c2b37a-7e24-41eb-92dd-44323b4c9776_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_29157365-3e61-4f89-b8e6-a1fddff0dae6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PaymentsforBusinessSeparation_fd4b1786-ea3e-437f-83b3-31f8ab5420b6_terseLabel_en-US" xlink:label="lab_vtrs_PaymentsforBusinessSeparation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Business Separation</link:label>
    <link:label id="lab_vtrs_PaymentsforBusinessSeparation_label_en-US" xlink:label="lab_vtrs_PaymentsforBusinessSeparation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Business Separation</link:label>
    <link:label id="lab_vtrs_PaymentsforBusinessSeparation_documentation_en-US" xlink:label="lab_vtrs_PaymentsforBusinessSeparation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Business Separation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsforBusinessSeparation" xlink:href="vtrs-20220331.xsd#vtrs_PaymentsforBusinessSeparation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PaymentsforBusinessSeparation" xlink:to="lab_vtrs_PaymentsforBusinessSeparation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ebf2981e-cf8f-4e55-bf95-aff64f95955d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction due to lapse in statues</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_32492105-14e1-4f29-bb4a-472b30a5687a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments Policy</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProductLiabilityMember_f4c508fe-edcd-4728-9ffc-5918899bc3f7_terseLabel_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability</link:label>
    <link:label id="lab_vtrs_ProductLiabilityMember_label_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability [Member]</link:label>
    <link:label id="lab_vtrs_ProductLiabilityMember_documentation_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember" xlink:href="vtrs-20220331.xsd#vtrs_ProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProductLiabilityMember" xlink:to="lab_vtrs_ProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_23938559-e9db-47f5-9a8b-6f6cf55663a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_3e373c87-cc29-41c8-bd64-0bc545425fef_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_314118dc-3759-4eff-b285-b4b6fcf5c7fb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_88ef295c-2472-4eaf-90f7-91162fcb9ea5_terseLabel_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of shares withheld (in shares)</link:label>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_label_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</link:label>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_documentation_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:href="vtrs-20220331.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:to="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_68f034d0-5b23-451e-93e9-b36aa3c4d6b8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EuropeSegmentMember_19aa6200-a096-401e-931b-fd960e0ac9c4_terseLabel_en-US" xlink:label="lab_vtrs_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China</link:label>
    <link:label id="lab_vtrs_EuropeSegmentMember_label_en-US" xlink:label="lab_vtrs_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:label id="lab_vtrs_EuropeSegmentMember_documentation_en-US" xlink:label="lab_vtrs_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember" xlink:href="vtrs-20220331.xsd#vtrs_EuropeSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EuropeSegmentMember" xlink:to="lab_vtrs_EuropeSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9e912e7c-9341-4bde-a95f-729596d5d0a1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, released</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_fb16a8cd-e271-4d00-bc4b-ed2a56b4260a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffexorMember_0ba36fcf-a1da-491b-8676-5256e3bf0f45_terseLabel_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174;</link:label>
    <link:label id="lab_vtrs_EffexorMember_label_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174; [Member]</link:label>
    <link:label id="lab_vtrs_EffexorMember_documentation_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember" xlink:href="vtrs-20220331.xsd#vtrs_EffexorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffexorMember" xlink:to="lab_vtrs_EffexorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorvascMember_886a87e5-8026-4674-b9d4-2c8e1ccf7efb_terseLabel_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc</link:label>
    <link:label id="lab_vtrs_NorvascMember_label_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc &#174; [Member]</link:label>
    <link:label id="lab_vtrs_NorvascMember_documentation_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember" xlink:href="vtrs-20220331.xsd#vtrs_NorvascMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorvascMember" xlink:to="lab_vtrs_NorvascMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_73f0922a-c59e-4747-b97e-e0542a85852c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_9f05f26b-e0d8-4ae5-9fb7-1ed78da539da_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_02b2125a-8f14-4221-966a-cf0a25c3df8f_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_7c7f84bc-e930-4d55-84b5-111c856c4cc7_terseLabel_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross sales</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_label_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Gross</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_documentation_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerGross" xlink:href="vtrs-20220331.xsd#vtrs_RevenuefromContractwithCustomerGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RevenuefromContractwithCustomerGross" xlink:to="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a44d6e9e-ff06-4fe4-8f1e-bcbf61d48b3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_f03070c6-8ab1-48cc-b11d-30c4d8a13f77_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_f2cc2332-5809-4a1d-8950-09df20f60bdb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_45efc943-f2d2-47c7-82d7-276ad9dc1bdd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_434f5333-dfb9-4221-908c-1f0340972d8d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_f65b3ab8-1249-4270-a61b-a6e9ce620907_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_9b9936b5-2fff-4dc9-a3b3-c4bc991b2d48_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember_4eb8f3c8-4ecc-4ff7-8df6-fb1623a829ff_terseLabel_en-US" xlink:label="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Revolving Credit Facility</link:label>
    <link:label id="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Senior Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Senior Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:href="vtrs-20220331.xsd#vtrs_A2016SeniorRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:to="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_b19c9ac8-1cda-4f8f-a7c6-170a39c9d9ac_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3254a8e9-d916-43ab-a1fa-843808ca03e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_09cb26d8-0fd5-4e62-8a85-a93adab075f3_negatedTerseLabel_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_label_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_documentation_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense" xlink:href="vtrs-20220331.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherOneTimeNonoperatingExpense" xlink:to="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9cb79ca5-1350-411d-aab5-8a8cc94bcaa5_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_c3d19a0b-5dd9-4fbc-ba5e-d4905a1f979b_terseLabel_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember" xlink:href="vtrs-20220331.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2048SeniorNotesMember" xlink:to="lab_vtrs_A2048SeniorNotesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>vtrs-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf4cfb5a-529b-48e5-98f7-7a0c9b128563,g:c48d1c16-74b3-4c20-a8f8-3b8e11527314-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com/role/CoverPage" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4094e7ec-b79a-4b22-a0b8-b3d4d5ba8f41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityAddressAddressLine1_4094e7ec-b79a-4b22-a0b8-b3d4d5ba8f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_de525bed-6575-40db-9304-beb07e730a59" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_Security12bTitle_de525bed-6575-40db-9304-beb07e730a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a66c2ccf-8099-4b12-bf25-9e5fce59d796" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_DocumentQuarterlyReport_a66c2ccf-8099-4b12-bf25-9e5fce59d796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9b6f6705-faae-460c-8f1d-ecd2f969e58d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_DocumentTransitionReport_9b6f6705-faae-460c-8f1d-ecd2f969e58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fc2caf95-29b0-40db-a583-2620eb2bda19" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fc2caf95-29b0-40db-a583-2620eb2bda19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_08313343-24d0-4918-9ec4-d7bfb4707042" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityTaxIdentificationNumber_08313343-24d0-4918-9ec4-d7bfb4707042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_95a2e297-22f7-4c37-90cd-cf84f46306fa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityFileNumber_95a2e297-22f7-4c37-90cd-cf84f46306fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1f83d40b-0db2-42b3-b6ef-b18595c35189" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityRegistrantName_1f83d40b-0db2-42b3-b6ef-b18595c35189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_86f36cd6-27b6-49f1-bbe4-ca85ab25e6bf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_DocumentType_86f36cd6-27b6-49f1-bbe4-ca85ab25e6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6100545e-a0d2-4e05-9eed-b74b22b233f2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_DocumentPeriodEndDate_6100545e-a0d2-4e05-9eed-b74b22b233f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_1dc2ac6b-e89a-4d5b-bb13-87f8f06ef3e1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityFilerCategory_1dc2ac6b-e89a-4d5b-bb13-87f8f06ef3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_ca098af4-dbba-4c23-bf8b-83da7ac53947" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntitySmallBusiness_ca098af4-dbba-4c23-bf8b-83da7ac53947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fa38d693-308a-4138-b026-4be2a0417ec1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityEmergingGrowthCompany_fa38d693-308a-4138-b026-4be2a0417ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b30751ff-d660-432d-8beb-5e4da9f9b9be" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b30751ff-d660-432d-8beb-5e4da9f9b9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2750bbcf-c65e-4a75-8f47-977341c68d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2750bbcf-c65e-4a75-8f47-977341c68d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5ea34778-83e2-419a-927d-234f8abe9d96" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_TradingSymbol_5ea34778-83e2-419a-927d-234f8abe9d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_43a048be-be3f-4190-aacc-802395c3c224" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_SecurityExchangeName_43a048be-be3f-4190-aacc-802395c3c224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_e3e24b78-86f3-4058-a37e-9344fd9528b1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityAddressAddressLine2_e3e24b78-86f3-4058-a37e-9344fd9528b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_aa0374e5-5d4c-481b-843f-b9e057f8a234" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityAddressAddressLine3_aa0374e5-5d4c-481b-843f-b9e057f8a234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_20fa3223-c8f4-416d-911a-3bcd621989df" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityAddressCityOrTown_20fa3223-c8f4-416d-911a-3bcd621989df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aff806b3-0988-42a0-90c7-2ddc5fbd9b17" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityAddressPostalZipCode_aff806b3-0988-42a0-90c7-2ddc5fbd9b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_952a7232-2674-45c0-b30b-e76050d59d1d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityAddressCountry_952a7232-2674-45c0-b30b-e76050d59d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_33e59116-5e49-49c6-9c47-640e0e5546ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_CountryRegion_33e59116-5e49-49c6-9c47-640e0e5546ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fa6196de-0536-490c-9941-ebf9723e3714" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_CityAreaCode_fa6196de-0536-490c-9941-ebf9723e3714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_92c94e5b-fb4e-4179-819b-8d03a71923a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_LocalPhoneNumber_92c94e5b-fb4e-4179-819b-8d03a71923a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2d14b7e1-4858-49db-b660-980b91431627" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityCurrentReportingStatus_2d14b7e1-4858-49db-b660-980b91431627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_995fad3b-95c9-4651-9aa7-0c8d8379895f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityInteractiveDataCurrent_995fad3b-95c9-4651-9aa7-0c8d8379895f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_70e74990-98f7-401b-b6a2-98ee8ef483d4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityShellCompany_70e74990-98f7-401b-b6a2-98ee8ef483d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4f35cb8d-9904-48b6-9642-4526f93a55d4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityCentralIndexKey_4f35cb8d-9904-48b6-9642-4526f93a55d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_40333c12-663f-401a-8a33-69c3de753fc0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_AmendmentFlag_40333c12-663f-401a-8a33-69c3de753fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_6bf86ac2-313b-4abd-9543-310a9c41e65c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_DocumentFiscalYearFocus_6bf86ac2-313b-4abd-9543-310a9c41e65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f4c31d3b-8da0-4a10-a7c1-1edd450b98c5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f4c31d3b-8da0-4a10-a7c1-1edd450b98c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_fc7e100f-a3ca-467e-9778-c690fc734479" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_CurrentFiscalYearEndDate_fc7e100f-a3ca-467e-9778-c690fc734479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_887a8b7f-e05f-422f-bdad-d511cae12e8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5877b34b-8d6b-4400-8334-065546dd6200" xlink:to="loc_dei_EntityAddressStateOrProvince_887a8b7f-e05f-422f-bdad-d511cae12e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfOperations"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7cc94a81-4fbb-4155-836f-32704fb28ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_441eb3f8-8fd6-4863-b55c-1e9c508f7845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc94a81-4fbb-4155-836f-32704fb28ff6" xlink:to="loc_us-gaap_StatementTable_441eb3f8-8fd6-4863-b55c-1e9c508f7845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28b63958-2762-4e0d-95ad-979f5be70969" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_441eb3f8-8fd6-4863-b55c-1e9c508f7845" xlink:to="loc_srt_ProductOrServiceAxis_28b63958-2762-4e0d-95ad-979f5be70969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c9e6cedb-a96f-430e-89cf-2d10b786ceac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_28b63958-2762-4e0d-95ad-979f5be70969" xlink:to="loc_srt_ProductsAndServicesDomain_c9e6cedb-a96f-430e-89cf-2d10b786ceac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_76615ede-19d1-46fe-9b5e-2b1e37afbb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c9e6cedb-a96f-430e-89cf-2d10b786ceac" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_76615ede-19d1-46fe-9b5e-2b1e37afbb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_441eb3f8-8fd6-4863-b55c-1e9c508f7845" xlink:to="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23173a61-edef-49b5-a79c-aeea5825ed91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23173a61-edef-49b5-a79c-aeea5825ed91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_abb8fdb2-0498-4cc5-8476-839115fb69c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_Revenues_abb8fdb2-0498-4cc5-8476-839115fb69c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_26c1d56d-9d7d-457a-b460-6dacf32e21c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_26c1d56d-9d7d-457a-b460-6dacf32e21c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4404a77f-27bd-4398-b220-bdc3c24cf1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_GrossProfit_4404a77f-27bd-4398-b220-bdc3c24cf1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b2088230-e9fe-4805-937c-1576529479ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b2088230-e9fe-4805-937c-1576529479ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7da1ea0c-7d7e-4b3c-8f10-e8ec9ebb05cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7da1ea0c-7d7e-4b3c-8f10-e8ec9ebb05cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_cd4eda9b-db03-4217-bc42-5d80d33b26e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_cd4eda9b-db03-4217-bc42-5d80d33b26e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ded6d5d4-9873-40e0-9f0e-a9698ed639df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_856a29d8-e3fc-42b7-8553-67c8d7ed1d4e" xlink:to="loc_us-gaap_OperatingExpenses_ded6d5d4-9873-40e0-9f0e-a9698ed639df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6753b5c1-be97-444d-8d4c-a8aae76d9e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_OperatingIncomeLoss_6753b5c1-be97-444d-8d4c-a8aae76d9e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ed2a9e04-f666-490b-8aef-bb89dd0430e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_InterestExpense_ed2a9e04-f666-490b-8aef-bb89dd0430e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0bf91610-953f-44f5-9ab5-a044a4a00f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0bf91610-953f-44f5-9ab5-a044a4a00f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9a444ec-9b4a-41c7-b3c6-bbd5b0e8f231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9a444ec-9b4a-41c7-b3c6-bbd5b0e8f231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bae6a5ef-4ff6-4da1-854d-6e810a76df35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bae6a5ef-4ff6-4da1-854d-6e810a76df35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_75feb260-ea79-4016-a64d-23fd56218402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_75feb260-ea79-4016-a64d-23fd56218402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4e19a11d-5085-429f-9ed3-544e7638d840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:to="loc_us-gaap_EarningsPerShareBasic_4e19a11d-5085-429f-9ed3-544e7638d840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_afacfd37-77f1-4aa2-8cdf-9e027ae1e952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ffd74c8-77bc-4937-a750-6ea6811eadcf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_afacfd37-77f1-4aa2-8cdf-9e027ae1e952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3afe4e3b-1d4b-46be-b382-88a2284fd8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3afe4e3b-1d4b-46be-b382-88a2284fd8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_612cfa9a-bedf-4afe-805a-aa0f55658f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe74e6af-89f1-49b8-833d-67a27fec52cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_612cfa9a-bedf-4afe-805a-aa0f55658f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_5af6dbe2-d2ee-43a7-bc3d-cf842a3c7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1379c756-da1e-4d7e-90ce-ab1158d95d4d" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_5af6dbe2-d2ee-43a7-bc3d-cf842a3c7c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0555490f-c3e2-4057-93fb-302f543c859d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_53978c45-3339-4b2e-9be4-835b041100c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0555490f-c3e2-4057-93fb-302f543c859d" xlink:to="loc_us-gaap_StatementTable_53978c45-3339-4b2e-9be4-835b041100c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6384712f-be22-45e6-8adb-cf6f61c1004f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_53978c45-3339-4b2e-9be4-835b041100c8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6384712f-be22-45e6-8adb-cf6f61c1004f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6384712f-be22-45e6-8adb-cf6f61c1004f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2e1aa328-6f8b-4306-9d25-6fdbdee66901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:to="loc_us-gaap_CashFlowHedgingMember_2e1aa328-6f8b-4306-9d25-6fdbdee66901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_b047a4f1-cf24-4c6e-a2b1-1c3a0993a5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff8dc706-6632-4622-a961-94428c4e265c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_b047a4f1-cf24-4c6e-a2b1-1c3a0993a5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_53978c45-3339-4b2e-9be4-835b041100c8" xlink:to="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5ec0aa99-9b5f-44eb-addd-8169a8c4fe4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5ec0aa99-9b5f-44eb-addd-8169a8c4fe4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_3eaf3c0c-280b-445d-bcaf-221828250877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_3eaf3c0c-280b-445d-bcaf-221828250877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_49f9c595-f6fe-4a85-9349-38144b0e9114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_49f9c595-f6fe-4a85-9349-38144b0e9114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_dfa3c833-b886-44ae-a212-b3f42fc7686b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_dfa3c833-b886-44ae-a212-b3f42fc7686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ab49cd0a-a009-4f13-9ea7-994fc76142c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ab49cd0a-a009-4f13-9ea7-994fc76142c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_b3b037a9-c0b9-40cc-8196-4b68381bcf20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_b3b037a9-c0b9-40cc-8196-4b68381bcf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf8fd308-3a26-41d8-8ade-150b961fc319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_23fa61b2-2292-485b-b9e0-56751126f921" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf8fd308-3a26-41d8-8ade-150b961fc319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_21d0b1a6-d10b-4864-890d-c3864901196e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_21d0b1a6-d10b-4864-890d-c3864901196e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_544463b8-ec18-4f26-9a86-f52ba3ab3613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3163a4dd-9170-4c44-ade5-d4a1976c6233" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_544463b8-ec18-4f26-9a86-f52ba3ab3613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8cb295d0-f04e-4923-b9c3-b7ff7c580e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8cb295d0-f04e-4923-b9c3-b7ff7c580e30" xlink:to="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1bd2fbdb-60c3-433d-b1cd-e5b74e95304d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1bd2fbdb-60c3-433d-b1cd-e5b74e95304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_56b5390f-7372-4797-9e8f-1c0612a77a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_56b5390f-7372-4797-9e8f-1c0612a77a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c58935b1-8652-41ec-99e4-e77c7e93fd60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:to="loc_us-gaap_InventoryNet_c58935b1-8652-41ec-99e4-e77c7e93fd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_96aabb9f-e100-4428-909a-6031d87a8a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_96aabb9f-e100-4428-909a-6031d87a8a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_163bbfcd-b743-443b-b645-b3a24969cda1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_163bbfcd-b743-443b-b645-b3a24969cda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_91bf8730-789b-403a-b4d3-341b561a5972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a96e3c0d-ae2c-4710-b51f-c77547fcd5f8" xlink:to="loc_us-gaap_AssetsCurrent_91bf8730-789b-403a-b4d3-341b561a5972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b0c4a995-496c-4b89-8ce8-61e72f11be9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b0c4a995-496c-4b89-8ce8-61e72f11be9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f3fc4318-addc-4da0-8193-92f26674e052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f3fc4318-addc-4da0-8193-92f26674e052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d38abb0c-02d4-48e8-a317-c4e217d1608a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:to="loc_us-gaap_Goodwill_d38abb0c-02d4-48e8-a317-c4e217d1608a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f1625d8a-31f6-492c-9329-b64572397bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f1625d8a-31f6-492c-9329-b64572397bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d3ffbb69-f9ee-493a-80df-b4b384f338b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d3ffbb69-f9ee-493a-80df-b4b384f338b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_05b9c600-e5d7-4f94-9c1c-e576d3948c52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6670c13d-29a3-46c3-a5c7-a4c996437081" xlink:to="loc_us-gaap_Assets_05b9c600-e5d7-4f94-9c1c-e576d3948c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd96036-5c8c-4a87-a43b-a9fecf2c7e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8cb295d0-f04e-4923-b9c3-b7ff7c580e30" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd96036-5c8c-4a87-a43b-a9fecf2c7e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bb9dbb68-e391-4bac-8070-75e5e4f91463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd96036-5c8c-4a87-a43b-a9fecf2c7e4f" xlink:to="loc_us-gaap_LiabilitiesAbstract_bb9dbb68-e391-4bac-8070-75e5e4f91463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bb9dbb68-e391-4bac-8070-75e5e4f91463" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_cd0156ef-465f-4826-b294-b657c9b1c74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_cd0156ef-465f-4826-b294-b657c9b1c74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_56d59704-7c11-4911-8a95-d9fcec6f23af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:to="loc_us-gaap_ShortTermBorrowings_56d59704-7c11-4911-8a95-d9fcec6f23af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_581415ec-ede7-4130-9cdb-1acf828089b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_581415ec-ede7-4130-9cdb-1acf828089b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_54e2ded9-2755-4977-9aa1-80c44cc6f20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:to="loc_us-gaap_LongTermDebtCurrent_54e2ded9-2755-4977-9aa1-80c44cc6f20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_7fc4bdc1-86b5-4b82-bb57-a9287aaa56b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_7fc4bdc1-86b5-4b82-bb57-a9287aaa56b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c2fd47f8-9b77-4bf7-a5f6-aeca282c3b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c2fd47f8-9b77-4bf7-a5f6-aeca282c3b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_018f6f4b-f405-4040-8152-3257a9566f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_856aae8e-f6d1-4d85-8e51-56e2d05f0e90" xlink:to="loc_us-gaap_LiabilitiesCurrent_018f6f4b-f405-4040-8152-3257a9566f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ab74ea82-7621-45d8-89dc-d4de8e6eb97a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bb9dbb68-e391-4bac-8070-75e5e4f91463" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ab74ea82-7621-45d8-89dc-d4de8e6eb97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0d4843e2-a084-4431-bffd-02c9a517a609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bb9dbb68-e391-4bac-8070-75e5e4f91463" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0d4843e2-a084-4431-bffd-02c9a517a609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2b243a23-6107-48b9-9b7a-d8e73c68b32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bb9dbb68-e391-4bac-8070-75e5e4f91463" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2b243a23-6107-48b9-9b7a-d8e73c68b32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_63706b88-6fd6-4de2-a40e-526fa85d2675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bb9dbb68-e391-4bac-8070-75e5e4f91463" xlink:to="loc_us-gaap_Liabilities_63706b88-6fd6-4de2-a40e-526fa85d2675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_74dc64a2-1d01-4700-acc9-57f7e8825859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd96036-5c8c-4a87-a43b-a9fecf2c7e4f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_74dc64a2-1d01-4700-acc9-57f7e8825859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_58b86c50-db28-4cf3-aa17-754b6076a39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_74dc64a2-1d01-4700-acc9-57f7e8825859" xlink:to="loc_us-gaap_StockholdersEquityAbstract_58b86c50-db28-4cf3-aa17-754b6076a39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5bcc117d-8245-4d22-a429-61f361eb30eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_58b86c50-db28-4cf3-aa17-754b6076a39e" xlink:to="loc_us-gaap_CommonStockValue_5bcc117d-8245-4d22-a429-61f361eb30eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_204c215a-9fd0-496f-9a2c-ec7116b67812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_58b86c50-db28-4cf3-aa17-754b6076a39e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_204c215a-9fd0-496f-9a2c-ec7116b67812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f08518fe-859c-45b3-926f-c46e0e511350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_58b86c50-db28-4cf3-aa17-754b6076a39e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f08518fe-859c-45b3-926f-c46e0e511350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a620de3-1b9d-4f8c-8e20-cc00b2517313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_58b86c50-db28-4cf3-aa17-754b6076a39e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a620de3-1b9d-4f8c-8e20-cc00b2517313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ba179364-6114-4686-9dcd-476af9a849ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_74dc64a2-1d01-4700-acc9-57f7e8825859" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ba179364-6114-4686-9dcd-476af9a849ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f256040e-083e-4fb7-9ae4-932695093e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd96036-5c8c-4a87-a43b-a9fecf2c7e4f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f256040e-083e-4fb7-9ae4-932695093e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7d2446ad-8cbd-4026-995d-dc99bfd9130c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_14f4921f-35dc-4c26-ac00-886f700d6ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7d2446ad-8cbd-4026-995d-dc99bfd9130c" xlink:to="loc_us-gaap_StatementTable_14f4921f-35dc-4c26-ac00-886f700d6ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08d68a5f-6b79-48d8-9732-7e7b96252eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14f4921f-35dc-4c26-ac00-886f700d6ffc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08d68a5f-6b79-48d8-9732-7e7b96252eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d7525bca-46cd-4928-88db-e923d0e87b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08d68a5f-6b79-48d8-9732-7e7b96252eba" xlink:to="loc_us-gaap_EquityComponentDomain_d7525bca-46cd-4928-88db-e923d0e87b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d5f70cec-8888-4cc4-8349-1cace23ef14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d7525bca-46cd-4928-88db-e923d0e87b3b" xlink:to="loc_us-gaap_CommonStockMember_d5f70cec-8888-4cc4-8349-1cace23ef14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14f4921f-35dc-4c26-ac00-886f700d6ffc" xlink:to="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_933ad64a-ce01-4033-98b5-dceafacecf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_933ad64a-ce01-4033-98b5-dceafacecf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8b3e49db-bbf6-4088-aa23-bb59797bf2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8b3e49db-bbf6-4088-aa23-bb59797bf2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4edd9cd4-4ccf-4a24-a11e-eedd06187ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0196b9dc-d4ec-4369-b970-86da4a78d780" xlink:to="loc_us-gaap_TreasuryStockShares_4edd9cd4-4ccf-4a24-a11e-eedd06187ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c67fa308-bfa9-4fcf-a6e3-c4231dcd5f60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_af8e74f5-0047-4ce5-b30b-022d027c062a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c67fa308-bfa9-4fcf-a6e3-c4231dcd5f60" xlink:to="loc_us-gaap_StatementTable_af8e74f5-0047-4ce5-b30b-022d027c062a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_af8e74f5-0047-4ce5-b30b-022d027c062a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff543cd1-b179-4e98-9fb2-8f7c0005f2f8" xlink:to="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a9e0b112-03cd-4891-af4a-797c7ce9a0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_CommonStockMember_a9e0b112-03cd-4891-af4a-797c7ce9a0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_466a1529-803f-42aa-a00e-496807f12907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_466a1529-803f-42aa-a00e-496807f12907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_96d65ba3-254e-4d1a-b2fa-d3d9a74788c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_RetainedEarningsMember_96d65ba3-254e-4d1a-b2fa-d3d9a74788c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4183f2ae-0a6c-4518-b613-221631fa6cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_TreasuryStockMember_4183f2ae-0a6c-4518-b613-221631fa6cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_924c41d9-0d6e-4565-b73b-77787ff92462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2d17d940-5ea0-494f-aec8-bf63d081744b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_924c41d9-0d6e-4565-b73b-77787ff92462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_af8e74f5-0047-4ce5-b30b-022d027c062a" xlink:to="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aeb25887-53a2-4794-9e86-55974dda15fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aeb25887-53a2-4794-9e86-55974dda15fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_106449f5-65de-43a2-8eea-77a11f804776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_SharesIssued_106449f5-65de-43a2-8eea-77a11f804776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_40d74c79-bbdb-48e1-8024-572777fea249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_TreasuryStockShares_40d74c79-bbdb-48e1-8024-572777fea249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a479c734-fd3c-4c37-857b-1d16a3d3fff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a479c734-fd3c-4c37-857b-1d16a3d3fff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c97eea45-eac3-4750-b316-add5fd8e920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c97eea45-eac3-4750-b316-add5fd8e920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_1b239381-feb2-48e0-aa41-6eaa34b1be4f" xlink:href="vtrs-20220331.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_1b239381-feb2-48e0-aa41-6eaa34b1be4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_b96a8096-4a71-4106-a40a-276e4ff11659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_b96a8096-4a71-4106-a40a-276e4ff11659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_5546da16-6481-4e03-8117-f214f1f04302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_5546da16-6481-4e03-8117-f214f1f04302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4092670e-17a1-42a1-a4a7-96894a524040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4092670e-17a1-42a1-a4a7-96894a524040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e18b2506-943e-4901-9da2-90fc2e2e4299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e18b2506-943e-4901-9da2-90fc2e2e4299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e85485cd-b146-4ddd-8bd3-823bf6524f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_SharesIssued_e85485cd-b146-4ddd-8bd3-823bf6524f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_9db50d78-b05f-43f0-b2fb-465a73032da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3fe0f21d-2590-4e05-b6d1-91e1585d7e3c" xlink:to="loc_us-gaap_TreasuryStockShares_9db50d78-b05f-43f0-b2fb-465a73032da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ad7a551c-eda5-471d-8ef7-7d66371577b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13922161-6c39-4543-b339-5a7792430600" xlink:to="loc_us-gaap_DividendsCommonStockCash_ad7a551c-eda5-471d-8ef7-7d66371577b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CondensedConsolidatedStatementsOfCashFlows"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_47e92530-a0d3-4fac-96d2-e948961c5ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_47e92530-a0d3-4fac-96d2-e948961c5ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b2a368dd-faa0-4950-8f34-f198f76a4f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_47e92530-a0d3-4fac-96d2-e948961c5ca7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b2a368dd-faa0-4950-8f34-f198f76a4f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_47e92530-a0d3-4fac-96d2-e948961c5ca7" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4c4be61f-1e07-49d1-be44-d640164b3d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4c4be61f-1e07-49d1-be44-d640164b3d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_460e9ecd-4f8a-43e5-b3e7-4dc5ac758535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:to="loc_us-gaap_ShareBasedCompensation_460e9ecd-4f8a-43e5-b3e7-4dc5ac758535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8196ceb4-8ad9-4e6e-b722-3f50e777f788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8196ceb4-8ad9-4e6e-b722-3f50e777f788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_36a5a731-fa34-480a-ab00-cfd138d3893d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_36a5a731-fa34-480a-ab00-cfd138d3893d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8cc2564a-a890-4a84-9bcc-0b26bcc1962b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8cc2564a-a890-4a84-9bcc-0b26bcc1962b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet_aa2c2cae-53ef-4590-89f3-93bdb85a8b0f" xlink:href="vtrs-20220331.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6b3edefb-6708-4b8f-8e70-9c02a4058ee4" xlink:to="loc_vtrs_Changeinnoncashlitigationsettlementsnet_aa2c2cae-53ef-4590-89f3-93bdb85a8b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b45ab28-57fd-480c-a219-99124d78d6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_47e92530-a0d3-4fac-96d2-e948961c5ca7" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b45ab28-57fd-480c-a219-99124d78d6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1b60fc63-211a-4133-9662-992517f515e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b45ab28-57fd-480c-a219-99124d78d6bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1b60fc63-211a-4133-9662-992517f515e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_15df95df-ca7a-405c-a46a-045ab505907c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b45ab28-57fd-480c-a219-99124d78d6bf" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_15df95df-ca7a-405c-a46a-045ab505907c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0a1920a5-ea2e-4056-afef-8751139854ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b45ab28-57fd-480c-a219-99124d78d6bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0a1920a5-ea2e-4056-afef-8751139854ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b7ef4a03-64b5-46a9-87ec-5cd51659a233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b45ab28-57fd-480c-a219-99124d78d6bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b7ef4a03-64b5-46a9-87ec-5cd51659a233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2b35e26d-79b2-4b5e-a6b5-e161d14c467a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b45ab28-57fd-480c-a219-99124d78d6bf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2b35e26d-79b2-4b5e-a6b5-e161d14c467a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fea0fdf8-6899-4133-a9fd-1ef9bfda8387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_47e92530-a0d3-4fac-96d2-e948961c5ca7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fea0fdf8-6899-4133-a9fd-1ef9bfda8387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ea4e3be1-a7a7-4c37-a150-0ef80171df48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ea4e3be1-a7a7-4c37-a150-0ef80171df48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5338d4db-ac21-4155-97d3-e1c6ea8a7d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5338d4db-ac21-4155-97d3-e1c6ea8a7d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_933ebd27-cbd9-42df-aaf9-64d45ca6c520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_933ebd27-cbd9-42df-aaf9-64d45ca6c520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_794764cc-6cf2-489f-a5ba-1d3f970297fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_794764cc-6cf2-489f-a5ba-1d3f970297fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b4c822ad-5d33-4229-8d26-a07bc665844b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b4c822ad-5d33-4229-8d26-a07bc665844b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_de67784b-742b-4c0b-94c5-7105748c1a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_de67784b-742b-4c0b-94c5-7105748c1a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2126f43f-4302-4b43-b5de-386a7d4f490f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7532f1c0-0863-4d01-8bf6-0e104f2c1c66" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2126f43f-4302-4b43-b5de-386a7d4f490f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_827c5955-98c8-4e2f-a415-2b695df6bae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_827c5955-98c8-4e2f-a415-2b695df6bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a9be8fae-02b8-4196-82dc-a781064e3064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a9be8fae-02b8-4196-82dc-a781064e3064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_ff05cd6d-c201-44f3-ba03-9a9186d8bea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_ff05cd6d-c201-44f3-ba03-9a9186d8bea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0778156e-a559-47a7-b734-9bacc8740efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0778156e-a559-47a7-b734-9bacc8740efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_78555bc2-a4b0-478d-af44-46ddc537df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_78555bc2-a4b0-478d-af44-46ddc537df5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_622bf922-d522-44ab-8f5d-3be023867d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_622bf922-d522-44ab-8f5d-3be023867d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_38231eef-441b-4201-a5e6-60713c74c060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_38231eef-441b-4201-a5e6-60713c74c060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c3e55124-ecf7-4e72-b667-10f5d31d344a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c3e55124-ecf7-4e72-b667-10f5d31d344a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_07f7301f-5498-454b-b77e-7570d99240c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c28f218-d121-4a0d-aca2-27843d51e318" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_07f7301f-5498-454b-b77e-7570d99240c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e8935e6-7e1b-4728-94ed-8f5878f718aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e8935e6-7e1b-4728-94ed-8f5878f718aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87445b09-31ca-4b75-b666-150daf476fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87445b09-31ca-4b75-b666-150daf476fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1921f56f-dc9f-4b45-9891-4651fac5f0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1921f56f-dc9f-4b45-9891-4651fac5f0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_640b46b2-b394-4572-bd5c-85a4dbb0a65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_640b46b2-b394-4572-bd5c-85a4dbb0a65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_1b9835af-3395-498c-8f5e-8665accb1ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2efc185c-48c9-477c-a4cc-dc4a9a175aef" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_1b9835af-3395-498c-8f5e-8665accb1ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/General" xlink:type="simple" xlink:href="vtrs-20220331.xsd#General"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/General" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_17f29696-8a25-46ba-bc0d-dd6f2a87f6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ad93ec35-55be-4a93-85dc-2e88ebd2d405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_17f29696-8a25-46ba-bc0d-dd6f2a87f6d2" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ad93ec35-55be-4a93-85dc-2e88ebd2d405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GeneralPolicies" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GeneralPolicies"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GeneralPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0c0e7d0e-5189-4f54-9ed0-9e4718e6f463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5546c50c-4daa-4c4c-840b-dfd433754d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0c0e7d0e-5189-4f54-9ed0-9e4718e6f463" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5546c50c-4daa-4c4c-840b-dfd433754d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_590dce27-24f8-4a78-be3d-6e3cd87f4e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0c0e7d0e-5189-4f54-9ed0-9e4718e6f463" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_590dce27-24f8-4a78-be3d-6e3cd87f4e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_ae0af7d7-5dab-4444-ab70-76c1d2497c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0c0e7d0e-5189-4f54-9ed0-9e4718e6f463" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_ae0af7d7-5dab-4444-ab70-76c1d2497c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GeneralDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GeneralDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GeneralDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_51dcd95e-0884-4974-9a58-a5751e4f6f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_51dcd95e-0884-4974-9a58-a5751e4f6f3f" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_694f9a9f-a338-4f6e-84b1-7194d2ba0484" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:to="loc_srt_StatementGeographicalAxis_694f9a9f-a338-4f6e-84b1-7194d2ba0484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ae737178-326a-4b7e-aed9-c181996bbb6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_694f9a9f-a338-4f6e-84b1-7194d2ba0484" xlink:to="loc_srt_SegmentGeographicalDomain_ae737178-326a-4b7e-aed9-c181996bbb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR_f1930e04-1bec-4f93-8cef-f6362ed5eb51" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_TR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ae737178-326a-4b7e-aed9-c181996bbb6e" xlink:to="loc_country_TR_f1930e04-1bec-4f93-8cef-f6362ed5eb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_baa74b99-f819-426c-a5a6-52d7077dbe60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_baa74b99-f819-426c-a5a6-52d7077dbe60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_41e8ede9-350b-4662-b3f9-be1df5e8ca56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_baa74b99-f819-426c-a5a6-52d7077dbe60" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_41e8ede9-350b-4662-b3f9-be1df5e8ca56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemMember_c25394b8-68d4-4087-9613-5041639301b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_41e8ede9-350b-4662-b3f9-be1df5e8ca56" xlink:to="loc_us-gaap_UnusualOrInfrequentItemMember_c25394b8-68d4-4087-9613-5041639301b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable_e312da66-da4d-4a9f-a3de-4781296780c8" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy_7c3bfacf-768e-48eb-8e0d-5aafdee41753" xlink:href="vtrs-20220331.xsd#vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:to="loc_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy_7c3bfacf-768e-48eb-8e0d-5aafdee41753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy_5d8cd280-f2fb-4738-85a2-3e066ba53a6a" xlink:href="vtrs-20220331.xsd#vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyLineItems_fa38ad16-2145-463c-9542-a1eef6eb853a" xlink:to="loc_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy_5d8cd280-f2fb-4738-85a2-3e066ba53a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivable"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f78184df-df9d-40e6-91ca-25308df0228d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b2b43bc-7e71-4ec0-a77d-ba46974cfb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f78184df-df9d-40e6-91ca-25308df0228d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b2b43bc-7e71-4ec0-a77d-ba46974cfb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_87177a06-8078-4b97-8df7-a8286b761bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_46ca0000-12aa-4a0e-9b32-f340587cf36b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_87177a06-8078-4b97-8df7-a8286b761bb5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_46ca0000-12aa-4a0e-9b32-f340587cf36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8645be8b-b861-426b-957b-352b4efe2bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_87177a06-8078-4b97-8df7-a8286b761bb5" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8645be8b-b861-426b-957b-352b4efe2bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2dda9907-0fee-4178-8c55-2d2ea6871e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_2cef27f3-1914-4ddc-bf98-1bc407f980a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2dda9907-0fee-4178-8c55-2d2ea6871e8b" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_2cef27f3-1914-4ddc-bf98-1bc407f980a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2100c5c1-79dc-47c6-bf0f-3ee5d65edaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2100c5c1-79dc-47c6-bf0f-3ee5d65edaf5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:to="loc_srt_ConsolidationItemsAxis_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_342ac7a5-3243-4c58-8e7e-fec69af4b645" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c50c1eb7-a5b6-45b1-87fd-0c368e425dd7" xlink:to="loc_srt_ConsolidationItemsDomain_342ac7a5-3243-4c58-8e7e-fec69af4b645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_94fccd11-8131-4b75-b11f-ccd9576bdbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_342ac7a5-3243-4c58-8e7e-fec69af4b645" xlink:to="loc_us-gaap_OperatingSegmentsMember_94fccd11-8131-4b75-b11f-ccd9576bdbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1c3a9a74-05dd-46f9-9f95-fd1d0885b593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1c3a9a74-05dd-46f9-9f95-fd1d0885b593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c3a9a74-05dd-46f9-9f95-fd1d0885b593" xlink:to="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_845eeb99-ad7c-42cb-9d7b-41262a97bdaf" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_845eeb99-ad7c-42cb-9d7b-41262a97bdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_1648fff3-9b2a-419b-85ff-bbc85a62e275" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_GreaterChinaSegmentMember_1648fff3-9b2a-419b-85ff-bbc85a62e275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_0f180bf6-da4b-43c1-b109-47b8637a0763" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_0f180bf6-da4b-43c1-b109-47b8637a0763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_364548ee-aa72-4fc9-a746-d19551a110e2" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1ab2daf6-b39c-4220-b987-101d41821b86" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_364548ee-aa72-4fc9-a746-d19551a110e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_86a9af97-6e15-4b7d-aeb7-1934da42255a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:to="loc_srt_ProductOrServiceAxis_86a9af97-6e15-4b7d-aeb7-1934da42255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_86a9af97-6e15-4b7d-aeb7-1934da42255a" xlink:to="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_7029222d-e214-4c9f-9009-34c4306434cc" xlink:href="vtrs-20220331.xsd#vtrs_BrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_BrandsMember_7029222d-e214-4c9f-9009-34c4306434cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_dc179698-2fe9-4064-b7ee-37442f35b71f" xlink:href="vtrs-20220331.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_dc179698-2fe9-4064-b7ee-37442f35b71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_7b7136df-0403-4e26-93a1-77b0d2775bc0" xlink:href="vtrs-20220331.xsd#vtrs_GenericsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_GenericsMember_7b7136df-0403-4e26-93a1-77b0d2775bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember_0cbb72f4-fe2f-4416-931d-5f3561c6c44f" xlink:href="vtrs-20220331.xsd#vtrs_LipitorMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_LipitorMember_0cbb72f4-fe2f-4416-931d-5f3561c6c44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember_db084fd8-ec5b-468b-8673-56cf773859dc" xlink:href="vtrs-20220331.xsd#vtrs_NorvascMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_NorvascMember_db084fd8-ec5b-468b-8673-56cf773859dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember_ab8cc800-c985-4221-ae44-2edc2b900a8d" xlink:href="vtrs-20220331.xsd#vtrs_LyricaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_LyricaMember_ab8cc800-c985-4221-ae44-2edc2b900a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember_ed0721db-26e0-44e6-9fa7-1d996a060fa1" xlink:href="vtrs-20220331.xsd#vtrs_ViagraMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_ViagraMember_ed0721db-26e0-44e6-9fa7-1d996a060fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember_d564f296-4138-4281-931e-0682ec80ff99" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_EpiPenAutoInjectorsMember_d564f296-4138-4281-931e-0682ec80ff99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember_3e40e07f-40b7-4935-8ce5-9b59d47f05b4" xlink:href="vtrs-20220331.xsd#vtrs_CelebrexMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_CelebrexMember_3e40e07f-40b7-4935-8ce5-9b59d47f05b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember_241a2be5-b6b1-474e-aa12-bccb7fa2ca41" xlink:href="vtrs-20220331.xsd#vtrs_EffexorMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_EffexorMember_241a2be5-b6b1-474e-aa12-bccb7fa2ca41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember_fd90fd84-10e1-4f15-ab5f-32c9f58d80ef" xlink:href="vtrs-20220331.xsd#vtrs_ZoloftMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_ZoloftMember_fd90fd84-10e1-4f15-ab5f-32c9f58d80ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember_97592e80-c635-4bf4-b936-018583ddab9b" xlink:href="vtrs-20220331.xsd#vtrs_CreonMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_CreonMember_97592e80-c635-4bf4-b936-018583ddab9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember_8a4c2ea3-59ce-4bab-a9ed-bbd3d483b709" xlink:href="vtrs-20220331.xsd#vtrs_XalabrandsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_XalabrandsMember_8a4c2ea3-59ce-4bab-a9ed-bbd3d483b709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember_e3087d92-25b6-448c-aec5-1319658092d3" xlink:href="vtrs-20220331.xsd#vtrs_AmitizaMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_AmitizaMember_e3087d92-25b6-448c-aec5-1319658092d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember_a151a935-e795-4e84-8140-57260f099bb0" xlink:href="vtrs-20220331.xsd#vtrs_XanaxMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_XanaxMember_a151a935-e795-4e84-8140-57260f099bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember_f0c1ab5b-a637-4df5-8fe9-69bc6d03a86f" xlink:href="vtrs-20220331.xsd#vtrs_DymistaMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_DymistaMember_f0c1ab5b-a637-4df5-8fe9-69bc6d03a86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember_8ae0e725-f86e-4097-9c83-e6a63502cb40" xlink:href="vtrs-20220331.xsd#vtrs_YupelriMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_YupelriMember_8ae0e725-f86e-4097-9c83-e6a63502cb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InfluvacMember_c12445c4-c46e-449a-a0ae-46fee22c5856" xlink:href="vtrs-20220331.xsd#vtrs_InfluvacMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69f220c0-323d-439f-af90-5c8f526466c5" xlink:to="loc_vtrs_InfluvacMember_c12445c4-c46e-449a-a0ae-46fee22c5856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8a05c078-447f-4724-809c-c55586e18755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_920fdde2-f407-4972-8a1d-9699006a2606" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8a05c078-447f-4724-809c-c55586e18755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c69f525-1fb0-4b41-8f6f-1201c14169f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a05c078-447f-4724-809c-c55586e18755" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c69f525-1fb0-4b41-8f6f-1201c14169f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerGross_9f42e4be-290c-4e43-a8d3-9083d75a97c1" xlink:href="vtrs-20220331.xsd#vtrs_RevenuefromContractwithCustomerGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:to="loc_vtrs_RevenuefromContractwithCustomerGross_9f42e4be-290c-4e43-a8d3-9083d75a97c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks_98c3463d-31ee-4eb7-8b49-2dcbf086c13d" xlink:href="vtrs-20220331.xsd#vtrs_Chargebacks"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:to="loc_vtrs_Chargebacks_98c3463d-31ee-4eb7-8b49-2dcbf086c13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances_1b193faa-b999-412b-af5c-be066d5139a4" xlink:href="vtrs-20220331.xsd#vtrs_AccruedSalesAllowances"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:to="loc_vtrs_AccruedSalesAllowances_1b193faa-b999-412b-af5c-be066d5139a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns_f8d3801d-0b97-4734-89f9-e73367c36dd3" xlink:href="vtrs-20220331.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:to="loc_vtrs_RevenuefromContractwithCustomerReturns_f8d3801d-0b97-4734-89f9-e73367c36dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates_496c9e32-2ecf-40ce-b408-64f59a7a5276" xlink:href="vtrs-20220331.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:to="loc_vtrs_Medicaidandothergovernmentalrebates_496c9e32-2ecf-40ce-b408-64f59a7a5276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments_21aacc58-1b23-4623-ae31-66107f8a1d46" xlink:href="vtrs-20220331.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:to="loc_vtrs_SalesRevenueGrosstonetadjustments_21aacc58-1b23-4623-ae31-66107f8a1d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4903091-1eda-40b1-a6e2-d01d50deaf10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc6ad45f-85ff-43f9-a81d-75436a77d3bb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4903091-1eda-40b1-a6e2-d01d50deaf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_94bf5271-518f-4ba3-886a-29770da00620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_664ed0bf-33fd-4f0c-a64b-b35059164a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_94bf5271-518f-4ba3-886a-29770da00620" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_664ed0bf-33fd-4f0c-a64b-b35059164a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_de65efc0-1106-480f-82e5-dc5013c00a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_664ed0bf-33fd-4f0c-a64b-b35059164a07" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_de65efc0-1106-480f-82e5-dc5013c00a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_9a3ffc32-c92c-48d7-a19a-8b39896912f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_de65efc0-1106-480f-82e5-dc5013c00a44" xlink:to="loc_us-gaap_ReceivableTypeDomain_9a3ffc32-c92c-48d7-a19a-8b39896912f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_962cd5d3-21af-47b0-8c1a-d5c1562bc270" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_9a3ffc32-c92c-48d7-a19a-8b39896912f5" xlink:to="loc_vtrs_VariableConsiderationMember_962cd5d3-21af-47b0-8c1a-d5c1562bc270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_664ed0bf-33fd-4f0c-a64b-b35059164a07" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7dfbb24e-3e61-4cfe-bd88-cc1aaa379739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7dfbb24e-3e61-4cfe-bd88-cc1aaa379739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_35ae51cb-8e9f-40b3-af2c-8e1eb0ba844c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_35ae51cb-8e9f-40b3-af2c-8e1eb0ba844c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_29ac00c5-8335-4fef-984a-cace6387b027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8e680a7-5d3f-4635-895b-19f4aff3170f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_29ac00c5-8335-4fef-984a-cace6387b027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RecentAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RecentAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_1ba9c322-2369-40fa-8721-703a9c94194b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c32eef99-2f3e-4288-945d-3af9a5bb7191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_1ba9c322-2369-40fa-8721-703a9c94194b" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c32eef99-2f3e-4288-945d-3af9a5bb7191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_d9d977d1-99b9-499b-adf8-2c104d826844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_85271c03-d958-446b-aacf-e34a6fdca758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_d9d977d1-99b9-499b-adf8-2c104d826844" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_85271c03-d958-446b-aacf-e34a6fdca758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3729ad6-0d07-4311-8ef1-9cc4f31aac37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_85271c03-d958-446b-aacf-e34a6fdca758" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3729ad6-0d07-4311-8ef1-9cc4f31aac37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb5ec6ae-ffab-4709-a131-3a869bb4dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3729ad6-0d07-4311-8ef1-9cc4f31aac37" xlink:to="loc_us-gaap_EquityComponentDomain_eb5ec6ae-ffab-4709-a131-3a869bb4dbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_067d392b-9a52-43e5-8efe-eb0375965a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb5ec6ae-ffab-4709-a131-3a869bb4dbcf" xlink:to="loc_us-gaap_RetainedEarningsMember_067d392b-9a52-43e5-8efe-eb0375965a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_85271c03-d958-446b-aacf-e34a6fdca758" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_834ef14a-3566-4c8c-bf91-9779d1836250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_834ef14a-3566-4c8c-bf91-9779d1836250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c776875e-d163-4d6c-81ff-26f04c295fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c776875e-d163-4d6c-81ff-26f04c295fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b26ad617-ec08-41ee-b754-095cc6ffee64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b26ad617-ec08-41ee-b754-095cc6ffee64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e6645cff-32b7-419f-89ba-fab4db629ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_Revenues_e6645cff-32b7-419f-89ba-fab4db629ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08ae9630-b3b1-42e3-8062-55ef64b2b7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08ae9630-b3b1-42e3-8062-55ef64b2b7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_a48393b6-de49-492e-8285-2d95505f37af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_a48393b6-de49-492e-8285-2d95505f37af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_005bf9ce-b794-420d-be96-7dc838935a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_005bf9ce-b794-420d-be96-7dc838935a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_64fd3252-4ec1-434b-b22f-6ae72f1c8da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d08aa6f5-f6bd-4006-97ab-1cb917479778" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_64fd3252-4ec1-434b-b22f-6ae72f1c8da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactions" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactions"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_942ab41f-6853-4617-876f-46fbba6b984b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c5175bd7-a394-4572-910f-42bf1fa1d97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_942ab41f-6853-4617-876f-46fbba6b984b" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c5175bd7-a394-4572-910f-42bf1fa1d97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9cb76172-7297-4cbc-85ce-0df5672eb0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_466c48ad-eee5-4c0e-b0af-90316a93d0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9cb76172-7297-4cbc-85ce-0df5672eb0d7" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_466c48ad-eee5-4c0e-b0af-90316a93d0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_c23f4f80-ec00-437b-8366-e7a163c88738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9cb76172-7297-4cbc-85ce-0df5672eb0d7" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_c23f4f80-ec00-437b-8366-e7a163c88738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a7b5f6c1-7748-4d79-9d9a-a7ff3e040411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a7b5f6c1-7748-4d79-9d9a-a7ff3e040411" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_2c09e330-81ba-4e01-8c29-97ddab5b1c66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_OwnershipAxis_2c09e330-81ba-4e01-8c29-97ddab5b1c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_77072540-f84c-4251-83d7-4a5b0be4fbe4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_2c09e330-81ba-4e01-8c29-97ddab5b1c66" xlink:to="loc_srt_OwnershipDomain_77072540-f84c-4251-83d7-4a5b0be4fbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_6ece6a21-a611-4825-a435-17c273938f47" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_77072540-f84c-4251-83d7-4a5b0be4fbe4" xlink:to="loc_vtrs_UpjohnInc.Member_6ece6a21-a611-4825-a435-17c273938f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c13d60b6-b139-4c6a-b708-800d4b92eae7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_ProductOrServiceAxis_c13d60b6-b139-4c6a-b708-800d4b92eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8cfff1e6-db79-42d4-849b-d830a65a047b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c13d60b6-b139-4c6a-b708-800d4b92eae7" xlink:to="loc_srt_ProductsAndServicesDomain_8cfff1e6-db79-42d4-849b-d830a65a047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_e68a2b3e-6c90-4af9-b104-84eafa65d247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8cfff1e6-db79-42d4-849b-d830a65a047b" xlink:to="loc_us-gaap_ProductMember_e68a2b3e-6c90-4af9-b104-84eafa65d247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b8537d01-d715-4e8b-8c9d-65a39d7d35d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_CounterpartyNameAxis_b8537d01-d715-4e8b-8c9d-65a39d7d35d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4d96c4f-89d7-4bfb-b51a-595e4b789b07" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b8537d01-d715-4e8b-8c9d-65a39d7d35d2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4d96c4f-89d7-4bfb-b51a-595e4b789b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_f534b680-6af4-4cec-bc58-dcb693b84c7e" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4d96c4f-89d7-4bfb-b51a-595e4b789b07" xlink:to="loc_vtrs_UpjohnInc.Member_f534b680-6af4-4cec-bc58-dcb693b84c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e8f06b9c-8c48-4d6c-8aaa-55f04785d43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_ebaf7c9a-5ee2-4bb8-a7b0-7b1770e9eb1f" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e8f06b9c-8c48-4d6c-8aaa-55f04785d43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_f82204d1-02c9-490b-b86d-580b1558790a" xlink:href="vtrs-20220331.xsd#vtrs_PfizerInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e8f06b9c-8c48-4d6c-8aaa-55f04785d43a" xlink:to="loc_vtrs_PfizerInc.Member_f82204d1-02c9-490b-b86d-580b1558790a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_412e8093-3246-430e-ae82-92479deed9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_412e8093-3246-430e-ae82-92479deed9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2845e8df-93bb-4f52-baeb-4dad4c6eef76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_412e8093-3246-430e-ae82-92479deed9f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2845e8df-93bb-4f52-baeb-4dad4c6eef76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_e2982eab-99b8-4f3b-a683-615b7fa42c9b" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2845e8df-93bb-4f52-baeb-4dad4c6eef76" xlink:to="loc_vtrs_UpjohnInc.Member_e2982eab-99b8-4f3b-a683-615b7fa42c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_933805be-6901-4bff-93db-cb493c5e60f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_933805be-6901-4bff-93db-cb493c5e60f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_933805be-6901-4bff-93db-cb493c5e60f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_a1f9c4c6-6831-49fa-9c08-dbf8bf0cb78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_a1f9c4c6-6831-49fa-9c08-dbf8bf0cb78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_4f9032f7-82b0-49b1-8636-9a286308ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:to="loc_us-gaap_BuildingMember_4f9032f7-82b0-49b1-8636-9a286308ab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_587cc655-5744-4c9d-9587-723ff51078fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d21ee8a6-61f4-4d2c-aaf6-85e3451031f1" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_587cc655-5744-4c9d-9587-723ff51078fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5191f922-d373-402f-98a1-3264c627fc49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_srt_RangeAxis_5191f922-d373-402f-98a1-3264c627fc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5191f922-d373-402f-98a1-3264c627fc49" xlink:to="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e46b3d41-28fc-4ac7-a166-76bf7b0dfeee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:to="loc_srt_MinimumMember_e46b3d41-28fc-4ac7-a166-76bf7b0dfeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2c83669-2bd4-499f-8c13-0581a78f69e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_846be156-405a-4b15-a0ff-e9591b0838fe" xlink:to="loc_srt_MaximumMember_a2c83669-2bd4-499f-8c13-0581a78f69e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4222f764-aef7-4daf-97d9-07cff509ca0c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfProducts_a71111eb-abba-4939-9f1e-3385a9a452c6" xlink:href="vtrs-20220331.xsd#vtrs_NumberOfProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_vtrs_NumberOfProducts_a71111eb-abba-4939-9f1e-3385a9a452c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_28e629d7-4790-409e-a65b-cf46d242d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_28e629d7-4790-409e-a65b-cf46d242d831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1c457736-899e-4bb7-9790-be4180aada8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1c457736-899e-4bb7-9790-be4180aada8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsforBusinessSeparation_c36a4476-f9dd-4841-a3a9-55da9774c2a9" xlink:href="vtrs-20220331.xsd#vtrs_PaymentsforBusinessSeparation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_vtrs_PaymentsforBusinessSeparation_c36a4476-f9dd-4841-a3a9-55da9774c2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2bddf59e-367e-404a-85cb-ea6b3db9fded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2bddf59e-367e-404a-85cb-ea6b3db9fded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_20524d47-62a9-4bdf-9996-2367d6426378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_20524d47-62a9-4bdf-9996-2367d6426378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_06a519dd-ac00-4b12-a5f3-e8715f100e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_06a519dd-ac00-4b12-a5f3-e8715f100e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dffe229e-a0d9-45fc-82e6-0cacd7ea2288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dffe229e-a0d9-45fc-82e6-0cacd7ea2288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_16d95b79-f429-409e-b25c-1dd222a65718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_16d95b79-f429-409e-b25c-1dd222a65718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2fd276b6-cc11-4f8f-95d0-c3b8128b7769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2fd276b6-cc11-4f8f-95d0-c3b8128b7769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a5a685df-b2d4-4131-805a-68df60d5921d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a5a685df-b2d4-4131-805a-68df60d5921d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_93b36685-054c-4801-9c9f-3a2a1bb6ed36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_Goodwill_93b36685-054c-4801-9c9f-3a2a1bb6ed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_13d60f20-53eb-46ae-b1ee-e559b6faa34a" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_13d60f20-53eb-46ae-b1ee-e559b6faa34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4cd0e480-6c11-4cb3-baea-eb15158acb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4cd0e480-6c11-4cb3-baea-eb15158acb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6689a57d-48da-4254-ba35-2a5f0a05f200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6689a57d-48da-4254-ba35-2a5f0a05f200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_6ef60b63-3ab8-48c1-b74d-f05cc64d166c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_6ef60b63-3ab8-48c1-b74d-f05cc64d166c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_7d7c4ef5-3bd5-40b9-bf51-9aaf7a63822e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_73ca9b4c-86e4-4053-8e95-41ba011785d7" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_7d7c4ef5-3bd5-40b9-bf51-9aaf7a63822e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationAbstract_5a3bd5af-5be1-4fd3-bbd4-419aac703fb9" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BusinessCombinationAbstract_5a3bd5af-5be1-4fd3-bbd4-419aac703fb9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b0c2a535-6798-4380-a610-6b3fd80cb256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b0c2a535-6798-4380-a610-6b3fd80cb256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b0c2a535-6798-4380-a610-6b3fd80cb256" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_23433d13-1f9e-49da-b719-a50e3e16909c" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:to="loc_vtrs_UpjohnInc.Member_23433d13-1f9e-49da-b719-a50e3e16909c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7da2a6d5-76ff-43ba-9bcf-f0cbed0397a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f502391-a4e3-4b9d-ab2e-1d484057ba68" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7da2a6d5-76ff-43ba-9bcf-f0cbed0397a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:to="loc_srt_CounterpartyNameAxis_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c71d9ec-6b26-4d37-a1bd-77bc0f5d3bfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7a6f90a9-fb76-4fcf-bcc6-1ba741a11c7f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c71d9ec-6b26-4d37-a1bd-77bc0f5d3bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_19baccc5-e57c-49c2-8925-132b0ca4539d" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c71d9ec-6b26-4d37-a1bd-77bc0f5d3bfb" xlink:to="loc_vtrs_UpjohnInc.Member_19baccc5-e57c-49c2-8925-132b0ca4539d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cef78a1d-41b4-4833-918f-6a217b8302fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cef78a1d-41b4-4833-918f-6a217b8302fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_4aac9795-b5d6-4537-a356-c257b3e5cefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cef78a1d-41b4-4833-918f-6a217b8302fc" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_4aac9795-b5d6-4537-a356-c257b3e5cefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_a9c701c2-a169-4864-8aad-a2bdcc685a52" xlink:href="vtrs-20220331.xsd#vtrs_PfizerInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_4aac9795-b5d6-4537-a356-c257b3e5cefa" xlink:to="loc_vtrs_PfizerInc.Member_a9c701c2-a169-4864-8aad-a2bdcc685a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_861697a5-b0af-4e56-8735-8b7fc67df8ef" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_601197e1-1e6f-428e-8ea0-c38436f7d5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_601197e1-1e6f-428e-8ea0-c38436f7d5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0f4085d5-1a32-456a-a905-484dfe37e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0f4085d5-1a32-456a-a905-484dfe37e8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4c53c594-98d3-4971-8286-6ddd9b330a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4c53c594-98d3-4971-8286-6ddd9b330a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ebae8ca7-4bc7-46ce-917e-860ef2d74680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ebae8ca7-4bc7-46ce-917e-860ef2d74680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_bc45c4a3-dff2-40be-afdc-01e979c2bfd6" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_bc45c4a3-dff2-40be-afdc-01e979c2bfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8dd2d825-0a7c-4782-bca1-52499266b7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_Goodwill_8dd2d825-0a7c-4782-bca1-52499266b7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_69e09548-3219-47ff-8e4c-32fd56028ac2" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_69e09548-3219-47ff-8e4c-32fd56028ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_a5161c8c-35d3-4c8f-8db3-580fc8645be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_a5161c8c-35d3-4c8f-8db3-580fc8645be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4fca4c7b-85ea-4d32-a81d-c3f201736356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_4fca4c7b-85ea-4d32-a81d-c3f201736356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_cb595b12-c9f9-4645-a25a-09fad6f410da" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_cb595b12-c9f9-4645-a25a-09fad6f410da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_938a9a91-cf18-4683-b5bd-c39e7f003d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_938a9a91-cf18-4683-b5bd-c39e7f003d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b71ed8e8-f44f-498a-8d86-bb0d9a6a97e0" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b71ed8e8-f44f-498a-8d86-bb0d9a6a97e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b2ce57e6-f496-4d45-a6a7-a6de70cc3127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b2ce57e6-f496-4d45-a6a7-a6de70cc3127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_88b0fbff-cd63-4b43-941a-ec075574dd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_88b0fbff-cd63-4b43-941a-ec075574dd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fcb766b0-23e2-41ff-a9b8-cdd15bbe83e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fcb766b0-23e2-41ff-a9b8-cdd15bbe83e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_7224374e-376b-447a-ba8a-e0c88546277a" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_7224374e-376b-447a-ba8a-e0c88546277a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_b1ba47f5-34dc-4055-b903-0ed9e24a857c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_b1ba47f5-34dc-4055-b903-0ed9e24a857c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0655ea82-6a40-4267-aa0d-fac94ce76bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0655ea82-6a40-4267-aa0d-fac94ce76bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_c697c0e4-7b0c-490d-a26d-b9b4ad03ed52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_c697c0e4-7b0c-490d-a26d-b9b4ad03ed52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_d140d0af-0acb-4bc4-8510-78e69f38a6f6" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_512b8220-7b2f-4dfc-9cce-ea011789ec0f" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_d140d0af-0acb-4bc4-8510-78e69f38a6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6e1a348d-196a-4cc6-9021-585faa43c3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e878b97-23bf-4885-ad7b-9e0822d1e709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6e1a348d-196a-4cc6-9021-585faa43c3e4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e878b97-23bf-4885-ad7b-9e0822d1e709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3158704d-bd66-473f-923f-376db852cd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e878b97-23bf-4885-ad7b-9e0822d1e709" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3158704d-bd66-473f-923f-376db852cd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb2427a5-0a1c-4aff-a445-e8cd4542410e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3158704d-bd66-473f-923f-376db852cd14" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb2427a5-0a1c-4aff-a445-e8cd4542410e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_e8d63d13-56ae-4606-b924-1c6cc954cb9e" xlink:href="vtrs-20220331.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb2427a5-0a1c-4aff-a445-e8cd4542410e" xlink:to="loc_vtrs_UpjohnInc.Member_e8d63d13-56ae-4606-b924-1c6cc954cb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e878b97-23bf-4885-ad7b-9e0822d1e709" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_24c62443-0329-480b-a581-8cc84c861bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_24c62443-0329-480b-a581-8cc84c861bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f4cb845d-141a-41f9-b115-f6c4bee5b67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f4cb845d-141a-41f9-b115-f6c4bee5b67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_facbfe1d-1dd1-488f-9003-788747f79736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_facbfe1d-1dd1-488f-9003-788747f79736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_c64ba92d-4ff0-44fc-b6b9-dc00d67be9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_c64ba92d-4ff0-44fc-b6b9-dc00d67be9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_d60c551b-826b-40c0-8e36-e0f08d0e57ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_d60c551b-826b-40c0-8e36-e0f08d0e57ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_d8e8c6bf-4cdc-45ff-a3c0-61f57adf8b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d1ef4d92-779e-4464-9c5f-c52872ddef5c" xlink:to="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_d8e8c6bf-4cdc-45ff-a3c0-61f57adf8b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlan" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ShareBasedIncentivePlan"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c611912-6795-41ce-9d78-531ab5ecc10a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_28dfca0f-9bb6-4f4a-983b-81bd870e8ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c611912-6795-41ce-9d78-531ab5ecc10a" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_28dfca0f-9bb6-4f4a-983b-81bd870e8ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ShareBasedIncentivePlanTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a4ce2dae-debe-4935-8a99-fd154afa29fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d790551f-9777-4e39-814f-ec3a3b232963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a4ce2dae-debe-4935-8a99-fd154afa29fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d790551f-9777-4e39-814f-ec3a3b232963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_8911d83d-bbac-4fc2-a04b-58394e44d07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a4ce2dae-debe-4935-8a99-fd154afa29fe" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_8911d83d-bbac-4fc2-a04b-58394e44d07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ShareBasedIncentivePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1c46511-3def-4b16-a77c-1486f8081054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1c46511-3def-4b16-a77c-1486f8081054" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_ee4b7090-c68f-44b2-abc1-75b54e44d520" xlink:href="vtrs-20220331.xsd#vtrs_ProgramNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_vtrs_ProgramNameAxis_ee4b7090-c68f-44b2-abc1-75b54e44d520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_bddd8bd2-f885-47df-8a74-365e08815d88" xlink:href="vtrs-20220331.xsd#vtrs_ProgramNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameAxis_ee4b7090-c68f-44b2-abc1-75b54e44d520" xlink:to="loc_vtrs_ProgramNameDomain_bddd8bd2-f885-47df-8a74-365e08815d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4b6958f3-21f0-46bc-a898-fa0e479c9d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_us-gaap_PlanNameAxis_4b6958f3-21f0-46bc-a898-fa0e479c9d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4b6958f3-21f0-46bc-a898-fa0e479c9d20" xlink:to="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_14e601fa-c78e-4273-bbe2-b5972356feab" xlink:href="vtrs-20220331.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_14e601fa-c78e-4273-bbe2-b5972356feab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_2d53385e-ffd1-4bb7-add5-62c1d26dee0a" xlink:href="vtrs-20220331.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7da65a60-fdd3-4e0b-9176-45763960f785" xlink:to="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_2d53385e-ffd1-4bb7-add5-62c1d26dee0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78732f9b-0be3-4cde-ba56-b009f089b530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_us-gaap_AwardTypeAxis_78732f9b-0be3-4cde-ba56-b009f089b530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b77d520c-afa4-47c9-a5f5-e50dcc5c8b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_78732f9b-0be3-4cde-ba56-b009f089b530" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b77d520c-afa4-47c9-a5f5-e50dcc5c8b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_321fd9e9-b761-42a1-a135-75a1ad202cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b77d520c-afa4-47c9-a5f5-e50dcc5c8b56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_321fd9e9-b761-42a1-a135-75a1ad202cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_srt_RangeAxis_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1b4f6ba1-6f44-4b55-85d3-c97ba0ad2059" xlink:to="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a91e830-97f1-427a-9287-2551ee42bf90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:to="loc_srt_MinimumMember_4a91e830-97f1-427a-9287-2551ee42bf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08d38710-9709-4db1-ae08-8239ee8a3fc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_85ed9bd4-e5f0-4063-a9c7-dd965c1addf6" xlink:to="loc_srt_MaximumMember_08d38710-9709-4db1-ae08-8239ee8a3fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5da23b5a-3bc7-4925-aa9d-0a179f60b731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5da23b5a-3bc7-4925-aa9d-0a179f60b731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0220f187-04ff-4f04-8fd5-4a8446c0c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5da23b5a-3bc7-4925-aa9d-0a179f60b731" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0220f187-04ff-4f04-8fd5-4a8446c0c12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ccaa9ab-f393-44b8-b39a-b0f334e3585f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_67c91f58-c3f3-4dd0-8e02-cd1b76bf2def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_67c91f58-c3f3-4dd0-8e02-cd1b76bf2def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_52ea217f-b419-46cd-84b3-26bff3de1fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_52ea217f-b419-46cd-84b3-26bff3de1fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b5afdf1c-2b32-45f1-8270-b635c700c61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b5afdf1c-2b32-45f1-8270-b635c700c61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_fac3d6dd-82ec-4647-a9a1-6c1a0e6f25c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_fac3d6dd-82ec-4647-a9a1-6c1a0e6f25c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d1cbdf4b-9267-4d3c-80a5-8338f2f9e3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d1cbdf4b-9267-4d3c-80a5-8338f2f9e3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_26961540-00da-4520-9b35-52402e0de430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_26961540-00da-4520-9b35-52402e0de430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a18d8e34-87ff-4382-9f68-f22bf27ee916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a18d8e34-87ff-4382-9f68-f22bf27ee916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_66152099-41d7-4b58-942a-8b28a9029416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_66152099-41d7-4b58-942a-8b28a9029416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ad488b91-2b24-46c2-bf4a-eb6726c0c30d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ad488b91-2b24-46c2-bf4a-eb6726c0c30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_03749c7a-a7c1-4f73-bcb6-b692a3b7bd94" xlink:href="vtrs-20220331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_03749c7a-a7c1-4f73-bcb6-b692a3b7bd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a6d9995-4cf3-4dbb-8392-7a8809e5104d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a6d9995-4cf3-4dbb-8392-7a8809e5104d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_324badf0-cfc3-41c1-a480-71350012ef84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_324badf0-cfc3-41c1-a480-71350012ef84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0c1c288c-46b3-46fc-a5bf-f5ed363f025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242a67b4-2884-404f-8e3f-a1916a18872e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0c1c288c-46b3-46fc-a5bf-f5ed363f025c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ShareBasedIncentivePlanStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_934b92c6-14fe-4db6-8d9d-312ff45aab61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_934b92c6-14fe-4db6-8d9d-312ff45aab61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f36229ed-3fb3-4ac2-8805-df98d2a16357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f36229ed-3fb3-4ac2-8805-df98d2a16357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_a5ff40ff-30ac-4700-a183-8092d5ed938f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_a5ff40ff-30ac-4700-a183-8092d5ed938f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7787c864-2b88-49ad-b757-2d27317edbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7787c864-2b88-49ad-b757-2d27317edbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_68b75a00-4df6-46c4-b887-058cefc9f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_68b75a00-4df6-46c4-b887-058cefc9f27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60201a9c-7262-4789-8e09-17c726319b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60201a9c-7262-4789-8e09-17c726319b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_04237bd4-c5a7-4d4b-8219-4fdb69723eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_04237bd4-c5a7-4d4b-8219-4fdb69723eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c75b35b8-b0ee-4a99-af50-f4f57526bfac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c75b35b8-b0ee-4a99-af50-f4f57526bfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0ebdd8a0-494f-437d-8333-5ba23e4eeadc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0ebdd8a0-494f-437d-8333-5ba23e4eeadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a26f6efe-f926-4577-a765-35335cad0e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a26f6efe-f926-4577-a765-35335cad0e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2f88bcfe-7cc6-43ea-a488-3bdceb3c92ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2f88bcfe-7cc6-43ea-a488-3bdceb3c92ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_73096150-1d32-43c5-9ad3-d99e67d9ada0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_73096150-1d32-43c5-9ad3-d99e67d9ada0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6dde6fdb-fa84-4687-9142-23758f682664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33ca0c41-baaa-4ce7-a1f6-822c738c3d6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6dde6fdb-fa84-4687-9142-23758f682664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8a8f22be-de3c-41b2-9b14-54f54ec9a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19a3082a-3470-42fa-8a67-90dbcfc62c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8a8f22be-de3c-41b2-9b14-54f54ec9a7ed" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19a3082a-3470-42fa-8a67-90dbcfc62c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19a3082a-3470-42fa-8a67-90dbcfc62c22" xlink:to="loc_us-gaap_AwardTypeAxis_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3449849-e5b3-45b7-a8e9-b92861b6a523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9e6d2168-9ecf-482a-b8e7-1366e93d1b9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3449849-e5b3-45b7-a8e9-b92861b6a523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_11983d75-d741-4c61-bcc4-d08f7881f06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3449849-e5b3-45b7-a8e9-b92861b6a523" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_11983d75-d741-4c61-bcc4-d08f7881f06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_52a57e56-c3d1-4b91-be7b-f4976397fc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19a3082a-3470-42fa-8a67-90dbcfc62c22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_52a57e56-c3d1-4b91-be7b-f4976397fc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_52a57e56-c3d1-4b91-be7b-f4976397fc7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eeeb82db-7b1c-4fca-bd04-adaa019f6ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eeeb82db-7b1c-4fca-bd04-adaa019f6ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_161dbff9-5e07-447d-98de-8458e8123262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_161dbff9-5e07-447d-98de-8458e8123262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4ec2ae86-9f86-4654-82c8-aea314ac79a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4ec2ae86-9f86-4654-82c8-aea314ac79a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3da75ca-3844-43cf-96bd-790c8dceac2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3da75ca-3844-43cf-96bd-790c8dceac2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9cc6483b-56e0-47f7-88f3-652dc081d570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9cc6483b-56e0-47f7-88f3-652dc081d570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25295cca-bbb0-4afa-a281-3a96d8f9faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25295cca-bbb0-4afa-a281-3a96d8f9faa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_409e5da9-ebba-4ca0-8662-08d8cad40cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_409e5da9-ebba-4ca0-8662-08d8cad40cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c70a362d-3f59-4895-b486-65e2dfa01487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c70a362d-3f59-4895-b486-65e2dfa01487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e261a634-49d2-4e4f-b05f-77fdf6c04361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e261a634-49d2-4e4f-b05f-77fdf6c04361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c6efab6-e3de-4898-be02-81cd76d6fff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_10705eb1-3913-42b5-9933-7c8ed8597c45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c6efab6-e3de-4898-be02-81cd76d6fff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefits" xlink:type="simple" xlink:href="vtrs-20220331.xsd#PensionsandOtherPostretirementBenefits"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_be4bb5cb-b9ca-4dbc-91d5-6bf6be78892b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e56b74fb-9d86-47a9-848d-9b0258d07e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_be4bb5cb-b9ca-4dbc-91d5-6bf6be78892b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e56b74fb-9d86-47a9-848d-9b0258d07e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#PensionsandOtherPostretirementBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f15539e1-7324-49ab-9cf3-7f025b568e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_39fe08f1-a926-430e-89ba-778c8252fea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f15539e1-7324-49ab-9cf3-7f025b568e88" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_39fe08f1-a926-430e-89ba-778c8252fea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#PensionandOtherPostretirementBenefitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42b8acf3-3f96-4c14-bee8-b48bdd8e8a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9f788519-3203-4565-8650-9f611bd111c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42b8acf3-3f96-4c14-bee8-b48bdd8e8a39" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9f788519-3203-4565-8650-9f611bd111c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_036d40c9-7a9d-45e2-b24a-719d428ead49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9f788519-3203-4565-8650-9f611bd111c9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_036d40c9-7a9d-45e2-b24a-719d428ead49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a60eb2b8-8fe3-49ec-aca5-32f9d360ca60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_036d40c9-7a9d-45e2-b24a-719d428ead49" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a60eb2b8-8fe3-49ec-aca5-32f9d360ca60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9f788519-3203-4565-8650-9f611bd111c9" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlansNumberofFrozenPlans_6c11c8c4-ecca-4a35-86cf-d739f0df2b26" xlink:href="vtrs-20220331.xsd#vtrs_DefinedBenefitPlansNumberofFrozenPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:to="loc_vtrs_DefinedBenefitPlansNumberofFrozenPlans_6c11c8c4-ecca-4a35-86cf-d739f0df2b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_01028af9-4777-4f3f-8a5d-8b2d1502b93e" xlink:href="vtrs-20220331.xsd#vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:to="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_01028af9-4777-4f3f-8a5d-8b2d1502b93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_dff5d866-4efb-4f6a-bf03-81a70933eb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_61cfd931-8197-4cf8-91a7-406531ba8fd3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_dff5d866-4efb-4f6a-bf03-81a70933eb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1a809741-64cf-4a99-94fe-2f8b24f58ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1a809741-64cf-4a99-94fe-2f8b24f58ac5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3bf86f24-2395-482e-af0c-0e583f20ae4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3bf86f24-2395-482e-af0c-0e583f20ae4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d2256b6-cde3-405f-9a92-ab692983008d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3bf86f24-2395-482e-af0c-0e583f20ae4a" xlink:to="loc_us-gaap_EquityComponentDomain_3d2256b6-cde3-405f-9a92-ab692983008d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3031b7c0-3eb7-4131-8399-ba9972bc2326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d2256b6-cde3-405f-9a92-ab692983008d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3031b7c0-3eb7-4131-8399-ba9972bc2326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fb547af5-fb9e-42d6-99b6-f7f55567ab84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_5d62e756-cc7b-4386-ac6a-7cc2a6f8d193" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fb547af5-fb9e-42d6-99b6-f7f55567ab84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_d34126f2-c38e-4099-97f8-00743a2740ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fb547af5-fb9e-42d6-99b6-f7f55567ab84" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_d34126f2-c38e-4099-97f8-00743a2740ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_04e68ba5-ce71-47e4-bf34-4a6a0f75948e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_04e68ba5-ce71-47e4-bf34-4a6a0f75948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4eae565a-687f-476c-9baa-f350ae61a373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_04e68ba5-ce71-47e4-bf34-4a6a0f75948e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4eae565a-687f-476c-9baa-f350ae61a373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e28c6f4a-cd43-4566-b6db-f8cfd6773244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4eae565a-687f-476c-9baa-f350ae61a373" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e28c6f4a-cd43-4566-b6db-f8cfd6773244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb21cf75-8e68-4e7a-84c9-7feb0b4c3186" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_382d8593-289d-487a-b828-5f21bf65cc30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_382d8593-289d-487a-b828-5f21bf65cc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f5ccf31b-550f-45f7-9674-17d9b7558c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f5ccf31b-550f-45f7-9674-17d9b7558c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a438168c-b3ae-48eb-87b3-3cb3c6d6a2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a438168c-b3ae-48eb-87b3-3cb3c6d6a2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_bfa38a76-26ee-4e1e-acf7-caf21a4aca80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_bfa38a76-26ee-4e1e-acf7-caf21a4aca80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e9571d4c-a219-43b4-a526-ae1d332b6537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e9571d4c-a219-43b4-a526-ae1d332b6537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7aca5aba-dd14-4850-8bea-b50da95c111f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea7906f6-a2f6-4442-a5a5-0edd835c0670" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7aca5aba-dd14-4850-8bea-b50da95c111f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_a582e629-03f8-4e2d-bb9b-68f038ecc811" xlink:href="vtrs-20220331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_6a196ef5-7a46-403c-ac0c-7884f02c5024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_a582e629-03f8-4e2d-bb9b-68f038ecc811" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_6a196ef5-7a46-403c-ac0c-7884f02c5024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:href="vtrs-20220331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_31c1f68e-4b68-47c1-bc96-5a8b6140a473" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_31c1f68e-4b68-47c1-bc96-5a8b6140a473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b795354b-0db2-4799-a398-94ee2b3a1e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b795354b-0db2-4799-a398-94ee2b3a1e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_e2cc3ca9-d708-44bb-8851-0dbfac75223a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_e2cc3ca9-d708-44bb-8851-0dbfac75223a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_dd399131-884b-491a-b366-90ec1af81ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_dd399131-884b-491a-b366-90ec1af81ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_ae622a58-5321-4681-91c9-4a5b1e12a97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_ae622a58-5321-4681-91c9-4a5b1e12a97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_b7e752de-0a0a-4e99-a21e-56bd0554ff1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_b7e752de-0a0a-4e99-a21e-56bd0554ff1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_014e34b5-85ad-42c5-a43e-bb63e6f86228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_014e34b5-85ad-42c5-a43e-bb63e6f86228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_99c12c6b-5ce1-44c1-b5c8-0b2ebfa588fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_99c12c6b-5ce1-44c1-b5c8-0b2ebfa588fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d1544f3a-8b28-490d-9059-932b94e09fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_3e01c3ee-c26e-491c-a8d7-09ec29550761" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d1544f3a-8b28-490d-9059-932b94e09fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_1e1e2a78-44a2-4d61-b532-481dc1a6797b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd305228-878d-4415-b7ab-ad3733f421a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_1e1e2a78-44a2-4d61-b532-481dc1a6797b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd305228-878d-4415-b7ab-ad3733f421a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0e2efa9e-a118-4aac-9c6d-9ee209fba21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_1e1e2a78-44a2-4d61-b532-481dc1a6797b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0e2efa9e-a118-4aac-9c6d-9ee209fba21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7101cfdc-80c2-4e40-8893-bf5bcb508186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_1e1e2a78-44a2-4d61-b532-481dc1a6797b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7101cfdc-80c2-4e40-8893-bf5bcb508186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_aef3500b-c371-4718-b2bf-d2137b4384b8" xlink:href="vtrs-20220331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8b2929eb-e916-4305-8e3e-898c8e521ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_aef3500b-c371-4718-b2bf-d2137b4384b8" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8b2929eb-e916-4305-8e3e-898c8e521ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_dfd8f21f-0328-4fb9-afa6-e19dc8fe899b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_aef3500b-c371-4718-b2bf-d2137b4384b8" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_dfd8f21f-0328-4fb9-afa6-e19dc8fe899b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70c36b3a-d587-40b9-8da0-45e8f0202c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_aef3500b-c371-4718-b2bf-d2137b4384b8" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70c36b3a-d587-40b9-8da0-45e8f0202c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_601fa949-dd38-4ad5-9d15-3e31afe67319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_aef3500b-c371-4718-b2bf-d2137b4384b8" xlink:to="loc_us-gaap_InventoryNet_601fa949-dd38-4ad5-9d15-3e31afe67319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_c56b203f-5b9c-4831-8da2-4a81dc925828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_c56b203f-5b9c-4831-8da2-4a81dc925828" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_56ebe897-35ed-4277-91d8-da3b2db362f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_56ebe897-35ed-4277-91d8-da3b2db362f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_74339951-27ee-4214-9789-edc2c766e0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_56ebe897-35ed-4277-91d8-da3b2db362f3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_74339951-27ee-4214-9789-edc2c766e0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_fb7fefaf-e918-4809-9fa8-fb4825e25c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_74339951-27ee-4214-9789-edc2c766e0b2" xlink:to="loc_us-gaap_DebtSecuritiesMember_fb7fefaf-e918-4809-9fa8-fb4825e25c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_47e7d9e4-7927-43b0-b98e-59d62ff9e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_47e7d9e4-7927-43b0-b98e-59d62ff9e98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ea63effb-9933-4898-b273-30edeb67f346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_47e7d9e4-7927-43b0-b98e-59d62ff9e98a" xlink:to="loc_us-gaap_ReceivableTypeDomain_ea63effb-9933-4898-b273-30edeb67f346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_c07aeeee-4e95-4213-90ce-9b35ddc9e6e3" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_ea63effb-9933-4898-b273-30edeb67f346" xlink:to="loc_vtrs_VariableConsiderationMember_c07aeeee-4e95-4213-90ce-9b35ddc9e6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8d059e7b-cae0-49df-afa5-60bbdd8351bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8d059e7b-cae0-49df-afa5-60bbdd8351bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5f1eb0b4-54fe-4e5a-8eee-df51b73339fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d059e7b-cae0-49df-afa5-60bbdd8351bc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5f1eb0b4-54fe-4e5a-8eee-df51b73339fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b86a9bcb-8b99-4d47-bfb0-f221ed0bf923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5f1eb0b4-54fe-4e5a-8eee-df51b73339fe" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b86a9bcb-8b99-4d47-bfb0-f221ed0bf923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17dd30b1-1fc7-4728-821a-acd642701a88" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17dd30b1-1fc7-4728-821a-acd642701a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_50dbdc38-c410-47c7-860e-cb6ad3f19687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17dd30b1-1fc7-4728-821a-acd642701a88" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_50dbdc38-c410-47c7-860e-cb6ad3f19687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_4fc31c4c-72a1-4a02-b009-87eb05a1e48c" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_50dbdc38-c410-47c7-860e-cb6ad3f19687" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_4fc31c4c-72a1-4a02-b009-87eb05a1e48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aaacd979-0e3c-4cad-98fd-36545dc740db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2fd4c5b7-4ef3-40a4-a8e8-570bd89de841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2fd4c5b7-4ef3-40a4-a8e8-570bd89de841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16f98d8f-2668-45a6-8a0a-48c970f1d25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16f98d8f-2668-45a6-8a0a-48c970f1d25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6ab366e9-4481-4bc2-b404-6e013fd32638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6ab366e9-4481-4bc2-b404-6e013fd32638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_f133f27e-27ac-40fd-8f2c-8f7609848447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_TradingSecurities_f133f27e-27ac-40fd-8f2c-8f7609848447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_705f2774-a8df-4dca-8692-ec3893f482be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_OtherAssetsCurrent_705f2774-a8df-4dca-8692-ec3893f482be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_84d53366-1be6-4902-8b66-93730b6245a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7127b59c-4778-49f9-b5ab-4d5fb2065f56" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_84d53366-1be6-4902-8b66-93730b6245a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_62a5a35c-c876-4353-830f-1cf8bf012ffb" xlink:href="vtrs-20220331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_618c5088-7b1b-47c7-83d4-8b8d1c96380b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_62a5a35c-c876-4353-830f-1cf8bf012ffb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_618c5088-7b1b-47c7-83d4-8b8d1c96380b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_618c5088-7b1b-47c7-83d4-8b8d1c96380b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_549dbf23-bdde-4bf2-b632-2a8cdb0bfddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a022b74e-119d-4f9e-a4b4-6c769ed38711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a022b74e-119d-4f9e-a4b4-6c769ed38711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_afffc8ef-77ac-40ba-a5a5-20c87711ec8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_afffc8ef-77ac-40ba-a5a5-20c87711ec8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_4da0f53b-6e97-453d-815f-ff1ee6cac24b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_ConstructionInProgressMember_4da0f53b-6e97-453d-815f-ff1ee6cac24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_98dcb9eb-3da6-45d4-b5da-94d7ead7b87b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b04f5963-785f-4832-96f1-ff399cd9a5a6" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_98dcb9eb-3da6-45d4-b5da-94d7ead7b87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_618c5088-7b1b-47c7-83d4-8b8d1c96380b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_db5b26fb-ead9-4292-b8e1-b96f1c11b01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_db5b26fb-ead9-4292-b8e1-b96f1c11b01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_05361681-e306-4f5c-8293-e0534c376ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_05361681-e306-4f5c-8293-e0534c376ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_28572d69-c780-4d93-88b1-9646fa70761e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f86f084a-dd86-40be-b97b-d8e4318e4721" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_28572d69-c780-4d93-88b1-9646fa70761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_526edd7f-8367-4d0a-8d51-1a80092c7792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_89da02e4-f49f-487c-bce4-db5fed1e1f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_526edd7f-8367-4d0a-8d51-1a80092c7792" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_89da02e4-f49f-487c-bce4-db5fed1e1f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets_004785a9-d957-4f43-869f-115acfc29fd8" xlink:href="vtrs-20220331.xsd#vtrs_Otherlongtermassets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_526edd7f-8367-4d0a-8d51-1a80092c7792" xlink:to="loc_vtrs_Otherlongtermassets_004785a9-d957-4f43-869f-115acfc29fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_33638b1c-ebc1-496a-af05-d38654980d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_526edd7f-8367-4d0a-8d51-1a80092c7792" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_33638b1c-ebc1-496a-af05-d38654980d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsTradeAccountsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAbstract_256a192c-9e4f-4541-bbea-89a3e9da6386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_c0168d7e-6481-4885-b470-6fa3da6080f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_256a192c-9e4f-4541-bbea-89a3e9da6386" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_c0168d7e-6481-4885-b470-6fa3da6080f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_62897eda-5154-4cec-be9e-6cf407b9f7be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_256a192c-9e4f-4541-bbea-89a3e9da6386" xlink:to="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_62897eda-5154-4cec-be9e-6cf407b9f7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_12f3dd1e-004b-45c7-9b22-4b177a153a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_256a192c-9e4f-4541-bbea-89a3e9da6386" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_12f3dd1e-004b-45c7-9b22-4b177a153a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_74628610-7a2e-4ea1-925a-dcc9ed16d0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_74628610-7a2e-4ea1-925a-dcc9ed16d0fa" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_4e725a79-31f6-4543-a482-9f702059a566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_4e725a79-31f6-4543-a482-9f702059a566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_727d8b71-9dc2-469c-bc22-b8f0d429cd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_4e725a79-31f6-4543-a482-9f702059a566" xlink:to="loc_us-gaap_ReceivableTypeDomain_727d8b71-9dc2-469c-bc22-b8f0d429cd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_8ffab555-88fa-4791-921d-a200ea3b84fa" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_727d8b71-9dc2-469c-bc22-b8f0d429cd68" xlink:to="loc_vtrs_VariableConsiderationMember_8ffab555-88fa-4791-921d-a200ea3b84fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6939fecf-81e7-4f07-9bcc-8a45184cb890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_04fe32f4-8ff4-42e4-81d7-5d95b98f9b89" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6939fecf-81e7-4f07-9bcc-8a45184cb890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_172545cc-fd32-4666-82f8-fc42720a117a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6939fecf-81e7-4f07-9bcc-8a45184cb890" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_172545cc-fd32-4666-82f8-fc42720a117a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_115b4f8e-ba2d-4348-8394-321bf538f56a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_115b4f8e-ba2d-4348-8394-321bf538f56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_963d6ca9-c07f-4e91-b87f-31ee80bbf647" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_115b4f8e-ba2d-4348-8394-321bf538f56a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_963d6ca9-c07f-4e91-b87f-31ee80bbf647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_ed194346-0db6-46fc-b4e4-39c1293aefd4" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_963d6ca9-c07f-4e91-b87f-31ee80bbf647" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_ed194346-0db6-46fc-b4e4-39c1293aefd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_5cdb0eff-04b6-4e58-944d-0344033cb446" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_de4a8a92-a798-4176-a349-822e0aa0e8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_de4a8a92-a798-4176-a349-822e0aa0e8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_6d0af42d-10a3-49a7-b500-96ed4b642fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_LitigationReserveCurrent_6d0af42d-10a3-49a7-b500-96ed4b642fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_88e81d2c-a579-4044-9111-a8577143db68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_88e81d2c-a579-4044-9111-a8577143db68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2fbc9ef4-1918-4b0c-be13-cdf5c20d3657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2fbc9ef4-1918-4b0c-be13-cdf5c20d3657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_ba644f2a-dd9f-49f4-b21b-65504cadfe59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_RestructuringReserveCurrent_ba644f2a-dd9f-49f4-b21b-65504cadfe59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_ed85c144-095c-42a4-a3f2-ae9e57b7c239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_InterestPayableCurrent_ed85c144-095c-42a4-a3f2-ae9e57b7c239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2c8c56a2-b8c2-4f2d-b144-4160eac2b48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2c8c56a2-b8c2-4f2d-b144-4160eac2b48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_86483072-6b70-4eda-bce3-c701d4c01329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_86483072-6b70-4eda-bce3-c701d4c01329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2622e3e6-e397-4335-87b7-3c373051fe05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2622e3e6-e397-4335-87b7-3c373051fe05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_25926b2c-050e-4c89-bf46-1e67e135b21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_58b8f572-6fb9-4b73-b2e7-bfafb7c48d9b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_25926b2c-050e-4c89-bf46-1e67e135b21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsOtherLongtermObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_51e7c6a6-a96f-46d4-9d36-240bc9b82369" xlink:href="vtrs-20220331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_940fcd71-2c4a-4ce2-92d9-3258922a9023" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_51e7c6a6-a96f-46d4-9d36-240bc9b82369" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_940fcd71-2c4a-4ce2-92d9-3258922a9023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_423cdc1f-530e-410d-af28-05f28c94d49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_940fcd71-2c4a-4ce2-92d9-3258922a9023" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_423cdc1f-530e-410d-af28-05f28c94d49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e9c31404-307e-4284-90f9-d4b4b4cbc4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_423cdc1f-530e-410d-af28-05f28c94d49a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e9c31404-307e-4284-90f9-d4b4b4cbc4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c0b6115c-7bc8-401b-93ab-c662e2ff5686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e9c31404-307e-4284-90f9-d4b4b4cbc4fa" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c0b6115c-7bc8-401b-93ab-c662e2ff5686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_940fcd71-2c4a-4ce2-92d9-3258922a9023" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_3f3e68b6-5820-4c13-aa6b-fb835def8f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_3f3e68b6-5820-4c13-aa6b-fb835def8f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14adba2a-c491-486d-b78b-8d6265dd1774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14adba2a-c491-486d-b78b-8d6265dd1774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_c7a52c65-bdc1-45f9-aac8-2d57b9238d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_c7a52c65-bdc1-45f9-aac8-2d57b9238d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87dcc578-db98-470e-9062-575670cf274d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87dcc578-db98-470e-9062-575670cf274d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_8337cb6a-342a-4326-b82a-e31295a354b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_8337cb6a-342a-4326-b82a-e31295a354b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_31142fce-e25f-4f65-9852-9e85fb9a0d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_31142fce-e25f-4f65-9852-9e85fb9a0d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f5fe8436-ef42-486d-ab95-a2e1d8f69faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_d00b4007-bc7c-4337-958c-949203a6debf" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f5fe8436-ef42-486d-ab95-a2e1d8f69faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ab6cb7cb-fd89-43e6-bff6-8887dbf48b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ab6cb7cb-fd89-43e6-bff6-8887dbf48b4b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_af0b7245-b547-4e9c-82ce-fd5a17b0077b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_af0b7245-b547-4e9c-82ce-fd5a17b0077b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ee906132-d32f-4ac1-a293-6a90f5448a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_af0b7245-b547-4e9c-82ce-fd5a17b0077b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ee906132-d32f-4ac1-a293-6a90f5448a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_4df3f64c-a0dd-4b48-afb5-b5f6205def14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ee906132-d32f-4ac1-a293-6a90f5448a19" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_4df3f64c-a0dd-4b48-afb5-b5f6205def14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e87d23ef-7497-4de9-a42a-50ed55d5186a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_srt_StatementScenarioAxis_e87d23ef-7497-4de9-a42a-50ed55d5186a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1de6de15-7248-4382-ad68-a56a94d4bb91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_e87d23ef-7497-4de9-a42a-50ed55d5186a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1de6de15-7248-4382-ad68-a56a94d4bb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_ee286e24-7334-4d65-96cb-15f3b94e804f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1de6de15-7248-4382-ad68-a56a94d4bb91" xlink:to="loc_srt_ScenarioForecastMember_ee286e24-7334-4d65-96cb-15f3b94e804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b89e0222-c4dc-4771-8811-52f61b47a770" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_srt_CounterpartyNameAxis_b89e0222-c4dc-4771-8811-52f61b47a770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_56d57477-419b-47b4-91a6-9f5b520a3a04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b89e0222-c4dc-4771-8811-52f61b47a770" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_56d57477-419b-47b4-91a6-9f5b520a3a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_4b21e006-b375-4f95-a606-d200d5b7fcb2" xlink:href="vtrs-20220331.xsd#vtrs_BioconBiologicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_56d57477-419b-47b4-91a6-9f5b520a3a04" xlink:to="loc_vtrs_BioconBiologicsMember_4b21e006-b375-4f95-a606-d200d5b7fcb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_063f9c18-ca09-4e3d-b825-3b56ce022b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_063f9c18-ca09-4e3d-b825-3b56ce022b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_325d9556-5001-45db-aad0-bf0850507f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_063f9c18-ca09-4e3d-b825-3b56ce022b23" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_325d9556-5001-45db-aad0-bf0850507f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BiosimilarsPortfolioMember_61408658-b9f4-40c8-a30a-6fd27b970500" xlink:href="vtrs-20220331.xsd#vtrs_BiosimilarsPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_325d9556-5001-45db-aad0-bf0850507f68" xlink:to="loc_vtrs_BiosimilarsPortfolioMember_61408658-b9f4-40c8-a30a-6fd27b970500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_128d29ee-be06-4201-9704-0c594311cdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_128d29ee-be06-4201-9704-0c594311cdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_54a95024-f179-49e5-8194-2367c0ce3b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_128d29ee-be06-4201-9704-0c594311cdb1" xlink:to="loc_us-gaap_ReceivableTypeDomain_54a95024-f179-49e5-8194-2367c0ce3b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_205bd9cb-af9e-4de2-b6c6-c9048bf42214" xlink:href="vtrs-20220331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_54a95024-f179-49e5-8194-2367c0ce3b87" xlink:to="loc_vtrs_VariableConsiderationMember_205bd9cb-af9e-4de2-b6c6-c9048bf42214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_67fb9d53-811d-48be-a835-a43fedced6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_67fb9d53-811d-48be-a835-a43fedced6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_959cd392-f8f9-444f-9f9f-0c47cd33e60b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_67fb9d53-811d-48be-a835-a43fedced6c2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_959cd392-f8f9-444f-9f9f-0c47cd33e60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_755540e4-e3b8-433b-b09d-730cf7e7db66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_959cd392-f8f9-444f-9f9f-0c47cd33e60b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_755540e4-e3b8-433b-b09d-730cf7e7db66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05904b4b-a7a5-451c-b1b9-078089d81d09" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05904b4b-a7a5-451c-b1b9-078089d81d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5f281e39-7eaa-4a32-a7da-7324260007b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05904b4b-a7a5-451c-b1b9-078089d81d09" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5f281e39-7eaa-4a32-a7da-7324260007b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_14cee8df-1f6a-457b-bf25-b67ce7504b3e" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f281e39-7eaa-4a32-a7da-7324260007b9" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_14cee8df-1f6a-457b-bf25-b67ce7504b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5b5fd751-9284-4de0-95b8-83e122281247" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_d0adf78f-4bf7-46ea-9d24-8684f9afdb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_d0adf78f-4bf7-46ea-9d24-8684f9afdb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership_50515561-8423-45bc-a3ef-37172cb5b12e" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership_50515561-8423-45bc-a3ef-37172cb5b12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh_3441a70d-662e-4fea-bc57-8d10c3d86386" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh_3441a70d-662e-4fea-bc57-8d10c3d86386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement_3c062af9-e6cc-4998-a626-c21b5c42b399" xlink:href="vtrs-20220331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement_3c062af9-e6cc-4998-a626-c21b5c42b399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_03ab970e-8a6f-49a7-9523-79d929ba2c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_03ab970e-8a6f-49a7-9523-79d929ba2c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0773015d-26a4-4e72-ada5-e58d49b41011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0773015d-26a4-4e72-ada5-e58d49b41011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7d23537-5358-441d-91df-35c65163cb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e7d23537-5358-441d-91df-35c65163cb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_6ca982d8-2540-4503-96e2-eb07d5174480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_6ca982d8-2540-4503-96e2-eb07d5174480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_adbf8ee6-ed9b-485b-91f6-2a293edbe836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_adbf8ee6-ed9b-485b-91f6-2a293edbe836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_23a79afb-31ea-401e-b153-5fe09f62cb93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_23a79afb-31ea-401e-b153-5fe09f62cb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_585a2274-587f-4cb4-bb6b-b66b8b4c4b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_585a2274-587f-4cb4-bb6b-b66b8b4c4b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_eba76d00-9415-4997-8f29-743e4c80a06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_eba76d00-9415-4997-8f29-743e4c80a06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_59f0ff4f-b7b5-45e1-bf59-31f8607bdbda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_59f0ff4f-b7b5-45e1-bf59-31f8607bdbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_36ac4115-0d75-4964-8f13-55ad4e42f4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_36ac4115-0d75-4964-8f13-55ad4e42f4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fd41869a-b1fb-4a94-86b1-7510730df1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c81ba576-9cf3-4a21-814a-d290496ea18e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fd41869a-b1fb-4a94-86b1-7510730df1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestments" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EquityMethodInvestments"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_db85e152-3086-408e-8a41-b50d00ad2b18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_5c1394b1-7681-4bff-8b58-6c3aa1a9c479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_db85e152-3086-408e-8a41-b50d00ad2b18" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_5c1394b1-7681-4bff-8b58-6c3aa1a9c479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EquityMethodInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_051e551b-fbea-4fd5-b86f-1b7179346b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_e1b7fa5b-50fd-4f5e-bbc4-e05aeacb35c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_051e551b-fbea-4fd5-b86f-1b7179346b51" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_e1b7fa5b-50fd-4f5e-bbc4-e05aeacb35c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EquityMethodInvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8c80d980-4349-4664-b526-394ae4e9fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff14ae19-1f43-43f3-a0d9-b662f2c1f8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8c80d980-4349-4664-b526-394ae4e9fbc9" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff14ae19-1f43-43f3-a0d9-b662f2c1f8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a33dff6b-057b-491a-ac3a-84e514771eb5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff14ae19-1f43-43f3-a0d9-b662f2c1f8d8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a33dff6b-057b-491a-ac3a-84e514771eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a8c29d42-219e-422e-b606-1adb1ff172c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a33dff6b-057b-491a-ac3a-84e514771eb5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a8c29d42-219e-422e-b606-1adb1ff172c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_7c126b4f-2315-40f4-a3aa-3fd506c04007" xlink:href="vtrs-20220331.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a8c29d42-219e-422e-b606-1adb1ff172c9" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_7c126b4f-2315-40f4-a3aa-3fd506c04007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff14ae19-1f43-43f3-a0d9-b662f2c1f8d8" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofequitymethodinvestments_2d65f032-eeda-4589-83af-e678a4926327" xlink:href="vtrs-20220331.xsd#vtrs_Numberofequitymethodinvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:to="loc_vtrs_Numberofequitymethodinvestments_2d65f032-eeda-4589-83af-e678a4926327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis_709fd5df-7761-49a1-835d-a449379ff3ae" xlink:href="vtrs-20220331.xsd#vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:to="loc_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis_709fd5df-7761-49a1-835d-a449379ff3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_73d351d5-115b-48f5-8995-f7346479f865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_af1ccb4e-ed87-4534-bd61-56fa84154cdc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_73d351d5-115b-48f5-8995-f7346479f865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EquityMethodInvestmentsIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_55beff31-031c-4543-804e-5b36d8b5ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_436e55c2-7f7c-460d-81c9-2b9a673a2b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_55beff31-031c-4543-804e-5b36d8b5ab61" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_436e55c2-7f7c-460d-81c9-2b9a673a2b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5a43904d-2c5b-4de3-b69b-bf90c714244a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_436e55c2-7f7c-460d-81c9-2b9a673a2b41" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5a43904d-2c5b-4de3-b69b-bf90c714244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7e72c2ef-745e-406c-9424-c7a52dc6d6ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a43904d-2c5b-4de3-b69b-bf90c714244a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7e72c2ef-745e-406c-9424-c7a52dc6d6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember_0d30f632-7cb6-4101-bc82-f070c2a0f47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7e72c2ef-745e-406c-9424-c7a52dc6d6ab" xlink:to="loc_us-gaap_ConsolidatedEntityExcludingVieMember_0d30f632-7cb6-4101-bc82-f070c2a0f47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_436e55c2-7f7c-460d-81c9-2b9a673a2b41" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_09bc6875-7203-4ef6-9770-22f509eb1e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_Revenues_09bc6875-7203-4ef6-9770-22f509eb1e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_42a805b9-b4e1-49ba-8272-92a077799f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_GrossProfit_42a805b9-b4e1-49ba-8272-92a077799f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f228658-bd00-4968-a717-a03d36e02b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f228658-bd00-4968-a717-a03d36e02b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5a64a4c1-4cb6-481e-91f6-b017717a25b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_aae0e058-95e0-4754-8878-81996eb5c707" xlink:to="loc_us-gaap_ProfitLoss_5a64a4c1-4cb6-481e-91f6-b017717a25b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShare" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EarningsLossperOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2163a267-d501-4fc5-9163-a19856892f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0b40f569-2bba-4120-b056-ed90957cf2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2163a267-d501-4fc5-9163-a19856892f11" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0b40f569-2bba-4120-b056-ed90957cf2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EarningsLossperOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df5da387-9f4b-4c2e-acf7-01cb987b1165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e63aaa54-8f28-46de-95eb-0c05e00e7329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df5da387-9f4b-4c2e-acf7-01cb987b1165" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e63aaa54-8f28-46de-95eb-0c05e00e7329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EarningsLossperOrdinaryShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9ff9ad59-76ca-46f0-8bd7-b8dd07e30992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_57e273c1-353b-4d12-a9c2-fc43c0553892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9ff9ad59-76ca-46f0-8bd7-b8dd07e30992" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_57e273c1-353b-4d12-a9c2-fc43c0553892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_57e273c1-353b-4d12-a9c2-fc43c0553892" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fe2b63f8-2f5f-4434-a22d-462e910f8d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2a00e58b-ac03-47f9-8d6b-d5e6b3a0d549" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fe2b63f8-2f5f-4434-a22d-462e910f8d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_889a40e3-869c-43ed-885f-a4e70b88ce45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fe2b63f8-2f5f-4434-a22d-462e910f8d6c" xlink:to="loc_us-gaap_SubsequentEventMember_889a40e3-869c-43ed-885f-a4e70b88ce45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_57e273c1-353b-4d12-a9c2-fc43c0553892" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6051690e-7c0e-496e-bf3e-c7ece55133dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6051690e-7c0e-496e-bf3e-c7ece55133dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1a0b8b9a-1424-4971-975f-e57a8c6349a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1a0b8b9a-1424-4971-975f-e57a8c6349a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_d5f9315f-9821-494c-823b-81f7254213bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_Dividends_d5f9315f-9821-494c-823b-81f7254213bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_e1b2bcfa-380d-49ae-8cdf-b99f70a90d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_e1b2bcfa-380d-49ae-8cdf-b99f70a90d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1fede50f-11a1-46b0-9c25-33bdc5eed8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1fede50f-11a1-46b0-9c25-33bdc5eed8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_bcc1df24-7927-4de9-9afe-36aadd1124dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_bcc1df24-7927-4de9-9afe-36aadd1124dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_dd3f1e39-7379-4b25-b038-417ec8b1fb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_98103ec1-48c5-4137-b886-c076a12d9dac" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_dd3f1e39-7379-4b25-b038-417ec8b1fb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ed1272f2-70c1-4e39-bcef-0473f6a2f0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ed1272f2-70c1-4e39-bcef-0473f6a2f0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_278d08f5-5a84-4c72-abaf-db0cef9d5784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:to="loc_us-gaap_ProfitLoss_278d08f5-5a84-4c72-abaf-db0cef9d5784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f1053452-28f6-48b2-82c3-834828a0d0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f1053452-28f6-48b2-82c3-834828a0d0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4ab61386-ced0-4c1f-bb53-263ed7ef13e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4ab61386-ced0-4c1f-bb53-263ed7ef13e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ac3a1d9-fd5a-42e9-8dae-99a8f817ee51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ac3a1d9-fd5a-42e9-8dae-99a8f817ee51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1ca2dc7d-5dce-4dad-b958-d8fc3a85d769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:to="loc_us-gaap_EarningsPerShareBasic_1ca2dc7d-5dce-4dad-b958-d8fc3a85d769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8f559caf-cd22-486a-9ae2-0f1ba81057fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9014453a-ac8c-4039-98b8-dfffbaccb2e1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8f559caf-cd22-486a-9ae2-0f1ba81057fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dcffca33-6fa0-4a64-8ca8-59cbbb0be36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e6397bb9-2a1f-4f20-bc78-1107257ecf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dcffca33-6fa0-4a64-8ca8-59cbbb0be36e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e6397bb9-2a1f-4f20-bc78-1107257ecf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f71f8dea-c854-4d4c-a324-6bee71560585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8f41e00e-44de-4f65-b2e9-97453afdbb24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f71f8dea-c854-4d4c-a324-6bee71560585" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_8f41e00e-44de-4f65-b2e9-97453afdbb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_8e12af08-7117-4af9-b25d-20c54219604b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f71f8dea-c854-4d4c-a324-6bee71560585" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_8e12af08-7117-4af9-b25d-20c54219604b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_cff37bb2-5045-45c0-9567-1f294020a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f71f8dea-c854-4d4c-a324-6bee71560585" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_cff37bb2-5045-45c0-9567-1f294020a7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_4a3ecd49-3a59-499a-ab65-f81902c1c55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f71f8dea-c854-4d4c-a324-6bee71560585" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_4a3ecd49-3a59-499a-ab65-f81902c1c55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7138b2f3-f77e-4cc3-9b9a-f927da3f2510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7138b2f3-f77e-4cc3-9b9a-f927da3f2510" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_6f746ccf-ab23-425c-a9b7-da24edc33956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_ReportingUnitAxis_6f746ccf-ab23-425c-a9b7-da24edc33956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_6f746ccf-ab23-425c-a9b7-da24edc33956" xlink:to="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_df91975d-5648-4a42-a0ae-ce7f68a57f29" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_RestofWorldSegmentMember_df91975d-5648-4a42-a0ae-ce7f68a57f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_d74560c6-7786-4a53-b612-f323c1c99451" xlink:href="vtrs-20220331.xsd#vtrs_EuropeSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_EuropeSegmentMember_d74560c6-7786-4a53-b612-f323c1c99451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaBrandsMember_064fbb61-65fe-4043-87b7-819621e2bd17" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaBrandsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_NorthAmericaBrandsMember_064fbb61-65fe-4043-87b7-819621e2bd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember_c0fc8b8d-597f-4e70-beea-c90060c69e10" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_15d51ef6-41a1-4198-81bb-6aa86155dfe4" xlink:to="loc_vtrs_NorthAmericaGenericsMember_c0fc8b8d-597f-4e70-beea-c90060c69e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_srt_ConsolidationItemsAxis_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f1eefe89-d356-4858-8152-f193223baba3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a5c67ea0-a4c0-4b0d-bbb1-6cdbc652cd08" xlink:to="loc_srt_ConsolidationItemsDomain_f1eefe89-d356-4858-8152-f193223baba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_f5a78c2e-6be2-487c-a3bb-b96a7cc99070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f1eefe89-d356-4858-8152-f193223baba3" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_f5a78c2e-6be2-487c-a3bb-b96a7cc99070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5e001d93-6b83-4c42-a78e-93c82fc5b6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9a1d3ce5-e5a0-4ed3-aa64-a1183b09b885" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5e001d93-6b83-4c42-a78e-93c82fc5b6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9d0c9801-c78e-4f39-af2e-56b2247a3f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5e001d93-6b83-4c42-a78e-93c82fc5b6a3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9d0c9801-c78e-4f39-af2e-56b2247a3f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_srt_RangeAxis_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_37a4af3c-87c3-40eb-a5f7-a6f700e1fe28" xlink:to="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9a312572-c7e3-4c4e-94bd-f03cf5f2f572" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:to="loc_srt_MinimumMember_9a312572-c7e3-4c4e-94bd-f03cf5f2f572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a45eee2d-0df6-499d-9f3c-0bc9a8ba6b51" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_870342a9-a537-48cb-a42b-21d1c7f7529e" xlink:to="loc_srt_MaximumMember_a45eee2d-0df6-499d-9f3c-0bc9a8ba6b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_142d96e0-a737-419f-b5e9-446f74abb00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_142d96e0-a737-419f-b5e9-446f74abb00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_142d96e0-a737-419f-b5e9-446f74abb00e" xlink:to="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember_9174da0e-856f-47fa-a0a6-52896751b796" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_NorthAmericaGenericsMember_9174da0e-856f-47fa-a0a6-52896751b796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaBrandsMember_e3950b6b-fdd4-417d-b6bd-c9b75a14bd69" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaBrandsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_NorthAmericaBrandsMember_e3950b6b-fdd4-417d-b6bd-c9b75a14bd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_9294d01e-d297-4b6c-8662-c9f2753d8054" xlink:href="vtrs-20220331.xsd#vtrs_EuropeSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_EuropeSegmentMember_9294d01e-d297-4b6c-8662-c9f2753d8054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_702c4d93-942c-4c96-8dc2-5f17eba1804d" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_RestofWorldSegmentMember_702c4d93-942c-4c96-8dc2-5f17eba1804d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember_670e012d-ae8c-4796-b329-d09be52dcbae" xlink:href="vtrs-20220331.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_NorthAmericaSegmentMember_670e012d-ae8c-4796-b329-d09be52dcbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_80337de9-786b-4096-9360-6190027915bc" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_80337de9-786b-4096-9360-6190027915bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_b24b55fd-7c32-4585-ab3d-d120b837f294" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_b24b55fd-7c32-4585-ab3d-d120b837f294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_c5290a6e-6d96-48fd-afbd-8bea07620118" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10b239b8-7c10-434a-80a3-c8e2789b3a93" xlink:to="loc_vtrs_GreaterChinaSegmentMember_c5290a6e-6d96-48fd-afbd-8bea07620118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_197b79f9-0d32-413f-bc66-b9b1ce3b9ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_ValuationTechniqueAxis_197b79f9-0d32-413f-bc66-b9b1ce3b9ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_e3d1e30b-3f84-4683-a789-c912787f20ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_197b79f9-0d32-413f-bc66-b9b1ce3b9ced" xlink:to="loc_us-gaap_ValuationTechniqueDomain_e3d1e30b-3f84-4683-a789-c912787f20ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_bc25a10e-0b1a-4bf6-a038-5b75c2ffb1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_e3d1e30b-3f84-4683-a789-c912787f20ef" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_bc25a10e-0b1a-4bf6-a038-5b75c2ffb1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_c2c42ceb-1720-4edb-a9d8-45f01c073b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_c2c42ceb-1720-4edb-a9d8-45f01c073b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_c2c42ceb-1720-4edb-a9d8-45f01c073b5c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7e617175-4d31-46b1-aba3-af50edae978b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7e617175-4d31-46b1-aba3-af50edae978b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_c67b358e-e5f7-44e9-b0f8-d6d59ee0aac1" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_c67b358e-e5f7-44e9-b0f8-d6d59ee0aac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputEstimatedTaxRateMember_4454b6e3-6d04-41c3-9aec-2573a564b69a" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputEstimatedTaxRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputEstimatedTaxRateMember_4454b6e3-6d04-41c3-9aec-2573a564b69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputEbitdaMultipleMember_d8e6ed21-0bd8-4943-8f8d-2f5b35642591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputEbitdaMultipleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputEbitdaMultipleMember_d8e6ed21-0bd8-4943-8f8d-2f5b35642591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputControlPremiumMember_7c7cd7cc-2e31-4183-b5ee-553954b7ba28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputControlPremiumMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputControlPremiumMember_7c7cd7cc-2e31-4183-b5ee-553954b7ba28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_e77f0825-4930-4990-a91f-5848e6b0e7f6" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_e77f0825-4930-4990-a91f-5848e6b0e7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_0a99be00-d57f-44a3-bec0-3d25e7e7e63d" xlink:href="vtrs-20220331.xsd#vtrs_MeasurementInputIncreaseInDiscountRateMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_0a99be00-d57f-44a3-bec0-3d25e7e7e63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_6e5c8c94-385d-445b-bd7d-dc68ba4ac860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_44c2e3a4-c340-4112-abc5-2099247bfca6" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_6e5c8c94-385d-445b-bd7d-dc68ba4ac860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c1d1233-b98c-42ac-b1f9-7a9d54ec6201" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_209ba12c-55a5-4148-900f-f39444e05fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_209ba12c-55a5-4148-900f-f39444e05fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c6481977-16cc-4664-a9e2-6a85821078c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c6481977-16cc-4664-a9e2-6a85821078c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_8d5f9cdc-26d4-41d1-a359-9df3a93b6277" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_8d5f9cdc-26d4-41d1-a359-9df3a93b6277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b8918dce-88bb-4eac-82a1-6ea7d470ae6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b8918dce-88bb-4eac-82a1-6ea7d470ae6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6fc9a251-626e-4149-9da2-85fe985d6786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_Goodwill_6fc9a251-626e-4149-9da2-85fe985d6786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_b8f7b48e-a778-4ade-8181-cb483d73615c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_b8f7b48e-a778-4ade-8181-cb483d73615c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_e52de30d-5355-45e5-89f0-de65f1fd9b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_e52de30d-5355-45e5-89f0-de65f1fd9b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_70c49a53-aaf7-4f16-9e49-81e55b5c7c76" xlink:href="vtrs-20220331.xsd#vtrs_GoodwillImpairmentMeasurementInputTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_70c49a53-aaf7-4f16-9e49-81e55b5c7c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInput_45904693-1543-4cc0-889b-957ba3179d36" xlink:href="vtrs-20220331.xsd#vtrs_GoodwillImpairmentMeasurementInput"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInput_45904693-1543-4cc0-889b-957ba3179d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification_f80318ca-bc58-46f2-afb0-b8fec15929d5" xlink:href="vtrs-20220331.xsd#vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c996274-1a02-4de6-ae55-34d93ae209a2" xlink:to="loc_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification_f80318ca-bc58-46f2-afb0-b8fec15929d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_83ae8eb5-ab1b-4f8a-a9d3-89699781d304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_342ff002-3534-4fc7-aac0-4a494307580b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_83ae8eb5-ab1b-4f8a-a9d3-89699781d304" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_342ff002-3534-4fc7-aac0-4a494307580b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e2bf0c35-6bfc-44b9-a1b7-a5202b327895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_342ff002-3534-4fc7-aac0-4a494307580b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e2bf0c35-6bfc-44b9-a1b7-a5202b327895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2bf0c35-6bfc-44b9-a1b7-a5202b327895" xlink:to="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_e753612b-ceab-4802-a2e7-48a85f91dca4" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_e753612b-ceab-4802-a2e7-48a85f91dca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_bc97b981-ed89-4af7-80c4-e8a65eda3fec" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_GreaterChinaSegmentMember_bc97b981-ed89-4af7-80c4-e8a65eda3fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_e740f477-f927-4ddd-ac48-cca2046bd70c" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_e740f477-f927-4ddd-ac48-cca2046bd70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_10e3ab6a-af93-491b-a99a-978167f9c499" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d85e6b9-3990-42ca-8d1a-d7cbf75b4a74" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_10e3ab6a-af93-491b-a99a-978167f9c499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c71f7402-524e-41e9-aea3-11a05e72f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_342ff002-3534-4fc7-aac0-4a494307580b" xlink:to="loc_us-gaap_GoodwillLineItems_c71f7402-524e-41e9-aea3-11a05e72f9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_c71f7402-524e-41e9-aea3-11a05e72f9c8" xlink:to="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_10828f91-1ae7-4bff-beaf-d0d130328971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillGross_10828f91-1ae7-4bff-beaf-d0d130328971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_83325cb9-b7a4-47e4-bf1c-6417266ef92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_83325cb9-b7a4-47e4-bf1c-6417266ef92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7bc5786e-b862-43fe-b8e1-1716f7bbc067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7bc5786e-b862-43fe-b8e1-1716f7bbc067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d248cc2e-4876-41ee-aadd-5a6ddf779ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_Goodwill_d248cc2e-4876-41ee-aadd-5a6ddf779ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3e5f59e6-0dbb-4b4e-8818-e5d8eaa1036e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3e5f59e6-0dbb-4b4e-8818-e5d8eaa1036e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_29b69b90-f547-44d5-a432-53efb0ded0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillGross_29b69b90-f547-44d5-a432-53efb0ded0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4c0ee23d-fa17-42cc-a87e-215ab8ada46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_Goodwill_4c0ee23d-fa17-42cc-a87e-215ab8ada46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_98d2e6b6-d700-4f98-b3b0-adc0d0c5e101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a6440d13-262b-4c2a-8bb0-20d9b14f19b2" xlink:to="loc_us-gaap_GoodwillTransfers_98d2e6b6-d700-4f98-b3b0-adc0d0c5e101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b423029e-6fc3-4bc7-a781-d93ae2c168bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_0f4c120e-9e78-4309-bdb0-88e760027080" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b423029e-6fc3-4bc7-a781-d93ae2c168bc" xlink:to="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_0f4c120e-9e78-4309-bdb0-88e760027080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f7538f8-e1ea-4136-9dca-987485fe7c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_0f4c120e-9e78-4309-bdb0-88e760027080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f7538f8-e1ea-4136-9dca-987485fe7c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aab95ab0-e44d-45c3-a780-632415700f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f7538f8-e1ea-4136-9dca-987485fe7c23" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aab95ab0-e44d-45c3-a780-632415700f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_ebe7ee12-716e-4611-95ac-77a2fb8b11b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aab95ab0-e44d-45c3-a780-632415700f30" xlink:to="loc_us-gaap_PatentsMember_ebe7ee12-716e-4611-95ac-77a2fb8b11b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:href="vtrs-20220331.xsd#vtrs_IntangibleAssetsbyMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_0f4c120e-9e78-4309-bdb0-88e760027080" xlink:to="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6b4791a1-62ad-4e84-ba76-dfcc73759e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6b4791a1-62ad-4e84-ba76-dfcc73759e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_682d15b5-d77b-4164-b11b-2d896440e036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_682d15b5-d77b-4164-b11b-2d896440e036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0651d0f9-ba27-47d2-8c9f-9aecdfe6341d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0651d0f9-ba27-47d2-8c9f-9aecdfe6341d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_614c936d-f95c-4284-90e9-fc54782eae0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_614c936d-f95c-4284-90e9-fc54782eae0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94bdcfe7-45c9-4373-a2e6-efac5d6d73e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94bdcfe7-45c9-4373-a2e6-efac5d6d73e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3418395e-300f-4dcd-8f7b-9934256043bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3418395e-300f-4dcd-8f7b-9934256043bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d9781b2d-1f06-4a89-be07-972b4f1c9c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d9781b2d-1f06-4a89-be07-972b4f1c9c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e767e678-a1a5-4765-97c8-249df1d8c4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_80bf6e79-3cd0-432c-be59-6736e3f790eb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e767e678-a1a5-4765-97c8-249df1d8c4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangibleAssetsAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27f39dfd-465f-428a-a23f-60178e153b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_71b18af0-1a4c-4125-aee2-68248496069f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27f39dfd-465f-428a-a23f-60178e153b00" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_71b18af0-1a4c-4125-aee2-68248496069f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f6f181e0-7ba1-48fd-a0dc-be6fee1c156d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27f39dfd-465f-428a-a23f-60178e153b00" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f6f181e0-7ba1-48fd-a0dc-be6fee1c156d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_fcaf13a9-979d-4197-b51b-4e74f99b007c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27f39dfd-465f-428a-a23f-60178e153b00" xlink:to="loc_us-gaap_AdjustmentForAmortization_fcaf13a9-979d-4197-b51b-4e74f99b007c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8bc44e5a-1318-4e9d-983d-c78b46b960dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_a4aa1df5-44f7-4587-98f1-abf5edea5429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8bc44e5a-1318-4e9d-983d-c78b46b960dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_a4aa1df5-44f7-4587-98f1-abf5edea5429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ddbfa72c-fa6d-4097-9473-863c41cb6bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8bc44e5a-1318-4e9d-983d-c78b46b960dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ddbfa72c-fa6d-4097-9473-863c41cb6bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2b2c632d-fdf6-4024-b5e3-28f2f712e17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8bc44e5a-1318-4e9d-983d-c78b46b960dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2b2c632d-fdf6-4024-b5e3-28f2f712e17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4b7acfff-2f84-40ee-b860-8c630f35e858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8bc44e5a-1318-4e9d-983d-c78b46b960dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4b7acfff-2f84-40ee-b860-8c630f35e858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b9fb6117-ba03-4f7f-a457-6cc2e456d5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8bc44e5a-1318-4e9d-983d-c78b46b960dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b9fb6117-ba03-4f7f-a457-6cc2e456d5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagement"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4db4547f-9155-430c-a0ec-865f0483ca38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_deba8825-752a-42a8-9f7a-b86daf37fded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4db4547f-9155-430c-a0ec-865f0483ca38" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_deba8825-752a-42a8-9f7a-b86daf37fded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02de4999-aa4b-45bd-94e4-912420fe6c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02de4999-aa4b-45bd-94e4-912420fe6c4c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7940fb7c-9c51-40e6-bd99-7558b9d3aec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:to="loc_us-gaap_HedgingDesignationAxis_7940fb7c-9c51-40e6-bd99-7558b9d3aec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7940fb7c-9c51-40e6-bd99-7558b9d3aec6" xlink:to="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d22f285-85b4-46c8-bfaf-9c691f4bcc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d22f285-85b4-46c8-bfaf-9c691f4bcc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ac5b51b1-573f-40de-87b0-bac98396d4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_400992bf-5a9a-41b5-91a8-3f158577d6af" xlink:to="loc_us-gaap_NondesignatedMember_ac5b51b1-573f-40de-87b0-bac98396d4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49d09f95-7ee3-45b9-95c1-1f29798ec2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49d09f95-7ee3-45b9-95c1-1f29798ec2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49d09f95-7ee3-45b9-95c1-1f29798ec2c8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_2e6da396-2edc-4d5c-8392-401eefe5593b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:to="loc_us-gaap_FairValueHedgingMember_2e6da396-2edc-4d5c-8392-401eefe5593b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_26411812-2023-4d36-96ff-aef81fe759da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:to="loc_us-gaap_CashFlowHedgingMember_26411812-2023-4d36-96ff-aef81fe759da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c3206869-68b1-47c2-900e-23143d90b6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8782c044-0e8f-464d-841f-1b25236de2bd" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c3206869-68b1-47c2-900e-23143d90b6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1d4b3a6a-fc56-418a-bf85-c90a2b375fd3" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8c55cda2-860d-472a-9a80-08651bad12a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8c55cda2-860d-472a-9a80-08651bad12a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f4fd5511-c607-4b22-94f4-c51b3d921cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f4fd5511-c607-4b22-94f4-c51b3d921cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_b81091d6-2c2b-4e7d-aa50-6adff742f833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_b81091d6-2c2b-4e7d-aa50-6adff742f833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_271b4d29-d3aa-4ed7-a53e-659bbc2ff487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_568fdfa5-ce21-4c00-a428-484cb1de821d" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_271b4d29-d3aa-4ed7-a53e-659bbc2ff487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dc1f58d6-a251-42e8-beb9-ce77b901c178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dc1f58d6-a251-42e8-beb9-ce77b901c178" xlink:to="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_11d9be2e-8b3b-4883-8391-80c9ddef0bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_66c3ec7e-1f1d-455f-bcd5-ce137bd9f90e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_11d9be2e-8b3b-4883-8391-80c9ddef0bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_286852a3-d7ab-49ab-856f-878152b0064f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_11d9be2e-8b3b-4883-8391-80c9ddef0bfc" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_286852a3-d7ab-49ab-856f-878152b0064f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2e2b6e1a-d667-47d1-8486-c93a5c38e57c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2e2b6e1a-d667-47d1-8486-c93a5c38e57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2e2b6e1a-d667-47d1-8486-c93a5c38e57c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d5c22495-d12a-4f59-b3a4-57e159287758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d5c22495-d12a-4f59-b3a4-57e159287758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fec85f24-324c-4dbd-b982-59ff7e9ef72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5daf1fe-b697-4762-ab22-faffe56f6d7e" xlink:to="loc_us-gaap_InterestRateSwapMember_fec85f24-324c-4dbd-b982-59ff7e9ef72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_25e2c246-bc07-45b4-8318-a2e7ccb552a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_59efe825-c9cd-4c9c-9ba5-3fe2368dcf46" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_25e2c246-bc07-45b4-8318-a2e7ccb552a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_a2faa629-66bd-475c-b5c7-b47013622c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_25e2c246-bc07-45b4-8318-a2e7ccb552a3" xlink:to="loc_us-gaap_OtherExpenseMember_a2faa629-66bd-475c-b5c7-b47013622c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7fe46988-67dd-483d-8b63-a0b3f6b918f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_DebtInstrumentAxis_7fe46988-67dd-483d-8b63-a0b3f6b918f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7fe46988-67dd-483d-8b63-a0b3f6b918f4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_50350493-2fc8-40b9-8971-6af3911bd58f" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_50350493-2fc8-40b9-8971-6af3911bd58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_fbed62b1-8774-4a82-9fca-3def80c4e3dc" xlink:href="vtrs-20220331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_fbed62b1-8774-4a82-9fca-3def80c4e3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_c9212e31-00d3-47bc-821d-a0e8c83673ae" xlink:href="vtrs-20220331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_c9212e31-00d3-47bc-821d-a0e8c83673ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_aa430441-de5b-4de5-8746-c4d626c1ceaf" xlink:href="vtrs-20220331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_aa430441-de5b-4de5-8746-c4d626c1ceaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_262d0936-c96f-4c96-9bf6-d76fb646380f" xlink:href="vtrs-20220331.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_262d0936-c96f-4c96-9bf6-d76fb646380f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_4849522f-7f90-4960-b726-68819bcf6ac3" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_4849522f-7f90-4960-b726-68819bcf6ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_339197e3-e5aa-4568-815a-b380597513a5" xlink:href="vtrs-20220331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_339197e3-e5aa-4568-815a-b380597513a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_b5e0cfbf-2be2-4f36-ab46-3c6f2c0d8837" xlink:href="vtrs-20220331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_b5e0cfbf-2be2-4f36-ab46-3c6f2c0d8837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_e7cf9c4e-e5ca-4edb-8ab6-9759592f0bbd" xlink:href="vtrs-20220331.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_e7cf9c4e-e5ca-4edb-8ab6-9759592f0bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_a58b1eb1-7a55-4f65-b745-ca289f9dd208" xlink:href="vtrs-20220331.xsd#vtrs_YENTermLoanMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2a19a78-3587-4f61-b02a-88916dd0e053" xlink:to="loc_vtrs_YENTermLoanMember_a58b1eb1-7a55-4f65-b745-ca289f9dd208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5360fc7f-d286-4828-b80b-38e5e3467eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5360fc7f-d286-4828-b80b-38e5e3467eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5360fc7f-d286-4828-b80b-38e5e3467eed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_2582d3a8-b9d1-41c2-ac4c-fe622d3b0227" xlink:href="vtrs-20220331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:to="loc_vtrs_ContingentConsiderationMember_2582d3a8-b9d1-41c2-ac4c-fe622d3b0227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_68bd01b7-f87b-4b38-be2b-e771d75f9784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0cb1e0ec-1786-4c06-81bb-d6f598b1df9f" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_68bd01b7-f87b-4b38-be2b-e771d75f9784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_620576d9-cec8-490d-8ed4-24a9f3241cba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_srt_RangeAxis_620576d9-cec8-490d-8ed4-24a9f3241cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_620576d9-cec8-490d-8ed4-24a9f3241cba" xlink:to="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c4974efd-94bd-46af-958d-deae15a7d063" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:to="loc_srt_MinimumMember_c4974efd-94bd-46af-958d-deae15a7d063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7a443f93-ae7a-4e93-94b4-5afb1e3024bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5975ac6d-914b-4b49-ba84-360ce719066f" xlink:to="loc_srt_MaximumMember_7a443f93-ae7a-4e93-94b4-5afb1e3024bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_696879d2-c897-4f3e-8a81-a56f01018f90" xlink:to="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_6d42449b-32bf-4608-bf2d-3a776fb81a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_6d42449b-32bf-4608-bf2d-3a776fb81a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65ab7d9b-78dc-4e27-90c2-205dcc285687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65ab7d9b-78dc-4e27-90c2-205dcc285687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_31c1921e-5b6f-4471-a46d-c3d693ae826b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_31c1921e-5b6f-4471-a46d-c3d693ae826b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dd225753-30c1-4c9b-8fb0-d3c1bccf51a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_LongTermDebt_dd225753-30c1-4c9b-8fb0-d3c1bccf51a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a60b66b4-53db-4560-b02b-39b3a89a4997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ecdc5a1e-7bdc-4e91-9425-78679a1bb6ec" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a60b66b4-53db-4560-b02b-39b3a89a4997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7db7d51f-cbe7-490d-bb8b-2683d9d968ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7db7d51f-cbe7-490d-bb8b-2683d9d968ba" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d210abfe-8735-4993-972d-ac7760a50146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:to="loc_us-gaap_HedgingDesignationAxis_d210abfe-8735-4993-972d-ac7760a50146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d210abfe-8735-4993-972d-ac7760a50146" xlink:to="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1dd81b9a-3c2c-4698-8b33-1d8250ce6a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1dd81b9a-3c2c-4698-8b33-1d8250ce6a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_86f19fc7-e603-495b-a007-d4bbf5a689fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0e5e6e7c-ea71-4335-bbb9-37a3bebda6b1" xlink:to="loc_us-gaap_NondesignatedMember_86f19fc7-e603-495b-a007-d4bbf5a689fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_60ccf5fa-4292-4114-9437-ffc170f4bba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_60ccf5fa-4292-4114-9437-ffc170f4bba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_60ccf5fa-4292-4114-9437-ffc170f4bba3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_23b0e7b5-f546-46d7-8566-e678e4d38e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_23b0e7b5-f546-46d7-8566-e678e4d38e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_596a638d-5c3c-42ca-b490-9578571abf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c1d4c9f-ebf1-4642-a619-238f6b3ca674" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_596a638d-5c3c-42ca-b490-9578571abf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_67c581c8-e032-4b93-b3c3-9f0302c7c108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_67c581c8-e032-4b93-b3c3-9f0302c7c108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_67c581c8-e032-4b93-b3c3-9f0302c7c108" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e16faf3a-cf95-4ff2-b80c-ea173d38521b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:to="loc_us-gaap_InterestRateSwapMember_e16faf3a-cf95-4ff2-b80c-ea173d38521b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f890a383-d934-4d7c-9695-a201d193d0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f890a383-d934-4d7c-9695-a201d193d0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5934ca48-ede6-47f5-86d0-0ac166301a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6016c945-c10a-477e-bd5b-1429b4a9d66c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5934ca48-ede6-47f5-86d0-0ac166301a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b68bd509-bbc9-47e6-a62d-528ce17bbd20" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2d05284f-fe0b-4bcb-bcd4-bfe94689914a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2d05284f-fe0b-4bcb-bcd4-bfe94689914a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_99791e36-c146-41f5-b89a-cc50865b5cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_99791e36-c146-41f5-b89a-cc50865b5cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e1c29d0e-5301-4174-ad56-8fca3223af79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0a4bfe0e-aaf2-450e-b1f3-be6ad6111b8f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e1c29d0e-5301-4174-ad56-8fca3223af79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_68161e53-f32b-4094-b77e-49d097554cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_68161e53-f32b-4094-b77e-49d097554cd5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0f340875-4b17-4f9f-b5d9-80050aa51545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:to="loc_us-gaap_HedgingDesignationAxis_0f340875-4b17-4f9f-b5d9-80050aa51545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0025359a-3d44-46df-827e-cfa9b271ea62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0f340875-4b17-4f9f-b5d9-80050aa51545" xlink:to="loc_us-gaap_HedgingDesignationDomain_0025359a-3d44-46df-827e-cfa9b271ea62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1a95c91f-553b-4e25-8840-67bc2675129f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0025359a-3d44-46df-827e-cfa9b271ea62" xlink:to="loc_us-gaap_NondesignatedMember_1a95c91f-553b-4e25-8840-67bc2675129f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_148a189a-a56e-4e73-977d-a615d16229c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_148a189a-a56e-4e73-977d-a615d16229c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_148a189a-a56e-4e73-977d-a615d16229c9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a3ff5ade-9f90-4f28-bc3c-0cae3cd7793a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a3ff5ade-9f90-4f28-bc3c-0cae3cd7793a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_76d8fe56-0ad3-4ecd-a665-c9187131d7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7f17afd-b616-4506-9f18-bf9877838024" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_76d8fe56-0ad3-4ecd-a665-c9187131d7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_547e47bf-67ac-4881-867b-118ce5f50dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_547e47bf-67ac-4881-867b-118ce5f50dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cd929680-193e-4cc5-b8a8-42e5070aa99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_547e47bf-67ac-4881-867b-118ce5f50dd0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cd929680-193e-4cc5-b8a8-42e5070aa99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b5391c50-c149-4519-859b-b2c8b196bbed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cd929680-193e-4cc5-b8a8-42e5070aa99c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b5391c50-c149-4519-859b-b2c8b196bbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3e35d59-0ef3-48a4-9193-edacd9c27a41" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d4cce358-0e94-499d-9844-fc1cab3df7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d4cce358-0e94-499d-9844-fc1cab3df7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1a94fc66-5428-4031-af87-f0d675eccb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_0540db59-438b-4727-8d99-e044b3c3b924" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1a94fc66-5428-4031-af87-f0d675eccb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f46f210-06de-4eec-8876-9b722bfca77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f46f210-06de-4eec-8876-9b722bfca77e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_34962b0e-5593-46fe-a73b-2c57529c9afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_34962b0e-5593-46fe-a73b-2c57529c9afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cc26c737-042d-414b-b83b-d712f83ff9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_34962b0e-5593-46fe-a73b-2c57529c9afb" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cc26c737-042d-414b-b83b-d712f83ff9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d5bef8c8-2120-4fe5-afaf-6110186d4e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cc26c737-042d-414b-b83b-d712f83ff9ed" xlink:to="loc_us-gaap_FairValueHedgingMember_d5bef8c8-2120-4fe5-afaf-6110186d4e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e8e2d8db-2f83-4076-a36a-68e88b3f649d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9f3111eb-cc9a-40d3-8c4a-27a04f28d21d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e8e2d8db-2f83-4076-a36a-68e88b3f649d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ba15b36e-2b3e-421e-b3f5-622484ddd9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e8e2d8db-2f83-4076-a36a-68e88b3f649d" xlink:to="loc_us-gaap_InterestExpenseMember_ba15b36e-2b3e-421e-b3f5-622484ddd9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_976ef58c-21e5-4152-abbc-f5c9342f82d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_976ef58c-21e5-4152-abbc-f5c9342f82d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_976ef58c-21e5-4152-abbc-f5c9342f82d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_edaea5c5-11dd-4633-8b35-c7f8b5730ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:to="loc_us-gaap_InterestRateSwapMember_edaea5c5-11dd-4633-8b35-c7f8b5730ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_aeb8b5d2-f906-4dc7-98eb-b541c45a9926" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8a9c8850-ca31-4899-aa9c-ede1fa94ecda" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_aeb8b5d2-f906-4dc7-98eb-b541c45a9926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_88394a59-486f-436b-802d-e94452386c38" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_45b2835b-5263-4395-a146-449a2dab0d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_45b2835b-5263-4395-a146-449a2dab0d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_872f78fe-7dae-4593-a736-f465774b24ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fd675f3a-be8b-436e-9ab8-9e941dcd4baa" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_872f78fe-7dae-4593-a736-f465774b24ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5fd61afe-5c24-48ad-b949-1bf3ddd1c50c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5fd61afe-5c24-48ad-b949-1bf3ddd1c50c" xlink:to="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fef68d5-f5fc-4e09-8d1d-cfd179665e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fef68d5-f5fc-4e09-8d1d-cfd179665e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_198e1665-3de4-4fe1-8052-21b726cc70d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2fef68d5-f5fc-4e09-8d1d-cfd179665e44" xlink:to="loc_us-gaap_HedgingRelationshipDomain_198e1665-3de4-4fe1-8052-21b726cc70d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_30a258c8-069e-431e-8774-d5e0811fe752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_198e1665-3de4-4fe1-8052-21b726cc70d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_30a258c8-069e-431e-8774-d5e0811fe752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cee36fb1-a272-4c93-b742-dfb261790e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cee36fb1-a272-4c93-b742-dfb261790e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cee36fb1-a272-4c93-b742-dfb261790e28" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_102fe1bf-be6f-4578-881b-7435fb716f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:to="loc_us-gaap_ForeignExchangeContractMember_102fe1bf-be6f-4578-881b-7435fb716f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6aa3c0e3-ba72-466c-825b-b085eb9f7d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5607d0b-17f2-4749-a73d-5b5022451cf3" xlink:to="loc_us-gaap_InterestRateSwapMember_6aa3c0e3-ba72-466c-825b-b085eb9f7d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_64f33cc1-dfba-40ab-afb7-2528fe15e149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff894d74-41b5-4f22-9f20-a8eda18ba15b" xlink:to="loc_us-gaap_DerivativeLineItems_64f33cc1-dfba-40ab-afb7-2528fe15e149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_7f7eaa1f-0827-49f0-9566-1e76d4519c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_64f33cc1-dfba-40ab-afb7-2528fe15e149" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_7f7eaa1f-0827-49f0-9566-1e76d4519c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cd5ce173-d27c-4564-a417-486449f41f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cd5ce173-d27c-4564-a417-486449f41f1b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fb1a647d-08e1-4a06-950f-380a98c0066b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fb1a647d-08e1-4a06-950f-380a98c0066b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3a69ef6a-5f93-46a4-a38b-fccf2181b478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fb1a647d-08e1-4a06-950f-380a98c0066b" xlink:to="loc_us-gaap_EquityComponentDomain_3a69ef6a-5f93-46a4-a38b-fccf2181b478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2be0ea44-a536-42ca-9138-6b663057ad17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3a69ef6a-5f93-46a4-a38b-fccf2181b478" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2be0ea44-a536-42ca-9138-6b663057ad17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b4af5da-6a4a-4486-9a18-195316634333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b4af5da-6a4a-4486-9a18-195316634333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_18953019-bd17-4ee0-9a2a-8ea1f1ce74bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b4af5da-6a4a-4486-9a18-195316634333" xlink:to="loc_us-gaap_HedgingRelationshipDomain_18953019-bd17-4ee0-9a2a-8ea1f1ce74bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_10868d52-9cb9-4b9d-bcb4-fcf28ce88c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_18953019-bd17-4ee0-9a2a-8ea1f1ce74bb" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_10868d52-9cb9-4b9d-bcb4-fcf28ce88c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5beae9-100b-4659-bc1e-19fff036635b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5beae9-100b-4659-bc1e-19fff036635b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a2c50ea2-aba3-4f71-b399-8cedf57ed11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5beae9-100b-4659-bc1e-19fff036635b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a2c50ea2-aba3-4f71-b399-8cedf57ed11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_48787ce0-f3ab-44fc-90c7-632d46d2923f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a2c50ea2-aba3-4f71-b399-8cedf57ed11c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_48787ce0-f3ab-44fc-90c7-632d46d2923f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5a381130-a512-4d27-a2bb-da31df93898f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc45f3d4-a068-47ca-8134-b7cb0b05ef73" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5a381130-a512-4d27-a2bb-da31df93898f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_4cde35da-cf31-40ef-8a9a-5cf3434883ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5a381130-a512-4d27-a2bb-da31df93898f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_4cde35da-cf31-40ef-8a9a-5cf3434883ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_03dea138-9a12-46aa-9276-8560b064610f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_03dea138-9a12-46aa-9276-8560b064610f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ffbd8bb-8d84-4a61-bb81-528e04cbba31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ffbd8bb-8d84-4a61-bb81-528e04cbba31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ffbd8bb-8d84-4a61-bb81-528e04cbba31" xlink:to="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1ae9296b-484e-4127-b028-9dda4b721a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:to="loc_us-gaap_CashFlowHedgingMember_1ae9296b-484e-4127-b028-9dda4b721a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9d35f4ba-74f6-4684-8705-7b5a471dbdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d9db6d-7b67-4863-b90b-8345be5e80c8" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9d35f4ba-74f6-4684-8705-7b5a471dbdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c39fd706-e900-4c01-92cd-39f648bb7284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c39fd706-e900-4c01-92cd-39f648bb7284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c39fd706-e900-4c01-92cd-39f648bb7284" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b3af5bb5-8720-4202-a965-6749437cfada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b3af5bb5-8720-4202-a965-6749437cfada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9e263310-66c5-4096-bbf3-3b0e6cacd79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_644f4997-c77e-499e-8a93-7706a0644153" xlink:to="loc_us-gaap_InterestRateSwapMember_9e263310-66c5-4096-bbf3-3b0e6cacd79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ece1ea20-31bc-4308-b74a-71c809d8d008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ece1ea20-31bc-4308-b74a-71c809d8d008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ece1ea20-31bc-4308-b74a-71c809d8d008" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_461fa7cb-defc-4501-ba2b-5f50e1e64a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:to="loc_us-gaap_SalesMember_461fa7cb-defc-4501-ba2b-5f50e1e64a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_b8ba5d4c-2ed4-453b-a74e-1396938d2b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:to="loc_us-gaap_InterestExpenseMember_b8ba5d4c-2ed4-453b-a74e-1396938d2b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_36eb5a16-118a-473a-9b49-3ee08a650716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad07e367-7744-4379-bce9-a7b20e21899f" xlink:to="loc_us-gaap_OtherExpenseMember_36eb5a16-118a-473a-9b49-3ee08a650716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_167eba2d-3196-4df8-88e2-ca1bcb7266a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_ValuationTechniqueAxis_167eba2d-3196-4df8-88e2-ca1bcb7266a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_ee4da984-c600-4efd-bdf1-8e36323e5502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_167eba2d-3196-4df8-88e2-ca1bcb7266a6" xlink:to="loc_us-gaap_ValuationTechniqueDomain_ee4da984-c600-4efd-bdf1-8e36323e5502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_720690c2-5b1b-42ea-be8f-df42dc3a2b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_720690c2-5b1b-42ea-be8f-df42dc3a2b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5810cb09-62a1-47f3-9663-f2912e13f7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_720690c2-5b1b-42ea-be8f-df42dc3a2b9a" xlink:to="loc_us-gaap_EquityComponentDomain_5810cb09-62a1-47f3-9663-f2912e13f7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e9026e76-2f82-43d2-985e-efa9105b01f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5810cb09-62a1-47f3-9663-f2912e13f7e6" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_e9026e76-2f82-43d2-985e-efa9105b01f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a769576-c5f1-4f39-bed7-ec2f5da54a06" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5b9bf5ec-5ec7-47fe-8a05-cf603637dbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5b9bf5ec-5ec7-47fe-8a05-cf603637dbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_2083e7ca-66e5-4193-bc81-3d5e783e0a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_2083e7ca-66e5-4193-bc81-3d5e783e0a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0df7277c-6eca-4df8-91b1-6560b923d91f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0df7277c-6eca-4df8-91b1-6560b923d91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_a0c92e9d-6b92-4959-9c11-2885c6adc7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_a0c92e9d-6b92-4959-9c11-2885c6adc7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_3299d71a-e890-4f20-9e80-50892fa61645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_3299d71a-e890-4f20-9e80-50892fa61645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7b5ea8ba-c3e9-4c13-981a-fc999759e9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7b5ea8ba-c3e9-4c13-981a-fc999759e9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6628f35a-5bfb-461f-b6cf-bb260e95a00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6628f35a-5bfb-461f-b6cf-bb260e95a00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_93abbf16-54d8-472b-b2df-d42ea9118cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0709a1d0-2aaa-412c-b164-df5005400da3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_93abbf16-54d8-472b-b2df-d42ea9118cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_66ab8fc2-7348-4129-90ff-e1a73341a668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_66ab8fc2-7348-4129-90ff-e1a73341a668" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7988068c-aa66-4ef9-a95d-48b9f521e04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7988068c-aa66-4ef9-a95d-48b9f521e04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ccce201d-ef0e-44ac-992d-551b791b8835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7988068c-aa66-4ef9-a95d-48b9f521e04d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ccce201d-ef0e-44ac-992d-551b791b8835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b0d45c1d-9899-42cd-9dd4-898d4a158f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ccce201d-ef0e-44ac-992d-551b791b8835" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b0d45c1d-9899-42cd-9dd4-898d4a158f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f8fad1b3-3703-4297-9bf0-4b9623a0d827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f8fad1b3-3703-4297-9bf0-4b9623a0d827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_11f3cf27-1e94-427b-a944-5901bb796057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f8fad1b3-3703-4297-9bf0-4b9623a0d827" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_11f3cf27-1e94-427b-a944-5901bb796057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_080c8f06-34b1-4cf9-b7a6-a24404971904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_11f3cf27-1e94-427b-a944-5901bb796057" xlink:to="loc_us-gaap_OtherExpenseMember_080c8f06-34b1-4cf9-b7a6-a24404971904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e3f385a-4a94-4fe3-8239-a02b57bfaea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_280d55b3-dd22-4cf1-9d85-d17be159a026" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e3f385a-4a94-4fe3-8239-a02b57bfaea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_116bb504-cc03-4f8c-a862-8d055dd66b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3e3f385a-4a94-4fe3-8239-a02b57bfaea9" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_116bb504-cc03-4f8c-a862-8d055dd66b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_914c9e06-b11f-4ba6-a076-88bbcde5a44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_914c9e06-b11f-4ba6-a076-88bbcde5a44f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b90a1f6d-77dd-4484-817d-7648e3d62595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b90a1f6d-77dd-4484-817d-7648e3d62595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18b6e182-14b4-40ee-a70d-5627d4335015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b90a1f6d-77dd-4484-817d-7648e3d62595" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18b6e182-14b4-40ee-a70d-5627d4335015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f033c35b-ff9d-4559-9643-d76f633611cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_18b6e182-14b4-40ee-a70d-5627d4335015" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f033c35b-ff9d-4559-9643-d76f633611cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d5d38e46-9dd2-4991-a0ef-cee4a253d261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_HedgingDesignationAxis_d5d38e46-9dd2-4991-a0ef-cee4a253d261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b46b9a55-afe0-4066-a11b-cca52e68dec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5d38e46-9dd2-4991-a0ef-cee4a253d261" xlink:to="loc_us-gaap_HedgingDesignationDomain_b46b9a55-afe0-4066-a11b-cca52e68dec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a97db846-0d5f-4598-b20b-e18e75ef4d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b46b9a55-afe0-4066-a11b-cca52e68dec1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a97db846-0d5f-4598-b20b-e18e75ef4d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_55cb9a3b-d227-4f65-a4c8-f65d8e04392c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_55cb9a3b-d227-4f65-a4c8-f65d8e04392c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_55cb9a3b-d227-4f65-a4c8-f65d8e04392c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7408a979-81e7-4030-b03c-a265d6aa40a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7408a979-81e7-4030-b03c-a265d6aa40a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1cf85cd0-6461-4c31-9df5-11ec4bfbd4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1cf85cd0-6461-4c31-9df5-11ec4bfbd4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9e9bf64e-1e3d-4eda-b95f-ec510380200b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8cbcf-47f0-45f0-9a45-a2afe21d1172" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9e9bf64e-1e3d-4eda-b95f-ec510380200b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_05421c79-28e5-4c0e-a476-656078be1464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_05421c79-28e5-4c0e-a476-656078be1464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_05421c79-28e5-4c0e-a476-656078be1464" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_cd0fda51-caff-4e16-a507-fe522ca54e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_MoneyMarketFundsMember_cd0fda51-caff-4e16-a507-fe522ca54e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_aa8bd4c7-967d-4d20-83d4-c14c8a4b1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_aa8bd4c7-967d-4d20-83d4-c14c8a4b1e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_9a893ed8-4187-4973-9ca5-4e242f1b0cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_9a893ed8-4187-4973-9ca5-4e242f1b0cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_c26b8d6c-77d7-432f-9fac-d4eb643c49fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_c26b8d6c-77d7-432f-9fac-d4eb643c49fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_a9ece3a7-2f78-455b-8a19-eddf4f6e3183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_a9ece3a7-2f78-455b-8a19-eddf4f6e3183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_33951f1b-c329-4305-9b89-f632397f8b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_33951f1b-c329-4305-9b89-f632397f8b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_e0839c09-c6d8-4065-b27b-5c51aed04cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_2adb6b7d-9fe2-4086-a9f5-5e8ab2ca8e6c" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_e0839c09-c6d8-4065-b27b-5c51aed04cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9b736ba7-e59b-465d-8bd3-758b85e2e1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_CommonStockMember_9b736ba7-e59b-465d-8bd3-758b85e2e1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e4da8708-685d-43da-9d44-09a579e8fb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd883332-a9f2-4519-8732-aa84e54235a0" xlink:to="loc_us-gaap_InterestRateSwapMember_e4da8708-685d-43da-9d44-09a579e8fb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_75fef593-5197-4f5c-a9fd-383f42ebf5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_75fef593-5197-4f5c-a9fd-383f42ebf5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_75fef593-5197-4f5c-a9fd-383f42ebf5a2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7e76afa0-cfdc-4f7e-af06-41f4feea9ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7e76afa0-cfdc-4f7e-af06-41f4feea9ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2aef646d-45ea-4d9e-b44b-a73069d896a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:to="loc_us-gaap_InterestRateSwapMember_2aef646d-45ea-4d9e-b44b-a73069d896a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_9dfe119e-7400-48e9-9ebc-676e332155e2" xlink:href="vtrs-20220331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_44e8cf6c-af1b-47a8-9dbd-0b693172e455" xlink:to="loc_vtrs_ContingentConsiderationMember_9dfe119e-7400-48e9-9ebc-676e332155e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6d5a044b-f01d-4a11-b386-2c1605406bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6d5a044b-f01d-4a11-b386-2c1605406bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d5a044b-f01d-4a11-b386-2c1605406bc7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6291af7f-23fa-4866-a3bb-0d129df21bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:to="loc_us-gaap_InterestRateSwapMember_6291af7f-23fa-4866-a3bb-0d129df21bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7a3d777d-1780-425b-9d92-232a848ab6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1445739-28c8-427f-ad58-5128fd3ac975" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7a3d777d-1780-425b-9d92-232a848ab6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_285f58d2-6c8d-4496-a0f5-71f112dcad04" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cebf1eb6-b42e-44e4-8eaa-6caf3c7897ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cebf1eb6-b42e-44e4-8eaa-6caf3c7897ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_0f52180e-9102-4e59-8c62-f529304f73cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_TradingSecurities_0f52180e-9102-4e59-8c62-f529304f73cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d4b1b19-21af-43b3-a2fc-ba4de0536752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d4b1b19-21af-43b3-a2fc-ba4de0536752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e60f3c9e-c8a4-4c86-ae0f-f882be5a91a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e60f3c9e-c8a4-4c86-ae0f-f882be5a91a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e996ad7a-2b5a-472d-a5b6-6099a26a3848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_DerivativeAssets_e996ad7a-2b5a-472d-a5b6-6099a26a3848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_450d0192-af06-4172-b394-487378575574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_450d0192-af06-4172-b394-487378575574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_37a6403d-f92b-498a-922e-faf7b8426d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_37a6403d-f92b-498a-922e-faf7b8426d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_24055013-b72f-4fa4-a625-31a4b5953d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_24055013-b72f-4fa4-a625-31a4b5953d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_7f3b972b-65ec-4228-810d-c3fa9f10539b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_7f3b972b-65ec-4228-810d-c3fa9f10539b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_eea11353-14cc-4ebe-bdab-5be98c26556d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d400e436-c14d-4c4b-badc-b15d1081d38a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_eea11353-14cc-4ebe-bdab-5be98c26556d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4a1ffef6-68dd-4e76-9632-097d604237e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_93e90bb4-42a1-4766-bf99-5f509b98271a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4a1ffef6-68dd-4e76-9632-097d604237e3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_93e90bb4-42a1-4766-bf99-5f509b98271a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_af5834eb-0a10-4836-84c5-3bdc5c441964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_93e90bb4-42a1-4766-bf99-5f509b98271a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_af5834eb-0a10-4836-84c5-3bdc5c441964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_af5834eb-0a10-4836-84c5-3bdc5c441964" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e6560cc5-8919-4c20-b4a2-5689d1c7e0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e6560cc5-8919-4c20-b4a2-5689d1c7e0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab7a3269-4170-4364-9737-44274bd906b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c6a20d8-b221-42d4-b958-547479d64317" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab7a3269-4170-4364-9737-44274bd906b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a8afc38-aca1-444e-a229-d43eb5d1cb37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_93e90bb4-42a1-4766-bf99-5f509b98271a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a8afc38-aca1-444e-a229-d43eb5d1cb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:href="vtrs-20220331.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a8afc38-aca1-444e-a229-d43eb5d1cb37" xlink:to="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_85307196-836f-4f0c-aca5-03f5ae93039a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_85307196-836f-4f0c-aca5-03f5ae93039a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_e7ce3409-ee4f-4034-b65a-b3d518381b2a" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_e7ce3409-ee4f-4034-b65a-b3d518381b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_6ddd6274-77f2-4649-b8d0-75e033d241a0" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_6ddd6274-77f2-4649-b8d0-75e033d241a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_46e288e5-bb76-4c4e-8a9a-f3a6b94069c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_us-gaap_AccretionExpense_46e288e5-bb76-4c4e-8a9a-f3a6b94069c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_020c0294-6d1b-4495-979e-1e94b587aeed" xlink:href="vtrs-20220331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_020c0294-6d1b-4495-979e-1e94b587aeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cd590968-780c-4f5f-8309-e6d7af47f537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_b725a7ad-fffe-4f55-92e6-bde8108d9349" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cd590968-780c-4f5f-8309-e6d7af47f537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Debt" xlink:type="simple" xlink:href="vtrs-20220331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bfedf0f8-55be-4707-bfa5-f901f41b8bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7fb7b956-3f05-4206-bc4f-778e460f14de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bfedf0f8-55be-4707-bfa5-f901f41b8bf0" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7fb7b956-3f05-4206-bc4f-778e460f14de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_547a22c4-068e-43d7-899f-40fc9761a11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_eda3444a-8c9a-489f-be3b-08931584303a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_547a22c4-068e-43d7-899f-40fc9761a11c" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_eda3444a-8c9a-489f-be3b-08931584303a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_453f24f3-f6d2-40b0-808a-7b8fabdfa285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_547a22c4-068e-43d7-899f-40fc9761a11c" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_453f24f3-f6d2-40b0-808a-7b8fabdfa285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_b1575d82-f013-4e65-8b77-2547ccac32e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_547a22c4-068e-43d7-899f-40fc9761a11c" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_b1575d82-f013-4e65-8b77-2547ccac32e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_dee05e1c-8e1e-4c44-9978-4a532919f8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_dee05e1c-8e1e-4c44-9978-4a532919f8a5" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75649326-825b-4d5c-8e4b-09b09270d696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_DebtInstrumentAxis_75649326-825b-4d5c-8e4b-09b09270d696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_75649326-825b-4d5c-8e4b-09b09270d696" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_96dcc8ad-0dcf-4686-b774-2d0f256c7c4b" xlink:href="vtrs-20220331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_96dcc8ad-0dcf-4686-b774-2d0f256c7c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0fe837a5-c304-4d51-95ea-ae83e76bf3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:to="loc_us-gaap_CommercialPaperMember_0fe837a5-c304-4d51-95ea-ae83e76bf3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_9b535735-7bd9-49e7-a05f-129af99b71d3" xlink:href="vtrs-20220331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebf3cd6b-d24a-4c69-84b5-2c245ccd8fc4" xlink:to="loc_vtrs_ReceivablesFacilityMember_9b535735-7bd9-49e7-a05f-129af99b71d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d40252c0-aad5-4220-887e-289c95e5f933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_VariableRateAxis_d40252c0-aad5-4220-887e-289c95e5f933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0ba1e32b-6458-42d3-932d-ff2cdc877a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d40252c0-aad5-4220-887e-289c95e5f933" xlink:to="loc_us-gaap_VariableRateDomain_0ba1e32b-6458-42d3-932d-ff2cdc877a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_00680ab1-e3c0-4683-a225-c22650aec0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_0ba1e32b-6458-42d3-932d-ff2cdc877a57" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_00680ab1-e3c0-4683-a225-c22650aec0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44fb6b9b-ac60-4d29-9fdc-221dfad258b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_srt_RangeAxis_44fb6b9b-ac60-4d29-9fdc-221dfad258b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_44fb6b9b-ac60-4d29-9fdc-221dfad258b2" xlink:to="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3afe6104-dc02-429b-ba2a-cbea84e126b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:to="loc_srt_MinimumMember_3afe6104-dc02-429b-ba2a-cbea84e126b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e7bff1a0-cdbd-48b5-8ade-f12c0e82e1cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2149bd7b-de38-483b-b6c4-19ce18bf7687" xlink:to="loc_srt_MaximumMember_e7bff1a0-cdbd-48b5-8ade-f12c0e82e1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_d43794a7-4505-416a-acb1-03ef7f49c5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_d43794a7-4505-416a-acb1-03ef7f49c5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d43794a7-4505-416a-acb1-03ef7f49c5d9" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_26609683-9a22-49bf-a3ea-e93f20126e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:to="loc_us-gaap_CommercialPaperMember_26609683-9a22-49bf-a3ea-e93f20126e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_c3d331cd-82c9-4202-86b9-dcb292d5208d" xlink:href="vtrs-20220331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:to="loc_vtrs_ReceivablesFacilityMember_c3d331cd-82c9-4202-86b9-dcb292d5208d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_3b1eac18-b7aa-4378-bcb8-9a03589d936d" xlink:href="vtrs-20220331.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0223f389-b66f-4e33-9a87-6c1dfec52dde" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_3b1eac18-b7aa-4378-bcb8-9a03589d936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_00f7476a-8ce8-4a57-a88b-fabf344bf078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_00f7476a-8ce8-4a57-a88b-fabf344bf078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d8480614-83dd-4036-bc5c-b9d53d24122f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_00f7476a-8ce8-4a57-a88b-fabf344bf078" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d8480614-83dd-4036-bc5c-b9d53d24122f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ee8b6e16-c304-4235-a7ec-06ef63ffe271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d8480614-83dd-4036-bc5c-b9d53d24122f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ee8b6e16-c304-4235-a7ec-06ef63ffe271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54ec465a-10da-42fa-bc78-4f42732214ce" xlink:to="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_f4412363-9d0a-4ee5-8d75-61ea779c72be" xlink:href="vtrs-20220331.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_f4412363-9d0a-4ee5-8d75-61ea779c72be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4b3881e8-6a4a-4409-8296-162cc8e7944f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4b3881e8-6a4a-4409-8296-162cc8e7944f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a55db9f-60f8-4901-894f-aa69cf455441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a55db9f-60f8-4901-894f-aa69cf455441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_be055afd-78fc-4f01-90bc-d2b671dcf328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3d8d7519-b0a7-4e37-b0ff-9c7feba55a7e" xlink:to="loc_us-gaap_ShortTermBorrowings_be055afd-78fc-4f01-90bc-d2b671dcf328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtSummaryofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9677fa00-ea40-4f8a-9670-1f1f53e815cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9677fa00-ea40-4f8a-9670-1f1f53e815cb" xlink:to="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_d562c7f3-72c1-4dac-9581-7f278acf1104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_d562c7f3-72c1-4dac-9581-7f278acf1104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1dc95c60-4086-43f3-ab0d-4ed13f2adef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d562c7f3-72c1-4dac-9581-7f278acf1104" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1dc95c60-4086-43f3-ab0d-4ed13f2adef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c1d89dd0-ff18-49eb-b4a7-7316c3f328a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1dc95c60-4086-43f3-ab0d-4ed13f2adef8" xlink:to="loc_us-gaap_SeniorNotesMember_c1d89dd0-ff18-49eb-b4a7-7316c3f328a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ed9c2b2-f95a-43ff-a565-8387b0187c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ed9c2b2-f95a-43ff-a565-8387b0187c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ed9c2b2-f95a-43ff-a565-8387b0187c7b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5601cb96-39ad-4062-8c61-29d6346ccc6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:to="loc_us-gaap_SeniorNotesMember_5601cb96-39ad-4062-8c61-29d6346ccc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_37babb0e-2eec-4715-81f4-3269928d3b28" xlink:href="vtrs-20220331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:to="loc_vtrs_OtherLongTermDebtMember_37babb0e-2eec-4715-81f4-3269928d3b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember_079d1f38-df87-44de-aac3-be9403519d66" xlink:href="vtrs-20220331.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b5d7d26-e45a-404a-8367-bc7572aeab47" xlink:to="loc_vtrs_CurrentPortionofLongTermDebtMember_079d1f38-df87-44de-aac3-be9403519d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1cdad835-759f-49c5-a23f-00844892a492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:to="loc_us-gaap_DebtInstrumentAxis_1cdad835-759f-49c5-a23f-00844892a492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1cdad835-759f-49c5-a23f-00844892a492" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_fc016d98-2e4b-44c5-91c0-2982893740c5" xlink:href="vtrs-20220331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_fc016d98-2e4b-44c5-91c0-2982893740c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a6065ad8-04b0-4bf7-bd1f-12b1674931da" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a6065ad8-04b0-4bf7-bd1f-12b1674931da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_1d20fd1b-f7f4-4125-9804-fd475dda3429" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_1d20fd1b-f7f4-4125-9804-fd475dda3429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_3f73a716-e003-494d-8b1d-c0fe5f1479bb" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_3f73a716-e003-494d-8b1d-c0fe5f1479bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember_507923c4-d043-4548-8ace-b6eae12a68d9" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteenMember_507923c4-d043-4548-8ace-b6eae12a68d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_a3178ec3-fdcc-4c9e-b322-4e5e19e9c1dc" xlink:href="vtrs-20220331.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_a3178ec3-fdcc-4c9e-b322-4e5e19e9c1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_b3f81235-9419-4d51-a3e6-43927d014f98" xlink:href="vtrs-20220331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_b3f81235-9419-4d51-a3e6-43927d014f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_40896a4b-9cd2-4852-b88b-b3585107ad92" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_40896a4b-9cd2-4852-b88b-b3585107ad92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_5de61bb2-e1be-4db9-81d4-a58598c0f0ee" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_5de61bb2-e1be-4db9-81d4-a58598c0f0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_00903098-9cb6-4b6d-b558-c5be97b2ea26" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_00903098-9cb6-4b6d-b558-c5be97b2ea26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_86e8b90f-89d5-448a-a80d-a9615c66f790" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_86e8b90f-89d5-448a-a80d-a9615c66f790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_22110405-2fc6-4889-b8a5-a7c9373019fb" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_22110405-2fc6-4889-b8a5-a7c9373019fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_133b2378-f69f-40c4-804b-b0e8b041ceb4" xlink:href="vtrs-20220331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_133b2378-f69f-40c4-804b-b0e8b041ceb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_8ced343d-ff40-48a3-bc47-5e9301bb47eb" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_8ced343d-ff40-48a3-bc47-5e9301bb47eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_92d7988b-6afa-4d64-a769-dc7b411df97c" xlink:href="vtrs-20220331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_92d7988b-6afa-4d64-a769-dc7b411df97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_8015d0c9-7d33-45f8-a2e3-045e355093c9" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandTwentyEightMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_8015d0c9-7d33-45f8-a2e3-045e355093c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_fbec4848-d30b-4635-b79a-c0ff00b0ef2d" xlink:href="vtrs-20220331.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2028SeniorNotesMember_fbec4848-d30b-4635-b79a-c0ff00b0ef2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_a9e0d762-990f-4c97-a2be-ec3895423b20" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_a9e0d762-990f-4c97-a2be-ec3895423b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_be685bbd-1416-42af-9cd5-1491d5f78eba" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_be685bbd-1416-42af-9cd5-1491d5f78eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_84f41c73-9ed3-47cb-8509-001e518cd25b" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotesTwoThousandFortyEightMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_84f41c73-9ed3-47cb-8509-001e518cd25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_14a840d6-2bbf-45b1-bccc-97115aa13bb9" xlink:href="vtrs-20220331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_OtherLongTermDebtMember_14a840d6-2bbf-45b1-bccc-97115aa13bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_2b55217f-0f2b-416d-bb87-4bc2adc4eb6e" xlink:href="vtrs-20220331.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2048SeniorNotesMember_2b55217f-0f2b-416d-bb87-4bc2adc4eb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2021Member_929ae468-c752-457d-af25-88eae22b7bfb" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotes2021Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotes2021Member_929ae468-c752-457d-af25-88eae22b7bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_b3bceeaf-a9df-4afd-a0ec-eaf3ac9e0dda" xlink:href="vtrs-20220331.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_b3bceeaf-a9df-4afd-a0ec-eaf3ac9e0dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2022Member_22f45ad8-ff51-4773-a24a-1fbfe1e2b29f" xlink:href="vtrs-20220331.xsd#vtrs_SeniorNotes2022Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_SeniorNotes2022Member_22f45ad8-ff51-4773-a24a-1fbfe1e2b29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_eb0d6e45-9f5d-45cf-83f1-fca642d7b94c" xlink:href="vtrs-20220331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_eb0d6e45-9f5d-45cf-83f1-fca642d7b94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_fc93d65b-6d65-4cfd-ae32-a9f585a291fd" xlink:href="vtrs-20220331.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2025SeniorNotesMember_fc93d65b-6d65-4cfd-ae32-a9f585a291fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_bcd22ac2-7300-4fe1-aae6-ae424dbf23fc" xlink:href="vtrs-20220331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_bcd22ac2-7300-4fe1-aae6-ae424dbf23fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_2d28fc8d-39fe-4087-80ee-fad5deffec97" xlink:href="vtrs-20220331.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2027SeniorNotesMember_2d28fc8d-39fe-4087-80ee-fad5deffec97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_433f8307-c5cd-4d72-adc2-d011b8537946" xlink:href="vtrs-20220331.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2030SeniorNotesMember_433f8307-c5cd-4d72-adc2-d011b8537946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_307aa8e0-c1b4-4e72-9ec2-e2994c05035c" xlink:href="vtrs-20220331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_307aa8e0-c1b4-4e72-9ec2-e2994c05035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_81cfc5e1-cfc9-4ea5-8e2e-dc2603f9f536" xlink:href="vtrs-20220331.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2040SeniorNotesMember_81cfc5e1-cfc9-4ea5-8e2e-dc2603f9f536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_9eedca2d-4eba-4b81-ab09-67ad9d94ba86" xlink:href="vtrs-20220331.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_A2050SeniorNotesMember_9eedca2d-4eba-4b81-ab09-67ad9d94ba86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TermLoanMember_26d097b5-dae4-462a-bddc-fe1716506409" xlink:href="vtrs-20220331.xsd#vtrs_TermLoanMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_171a38c0-a29a-4818-b87f-e39f2dbd317d" xlink:to="loc_vtrs_TermLoanMember_26d097b5-dae4-462a-bddc-fe1716506409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e687a955-8d4b-49e8-aefd-ae592a881429" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_84ac10e0-715c-4893-9bfb-0b7faeeae93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_84ac10e0-715c-4893-9bfb-0b7faeeae93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d493080b-6343-42fd-b6f7-4446e50e9327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_DebtCurrent_d493080b-6343-42fd-b6f7-4446e50e9327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9eaeb8a-a609-40cf-8ce5-6d236f206b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_LongTermDebt_b9eaeb8a-a609-40cf-8ce5-6d236f206b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_c6d8d0f4-557e-4a96-bdce-2586b9e66331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_c6d8d0f4-557e-4a96-bdce-2586b9e66331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0f309e9c-e61d-4f68-aa3b-45248c6eeb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0f309e9c-e61d-4f68-aa3b-45248c6eeb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable_2545a672-db54-4cb9-86f6-d07e6f694996" xlink:href="vtrs-20220331.xsd#vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable_2545a672-db54-4cb9-86f6-d07e6f694996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f57be9c0-04bf-46ef-86e3-015124d5dcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f57be9c0-04bf-46ef-86e3-015124d5dcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_a49d4d65-8550-4c07-a61c-f4fa0c113e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5c06dfb1-7fd2-425d-b054-81609ea22ffa" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_a49d4d65-8550-4c07-a61c-f4fa0c113e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d6bc7508-6860-41db-9b50-4233e4c0047c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d6bc7508-6860-41db-9b50-4233e4c0047c" xlink:to="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d7606fd9-9afc-4da4-b5b3-c48f4a832290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d7606fd9-9afc-4da4-b5b3-c48f4a832290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ebd540e6-8902-400c-90fc-bf62e5455f60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d7606fd9-9afc-4da4-b5b3-c48f4a832290" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ebd540e6-8902-400c-90fc-bf62e5455f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_495438e6-3dca-4eba-9a1c-4c67ea1bd450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ebd540e6-8902-400c-90fc-bf62e5455f60" xlink:to="loc_us-gaap_LineOfCreditMember_495438e6-3dca-4eba-9a1c-4c67ea1bd450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_57b90639-0bd1-4be8-a35b-70f73792eced" xlink:href="vtrs-20220331.xsd#vtrs_PeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:to="loc_vtrs_PeriodAxis_57b90639-0bd1-4be8-a35b-70f73792eced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_fd9d3996-b366-4afe-8d99-2b427769ccea" xlink:href="vtrs-20220331.xsd#vtrs_PeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodAxis_57b90639-0bd1-4be8-a35b-70f73792eced" xlink:to="loc_vtrs_PeriodDomain_fd9d3996-b366-4afe-8d99-2b427769ccea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TrailingFourQuartersMember_c9dad856-44ce-41aa-8dae-a4da313540b1" xlink:href="vtrs-20220331.xsd#vtrs_TrailingFourQuartersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodDomain_fd9d3996-b366-4afe-8d99-2b427769ccea" xlink:to="loc_vtrs_TrailingFourQuartersMember_c9dad856-44ce-41aa-8dae-a4da313540b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_73125d51-8246-465b-b650-59ef45ec9ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:to="loc_us-gaap_DebtInstrumentAxis_73125d51-8246-465b-b650-59ef45ec9ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9fdeb08a-3e70-4126-9ab8-bf1c797f918b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_73125d51-8246-465b-b650-59ef45ec9ab7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9fdeb08a-3e70-4126-9ab8-bf1c797f918b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_c599d175-b474-4d37-8bbc-65d027d0164b" xlink:href="vtrs-20220331.xsd#vtrs_A2016SeniorRevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9fdeb08a-3e70-4126-9ab8-bf1c797f918b" xlink:to="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_c599d175-b474-4d37-8bbc-65d027d0164b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4af3409b-b3c9-45aa-813e-bcabe2025b36" xlink:to="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_136946c6-c73f-4c76-894d-17007dee0258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_136946c6-c73f-4c76-894d-17007dee0258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_aec35874-3347-46bc-90c7-9f394c324b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_DebtCurrent_aec35874-3347-46bc-90c7-9f394c324b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9120dd9b-23d3-47e7-875c-0ec88510b9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9120dd9b-23d3-47e7-875c-0ec88510b9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCovenantTerms_89b86475-66a5-49e5-99a7-32404a6b3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCovenantTerms"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_634346c6-58a0-4ed8-b945-741cd8a0eaf5" xlink:to="loc_us-gaap_LineOfCreditFacilityCovenantTerms_89b86475-66a5-49e5-99a7-32404a6b3c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtFairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fad90b0f-a8a9-41c6-beb9-6af8dbbc6200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3bc1882c-e476-4912-8afe-e8316d99dc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fad90b0f-a8a9-41c6-beb9-6af8dbbc6200" xlink:to="loc_us-gaap_DebtInstrumentTable_3bc1882c-e476-4912-8afe-e8316d99dc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b1bf002d-02eb-40b0-bc22-01d3d7c36606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3bc1882c-e476-4912-8afe-e8316d99dc33" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b1bf002d-02eb-40b0-bc22-01d3d7c36606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c295ab0a-2b58-4a6e-a957-7c5d948464bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b1bf002d-02eb-40b0-bc22-01d3d7c36606" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c295ab0a-2b58-4a6e-a957-7c5d948464bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d1191c9c-0235-4d65-849b-4c40ef34e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c295ab0a-2b58-4a6e-a957-7c5d948464bb" xlink:to="loc_us-gaap_SeniorNotesMember_d1191c9c-0235-4d65-849b-4c40ef34e7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2312a634-1e49-4179-a884-2776862313a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3bc1882c-e476-4912-8afe-e8316d99dc33" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2312a634-1e49-4179-a884-2776862313a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_783590f2-582a-40f1-9db6-28f98333c70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2312a634-1e49-4179-a884-2776862313a3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_783590f2-582a-40f1-9db6-28f98333c70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#DebtMinimumRepaymentsonOutstandingBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e408d1e3-438f-4c61-b464-d03964aaa0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e408d1e3-438f-4c61-b464-d03964aaa0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_108b0eb1-ab45-43f2-97c4-7dc73f201912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_108b0eb1-ab45-43f2-97c4-7dc73f201912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_aa6b914a-7e8a-4c90-b10f-b7c4b9dfcae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_aa6b914a-7e8a-4c90-b10f-b7c4b9dfcae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5c7517b8-0f6d-4090-95c7-863016fc4d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5c7517b8-0f6d-4090-95c7-863016fc4d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c5bc991e-5e61-4cab-b0ff-11c86173abc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c5bc991e-5e61-4cab-b0ff-11c86173abc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d35dd12c-149c-4523-8ec0-b836d3603b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d35dd12c-149c-4523-8ec0-b836d3603b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_37fd5673-c215-4fd0-9adb-7baa0b547f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03d01a58-a357-4063-bb4b-061c08ca8fa2" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_37fd5673-c215-4fd0-9adb-7baa0b547f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarnings" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ComprehensiveEarnings"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_62759a70-b91a-4a2a-a466-a16fa2449363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7c86766e-0dd4-491b-85eb-0ea8319d5ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_62759a70-b91a-4a2a-a466-a16fa2449363" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7c86766e-0dd4-491b-85eb-0ea8319d5ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ComprehensiveEarningsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b9ca19ec-6ec1-4b20-9bbe-c5360873442e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0bbc917d-a87b-46b6-86eb-5f94c0877ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b9ca19ec-6ec1-4b20-9bbe-c5360873442e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0bbc917d-a87b-46b6-86eb-5f94c0877ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_1b211fb8-9683-47c7-9fa3-00eda95063f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b9ca19ec-6ec1-4b20-9bbe-c5360873442e" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_1b211fb8-9683-47c7-9fa3-00eda95063f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_151e5226-1e64-48c1-bd7e-670fd1b8b294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_151e5226-1e64-48c1-bd7e-670fd1b8b294" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dd68d7ef-0ee5-485d-95da-02f934833ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dd68d7ef-0ee5-485d-95da-02f934833ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3d4b1c4b-d596-4d52-b6b8-738f3fed669d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dd68d7ef-0ee5-485d-95da-02f934833ec5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3d4b1c4b-d596-4d52-b6b8-738f3fed669d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_16e60c36-bc8d-4a84-b345-5b79d4449c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3d4b1c4b-d596-4d52-b6b8-738f3fed669d" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_16e60c36-bc8d-4a84-b345-5b79d4449c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4a9a702c-4af6-4370-9604-53d8de5c696e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4a9a702c-4af6-4370-9604-53d8de5c696e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4a9a702c-4af6-4370-9604-53d8de5c696e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e12215c8-c4f3-4ea1-8fe3-055aca447219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e12215c8-c4f3-4ea1-8fe3-055aca447219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d156b725-b2a9-440c-bacb-1fa0d1b0a769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6aa0e27a-940c-43ae-9184-cd271bf82257" xlink:to="loc_us-gaap_InterestRateSwapMember_d156b725-b2a9-440c-bacb-1fa0d1b0a769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_905415c8-5f79-4d1e-be3b-531cf6c5edab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_srt_ConsolidatedEntitiesAxis_905415c8-5f79-4d1e-be3b-531cf6c5edab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4e8ff338-154c-49d7-8ed8-7a640e806db6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_905415c8-5f79-4d1e-be3b-531cf6c5edab" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4e8ff338-154c-49d7-8ed8-7a640e806db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_1c58e2b2-b4fa-421b-afba-cdb254cc9c12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_4e8ff338-154c-49d7-8ed8-7a640e806db6" xlink:to="loc_srt_ParentCompanyMember_1c58e2b2-b4fa-421b-afba-cdb254cc9c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f93d3494-1c5c-4977-ad80-e7af1a46cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f93d3494-1c5c-4977-ad80-e7af1a46cad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c48b55c1-37d2-478b-9c4a-ed4527e0cae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f93d3494-1c5c-4977-ad80-e7af1a46cad6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c48b55c1-37d2-478b-9c4a-ed4527e0cae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_cc1d798a-fe95-42b5-b9e8-b0f5dcbc2dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c48b55c1-37d2-478b-9c4a-ed4527e0cae7" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_cc1d798a-fe95-42b5-b9e8-b0f5dcbc2dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cc544d3-2d5f-462f-bc38-e749eabf2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cc544d3-2d5f-462f-bc38-e749eabf2f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cc544d3-2d5f-462f-bc38-e749eabf2f7d" xlink:to="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bf53a561-cc75-4b2e-90c0-2a2dc982fc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bf53a561-cc75-4b2e-90c0-2a2dc982fc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_45d9bb76-30f5-43d8-97e9-cf670ea5b85b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_45d9bb76-30f5-43d8-97e9-cf670ea5b85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_32e0f89f-5e87-45d8-9094-639d3c059b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_32e0f89f-5e87-45d8-9094-639d3c059b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_30842786-1584-45f1-997e-2d30c2c0079d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_30842786-1584-45f1-997e-2d30c2c0079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6617dc0c-74d4-4bdd-963b-87dd320759f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_345ddcd0-761f-4de0-9e36-232a852b47f1" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6617dc0c-74d4-4bdd-963b-87dd320759f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a43007b1-7499-4dc7-ba47-0c66aa079090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a43007b1-7499-4dc7-ba47-0c66aa079090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a43007b1-7499-4dc7-ba47-0c66aa079090" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_036caaef-7611-4167-8503-d1fb176a54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:to="loc_us-gaap_CashFlowHedgingMember_036caaef-7611-4167-8503-d1fb176a54a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a0f7c104-fe96-4533-a91a-98c398924ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ae1fa3a7-661b-47b0-949b-1c225e06b9ba" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a0f7c104-fe96-4533-a91a-98c398924ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20f7d1eb-6afc-411e-9f19-6ee02c747214" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1b6e9478-029c-4af8-9d20-b7dd5c14b7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1b6e9478-029c-4af8-9d20-b7dd5c14b7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_690678fd-d15b-467e-9550-42c26413debc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_690678fd-d15b-467e-9550-42c26413debc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1a3f1b13-07c0-4122-8758-7a53aa7a3642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1a3f1b13-07c0-4122-8758-7a53aa7a3642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_de714ddd-b746-4238-b709-bd0e2aa632af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_de714ddd-b746-4238-b709-bd0e2aa632af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_e446cfa8-23d2-4843-b1fc-0e2369c7a846" xlink:href="vtrs-20220331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_e446cfa8-23d2-4843-b1fc-0e2369c7a846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_9e14b921-4d28-4236-9f52-838f78334358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_9e14b921-4d28-4236-9f52-838f78334358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d166a9de-fcdb-4165-ba20-04e6e7e32111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d166a9de-fcdb-4165-ba20-04e6e7e32111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_ec29d2c6-7474-45f5-a525-0b5a8dfbae87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_ec29d2c6-7474-45f5-a525-0b5a8dfbae87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_15a7cf16-ef55-45d3-a33e-e8953769b41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_15a7cf16-ef55-45d3-a33e-e8953769b41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_e2723303-4b71-4336-9dbd-7b61afb369aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_e2723303-4b71-4336-9dbd-7b61afb369aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_7114f21d-7569-4c6e-8142-ddb64def460f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_7114f21d-7569-4c6e-8142-ddb64def460f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_5ecaa4ba-8903-4bc0-880b-5082a78cd040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_5ecaa4ba-8903-4bc0-880b-5082a78cd040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_be6f781a-bc16-459e-abeb-1ec69910f853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_be6f781a-bc16-459e-abeb-1ec69910f853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e78f5009-f219-47d4-852f-1a6427a6cb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_InterestExpense_e78f5009-f219-47d4-852f-1a6427a6cb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2eb395c3-d411-4a8c-a932-5f0bf83f66e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2eb395c3-d411-4a8c-a932-5f0bf83f66e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_85fa4f53-09fb-4ff9-9842-2b784da3d270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_85fa4f53-09fb-4ff9-9842-2b784da3d270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_621b4289-e588-45c7-85c6-9cf0ec65c416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a1f3214c-2756-4eeb-b5e1-834309957cd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_621b4289-e588-45c7-85c6-9cf0ec65c416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_912c6f8b-12f1-40b3-a810-f9fddcaf1b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_912c6f8b-12f1-40b3-a810-f9fddcaf1b61" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_30b46b6b-6b11-4f5d-9c62-f471cb40891c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_30b46b6b-6b11-4f5d-9c62-f471cb40891c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0633d80c-5999-400d-a111-f4c23255f2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_30b46b6b-6b11-4f5d-9c62-f471cb40891c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0633d80c-5999-400d-a111-f4c23255f2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_01dbfdbf-02ba-49e7-8c38-9351697c1154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0633d80c-5999-400d-a111-f4c23255f2d6" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_01dbfdbf-02ba-49e7-8c38-9351697c1154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4e401240-0686-498d-b6f5-d392659442ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4e401240-0686-498d-b6f5-d392659442ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_19539f15-1652-4e27-a398-d105cf65877a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4e401240-0686-498d-b6f5-d392659442ee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_19539f15-1652-4e27-a398-d105cf65877a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_a7a8b03c-ed94-4d98-9340-a82bcff7dbf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_19539f15-1652-4e27-a398-d105cf65877a" xlink:to="loc_srt_ParentCompanyMember_a7a8b03c-ed94-4d98-9340-a82bcff7dbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c5bc7b56-590f-44c6-b712-5c1ad48ffc26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c5bc7b56-590f-44c6-b712-5c1ad48ffc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c5bc7b56-590f-44c6-b712-5c1ad48ffc26" xlink:to="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7f59dbee-2c14-40e8-b9b2-b1ae759f069e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:to="loc_us-gaap_CashFlowHedgingMember_7f59dbee-2c14-40e8-b9b2-b1ae759f069e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d979928e-4a8f-4248-8937-41262889c3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_585bedf4-689e-4bfb-a08e-7ab16182bc76" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d979928e-4a8f-4248-8937-41262889c3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_45a0746f-5b5a-4c06-bb0d-462dd039f6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_45a0746f-5b5a-4c06-bb0d-462dd039f6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_45a0746f-5b5a-4c06-bb0d-462dd039f6fb" xlink:to="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_22c31e72-7f9f-4a4c-97c8-affecaa2948f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_22c31e72-7f9f-4a4c-97c8-affecaa2948f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_819e58cb-be4c-4bc7-b467-698dd8bb26b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_819e58cb-be4c-4bc7-b467-698dd8bb26b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7035b02f-017c-4fc0-b691-f39bf2a047f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7035b02f-017c-4fc0-b691-f39bf2a047f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e1d37bf1-6aa8-47e6-be86-b8ac5da71aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e1d37bf1-6aa8-47e6-be86-b8ac5da71aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52f45619-0909-4815-a428-10f1e2068667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1c47f85-0438-4f98-8f06-539b20a72bff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52f45619-0909-4815-a428-10f1e2068667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d6a43d9d-21db-41ef-b6bd-d4511a98c587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d6a43d9d-21db-41ef-b6bd-d4511a98c587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_40236701-c250-406f-923a-a7fa675f7451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d6a43d9d-21db-41ef-b6bd-d4511a98c587" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_40236701-c250-406f-923a-a7fa675f7451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_6ebab497-e79f-4881-a223-2462e69eaec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_40236701-c250-406f-923a-a7fa675f7451" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_6ebab497-e79f-4881-a223-2462e69eaec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_86deaac9-c664-4c47-b96e-5fbdde9bf695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_86deaac9-c664-4c47-b96e-5fbdde9bf695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_86deaac9-c664-4c47-b96e-5fbdde9bf695" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_77a81fb8-619c-4c34-9076-75d319bd12ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_77a81fb8-619c-4c34-9076-75d319bd12ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_22c8f035-3bdb-402b-93ef-52bab0acdd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_43eb8ead-e118-4d45-a5f5-dc6eec399fa1" xlink:to="loc_us-gaap_InterestRateSwapMember_22c8f035-3bdb-402b-93ef-52bab0acdd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7da1a627-84cd-4726-8ec5-2b1526ec659b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_668b0703-046b-41f1-860e-9e1f278a3665" xlink:href="vtrs-20220331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_668b0703-046b-41f1-860e-9e1f278a3665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_7a289458-a359-483b-ac6b-2b0a809e4b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_7a289458-a359-483b-ac6b-2b0a809e4b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ef8b0b6f-16fc-4d7f-b649-a72c7426c975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ef8b0b6f-16fc-4d7f-b649-a72c7426c975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c5429a52-442f-4bdf-bd8a-838a1693da31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c5429a52-442f-4bdf-bd8a-838a1693da31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3666b1f7-bcb0-4f28-b91d-4afdf58d87bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3666b1f7-bcb0-4f28-b91d-4afdf58d87bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_10800ddd-be0b-443a-b9d0-54af8eba4f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_10800ddd-be0b-443a-b9d0-54af8eba4f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_0aaa7114-3cf4-4e7b-8ce5-9b13392ed4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_0aaa7114-3cf4-4e7b-8ce5-9b13392ed4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d60bbe93-e36c-46cd-9e5a-5f7eb5835178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d60bbe93-e36c-46cd-9e5a-5f7eb5835178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a5a6b9fe-7123-4189-ba6d-ef8f03e040e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_InterestExpense_a5a6b9fe-7123-4189-ba6d-ef8f03e040e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_4b10a909-c63d-4f9f-8aa3-03496f633ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_4b10a909-c63d-4f9f-8aa3-03496f633ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_04102e84-ab69-4c40-99d8-59011f2ca367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_04102e84-ab69-4c40-99d8-59011f2ca367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_032f938a-a9bc-4f19-8729-65ea7fbb23b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_032f938a-a9bc-4f19-8729-65ea7fbb23b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_34e96fc4-6ab5-42f3-88f6-9628b419abcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_34e96fc4-6ab5-42f3-88f6-9628b419abcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_e734135d-d8ff-4058-addc-0c9975356afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_e734135d-d8ff-4058-addc-0c9975356afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_3563030d-27fb-4ea2-9903-9db4091a2dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_3563030d-27fb-4ea2-9903-9db4091a2dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_188dff58-e222-4c5e-80ce-b80f6fadf963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_188dff58-e222-4c5e-80ce-b80f6fadf963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_839fca35-e7a8-4c88-a1cf-d129524f0390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_839fca35-e7a8-4c88-a1cf-d129524f0390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c3a8c43e-bbd7-40ca-98d0-75b311979b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c3a8c43e-bbd7-40ca-98d0-75b311979b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_095ece77-39dc-4db0-b374-5f1743ae2b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_095ece77-39dc-4db0-b374-5f1743ae2b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e24ae32d-6c3f-49d1-9b9d-c061748c52d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e24ae32d-6c3f-49d1-9b9d-c061748c52d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e2b4e376-8fbd-4b8f-b903-7a9f245509c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e2b4e376-8fbd-4b8f-b903-7a9f245509c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_bcc42e01-0799-48f1-b8ab-617c20a6d22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_bcc42e01-0799-48f1-b8ab-617c20a6d22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_97d464d6-e9e8-4a69-82ef-a48e1b8d7acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_97d464d6-e9e8-4a69-82ef-a48e1b8d7acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_d16cee81-2d71-43ad-9c02-1c08e1bba0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_be1560a0-b3e0-4b4d-af66-32694fd31bd9" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_d16cee81-2d71-43ad-9c02-1c08e1bba0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformation" xlink:type="simple" xlink:href="vtrs-20220331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_59231fe3-d054-4df8-a8e9-e8e014752dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c6e9e5a7-a371-49f7-b0e4-bed5705b0719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_59231fe3-d054-4df8-a8e9-e8e014752dba" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c6e9e5a7-a371-49f7-b0e4-bed5705b0719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationPolicies" xlink:type="simple" xlink:href="vtrs-20220331.xsd#SegmentInformationPolicies"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_603ebeb0-1c6a-4d42-bb93-d6aa1789784a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_1f74cde3-2198-423d-a68e-2384e5e644d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_603ebeb0-1c6a-4d42-bb93-d6aa1789784a" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_1f74cde3-2198-423d-a68e-2384e5e644d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a62595e1-c91a-4a96-a61c-ff442769fb74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9ca8fb2c-83bb-485f-b6f9-c7967acda3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a62595e1-c91a-4a96-a61c-ff442769fb74" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9ca8fb2c-83bb-485f-b6f9-c7967acda3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_01aefc5e-6de5-4c67-b7bc-8f066a95b0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_01aefc5e-6de5-4c67-b7bc-8f066a95b0f4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7148a8b7-7324-4b50-879d-04426b9d9b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7148a8b7-7324-4b50-879d-04426b9d9b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_447dc8f9-e4ac-4596-9140-b0f46d0e2902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7148a8b7-7324-4b50-879d-04426b9d9b7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_447dc8f9-e4ac-4596-9140-b0f46d0e2902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_fc5f2541-fcfb-46b0-a41b-97a59e1ae0d6" xlink:href="vtrs-20220331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_447dc8f9-e4ac-4596-9140-b0f46d0e2902" xlink:to="loc_vtrs_ContingentConsiderationMember_fc5f2541-fcfb-46b0-a41b-97a59e1ae0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c209261b-eee7-4c08-8a73-d8fbfdb94e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c209261b-eee7-4c08-8a73-d8fbfdb94e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c209261b-eee7-4c08-8a73-d8fbfdb94e23" xlink:to="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_197581c4-2265-48a3-92c6-d69b6846522c" xlink:href="vtrs-20220331.xsd#vtrs_EuropeSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:to="loc_vtrs_EuropeSegmentMember_197581c4-2265-48a3-92c6-d69b6846522c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_f4b08cc5-da74-41f4-961d-0a9e52971817" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6c97ed4c-9621-4406-a451-da117962d536" xlink:to="loc_vtrs_RestofWorldSegmentMember_f4b08cc5-da74-41f4-961d-0a9e52971817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_187af759-44b9-44bb-963b-1c038f6fdbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_28bba232-8ede-4cea-807c-e8dabc4b4301" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_187af759-44b9-44bb-963b-1c038f6fdbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_28525541-d8f2-4d49-bbd0-402a6d0156bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_187af759-44b9-44bb-963b-1c038f6fdbb9" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_28525541-d8f2-4d49-bbd0-402a6d0156bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8be6bb5a-3e0f-4672-8af0-981bca465376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8be6bb5a-3e0f-4672-8af0-981bca465376" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_08e217f8-a18f-4430-9194-8656cb7933ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:to="loc_srt_ProductOrServiceAxis_08e217f8-a18f-4430-9194-8656cb7933ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3a0c7dfb-534c-4039-a211-df9312bdfa4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_08e217f8-a18f-4430-9194-8656cb7933ff" xlink:to="loc_srt_ProductsAndServicesDomain_3a0c7dfb-534c-4039-a211-df9312bdfa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_d14d392a-9c84-4cfc-a2fb-9cc78dd879e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3a0c7dfb-534c-4039-a211-df9312bdfa4d" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_d14d392a-9c84-4cfc-a2fb-9cc78dd879e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_352378b8-7bb7-4cb1-89d5-0ebb80c31224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_352378b8-7bb7-4cb1-89d5-0ebb80c31224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_352378b8-7bb7-4cb1-89d5-0ebb80c31224" xlink:to="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_4558315a-60ed-4b0f-aaa9-2fdfb5dd2497" xlink:href="vtrs-20220331.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_RestofWorldSegmentMember_4558315a-60ed-4b0f-aaa9-2fdfb5dd2497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_4ebfc797-0483-49b3-ae90-37767c411b95" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_4ebfc797-0483-49b3-ae90-37767c411b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_c0d1dfe0-ee9b-45ef-ae24-f601470a4561" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_GreaterChinaSegmentMember_c0d1dfe0-ee9b-45ef-ae24-f601470a4561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_d1b3f31b-0c4a-4a9b-a38e-85cd11cfb296" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_d1b3f31b-0c4a-4a9b-a38e-85cd11cfb296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_347c435c-9f53-41aa-aaa0-6699c7cfffce" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3c1cb2d-c010-45c0-8809-1f81b9b276d5" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_347c435c-9f53-41aa-aaa0-6699c7cfffce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_354bf728-f3ee-4c22-9a68-b13796638ff3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:to="loc_srt_ConsolidationItemsAxis_354bf728-f3ee-4c22-9a68-b13796638ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_354bf728-f3ee-4c22-9a68-b13796638ff3" xlink:to="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_67f55cf2-0a0d-405e-86a0-32f47fbd8efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:to="loc_us-gaap_OperatingSegmentsMember_67f55cf2-0a0d-405e-86a0-32f47fbd8efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_75018b2d-855f-4d79-bd04-16fbaf2f78d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_75018b2d-855f-4d79-bd04-16fbaf2f78d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_783c19cf-23ef-4ab1-bb17-74f9833618c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f54fde81-9602-4d68-9a58-32495792b823" xlink:to="loc_us-gaap_CorporateNonSegmentMember_783c19cf-23ef-4ab1-bb17-74f9833618c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1fc6163d-5f46-4f06-bd1f-fdb91423f9fd" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_18a1f205-9738-4889-a32d-5652b451aae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_18a1f205-9738-4889-a32d-5652b451aae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90716c8f-98c5-4091-a09e-da5ef7c0d1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_Revenues_90716c8f-98c5-4091-a09e-da5ef7c0d1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7496d70d-fc71-4244-a3de-d18f7d065a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7496d70d-fc71-4244-a3de-d18f7d065a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b0343b84-c541-4f88-b84b-711dae20fdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b0343b84-c541-4f88-b84b-711dae20fdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f1861ede-3895-41fb-873f-8a8fb5891a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f1861ede-3895-41fb-873f-8a8fb5891a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts_24f7863b-7ac3-4334-ba55-d5dd50036ff3" xlink:href="vtrs-20220331.xsd#vtrs_Corporatecosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_vtrs_Corporatecosts_24f7863b-7ac3-4334-ba55-d5dd50036ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_ab2f869c-7523-4d89-a17a-d4d039e25d55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_ab2f869c-7523-4d89-a17a-d4d039e25d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9d84f1f2-3ae4-43b1-9b55-9237935d0592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_us-gaap_OperatingIncomeLoss_9d84f1f2-3ae4-43b1-9b55-9237935d0592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense_c13543ad-5cbd-47a1-ab74-14dc2fa76a87" xlink:href="vtrs-20220331.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0837dd8d-cfd9-4f77-95a9-9ac53f842fe7" xlink:to="loc_vtrs_OtherOneTimeNonoperatingExpense_c13543ad-5cbd-47a1-ab74-14dc2fa76a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Restructuring" xlink:type="simple" xlink:href="vtrs-20220331.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8a2fd277-ff25-49b7-b0c6-08eac7b04d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_62ddece7-1d64-4087-9aee-ad445614f95e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8a2fd277-ff25-49b7-b0c6-08eac7b04d35" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_62ddece7-1d64-4087-9aee-ad445614f95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringTables" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ee1ba167-b087-4d73-83ce-dc68dc25157c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4def68b5-71ee-42f7-a7d8-e9aa4b7906f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ee1ba167-b087-4d73-83ce-dc68dc25157c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4def68b5-71ee-42f7-a7d8-e9aa4b7906f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#RestructuringRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b2982622-2626-4ba9-a769-c3aeec2e470f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b2982622-2626-4ba9-a769-c3aeec2e470f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_703a5c65-df1b-4afb-8e13-35ba89e64205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_703a5c65-df1b-4afb-8e13-35ba89e64205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_703a5c65-df1b-4afb-8e13-35ba89e64205" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_754429e5-9b86-45db-b37e-18de5fabf6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_754429e5-9b86-45db-b37e-18de5fabf6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_6b7bd544-d13c-4aa0-8739-1fe24220f3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fd60f7bd-f723-4f4d-95d2-7e7f2e2b2a5e" xlink:to="loc_us-gaap_OtherRestructuringMember_6b7bd544-d13c-4aa0-8739-1fe24220f3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b9e27bec-ff57-440e-b984-c92d6e56c3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b9e27bec-ff57-440e-b984-c92d6e56c3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b9e27bec-ff57-440e-b984-c92d6e56c3db" xlink:to="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_a399370c-d5cb-435e-900c-e2eadfabbf7c" xlink:href="vtrs-20220331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_a399370c-d5cb-435e-900c-e2eadfabbf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_ad15e26d-d2f2-40e3-ab88-046b7e70a115" xlink:href="vtrs-20220331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_GreaterChinaSegmentMember_ad15e26d-d2f2-40e3-ab88-046b7e70a115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3fbc8c49-7366-426f-8219-7dd4de49881e" xlink:href="vtrs-20220331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3fbc8c49-7366-426f-8219-7dd4de49881e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_00b8408f-bf3b-41a8-9fd1-cc7a4136d840" xlink:href="vtrs-20220331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_00b8408f-bf3b-41a8-9fd1-cc7a4136d840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_1e54c943-b4a7-453d-8518-877a4d25f343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8280445e-2acb-4770-aca3-9818a4001aa6" xlink:to="loc_us-gaap_CorporateAndOtherMember_1e54c943-b4a7-453d-8518-877a4d25f343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b759a50f-7de4-4334-8c94-d95e8601e061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_srt_RangeAxis_b759a50f-7de4-4334-8c94-d95e8601e061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b759a50f-7de4-4334-8c94-d95e8601e061" xlink:to="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_827ffc79-7ffb-4d1f-bd41-ceaed0ea3361" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:to="loc_srt_MinimumMember_827ffc79-7ffb-4d1f-bd41-ceaed0ea3361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_41e6966f-b38a-499b-ac6e-da2b16b4a4fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55ca8b0b-eeb3-4f8e-b9aa-d7777b89d0aa" xlink:to="loc_srt_MaximumMember_41e6966f-b38a-499b-ac6e-da2b16b4a4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0f76278a-0ccd-45bc-b58f-b025fdcda293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_us-gaap_RestructuringPlanAxis_0f76278a-0ccd-45bc-b58f-b025fdcda293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cf3dd219-b6a2-496d-8e23-8906ea0110aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_0f76278a-0ccd-45bc-b58f-b025fdcda293" xlink:to="loc_us-gaap_RestructuringPlanDomain_cf3dd219-b6a2-496d-8e23-8906ea0110aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember_50940e48-a54c-49f3-9102-9587aa87f663" xlink:href="vtrs-20220331.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cf3dd219-b6a2-496d-8e23-8906ea0110aa" xlink:to="loc_vtrs_A2020RestructuringPlanMember_50940e48-a54c-49f3-9102-9587aa87f663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_48279b38-ca6e-4e0d-abd0-18e9243f794b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_srt_StatementScenarioAxis_48279b38-ca6e-4e0d-abd0-18e9243f794b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3bda708d-3ff4-4234-bc42-75dab3d10a5f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_48279b38-ca6e-4e0d-abd0-18e9243f794b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3bda708d-3ff4-4234-bc42-75dab3d10a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_21ee6aa6-b805-48ac-9381-32c158a65730" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3bda708d-3ff4-4234-bc42-75dab3d10a5f" xlink:to="loc_srt_ScenarioForecastMember_21ee6aa6-b805-48ac-9381-32c158a65730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4d1b0009-273f-4638-a40a-6386e313a119" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_24aa6dab-695d-4623-bf05-518edb1eeb52" xlink:href="vtrs-20220331.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_24aa6dab-695d-4623-bf05-518edb1eeb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4af4d7e7-9256-43fa-bb9a-6f94e3b50fb0" xlink:href="vtrs-20220331.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4af4d7e7-9256-43fa-bb9a-6f94e3b50fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_45c03da5-f4b7-4ce3-a282-e6fcacdaebbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_45c03da5-f4b7-4ce3-a282-e6fcacdaebbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fc483d5a-778c-4efa-957b-6c6cf718ae38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fc483d5a-778c-4efa-957b-6c6cf718ae38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_c1cc51b8-67a4-42c8-9a97-0a782fd1904d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_c1cc51b8-67a4-42c8-9a97-0a782fd1904d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_829070dd-b8e0-4f55-aff0-6900ab212883" xlink:to="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_733f3422-41eb-402c-8426-82e7bb07d903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringReserve_733f3422-41eb-402c-8426-82e7bb07d903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_64143829-b7d5-4cc6-b02d-b34b0194520d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringCharges_64143829-b7d5-4cc6-b02d-b34b0194520d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_fd2d11f8-05dc-48ac-837d-e28c4d5178f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_PaymentsForRestructuring_fd2d11f8-05dc-48ac-837d-e28c4d5178f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a27d854d-b6a7-4dbe-b5ef-6d083ed297a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a27d854d-b6a7-4dbe-b5ef-6d083ed297a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_e64afca0-acc2-43f4-aa4d-17a370ec97bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_e64afca0-acc2-43f4-aa4d-17a370ec97bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_fdde4409-5122-4ea7-b20f-fdf89d838155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d12abc12-41e8-47a4-ade1-45332fc00c4c" xlink:to="loc_us-gaap_RestructuringReserve_fdde4409-5122-4ea7-b20f-fdf89d838155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount_b614b070-3c60-43b0-aae5-87b606727ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b2982622-2626-4ba9-a769-c3aeec2e470f" xlink:to="loc_us-gaap_EffectOnFutureCashFlowsAmount_b614b070-3c60-43b0-aae5-87b606727ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreements" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CollaborationandLicensingAgreements"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60f0f8a7-ff2d-485b-812a-17b117e95ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_06623aae-e41a-4be4-b866-623dddfd44c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60f0f8a7-ff2d-485b-812a-17b117e95ec4" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_06623aae-e41a-4be4-b866-623dddfd44c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#CollaborationandLicensingAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e1f8bb7-c104-41e8-aa2d-300a848f7222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e1f8bb7-c104-41e8-aa2d-300a848f7222" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f03065fc-a3e6-4dbd-a3e7-435ee7756f31" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:to="loc_srt_RangeAxis_f03065fc-a3e6-4dbd-a3e7-435ee7756f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed32d906-7408-4ea6-8a22-5de15530e10b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f03065fc-a3e6-4dbd-a3e7-435ee7756f31" xlink:to="loc_srt_RangeMember_ed32d906-7408-4ea6-8a22-5de15530e10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c6e40fd1-35c8-4f7e-9476-e9ad62dc68c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ed32d906-7408-4ea6-8a22-5de15530e10b" xlink:to="loc_srt_MaximumMember_c6e40fd1-35c8-4f7e-9476-e9ad62dc68c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_feb183bf-b7bb-4057-8b16-b07596b3fc05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:to="loc_us-gaap_TypeOfArrangementAxis_feb183bf-b7bb-4057-8b16-b07596b3fc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f2dcc6d-60f3-4803-a609-03573a8114c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_feb183bf-b7bb-4057-8b16-b07596b3fc05" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f2dcc6d-60f3-4803-a609-03573a8114c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_f7147200-d8b2-4f59-ad4a-e2a6012ad3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f2dcc6d-60f3-4803-a609-03573a8114c3" xlink:to="loc_us-gaap_CollaborativeArrangementMember_f7147200-d8b2-4f59-ad4a-e2a6012ad3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c332a810-1128-4beb-a1a9-98ede9e84f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_84c947ae-981f-4d2c-9e8a-f03f753a7ce0" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c332a810-1128-4beb-a1a9-98ede9e84f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments_821b9d3a-efc0-4438-8f37-87d131702b6d" xlink:href="vtrs-20220331.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c332a810-1128-4beb-a1a9-98ede9e84f65" xlink:to="loc_vtrs_Developmentandsalesmilestonepayments_821b9d3a-efc0-4438-8f37-87d131702b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxes" xlink:type="simple" xlink:href="vtrs-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fcac91c7-6f8b-49ae-9fb8-2e1070955d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_215679ec-6cf5-4944-a642-c3c513d83bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fcac91c7-6f8b-49ae-9fb8-2e1070955d5b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_215679ec-6cf5-4944-a642-c3c513d83bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#IncomeTaxesIncomeTaxesDisclosureDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9a14cfa5-e1f5-43e0-85bb-64799353ee0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9a14cfa5-e1f5-43e0-85bb-64799353ee0a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eccda2b3-8c70-42fe-9410-6ec8045238f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:to="loc_srt_StatementScenarioAxis_eccda2b3-8c70-42fe-9410-6ec8045238f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5d5249e3-ff7d-444a-855f-ebbd71fb655b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_eccda2b3-8c70-42fe-9410-6ec8045238f1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5d5249e3-ff7d-444a-855f-ebbd71fb655b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_43204abc-ae8f-4810-9968-9dbc5b929e53" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5d5249e3-ff7d-444a-855f-ebbd71fb655b" xlink:to="loc_srt_ScenarioForecastMember_43204abc-ae8f-4810-9968-9dbc5b929e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_68e231fc-ef7e-4568-90c1-8c64197b34df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_68e231fc-ef7e-4568-90c1-8c64197b34df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_97fa1c46-9393-4be9-84a5-5b87bc5e7b18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_68e231fc-ef7e-4568-90c1-8c64197b34df" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_97fa1c46-9393-4be9-84a5-5b87bc5e7b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_22038f66-aacd-4b61-8dc9-a68d1113417d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_97fa1c46-9393-4be9-84a5-5b87bc5e7b18" xlink:to="loc_us-gaap_ForeignCountryMember_22038f66-aacd-4b61-8dc9-a68d1113417d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_c195b8e0-a411-48f8-b96b-9eaabc1b9244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_c195b8e0-a411-48f8-b96b-9eaabc1b9244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe47f062-39db-47c3-a2f0-871487ae9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_c195b8e0-a411-48f8-b96b-9eaabc1b9244" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe47f062-39db-47c3-a2f0-871487ae9cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_82170bac-eff6-4c4b-8ccd-243db1c75e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe47f062-39db-47c3-a2f0-871487ae9cbc" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_82170bac-eff6-4c4b-8ccd-243db1c75e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_675b4b39-08b2-4eee-9315-d30e577f2a8f" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount_5809048c-0036-48cd-8011-31abfa00e782" xlink:href="vtrs-20220331.xsd#vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount_5809048c-0036-48cd-8011-31abfa00e782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_6a4e1b57-6e69-46ec-8556-3fa160a9ffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_6a4e1b57-6e69-46ec-8556-3fa160a9ffd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_9569b657-1dc2-4231-bab0-d7e03e885342" xlink:href="vtrs-20220331.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_9569b657-1dc2-4231-bab0-d7e03e885342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_1ad9d740-4ff3-4d17-a97d-ed7a7f4c1044" xlink:href="vtrs-20220331.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab4824f1-20fa-4a47-ab72-04b2cc2dfe4c" xlink:to="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_1ad9d740-4ff3-4d17-a97d-ed7a7f4c1044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Litigation" xlink:type="simple" xlink:href="vtrs-20220331.xsd#Litigation"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Litigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ae01aeee-0a65-482c-923a-7271fa9e655b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_56b61741-7cd5-4722-b921-e48fed52a2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ae01aeee-0a65-482c-923a-7271fa9e655b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_56b61741-7cd5-4722-b921-e48fed52a2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_5fa032e8-bd6f-4a8c-bd6c-dbcc80d6d501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ae01aeee-0a65-482c-923a-7271fa9e655b" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_5fa032e8-bd6f-4a8c-bd6c-dbcc80d6d501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationLorazepamandClorazepateNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96e22797-e8e6-400b-90aa-22e7c4af898d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96e22797-e8e6-400b-90aa-22e7c4af898d" xlink:to="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7cc6ab12-0149-4b0b-a557-b2e57f87ba01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:to="loc_srt_LitigationCaseAxis_7cc6ab12-0149-4b0b-a557-b2e57f87ba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1821d693-3b6c-4255-b1a9-765a229fcfc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7cc6ab12-0149-4b0b-a557-b2e57f87ba01" xlink:to="loc_srt_LitigationCaseTypeDomain_1821d693-3b6c-4255-b1a9-765a229fcfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9715b7fc-3a43-4589-84ab-fd18f0d9e16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9715b7fc-3a43-4589-84ab-fd18f0d9e16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d11322c7-5931-49f4-a757-0a9f789eda3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9715b7fc-3a43-4589-84ab-fd18f0d9e16f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d11322c7-5931-49f4-a757-0a9f789eda3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f4d4d16a-b9e1-4279-abb1-4f14bf1ec4e7" xlink:to="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c791240e-e4fd-4c8a-a7e2-ec6221bc6f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c791240e-e4fd-4c8a-a7e2-ec6221bc6f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_1e9ffecf-4690-4f87-9afd-e90fee3defec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae1a7a26-442e-435a-9385-2e3321ae6cf8" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_1e9ffecf-4690-4f87-9afd-e90fee3defec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationPricingandMedicaidLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_91abe820-4acc-4ef7-9276-b48a9ac63ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_91abe820-4acc-4ef7-9276-b48a9ac63ae7" xlink:to="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_642e8fff-2be3-4450-8e90-bf81b5f80228" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:to="loc_srt_LitigationCaseAxis_642e8fff-2be3-4450-8e90-bf81b5f80228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e45b3d5a-8a1d-4346-909d-93d26128b23c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_642e8fff-2be3-4450-8e90-bf81b5f80228" xlink:to="loc_srt_LitigationCaseTypeDomain_e45b3d5a-8a1d-4346-909d-93d26128b23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3c996fa0-a34d-4707-9b50-4ed63b201835" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:to="loc_dei_LegalEntityAxis_3c996fa0-a34d-4707-9b50-4ed63b201835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1760eebc-325c-4ed0-8f95-bf9754ef649a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3c996fa0-a34d-4707-9b50-4ed63b201835" xlink:to="loc_dei_EntityDomain_1760eebc-325c-4ed0-8f95-bf9754ef649a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_33ac9246-967e-4b38-87a7-21fa8f1982ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_33ac9246-967e-4b38-87a7-21fa8f1982ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_94223a6d-5af0-4d8f-94c2-de81285495e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_33ac9246-967e-4b38-87a7-21fa8f1982ef" xlink:to="loc_us-gaap_LossContingencyNatureDomain_94223a6d-5af0-4d8f-94c2-de81285495e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2d875fc7-8440-4f2d-b21a-bd5472ab4218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5785fa9e-9730-4ca3-a2f9-d279e04cb48b" xlink:to="loc_us-gaap_LossContingenciesLineItems_2d875fc7-8440-4f2d-b21a-bd5472ab4218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c38172d3-60af-47ad-be98-7a84fdd63501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2d875fc7-8440-4f2d-b21a-bd5472ab4218" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c38172d3-60af-47ad-be98-7a84fdd63501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08c20b49-aa50-4719-a862-c85157dd8341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08c20b49-aa50-4719-a862-c85157dd8341" xlink:to="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_50a0d1d3-4058-4f25-a271-3244f83ca59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_50a0d1d3-4058-4f25-a271-3244f83ca59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2fb025e4-7206-4961-8b91-2405da5a321f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_50a0d1d3-4058-4f25-a271-3244f83ca59f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2fb025e4-7206-4961-8b91-2405da5a321f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e7445d39-1f68-429b-bdca-176d20db7db8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:to="loc_srt_LitigationCaseAxis_e7445d39-1f68-429b-bdca-176d20db7db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d115eb79-efff-4701-a6ef-f1fc63191b97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e7445d39-1f68-429b-bdca-176d20db7db8" xlink:to="loc_srt_LitigationCaseTypeDomain_d115eb79-efff-4701-a6ef-f1fc63191b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember_548ec014-c455-42ff-84e9-81402282dbb6" xlink:href="vtrs-20220331.xsd#vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_d115eb79-efff-4701-a6ef-f1fc63191b97" xlink:to="loc_vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember_548ec014-c455-42ff-84e9-81402282dbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_00c88334-b6c4-4bab-ad98-1d0d9846b0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_00c88334-b6c4-4bab-ad98-1d0d9846b0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dc587a6a-94d8-4626-9925-4b7c426bf23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_00c88334-b6c4-4bab-ad98-1d0d9846b0f9" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dc587a6a-94d8-4626-9925-4b7c426bf23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_41521fdd-99f4-4bb7-aeb2-623a5ce20081" xlink:href="vtrs-20220331.xsd#vtrs_OtherCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_dc587a6a-94d8-4626-9925-4b7c426bf23d" xlink:to="loc_vtrs_OtherCompaniesMember_41521fdd-99f4-4bb7-aeb2-623a5ce20081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8460bb15-c4c3-466c-b116-1ca4817a2f84" xlink:to="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_348244e5-07e8-4822-b517-55c005d4b985" xlink:href="vtrs-20220331.xsd#vtrs_Numberofstates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_vtrs_Numberofstates_348244e5-07e8-4822-b517-55c005d4b985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_69402232-d926-4a61-87fa-9e6c1790c663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_69402232-d926-4a61-87fa-9e6c1790c663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_adf6493f-b903-4cb6-8247-2eb9a5ce102f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_adf6493f-b903-4cb6-8247-2eb9a5ce102f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_58a07f80-8336-4842-8019-4a86fc657670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a8a2c895-b988-4909-acc6-dac97b4a81f6" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_58a07f80-8336-4842-8019-4a86fc657670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationPioglitazoneNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c083fb84-18d6-4f02-8196-a18c2d2ff360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d1119342-c6ce-43e1-a251-fb343f7e1759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c083fb84-18d6-4f02-8196-a18c2d2ff360" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d1119342-c6ce-43e1-a251-fb343f7e1759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationShareholderClassActionDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationShareholderClassActionDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationShareholderClassActionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d1c5a50e-35dc-4873-903b-6e0d810df386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d1c5a50e-35dc-4873-903b-6e0d810df386" xlink:to="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_26040c91-1dc3-497d-90b4-99cad08a1b19" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:to="loc_srt_LitigationCaseAxis_26040c91-1dc3-497d-90b4-99cad08a1b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_26040c91-1dc3-497d-90b4-99cad08a1b19" xlink:to="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorCivilLitigationMember_1a551727-ce75-4a00-bb70-dfabe98ece02" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorCivilLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:to="loc_vtrs_EpiPenAutoInjectorCivilLitigationMember_1a551727-ce75-4a00-bb70-dfabe98ece02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorLitigationMember_469c9cd3-18f3-4ab3-b121-520dc7edacdb" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenAutoInjectorLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1e8e094a-daee-4dbf-a2a3-27d1252ce90d" xlink:to="loc_vtrs_EpiPenAutoInjectorLitigationMember_469c9cd3-18f3-4ab3-b121-520dc7edacdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3700caf8-d528-4c91-a08b-57c0296816a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3700caf8-d528-4c91-a08b-57c0296816a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0bedc68e-3045-46d8-a5f2-abdcdb4f3ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3700caf8-d528-4c91-a08b-57c0296816a4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0bedc68e-3045-46d8-a5f2-abdcdb4f3ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f7b4b481-7ff4-4775-9605-c31f03457711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0bedc68e-3045-46d8-a5f2-abdcdb4f3ff6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f7b4b481-7ff4-4775-9605-c31f03457711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cb08d295-b2b5-42ed-9f97-35befdbf324e" xlink:to="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_609f3253-0942-4e1a-82fa-da280e46a291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_609f3253-0942-4e1a-82fa-da280e46a291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_87047d9d-f14b-4ca7-83b3-da7309a9ec87" xlink:href="vtrs-20220331.xsd#vtrs_Numberofstates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:to="loc_vtrs_Numberofstates_87047d9d-f14b-4ca7-83b3-da7309a9ec87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_eccae072-0d11-402b-bcce-a34eeac74e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e056f042-5a03-4ed4-b6ab-459a22acdba5" xlink:to="loc_us-gaap_LitigationReserve_eccae072-0d11-402b-bcce-a34eeac74e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationDrugPricingMattersDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_056eed55-666a-4439-aedd-101a197d8f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d15b3b98-f073-445e-9344-ea900f9059ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_056eed55-666a-4439-aedd-101a197d8f1c" xlink:to="loc_us-gaap_LossContingenciesTable_d15b3b98-f073-445e-9344-ea900f9059ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1293e7ea-e534-4d4f-bf37-06fa0f2a642d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d15b3b98-f073-445e-9344-ea900f9059ee" xlink:to="loc_srt_LitigationCaseAxis_1293e7ea-e534-4d4f-bf37-06fa0f2a642d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_1293e7ea-e534-4d4f-bf37-06fa0f2a642d" xlink:to="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember_54975a95-215c-4242-8646-082a3b1747fd" xlink:href="vtrs-20220331.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_MultiDistrictLitigationMember_54975a95-215c-4242-8646-082a3b1747fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_d01624ae-6ae6-4e2f-bc61-2bf8c1f4f6ca" xlink:href="vtrs-20220331.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_d01624ae-6ae6-4e2f-bc61-2bf8c1f4f6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_91a54946-2e7a-4e65-8881-3ee6c93afc20" xlink:href="vtrs-20220331.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_91a54946-2e7a-4e65-8881-3ee6c93afc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_a5b25622-2979-4115-ad16-75748f4b4811" xlink:href="vtrs-20220331.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_eb2a6a97-da89-4824-bab4-0b5dab05e4de" xlink:to="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_a5b25622-2979-4115-ad16-75748f4b4811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_22c2296b-db37-4f08-8916-714880ff268a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d15b3b98-f073-445e-9344-ea900f9059ee" xlink:to="loc_us-gaap_LossContingenciesLineItems_22c2296b-db37-4f08-8916-714880ff268a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_932fd972-8954-4f04-84f1-47b85c929d24" xlink:href="vtrs-20220331.xsd#vtrs_Numberofstates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_22c2296b-db37-4f08-8916-714880ff268a" xlink:to="loc_vtrs_Numberofstates_932fd972-8954-4f04-84f1-47b85c929d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationEuropeanCommissionProceedingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_03b95972-162e-44ba-b08b-207558649117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_03b95972-162e-44ba-b08b-207558649117" xlink:to="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0ed45935-05af-4228-8e6a-ce102dff35f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:to="loc_srt_LitigationCaseAxis_0ed45935-05af-4228-8e6a-ce102dff35f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_0ed45935-05af-4228-8e6a-ce102dff35f4" xlink:to="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsPerindorprilMember_a616f736-ea1a-4bfe-bfc2-d477628fa16e" xlink:href="vtrs-20220331.xsd#vtrs_EUCommissionProceedingsPerindorprilMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:to="loc_vtrs_EUCommissionProceedingsPerindorprilMember_a616f736-ea1a-4bfe-bfc2-d477628fa16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsCitalopramMember_5cb1d3b7-b149-4f74-ae7d-4d43d60d747c" xlink:href="vtrs-20220331.xsd#vtrs_EUCommissionProceedingsCitalopramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ae786422-47fc-4f48-b013-b1035f47ab26" xlink:to="loc_vtrs_EUCommissionProceedingsCitalopramMember_5cb1d3b7-b149-4f74-ae7d-4d43d60d747c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_023f0a49-a5f6-4714-9ea8-4a4c619c9906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_023f0a49-a5f6-4714-9ea8-4a4c619c9906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_a1418f29-77ba-4eef-928d-aa2448fb5a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_023f0a49-a5f6-4714-9ea8-4a4c619c9906" xlink:to="loc_us-gaap_LossContingencyNatureDomain_a1418f29-77ba-4eef-928d-aa2448fb5a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AntitrustProceedingsMember_7914bb46-8e4b-4abd-a6f1-97bc48590f91" xlink:href="vtrs-20220331.xsd#vtrs_AntitrustProceedingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_a1418f29-77ba-4eef-928d-aa2448fb5a04" xlink:to="loc_vtrs_AntitrustProceedingsMember_7914bb46-8e4b-4abd-a6f1-97bc48590f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0b969290-9528-4e01-b32c-efe102775eb6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0b969290-9528-4e01-b32c-efe102775eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0b969290-9528-4e01-b32c-efe102775eb6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_db21dafc-0ba9-4995-92a7-386f7b762ae7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:to="loc_srt_SubsidiariesMember_db21dafc-0ba9-4995-92a7-386f7b762ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_9edb055b-032a-4b6b-bc17-32d9e20ce102" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8f55520f-858e-42e0-9123-d584de107900" xlink:to="loc_srt_ParentCompanyMember_9edb055b-032a-4b6b-bc17-32d9e20ce102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_46dd5f9a-4168-4a55-924b-aabd7a9eb1df" xlink:to="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_434d1199-9f6b-48c2-b582-1ede8080e25c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_434d1199-9f6b-48c2-b582-1ede8080e25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_d83c1c79-9dc7-43e6-8059-cf6ee06027d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_d83c1c79-9dc7-43e6-8059-cf6ee06027d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_328d67d9-6598-457f-ba62-a6c09322a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_328d67d9-6598-457f-ba62-a6c09322a5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_338751d3-96f7-40c7-9bcf-38ba4d45204f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8ffe6b6b-24e8-4df8-9e4c-a29c4c555379" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_338751d3-96f7-40c7-9bcf-38ba4d45204f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c3d297f-9cad-4335-91cc-34610d2c5f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c3d297f-9cad-4335-91cc-34610d2c5f67" xlink:to="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_80ae2177-b253-4afd-a092-ec73215ad3c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:to="loc_srt_LitigationCaseAxis_80ae2177-b253-4afd-a092-ec73215ad3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5af91b33-6d1d-4185-9725-e3f8b1312ab9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_80ae2177-b253-4afd-a092-ec73215ad3c4" xlink:to="loc_srt_LitigationCaseTypeDomain_5af91b33-6d1d-4185-9725-e3f8b1312ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_89336ef5-e047-437d-88a7-b8ade7048864" xlink:href="vtrs-20220331.xsd#vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_5af91b33-6d1d-4185-9725-e3f8b1312ab9" xlink:to="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_89336ef5-e047-437d-88a7-b8ade7048864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_73521016-47a2-4238-a8fb-32c4304d56fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_73521016-47a2-4238-a8fb-32c4304d56fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_960ec0fd-cb51-4d3b-aaa9-d919ca404afe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_73521016-47a2-4238-a8fb-32c4304d56fa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_960ec0fd-cb51-4d3b-aaa9-d919ca404afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_0411ea3b-b8f1-4b38-a639-c0595555b92f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_960ec0fd-cb51-4d3b-aaa9-d919ca404afe" xlink:to="loc_srt_ParentCompanyMember_0411ea3b-b8f1-4b38-a639-c0595555b92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f5abb7ca-536f-4c3d-9931-67c4b11b2953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7b36bc70-e56d-497f-8eea-e178017a1ea3" xlink:to="loc_us-gaap_LossContingenciesLineItems_f5abb7ca-536f-4c3d-9931-67c4b11b2953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_51765cdb-860b-453c-a790-bc1361911509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f5abb7ca-536f-4c3d-9931-67c4b11b2953" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_51765cdb-860b-453c-a790-bc1361911509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationProductLiabilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_99e66489-ce7e-4939-912a-f1c6645402c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_61ae4e1e-5fdd-4f96-a834-13173230bf60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_99e66489-ce7e-4939-912a-f1c6645402c2" xlink:to="loc_us-gaap_LossContingenciesTable_61ae4e1e-5fdd-4f96-a834-13173230bf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_644cc8be-b235-420e-a33f-150211b5bd00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_61ae4e1e-5fdd-4f96-a834-13173230bf60" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_644cc8be-b235-420e-a33f-150211b5bd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e4c39b3e-f11c-474e-8c84-e26a4ad244d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_644cc8be-b235-420e-a33f-150211b5bd00" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e4c39b3e-f11c-474e-8c84-e26a4ad244d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_eaa1885f-3abe-48da-bc54-0a4d96fd91d4" xlink:href="vtrs-20220331.xsd#vtrs_ProductLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e4c39b3e-f11c-474e-8c84-e26a4ad244d2" xlink:to="loc_vtrs_ProductLiabilityMember_eaa1885f-3abe-48da-bc54-0a4d96fd91d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0a9009f1-46de-4de1-bc5c-fa591ec3d7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_61ae4e1e-5fdd-4f96-a834-13173230bf60" xlink:to="loc_us-gaap_LossContingenciesLineItems_0a9009f1-46de-4de1-bc5c-fa591ec3d7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0386405c-36d0-491b-92a2-2348817484eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a9009f1-46de-4de1-bc5c-fa591ec3d7cc" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0386405c-36d0-491b-92a2-2348817484eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationIntellectualPropertyNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ba26e7d-d3b4-4118-b2e1-da496044a0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0b2f1ce3-0411-4196-9228-934b11d94e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ba26e7d-d3b4-4118-b2e1-da496044a0f5" xlink:to="loc_us-gaap_LossContingenciesTable_0b2f1ce3-0411-4196-9228-934b11d94e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_57264fcc-d031-4b63-b682-2c17c853df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0b2f1ce3-0411-4196-9228-934b11d94e64" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_57264fcc-d031-4b63-b682-2c17c853df1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_3007ea14-ce9b-4b69-8448-373b52406f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_57264fcc-d031-4b63-b682-2c17c853df1c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_3007ea14-ce9b-4b69-8448-373b52406f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3c107fde-e1ec-4176-8463-7fbd9a65b122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_3007ea14-ce9b-4b69-8448-373b52406f50" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3c107fde-e1ec-4176-8463-7fbd9a65b122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0b2f1ce3-0411-4196-9228-934b11d94e64" xlink:to="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_461be15b-7293-4f8e-88a5-104edda8e434" xlink:href="vtrs-20220331.xsd#vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:to="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_461be15b-7293-4f8e-88a5-104edda8e434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_7ad58ec9-2b03-492d-93e0-66cb48856bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3e40c2b-b8a2-4c08-91ec-d6a1dc32699d" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_7ad58ec9-2b03-492d-93e0-66cb48856bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20220331.xsd#LitigationOtherLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93a7be25-736c-4062-be6a-aee6bf04780c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93a7be25-736c-4062-be6a-aee6bf04780c" xlink:to="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:to="loc_srt_LitigationCaseAxis_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_dc97c1a9-b5ee-4810-a40b-431170a47a0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2bb7945e-b2f2-4ba8-977f-bccb5d4b6b9d" xlink:to="loc_srt_LitigationCaseTypeDomain_dc97c1a9-b5ee-4810-a40b-431170a47a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenIsraeliSecuritiesLitigationMember_2b4226c6-ed76-4448-9c94-9699e011744f" xlink:href="vtrs-20220331.xsd#vtrs_EpiPenIsraeliSecuritiesLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dc97c1a9-b5ee-4810-a40b-431170a47a0f" xlink:to="loc_vtrs_EpiPenIsraeliSecuritiesLitigationMember_2b4226c6-ed76-4448-9c94-9699e011744f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_2305ac79-4327-44c7-8002-e193dd09bce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_2305ac79-4327-44c7-8002-e193dd09bce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_60845b0a-95a2-4edb-9e6b-0a74e6759869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_2305ac79-4327-44c7-8002-e193dd09bce3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_60845b0a-95a2-4edb-9e6b-0a74e6759869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_c1e8eef8-5962-4025-aa10-b03ee9c85d9b" xlink:href="vtrs-20220331.xsd#vtrs_OtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_60845b0a-95a2-4edb-9e6b-0a74e6759869" xlink:to="loc_vtrs_OtherMember_c1e8eef8-5962-4025-aa10-b03ee9c85d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3a347e5-8502-4963-b8d9-e96d47bdbad0" xlink:to="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_82e7fc98-391e-46b4-975f-c561d215b265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_82e7fc98-391e-46b4-975f-c561d215b265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases_53674ff8-8cb9-48ed-aa54-b6adab92b96d" xlink:href="vtrs-20220331.xsd#vtrs_Numberofcases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:to="loc_vtrs_Numberofcases_53674ff8-8cb9-48ed-aa54-b6adab92b96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_31794540-6092-4f82-93bd-afca65b52209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_92bb7b64-5349-4a82-a4b1-93564def3129" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_31794540-6092-4f82-93bd-afca65b52209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472341480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - &#8364; / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1000 Mylan Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-4364296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIATRIS INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filler Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Ordinary Shares, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,212,326,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VTRS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Canonsburg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">15317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">514-1800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001792044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472653704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,178.2<span></span>
</td>
<td class="nump">$ 4,400.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">4,191.7<span></span>
</td>
<td class="nump">4,430.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,420.5<span></span>
</td>
<td class="nump">3,303.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,771.2<span></span>
</td>
<td class="nump">1,127.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">142.3<span></span>
</td>
<td class="nump">184.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">915.3<span></span>
</td>
<td class="nump">1,186.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements and other contingencies, net</a></td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,063.8<span></span>
</td>
<td class="nump">1,393.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">707.4<span></span>
</td>
<td class="num">(266.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">146.2<span></span>
</td>
<td class="nump">169.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">33.7<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">527.5<span></span>
</td>
<td class="num">(441.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">128.3<span></span>
</td>
<td class="nump">596.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss)</a></td>
<td class="nump">$ 399.2<span></span>
</td>
<td class="num">$ (1,037.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share attributable to Viatris Inc. shareholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="num">$ (0.86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="num">$ (0.86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">1,210.5<span></span>
</td>
<td class="nump">1,207.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">1,213.1<span></span>
</td>
<td class="nump">1,207.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Revenue Not from Contract with Customer</a></td>
<td class="nump">$ 13.5<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472210888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss) attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">$ 399.2<span></span>
</td>
<td class="num">$ (1,037.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(469.2)<span></span>
</td>
<td class="num">(721.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Change in unrecognized (loss) gain and prior service cost related to defined benefit plans</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent', window );">Net unrealized loss on marketable securities</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive loss, before tax</a></td>
<td class="num">(272.0)<span></span>
</td>
<td class="num">(490.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax provision</a></td>
<td class="nump">44.7<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(316.7)<span></span>
</td>
<td class="num">(527.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings (loss)</a></td>
<td class="nump">82.5<span></span>
</td>
<td class="num">(1,565.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">$ 201.3<span></span>
</td>
<td class="nump">$ 227.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472700344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 752,400,000<span></span>
</td>
<td class="nump">$ 701,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">4,093,900,000<span></span>
</td>
<td class="nump">4,266,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,797,300,000<span></span>
</td>
<td class="nump">3,977,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,763,600,000<span></span>
</td>
<td class="nump">1,957,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="nump">1,337,100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">11,744,300,000<span></span>
</td>
<td class="nump">10,902,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">3,150,200,000<span></span>
</td>
<td class="nump">3,188,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">25,251,800,000<span></span>
</td>
<td class="nump">26,134,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,978,800,000<span></span>
</td>
<td class="nump">12,113,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax benefit</a></td>
<td class="nump">1,285,800,000<span></span>
</td>
<td class="nump">1,332,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,056,000,000<span></span>
</td>
<td class="nump">1,170,700,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">53,466,900,000<span></span>
</td>
<td class="nump">54,842,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">1,499,600,000<span></span>
</td>
<td class="nump">1,657,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">655,400,000<span></span>
</td>
<td class="nump">1,493,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">177,800,000<span></span>
</td>
<td class="nump">236,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt and other long-term obligations</a></td>
<td class="nump">2,606,100,000<span></span>
</td>
<td class="nump">1,877,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="nump">277,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,426,300,000<span></span>
</td>
<td class="nump">4,619,600,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">9,642,900,000<span></span>
</td>
<td class="nump">9,884,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">18,762,500,000<span></span>
</td>
<td class="nump">19,717,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liability</a></td>
<td class="nump">2,729,500,000<span></span>
</td>
<td class="nump">2,815,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term obligations</a></td>
<td class="nump">1,884,300,000<span></span>
</td>
<td class="nump">1,933,600,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">33,019,200,000<span></span>
</td>
<td class="nump">34,350,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Viatris Inc. shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">12,100,000<span></span>
</td>
<td class="nump">12,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">18,555,100,000<span></span>
</td>
<td class="nump">18,536,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">3,941,500,000<span></span>
</td>
<td class="nump">3,688,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,061,000,000)<span></span>
</td>
<td class="num">(1,744,300,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">20,447,700,000<span></span>
</td>
<td class="nump">20,492,700,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 53,466,900,000<span></span>
</td>
<td class="nump">$ 54,842,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475677320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">3,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469715848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 22,954.1<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 18,438.8<span></span>
</td>
<td class="nump">$ 5,361.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (858.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,206,895,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss)</a></td>
<td class="num">(1,037.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(527.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(527.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment', window );">Issuance of restricted stock, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,635,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Issuance of restricted stock, net of shares withheld</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet', window );">Taxes related to the net share settlement of equity awards</a></td>
<td class="num">(6.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
<td class="nump">32.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">21,414.7<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">18,464.6<span></span>
</td>
<td class="nump">4,323.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">(1,385.6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,208,530,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">20,492.7<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">18,536.1<span></span>
</td>
<td class="nump">3,688.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">(1,744.3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,209,507,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss)</a></td>
<td class="nump">399.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(316.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(316.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment', window );">Issuance of restricted stock, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,816,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Issuance of restricted stock, net of shares withheld</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet', window );">Taxes related to the net share settlement of equity awards</a></td>
<td class="num">(9.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
<td class="nump">28.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 20,447.7<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 18,555.1<span></span>
</td>
<td class="nump">3,941.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (2,061.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,212,323,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends, Common Stock, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (146.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469529352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss) attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">$ 399.2<span></span>
</td>
<td class="num">$ (1,037.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">736.0<span></span>
</td>
<td class="nump">1,422.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">28.3<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) expense</a></td>
<td class="num">(52.8)<span></span>
</td>
<td class="nump">288.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investments</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">37.8<span></span>
</td>
<td class="nump">33.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Changeinnoncashlitigationsettlementsnet', window );">Litigation settlements and other contingencies, net</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(115.5)<span></span>
</td>
<td class="num">(59.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(69.1)<span></span>
</td>
<td class="num">(203.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="num">(30.2)<span></span>
</td>
<td class="nump">191.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="nump">67.0<span></span>
</td>
<td class="nump">494.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other operating assets and liabilities, net</a></td>
<td class="nump">132.7<span></span>
</td>
<td class="num">(354.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,138.5<span></span>
</td>
<td class="nump">848.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">277.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(64.5)<span></span>
</td>
<td class="num">(49.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(8.6)<span></span>
</td>
<td class="num">(12.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from the sale of marketable securities</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Payments for product rights and other, net</a></td>
<td class="num">(7.4)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from the sale of assets</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(66.9)<span></span>
</td>
<td class="nump">236.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of long-term debt</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Change in short-term borrowings, net</a></td>
<td class="num">(837.9)<span></span>
</td>
<td class="num">(1,063.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(9.9)<span></span>
</td>
<td class="num">(7.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities', window );">Contingent consideration payments</a></td>
<td class="num">(15.5)<span></span>
</td>
<td class="num">(26.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments of financing fees</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other items, net</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,009.0)<span></span>
</td>
<td class="num">(1,099.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect on cash of changes in exchange rates</a></td>
<td class="num">(11.4)<span></span>
</td>
<td class="num">(22.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">51.2<span></span>
</td>
<td class="num">(36.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash &#8212; beginning of period</a></td>
<td class="nump">706.2<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash &#8212; end of period</a></td>
<td class="nump">757.4<span></span>
</td>
<td class="nump">813.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">$ (145.1)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for financing costs associated with business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Changeinnoncashlitigationsettlementsnet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncash litigation settlements, net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Changeinnoncashlitigationsettlementsnet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475773208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Agreements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration and Licensing Agreements</a></td>
<td class="text">Licensing and Other Partner Agreements<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically enter into licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple, high-value generic biologic compounds, insulin analog products and respiratory products, among other complex products. Under these agreements, we have future potential milestone payments and co-development expenses payable to third parties as part of our licensing, development and co-development programs. Payments under these agreements generally become due and are payable upon the satisfaction or achievement of certain developmental, regulatory or commercial milestones or as development expenses are incurred on defined projects. Milestone payment obligations are uncertain, including the prediction of timing and the occurrence of events triggering a future obligation and are not reflected as liabilities in the condensed consolidated balance sheets, except for obligations reflected as acquisition related contingent consideration. Refer to Note 10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of contingent consideration. </span><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential maximum development milestones not accrued for at&#160;March&#160;31, 2022&#160;totaled approximately&#160;$338 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the amounts that may be paid through the end of 2022 to be approximately $10 million. These agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. The amounts disclosed do not include sales-based milestones or royalty or profit share obligations on future sales of product as the timing and amount of future sales levels and costs to produce products subject to these obligations is not reasonably estimable. These sales-based milestones or royalty or profit share obligations may be significant depending upon the level of commercial sales for each product.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our licensing and other partner agreements as disclosed in our 2021 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475642184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">General</a></td>
<td class="text">General<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements (&#8220;interim financial statements&#8221;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto in Viatris&#8217; 2021 Form&#160;10-K. The December&#160;31, 2021 condensed consolidated balance sheet was derived from audited financial statements. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Turkey Highly Inflationary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Under ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 830&#8221;), a highly inflationary economy is one that has cumulative inflation of approximately 100% or more over a three-year period. Effective April 1, 2022, we classified Turkey as highly inflationary. In accordance with ASC 830, starting with the second quarter of 2022, we will begin to use the U.S. dollar as our functional currency in Turkey, which historically utilized the Turkish lira as the functional currency. The impacted net sales for the three months ended March 31, 2022 and total assets at March 31, 2022 represented less than 1% of our consolidated net sales and total assets, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim results of operations, comprehensive earnings and cash flows for the three months ended March&#160;31, 2022 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475637736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition and Accounts Receivable</a></td>
<td class="text">Revenue Recognition and Accounts Receivable<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the condensed consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash).</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#8217;s subsequent sales or usages occur. Such consideration is included in other revenues in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2022 and 2021: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2022 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration and Accounts Receivable</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,198.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,567.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,205.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,568.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,020.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,166.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No significant revisions were made to the methodology used in determining these provisions or the nature of the provisions during the three months ended March&#160;31, 2022. Such allowances were comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,802.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net was comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,556.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,774.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,266.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Factoring Arrangements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $55.1 million and $29.6 million of accounts receivable as of March&#160;31, 2022 and December&#160;31, 2021, respectively, under these factoring arrangements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475696664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">Recent Accounting Pronouncements<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standard</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued Accounting Standards Update 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. We adopted the ASU prospectively on January 1, 2022. The additional annual disclosures required are not expected to have a material impact on our consolidated financial statements.</span></div>There were no other significant changes in new accounting standards from those disclosed in Viatris&#8217; 2021 Form 10-K. Refer to Viatris&#8217; 2021 Form 10-K for additional information.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475749416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Incentive Plan</a></td>
<td class="text">Share-Based Incentive Plan<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#8217; sole stockholder at such time, approved the Plan which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP, which had previously been approved by Mylan shareholders. The Plan and 2003 LTIP include (i) 72,500,000 shares of common stock authorized for grant pursuant to the Plan, which may include dividend payments payable in common stock on unvested shares granted under awards, (ii) 6,757,640 shares of common stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) 13,535,627 shares of common stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTU_c0f2427b-1baa-41a5-bae1-4668a072522c">three</span> to four years, and generally expire in ten years.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,576,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,126,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,077,897&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,831,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of 4.7 years, 4.6 years and 4.5 years, respectively. Also, at March&#160;31, 2022, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had no aggregate intrinsic value.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs) as of March&#160;31, 2022 and the changes during the three months ended March&#160;31, 2022 are presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock&#160;Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair&#160;Value&#160;Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,858,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,635,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,517,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,060&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had $272.7 million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of 2.0 years. The total intrinsic value of restricted stock units released during the three months ended March&#160;31, 2022 and 2021 was $63.1 million and $30.8 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475670312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension and Other Postretirement Benefits Disclosure</a></td>
<td class="text">Pensions and Other Postretirement Benefits<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the three months ended March&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is making the minimum mandatory contributions to its defined benefit pension plans in the U.S. and Puerto Rico for the 2022 plan year. The Company expects to make total benefit payments of approximately $118.0 million from pension and other postretirement benefit plans in 2022. The Company anticipates making contributions to pension and other postretirement benefit plans of approximately $52.0 million in 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475612584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected balance sheet components consist of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,797.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,977.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,845.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,092.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,589.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,942.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,150.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,188.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,426.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475627960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Equity Method Investments</a></td>
<td class="text">Equity Method Investments<div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The law that provides for IRC Section 45 tax credits expired during the year ended December 31, 2021 for all three clean energy investments and all of the clean energy investments have wound down operations. Summarized financial information, in the aggregate, for the Company&#8217;s three equity method, clean energy investments on a 100% basis for the three months ended March&#160;31, 2021 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.350%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating and non-operating expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The Company&#8217;s net losses from its equity method investments included amortization expense related to the excess of the cost basis of the Company&#8217;s investment over the underlying assets of each individual investee. For the three months ended March&#160;31, 2021, the Company recognized net losses from equity method investments of $17.9 million, which were recognized as a component of other expense, net in the condensed consolidated statements of operations. The Company recognized the income tax credits and benefits from the clean energy investments as part of its provision for income taxes.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067476135768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) per Ordinary Share</a></td>
<td class="text">Earnings (Loss)&#160;per Share<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,037.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,037.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional stock awards and restricted stock awards were outstanding during the three months ended March&#160;31, 2022 and 2021, but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares at March&#160;31, 2022 include certain share-based compensation awards whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 15.5 million shares and 10.9 million shares for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid a quarterly dividend of $0.12 per share on the Company&#8217;s issued and outstanding common stock on March 16, 2022. On May 5, 2022, the Company&#8217;s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company&#8217;s issued and outstanding common stock, which will be payable on June 16, 2022 to shareholders of record as of the close of business on May 24, 2022. The declaration and payment of future dividends to holders of the Company&#8217;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#8217;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2022, the Company announced that its Board of Directors had authorized a DRIP. The DRIP will allow shareholders to automatically reinvest all or a portion of the cash dividends paid on their shares of the Company&#8217;s common stock and to make certain additional optional cash investments in the Company&#8217;s common stock.</span></div>On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0&#160;billion of the Company&#8217;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475715896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Earnings</a></td>
<td class="text">Comprehensive Loss<div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected on the condensed consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,271.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,061.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.121%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,271.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,061.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(490.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,182.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,385.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475685656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of intangible assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in the 2021 Form 10-K, and Note 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(993.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(509.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475839464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">Restructuring<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and ongoing cost reduction initiatives are recorded in the period the Company commits to a restructuring or cost reduction plan, or executes specific actions contemplated by the plan and all criteria for liability recognition have been met. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2021 to March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the three months ended March 31, 2022, total restructuring charges in Developed Markets, Emerging Markets, Greater China, JANZ, Emerging Markets and Corporate/Other were approximately $12.7 million, $2.6 million, $1.3 million, $0.1 million, and $0.1 million, respectively.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475687224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Examinations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#8217;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#8217;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to ongoing IRS examinations. The years 2015 through 2019 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments or issued assessments to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law.  As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2020, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments for the years ended December 2009 to December 2019 and we have commenced litigation in the Australian Federal Court challenging that decision. A decision on our objection to the assessment for the year ended December 2020 is pending. The Company made a partial payment of $56.0&#160;million in 2021 and $5.2&#160;million in 2022 in order to stay potential interest and penalties resulting from this litigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2015 concerning our tax position with respect to whether income earned by a Company entity not domiciled in France should be subject to French tax.  We have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. Some of these assessments remain in the audit phase where we are challenging them before the tax authorities while we are challenging some of the other assessments in the Indian tax courts.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a net reserve for uncertain tax positions of $317.0&#160;million and $315.6&#160;million, including interest and penalties, in connection with its international audits at March 31, 2022 and December 31, 2021, respectively. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2020, with several state audits currently in progress. The Company&#8217;s major international taxing jurisdictions remain open from 2012 through 2020.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Court Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#8217;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS has appealed this decision.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Uncertainty in Income Taxes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a&#160;50%&#160;likelihood of being sustained.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475756568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting Policy</a></td>
<td class="text">The accompanying unaudited condensed consolidated financial statements (&#8220;interim financial statements&#8221;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Share Policy</a></td>
<td class="text">Basic earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments Policy</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475641608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of intangible assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in the 2021 Form 10-K, and Note 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Form 10-Q.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067479524408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2022 and 2021: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2022 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration and Accounts Receivable</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,198.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,567.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,205.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,568.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,020.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,166.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable, Net</a></td>
<td class="text">Such allowances were comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:<div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,802.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net was comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,556.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,774.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,266.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067478202264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Awards Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,576,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,126,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,077,897&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,831,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Nonvested Restricted Stock and Restricted Stock Unit Awards Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs) as of March&#160;31, 2022 and the changes during the three months ended March&#160;31, 2022 are presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock&#160;Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair&#160;Value&#160;Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,858,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,635,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,517,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,060&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475809224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the three months ended March&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469563816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock', window );">Schedule of Cash, cash equivalents, and restricted cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,797.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,977.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,845.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,092.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,589.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,942.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,150.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,188.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Other Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Accounts payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,426.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text">The amounts associated with the biosimilars portfolio classified as held for sale consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475791224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text">Summarized financial information, in the aggregate, for the Company&#8217;s three equity method, clean energy investments on a 100% basis for the three months ended March&#160;31, 2021 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.350%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating and non-operating expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475684536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V.</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,037.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,037.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472193992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2022 are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,108.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,498.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,113.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(762.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(953.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,789.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,978.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,174.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,363.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,789.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,978.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components of Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following components at March&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,550.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,206.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,596.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,251.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,006.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,918.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,087.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,052.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,918.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,134.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div>(1)Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Finite-lived Intangible Assets Amortization Expense</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible asset amortization expense (including impairment charges)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Expected Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense over the remainder of 2022 and for the years ending December&#160;31, 2023 through 2026 is estimated to be as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:88.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469518376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2021 to March&#160;31, 2022 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Financial Assets and Liabilities Carried at Fair Value</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td></tr><tr style="height:15pt"><td colspan="24" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472643416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Long-Term Debt</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A summary of long-term debt is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate as of March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,241.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,241.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2046 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> **</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,762.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,717.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The fair value adjustment is being amortized to interest expense over the remaining term of the notes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Mylan Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Viatris Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Upjohn Finance B.V.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Minimum Repayments on Outstanding Borrowings</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2022 were as follows for each of the periods ending December 31:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $655.4 million and $1.49 billion of short-term borrowings as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475746504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected on the condensed consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,271.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,061.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Components of Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.121%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,271.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,061.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(490.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,182.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,385.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067476142200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Reconciliation of Segment Information to Total Consolidated Information</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(993.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(509.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475706328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring - employee related</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2021 to March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the three months ended March 31, 2022, total restructuring charges in Developed Markets, Emerging Markets, Greater China, JANZ, Emerging Markets and Corporate/Other were approximately $12.7 million, $2.6 million, $1.3 million, $0.1 million, and $0.1 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067479255352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details) - TURKEY - Unusual or Infrequent Item, or Both<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualRiskOrUncertaintyLineItems', window );"><strong>Unusual Risk or Uncertainty [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy', window );">Percent Of Net Sales Impacted, High Inflationary Economy</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy', window );">Percent Of Total Assets Impacted, High Inflationary Economy</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRiskOrUncertaintyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRiskOrUncertaintyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent Of Consolidated Net Sales Impacted, High Inflationary Economy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent Of Total Assets Impacted, High Inflationary Economy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_TR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_TR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=us-gaap_UnusualOrInfrequentItemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=us-gaap_UnusualOrInfrequentItemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067670496424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables', window );">Proceeds from sale and collection of receivables</a></td>
<td class="nump">$ 55.1<span></span>
</td>
<td class="nump">$ 29.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale and collection of receivables during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067468785736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,178.2<span></span>
</td>
<td class="nump">$ 4,400.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_BrandsMember', window );">Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,554.1<span></span>
</td>
<td class="nump">2,724.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember', window );">Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">390.8<span></span>
</td>
<td class="nump">328.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_GenericsMember', window );">Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,233.3<span></span>
</td>
<td class="nump">1,346.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_LipitorMember', window );">Lipitor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">440.1<span></span>
</td>
<td class="nump">464.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_NorvascMember', window );">Norvasc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">207.8<span></span>
</td>
<td class="nump">227.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_LyricaMember', window );">Lyrica &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">171.7<span></span>
</td>
<td class="nump">187.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ViagraMember', window );">Viagra &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">129.8<span></span>
</td>
<td class="nump">139.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember', window );">EpiPen&#174; Auto-Injectors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">88.8<span></span>
</td>
<td class="nump">103.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_CelebrexMember', window );">Celebrex &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">85.2<span></span>
</td>
<td class="nump">89.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_EffexorMember', window );">Effexor &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">77.5<span></span>
</td>
<td class="nump">76.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ZoloftMember', window );">Zoloft &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">73.1<span></span>
</td>
<td class="nump">76.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_CreonMember', window );">Creon &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">69.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_XalabrandsMember', window );">Xalabrands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53.0<span></span>
</td>
<td class="nump">57.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_AmitizaMember', window );">Amitiza &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">41.8<span></span>
</td>
<td class="nump">45.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_XanaxMember', window );">Xanax &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">40.0<span></span>
</td>
<td class="nump">45.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_DymistaMember', window );">Dymista &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_YupelriMember', window );">Yupelri &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">36.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,298.7<span></span>
</td>
<td class="nump">1,403.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">364.1<span></span>
</td>
<td class="nump">312.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">813.3<span></span>
</td>
<td class="nump">855.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">569.7<span></span>
</td>
<td class="nump">590.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">249.0<span></span>
</td>
<td class="nump">284.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">164.5<span></span>
</td>
<td class="nump">189.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">436.7<span></span>
</td>
<td class="nump">446.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">252.1<span></span>
</td>
<td class="nump">300.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,476.1<span></span>
</td>
<td class="nump">2,571.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">573.1<span></span>
</td>
<td class="nump">591.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">423.8<span></span>
</td>
<td class="nump">481.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 705.2<span></span>
</td>
<td class="nump">$ 754.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_BrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_BrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_GenericsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_GenericsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_LipitorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_LipitorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_NorvascMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_NorvascMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_LyricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_LyricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ViagraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ViagraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_CelebrexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_CelebrexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_EffexorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_EffexorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ZoloftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ZoloftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_CreonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_CreonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_XalabrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_XalabrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_AmitizaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_AmitizaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_XanaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_XanaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_DymistaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_DymistaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_YupelriMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_YupelriMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475865528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Variable Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RevenuefromContractwithCustomerGross', window );">Gross sales</a></td>
<td class="nump">$ 7,198.3<span></span>
</td>
<td class="nump">$ 7,567.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Chargebacks', window );">Chargebacks</a></td>
<td class="num">(1,584.2)<span></span>
</td>
<td class="num">(1,318.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccruedSalesAllowances', window );">Rebates, promotional programs and other sales allowances</a></td>
<td class="num">(1,205.9)<span></span>
</td>
<td class="num">(1,568.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RevenuefromContractwithCustomerReturns', window );">Returns</a></td>
<td class="num">(82.6)<span></span>
</td>
<td class="num">(113.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Medicaidandothergovernmentalrebates', window );">Medicaid and other governmental rebates</a></td>
<td class="num">(147.4)<span></span>
</td>
<td class="num">(167.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_SalesRevenueGrosstonetadjustments', window );">Sales Revenue, Gross to net adjustments</a></td>
<td class="num">(3,020.1)<span></span>
</td>
<td class="num">(3,166.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,178.2<span></span>
</td>
<td class="nump">$ 4,400.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccruedSalesAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Sales Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccruedSalesAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Chargebacks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Chargebacks</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Chargebacks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Medicaidandothergovernmentalrebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medicaid and other governmental rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Medicaidandothergovernmentalrebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RevenuefromContractwithCustomerGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RevenuefromContractwithCustomerGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RevenuefromContractwithCustomerReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RevenuefromContractwithCustomerReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_SalesRevenueGrosstonetadjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales Revenue, Gross to net adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_SalesRevenueGrosstonetadjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469662456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Revenue Recognition And Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">$ 3,556.9<span></span>
</td>
<td class="nump">$ 3,774.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">537.0<span></span>
</td>
<td class="nump">492.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">4,093.9<span></span>
</td>
<td class="nump">4,266.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Revenue Recognition And Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">1,707.1<span></span>
</td>
<td class="nump">1,688.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">1,095.8<span></span>
</td>
<td class="nump">1,362.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 2,802.9<span></span>
</td>
<td class="nump">$ 3,050.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469591000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">$ 2,420.5<span></span>
</td>
<td class="nump">$ 3,303.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">128.3<span></span>
</td>
<td class="nump">596.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss) attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">399.2<span></span>
</td>
<td class="num">(1,037.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,191.7<span></span>
</td>
<td class="nump">$ 4,430.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,763.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,957.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">177.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">3,941.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,688.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (2,061.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,744.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472602264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 10,978.8<span></span>
</td>
<td class="nump">$ 12,113.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475747832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Purchase Price Allocations) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 10,978.8<span></span>
</td>
<td class="nump">$ 12,113.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472013144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 16, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option award expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,126,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,576,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="nump">6,757,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation expense, net of estimated forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue', window );">Intrinsic value of stock-based awards exercised and restricted stock units converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.1<span></span>
</td>
<td class="nump">$ 30.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">13,535,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003 | Stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual term for stock awards outstanding, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term for stock awards vested and expected to vest, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term for stock awards exercisable, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003 | Stock awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003 | Stock awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember', window );">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares reserved for issuance</a></td>
<td class="nump">72,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469539928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Stock Awards) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 38.04<span></span>
</td>
<td class="nump">$ 37.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</a></td>
<td class="num">(450,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 27.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</a></td>
<td class="nump">5,077,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 38.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">4,831,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 39.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">5,126,329<span></span>
</td>
<td class="nump">5,576,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472971944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details) - Restricted stock awards<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock awards, nonvested beginning of period | shares</a></td>
<td class="nump">16,858,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, nonvested beginning of period | $ / shares</a></td>
<td class="nump">$ 15.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock awards, granted | shares</a></td>
<td class="nump">16,635,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, granted | $ / shares</a></td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of restricted stock awards, released | shares</a></td>
<td class="num">(3,517,219)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, released | $ / shares</a></td>
<td class="nump">$ 17.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of restricted stock awards, forfeited | shares</a></td>
<td class="num">(229,241)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, forfeited | $ / shares</a></td>
<td class="nump">$ 13.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock awards, nonvested end of period | shares</a></td>
<td class="nump">29,747,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, nonvested end of period | $ / shares</a></td>
<td class="nump">$ 12.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475973432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Postretirement Benefit (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear', window );">Defined benefit plans, estimated benefit payments, in current fiscal year</a></td>
<td class="nump">$ 118.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Estimated employer contributions in current year</a></td>
<td class="nump">$ 52.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plans, estimated benefit payments, in current fiscal year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475890328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(16.6)<span></span>
</td>
<td class="num">(16.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Recognized net actuarial losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items | Reclassification out of Accumulated Other Comprehensive Income [Member] | Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067478366264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 752.4<span></span>
</td>
<td class="nump">$ 701.2<span></span>
</td>
<td class="nump">$ 806.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 757.4<span></span>
</td>
<td class="nump">$ 706.2<span></span>
</td>
<td class="nump">$ 813.1<span></span>
</td>
<td class="nump">$ 850.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472580824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Inventories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 868.1<span></span>
</td>
<td class="nump">$ 922.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">767.5<span></span>
</td>
<td class="nump">993.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">2,161.7<span></span>
</td>
<td class="nump">2,062.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 3,797.3<span></span>
</td>
<td class="nump">$ 3,977.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469604856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 268.1<span></span>
</td>
<td class="nump">$ 256.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">202.8<span></span>
</td>
<td class="nump">144.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">48.0<span></span>
</td>
<td class="nump">51.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,208.1<span></span>
</td>
<td class="nump">1,467.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,763.6<span></span>
</td>
<td class="nump">1,957.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember', window );">Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">$ 36.6<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067468756680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Property, Plant and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 5,092.5<span></span>
</td>
<td class="nump">$ 5,589.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">1,942.3<span></span>
</td>
<td class="nump">2,400.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">3,150.2<span></span>
</td>
<td class="nump">3,188.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,845.8<span></span>
</td>
<td class="nump">3,054.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,578.4<span></span>
</td>
<td class="nump">1,808.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">541.8<span></span>
</td>
<td class="nump">588.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 126.5<span></span>
</td>
<td class="nump">$ 137.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469657192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 281.7<span></span>
</td>
<td class="nump">$ 290.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Otherlongtermassets', window );">Other long-term assets</a></td>
<td class="nump">774.3<span></span>
</td>
<td class="nump">879.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">$ 1,056.0<span></span>
</td>
<td class="nump">$ 1,170.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Otherlongtermassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other long-term assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Otherlongtermassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472338104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Trade Accounts Payable) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAbstract', window );"><strong>Accounts Payable, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Trade accounts payable</a></td>
<td class="nump">$ 928.4<span></span>
</td>
<td class="nump">$ 1,056.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent', window );">Other payables</a></td>
<td class="nump">571.2<span></span>
</td>
<td class="nump">601.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 1,499.6<span></span>
</td>
<td class="nump">$ 1,657.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred and payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067473545448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Current Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 537.0<span></span>
</td>
<td class="nump">$ 492.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal and professional accruals, including litigation accruals</a></td>
<td class="nump">694.9<span></span>
</td>
<td class="nump">715.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and employee benefit liabilities</a></td>
<td class="nump">567.1<span></span>
</td>
<td class="nump">741.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">198.4<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring</a></td>
<td class="nump">171.8<span></span>
</td>
<td class="nump">233.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">228.8<span></span>
</td>
<td class="nump">86.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Equity method investments, clean energy investments</a></td>
<td class="nump">4,426.3<span></span>
</td>
<td class="nump">4,619.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">98.9<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">89.9<span></span>
</td>
<td class="nump">86.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,388.6<span></span>
</td>
<td class="nump">1,254.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember', window );">Clean energy investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Equity method investments, clean energy investments</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">86.2<span></span>
</td>
<td class="nump">66.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 1,095.8<span></span>
</td>
<td class="nump">$ 1,362.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofothercurrentliabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of other current liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofothercurrentliabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469757912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Long-term Obligations) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems', window );"><strong>Schedule of Other Noncurrent Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Employee benefit liabilities</a></td>
<td class="nump">$ 861.3<span></span>
</td>
<td class="nump">$ 876.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">198.4<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Tax related items, including contingencies</a></td>
<td class="nump">429.5<span></span>
</td>
<td class="nump">426.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">191.7<span></span>
</td>
<td class="nump">200.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring Reserve, Noncurrent</a></td>
<td class="nump">51.4<span></span>
</td>
<td class="nump">64.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Other</a></td>
<td class="nump">238.2<span></span>
</td>
<td class="nump">232.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term obligations</a></td>
<td class="nump">1,884.3<span></span>
</td>
<td class="nump">1,933.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems', window );"><strong>Schedule of Other Noncurrent Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 112.2<span></span>
</td>
<td class="nump">$ 133.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Other Noncurrent Liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469771672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Assets and Liabilities Held For Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue of biosimilars portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Biocon Biologics | Biosimilars Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Scenario, Forecast | Biocon Biologics | Biosimilars Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Upfront payment subject to certain adjustments</a></td>
<td class="nump">$ 2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership', window );">Percent ownership after transaction</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh', window );">Additional cash payments to be received</a></td>
<td class="nump">$ 335.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement', window );">Term of transition services agreement</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand, demand deposits with banks or financial institutions, and  other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vtrs_BioconBiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vtrs_BioconBiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BiosimilarsPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BiosimilarsPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067469696344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis', window );">Equity method investments summarized financial data basis</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investments</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 17.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember', window );">Clean energy investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofequitymethodinvestments', window );">Number of equity method investments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments Summarized Financial Data Basis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofequitymethodinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity method investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofequitymethodinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067468746136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments (Income Statement) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 4,191.7<span></span>
</td>
<td class="nump">$ 4,430.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="nump">1,771.2<span></span>
</td>
<td class="nump">1,127.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Operating and non-operating expense</a></td>
<td class="nump">$ 527.5<span></span>
</td>
<td class="num">(441.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember', window );">Consolidated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Operating and non-operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475916728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share (Narrative) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 05, 2022</div></th>
<th class="th"><div>Mar. 16, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="num">$ (0.86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067477355032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss) attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">$ 399.2<span></span>
</td>
<td class="num">$ (1,037.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding</a></td>
<td class="nump">1,210.5<span></span>
</td>
<td class="nump">1,207.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total dilutive shares outstanding</a></td>
<td class="nump">1,213.1<span></span>
</td>
<td class="nump">1,207.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share attributable to Viatris Inc. shareholders</a></td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="num">$ (0.86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per ordinary share</a></td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="num">$ (0.86)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067466883096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">$ 45.7<span></span>
</td>
<td class="nump">$ 45.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">198.4<span></span>
</td>
<td class="nump">198.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Business Combination Contingent Consideration Liability Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 83.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,978.8<span></span>
</td>
<td class="nump">10,978.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,113.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">$ 797.0<span></span>
</td>
<td class="nump">$ 797.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification', window );">Good will, After Amortization Expense, Before Reclassification</a></td>
<td class="nump">$ 4,950.0<span></span>
</td>
<td class="nump">$ 4,950.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Measurement Input, Long-term Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.005)<span></span>
</td>
<td class="num">(0.005)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInputTerm', window );">Goodwill Impairment, Measurement Input, Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, Long-term Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.095)<span></span>
</td>
<td class="num">(0.095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, Terminal Year Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.010)<span></span>
</td>
<td class="num">(0.010)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, Estimated Tax Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.153)<span></span>
</td>
<td class="num">(0.153)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, Control Premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.150)<span></span>
</td>
<td class="num">(0.150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, Reduction in Terminal Year Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.030<span></span>
</td>
<td class="nump">0.030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, Increase in Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.015)<span></span>
</td>
<td class="num">(0.015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_NorthAmericaSegmentMember', window );">North America Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification', window );">Good will, After Amortization Expense, Before Reclassification</a></td>
<td class="nump">$ 3,610.0<span></span>
</td>
<td class="nump">$ 3,610.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,483.5<span></span>
</td>
<td class="nump">1,483.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,644.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">$ 816.0<span></span>
</td>
<td class="nump">$ 816.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">10.30%<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification', window );">Good will, After Amortization Expense, Before Reclassification</a></td>
<td class="nump">$ 1,640.0<span></span>
</td>
<td class="nump">$ 1,640.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInputTerm', window );">Goodwill Impairment, Measurement Input, Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow | Measurement Input, Long-term Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.016)<span></span>
</td>
<td class="num">(0.016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow | Measurement Input, Terminal Year Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.008)<span></span>
</td>
<td class="num">(0.008)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow | Measurement Input, Estimated Tax Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.184)<span></span>
</td>
<td class="num">(0.184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow | Measurement Input, EBITDA Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow | Measurement Input, Reduction in Terminal Year Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.085<span></span>
</td>
<td class="nump">0.085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow | Measurement Input, Increase in Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.030)<span></span>
</td>
<td class="num">(0.030)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.105)<span></span>
</td>
<td class="num">(0.105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 738.9<span></span>
</td>
<td class="nump">$ 738.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">776.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">$ 231.0<span></span>
</td>
<td class="nump">$ 231.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification', window );">Good will, After Amortization Expense, Before Reclassification</a></td>
<td class="nump">$ 780.0<span></span>
</td>
<td class="nump">$ 780.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInputTerm', window );">Goodwill Impairment, Measurement Input, Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, Long-term Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.048)<span></span>
</td>
<td class="num">(0.048)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, Terminal Year Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, Estimated Tax Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.304)<span></span>
</td>
<td class="num">(0.304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, EBITDA Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, Control Premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.150)<span></span>
</td>
<td class="num">(0.150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, Reduction in Terminal Year Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.035<span></span>
</td>
<td class="nump">0.035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, Increase in Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.020)<span></span>
</td>
<td class="num">(0.020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.060)<span></span>
</td>
<td class="num">(0.060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 967.2<span></span>
</td>
<td class="nump">$ 967.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">969.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification', window );">Good will, After Amortization Expense, Before Reclassification</a></td>
<td class="nump">$ 970.0<span></span>
</td>
<td class="nump">$ 970.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, EBITDA Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Greater China | Valuation Technique, Discounted Cash Flow | Measurement Input, EBITDA Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 86.2<span></span>
</td>
<td class="nump">$ 86.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Business Combination Contingent Consideration Liability Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Reconciling items:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 83.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Liability Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Good will, After Amortization Expense, Before Reclassification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_GoodwillImpairmentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_GoodwillImpairmentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_GoodwillImpairmentMeasurementInputTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment, Measurement Input, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_GoodwillImpairmentMeasurementInputTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputEstimatedTaxRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputEstimatedTaxRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputControlPremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputControlPremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputIncreaseInDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputIncreaseInDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_NorthAmericaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_NorthAmericaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067466714856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">$ 12,498.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="num">(385.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="num">(181.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">12,113.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="num">(385.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">11,363.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">10,978.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(953.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">9,108.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="num">(385.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="num">(172.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">8,723.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="num">(385.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">8,174.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">7,789.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(762.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">969.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">969.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">967.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">967.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">776.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">776.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">738.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">738.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(37.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">1,644.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">1,644.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">1,483.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">1,483.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">$ (151.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067468746024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Components of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_IntangibleAssetsbyMajorClassLineItems', window );"><strong>Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 83.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, original cost</a></td>
<td class="nump">38,550.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,006.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="nump">13,344.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,918.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net book value</a></td>
<td class="nump">25,206.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,087.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">45.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross, excluding goodwill</a></td>
<td class="nump">38,596.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,052.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net book value, excluding goodwill</a></td>
<td class="nump">$ 25,251.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,134.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents and technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_IntangibleAssetsbyMajorClassLineItems', window );"><strong>Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, estimated useful life, in years</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_IntangibleAssetsbyMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets by Major Class</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_IntangibleAssetsbyMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472975960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Amortization Expense) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="nump">$ 648.1<span></span>
</td>
<td class="nump">$ 684.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">83.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Total intangible asset amortization expense (including impairment charges)</a></td>
<td class="nump">$ 648.1<span></span>
</td>
<td class="nump">$ 767.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067471853816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 1,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">2,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">2,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">$ 2,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067468818024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Narrative) (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="3"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from sale of terminated interest rate swaps | $</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months | $</a></td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember', window );">2020 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 328.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember', window );">YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 328.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,850.0<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,850.0<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,850.0<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2024 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2028 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2022 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2024 Euro Senior Notes, 1.023%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.080<span></span>
</td>
<td class="nump">0.080<span></span>
</td>
<td class="nump">0.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=vtrs_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=vtrs_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067471882216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 202.8<span></span>
</td>
<td class="nump">$ 144.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 98.9<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td></tr><tr style="height:15pt"><td colspan="24" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 63.9<span></span>
</td>
<td class="nump">62.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Prepaid expenses and other current assets | Foreign exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">62.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other Current Liabilities [Member] | Foreign exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">138.9<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">91.3<span></span>
</td>
<td class="nump">56.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">138.9<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Other Current Liabilities [Member] | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 91.3<span></span>
</td>
<td class="nump">$ 56.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067471916248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 202.8<span></span>
</td>
<td class="nump">$ 144.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">98.9<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">138.9<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">91.3<span></span>
</td>
<td class="nump">56.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">138.9<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Other current liabilities | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 91.3<span></span>
</td>
<td class="nump">$ 56.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475656584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">$ 21.7<span></span>
</td>
<td class="nump">$ 35.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067471884488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">21.7<span></span>
</td>
<td class="nump">35.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">165.1<span></span>
</td>
<td class="nump">263.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</a></td>
<td class="nump">21.7<span></span>
</td>
<td class="nump">35.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign currency forward contracts | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest rate swaps | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Foreign currency forward contracts | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="nump">$ 156.3<span></span>
</td>
<td class="nump">$ 258.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067479259816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations, Derivatives Not Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</a></td>
<td class="nump">$ 21.7<span></span>
</td>
<td class="nump">$ 35.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067473854216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">$ 48.0<span></span>
</td>
<td class="nump">$ 51.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">202.8<span></span>
</td>
<td class="nump">144.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember', window );">Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">36.6<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">48.0<span></span>
</td>
<td class="nump">51.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="nump">48.4<span></span>
</td>
<td class="nump">101.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Exchange traded funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">47.3<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="nump">239.4<span></span>
</td>
<td class="nump">182.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">98.9<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign exchange derivative assets</a></td>
<td class="nump">202.8<span></span>
</td>
<td class="nump">144.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign exchange derivative liabilities</a></td>
<td class="nump">98.9<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">36.6<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate Bond Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Agency mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Asset-backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">198.4<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="nump">198.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 63.9<span></span>
</td>
<td class="nump">$ 62.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ExchangeTradedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ExchangeTradedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vtrs_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vtrs_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067478134920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">$ 199.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss</a></td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">198.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">66.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">35.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">86.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term obligations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">133.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="num">(35.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss</a></td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">$ 112.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Reclassifications</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Liability Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Activity in Contingent Consideration [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofActivityinContingentConsiderationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475906632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Receivables, Securitization Facility and Commercial Paper) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">$ 655,400,000<span></span>
</td>
<td class="nump">$ 1,493,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">328,500,000<span></span>
</td>
<td class="nump">1,173,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember', window );">Receivables Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">325,500,000<span></span>
</td>
<td class="nump">318,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember', window );">Other Current Portion of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_ReceivablesFacilityMember', window );">Receivables Facility | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_ReceivablesFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_ReceivablesFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067468412152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Summary of Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 2,595.4<span></span>
</td>
<td class="nump">$ 1,860.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance expense</a></td>
<td class="num">(39.9)<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">18,762.5<span></span>
</td>
<td class="nump">19,717.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from sale of terminated interest rate swaps</a></td>
<td class="nump">45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember', window );">Other Current Portion of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember', window );">2020 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 831.8<span></span>
</td>
<td class="nump">856.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 328.7<span></span>
</td>
<td class="nump">347.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember', window );">2020 Senior Notes (3.750% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 1,001.4<span></span>
</td>
<td class="nump">1,002.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember', window );">2023 Senior Notes (3.125% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 762.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member', window );">2024 Euro Senior Notes, 1.023%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.023%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember', window );">2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.362%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember', window );">2027 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2023 Senior Notes (3.125% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">766.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2023 Senior Notes (4.200% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 499.6<span></span>
</td>
<td class="nump">499.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2024 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,105.7<span></span>
</td>
<td class="nump">1,135.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 552.7<span></span>
</td>
<td class="nump">567.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2026 Senior Notes (3.950% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 2,241.9<span></span>
</td>
<td class="nump">2,241.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 825.0<span></span>
</td>
<td class="nump">847.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | SeniorNotesTwoThousandTwentyEight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 748.8<span></span>
</td>
<td class="nump">748.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2043 Senior Notes (5.400% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 497.3<span></span>
</td>
<td class="nump">497.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2046 Senior Notes (5.250% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 999.9<span></span>
</td>
<td class="nump">999.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2048 Senior Notes (5.200%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2048 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 747.8<span></span>
</td>
<td class="nump">747.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2024 Euro Senior Notes, 1.023%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 846.5<span></span>
</td>
<td class="nump">871.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 762.4<span></span>
</td>
<td class="nump">763.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">984.0<span></span>
</td>
<td class="nump">1,013.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2027 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 779.4<span></span>
</td>
<td class="nump">780.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2030 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,518.6<span></span>
</td>
<td class="nump">1,520.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.908%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,502.8<span></span>
</td>
<td class="nump">1,546.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2040 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,655.4<span></span>
</td>
<td class="nump">1,657.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2050 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,204.0<span></span>
</td>
<td class="nump">2,205.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember', window );">Current Portion of Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance expense</a></td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067477474648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 2,595.4<span></span>
</td>
<td class="nump">$ 1,860.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472301272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Fair Value) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of long-term debt</a></td>
<td class="nump">$ 19,490<span></span>
</td>
<td class="nump">$ 22,010<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472580696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Minimum Repayments on Outstanding Borrowings) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 1,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">1,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">1,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">2,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">11,854<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 20,753<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067467141736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">$ 128.3<span></span>
</td>
<td class="nump">$ 596.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain on marketable securities, net of tax</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="num">(29.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(2,271.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,802.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,061.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive loss, before tax</a></td>
<td class="num">(272.0)<span></span>
</td>
<td class="num">(490.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent', window );">Net unrealized loss on marketable securities</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">4,178.2<span></span>
</td>
<td class="nump">4,400.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">146.2<span></span>
</td>
<td class="nump">169.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx', window );">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</a></td>
<td class="nump">173.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,385.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (858.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(259.0)<span></span>
</td>
<td class="num">(485.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">44.9<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(161.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(353.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain on marketable securities, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,182.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (461.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(469.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">44.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) provision</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive loss, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(721.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Mylan N.V. | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="nump">201.3<span></span>
</td>
<td class="nump">227.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Gains and Losses on Derivatives | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Reclassification out of Accumulated Other Comprehensive Income [Member] | AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="num">(14.2)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="num">(14.2)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Gains and Losses on Derivatives | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income [Member] | AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits | Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge, attributable to parent. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067467965928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, beginning of period</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="num">(29.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, beginning of period</a></td>
<td class="num">(1,802.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, beginning of period</a></td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,178.2<span></span>
</td>
<td class="nump">$ 4,400.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">146.2<span></span>
</td>
<td class="nump">169.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent', window );">Net unrealized loss on marketable securities</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Change in unrecognized gain and prior service cost related to defined benefit plans</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive loss, before tax</a></td>
<td class="num">(272.0)<span></span>
</td>
<td class="num">(490.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">128.3<span></span>
</td>
<td class="nump">596.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, end of period</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period</a></td>
<td class="num">(29.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, end of period</a></td>
<td class="num">(2,271.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, end of period</a></td>
<td class="num">(2,061.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Reclassification out of Accumulated Other Comprehensive Income [Member] | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(14.2)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Reclassification out of Accumulated Other Comprehensive Income [Member] | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Change in unrecognized gain and prior service cost related to defined benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(461.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(469.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,182.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive loss, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(721.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(858.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(259.0)<span></span>
</td>
<td class="num">(485.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,385.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">44.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(14.2)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Gains and Losses on Derivatives | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Gains and Losses on Derivatives | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx', window );">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</a></td>
<td class="nump">173.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(353.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">44.9<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(161.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Mylan N.V. | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</a></td>
<td class="nump">201.3<span></span>
</td>
<td class="nump">227.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Recognized net actuarial losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits | Defined Benefit Plan Items | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge, attributable to parent. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067473580904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">$ 4,178.2<span></span>
</td>
<td class="nump">$ 4,400.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,191.7<span></span>
</td>
<td class="nump">4,430.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="num">(648.1)<span></span>
</td>
<td class="num">(684.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(83.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(142.3)<span></span>
</td>
<td class="num">(184.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements and other contingencies, net</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(22.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">707.4<span></span>
</td>
<td class="num">(266.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">2,148.8<span></span>
</td>
<td class="nump">2,211.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Reconciling items:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="num">(648.1)<span></span>
</td>
<td class="num">(684.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(83.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(142.3)<span></span>
</td>
<td class="num">(184.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements and other contingencies, net</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(22.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_OtherOneTimeNonoperatingExpense', window );">Other One-Time Nonoperating Expense</a></td>
<td class="num">(185.6)<span></span>
</td>
<td class="num">(993.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Corporatecosts', window );">Corporate costs</a></td>
<td class="nump">459.2<span></span>
</td>
<td class="nump">509.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">2,476.1<span></span>
</td>
<td class="nump">2,571.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">1,211.5<span></span>
</td>
<td class="nump">1,285.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">573.1<span></span>
</td>
<td class="nump">591.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">417.7<span></span>
</td>
<td class="nump">404.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">423.8<span></span>
</td>
<td class="nump">481.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">174.3<span></span>
</td>
<td class="nump">184.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">705.2<span></span>
</td>
<td class="nump">754.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">$ 345.3<span></span>
</td>
<td class="nump">$ 337.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Corporatecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Corporatecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_OtherOneTimeNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other One-Time Nonoperating Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_OtherOneTimeNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067468209208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Restructuring Charges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 296.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payment</a></td>
<td class="num">(83.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Utilization</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Foreign currency translation</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">223.3<span></span>
</td>
<td class="nump">$ 296.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="nump">450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Restructuring Plan | Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1', window );">Restructuring and Related Cost, Expected Cost Remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">12.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">292.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payment</a></td>
<td class="num">(77.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Utilization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Foreign currency translation</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">220.2<span></span>
</td>
<td class="nump">292.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payment</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Utilization</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Foreign currency translation</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected cost remaining for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067477192872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Agreements (Details) - Maximum<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="nump">$ 338.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Developmentandsalesmilestonepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development and sales milestone payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Developmentandsalesmilestonepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067471853816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income Taxes Disclosure (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties', window );">Reserve for Uncertain Tax Positions, Including Interest And Penalties</a></td>
<td class="nump">$ 317.0<span></span>
</td>
<td class="nump">$ 315.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | Australian Taxation Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense', window );">Income Tax Examination, Partial Payment Of Income Tax Expense</a></td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 56.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Partial Payment Of Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve for Uncertain Tax Positions, Including Interest And Penalties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475796872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Pricing and Medicaid Litigation) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 4,426.3<span></span>
</td>
<td class="nump">$ 4,619.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067472537784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated litigation liability</a></td>
<td class="nump">$ 269.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember', window );">EpiPen Auto-Injector Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067478137784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Drug Pricing Matters) (Details) - Mar. 31, 2022<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>state</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember', window );">Multi District Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember', window );">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember', window );">Anticompetitive Conduct with Generic Drugs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember', window );">Amended Anticompetitive Conduct with Generic Drugs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofstates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of states</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofstates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067475826664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Product Liability) (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember', window );">Product Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="nump">$ 75.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067568743896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation (Intellectual Property) (Narrative) (Details) - Intellectual Property<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>increase</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement', window );">Number of times damages may be increased in cases of willful infringement | increase</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages to be paid | $</a></td>
<td class="nump">$ 211.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of times damages may be increased in cases of willful infringement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140067479258104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Other Litigation) (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofcases', window );">Number of cases</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember', window );">Other Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="nump">$ 34.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofcases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofcases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>vtrs-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:vtrs="http://www.viatris.com/20220331"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vtrs-20220331.xsd" xlink:type="simple"/>
    <context id="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibb3acc72c20e4e09b7934a67fa2aa217_I20220504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2022-05-04</instant>
        </period>
    </context>
    <context id="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8d2ff4971a6c4d628f7e2a84354fde90_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia3da2991a25341b09ab36340008ea196_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib578d781d99c4f47885649d77583e23e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3915b76fc6ea48ff93b407a9221bd01f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie352cada5a604c7d8404347ba1732ca1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iad7c661b920b42e4bb603f29ac39dd7f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic0f234c800024956b447083ed4d02c3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e37563a7f3a4909b7dd02085a753d01_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i540972ea3b894aad8a249c7604f8d68d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b0cf057ebfd4957826fe40ac96ad443_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b8608f018ae44cfa0a49be1967faa7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f380484fc704f83a0342b6bdf44bebd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifec90faf56074071843d5dff2b177e01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i067dee996df34e2f84a35524e9e8481c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i93966d3931bb4b9a9d064377829d20d5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id369222933c4479abd90313ae11b86e9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i269ed4494e9b4057b6b5fd874978d0ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia304a43e569c442dabdb1c25c2e35832_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i949fd9a15d71419c9f66a4369a131379_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8e4b05435485489b9e8b4fad080fe718_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8f01433cbdfb450fa016216bdc117a8f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieaf18a35c07d4619b44d7c23d09f585e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaff1f52f268c4433b7551e32308c1640_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41532774e5ff4f418b14c53f63cb7d8a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3eaf90e86a23405aa9ca93eeeb3b40f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bc0f9f8a1bf4a9a967c3233ef153a6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie72c892bc6534c14adab5d7152694449_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i869a99efa4864d4490272885dbb4c20d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icf75acc573ac4b3ea45a192607841887_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i758900e2e79742f39cd9b920398e128d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia4d981978cc94683b97f4e364187100f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i16129c8fa4c146e7b0efbdba33260113_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i84ae372e0d4640afaf6ca7d236588eca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8dd750c9019453f8f3c004524321932_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if11d265b55994603936bcc00f3604ac6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">us-gaap:UnusualOrInfrequentItemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i86ba39e9fd3f4576a6e3ba8ea5af515d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2e9f96c4bfdf4076a41b2f57ff65da66_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i292d6065b18c456da950161dc0ed5cdc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i955056f26f174344a59efe72d96b834c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba711be447b3478c996341536356cdf5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6fe9d75ef6164e1aba47dd0b90e867b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5a2e8d20544d4bc2a6e3f00cdd628190_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i474b93c64de34a159cbfd01885dbf1f1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if294433954e94b85a607d271a2bd0aa8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i491eb04d3a654f62b1752d08b7f0ac78_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib7d16d65a7504e289ccdc9b0fe5363e9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib9174fff41b14aaca81b7b98168f76b6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd7dbc12b4304f5c84ac1ca236493c73_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0f0d8fcddec412b8d97bd5a1419a982_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i25e59d16c05e4059bb82ad3b1d4de7c2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibde6978e33374457b942a44020cb10ac_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie9d1621479f04da080f48af407080848_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id2820f52c9a448be8acecbf9c082bfca_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibc3684b9a82c4961986055887197e3e0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibbaa3dc1ea00496aa8394b48d658329d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i748408c8afd2496db200ffab60f6309a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia11c96949c8246b1a6f02ad3e9a1b8ff_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8a80de9958be4b8999ac5f83c006a04d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i43c27f0d85da4abe8f1080ed37fb7cc5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7fb745d16ade49188c879e9695ef5f1f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibcee3429c94d4f49a2cdae32dc34c903_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id284b62a1ee441a690f5d1dc632ff0f0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia59211776b6c4a7691d42c9ca7bf9112_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2bb7352eee5c4e39a4037e1da189dcd5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id9f9d84adfd04a3190bc51b5249c2bb3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e1cab044e074c6892720c7206be4d3e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1835a54addd6406c921c384df5914a3a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i135d47fb8e1749deb28406184113a7f3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9abec7680e7e486b9c3cba801e828c78_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52fa1580002c42d589ddb55c78697ff0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e79823554854c9994555c6c449804f0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ffa584bf64441bfa32a52dfbd8ccd56_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id717ea1bde634a34a611f888a445e7bc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie24ff44d1ac94a97977bf67c683e1249_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3006593f3b0c4bff83619b0e08ba5ff4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0b41aeba1a37461eb3d32c974467161a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib02f402791b04a8a848fabcaebd62823_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i158536bda5ef4607b007205257c61c21_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i62ede27cc7454699baf57d0d454a0244_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i85796e832ed74154ae053fee7baad954_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iad726170615b4ba3addd534151d713e8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48022c64e99b421c837601b663c4be1c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8c7b925316344a58a37be2388b7ffca1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9199b9cb6f924570befa8e11e3b7a86f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i87788733377c4d97813f696f3baef142_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic0b104192aa044c58ca3556d6141607c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i84563bdbb5d44725a06b2c5fbc62e422_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie4fea5e9149f40bfa10bc9bd2936bc6d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6e58994728654ea6896d5c8702fe2b3b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0912a24a584447deb9f3b49a05227ef6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6cfaa89f38c84069b2fa8d501cbd8580_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1daacd537079404ba5c511f26c26f483_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5583a6d8429e4a15a832e3cb417de6c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0dca7477e77e4046b85ab1d82f7b0be9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i126834f952d14d5ba0e012629f9f51b8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2348a305e98341d6b3d64a25bd98d99f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08cd6d30ddde4135b38cb6b4509af6be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia1403ea4a4ff462894d5f150c3fc0424_I20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="i300f9d815ab347b99f79dd4a94ef5112_D20201116-20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-16</startDate>
            <endDate>2020-11-16</endDate>
        </period>
    </context>
    <context id="i1b945f241fe546d3b6b6002a03ff26fc_I20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="i32276e78cf4b4306ab1293b0c1151e0b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4d074444c7494355a757a9e0ab0d8ffd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibd6d8a15669b44269a74dc8552c59bff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i172cb95ff1b1402d846fc493dacaeb9c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56b037f5e77a4f00aa5d7a3f375a6f96_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1d97c12bd31b4009bd5259d649284b90_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f30854d5be84566bce9b02e6adf2bc7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idf19978eee644aba94ea1363e7675424_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5151f58ea94c4939ae23348ce92f1b70_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie815b9c252a444bb82e640d926a75aaa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icde1a85ed6e247a086a8aad3326c4e01_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1d8d5eff296a4e6d8f34d3fd83d2fa04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4505670638054dd8bdc85765bd7b5bb5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i67b06c877d5645eca6b4db2020388c0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02260e2d4d964332930fc8ba5cb79fd1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i992fd5c4440f4ad69a507b4b2076605b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc828c926f7f4226bb0765da134ca177_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id5a293effe2d476e8a82ca69b066c37a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e4d7d622da84b43bba3a6f1313667a9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icf8ebd1f9f2b43aea75b756394d24cc8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia835a6c092bb43bdaabb4af69cf5c32b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icd41d809933d449a9b51ef98b9a9d921_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5cf551f83c9439aa1d37ce9a597c5af_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i83bfda8fa6a3472ab6b18074c291d3ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id222bc967c45426a9e0cbe615268daea_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8a3a5f469f2a41ea9dba3560f618f489_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iad95ad3c0d504290a9510ac2d347f752_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i286f6b049173419eb8a591dad67f9db8_D20220316-20220316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2022-03-16</startDate>
            <endDate>2022-03-16</endDate>
        </period>
    </context>
    <context id="ie2c8bb318051412cb62ce2064e9b0c5d_I20220505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-05</instant>
        </period>
    </context>
    <context id="ibaa26d9c588c4182ac69aa58107614ff_D20220505-20220505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-05</startDate>
            <endDate>2022-05-05</endDate>
        </period>
    </context>
    <context id="ic6ae763f13a34754b0fd888a4b714401_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="idb635dccb0e2485ba7f187b187e581b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f004bc05e4d45dcbf537fff903cba0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i752b23ca41c0414ca31a93d78f55cae9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89e0a6768c4f4658ba5394068805bb7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifb4bb3504c5e414bbca00d5745e6a325_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibdf9310863c94efea7cc955d04dbeb08_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i820840cef80c4d0abf74da03594e7239_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id0854ccbdb6a48ee945effcd9ab00b5f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7d6f0a30fe8f420c8ddd936989792b64_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6a2086ac5d6c416b8cc71c7c9d2219a7_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id333e02064fc4188b6fa4779c0cbfc27_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4b9e3a7f9cd84f3382111f444d8fd22f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icd36615fdc104e8db3c91f5da47da6f3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01f391ba0c104b98ac8794ec261fe166_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icb1ec291d2a84558b24739819de98b81_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ide2d1af249e641b2bbe8c69bb9739743_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i818820f897ea49ce9285f09c3e769eef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1a466c9613234adb9f17ffade4f5a431_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d62cc2f2fbf44be90f3fd74e62058f7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i644ef34e48024030985c3c07b31dd73b_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6cf43177df974a66a92ba7c52d11995c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iafaccb0fcfc84110aeb682de67ac7598_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4a75f125239e4b0dba35bc1553cb1180_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2c6e60c0df4e41c9bebb8ff1ffb5fda7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i61d256d33cc44601b273de07772fa27f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if9c68f36a2124e6f86cc33905c166b9a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic1428e3de2174baeb5d4ae097870b5b2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id49e7597eca549ac831d9ddf6e7f90c6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5e1a767e23ce445bb33d791ad179db05_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i55c3c1a407b84d5394d09bf25fdf32eb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia6f95d2c71ab4e0fae07e7b6378dcf77_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3aaa3d21b6224eb5a1c10a50ead809a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib03b774597744b8b834dd7a887f814c2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idc71de7a5d384a43a72d12d1445db364_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8f3b4b5b39b34c1089e08a978b8bc67e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8cfb365259e146c6bba35a35319a19c5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ica9478897d044e4bbb3db8f4e11cc304_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4601448e1f8540a6ba7701a19f013bd5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i168375750af04b89bb5edbe12849ea57_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia67acd3202fe49928ecd11cf6bb82d49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if4e25a7630854faa8b10ecbe7048f2c1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i185546023b6e445993a678e5d4722fff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc273f6b86c64387bac8a24acd1ec9cc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i64717797560f4b29aaf331840961ba46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e7c0c2a027c4880bf99a89c7fb9f689_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3248c8cc8d1d4263a978a30127f1f7be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if30ad4912b2043e7b71727fd26678a9d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib2c2ac9f4fde4bc0a2f15e30264bf399_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20ba0871dd394cf28d8d432a947229c7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i29c57a318497434ea45fb2cedd9123a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6af29a91f22a4587acfbe0f78b537ef4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibde372d79c2146ddadac6aed84087ad7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46d8094561c746b4943fe946808e87b4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i489b4bee565a43f1b5c420df05100124_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibddc3eacd6dd4edfae437c8842c62937_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2666c0b7ccc347c8bdd95d798a089cf1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2315c69a559e4eae91ade095257f342e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i24df969ffb85419eae1c0c148008a809_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia1191c9e9a6448b388ec9d255cffdfa0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a60db9d80e0425e83e2738fe92d001c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6831aec7acf4e11b1bc17696acc3144_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7ca1a79cd858475c8b6530e800e63398_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9fdb2ff01ac847c19778cd87d74222f1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b01b262a9d74022bcf13a779fe76cca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i740a3710177c4f15a0f461ce34a65593_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9864394108cb4f43a773c02f1d88b974_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3710c0edc8c84beeb61925296b505b14_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic21bb23c7f724ec68483061e279115c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58199c3b9d0f49d7b609e6c79d1d2858_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia358047e46fc47289a9c1fc7e5a31fea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c9296c20f324c8fafc1080799a70da3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2b4474a8a96541b39e3b1d4e792ff2c0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id20f8c33191c4815bf929abe5e50121a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i41a2e2ea84564d72a4afb25e8c4ec35c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idb235bc6a0834cf8b1051570d9efcfd2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0b19775d069f423880e9edef937484af_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifbdf89a5e09043f89d464a52f1f1cbcf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia669f6d3e67f4786bbd8d4cfa62c4a11_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib21734e807cd4e47b6955ff0fcbecc9c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6cf147b8a161451fa1f8ea341adcecb0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if8a1b50cf22c46cba7f94a3405c8b929_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52d8935dcf644389a84187c0bf9ec7f2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1b41955007d149708ebff22ad2acdb2b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01bcaaa4b3194bcd9c8ab64e7e506f0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic47baa2563274d178d24b9c707cec448_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic2c37287ee4c4f9baecb393bab99f75a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a3013e3234d4648b00f091ea9483ca7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4740a19848394a6490ab4788151155ac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7b8800864c446e3bfb4396ac7251eba_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i13cab697039642b0953eef067bf76e23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5318b8966de4c9ab5c12c99f7de2b32_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i677b7ff6d33c441eaf16aa67eb7dc18f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i820b54ced26a43b8942c3d0dc474c2aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4ffddd3ebd9249b282c2a947e3995e55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3240de2751ea4f6caf10457b795b3d54_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i47a9183eea87483492bb05c98ca32541_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica31ae73f51947efba3f84f2f5e73f75_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f6d283f86b4446cade80f58f4010940_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c01cb8bf2d74226a4d1bb1d254e5e1d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i20c1042f293c4a6cb388f7e3e3500abc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb4b6849d2bc41cab8e20fa6106f5c67_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i64bab9ba75b1441cb4e430c740dd70d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i010e212468d14224aaf4661c0271995c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idbb6f6a4865a4b13846c0311a8198fc1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3a6d2ba35574c48b54a634add899b86_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77480a5aa2164b569a9e91f030454ffb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1194fb7125fd48feb4af6f6c94758641_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77dc0798004d44c791a5bbb08b126c3e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iebdd0591acbe4bef9892e17e437e510c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic828aa0199d948a4a260f04156670656_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia28510b5c71d4182aa49d69fb01fa474_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie18b5d9e71fd45c2b8cb4bb900be2c8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9efa78417d2452cb7a8ab1ecd2e2f9b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5878664ac9f14f6b85a0598e1613ce8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb3906df3ad546cd8e29117ea61b2a8d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i82800c514aa0452d855d2b15e4818734_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d46a4c2ea764c4ea5d63935feab31f1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i920805edb6bd4fc6b02db9ae904e4bce_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iacc4c1e487a74688ab81273067a97cf2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34906e61f9a74e3a9907c245d674475d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i730b6b0ebf854761bfab2a3d7849fe20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib033b18c10b54540877cb94c0a2c2d1b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i616a7760ff9a412f95e120d328a13496_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic62d942e80a44f328ced46abd8385b8f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i21352fc4b3034be49d25e0fe2cc81ea9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i235e89926eb74f3d88770caa518d54ab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77c67b48aac04b57a96558d5638e2069_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8760241a3c7746f88dfc82fd0dc38eb9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1c88993426de4bfa82c2af5b9e9ed5cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3495d968dabe49db8632cd8419777821_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if209dd52df884edca3b342ed0f29e0ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i005465bb6d4141108265ad72c8d64c05_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1871f3ae6b044568aa7edef970da41e8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i87954de7b4154d90921ac559950690e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i410da26a1bdf4849ad61862472be13bd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if4393b7ef55d44b491ed13b410ae5f95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a2f21b97703441394122c32e24bae16_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i59e61082e1f54d149a0319da03a3379f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a7f0dc2e5b0416aa4a0385ea9cf3510_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i674842c707794f4b9c18faf16d310ee6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a34081d5ebc44a2b5346da3d6b8808e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i88e2860e30684408955db848202e3b35_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5a4808a45c314bcbb675ab9e037ae38d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i724052a3d05f4c35a5c6a00a2fea921f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3d84cd5ad0974a9989194bfb8e273bb0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0a475c2355f74134b164dcccd5dfb7d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbb10749b14e419a92f4ae26723a62ac_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaaa95b408619484988378fae1c283bb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e4efee03b0b4da6844362cd1376dc49_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icab334cf12f3428e832773ef37592e11_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifdcab6e29434459989a147cd7b7e7450_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f77a33b8832445ca8a138130657da67_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic9ec6ac3b5374b0a8f1f65dd3c2855cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39206c4f1d9c4866a802fcd055a7e2a1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i05c5629823074ba09faf3ca2ad8969a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb2326817a4c4b8aa31f1fcf83769a0a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3aed418e17ea4186b695f6810d200726_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i177681bbc11b40ee9f75db3045c19e95_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5606c2ba35cb4d71b8656f287034dcec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13bcb00848b642c88bfcc2a3c877ede2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifc8c69e7703a44399519315b43924c3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia40f39ee6378480184a30bc13c9e3594_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i992ae6748a1644e29dc32186549f45e4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied7473c049234582bd30c2c495ac8ba9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ad052255252472887637ab010a153d2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaa54af0ed26448d9b6ab8f7c2c6167a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8245ebc2dc2948b69c11fb33e05f36b6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idc759c1f2ebc440c8f306b8b1ca6b9f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id07178dd71fc4b9d989a85d7e37587c8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i05ca82ad60f24969bc24380087f4af1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97cceb4d5127408091af840823fc721e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8bf7ecce65c9422f8f5f4fe13d646c1e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a532fa1402b4fc68731b04ccee54724_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9319cb1e85a2470bbb378e5ce64d1b1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia55bbf8c4e19462595c29c8a377dea3e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if7f17a49b80d45fab66d262a44deaace_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5e368b781a74d6686679790d4bff5a8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia55ac01c2b07425bbe40921fb5981f21_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ide8689d47bf04a43bf675d0763fad522_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4988c8f213a042118b4b5eaf9c7f1e82_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib01b91695a1b4712b96033763cf44ccb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4771d8abfecc4e1e95bac68b8f627709_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a0f1e83bb0d410fbdd5481b44ffd1f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i47a8319f4395450dbae6322e0e8646d3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ide368397434c48e59036b17de6b68663_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic2ded494c0c74830993e23285344ef34_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i879cd700e4194424af2d4d04eef590c5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i413aa6ce376641bdba0e00e871461952_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i72e12d4aab9b464eb4d8ad17759e7f56_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib31b0884d24244149616a8b8da8525b4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i058f357ea23c4c98b73c618d1d854722_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03493d8105474aeb862abf63b7ef74a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78ad5902fd35439c8f4af1782d4c7515_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31e0fdd1fab64cb898debb3cb62f7b63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb76b00d31784891b8cb395e638378b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcbcb91759414078b56888757bdb9d8c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i557fd976de2e4b8c83c710c96321b9ba_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2b30c4edf7ef407098a198c2ade53163_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b05065a6c98419eb5b6caba576c82bf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id5db4cd0e0a14bd7b8ad825332acc3a2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id851527d609c4cc481afc6dd44e8b9c8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iefe2b30097f544b791322bb2f629e462_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i13e37fd7655a489ca62fce5309929cdc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idfeddcfa49be4a9f9ca7273bb0bc0b2d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife06d4353ee146d29a89e17a68a9eb78_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibac83a8acaf741ca954ebb93d7b9c302_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6bf21bcb23a34c3498a8a496b6117bb3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i59b28feb2f7d45d7b83dc9fca6123f83_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i156daef6d1e44bdbb6b3a817528d646d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib366aa410a2f41b6a5c4c31aaf520612_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i69c1db3a5e434cf2b0bec2a19b9128b1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iae9a8abb5cdb4a0988a591e31a0ac4e6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7a0499bbe67f4f29816cc986f12548ee_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia7c23dc951cc4e8989a77c2c56fbd5cc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibf733ae3e5124ab199c7831a4facfe9e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icf02807bb1474b44a231a8d6a3b86371_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifa7571660234425ca582abda7db56793_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1dbf52cc348a44cba02d8ba438c2c120_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i10246c296fdb4978908586b17cec13ad_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia41f4e43848544a8b3cd335d5ac9237e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1e5b4b8499b48638e60332fdcb0ebb0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib1452feb5e534b13a92ff4d8dc1fd100_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea8b0cc4e1164b799a97e32fa53ec105_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie81001995ccc476fb965e3e428336426_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i434ad84a039c49a7b73a32c66eff9799_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i939eb9ebbfc9436e9ef6a820918949ed_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6271454a81c6421fbe19f900527e1bbe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4cd2df5979694abd9cfb33abc0ae4026_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib755013306ad4359a6aae01eb324d613_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib58c46b4f27f41a69c77fc95bcc936c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c8958a092304f48b6c503090ac334f6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i38aa3e44188c4557aa18bc19d33a2f00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaafdd9a3a724498080488d52b9b8e49a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:MultiDistrictLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifef39d3d08a74324abe20f3b54b78a71_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2cebc8f9c5ae49bab6671a9b180b170e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic49cbe2fbefc424a92f99179077a1f8a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AmendedAnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c504afee4fe48c49e1b8ec64187b6b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id8a766f58ff5477781e10e45ea959330_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="state">
        <measure>vtrs:state</measure>
    </unit>
    <unit id="increase">
        <measure>vtrs:increase</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF80LTEtMS0xLTU4OTc5_5afbec66-6f73-45d9-bd56-da39197dfd24">0001792044</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF83LTEtMS0xLTU4OTc5_9b5203b6-9f01-4436-b787-7ab78e735780">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF84LTEtMS0xLTU4OTc5_6a77005f-92e6-4aea-bdae-a61cc4440bb5">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF85LTEtMS0xLTU4OTc5_7452ef4d-3391-447e-81f1-5ec48f4849e8">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83L2ZyYWc6MjA3MDJjMzdhMzkwNDc5NGE1YTQ4NDQzNjJlN2Q3ZTMvdGFibGU6ZmI0NGMzMjY0NTkyNGM0MmJiYmJlZDdjNTdlZWExYmQvdGFibGVyYW5nZTpmYjQ0YzMyNjQ1OTI0YzQyYmJiYmVkN2M1N2VlYTFiZF8xMC0xLTEtMS01ODk3OQ_a84f5658-bbdc-4a44-a601-24402b07223d">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i32276e78cf4b4306ab1293b0c1151e0b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTU_c0f2427b-1baa-41a5-bae1-4668a072522c">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement
      contextRef="i8a3a5f469f2a41ea9dba3560f618f489_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTUzOTMxNjI3OTU3NDY_e1f2e313-6d28-4936-b405-9423e140767f">P2Y</vtrs:DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement>
    <dei:DocumentType
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTMz_4f9848c1-b099-438e-85f4-7aee237463ad">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTg4NzM2MzBlNTQyNDViZGI0MTIwZDFiMGZhZmQ1NmUvdGFibGVyYW5nZTo1ODg3MzYzMGU1NDI0NWJkYjQxMjBkMWIwZmFmZDU2ZV8wLTAtMS0xLTU4OTc5_ffe63faf-c93b-4d60-b494-112d9d5eed8e">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xMjQ_d1fc21a4-aeb7-4f63-b900-fe69df3d606e">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6M2MxNWM5MjExZGE2NDI3YmIzMWU0M2ZmZWJlNmRlMmIvdGFibGVyYW5nZTozYzE1YzkyMTFkYTY0MjdiYjMxZTQzZmZlYmU2ZGUyYl8wLTAtMS0xLTU4OTc5_c5eb021e-ffa8-4f33-b393-76e330480892">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM0_45941027-5648-4e96-85eb-420fcc569d16">001-39695</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8yNDE_ec71c905-29ef-4bdf-b156-15f40ee4d6b1">VIATRIS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTM0ZWQ2ZjA4YjM0NDZmYWExNmZmM2E5MTNiNDBkZTYvdGFibGVyYW5nZTo1MzRlZDZmMDhiMzQ0NmZhYTE2ZmYzYTkxM2I0MGRlNl8wLTAtMS0xLTU4OTc5_991071ff-9c66-415f-95a8-a84d208352a4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTM0ZWQ2ZjA4YjM0NDZmYWExNmZmM2E5MTNiNDBkZTYvdGFibGVyYW5nZTo1MzRlZDZmMDhiMzQ0NmZhYTE2ZmYzYTkxM2I0MGRlNl8wLTItMS0xLTU4OTc5_1ed38cef-0794-4a11-ba65-b968ace624ee">83-4364296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM4_874ae838-7a4b-458a-a6fe-19ed23daeb19">1000 Mylan Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM5_c7130cf0-7973-4f24-9d85-8ccd96593ea3">Canonsburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM1_0587908a-b8e1-4e35-9730-6b3abc3e00e3">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTQw_b1a5f400-ee5d-4321-b4a3-cf7af9108927">15317</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8zOTc_3f4d34f1-0791-4d46-9580-0443a94c913f">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8zOTk_0db85f17-a85e-47a6-9b85-215033a4237d">514-1800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6MmVhYTQ0NDRmMWYwNDkyNWE4YmZlZGFiNjRlODdlNTcvdGFibGVyYW5nZToyZWFhNDQ0NGYxZjA0OTI1YThiZmVkYWI2NGU4N2U1N18yLTAtMS0xLTU4OTc5_090b311d-b68f-466a-abda-e1bfde3b2555">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6MmVhYTQ0NDRmMWYwNDkyNWE4YmZlZGFiNjRlODdlNTcvdGFibGVyYW5nZToyZWFhNDQ0NGYxZjA0OTI1YThiZmVkYWI2NGU4N2U1N18yLTItMS0xLTU4OTc5_f4193e49-37be-4a57-a0eb-5bcf25f15412">VTRS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6MmVhYTQ0NDRmMWYwNDkyNWE4YmZlZGFiNjRlODdlNTcvdGFibGVyYW5nZToyZWFhNDQ0NGYxZjA0OTI1YThiZmVkYWI2NGU4N2U1N18yLTQtMS0xLTU4OTc5_ea905c22-7be9-48da-a5a6-a7d8aa763464">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM2_517b2236-e66a-4b44-aaec-7f9ea8e5cc61">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTMy_f9fa4a9d-e658-4200-8d3a-c74cd212e67c">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTQ4MWQ3ZGQ4MWYyNGUwNDk5OTkxMTI3ZTcwNTYzNzYvdGFibGVyYW5nZTo1NDgxZDdkZDgxZjI0ZTA0OTk5OTExMjdlNzA1NjM3Nl8wLTAtMS0xLTU5NDIw_17a888c9-a46c-4145-a957-2c7c2af4b86a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTQ4MWQ3ZGQ4MWYyNGUwNDk5OTkxMTI3ZTcwNTYzNzYvdGFibGVyYW5nZTo1NDgxZDdkZDgxZjI0ZTA0OTk5OTExMjdlNzA1NjM3Nl8yLTYtMS0xLTU4OTc5_ed94347c-deb2-4344-bbca-807b2d02f4c6">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGFibGU6NTQ4MWQ3ZGQ4MWYyNGUwNDk5OTkxMTI3ZTcwNTYzNzYvdGFibGVyYW5nZTo1NDgxZDdkZDgxZjI0ZTA0OTk5OTExMjdlNzA1NjM3Nl80LTYtMS0xLTU4OTc5_6e9d9aca-c854-4516-98fd-0feaaa858f0c">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTM3_129e3f92-e5a9-4f4f-90c6-9accc675873f">false</dei:EntityShellCompany>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xODgx_4fb422e8-fffa-46f5-a612-dd3186c20807"
      unitRef="eurPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ibb3acc72c20e4e09b7934a67fa2aa217_I20220504"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xL2ZyYWc6YTc1YmRmMjM0OTk4NDk5OWE5YzMxNmRlNmMyMzZkNTUvdGV4dHJlZ2lvbjphNzViZGYyMzQ5OTg0OTk5YTljMzE2ZGU2YzIzNmQ1NV8xOTI2_ab7ed90d-c3b7-456f-a406-bd6d1e004145"
      unitRef="shares">1212326908</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNC01LTEtMS01ODk3OQ_e818dee5-edca-4a32-97ab-67b0b665e6da"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNC03LTEtMS01ODk3OQ_423640aa-222e-4e82-b933-17a3231451fd"
      unitRef="usd">4400100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i8d2ff4971a6c4d628f7e2a84354fde90_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNS01LTEtMS01ODk3OQ_dc6f9bf0-db68-4da5-b034-870a6e409914"
      unitRef="usd">13500000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="ia3da2991a25341b09ab36340008ea196_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNS03LTEtMS01ODk3OQ_0f56dd3d-c987-45ba-baa4-784784735925"
      unitRef="usd">30200000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNi01LTEtMS01ODk3OQ_0b87a6f7-77b6-4173-945c-badcfa15b5c2"
      unitRef="usd">4191700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNi03LTEtMS01ODk3OQ_7b4af28f-98f4-43e3-815a-80abe0348762"
      unitRef="usd">4430300000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNy01LTEtMS01ODk3OQ_a2c3c2b9-52c8-4ce9-ba91-88b6c7f8cac0"
      unitRef="usd">2420500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfNy03LTEtMS01ODk3OQ_00007aa4-d359-4aab-9829-25172314e1ff"
      unitRef="usd">3303000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfOC01LTEtMS01ODk3OQ_148b78c1-d381-4731-bc76-db6ff98721bc"
      unitRef="usd">1771200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfOC03LTEtMS01ODk3OQ_6b85632b-c75c-4f80-a808-5add33338371"
      unitRef="usd">1127300000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTAtNS0xLTEtNTg5Nzk_8ec57e90-6986-4b8b-9428-eb11ceb20bba"
      unitRef="usd">142300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTAtNy0xLTEtNTg5Nzk_4692c6c2-9245-4ce5-ac38-dbb43d426cba"
      unitRef="usd">184100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTEtNS0xLTEtNTg5Nzk_6a799aec-4ad4-47cf-9532-f06b6518cd80"
      unitRef="usd">915300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTEtNy0xLTEtNTg5Nzk_ff69ea64-1dc0-48f6-a395-51cf683ca3e5"
      unitRef="usd">1186500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTItNS0xLTEtNTg5Nzk_67a95c3d-aabc-4265-87c5-6466fa483280"
      unitRef="usd">-6200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTItNy0xLTEtNTg5Nzk_548870cd-e61d-432d-aa3a-28d25345ac2a"
      unitRef="usd">-22900000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingExpenses
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTMtNS0xLTEtNTg5Nzk_96a1f15d-32a0-4ab8-b8d8-21490b56da7e"
      unitRef="usd">1063800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTMtNy0xLTEtNTg5Nzk_7bea4946-3ee3-4c45-b7c1-119f7ed2682e"
      unitRef="usd">1393500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTQtNS0xLTEtNTg5Nzk_73298397-7c40-478e-98cf-05dca382e72a"
      unitRef="usd">707400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTQtNy0xLTEtNTg5Nzk_962311fc-721a-454c-b183-2a46507109b3"
      unitRef="usd">-266200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTUtNS0xLTEtNTg5Nzk_c4a283a2-f07b-4738-9f96-ab506f950bab"
      unitRef="usd">146200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTUtNy0xLTEtNTg5Nzk_488521b0-298e-4a22-90ec-1f3c659752fe"
      unitRef="usd">169000000.0</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTYtNS0xLTEtNTg5Nzk_6b46cc81-983f-456c-a50c-c633adcf02fc"
      unitRef="usd">-33700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTYtNy0xLTEtNTg5Nzk_bb6d1382-2543-4e77-9341-454fd4f9ac53"
      unitRef="usd">-6100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTctNS0xLTEtNTg5Nzk_0607d6a5-833e-4673-af0b-4b1f9c16cf8c"
      unitRef="usd">527500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTctNy0xLTEtNTg5Nzk_2b06d101-7dc7-4d4c-9791-20b4bf9c7993"
      unitRef="usd">-441300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTgtNS0xLTEtNTg5Nzk_a57eee3e-e528-4671-ae19-b18506c87183"
      unitRef="usd">128300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTgtNy0xLTEtNTg5Nzk_0141e36c-1ee3-44c4-9789-3b5ba16c972e"
      unitRef="usd">596300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTktNS0xLTEtNTg5Nzk_1aa781b6-2cfa-421d-a929-6c4442f5b385"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMTktNy0xLTEtNTg5Nzk_1701f0f1-81f3-49f0-a843-430ea0281202"
      unitRef="usd">-1037600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjEtNS0xLTEtNTg5Nzk_a0a80fa8-134a-4fc4-862b-967b29b2aa16"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjEtNy0xLTEtNTg5Nzk_5b1bf627-345c-4a4a-9bbe-f2a754ab02a6"
      unitRef="usdPerShare">-0.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjItNS0xLTEtNTg5Nzk_33fafc8c-be6b-424b-ba1f-1a4d2420f0a5"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjItNy0xLTEtNTg5Nzk_2ecd9488-03aa-4e33-9be4-85bc38bed2fb"
      unitRef="usdPerShare">-0.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjQtNS0xLTEtNTg5Nzk_7287e534-3261-493a-92fb-58aeabe6399a"
      unitRef="shares">1210500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjQtNy0xLTEtNTg5Nzk_6f62822d-a6c6-44fe-95aa-3a3ed3ada22e"
      unitRef="shares">1207500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjUtNS0xLTEtNTg5Nzk_6eb9b7f3-38d7-45f4-bc02-25a07fd00187"
      unitRef="shares">1213100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xOS9mcmFnOjE5ZDlhZGFlYmMxNTRkODM5NDlmMDU1MDgxYmE5NzNiL3RhYmxlOjg4ZWRkNDIzODlkODRkYzY5YTc5MjRjZDE4MjczYmFiL3RhYmxlcmFuZ2U6ODhlZGQ0MjM4OWQ4NGRjNjlhNzkyNGNkMTgyNzNiYWJfMjUtNy0xLTEtNTg5Nzk_3e92f14e-c50a-43b3-96dd-f169af598400"
      unitRef="shares">1207500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMy01LTEtMS01ODk3OQ_1aa781b6-2cfa-421d-a929-6c4442f5b385"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMy03LTEtMS01ODk3OQ_1701f0f1-81f3-49f0-a843-430ea0281202"
      unitRef="usd">-1037600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNS01LTEtMS01ODk3OQ_106a6c7e-a32a-4304-b453-6a3c59816fd3"
      unitRef="usd">-469200000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNS03LTEtMS01ODk3OQ_5420e493-27f7-474d-b3b7-fea768103131"
      unitRef="usd">-721200000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNi01LTEtMS01ODk3OQ_9a604b8d-b1cc-44ac-b2a1-e7729573c4fa"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNi03LTEtMS01ODk3OQ_4a9bf70e-dcd6-47fe-865c-ad89c1be1ae3"
      unitRef="usd">-800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib578d781d99c4f47885649d77583e23e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNy01LTEtMS01ODk3OQ_5c8b6d4d-193f-47e5-ae70-81712beafb00"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3915b76fc6ea48ff93b407a9221bd01f_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfNy03LTEtMS01ODk3OQ_6fb77c42-0a37-410e-be57-319e7081112b"
      unitRef="usd">3300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie352cada5a604c7d8404347ba1732ca1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOC01LTEtMS01ODk3OQ_7ae5a9ad-f5ec-4153-bc0c-56748da56d74"
      unitRef="usd">201300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iad7c661b920b42e4bb603f29ac39dd7f_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOC03LTEtMS01ODk3OQ_97148c31-f881-4554-ae21-67dec0d809c2"
      unitRef="usd">227400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOS01LTEtMS01ODk3OQ_6039bbea-f024-4fe5-a429-b345934215b8"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfOS03LTEtMS01ODk3OQ_3b0a7ba5-9602-407b-b047-98cb539bb136"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTAtNS0xLTEtNTg5Nzk_c294e6f1-a34c-4ce5-a6f6-aec06836d8bd"
      unitRef="usd">-272000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTAtNy0xLTEtNTg5Nzk_e95a98a1-f8d4-44b8-9266-de99d967f2e9"
      unitRef="usd">-490600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTEtNS0xLTEtNTg5Nzk_c5f5ee1d-4cca-4f8c-8a53-fa405bf8e22e"
      unitRef="usd">44700000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTEtNy0xLTEtNTg5Nzk_de72b97c-eb15-4500-90f5-39c697bd20ff"
      unitRef="usd">37000000.0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTItNS0xLTEtNTg5Nzk_7a7128f6-7f3a-4fdc-95cd-5367b18470f1"
      unitRef="usd">-316700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTItNy0xLTEtNTg5Nzk_60e08eae-b784-4732-b4ee-5bbb9b80f7b0"
      unitRef="usd">-527600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTMtNS0xLTEtNTg5Nzk_b8270d0c-a451-47d9-b7d9-7ea09dccffff"
      unitRef="usd">82500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yMi9mcmFnOmY1ZGNjNzhmMTcwNTQxNWM5YjZiZmU4ZmFhOWJhOTRmL3RhYmxlOjA5Mjc4N2Q2ZTRiMDQ3YWU4MDY4ZTRlNzUyNmE1NTUyL3RhYmxlcmFuZ2U6MDkyNzg3ZDZlNGIwNDdhZTgwNjhlNGU3NTI2YTU1NTJfMTMtNy0xLTEtNTg5Nzk_94a3c4d2-1fd2-4c56-bce7-e97cae580da3"
      unitRef="usd">-1565200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNC0xLTEtMS01ODk3OQ_b28ef41d-4c66-4290-b4f0-b292aae141e4"
      unitRef="usd">752400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNC0zLTEtMS01ODk3OQ_af007108-94f3-4f6a-bf4e-3be1967a731d"
      unitRef="usd">701200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNS0xLTEtMS01ODk3OQ_3ed3f340-b9a4-4a00-9bce-59a5fcc0ff28"
      unitRef="usd">4093900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNS0zLTEtMS01ODk3OQ_2b049a5d-4827-4809-8ea5-3509fa2004cb"
      unitRef="usd">4266400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNi0xLTEtMS01ODk3OQ_110a1e15-af11-454f-8a0b-7ec43971f934"
      unitRef="usd">3797300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNi0zLTEtMS01ODk3OQ_8245a4b1-d776-4b7b-9bd8-6317c2ebc859"
      unitRef="usd">3977700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNy0xLTEtMS01ODk3OQ_204169c6-4ad7-489a-9c49-ad5f6a447c64"
      unitRef="usd">1763600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNy0zLTEtMS01ODk3OQ_5ef458dd-cd51-47f4-9719-cd12f22a83ad"
      unitRef="usd">1957600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0xLTEtMS02MzkzMg_0c29e7c8-27d3-4f02-bd00-654a92b49e84"
      unitRef="usd">1337100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0zLTEtMS02MzkzOA_326f4d60-f592-46b6-9238-e047264d179c"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0xLTEtMS01ODk3OQ_921682db-3a75-4590-8c43-7217fc8b146c"
      unitRef="usd">11744300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOC0zLTEtMS01ODk3OQ_e9c16e79-4c9a-4431-b2f2-ab69416a98d6"
      unitRef="usd">10902900000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOS0xLTEtMS01ODk3OQ_0186bb33-a1ec-4a3a-845a-4702767d1a48"
      unitRef="usd">3150200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfOS0zLTEtMS01ODk3OQ_f45153cd-7f8e-4dad-bb20-3faa21350d84"
      unitRef="usd">3188600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTAtMS0xLTEtNTg5Nzk_f3329e87-0a20-4bb3-bd3a-d2f63aac3d6c"
      unitRef="usd">25251800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTAtMy0xLTEtNTg5Nzk_5a087041-c4a4-456a-ac5c-6303664e6ba4"
      unitRef="usd">26134200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTEtMS0xLTEtNTg5Nzk_f734a5cc-561c-41c2-a26b-ce3420adbf4c"
      unitRef="usd">10978800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTEtMy0xLTEtNTg5Nzk_220e6ae1-80d7-4f8a-8c71-5a64b5cc58e2"
      unitRef="usd">12113700000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTItMS0xLTEtNTg5Nzk_4b1c0d24-101f-49a3-ad88-09bedc68d824"
      unitRef="usd">1285800000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTItMy0xLTEtNTg5Nzk_d8e83865-a356-4311-a1d1-bab1a741bbab"
      unitRef="usd">1332700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTMtMS0xLTEtNTg5Nzk_4b41ce87-83d8-4040-9a60-c9987e38e2b2"
      unitRef="usd">1056000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTMtMy0xLTEtNTg5Nzk_fbd55628-d875-4863-aa67-eeb16f279f31"
      unitRef="usd">1170700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTQtMS0xLTEtNTg5Nzk_8e3679b3-a4ad-4c29-bd91-8a6a78a353a3"
      unitRef="usd">53466900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTQtMy0xLTEtNTg5Nzk_55c48110-4720-4ab1-b8dc-e14ee3f29d2a"
      unitRef="usd">54842800000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTktMS0xLTEtNTg5Nzk_60366fe9-7880-4332-a43c-7c7a931a6702"
      unitRef="usd">1499600000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMTktMy0xLTEtNTg5Nzk_2b7022e9-da47-43b4-aa41-83aaacde7509"
      unitRef="usd">1657400000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjAtMS0xLTEtNTg5Nzk_2851a404-ee95-430a-9095-9101e419f8af"
      unitRef="usd">655400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjAtMy0xLTEtNTg5Nzk_8924d811-c8b6-4d9f-95a3-0b6f7353574d"
      unitRef="usd">1493000000</us-gaap:ShortTermBorrowings>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjEtMS0xLTEtNTg5Nzk_b087bfd4-f17a-4973-ae99-5108c6ebbd52"
      unitRef="usd">177800000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjEtMy0xLTEtNTg5Nzk_481ad3f3-b442-4766-9238-64c06e6d961d"
      unitRef="usd">236900000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjItMS0xLTEtNTg5Nzk_f5261288-3803-47b7-af5b-89bf378398b6"
      unitRef="usd">2606100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjItMy0xLTEtNTg5Nzk_6b1e1a18-0ab9-42d0-99ad-5a999f0a2252"
      unitRef="usd">1877500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMS0xLTEtNjM5Njc_6fe9c473-2b37-4a08-bd8c-92a50efa501d"
      unitRef="usd">277700000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMy0xLTEtNjM5NzM_55b603ab-a482-474e-938a-39bf3fcd5adb"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjMtMS0xLTEtNTg5Nzk_95d1751a-dc58-4423-9a68-93f011c7fe7a"
      unitRef="usd">4426300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjMtMy0xLTEtNTg5Nzk_631893f6-2821-4e96-88cc-2601f2eb72e8"
      unitRef="usd">4619600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMS0xLTEtNTg5Nzk_1b18ea4d-da33-4582-b60f-aba67c254e50"
      unitRef="usd">9642900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjQtMy0xLTEtNTg5Nzk_d7fb8fb8-9056-45ff-a9ee-8b128f1dfaa2"
      unitRef="usd">9884400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjUtMS0xLTEtNTg5Nzk_2ac6cd0b-7d75-406b-ac68-d6583f7b708f"
      unitRef="usd">18762500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjUtMy0xLTEtNTg5Nzk_4dbb5c6f-aba5-4f10-a5c4-6828d7ead372"
      unitRef="usd">19717100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjYtMS0xLTEtNTg5Nzk_80c4ef80-5789-4cd2-ac7c-d6d5f0beabe1"
      unitRef="usd">2729500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjYtMy0xLTEtNTg5Nzk_60b11b71-df64-44bb-9b6c-55b483d7b224"
      unitRef="usd">2815000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjctMS0xLTEtNTg5Nzk_a11371ef-c0de-486e-9f27-8cf4cdaa7fa0"
      unitRef="usd">1884300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjctMy0xLTEtNTg5Nzk_d89c92b4-3274-4bde-9f9c-feba20b64084"
      unitRef="usd">1933600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjgtMS0xLTEtNTg5Nzk_5a96f327-2263-4be2-9ee2-5f35734d7837"
      unitRef="usd">33019200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMjgtMy0xLTEtNTg5Nzk_8aa5457b-9889-47cd-8f2a-63901321962c"
      unitRef="usd">34350100000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8xMDk5NTExNjI3ODQ0_4fb422e8-fffa-46f5-a612-dd3186c20807"
      unitRef="eurPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8xMDk5NTExNjI3ODgz_985616b3-85ce-4f49-915c-183fb6af2f08"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharesIssued
      contextRef="i3e37563a7f3a4909b7dd02085a753d01_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8xOQ_4cec96ff-e853-434b-8d10-6ede83b07411"
      unitRef="shares">1212323483</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i540972ea3b894aad8a249c7604f8d68d_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMC0xLTEtNTg5NzkvdGV4dHJlZ2lvbjplYzU1ODExNTM5ODg0MGJmODczMGIyNDM4ODdjMTg0OF8yNg_3c07351c-e734-4239-9755-9520cd7ba674"
      unitRef="shares">1209507463</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMS0xLTEtNTg5Nzk_a95f9d8c-e35a-498a-ad8b-c30108778362"
      unitRef="usd">12100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzMtMy0xLTEtNTg5Nzk_63670ef2-cee3-4e9a-9399-5bcf4145320a"
      unitRef="usd">12100000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzQtMS0xLTEtNTg5Nzk_a437f9c2-3e22-4fd6-8130-29bed16a5b39"
      unitRef="usd">18555100000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzQtMy0xLTEtNTg5Nzk_40eb7893-be88-4a74-8041-8f288e1d5d06"
      unitRef="usd">18536100000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzUtMS0xLTEtNTg5Nzk_c2079690-b552-4f05-857a-c83c77443687"
      unitRef="usd">3941500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzUtMy0xLTEtNTg5Nzk_4a539680-a7df-4a48-a8f1-f7e36fa81854"
      unitRef="usd">3688800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzYtMS0xLTEtNTg5Nzk_048114c8-2499-4833-a5ec-62e4e34afd5c"
      unitRef="usd">-2061000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfMzYtMy0xLTEtNTg5Nzk_c669d75d-c8d8-434c-ba3e-95612c2841a8"
      unitRef="usd">-1744300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDEtMS0xLTEtNTg5Nzk_5907062c-e2d9-40f8-ac0e-e0fd7f0f5ccd"
      unitRef="usd">20447700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDEtMy0xLTEtNTg5Nzk_3bbda29b-0bf3-485e-96ba-accffcbcbbc4"
      unitRef="usd">20492700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDMtMS0xLTEtNTg5Nzk_8835f971-10fc-4d38-bf42-c2b15909e1e6"
      unitRef="usd">53466900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8yNS9mcmFnOjViM2IzZTU4MTkxNDQzNTRiNGYyODNlNGJkZjQ2OThhL3RhYmxlOjg3MTk4MmI5ZjVjZDRjYmI5NTBlZTUxNTA2NmQ4NTkzL3RhYmxlcmFuZ2U6ODcxOTgyYjlmNWNkNGNiYjk1MGVlNTE1MDY2ZDg1OTNfNDMtMy0xLTEtNTg5Nzk_4955669a-1803-48c7-b6cf-c45ad020c912"
      unitRef="usd">54842800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i540972ea3b894aad8a249c7604f8d68d_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMS0xLTEtNTg5Nzk_3c07351c-e734-4239-9755-9520cd7ba674"
      unitRef="shares">1209507463</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i540972ea3b894aad8a249c7604f8d68d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMy0xLTEtNTg5Nzk_16429b9c-1d62-4739-8fde-16bbd1ca7555"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b0cf057ebfd4957826fe40ac96ad443_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktNS0xLTEtNTg5Nzk_2940633c-70c7-4a41-b5dd-56443ea1618d"
      unitRef="usd">18536100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b8608f018ae44cfa0a49be1967faa7d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktNy0xLTEtNTg5Nzk_59ee5dbc-327f-4cc1-a06c-3cbccf899da2"
      unitRef="usd">3688800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i2f380484fc704f83a0342b6bdf44bebd_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktOS0xLTEtNTg5Nzk_e8049d50-a26e-452d-9aec-62bb70f0c528"
      unitRef="shares">0</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f380484fc704f83a0342b6bdf44bebd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMTEtMS0xLTU4OTc5_dc274b9c-cb5b-480b-b0ad-2646c17b6472"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifec90faf56074071843d5dff2b177e01_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMTMtMS0xLTU4OTc5_14cdc7ab-aff8-4774-bd65-37e62bcd45c6"
      unitRef="usd">-1744300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMTktMTctMS0xLTU4OTc5_3bbda29b-0bf3-485e-96ba-accffcbcbbc4"
      unitRef="usd">20492700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjAtNy0xLTEtNTg5Nzk_1aa781b6-2cfa-421d-a929-6c4442f5b385"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjAtMTctMS0xLTU4OTc5_a5221870-c00a-4ec1-b8e1-3a17012e27f7"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i067dee996df34e2f84a35524e9e8481c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjEtMTMtMS0xLTU4OTc5_4871eb77-93b5-4de9-a452-006da674b5c7"
      unitRef="usd">-316700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjEtMTctMS0xLTU4OTc5_a4fcdca7-757a-46ad-b633-af79e22af574"
      unitRef="usd">-316700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment
      contextRef="i93966d3931bb4b9a9d064377829d20d5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItMS0xLTEtNTg5Nzk_f6101876-cc99-4103-a792-3bd24fca6f59"
      unitRef="shares">2816020</vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i93966d3931bb4b9a9d064377829d20d5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItMy0xLTEtNTg5Nzk_49e27b0d-79eb-4720-a0c0-5c535d03ed0d"
      unitRef="usd">0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="id369222933c4479abd90313ae11b86e9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItNS0xLTEtNTg5Nzk_aab4cf42-3878-46da-b03f-31cb349d78ab"
      unitRef="usd">0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjItMTctMS0xLTU4OTc5_f164c2dd-f4fc-4e7d-b5c8-31b672c67075"
      unitRef="usd">0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="id369222933c4479abd90313ae11b86e9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjMtNS0xLTEtNTg5Nzk_bedd7e58-c904-44fd-8811-c7c0bdcb7fd9"
      unitRef="usd">-9300000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjMtMTctMS0xLTU4OTc5_a98be003-b7c9-4da8-a873-2b01da48b9c0"
      unitRef="usd">-9300000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id369222933c4479abd90313ae11b86e9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjQtNS0xLTEtNTg5Nzk_230c1424-629c-47c3-9811-b1e638b28097"
      unitRef="usd">28300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjQtMTctMS0xLTU4OTc5_9e70f1b1-613c-47d1-a045-2b6acde73ae5"
      unitRef="usd">28300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStockCash
      contextRef="i269ed4494e9b4057b6b5fd874978d0ee_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjktNy0xLTEtNjAxMDg_80cd7c98-99e9-4038-9cdb-fa8d87ee0c56"
      unitRef="usd">146500000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i269ed4494e9b4057b6b5fd874978d0ee_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMjktMTctMS0xLTYwMTA4_4f1ba383-a0e9-4d97-af8e-0cec53a7a951"
      unitRef="usd">146500000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesIssued
      contextRef="i3e37563a7f3a4909b7dd02085a753d01_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMS0xLTEtNTg5Nzk_4cec96ff-e853-434b-8d10-6ede83b07411"
      unitRef="shares">1212323483</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e37563a7f3a4909b7dd02085a753d01_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMy0xLTEtNTg5Nzk_904694a5-e343-42a7-a756-d2c5655d5ec1"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia304a43e569c442dabdb1c25c2e35832_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtNS0xLTEtNTg5Nzk_02e54aab-c7fe-4a95-b528-30e4170e5a3a"
      unitRef="usd">18555100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i949fd9a15d71419c9f66a4369a131379_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtNy0xLTEtNTg5Nzk_152078c4-484a-43c3-bd1c-e55495027ddb"
      unitRef="usd">3941500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i8e4b05435485489b9e8b4fad080fe718_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtOS0xLTEtNTg5Nzk_e90015fd-2477-44fb-9d15-f0c714663c73"
      unitRef="shares">0</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e4b05435485489b9e8b4fad080fe718_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMTEtMS0xLTU4OTc5_bbb3fafe-12d6-467c-b4ed-8dd09540469c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f01433cbdfb450fa016216bdc117a8f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMTMtMS0xLTU4OTc5_d552e804-fc21-44d9-8292-e7a4e8ca4c90"
      unitRef="usd">-2061000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjY2M2E3M2Q4NTFhOTRmYTY4NTMxNGQxNWUzMDY0NjZkL3RhYmxlcmFuZ2U6NjYzYTczZDg1MWE5NGZhNjg1MzE0ZDE1ZTMwNjQ2NmRfMzAtMTctMS0xLTU4OTc5_5907062c-e2d9-40f8-ac0e-e0fd7f0f5ccd"
      unitRef="usd">20447700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ieaf18a35c07d4619b44d7c23d09f585e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMS0xLTEtNTg5Nzk_bfe982ac-9d03-46d1-8a21-0fcdf8426872"
      unitRef="shares">1206895644</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieaf18a35c07d4619b44d7c23d09f585e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMy0xLTEtNTg5Nzk_4b410a4a-e4cb-4128-8c87-26bc9fe5aa1a"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaff1f52f268c4433b7551e32308c1640_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtNS0xLTEtNTg5Nzk_31878032-b6d6-4ce6-9233-fcab9f647432"
      unitRef="usd">18438800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41532774e5ff4f418b14c53f63cb7d8a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtNy0xLTEtNTg5Nzk_b764cb99-182d-41cc-9bd3-56a37dc773e3"
      unitRef="usd">5361200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i3eaf90e86a23405aa9ca93eeeb3b40f6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtOS0xLTEtNTg5Nzk_4c2aedbe-6ca7-4ecd-ade6-cb9bcb17e938"
      unitRef="shares">0</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3eaf90e86a23405aa9ca93eeeb3b40f6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMTEtMS0xLTU4OTc5_845f4955-3a0e-4c43-8922-e32dcffca233"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bc0f9f8a1bf4a9a967c3233ef153a6d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMTMtMS0xLTU4OTc5_121c1f94-cd26-454b-9ee0-e69fe29cc72a"
      unitRef="usd">-858000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTgtMTctMS0xLTU4OTc5_48df6aef-abaf-45fd-9e8b-9d2e063f268a"
      unitRef="usd">22954100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTktNy0xLTEtNTg5Nzk_1701f0f1-81f3-49f0-a843-430ea0281202"
      unitRef="usd">-1037600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMTktMTctMS0xLTU4OTc5_b904a2c6-5fa5-4730-a062-d04c05d481cb"
      unitRef="usd">-1037600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie72c892bc6534c14adab5d7152694449_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjAtMTMtMS0xLTU4OTc5_922c8c50-ab74-4043-9c7c-3de5e9a316be"
      unitRef="usd">-527600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjAtMTctMS0xLTU4OTc5_8a0853a5-c1f5-4817-a905-e8e4fedf4bc3"
      unitRef="usd">-527600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment
      contextRef="i869a99efa4864d4490272885dbb4c20d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjEtMS0xLTEtNTg5Nzk_3154bc7f-76a0-4e2c-aaf4-8551d576aefa"
      unitRef="shares">1635326</vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjEtNS0xLTEtNTg5Nzk_a19dc4cd-0d9b-41df-97b7-df10f947d6be"
      unitRef="usd">0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjEtMTctMS0xLTU4OTc5_d3367c21-54f2-4292-b700-99e1e7125aa8"
      unitRef="usd">0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjItNS0xLTEtNTg5Nzk_d7e69553-b886-4d06-8cd7-1777af88975a"
      unitRef="usd">-6900000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjItMTctMS0xLTU4OTc5_7a13a112-075d-4205-97cb-9dadf6c7137f"
      unitRef="usd">-6900000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3aad378f93c3488bbdb050abd4c3ae84_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjMtNS0xLTEtNTg5Nzk_52774262-395f-4a5c-8a34-cf7484fce781"
      unitRef="usd">32700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjMtMTctMS0xLTU4OTc5_d5e4f772-24ff-44d3-8be6-15d1dbd72c96"
      unitRef="usd">32700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="icf75acc573ac4b3ea45a192607841887_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMS0xLTEtNTg5Nzk_857505a8-bfde-44a8-88df-3d272d3e49db"
      unitRef="shares">1208530970</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf75acc573ac4b3ea45a192607841887_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMy0xLTEtNTg5Nzk_9fcca5ca-f683-496c-bd81-6ad410ae7b35"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i758900e2e79742f39cd9b920398e128d_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtNS0xLTEtNTg5Nzk_2f1fc305-4551-40eb-a6bd-04087a35404c"
      unitRef="usd">18464600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4d981978cc94683b97f4e364187100f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtNy0xLTEtNTg5Nzk_314bf3e2-29a9-4877-a5bf-db7e9dc1eade"
      unitRef="usd">4323600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i16129c8fa4c146e7b0efbdba33260113_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtOS0xLTEtNTg5Nzk_d2a6d1d7-cbd1-481f-aebb-778dc6f71821"
      unitRef="shares">0</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16129c8fa4c146e7b0efbdba33260113_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMTEtMS0xLTU4OTc5_cb0842a5-770d-486b-a93a-dac9abb409a5"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84ae372e0d4640afaf6ca7d236588eca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMTMtMS0xLTU4OTc5_fb90c38f-ae66-4e21-8062-e52904969199"
      unitRef="usd">-1385600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8dd750c9019453f8f3c004524321932_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zMS9mcmFnOmM3NjgyM2VjNjI3ODRhYmViYzZmNmFhNWRhOGEzNDc1L3RhYmxlOjMyYWYwMTgwMjI3NTRmMGI4OGRiNDkzNGYyM2YzODBlL3RhYmxlcmFuZ2U6MzJhZjAxODAyMjc1NGYwYjg4ZGI0OTM0ZjIzZjM4MGVfMjgtMTctMS0xLTU4OTc5_3e2685a0-d62a-4bb7-a9d2-f9bdc42931b3"
      unitRef="usd">21414700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNC0xLTEtMS01ODk3OQ_1aa781b6-2cfa-421d-a929-6c4442f5b385"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNC0zLTEtMS01ODk3OQ_52c2cd04-8fdb-4468-ab28-642f067f9fc3"
      unitRef="usd">-1037600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNi0xLTEtMS01ODk3OQ_a252c4a9-dccc-4966-a6d3-78e37678d266"
      unitRef="usd">736000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNi0zLTEtMS01ODk3OQ_e4881907-72da-4648-970e-66b62e255431"
      unitRef="usd">1422500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNy0xLTEtMS01ODk3OQ_75a24247-f26f-4a6a-809b-0da6e735475c"
      unitRef="usd">28300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNy0zLTEtMS01ODk3OQ_bc4c732d-5099-4afb-8210-c89938b17ce6"
      unitRef="usd">32700000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOC0xLTEtMS01ODk3OQ_ffd373a9-916f-4bff-b14e-fe587611b582"
      unitRef="usd">-52800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOC0zLTEtMS01ODk3OQ_6bc014d8-17b4-4d1f-84dc-f01326cac8cc"
      unitRef="usd">288400000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOS0xLTEtMS01ODk3OQ_7b707fae-313c-4a18-a8f4-50ff29417a33"
      unitRef="usd">100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfOS0zLTEtMS01ODk3OQ_8a48cd19-891b-4058-a27f-a0af6e626740"
      unitRef="usd">-17900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTAtMS0xLTEtNTg5Nzk_b7e47da9-2980-462a-b81f-b6e705ee5440"
      unitRef="usd">-37800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTAtMy0xLTEtNTg5Nzk_c3c9ad56-5d1d-4ef7-8bcb-2086d8164cb1"
      unitRef="usd">-33300000</us-gaap:OtherNoncashIncomeExpense>
    <vtrs:Changeinnoncashlitigationsettlementsnet
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTEtMS0xLTEtNTg5Nzk_3afbb225-c599-400d-8fa1-0d5beb808a3c"
      unitRef="usd">-5200000</vtrs:Changeinnoncashlitigationsettlementsnet>
    <vtrs:Changeinnoncashlitigationsettlementsnet
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTEtMy0xLTEtNTg5Nzk_d3bf34e3-7c44-4cd5-ba0c-32f971fcdbfa"
      unitRef="usd">-22900000</vtrs:Changeinnoncashlitigationsettlementsnet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTMtMS0xLTEtNTg5Nzk_c38094fe-a7dd-4445-8fef-af3c2b470f99"
      unitRef="usd">115500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTMtMy0xLTEtNTg5Nzk_8a3379ef-502f-48fe-bc06-c134d1eaaf0a"
      unitRef="usd">59800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTQtMS0xLTEtNTg5Nzk_3eed4b4d-969f-4586-b51c-f45451ab4fc5"
      unitRef="usd">69100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTQtMy0xLTEtNTg5Nzk_fa2e21e7-28b5-4a30-aace-5d5b06f373a5"
      unitRef="usd">203400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTUtMS0xLTEtNTg5Nzk_69e9e58f-03c6-437f-8407-fb239aaef269"
      unitRef="usd">-30200000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTUtMy0xLTEtNTg5Nzk_c56b1fc3-9042-4c18-af97-b6b0dcd06fdd"
      unitRef="usd">191900000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTYtMS0xLTEtNTg5Nzk_ff5a109b-29ff-4eec-a5aa-a126820e30b5"
      unitRef="usd">67000000.0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTYtMy0xLTEtNTg5Nzk_b5d59630-f812-4bd4-954b-92a79b035e1c"
      unitRef="usd">494600000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTctMS0xLTEtNTg5Nzk_688eaf2a-4a3b-4938-80cb-fdddbfdc2116"
      unitRef="usd">-132700000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTctMy0xLTEtNTg5Nzk_2179d553-9ea3-42c9-b316-f04b9008132d"
      unitRef="usd">354600000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTgtMS0xLTEtNTg5Nzk_44f59e37-3667-48a3-bccb-a3509513a61e"
      unitRef="usd">1138500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMTgtMy0xLTEtNTg5Nzk_d658c0af-12e3-404b-b276-3af433852025"
      unitRef="usd">848800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjAtMS0xLTEtNTg5Nzk_9eca6eae-744a-4572-b7ff-ba86bcd78068"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjAtMy0xLTEtNTg5Nzk_7be72ddb-f4d4-4a9f-95ec-39d664153bf0"
      unitRef="usd">-277000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjEtMS0xLTEtNTg5Nzk_56eac795-3e8f-493d-b80a-d6b00ef8610c"
      unitRef="usd">64500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjEtMy0xLTEtNTg5Nzk_d3fb0dc9-19ec-422f-9c3a-eecfca71f1c5"
      unitRef="usd">49500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjItMS0xLTEtNTg5Nzk_dd837920-3718-4346-a717-3ae616156439"
      unitRef="usd">8600000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjItMy0xLTEtNTg5Nzk_23dc572a-098b-47a6-a1b9-e5c06d7d3d84"
      unitRef="usd">12300000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjMtMS0xLTEtNTg5Nzk_3adbd4e3-03ee-49ee-9db1-ed2e39775681"
      unitRef="usd">8500000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjMtMy0xLTEtNTg5Nzk_89845c50-4404-4b1f-aa2a-c6a2fcca4279"
      unitRef="usd">12300000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjQtMS0xLTEtNTg5Nzk_5fd24dd6-693a-4277-b119-d0b90239543b"
      unitRef="usd">7400000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjQtMy0xLTEtNTg5Nzk_4773249e-3acf-4a62-b219-dff85ae9e9f5"
      unitRef="usd">3700000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjUtMS0xLTEtNTg5Nzk_c0596ca5-8156-4176-9eb4-c34a224b67f6"
      unitRef="usd">5100000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjUtMy0xLTEtNTg5Nzk_b6597861-073a-4799-9e2c-67b6babcc56d"
      unitRef="usd">12500000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjYtMS0xLTEtNTg5Nzk_b274a2b9-07f7-4eeb-8a14-bab3aab10460"
      unitRef="usd">-66900000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjYtMy0xLTEtNTg5Nzk_814ac379-757c-4b71-a142-4af0aef6c962"
      unitRef="usd">236300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjgtMS0xLTEtNTg5Nzk_bdac8c78-b7fb-41fb-9c42-2499634d41cf"
      unitRef="usd">100000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjgtMy0xLTEtNTg5Nzk_6d2fd9f2-1d75-4d93-943e-11e8e7cdd257"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjktMS0xLTEtNTg5Nzk_e441245a-d028-455a-bee6-c38fbcbd98ad"
      unitRef="usd">100000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMjktMy0xLTEtNTg5Nzk_eca4287d-ba2a-4db5-a77e-23e04e431799"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzEtMS0xLTEtNTg5Nzk_11191e4f-43a4-4f19-816a-4f9c9f565661"
      unitRef="usd">-837900000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzEtMy0xLTEtNTg5Nzk_37be0777-9a3a-4529-b971-5a290bf79310"
      unitRef="usd">-1063900000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzItMS0xLTEtNTg5Nzk_a0ffb358-1941-4859-8825-fcc68d4db3ef"
      unitRef="usd">9900000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzItMy0xLTEtNTg5Nzk_15a451fb-d35a-494b-914b-dc6d73a834ee"
      unitRef="usd">7800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzMtMS0xLTEtNTg5Nzk_b192c18e-57a8-4431-b9d0-542a59c987e4"
      unitRef="usd">15500000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzMtMy0xLTEtNTg5Nzk_fdb40998-c1a6-41aa-814f-c6a999c07744"
      unitRef="usd">26000000.0</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzQtMS0xLTEtNTg5Nzk_64f84bfe-674b-403f-818c-7ea56817059a"
      unitRef="usd">400000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzQtMy0xLTEtNTg5Nzk_05e73e8c-6f1e-406d-b2f0-688f0c25c504"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzUtMS0xLTEtNjQxOTU_0b079369-5a71-428f-8a25-02f4b7dbecfb"
      unitRef="usd">145100000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzUtMy0xLTEtNjQxOTU_85f4a6f3-a591-4921-93ae-1291fa35774d"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzYtMS0xLTEtNTg5Nzk_158adb76-03ac-4744-8a88-c88f9ba33dc9"
      unitRef="usd">-200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzYtMy0xLTEtNTg5Nzk_7b9a7c4b-4d62-4f3a-80ea-58f7a06c6127"
      unitRef="usd">-2100000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzctMS0xLTEtNTg5Nzk_a61ebf48-0335-4468-93c5-f02ab9ded29a"
      unitRef="usd">-1009000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzctMy0xLTEtNTg5Nzk_7d708256-bd4b-4305-842e-1dba35af232d"
      unitRef="usd">-1099800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzgtMS0xLTEtNTg5Nzk_efa328c1-d121-4b74-9a56-6d31b912d1eb"
      unitRef="usd">-11400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzgtMy0xLTEtNTg5Nzk_afa7ff67-be1b-426b-ab30-1a2ac3ca6180"
      unitRef="usd">-22200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzktMS0xLTEtNTg5Nzk_b343e1c5-11cc-4b3b-b804-b970aeb4eff3"
      unitRef="usd">51200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfMzktMy0xLTEtNTg5Nzk_270d227e-6592-4e06-8a28-41cb217d9bbf"
      unitRef="usd">-36900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDAtMS0xLTEtNTg5Nzk_242d6296-f231-4210-9f17-ee8e3c459cee"
      unitRef="usd">706200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDAtMy0xLTEtNTg5Nzk_c5a28ff4-b313-44ee-a439-f62ed8c93d9d"
      unitRef="usd">850000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDEtMS0xLTEtNTg5Nzk_e646c6c1-d83e-490a-9be0-8b5dc46fd0d2"
      unitRef="usd">757400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8dd750c9019453f8f3c004524321932_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8zNC9mcmFnOjgxMjQ5ZDA3ZTAwZjQwZGZiOWNiM2QwMTA3MDc5MTI0L3RhYmxlOjE2YTk1ZTlkZjAyOTQ2NTk4MDVlMzA4NjcxZWY1NDE0L3RhYmxlcmFuZ2U6MTZhOTVlOWRmMDI5NDY1OTgwNWUzMDg2NzFlZjU0MTRfNDEtMy0xLTEtNTg5Nzk_5f1abadc-5309-4f21-a978-61d10e300efe"
      unitRef="usd">813100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTM1NA_d88c2415-56e6-4da8-8b0a-786ccfc34867">General&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements (&#x201c;interim financial statements&#x201d;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto in Viatris&#x2019; 2021 Form&#160;10-K. The December&#160;31, 2021 condensed consolidated balance sheet was derived from audited financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Turkey Highly Inflationary&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Under ASC 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 830&#x201d;), a highly inflationary economy is one that has cumulative inflation of approximately 100% or more over a three-year period. Effective April 1, 2022, we classified Turkey as highly inflationary. In accordance with ASC 830, starting with the second quarter of 2022, we will begin to use the U.S. dollar as our functional currency in Turkey, which historically utilized the Turkish lira as the functional currency. The impacted net sales for the three months ended March 31, 2022 and total assets at March 31, 2022 represented less than 1% of our consolidated net sales and total assets, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interim results of operations, comprehensive earnings and cash flows for the three months ended March&#160;31, 2022 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTM1NQ_34579f3f-460b-4c9e-9af7-d37cd0df3680">The accompanying unaudited condensed consolidated financial statements (&#x201c;interim financial statements&#x201d;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <vtrs:PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy
      contextRef="if11d265b55994603936bcc00f3604ac6_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTA5OTUxMTYzMjcxMw_139e664a-72c4-49f0-a28e-33a0550fb7c6"
      unitRef="number">0.01</vtrs:PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy>
    <vtrs:PercentOfTotalAssetsImpactedHighInflationaryEconomy
      contextRef="if11d265b55994603936bcc00f3604ac6_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80MC9mcmFnOmEyYjdhNzE2MWUyNjQ1MTFhMTVmZWM4MTU1MTY1MDc2L3RleHRyZWdpb246YTJiN2E3MTYxZTI2NDUxMWExNWZlYzgxNTUxNjUwNzZfMTA5OTUxMTYzMjcxMw_a7651d0e-9743-4541-80dd-72dce6e7f890"
      unitRef="number">0.01</vtrs:PercentOfTotalAssetsImpactedHighInflationaryEconomy>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzI1Mg_0a6a04d4-dbb3-4f77-ae4b-ccbfba47238b">Revenue Recognition and Accounts Receivable&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenues in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the condensed consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#x2019;s subsequent sales or usages occur. Such consideration is included in other revenues in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,554.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Global Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lipitor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Norvasc &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lyrica &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Viagra &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EpiPen&#xae; Auto-Injectors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celebrex &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effexor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Creon &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zoloft &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xalabrands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Segment Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dymista &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yupelri &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amitiza &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xanax &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;The Company does not disclose net sales for any products considered competitively sensitive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;Amounts for the three months ended March&#160;31, 2022 include the unfavorable impact of foreign currency translations compared to the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration and Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,567.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross to net adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,584.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,318.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,205.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,568.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Governmental rebate programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross to net adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,020.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,166.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No significant revisions were made to the methodology used in determining these provisions or the nature of the provisions during the three months ended March&#160;31, 2022. Such allowances were comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,802.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net was comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,556.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,774.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable Factoring Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $55.1 million and $29.6 million of accounts receivable as of March&#160;31, 2022 and December&#160;31, 2021, respectively, under these factoring arrangements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzI1Mw_797a2695-5ed3-4f11-87da-bd96f8606ca0">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,554.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Global Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lipitor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Norvasc &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lyrica &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Viagra &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EpiPen&#xae; Auto-Injectors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celebrex &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effexor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Creon &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zoloft &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xalabrands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Segment Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dymista &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yupelri &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amitiza &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xanax &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;The Company does not disclose net sales for any products considered competitively sensitive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;Amounts for the three months ended March&#160;31, 2022 include the unfavorable impact of foreign currency translations compared to the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration and Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,567.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross to net adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,584.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,318.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,205.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,568.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Governmental rebate programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross to net adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,020.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,166.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86ba39e9fd3f4576a6e3ba8ea5af515d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi0xLTEtMS01ODk3OQ_a753a315-d561-4817-b243-2a566135b279"
      unitRef="usd">1298700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e9f96c4bfdf4076a41b2f57ff65da66_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi0zLTEtMS01ODk3OQ_19647209-762e-46f1-9f44-142ce5eabf16"
      unitRef="usd">569700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i292d6065b18c456da950161dc0ed5cdc_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi01LTEtMS01ODk3OQ_e9b2c4e3-a4de-4bde-a151-53c3940101f5"
      unitRef="usd">249000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i955056f26f174344a59efe72d96b834c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi03LTEtMS01ODk3OQ_265c87d6-b359-4736-b6b8-bc52148491bb"
      unitRef="usd">436700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba711be447b3478c996341536356cdf5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMi05LTEtMS01ODk3OQ_1c9f1523-16c2-4261-98f7-1a343bdcfe68"
      unitRef="usd">2554100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fe9d75ef6164e1aba47dd0b90e867b5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy0xLTEtMS01ODk3OQ_8c6c384a-1902-4609-a6cb-aabcb05c3ae0"
      unitRef="usd">364100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a2e8d20544d4bc2a6e3f00cdd628190_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy0zLTEtMS01ODk3OQ_8eb61fcd-11f7-434b-8ce2-d71ac46df009"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i474b93c64de34a159cbfd01885dbf1f1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy01LTEtMS01ODk3OQ_599316d9-3aae-4e82-ba77-90fa52b93b97"
      unitRef="usd">10300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if294433954e94b85a607d271a2bd0aa8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy03LTEtMS01ODk3OQ_fd413999-1d75-412e-8079-2abe44fce840"
      unitRef="usd">16400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i491eb04d3a654f62b1752d08b7f0ac78_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfMy05LTEtMS01ODk3OQ_0725a791-2cc1-48bd-9e45-ce1c1cd69d8c"
      unitRef="usd">390800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7d16d65a7504e289ccdc9b0fe5363e9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC0xLTEtMS01ODk3OQ_d911439f-d7d8-4348-a3f1-c2048333e0bf"
      unitRef="usd">813300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9174fff41b14aaca81b7b98168f76b6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC0zLTEtMS01ODk3OQ_f0f6881a-ba33-407b-ae90-3a11026a0001"
      unitRef="usd">3400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd7dbc12b4304f5c84ac1ca236493c73_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC01LTEtMS01ODk3OQ_76292799-813d-4c6c-9ba8-396e36f3aec9"
      unitRef="usd">164500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0f0d8fcddec412b8d97bd5a1419a982_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC03LTEtMS01ODk3OQ_e0993c15-04a1-476e-98cd-eb3cdc8145c8"
      unitRef="usd">252100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25e59d16c05e4059bb82ad3b1d4de7c2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNC05LTEtMS01ODk3OQ_01a75c56-ea8d-4f0c-a2ce-a5aed8f5c210"
      unitRef="usd">1233300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS0xLTEtMS01ODk3OQ_f587dc67-a18a-4660-b386-f31166d0cf64"
      unitRef="usd">2476100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS0zLTEtMS01ODk3OQ_18c9c919-92bc-4a34-b58f-6b44f1cdee49"
      unitRef="usd">573100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibde6978e33374457b942a44020cb10ac_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS01LTEtMS01ODk3OQ_a70588b8-a4e4-4457-966d-93552a47166e"
      unitRef="usd">423800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS03LTEtMS01ODk3OQ_27d7685b-986a-4223-9574-ba172d170cfa"
      unitRef="usd">705200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjM2ZDM2NzczZjhiNTQ3YzlhNDQ4Mzk4M2FmNTAxNDU1L3RhYmxlcmFuZ2U6MzZkMzY3NzNmOGI1NDdjOWE0NDgzOTgzYWY1MDE0NTVfNS05LTEtMS01ODk3OQ_e818dee5-edca-4a32-97ab-67b0b665e6da"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9d1621479f04da080f48af407080848_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi0xLTEtMS01ODk3OQ_c4b28317-390c-4fa8-b95a-3ac7b6a76566"
      unitRef="usd">1403700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2820f52c9a448be8acecbf9c082bfca_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi0zLTEtMS01ODk3OQ_dbc5b6c5-15a1-4578-b3ca-9f5313b19259"
      unitRef="usd">590900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc3684b9a82c4961986055887197e3e0_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi01LTEtMS01ODk3OQ_15f76ed7-0882-440e-a8cc-d19885bf1be2"
      unitRef="usd">284000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbaa3dc1ea00496aa8394b48d658329d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi03LTEtMS01ODk3OQ_fd130db3-e70c-48af-a37d-d0fe6a71758d"
      unitRef="usd">446000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i748408c8afd2496db200ffab60f6309a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMi05LTEtMS01ODk3OQ_a763e333-ecdb-4867-be30-b5406a2c0cb8"
      unitRef="usd">2724600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia11c96949c8246b1a6f02ad3e9a1b8ff_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy0xLTEtMS01ODk3OQ_1b600170-a1d6-4b76-b4a8-28c83507dd64"
      unitRef="usd">312000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a80de9958be4b8999ac5f83c006a04d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy0zLTEtMS01ODk3OQ_48cc1afd-aebf-4f93-a5fa-0ca064668cd8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43c27f0d85da4abe8f1080ed37fb7cc5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy01LTEtMS01ODk3OQ_c5d7fd33-70b2-40bf-822c-3e8689005080"
      unitRef="usd">8900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fb745d16ade49188c879e9695ef5f1f_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy03LTEtMS01ODk3OQ_7fbf7313-1381-4aec-893c-3733c746ad3d"
      unitRef="usd">8000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcee3429c94d4f49a2cdae32dc34c903_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfMy05LTEtMS01ODk3OQ_05f45a2f-e05a-4d5f-bc14-265cf3f5855c"
      unitRef="usd">328900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id284b62a1ee441a690f5d1dc632ff0f0_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC0xLTEtMS01ODk3OQ_1fffc320-e458-4b05-9b05-ea97d1ee2607"
      unitRef="usd">855900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia59211776b6c4a7691d42c9ca7bf9112_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC0zLTEtMS01ODk3OQ_210d47a4-a827-4e13-87cc-dfe4866dba5a"
      unitRef="usd">1000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bb7352eee5c4e39a4037e1da189dcd5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC01LTEtMS01ODk3OQ_a56230ce-09e0-4978-9574-c80f7e9e7fc4"
      unitRef="usd">189000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9f9d84adfd04a3190bc51b5249c2bb3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC03LTEtMS01ODk3OQ_26bbd377-70aa-4ff8-a8d4-319acd6b337e"
      unitRef="usd">300700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e1cab044e074c6892720c7206be4d3e_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNC05LTEtMS01ODk3OQ_c14ba6f8-55c9-4e39-adfe-f1803297e0f5"
      unitRef="usd">1346600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS0xLTEtMS01ODk3OQ_4d12581e-041a-4545-8231-bd618bdae72a"
      unitRef="usd">2571600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS0zLTEtMS01ODk3OQ_3f3bc3a1-723f-4e44-a614-8af577ac723d"
      unitRef="usd">591900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS01LTEtMS01ODk3OQ_269d0470-e8b7-41f0-a76e-a7651433ddc1"
      unitRef="usd">481900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS03LTEtMS01ODk3OQ_651f7874-3c5f-4cf9-89d6-484197903b3b"
      unitRef="usd">754700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjU2MTljODg2MDA3ZDRiZWViYmI2YTlhNjU4NzVhYTY3L3RhYmxlcmFuZ2U6NTYxOWM4ODYwMDdkNGJlZWJiYjZhOWE2NTg3NWFhNjdfNS05LTEtMS01ODk3OQ_423640aa-222e-4e82-b933-17a3231451fd"
      unitRef="usd">4400100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1835a54addd6406c921c384df5914a3a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMy04LTEtMS01ODk3OQ_acf85fde-dd20-4b78-888d-30517b2b2090"
      unitRef="usd">440100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i135d47fb8e1749deb28406184113a7f3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMy0xMC0xLTEtNTg5Nzk_ddafa5e2-dae7-4418-a760-255ba3eb938e"
      unitRef="usd">464600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9abec7680e7e486b9c3cba801e828c78_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNC04LTEtMS01ODk3OQ_1be9da5b-0ccd-46d1-9da2-ae3bcb538833"
      unitRef="usd">207800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52fa1580002c42d589ddb55c78697ff0_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNC0xMC0xLTEtNTg5Nzk_aa8dc921-2c6b-4722-b0fd-956a85bb71d7"
      unitRef="usd">227700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e79823554854c9994555c6c449804f0_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNS04LTEtMS01ODk3OQ_cf14d161-c866-47aa-bba6-8c8d62513a37"
      unitRef="usd">171700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ffa584bf64441bfa32a52dfbd8ccd56_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNS0xMC0xLTEtNTg5Nzk_e0527d32-b2cf-43cf-b28f-3e2588485da2"
      unitRef="usd">187800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id717ea1bde634a34a611f888a445e7bc_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNi04LTEtMS01ODk3OQ_65813525-9b04-492d-a434-b1b35c80fcfe"
      unitRef="usd">129800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie24ff44d1ac94a97977bf67c683e1249_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNi0xMC0xLTEtNTg5Nzk_af68e266-6903-4f74-8b2f-d1460c67d807"
      unitRef="usd">139600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3006593f3b0c4bff83619b0e08ba5ff4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNy04LTEtMS01ODk3OQ_47122ba9-95ec-47d7-ac05-cf902aae68b7"
      unitRef="usd">88800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b41aeba1a37461eb3d32c974467161a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfNy0xMC0xLTEtNTg5Nzk_5bf99b48-cf3b-4722-9511-412eee67b7ac"
      unitRef="usd">103700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib02f402791b04a8a848fabcaebd62823_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOC04LTEtMS01ODk3OQ_62492f3d-0927-493b-9386-e799d7ab7806"
      unitRef="usd">85200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i158536bda5ef4607b007205257c61c21_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOC0xMC0xLTEtNTg5Nzk_a6b5e384-23c7-4203-ab72-bf8a4ee497a6"
      unitRef="usd">89000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62ede27cc7454699baf57d0d454a0244_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOS04LTEtMS01ODk3OQ_f40a7354-56bd-4878-adc1-e1e51e8f6b9e"
      unitRef="usd">77500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85796e832ed74154ae053fee7baad954_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfOS0xMC0xLTEtNTg5Nzk_757f3826-e082-40e0-823f-ddd9b063c2d4"
      unitRef="usd">76600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad726170615b4ba3addd534151d713e8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTEtMi0xLTEtNjU4ODc_d8ec241a-fd47-44e3-a961-53119d6d4a65"
      unitRef="usd">74700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48022c64e99b421c837601b663c4be1c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTEtNC0xLTEtNjU4ODc_2f0c9e58-06eb-4ee4-8747-6856e47dc7b6"
      unitRef="usd">69900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c7b925316344a58a37be2388b7ffca1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTAtOC0xLTEtNTg5Nzk_233670d7-7691-4d29-a95b-f87dfaf3ee80"
      unitRef="usd">73100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9199b9cb6f924570befa8e11e3b7a86f_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTAtMTAtMS0xLTU4OTc5_fcf4a49b-9381-4a5a-b919-f97cf050e220"
      unitRef="usd">76600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87788733377c4d97813f696f3baef142_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTItOC0xLTEtNTg5Nzk_2e74e5d1-8485-4d5e-a149-53f9e5dd240b"
      unitRef="usd">53000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b104192aa044c58ca3556d6141607c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTItMTAtMS0xLTU4OTc5_e918d8ab-82f0-45c2-b3c8-d807901a15b4"
      unitRef="usd">57900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84563bdbb5d44725a06b2c5fbc62e422_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctMi0xLTEtNzAxMDk_537646ab-3acc-474e-b3d8-e1806012f890"
      unitRef="usd">44000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4fea5e9149f40bfa10bc9bd2936bc6d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctNC0xLTEtNzAxMDk_e468ecaf-f9f8-4dbf-8d4e-f5c1570818eb"
      unitRef="usd">40300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e58994728654ea6896d5c8702fe2b3b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctMi0xLTEtNjU4Nzk_4560cc25-67ea-4d76-b222-c2a2d2d1e588"
      unitRef="usd">43700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0912a24a584447deb9f3b49a05227ef6_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTctNC0xLTEtNjU4Nzk_0f3dbafc-d3b5-4e00-a5fd-59be1951835b"
      unitRef="usd">36900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cfaa89f38c84069b2fa8d501cbd8580_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTUtOC0xLTEtNTg5Nzk_385e6dc0-7a63-4969-b55b-97f79838104b"
      unitRef="usd">41800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1daacd537079404ba5c511f26c26f483_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTUtMTAtMS0xLTU4OTc5_f49ba4cc-0d5a-4dee-823d-d8d8632bdff0"
      unitRef="usd">45900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5583a6d8429e4a15a832e3cb417de6c1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTYtOC0xLTEtNTg5Nzk_8417cb88-2750-4964-83ae-efeb6fbd80d5"
      unitRef="usd">40000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0dca7477e77e4046b85ab1d82f7b0be9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOmQ2MDQ3YTEzNGE0MDQ0OGI4Y2MyODRmOGY2NWNiNzgwL3RhYmxlcmFuZ2U6ZDYwNDdhMTM0YTQwNDQ4YjhjYzI4NGY4ZjY1Y2I3ODBfMTYtMTAtMS0xLTU4OTc5_bca4f648-ae28-496a-8ab8-9744b4b87485"
      unitRef="usd">45100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <vtrs:RevenuefromContractwithCustomerGross
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMy01LTEtMS01ODk3OQ_26438f67-4a14-4293-b3c7-99fa8c0ea51c"
      unitRef="usd">7198300000</vtrs:RevenuefromContractwithCustomerGross>
    <vtrs:RevenuefromContractwithCustomerGross
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMy03LTEtMS01ODk3OQ_62b275cf-8d21-4a72-aaa6-04715e91d86c"
      unitRef="usd">7567000000</vtrs:RevenuefromContractwithCustomerGross>
    <vtrs:Chargebacks
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNS01LTEtMS01ODk3OQ_3616a8f5-d460-4c0a-bf14-7d67c6c7e760"
      unitRef="usd">1584200000</vtrs:Chargebacks>
    <vtrs:Chargebacks
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNS03LTEtMS01ODk3OQ_0ac6579a-b460-4c56-a3f4-8a2bd6466e35"
      unitRef="usd">1318000000</vtrs:Chargebacks>
    <vtrs:AccruedSalesAllowances
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNi01LTEtMS01ODk3OQ_3a83a365-7ad5-400a-b735-bb9cbc51a61a"
      unitRef="usd">1205900000</vtrs:AccruedSalesAllowances>
    <vtrs:AccruedSalesAllowances
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNi03LTEtMS01ODk3OQ_2bbb5202-27d6-4be1-89b3-a3a3b7b6dead"
      unitRef="usd">1568500000</vtrs:AccruedSalesAllowances>
    <vtrs:RevenuefromContractwithCustomerReturns
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNy01LTEtMS01ODk3OQ_94fe3dad-909d-4e2c-9e07-268d58e5e4e8"
      unitRef="usd">82600000</vtrs:RevenuefromContractwithCustomerReturns>
    <vtrs:RevenuefromContractwithCustomerReturns
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfNy03LTEtMS01ODk3OQ_5da18840-207c-443e-9618-b4c1bdc53c36"
      unitRef="usd">113000000.0</vtrs:RevenuefromContractwithCustomerReturns>
    <vtrs:Medicaidandothergovernmentalrebates
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOC01LTEtMS01ODk3OQ_cdc712b3-edbe-44b8-9206-df13315e1f76"
      unitRef="usd">147400000</vtrs:Medicaidandothergovernmentalrebates>
    <vtrs:Medicaidandothergovernmentalrebates
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOC03LTEtMS01ODk3OQ_d6f4383a-258d-427b-97a7-69c908dde927"
      unitRef="usd">167400000</vtrs:Medicaidandothergovernmentalrebates>
    <vtrs:SalesRevenueGrosstonetadjustments
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOS01LTEtMS01ODk3OQ_d66e2730-4425-48cd-8613-4a25f2b67da5"
      unitRef="usd">3020100000</vtrs:SalesRevenueGrosstonetadjustments>
    <vtrs:SalesRevenueGrosstonetadjustments
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfOS03LTEtMS01ODk3OQ_2b8ac42a-79c6-403f-8b28-497faf6798f2"
      unitRef="usd">3166900000</vtrs:SalesRevenueGrosstonetadjustments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMTAtNS0xLTEtNTg5Nzk_e818dee5-edca-4a32-97ab-67b0b665e6da"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjNhZWYxNDY4MjgxODRjYzU4NmE1M2NkMzk3NWE0ZjRkL3RhYmxlcmFuZ2U6M2FlZjE0NjgyODE4NGNjNTg2YTUzY2QzOTc1YTRmNGRfMTAtNy0xLTEtNTg5Nzk_423640aa-222e-4e82-b933-17a3231451fd"
      unitRef="usd">4400100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzI1Nw_d92ddfbd-d7a9-4578-9196-622b7227a29f">Such allowances were comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,802.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net was comprised of the following at March&#160;31, 2022 and December&#160;31, 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,556.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,774.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMS0xLTEtMS01ODk3OQ_ce93f761-e2ad-4565-963a-99b4616994ce"
      unitRef="usd">1707100000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMS0zLTEtMS01ODk3OQ_dedf1e17-de0f-409a-8a62-dc2c6c84525e"
      unitRef="usd">1688600000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMi0xLTEtMS01ODk3OQ_25fcebd5-0573-49ee-ac92-e59ac35e981a"
      unitRef="usd">1095800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMi0zLTEtMS01ODk3OQ_7b325a47-1c11-4c36-aebc-ede242163130"
      unitRef="usd">1362100000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMy0xLTEtMS01ODk3OQ_f26e3fae-7af2-4186-b32f-11a92af7fb29"
      unitRef="usd">2802900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjI5N2I1MGM2MjQxNjQ3MDg4NTkyNmI0ZWM0NDE0ZDJmL3RhYmxlcmFuZ2U6Mjk3YjUwYzYyNDE2NDcwODg1OTI2YjRlYzQ0MTRkMmZfMy0zLTEtMS01ODk3OQ_4e8b7f95-0f81-44a7-930c-64f962d9e829"
      unitRef="usd">3050700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMS0xLTEtMS01ODk3OQ_94c2edb2-5113-442a-90c4-a059ffc19d6d"
      unitRef="usd">3556900000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMS0zLTEtMS01ODk3OQ_d249a635-91a2-4a75-89e7-4fa6202ac8b9"
      unitRef="usd">3774400000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMi0xLTEtMS01ODk3OQ_a0d7b22e-3cd0-4325-b86c-7d994515437a"
      unitRef="usd">537000000.0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMi0zLTEtMS01ODk3OQ_5d2e8e84-8661-4eea-8ffb-a789822d86b3"
      unitRef="usd">492000000.0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMy0xLTEtMS01ODk3OQ_3ed3f340-b9a4-4a00-9bce-59a5fcc0ff28"
      unitRef="usd">4093900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RhYmxlOjYyNWQzOTlhYzA3YjRmMTFhNDU5MzUyOTdkOGI2NGVlL3RhYmxlcmFuZ2U6NjI1ZDM5OWFjMDdiNGYxMWE0NTkzNTI5N2Q4YjY0ZWVfMy0zLTEtMS01ODk3OQ_2b049a5d-4827-4809-8ea5-3509fa2004cb"
      unitRef="usd">4266400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ProceedsFromSaleAndCollectionOfReceivables
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzE0MA_9097eab6-fc9d-4846-a73e-e0702ec6d416"
      unitRef="usd">55100000</us-gaap:ProceedsFromSaleAndCollectionOfReceivables>
    <us-gaap:ProceedsFromSaleAndCollectionOfReceivables
      contextRef="i08cd6d30ddde4135b38cb6b4509af6be_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80My9mcmFnOmZmNzIyZGQ1NTUyYTQ3NThiNDE2ZWJjN2Q5Y2FjNTRkL3RleHRyZWdpb246ZmY3MjJkZDU1NTJhNDc1OGI0MTZlYmM3ZDljYWM1NGRfMzE0Nw_f0259161-ebaa-478a-9e88-fcd0f6b5873b"
      unitRef="usd">29600000</us-gaap:ProceedsFromSaleAndCollectionOfReceivables>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF80Ni9mcmFnOjgzODc3M2I2NzBhMzQ2MmE5Mzk2ODk3Y2U2NjMzZDVkL3RleHRyZWdpb246ODM4NzczYjY3MGEzNDYyYTkzOTY4OTdjZTY2MzNkNWRfMjYxNA_99fcf2d0-11f1-4fa6-9311-a0adc940fc3d">Recent Accounting Pronouncements&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Standard&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued Accounting Standards Update 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2021-10&#x201d;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. We adopted the ASU prospectively on January 1, 2022. The additional annual disclosures required are not expected to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;There were no other significant changes in new accounting standards from those disclosed in Viatris&#x2019; 2021 Form 10-K. Refer to Viatris&#x2019; 2021 Form 10-K for additional information.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjYyNA_7de22873-f716-4329-bd82-749cd8968147">Share-Based Incentive Plan&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#x2019; sole stockholder at such time, approved the Plan which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP, which had previously been approved by Mylan shareholders. The Plan and 2003 LTIP include (i) 72,500,000 shares of common stock authorized for grant pursuant to the Plan, which may include dividend payments payable in common stock on unvested shares granted under awards, (ii) 6,757,640 shares of common stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) 13,535,627 shares of common stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTU_c0f2427b-1baa-41a5-bae1-4668a072522c"&gt;three&lt;/span&gt; to four years, and generally expire in ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares Under Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,576,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,126,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,077,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,831,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of 4.7 years, 4.6 years and 4.5 years, respectively. Also, at March&#160;31, 2022, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had no aggregate intrinsic value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company&#x2019;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs) as of March&#160;31, 2022 and the changes during the three months ended March&#160;31, 2022 are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Restricted Stock&#160;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair&#160;Value&#160;Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,858,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,635,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,517,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,747,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company had $272.7 million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of 2.0 years. The total intrinsic value of restricted stock units released during the three months ended March&#160;31, 2022 and 2021 was $63.1 million and $30.8 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ia1403ea4a4ff462894d5f150c3fc0424_I20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTA5OTUxMTYzMTE5MA_f6647c8c-9320-4c50-a7f7-c4b4543ae69a"
      unitRef="shares">72500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i300f9d815ab347b99f79dd4a94ef5112_D20201116-20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTA5OTUxMTYzMTIwMg_e1586451-48e2-4c94-a318-105613f06f0c"
      unitRef="shares">6757640</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i1b945f241fe546d3b6b6002a03ff26fc_I20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTA5OTUxMTYzMTIxMw_5add54e5-6d97-48a5-b39b-1caf5abc62c6"
      unitRef="shares">13535627</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4d074444c7494355a757a9e0ab0d8ffd_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTY_ce08e511-280a-467c-a3da-2d8afa767cfc">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTUzOTMxNjI3OTIzMTc_03628b07-1c1b-44dc-a0fd-7956e1b998ac">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjYyMg_631645e5-63bf-4dbe-819e-cde36a331b82">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares Under Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,576,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,126,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,077,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,831,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfMS0xLTEtMS01ODk3OQ_085d44f5-3ad2-4a21-8fdf-e0bb60903bdb"
      unitRef="shares">5576490</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfMS0zLTEtMS01ODk3OQ_f2806a32-fd80-446f-a94a-72b6cc85129d"
      unitRef="usdPerShare">37.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNC0xLTEtMS01ODk3OQ_c0bb99db-34b2-44d4-8bc1-ce5898b46eb1"
      unitRef="shares">450161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNC0zLTEtMS01ODk3OQ_b1a2889e-a519-49f0-baad-9efc216c9811"
      unitRef="usdPerShare">27.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNS0xLTEtMS01ODk3OQ_2b9f9590-78d9-482c-9032-974af756b763"
      unitRef="shares">5126329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNS0zLTEtMS01ODk3OQ_f5be6b82-301c-4979-898c-b0525d4813c2"
      unitRef="usdPerShare">38.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNi0xLTEtMS01ODk3OQ_384192d6-f494-4274-ae7d-c8842d3c3110"
      unitRef="shares">5077897</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNi0zLTEtMS01ODk3OQ_1ad93f39-bdbf-420a-9644-14d7492e7953"
      unitRef="usdPerShare">38.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNy0xLTEtMS01ODk3OQ_faae0ae3-ce07-4125-92d1-79394fba3fba"
      unitRef="shares">4831333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOjIzYWZjMmFjY2Y0NzQ5OTJhNGYxODhlYmUwOGIwM2I5L3RhYmxlcmFuZ2U6MjNhZmMyYWNjZjQ3NDk5MmE0ZjE4OGViZTA4YjAzYjlfNy0zLTEtMS01ODk3OQ_44d2199f-af68-4bf3-9c47-4b9859d09277"
      unitRef="usdPerShare">39.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTkyOA_2aec001c-3fd6-4b0c-8d8c-a6b97a514d73">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTkzMg_839d914a-6e6a-4094-b9c3-bba67d27a3a8">P4Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="iaa4c9432acb8476dbbf1279bd512b52a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMTkzOQ_ca124633-0163-4b52-a298-fc45f312cd29">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjYwNQ_f71f2399-0389-4d56-b9f7-24f0864bd443">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company&#x2019;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs) as of March&#160;31, 2022 and the changes during the three months ended March&#160;31, 2022 are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Restricted Stock&#160;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair&#160;Value&#160;Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,858,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,635,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,517,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,747,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ibd6d8a15669b44269a74dc8552c59bff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMS0xLTEtMS01ODk3OQ_8f47740d-574f-4610-9fd1-96ca6f274d40"
      unitRef="shares">16858128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ibd6d8a15669b44269a74dc8552c59bff_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMS0zLTEtMS01ODk3OQ_4df99e93-3f7e-4a2c-95d6-2987c0354a10"
      unitRef="usdPerShare">15.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMi0xLTEtMS01ODk3OQ_bb114cb4-5024-4a21-bc44-750f2ccc7692"
      unitRef="shares">16635392</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMi0zLTEtMS01ODk3OQ_4bf3f673-1a98-4776-ac68-256094934b94"
      unitRef="usdPerShare">10.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMy0xLTEtMS01ODk3OQ_95ba7d7f-d274-4f88-b144-0ca2e48e9092"
      unitRef="shares">3517219</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfMy0zLTEtMS01ODk3OQ_83ca2700-e9cc-4010-90ae-37670f8f45d7"
      unitRef="usdPerShare">17.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNC0xLTEtMS01ODk3OQ_118024e8-aba4-44b6-826c-1b8d8aed9ca4"
      unitRef="shares">229241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="iedfb1b0dfaed4159b91c72cbe5947a3a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNC0zLTEtMS01ODk3OQ_2b5fff6c-1560-498f-91ff-e51d5ca09020"
      unitRef="usdPerShare">13.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i172cb95ff1b1402d846fc493dacaeb9c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNS0xLTEtMS01ODk3OQ_49211842-4925-4b85-9595-bab6830b93dd"
      unitRef="shares">29747060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i172cb95ff1b1402d846fc493dacaeb9c_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RhYmxlOmFiM2NmZjg4NTgzOTQ2Y2JhYWNiZGRmOTMzMDA4ZWUxL3RhYmxlcmFuZ2U6YWIzY2ZmODg1ODM5NDZjYmFhY2JkZGY5MzMwMDhlZTFfNS0zLTEtMS01ODk3OQ_cb299974-c5bf-4262-b898-6520b0f606b2"
      unitRef="usdPerShare">12.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i56b037f5e77a4f00aa5d7a3f375a6f96_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjI1Nw_40220796-5100-471e-8d1f-25bb297e4905"
      unitRef="usd">272700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i1d97c12bd31b4009bd5259d649284b90_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjQ1OQ_fab41223-43ed-496e-92bf-803bd580efe9">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i1d97c12bd31b4009bd5259d649284b90_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjU3OQ_554917a8-a5f8-4830-8df5-d47674028fd2"
      unitRef="usd">63100000</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i2f30854d5be84566bce9b02e6adf2bc7_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81Mi9mcmFnOmVjZTdjNjI2NzY2ODQ5MDFiYzI3YjE5NmMyOTcxYjc1L3RleHRyZWdpb246ZWNlN2M2MjY3NjY4NDkwMWJjMjdiMTk2YzI5NzFiNzVfMjU4Ng_2890ffe9-cf2a-438b-af3e-56fcafa3ee26"
      unitRef="usd">30800000</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMjA4NA_6eba9f6f-c875-4d49-8333-686f4d0e2d61">Pensions and Other Postretirement Benefits&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Periodic Benefit Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost for the three months ended March&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension and Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is making the minimum mandatory contributions to its defined benefit pension plans in the U.S. and Puerto Rico for the 2022 plan year. The Company expects to make total benefit payments of approximately $118.0 million from pension and other postretirement benefit plans in 2022. The Company anticipates making contributions to pension and other postretirement benefit plans of approximately $52.0 million in 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMjA4OA_39e8d366-21eb-4abf-bc69-dcb53f61c4d7">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost for the three months ended March&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension and Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNC01LTEtMS01ODk3OQ_aceb58d3-cd8e-456e-904d-9e83ed2e368f"
      unitRef="usd">9500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNC03LTEtMS01ODk3OQ_d88a3b22-fce7-4a2b-8696-5454bbe59b93"
      unitRef="usd">10800000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNS01LTEtMS01ODk3OQ_3a8d71eb-f7f4-403a-b649-0dfce52d8f58"
      unitRef="usd">10400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNS03LTEtMS01ODk3OQ_a1bc43b2-4dde-4f6d-af92-ab9b93ab694a"
      unitRef="usd">8500000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNi01LTEtMS01ODk3OQ_0dc3eb50-3875-4f3a-8fb6-79920196476c"
      unitRef="usd">16600000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNi03LTEtMS01ODk3OQ_75608d53-8a69-4cf3-80ac-b7fe662987c9"
      unitRef="usd">16500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNy01LTEtMS01ODk3OQ_8333c1de-af14-4130-9640-17b3ac848732"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfNy03LTEtMS01ODk3OQ_053f9a32-3671-449d-95f6-2defe001e3f5"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOC01LTEtMS01ODk3OQ_c21f3540-4622-42f8-95dd-70bb38d94fab"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOC03LTEtMS01ODk3OQ_67069601-f4c4-4afd-b066-2ff6df46958d"
      unitRef="usd">-300000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idf19978eee644aba94ea1363e7675424_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOS01LTEtMS01ODk3OQ_67f31304-bd06-4ed4-bb5e-56c783221be0"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RhYmxlOmYzNDJlMzQzNDBlOTQ2YjI4ZjNkMmI2ZWI4YmUzNTJmL3RhYmxlcmFuZ2U6ZjM0MmUzNDM0MGU5NDZiMjhmM2QyYjZlYjhiZTM1MmZfOS03LTEtMS01ODk3OQ_1e1ae23a-7d87-4e73-af38-56064e83edcf"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMTkwMg_8b3fa94b-9d32-42a2-8d03-3f22fb5c5159"
      unitRef="usd">118000000</vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF81OC9mcmFnOmQ3YTRkYTVmODBmMTQ1NjViMzZiYzI5ZDg5ZWFkMGNiL3RleHRyZWdpb246ZDdhNGRhNWY4MGYxNDU2NWIzNmJjMjlkODllYWQwY2JfMjA3Ng_f96e179b-8b0a-4f7a-af40-bb8c76a7eec1"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDE4_dfd6ded9-925e-4c3e-a210-2dff36cdcc95">Balance Sheet Components&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected balance sheet components consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, included in prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,797.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,977.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,763.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,845.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,092.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,589.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,942.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,400.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,150.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,188.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and professional accruals, including litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments, clean energy investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,388.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other long-term obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax related items, including contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other long-term obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,933.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDUz_5ac0f066-66c8-47c7-9e9e-09a7a0043796">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, included in prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMS0xLTEtMS01ODk3OQ_b28ef41d-4c66-4290-b4f0-b292aae141e4"
      unitRef="usd">752400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMS0zLTEtMS01ODk3OQ_af007108-94f3-4f6a-bf4e-3be1967a731d"
      unitRef="usd">701200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if8dd750c9019453f8f3c004524321932_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMS01LTEtMS01ODk3OQ_a2bdd8aa-0e4b-4607-bb57-33830c7e4829"
      unitRef="usd">806900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMi0xLTEtMS01ODk3OQ_43dbdabc-01af-4695-9f00-133d05d0c362"
      unitRef="usd">5000000.0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMi0zLTEtMS01ODk3OQ_23911ace-542e-4285-9cbd-806055d1a430"
      unitRef="usd">5000000.0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="if8dd750c9019453f8f3c004524321932_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMi01LTEtMS01ODk3OQ_70d8288f-d7c9-4786-902e-92793e54f11d"
      unitRef="usd">6200000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMy0xLTEtMS01ODk3OQ_e646c6c1-d83e-490a-9be0-8b5dc46fd0d2"
      unitRef="usd">757400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMy0zLTEtMS01ODk3OQ_242d6296-f231-4210-9f17-ee8e3c459cee"
      unitRef="usd">706200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8dd750c9019453f8f3c004524321932_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjUwNmM0MDYwZjFmOTQ1YmE4Y2M0YzFlZjVmNmI4MmMxL3RhYmxlcmFuZ2U6NTA2YzQwNjBmMWY5NDViYThjYzRjMWVmNWY2YjgyYzFfMy01LTEtMS01ODk3OQ_f2106f92-ab38-462c-a95e-f3be76ad7d73"
      unitRef="usd">813100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDU3_daa6caf1-c048-4f15-aaec-b727c9b65c50">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,797.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,977.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMS0xLTEtMS01ODk3OQ_5aea8864-967c-442e-bc6e-5dbaf0664703"
      unitRef="usd">868100000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMS0zLTEtMS01ODk3OQ_0ca5db1f-2f4e-4cd6-ba6b-26e6c0523759"
      unitRef="usd">922400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMi0xLTEtMS01ODk3OQ_8a3ac55f-d702-4891-8398-ac3b8c057552"
      unitRef="usd">767500000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMi0zLTEtMS01ODk3OQ_94112ab8-65d7-4dca-a586-f8dca231e251"
      unitRef="usd">993300000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMy0xLTEtMS01ODk3OQ_16aa14f0-46c2-4cea-af90-e126f5c3398d"
      unitRef="usd">2161700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfMy0zLTEtMS01ODk3OQ_993b2b2d-ec3b-4d7e-9e58-f3ebebac5ee6"
      unitRef="usd">2062000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfNC0xLTEtMS01ODk3OQ_110a1e15-af11-454f-8a0b-7ec43971f934"
      unitRef="usd">3797300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjA0YmU2ZjNhZWU4NTQ2MzE4Y2ZjNDhlNjg3N2I3MjQ2L3RhYmxlcmFuZ2U6MDRiZTZmM2FlZTg1NDYzMThjZmM0OGU2ODc3YjcyNDZfNC0zLTEtMS01ODk3OQ_8245a4b1-d776-4b7b-9bd8-6317c2ebc859"
      unitRef="usd">3977700000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDU1_ac5530f0-fff0-415a-b579-557b882326df">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,763.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMS0xLTEtMS01ODk3OQ_0bbe1ef0-9ef6-41dd-a341-d7a8f2dc7cbf"
      unitRef="usd">268100000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMS0zLTEtMS01ODk3OQ_760260bb-95e9-44ff-a3ef-c988194d33a6"
      unitRef="usd">256700000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5151f58ea94c4939ae23348ce92f1b70_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMy0xLTEtMS01ODk3OQ_14737803-a528-4d4b-beaf-837713a67cf1"
      unitRef="usd">36600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie815b9c252a444bb82e640d926a75aaa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfMy0zLTEtMS01ODk3OQ_7e68e83e-098d-443f-aca3-be7b7cbf8f0a"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNC0xLTEtMS01ODk3OQ_9289c09a-12b6-4714-ab6e-612cbb4f048c"
      unitRef="usd">202800000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNC0zLTEtMS01ODk3OQ_aeb695a3-f99e-44a5-b595-5804b3c884c2"
      unitRef="usd">144600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:TradingSecurities
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNS0xLTEtMS01ODk3OQ_7751f758-da17-409d-a852-33660b11402e"
      unitRef="usd">48000000.0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNS0zLTEtMS01ODk3OQ_85ad8ef6-06d8-4b1f-99e3-192c3d21947c"
      unitRef="usd">51000000.0</us-gaap:TradingSecurities>
    <us-gaap:OtherAssetsCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNi0xLTEtMS01ODk3OQ_31e94884-3b7d-4974-b079-79fa9f81840c"
      unitRef="usd">1208100000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNi0zLTEtMS01ODk3OQ_844b1567-163e-4645-b4fa-5c7fd9cf70e4"
      unitRef="usd">1467100000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNy0xLTEtMS01ODk3OQ_204169c6-4ad7-489a-9c49-ad5f6a447c64"
      unitRef="usd">1763600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmI4YTdkMzVlOGQ5YjRiODJhNzg5M2JjZjIzNjY4MWRjL3RhYmxlcmFuZ2U6YjhhN2QzNWU4ZDliNGI4MmE3ODkzYmNmMjM2NjgxZGNfNy0zLTEtMS01ODk3OQ_5ef458dd-cd51-47f4-9719-cd12f22a83ad"
      unitRef="usd">1957600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDUx_9285f43c-3ea9-430f-973d-d47e41d95602">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,845.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,092.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,589.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,942.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,400.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,150.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,188.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icde1a85ed6e247a086a8aad3326c4e01_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMS0xLTEtMS01ODk3OQ_044aa6d8-e1fb-42cc-a405-32fce991a952"
      unitRef="usd">2845800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1d8d5eff296a4e6d8f34d3fd83d2fa04_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMS0zLTEtMS01ODk3OQ_7b3b2470-5ebf-47ec-9685-ef6b89bb88ec"
      unitRef="usd">3054000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4505670638054dd8bdc85765bd7b5bb5_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMi0xLTEtMS01ODk3OQ_937f2f88-5ea4-4a37-b174-6875f5328d26"
      unitRef="usd">1578400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i67b06c877d5645eca6b4db2020388c0f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMi0zLTEtMS01ODk3OQ_82645fbe-57a3-4c2d-8dd2-fecbdfe0711a"
      unitRef="usd">1808500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i02260e2d4d964332930fc8ba5cb79fd1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMy0xLTEtMS01ODk3OQ_ba8b4e1b-05f9-477a-8c78-2453c7f9b59a"
      unitRef="usd">541800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i992fd5c4440f4ad69a507b4b2076605b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfMy0zLTEtMS01ODk3OQ_22174759-5612-446f-afb3-733021bac62e"
      unitRef="usd">588700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibc828c926f7f4226bb0765da134ca177_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNC0xLTEtMS01ODk3OQ_1ba1bb17-c5cc-4bcd-8d12-38fa5a6c46db"
      unitRef="usd">126500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id5a293effe2d476e8a82ca69b066c37a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNC0zLTEtMS01ODk3OQ_367e26d4-94f4-4868-8a2a-7f1a7593e594"
      unitRef="usd">137900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNS0xLTEtMS01ODk3OQ_88e68608-7a96-459e-8f98-132e60688b6b"
      unitRef="usd">5092500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNS0zLTEtMS01ODk3OQ_d86521da-d3bc-4406-b7c6-760f1d6e1054"
      unitRef="usd">5589100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNi0xLTEtMS01ODk3OQ_3056b608-2e50-40ef-870c-72ac2bacd352"
      unitRef="usd">1942300000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNi0zLTEtMS01ODk3OQ_cb54dc1c-40b8-4b1b-9b17-7869e97981a9"
      unitRef="usd">2400500000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNy0xLTEtMS01ODk3OQ_0186bb33-a1ec-4a3a-845a-4702767d1a48"
      unitRef="usd">3150200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQwZjY1N2YyNzJiYjRkNTBhNTQ3MTNhY2ZhNjkzMjMzL3RhYmxlcmFuZ2U6ZDBmNjU3ZjI3MmJiNGQ1MGE1NDcxM2FjZmE2OTMyMzNfNy0zLTEtMS01ODk3OQ_f45153cd-7f8e-4dad-bb20-3faa21350d84"
      unitRef="usd">3188600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDYw_815b0a53-1e37-4552-8575-8f85088b00d1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMi0xLTEtMS01ODk3OQ_2642f3df-4d7e-401c-b017-bb5eec1774e5"
      unitRef="usd">281700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMi0zLTEtMS01ODk3OQ_e5fb9b65-d555-467c-8d86-9734bdd88431"
      unitRef="usd">290800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <vtrs:Otherlongtermassets
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMy0xLTEtMS01ODk3OQ_cbbad063-eb28-4319-8570-cf7b443d16e5"
      unitRef="usd">774300000</vtrs:Otherlongtermassets>
    <vtrs:Otherlongtermassets
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfMy0zLTEtMS01ODk3OQ_79c268d5-fce0-401c-84b8-a0ed6fa5230f"
      unitRef="usd">879900000</vtrs:Otherlongtermassets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfNC0xLTEtMS01ODk3OQ_4b41ce87-83d8-4040-9a60-c9987e38e2b2"
      unitRef="usd">1056000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjU0MGY5ZjdiNDg4NTRjODM5MjFmNzM1NDUxZDI3NTc5L3RhYmxlcmFuZ2U6NTQwZjlmN2I0ODg1NGM4MzkyMWY3MzU0NTFkMjc1NzlfNC0zLTEtMS01ODk3OQ_fbd55628-d875-4863-aa67-eeb16f279f31"
      unitRef="usd">1170700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDQ4_f990b80f-19c9-42aa-b019-f32ee2db76c2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMS0xLTEtMS01ODk3OQ_1a1f9275-2076-48eb-9efa-2bb167b03201"
      unitRef="usd">928400000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMS0zLTEtMS01ODk3OQ_7cfb3531-ec13-4af6-821b-57c45ac86915"
      unitRef="usd">1056100000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMi0xLTEtMS01ODk3OQ_fa25d64a-dee1-4c5d-b6c0-8e6bfffc43b4"
      unitRef="usd">571200000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMi0zLTEtMS01ODk3OQ_376e1186-bf9a-4da5-a3db-35afd6aaa81b"
      unitRef="usd">601300000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMy0xLTEtMS01ODk3OQ_60366fe9-7880-4332-a43c-7c7a931a6702"
      unitRef="usd">1499600000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmQ0NzZkYTJkYjAyYjQxYmI5ZDY2MTMwZmM4NjAxODZlL3RhYmxlcmFuZ2U6ZDQ3NmRhMmRiMDJiNDFiYjlkNjYxMzBmYzg2MDE4NmVfMy0zLTEtMS01ODk3OQ_2b7022e9-da47-43b4-aa41-83aaacde7509"
      unitRef="usd">1657400000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDEy_83e3743e-743d-43cb-9ab8-19bdbaac3b01">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and professional accruals, including litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments, clean energy investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,388.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i126834f952d14d5ba0e012629f9f51b8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMS0xLTEtMS01ODk3OQ_25fcebd5-0573-49ee-ac92-e59ac35e981a"
      unitRef="usd">1095800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i2348a305e98341d6b3d64a25bd98d99f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMS0zLTEtMS01ODk3OQ_7b325a47-1c11-4c36-aebc-ede242163130"
      unitRef="usd">1362100000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMi0xLTEtMS01ODk3OQ_d73d96e7-9ebe-4afa-915d-8dd96823d745"
      unitRef="usd">694900000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMi0zLTEtMS01ODk3OQ_6f08bb2e-a437-4741-9ff2-8cc16cd28db0"
      unitRef="usd">715600000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMy0xLTEtMS01ODk3OQ_bda65a13-9b5c-46da-9499-65566d9da58d"
      unitRef="usd">567100000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMy0zLTEtMS01ODk3OQ_60737995-3213-4c07-9850-6016f8d93d3c"
      unitRef="usd">741900000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3e4d7d622da84b43bba3a6f1313667a9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNC0xLTEtMS01ODk3OQ_b4653449-fd99-4abd-9a03-9dd65d7081b4"
      unitRef="usd">86200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icf8ebd1f9f2b43aea75b756394d24cc8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNC0zLTEtMS01ODk3OQ_19cc38be-b9dc-4cc9-9687-25a0b3705075"
      unitRef="usd">66700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0xLTEtMS02MDYxMg_5b444113-c4fe-434f-ac8e-911f7aa8a154"
      unitRef="usd">171800000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0zLTEtMS02MDYxOQ_79bcd3a2-58b8-4a9c-bec2-af173711450a"
      unitRef="usd">233500000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0xLTEtMS01ODk3OQ_132c8fc6-a0bc-4687-998a-d5ea7c9affc6"
      unitRef="usd">228800000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNS0zLTEtMS01ODk3OQ_5ca5e544-5565-4d8b-aa51-05e1efe0c910"
      unitRef="usd">86600000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia835a6c092bb43bdaabb4af69cf5c32b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNy0xLTEtMS01ODk3OQ_f58da765-0bf9-40c6-96b6-fc40fe76ac77"
      unitRef="usd">4300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="icd41d809933d449a9b51ef98b9a9d921_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfNy0zLTEtMS01ODk3OQ_96c6dfb8-015c-42bf-9aea-85c409b73b5c"
      unitRef="usd">10900000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOC0xLTEtMS01ODk3OQ_6faab031-6173-49ec-9f01-96e54a614dc4"
      unitRef="usd">98900000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOC0zLTEtMS01ODk3OQ_15fc38ed-b066-4f75-82b5-9efe681d70be"
      unitRef="usd">61000000.0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOS0xLTEtMS01ODk3OQ_33b7858e-e544-42c1-8453-8c593f544e31"
      unitRef="usd">89900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfOS0zLTEtMS01ODk3OQ_c2d444d5-3022-4518-9821-5c000fddd0fc"
      unitRef="usd">86700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTAtMS0xLTEtNTg5Nzk_f9f45b18-c3a9-45a8-8194-d4072ff8ed60"
      unitRef="usd">1388600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTAtMy0xLTEtNTg5Nzk_4c05ddc8-33d8-4031-83c2-ac50d2b782f5"
      unitRef="usd">1254600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTEtMS0xLTEtNTg5Nzk_95d1751a-dc58-4423-9a68-93f011c7fe7a"
      unitRef="usd">4426300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOmUxZGI1NTk4ZmY2NDQwMzM5OGI0OWU4OTNiYTAwNWZjL3RhYmxlcmFuZ2U6ZTFkYjU1OThmZjY0NDAzMzk4YjQ5ZTg5M2JhMDA1ZmNfMTEtMy0xLTEtNTg5Nzk_631893f6-2821-4e96-88cc-2601f2eb72e8"
      unitRef="usd">4619600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfNDM5_3d79c6ae-f726-4e5d-b1d7-896751b3cf66">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other long-term obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax related items, including contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other long-term obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,933.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMS0xLTEtMS01ODk3OQ_a129d7c6-6503-485a-8b09-6dfe2f98564f"
      unitRef="usd">861300000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMS0zLTEtMS01ODk3OQ_d695c183-ed5f-4415-8930-672d334dae0c"
      unitRef="usd">876400000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic5cf551f83c9439aa1d37ce9a597c5af_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMi0xLTEtMS01ODk3OQ_becf76e4-0565-4f33-b72e-3071fe5839ca"
      unitRef="usd">112200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i83bfda8fa6a3472ab6b18074c291d3ba_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfMi0zLTEtMS01ODk3OQ_fa38e2d6-6194-4346-9193-514603c8a255"
      unitRef="usd">133000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNC0xLTEtMS01ODk3OQ_f6fca34b-4b74-4715-85ce-5499fa2d3f7c"
      unitRef="usd">429500000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNC0zLTEtMS01ODk3OQ_8853ee8f-d43f-4f3b-855d-7557a55ecb8d"
      unitRef="usd">426100000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNS0xLTEtMS01ODk3OQ_5186ac18-1dee-4ee0-abd1-7cbff1d13f84"
      unitRef="usd">191700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNS0zLTEtMS01ODk3OQ_167a2ef8-6a79-46ac-af5f-cfb304294730"
      unitRef="usd">200900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNi0xLTEtMS01ODk3OQ_1e72d8f1-4ee9-4647-a6ba-240f1c3a2923"
      unitRef="usd">51400000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNi0zLTEtMS01ODk3OQ_ef2af271-5c09-4874-a4f6-a7005818c4ec"
      unitRef="usd">64300000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNy0xLTEtMS01ODk3OQ_fac18d11-6245-4233-a235-9fe54b2b0504"
      unitRef="usd">238200000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfNy0zLTEtMS01ODk3OQ_725e32bb-d580-45d8-b7f5-40f598105d8d"
      unitRef="usd">232900000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfOC0xLTEtMS01ODk3OQ_a11371ef-c0de-486e-9f27-8cf4cdaa7fa0"
      unitRef="usd">1884300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjAwZWY1MTYyNzNiNDQ2NDk4ZDJkOWI0NWZiOTNmMGJkL3RhYmxlcmFuZ2U6MDBlZjUxNjI3M2I0NDY0OThkMmQ5YjQ1ZmI5M2YwYmRfOC0zLTEtMS01ODk3OQ_d89c92b4-3274-4bde-9f9c-feba20b64084"
      unitRef="usd">1933600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="id222bc967c45426a9e0cbe615268daea_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTA5OTUxMTYzMTE2Mw_b63bc9f9-df9f-4357-8ed0-e4e61ed1909e"
      unitRef="usd">2000000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership
      contextRef="i8a3a5f469f2a41ea9dba3560f618f489_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTA5OTUxMTYzMTIwNA_c255f123-66bf-401f-9160-ca43c30be39d"
      unitRef="number">0.129</vtrs:DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh
      contextRef="id222bc967c45426a9e0cbe615268daea_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTA5OTUxMTYzMTE4NA_1e7fa35f-38e0-4945-aece-4d7988807271"
      unitRef="usd">335000000</vtrs:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTUzOTMxNjI3OTU5MjM_56cbdbee-7a2c-481f-ac04-6be405f7d321">The amounts associated with the biosimilars portfolio classified as held for sale consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,337.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMy0yLTEtMS02ODA0NQ_95ad3a2f-3081-4c08-9591-6d4d95a5fd51"
      unitRef="usd">136100000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNC0yLTEtMS02ODA0NQ_04f7269c-eb92-450b-a9b2-a435b14cae3b"
      unitRef="usd">122400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNS0yLTEtMS03MTIyNQ_a96f170f-67fa-4295-bd83-6f7b9568bbd0"
      unitRef="usd">12500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNS0yLTEtMS02ODA0NQ_34fb1a16-58a2-451f-a06b-80a794e8b93a"
      unitRef="usd">7500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNi0yLTEtMS02ODA0NQ_6126324f-4af8-4cb3-8c62-e189342a4055"
      unitRef="usd">953000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfNy0yLTEtMS02ODA0NQ_8dd6f902-f074-4a56-9031-4a7b27880cf0"
      unitRef="usd">105600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfOC0yLTEtMS02ODA0NQ_0c29e7c8-27d3-4f02-bd00-654a92b49e84"
      unitRef="usd">1337100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMTEtMi0xLTEtNjgwNTg_bacfb0c2-56bc-404b-980e-079dfc1c0e48"
      unitRef="usd">95400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="iad95ad3c0d504290a9510ac2d347f752_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMTItMi0xLTEtNjgwNTg_24e9232e-d570-443d-b801-875c940e5c2c"
      unitRef="usd">182300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RhYmxlOjFiNjU4NmE2NmU0NTRmM2NhNzU1OTRkN2JlMWRjNTZlL3RhYmxlcmFuZ2U6MWI2NTg2YTY2ZTQ1NGYzY2E3NTU5NGQ3YmUxZGM1NmVfMTMtMi0xLTEtNjgwNTg_6fe9c473-2b37-4a08-bd8c-92a50efa501d"
      unitRef="usd">277700000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF82MS9mcmFnOjJmZTlkNWM0MzlkNTRmMDBhOGViOTYyMTgxM2JiOTUwL3RleHRyZWdpb246MmZlOWQ1YzQzOWQ1NGYwMGE4ZWI5NjIxODEzYmI5NTBfMTY0OTI2NzQ0NTYyNQ_bdc3245f-c8fa-47d8-b784-8104f608efea"
      unitRef="usd">169100000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfNzMz_da0e18f9-43fa-4347-8b92-5de7b60b1794">Equity Method Investments&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The law that provides for IRC Section 45 tax credits expired during the year ended December 31, 2021 for all three clean energy investments and all of the clean energy investments have wound down operations. Summarized financial information, in the aggregate, for the Company&#x2019;s three equity method, clean energy investments on a 100% basis for the three months ended March&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating and non-operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company&#x2019;s net losses from its equity method investments included amortization expense related to the excess of the cost basis of the Company&#x2019;s investment over the underlying assets of each individual investee. For the three months ended March&#160;31, 2021, the Company recognized net losses from equity method investments of $17.9 million, which were recognized as a component of other expense, net in the condensed consolidated statements of operations. The Company recognized the income tax credits and benefits from the clean energy investments as part of its provision for income taxes.</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfNzMy_3305e7e8-fc1e-4be0-a52b-a51fa570db20">Summarized financial information, in the aggregate, for the Company&#x2019;s three equity method, clean energy investments on a 100% basis for the three months ended March&#160;31, 2021 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating and non-operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <vtrs:Numberofequitymethodinvestments
      contextRef="ia835a6c092bb43bdaabb4af69cf5c32b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfMTAy_591c70e0-8b34-4705-bf0b-916e95907e98"
      unitRef="number">3</vtrs:Numberofequitymethodinvestments>
    <vtrs:EquityMethodInvestmentsSummarizedFinancialDataBasis
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfMTUw_cf67537c-2246-4832-bb43-d9cd0faa2e56"
      unitRef="number">1</vtrs:EquityMethodInvestmentsSummarizedFinancialDataBasis>
    <us-gaap:Revenues
      contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfMy03LTEtMS01ODk3OQ_0d586028-e7ec-46c5-90dd-6f6b0c5a16b5"
      unitRef="usd">109500000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfNC03LTEtMS01ODk3OQ_c9135dfd-5b2f-4fc5-a8c4-ca84a23dbacd"
      unitRef="usd">-1400000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfNS03LTEtMS01ODk3OQ_e7141dfd-21d2-413f-a46b-5e6fb17385a6"
      unitRef="usd">4900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RhYmxlOjJjZDI3MDNlNGIwYzQzN2ViMzgzODc1NWViZWU1YjQxL3RhYmxlcmFuZ2U6MmNkMjcwM2U0YjBjNDM3ZWIzODM4NzU1ZWJlZTViNDFfNi03LTEtMS01ODk3OQ_2e3f817a-4b01-45ab-b8d0-93217fa25479"
      unitRef="usd">-6300000</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83MC9mcmFnOjBiNWUyNTBiMzUzZDRlODA5MDFjM2I2ODczNmVmNWE0L3RleHRyZWdpb246MGI1ZTI1MGIzNTNkNGU4MDkwMWMzYjY4NzM2ZWY1YTRfNTA1_8a48cd19-891b-4058-a27f-a0af6e626740"
      unitRef="usd">-17900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTc2Mw_7740daf7-5f80-4b4d-bffe-03574f360c10">Earnings (Loss)&#160;per Share&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share attributable to Viatris Inc. are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,037.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings (loss) per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,037.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total dilutive shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional stock awards and restricted stock awards were outstanding during the three months ended March&#160;31, 2022 and 2021, but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares at March&#160;31, 2022 include certain share-based compensation awards whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 15.5 million shares and 10.9 million shares for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid a quarterly dividend of $0.12 per share on the Company&#x2019;s issued and outstanding common stock on March 16, 2022. On May 5, 2022, the Company&#x2019;s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company&#x2019;s issued and outstanding common stock, which will be payable on June 16, 2022 to shareholders of record as of the close of business on May 24, 2022. The declaration and payment of future dividends to holders of the Company&#x2019;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#x2019;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 6, 2022, the Company announced that its Board of Directors had authorized a DRIP. The DRIP will allow shareholders to automatically reinvest all or a portion of the cash dividends paid on their shares of the Company&#x2019;s common stock and to make certain additional optional cash investments in the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0&#160;billion of the Company&#x2019;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTc1Mg_097ead93-e650-4028-95bc-a641be1c29ab">Basic earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTc1NA_a35e8435-bb27-407c-959a-2b58db678ebf">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share attributable to Viatris Inc. are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,037.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings (loss) per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,037.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total dilutive shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNC01LTEtMS01ODk3OQ_1aa781b6-2cfa-421d-a929-6c4442f5b385"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNC03LTEtMS01ODk3OQ_1701f0f1-81f3-49f0-a843-430ea0281202"
      unitRef="usd">-1037600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNi01LTEtMS01ODk3OQ_7287e534-3261-493a-92fb-58aeabe6399a"
      unitRef="shares">1210500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNi03LTEtMS01ODk3OQ_6f62822d-a6c6-44fe-95aa-3a3ed3ada22e"
      unitRef="shares">1207500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNy01LTEtMS01ODk3OQ_a0a80fa8-134a-4fc4-862b-967b29b2aa16"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfNy03LTEtMS01ODk3OQ_5b1bf627-345c-4a4a-9bbe-f2a754ab02a6"
      unitRef="usdPerShare">-0.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTAtNS0xLTEtNTg5Nzk_1aa781b6-2cfa-421d-a929-6c4442f5b385"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTAtNy0xLTEtNTg5Nzk_1701f0f1-81f3-49f0-a843-430ea0281202"
      unitRef="usd">-1037600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTItNS0xLTEtNTg5Nzk_7287e534-3261-493a-92fb-58aeabe6399a"
      unitRef="shares">1210500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTItNy0xLTEtNTg5Nzk_6f62822d-a6c6-44fe-95aa-3a3ed3ada22e"
      unitRef="shares">1207500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTMtNS0xLTEtNTg5Nzk_cfcbc739-befa-4343-ae95-55b7ed912aac"
      unitRef="shares">2600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTMtNy0xLTEtNTg5Nzk_210432ed-5c61-4e73-9025-c2c737218ada"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTQtNS0xLTEtNTg5Nzk_6eb9b7f3-38d7-45f4-bc02-25a07fd00187"
      unitRef="shares">1213100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTQtNy0xLTEtNTg5Nzk_3e92f14e-c50a-43b3-96dd-f169af598400"
      unitRef="shares">1207500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTUtNS0xLTEtNTg5Nzk_33fafc8c-be6b-424b-ba1f-1a4d2420f0a5"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RhYmxlOjdjODM1OTAzY2IzZjQxYWM4N2EwMjQzYzU0MGI5OTAxL3RhYmxlcmFuZ2U6N2M4MzU5MDNjYjNmNDFhYzg3YTAyNDNjNTQwYjk5MDFfMTUtNy0xLTEtNTg5Nzk_2ecd9488-03aa-4e33-9be4-85bc38bed2fb"
      unitRef="usdPerShare">-0.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTAwMQ_9e5709b4-1ab9-421a-b6f5-9aa238f1dc26"
      unitRef="shares">15500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTAxNQ_ae6c50c1-666c-436b-aa72-46e8e0683e6a"
      unitRef="shares">10900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i286f6b049173419eb8a591dad67f9db8_D20220316-20220316"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDUxOQ_1af8de33-ed0f-455b-a552-15acb4bef112"
      unitRef="usdPerShare">0.12</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ie2c8bb318051412cb62ce2064e9b0c5d_I20220505"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDUxMg_0c476a22-7f02-431f-bb9a-bf2b4a03ae6e"
      unitRef="usdPerShare">0.12</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ibaa26d9c588c4182ac69aa58107614ff_D20220505-20220505"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDUxMg_5388a588-b574-40ed-ae01-cdba284c9a27"
      unitRef="usdPerShare">0.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ic6ae763f13a34754b0fd888a4b714401_I20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83My9mcmFnOjM0MjRiN2VjOGFlYTRlZmViZDg5ZjVhYjljZjY1ZDY2L3RleHRyZWdpb246MzQyNGI3ZWM4YWVhNGVmZWJkODlmNWFiOWNmNjVkNjZfMTY0OTI2NzQ1NDQ5Nw_d007e3cf-ed09-46c0-8906-308e8a116984"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODYy_f673b1bd-4499-4c6e-b366-a3f86844eb01">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,108.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,498.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,113.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(762.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(953.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,789.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,978.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,174.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,363.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,789.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,978.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="idb635dccb0e2485ba7f187b187e581b3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi0xLTEtMS01ODk3OQ_34cd31d9-54bf-402f-af40-4f8be4014d37"
      unitRef="usd">9108400000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i7f004bc05e4d45dcbf537fff903cba0a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi0zLTEtMS01ODk3OQ_329ad2ab-042d-4afa-8e93-fd406244ee29"
      unitRef="usd">969500000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i752b23ca41c0414ca31a93d78f55cae9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi01LTEtMS01ODk3OQ_c7f54027-549a-491b-aee9-9dac0dea401c"
      unitRef="usd">776300000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i89e0a6768c4f4658ba5394068805bb7e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi03LTEtMS01ODk3OQ_6c36c900-8d6f-421e-ac0a-9783c79ea96a"
      unitRef="usd">1644500000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMi05LTEtMS01ODk3OQ_3e93911e-594a-464d-bb94-dd841b58209b"
      unitRef="usd">12498700000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="idb635dccb0e2485ba7f187b187e581b3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy0xLTEtMS01ODk3OQ_0288da95-03e0-4261-8844-a30aae711937"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i7f004bc05e4d45dcbf537fff903cba0a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy0zLTEtMS01ODk3OQ_0c07b1ba-1080-427b-a590-c6bc7a692db1"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i752b23ca41c0414ca31a93d78f55cae9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy01LTEtMS01ODk3OQ_9f97ad81-0a09-4c8b-b1dc-3c5f3bc17cdf"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i89e0a6768c4f4658ba5394068805bb7e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy03LTEtMS01ODk3OQ_b53a07b7-a823-4b3a-846e-e5e99aaff030"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMy05LTEtMS01ODk3OQ_75379d2f-bb65-48a8-afd6-882da9ca003f"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="idb635dccb0e2485ba7f187b187e581b3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC0xLTEtMS01ODk3OQ_41974709-cfa5-4692-9aba-f75933033f22"
      unitRef="usd">8723400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7f004bc05e4d45dcbf537fff903cba0a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC0zLTEtMS01ODk3OQ_6c2a9331-231f-4a2b-a0f3-9c916f6c9a87"
      unitRef="usd">969500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i752b23ca41c0414ca31a93d78f55cae9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC01LTEtMS01ODk3OQ_8baa99f2-de5e-4bf2-92c9-18d2eac5e292"
      unitRef="usd">776300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i89e0a6768c4f4658ba5394068805bb7e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC03LTEtMS01ODk3OQ_a900792b-b50b-46f6-9b62-0b8dec722eaa"
      unitRef="usd">1644500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNC05LTEtMS01ODk3OQ_220e6ae1-80d7-4f8a-8c71-5a64b5cc58e2"
      unitRef="usd">12113700000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS0xLTEtMS01ODk3OQ_cd28437e-4fb4-4079-ba1b-9af2f1793877"
      unitRef="usd">-762000000.0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS0zLTEtMS01ODk3OQ_fcb70ee6-2eac-4d10-9522-4f3ffcda5131"
      unitRef="usd">-3000000.0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS01LTEtMS01ODk3OQ_1fc0177b-2a8a-4256-b403-b4ab1bd4cc54"
      unitRef="usd">-37000000.0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS03LTEtMS01ODk3OQ_7d65a824-1b69-4dec-bc2f-b184b6ac5c53"
      unitRef="usd">-151000000.0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNS05LTEtMS01ODk3OQ_d2dd022f-7ef8-44cd-a21c-d44946807337"
      unitRef="usd">-953000000.0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi0xLTEtMS01ODk3OQ_455ef652-55d0-4cb4-b89c-159d40d4c7f0"
      unitRef="usd">-172200000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi0zLTEtMS01ODk3OQ_eae99ca7-83d8-4cba-b278-4fe0e42148d3"
      unitRef="usd">700000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi01LTEtMS01ODk3OQ_ae94c2ba-f441-4033-949d-75093ebad28d"
      unitRef="usd">-400000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi03LTEtMS01ODk3OQ_faf0d47b-5191-4c44-ba32-ef7f8f7a58b7"
      unitRef="usd">-10000000.0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNi05LTEtMS01ODk3OQ_a0ebb16f-5ae6-4972-87fd-2a6d32251543"
      unitRef="usd">-181900000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy0xLTEtMS01ODk3OQ_8061c737-064b-482d-9c43-f4751d490d30"
      unitRef="usd">7789200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy0zLTEtMS01ODk3OQ_b65947db-eeba-49b2-ba83-64b5b3aede13"
      unitRef="usd">967200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i820840cef80c4d0abf74da03594e7239_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy01LTEtMS01ODk3OQ_10b7f972-ab9d-459c-ba2b-0508c3af6e3d"
      unitRef="usd">738900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy03LTEtMS01ODk3OQ_995543ed-7a9c-4266-9f31-99edfca74889"
      unitRef="usd">1483500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfNy05LTEtMS01ODk3OQ_f734a5cc-561c-41c2-a26b-ce3420adbf4c"
      unitRef="usd">10978800000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS0xLTEtMS01ODk3OQ_070a6d14-d34d-40d9-8af3-b62c9bfe5f2e"
      unitRef="usd">8174200000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS0zLTEtMS01ODk3OQ_dd8a8e43-4398-47be-8e30-1542ba028afa"
      unitRef="usd">967200000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i820840cef80c4d0abf74da03594e7239_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS01LTEtMS01ODk3OQ_604d627e-1e3a-4007-8663-929c96ab91fb"
      unitRef="usd">738900000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS03LTEtMS01ODk3OQ_1dd65bbc-5ed9-487f-9fb1-5b903c5e4f7d"
      unitRef="usd">1483500000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfOS05LTEtMS01ODk3OQ_8548bdda-3f7e-47fd-933b-78ea9da92708"
      unitRef="usd">11363800000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtMS0xLTEtNTg5Nzk_a0fffcd7-7f12-4403-b287-f8c6fa35d6fa"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtMy0xLTEtNTg5Nzk_f1f4f2f2-1bf6-42e7-bd82-c8b373b89711"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i820840cef80c4d0abf74da03594e7239_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtNS0xLTEtNTg5Nzk_688b428a-bf1e-4bbd-9dbc-63b72fe63d46"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtNy0xLTEtNTg5Nzk_4dd5c43e-cf45-47a1-8073-95bb47c0e3ea"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTAtOS0xLTEtNTg5Nzk_6d64d8cf-2700-411e-850e-6504f0a43957"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ifb4bb3504c5e414bbca00d5745e6a325_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtMS0xLTEtNTg5Nzk_2a9b8a6b-aaaf-4c10-af9b-44371734b31c"
      unitRef="usd">7789200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtMy0xLTEtNTg5Nzk_342d2828-c2d3-45ce-addd-d15a3c477eed"
      unitRef="usd">967200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i820840cef80c4d0abf74da03594e7239_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtNS0xLTEtNTg5Nzk_3d69dd2e-ab18-40fe-8652-2bcf99bfdafb"
      unitRef="usd">738900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtNy0xLTEtNTg5Nzk_814df981-b95c-43f9-95f1-7ad5842015e7"
      unitRef="usd">1483500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjIwOWJjNGM3NDQ5ZDQxOTY4YTJkYzBiOTliODE0Y2I0L3RhYmxlcmFuZ2U6MjA5YmM0Yzc0NDlkNDE5NjhhMmRjMGI5OWI4MTRjYjRfMTEtOS0xLTEtNTg5Nzk_f734a5cc-561c-41c2-a26b-ce3420adbf4c"
      unitRef="usd">10978800000</us-gaap:Goodwill>
    <vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification
      contextRef="id0854ccbdb6a48ee945effcd9ab00b5f_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk4NTc_3736ec28-816a-430e-b311-4bcec97a8bf8"
      unitRef="usd">3610000000</vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification>
    <vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification
      contextRef="i7d6f0a30fe8f420c8ddd936989792b64_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk4NzI_648e775c-7be5-473c-a71a-f63e90ab875a"
      unitRef="usd">4950000000</vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification>
    <vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification
      contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk4ODc_c9887667-f599-406c-81c0-f41feee0047b"
      unitRef="usd">1640000000</vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification>
    <vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification
      contextRef="i820840cef80c4d0abf74da03594e7239_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk5MDI_7ceeea54-1f91-41dc-92ee-dcbf201e8d0e"
      unitRef="usd">780000000</vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification>
    <vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification
      contextRef="ibdf9310863c94efea7cc955d04dbeb08_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTk5MTc_f7861a0d-db7e-4e1f-b768-c63e64a6f2f7"
      unitRef="usd">970000000</vtrs:GoodWillAfterAmortizationExpenseBeforeReclassification>
    <us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount
      contextRef="i7d6f0a30fe8f420c8ddd936989792b64_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNjQ_e6482b07-90b4-425a-8597-575c704a889c"
      unitRef="usd">797000000</us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i7d6f0a30fe8f420c8ddd936989792b64_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTc0MDY_80fdbe3c-cc3a-4737-93c8-83a5fe3e50fa"
      unitRef="number">0.053</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <vtrs:GoodwillImpairmentMeasurementInputTerm
      contextRef="i6a2086ac5d6c416b8cc71c7c9d2219a7_D20220331-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMzg0ODI5MDc3MjA3OQ_04e4264c-5543-4016-8562-73c4d4504c50">P10Y</vtrs:GoodwillImpairmentMeasurementInputTerm>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="id333e02064fc4188b6fa4779c0cbfc27_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MTQ_88afee52-46b8-40e4-957b-d9ccedc31939"
      unitRef="number">0.005</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i4b9e3a7f9cd84f3382111f444d8fd22f_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MjA_c4ea711f-a29c-4dbc-867a-59966438f742"
      unitRef="number">0.010</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="icd36615fdc104e8db3c91f5da47da6f3_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MjY_71baa09a-86e5-4aff-ac9c-7b7a7653e2ac"
      unitRef="number">0.095</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i01f391ba0c104b98ac8794ec261fe166_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1MzI_454b5883-6307-41b3-94ce-f1d96045f702"
      unitRef="number">0.153</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="icb1ec291d2a84558b24739819de98b81_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NDQ_481cc7cf-f3e3-4a67-95eb-4fbd53713953"
      unitRef="number">7.5</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ide2d1af249e641b2bbe8c69bb9739743_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1Mzk_192b9238-9f41-4aa8-9e58-fe5f7753f607"
      unitRef="number">8.0</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i818820f897ea49ce9285f09c3e769eef_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NDk_7723d6d6-c864-4eb6-b691-491bc3da6688"
      unitRef="number">0.150</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i1a466c9613234adb9f17ffade4f5a431_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NjI_3da824df-9235-4b4b-ac7a-367b8063eae8"
      unitRef="number">-0.030</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i4d62cc2f2fbf44be90f3fd74e62058f7_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NTY_133a544d-1ee0-4e28-b493-853887ac3900"
      unitRef="number">0.015</vtrs:GoodwillImpairmentMeasurementInput>
    <us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount
      contextRef="i820840cef80c4d0abf74da03594e7239_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNzk_f2afed59-7a12-45d8-b627-4396b35f0d70"
      unitRef="usd">231000000</us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i820840cef80c4d0abf74da03594e7239_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczOTY_49aaef40-b076-46c0-8492-457da185e72e"
      unitRef="number">0.074</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <vtrs:GoodwillImpairmentMeasurementInputTerm
      contextRef="i644ef34e48024030985c3c07b31dd73b_D20220331-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMzg0ODI5MDc3MjA5NQ_4ec632a7-0ef9-4d28-94ca-d423fa069da1">P10Y</vtrs:GoodwillImpairmentMeasurementInputTerm>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i6cf43177df974a66a92ba7c52d11995c_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1NzI_f9e1c67f-04af-4010-a30d-1aea033ac854"
      unitRef="number">0.048</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="iafaccb0fcfc84110aeb682de67ac7598_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNTA_77df67ce-bd5b-4381-84a4-b74de7326842"
      unitRef="number">0</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i4a75f125239e4b0dba35bc1553cb1180_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczMjE_7be0a879-a015-4414-a1b1-67142f029f70"
      unitRef="number">0.060</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i2c6e60c0df4e41c9bebb8ff1ffb5fda7_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczMjk_a76633c6-29d8-4eaa-82ce-ad68060d396c"
      unitRef="number">0.304</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i61d256d33cc44601b273de07772fa27f_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczMzY_2e73d154-c526-4981-b245-cfed1e191b2d"
      unitRef="number">6.0</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="if9c68f36a2124e6f86cc33905c166b9a_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTIwOTQ2Mjc5NTczNDE_436d22ee-7863-431f-8e4d-08df83ddb916"
      unitRef="number">0.150</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ic1428e3de2174baeb5d4ae097870b5b2_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1Nzg_47254988-2f99-41dc-8155-54107e613290"
      unitRef="number">-0.035</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="id49e7597eca549ac831d9ddf6e7f90c6_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1ODQ_1ba86cb7-b455-491c-8fc5-55798980b079"
      unitRef="number">0.020</vtrs:GoodwillImpairmentMeasurementInput>
    <us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount
      contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2NzA_4de093a6-ba25-4283-84b2-5a8f67a6dc48"
      unitRef="usd">816000000</us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i768647eb7ba241a0b02dbadb48ac2d2a_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2OTA_afe6a223-ecdd-4c46-be12-db59f5a2608e"
      unitRef="number">0.103</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <vtrs:GoodwillImpairmentMeasurementInputTerm
      contextRef="i5e1a767e23ce445bb33d791ad179db05_D20220331-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMzg0ODI5MDc3MjExMQ_c18fb67f-4e17-4b48-ac64-60cc914ab520">P10Y</vtrs:GoodwillImpairmentMeasurementInputTerm>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i55c3c1a407b84d5394d09bf25fdf32eb_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MzY_de570d1c-5ce5-46a6-a4f2-97990d460ad3"
      unitRef="number">0.016</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ia6f95d2c71ab4e0fae07e7b6378dcf77_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2Mjk_cfa34f2b-85cb-41b1-ac70-027a0e2b3d9b"
      unitRef="number">0.008</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i3aaa3d21b6224eb5a1c10a50ead809a2_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MjI_d8d34f4f-3d00-4202-9c3a-a93c335d4063"
      unitRef="number">0.105</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ib03b774597744b8b834dd7a887f814c2_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MTU_cea94134-22c5-4b44-9699-99c41995d573"
      unitRef="number">0.184</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="idc71de7a5d384a43a72d12d1445db364_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MTA_3f368b68-c1b8-4e71-9ce7-807e73e915c3"
      unitRef="number">7.5</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="if9c68f36a2124e6f86cc33905c166b9a_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU2MDM_2537cfea-089a-47fb-ac84-89f4a73825f7"
      unitRef="number">0.150</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i8f3b4b5b39b34c1089e08a978b8bc67e_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1OTA_8780b4e4-21b2-4db3-a9e8-489171bc9942"
      unitRef="number">-0.085</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i8cfb365259e146c6bba35a35319a19c5_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTE1NDQ4NzIxNDU1OTc_8218ed49-d979-40cb-bee8-8f228e8a2e61"
      unitRef="number">0.030</vtrs:GoodwillImpairmentMeasurementInput>
    <us-gaap:GoodwillTransfers
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTY0OTI2NzUwMTM5OA_d2dd022f-7ef8-44cd-a21c-d44946807337"
      unitRef="usd">-953000000</us-gaap:GoodwillTransfers>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODk2_7bb6c1c0-d35d-4c31-804e-f854e1e8ebe8">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following components at March&#160;31, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,550.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,206.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,596.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,251.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,006.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,918.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,087.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,052.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,918.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;(1)Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights.</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ica9478897d044e4bbb3db8f4e11cc304_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi0xLTEtMS01ODk3OQ_922602b4-ae6d-48a5-a49b-3b02c8857691">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi0zLTEtMS01ODk3OQ_129b77c3-b2c3-4d60-acaa-e1f7ee159fa6"
      unitRef="usd">38550700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi01LTEtMS01ODk3OQ_cf406ef4-051e-46cd-bf89-8d5ca662b779"
      unitRef="usd">13344600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMi03LTEtMS01ODk3OQ_7f0397c4-0801-42eb-abd4-fe8ef8a79e02"
      unitRef="usd">25206100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMy0zLTEtMS01ODk3OQ_b1f4428a-b6a9-47f6-8a1a-c0157e6e006b"
      unitRef="usd">45700000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfMy03LTEtMS01ODk3OQ_79a69b6c-c055-4b34-adee-f1cfe38c5dd5"
      unitRef="usd">45700000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNC0zLTEtMS01ODk3OQ_3ef3db7a-535c-4077-99b0-4e410d71ad04"
      unitRef="usd">38596400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNC01LTEtMS01ODk3OQ_55b7116e-4b87-4017-9139-5db212282436"
      unitRef="usd">13344600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNC03LTEtMS01ODk3OQ_f3329e87-0a20-4bb3-bd3a-d2f63aac3d6c"
      unitRef="usd">25251800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4601448e1f8540a6ba7701a19f013bd5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi0xLTEtMS01ODk3OQ_8a974647-9760-4628-bfd1-2d566053396b">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi0zLTEtMS01ODk3OQ_18a61266-02c8-4309-80a4-2d865ce041d7"
      unitRef="usd">39006200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi01LTEtMS01ODk3OQ_5c264941-d2a2-4c84-a297-0b51d470d831"
      unitRef="usd">12918500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNi03LTEtMS01ODk3OQ_c485e54d-ed74-4257-808b-923a42979d6b"
      unitRef="usd">26087700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNy0zLTEtMS01ODk3OQ_7f7a2b7c-173d-4341-bfbe-b59cabcb882a"
      unitRef="usd">46500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfNy03LTEtMS01ODk3OQ_74112713-e9e8-4007-ae04-cea8b873b750"
      unitRef="usd">46500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfOC0zLTEtMS01ODk3OQ_b99da3e3-c199-45db-bef8-dbd077427af2"
      unitRef="usd">39052700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfOC01LTEtMS01ODk3OQ_e87ddef4-01ee-4b42-a3cd-5bfaa755ed32"
      unitRef="usd">12918500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmEyNzFlOWQzZjUzOTRmMTdiMWY3OGQ0ZDY0YzYxYjY3L3RhYmxlcmFuZ2U6YTI3MWU5ZDNmNTM5NGYxN2IxZjc4ZDRkNjRjNjFiNjdfOC03LTEtMS01ODk3OQ_5a087041-c4a4-456a-ac5c-6303664e6ba4"
      unitRef="usd">26134200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODgx_9c2edef5-e217-4b56-b946-3e11e4a6478a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible asset amortization expense (including impairment charges)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfMy01LTEtMS01ODk3OQ_1dc11947-1205-45e4-9444-2574ff14343c"
      unitRef="usd">648100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfMy03LTEtMS01ODk3OQ_0a8b7518-a640-410b-87d0-b32593daa42d"
      unitRef="usd">684400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNC01LTEtMS01ODk3OQ_8bed7d9b-406e-45cb-a5ba-9deb075e8517"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNC03LTEtMS01ODk3OQ_4587b953-8b95-4eaf-ad9d-6c2ee7fd212f"
      unitRef="usd">83400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:AdjustmentForAmortization
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNi01LTEtMS01ODk3OQ_140370b3-4d64-4597-9f41-544f74446827"
      unitRef="usd">648100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOjU3YjczMDdiMjk2YTRlOThhNzk0MzU1ZTliYWY0NTI0L3RhYmxlcmFuZ2U6NTdiNzMwN2IyOTZhNGU5OGE3OTQzNTVlOWJhZjQ1MjRfNi03LTEtMS01ODk3OQ_1298a1b1-dd5e-4bbb-9563-13979ef28280"
      unitRef="usd">767800000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfMTA5OTUxMTY2MTE2MQ_4587b953-8b95-4eaf-ad9d-6c2ee7fd212f"
      unitRef="usd">83400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RleHRyZWdpb246NmZiYjkxZmYzYmUzNGVhOTllOTZkYTNmOWJmYTJhOGZfODY2_6652d4f0-d280-46fe-af12-067dd774390a">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense over the remainder of 2022 and for the years ending December&#160;31, 2023 through 2026 is estimated to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfMS0xLTEtMS01ODk3OQ_43680767-9b69-4901-91e2-9782b4f99353"
      unitRef="usd">1916000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfMi0xLTEtMS01ODk3OQ_bb73cbf7-5c50-432b-b242-c7aeb43c9aad"
      unitRef="usd">2392000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfMy0xLTEtMS01ODk3OQ_9801dc15-1a4a-46a1-820b-cf7f5b9460a6"
      unitRef="usd">2295000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfNC0xLTEtMS01ODk3OQ_2cd03095-0d73-4bf9-9c89-14fdcd8b088a"
      unitRef="usd">2198000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83Ni9mcmFnOjZmYmI5MWZmM2JlMzRlYTk5ZTk2ZGEzZjliZmEyYThmL3RhYmxlOmNkYThiNTA3MTZmOTQ4ZWU4MTQ4MWExMDBjYmJmZGVlL3RhYmxlcmFuZ2U6Y2RhOGI1MDcxNmY5NDhlZTgxNDgxYTEwMGNiYmZkZWVfNS0xLTEtMS01ODk3OQ_1fa7b0a0-445d-411b-85ff-39367e221dc1"
      unitRef="usd">2141000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:LongTermDebt
      contextRef="i168375750af04b89bb5edbe12849ea57_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMi0yLTEtMS01ODk3OQ_c4ebebfd-ab85-4fbe-b649-1d2a34a58ff0"
      unitRef="eur">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i168375750af04b89bb5edbe12849ea57_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMi00LTEtMS01ODk3OQ_5ea78b87-80cf-414e-ab9f-ef9a95bb792b"
      unitRef="eur">1000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia67acd3202fe49928ecd11cf6bb82d49_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMi02LTEtMS01ODk3OQ_2759f9c8-b191-4c04-be27-8b1ca8aedec6"
      unitRef="eur">1000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="if4e25a7630854faa8b10ecbe7048f2c1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMy0yLTEtMS01ODk3OQ_cd5bff5d-0f4b-4581-b160-22f74814356b"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if4e25a7630854faa8b10ecbe7048f2c1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMy00LTEtMS01ODk3OQ_abd2f5a8-d5bf-4415-a61f-02fdaab3f82f"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i185546023b6e445993a678e5d4722fff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMy02LTEtMS01ODk3OQ_8d7a7342-ed80-4a4d-87c7-dad89cf8fff2"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ibc273f6b86c64387bac8a24acd1ec9cc_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNS0yLTEtMS01ODk3OQ_403244b4-5521-4fd2-a98b-f1f4a09031e3"
      unitRef="eur">500000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ibc273f6b86c64387bac8a24acd1ec9cc_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNS00LTEtMS01ODk3OQ_00f670e2-154e-4702-ad4d-6ed732709fec"
      unitRef="eur">500000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i64717797560f4b29aaf331840961ba46_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNS02LTEtMS01ODk3OQ_b653f2fb-a4e5-46e6-b82a-5f9be2f3d899"
      unitRef="eur">500000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i5e7c0c2a027c4880bf99a89c7fb9f689_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNi0yLTEtMS01ODk3OQ_e3a7b6dc-d938-415a-860e-16db3a273137"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i5e7c0c2a027c4880bf99a89c7fb9f689_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNi00LTEtMS01ODk3OQ_2c58c20f-1cb2-4cdb-940e-90283b4e7fd6"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3248c8cc8d1d4263a978a30127f1f7be_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNi02LTEtMS01ODk3OQ_0d8fddba-013c-488b-9cef-ca99b75c0b99"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="if30ad4912b2043e7b71727fd26678a9d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNy0yLTEtMS01ODk3OQ_5887e8f4-7a83-456c-9d53-9525fcdec688"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if30ad4912b2043e7b71727fd26678a9d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNy00LTEtMS01ODk3OQ_28679b0d-12c9-4766-accc-c7d1f7a691f6"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib2c2ac9f4fde4bc0a2f15e30264bf399_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfNy02LTEtMS01ODk3OQ_b064aefb-5e43-40e6-8236-60008bd720f4"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i20ba0871dd394cf28d8d432a947229c7_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOC0yLTEtMS01ODk3OQ_ac96608b-12c3-4c93-aacb-f4b07729d0cc"
      unitRef="eur">850000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i20ba0871dd394cf28d8d432a947229c7_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOC00LTEtMS01ODk3OQ_48c083ec-dc76-4026-95ca-149e8c5348fa"
      unitRef="eur">850000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i29c57a318497434ea45fb2cedd9123a4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOC02LTEtMS01ODk3OQ_861f533f-1267-4db9-bbfc-213a29bbc44b"
      unitRef="eur">850000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i6af29a91f22a4587acfbe0f78b537ef4_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOS0yLTEtMS01ODk3OQ_d31006c0-8505-4048-937e-18d8299433f2"
      unitRef="eur">1250000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i6af29a91f22a4587acfbe0f78b537ef4_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOS00LTEtMS01ODk3OQ_27ca8ebe-d274-47ab-81d5-e5c3d62fea62"
      unitRef="eur">1250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ibde372d79c2146ddadac6aed84087ad7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfOS02LTEtMS01ODk3OQ_74d3569e-dd56-4e04-8557-60e5eede5587"
      unitRef="eur">1250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i46d8094561c746b4943fe946808e87b4_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTEtMi0xLTEtNTg5Nzk_3e5aa6c5-c4b4-4bb6-aa4f-3baf50fc21d9"
      unitRef="eur">5850000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i46d8094561c746b4943fe946808e87b4_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTEtNC0xLTEtNTg5Nzk_aa9954b8-6816-406c-94f7-d710576ae304"
      unitRef="eur">5850000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i489b4bee565a43f1b5c420df05100124_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTEtNi0xLTEtNTg5Nzk_5606a952-155c-4ada-8dd9-a7f97f271881"
      unitRef="eur">5850000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ibddc3eacd6dd4edfae437c8842c62937_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTQtMi0xLTEtNjEyODc_8df65ca0-8510-4e65-a15c-3c58558f95e3"
      unitRef="jpy">40000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ibddc3eacd6dd4edfae437c8842c62937_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTQtNC0xLTEtNjEyODc_1692484f-52c2-4301-820c-a6a561085393"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2666c0b7ccc347c8bdd95d798a089cf1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTQtNi0xLTEtNjEyOTM_5a686b51-0c30-4269-8d15-1ba1a14cce55"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i46d8094561c746b4943fe946808e87b4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTUtMi0xLTEtNjEyODc_8b5ae916-5b19-4a1d-866e-075375c1acda"
      unitRef="jpy">40000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i46d8094561c746b4943fe946808e87b4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTUtNC0xLTEtNjEyODc_aa97bd2c-efaa-4660-b40d-2628d9a0c08e"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i489b4bee565a43f1b5c420df05100124_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjc2OWMxZDY3OWM3NzQzMmFhNjI0YzQwNDI2NmUwZmIxL3RhYmxlcmFuZ2U6NzY5YzFkNjc5Yzc3NDMyYWE2MjRjNDA0MjY2ZTBmYjFfMTUtNi0xLTEtNjEyOTM_002e4f28-857f-4dfe-a519-fbb098585ab5"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i2315c69a559e4eae91ade095257f342e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfMTA5OTUxMTYzNzYwMQ_b9973635-d010-4e7d-a6e1-2755ede463d5"
      unitRef="usd">328700000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i24df969ffb85419eae1c0c148008a809_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTIzMw_de43511e-5195-414d-aa6f-dba2fba1be7d">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="24" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia1191c9e9a6448b388ec9d255cffdfa0_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS0yLTEtMS01ODk3OQ_d5145f43-de94-4dab-9f9f-ec9cac8d25b4"
      unitRef="usd">63900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9a60db9d80e0425e83e2738fe92d001c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS0zLTEtMS01ODk3OQ_2872f80c-01a2-4790-a100-98c186fa24eb"
      unitRef="usd">62000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if6831aec7acf4e11b1bc17696acc3144_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS02LTEtMS01ODk3OQ_813f417a-ff35-45e2-9055-70162d77c689"
      unitRef="usd">7600000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7ca1a79cd858475c8b6530e800e63398_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNS03LTEtMS01ODk3OQ_d7ac49ae-ef9a-40f2-8eeb-9fc38c5f9434"
      unitRef="usd">4300000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9fdb2ff01ac847c19778cd87d74222f1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi0yLTEtMS01ODk3OQ_42140a32-8558-46d7-9b0f-c5eaa4d62350"
      unitRef="usd">63900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7b01b262a9d74022bcf13a779fe76cca_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi0zLTEtMS01ODk3OQ_3b236cc1-8b03-4e08-954b-9fc9e674dbc3"
      unitRef="usd">62000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9fdb2ff01ac847c19778cd87d74222f1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi02LTEtMS01ODk3OQ_5a3864cd-aa2a-4bbf-b909-9c98ccbd6219"
      unitRef="usd">7600000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7b01b262a9d74022bcf13a779fe76cca_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfNi03LTEtMS01ODk3OQ_275fb67c-a68a-4e6a-9bb3-2aa7acb4bca7"
      unitRef="usd">4300000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i740a3710177c4f15a0f461ce34a65593_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC0yLTEtMS01ODk3OQ_bdd73a3d-9997-41aa-9d9f-bb01fb595f10"
      unitRef="usd">138900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9864394108cb4f43a773c02f1d88b974_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC0zLTEtMS01ODk3OQ_2f2b9a93-4ecb-42b1-b145-0350d8cd342d"
      unitRef="usd">82600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3710c0edc8c84beeb61925296b505b14_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC02LTEtMS01ODk3OQ_2119fb9e-a105-423a-b84c-624826684dac"
      unitRef="usd">91300000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic21bb23c7f724ec68483061e279115c5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOC03LTEtMS01ODk3OQ_58c9dd1e-40b2-45b9-b282-6aaa8dd6b2cf"
      unitRef="usd">56700000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i58199c3b9d0f49d7b609e6c79d1d2858_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS0yLTEtMS01ODk3OQ_ee7f6757-69fa-41c7-8751-11f91bba5ec8"
      unitRef="usd">138900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia358047e46fc47289a9c1fc7e5a31fea_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS0zLTEtMS01ODk3OQ_a989ac4a-8b1e-4062-97f7-c760f8d81cd6"
      unitRef="usd">82600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i58199c3b9d0f49d7b609e6c79d1d2858_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS02LTEtMS01ODk3OQ_af8e80a8-2be4-4a17-a059-be3c00505bd8"
      unitRef="usd">91300000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia358047e46fc47289a9c1fc7e5a31fea_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfOS03LTEtMS01ODk3OQ_fb484d22-b2b8-46c5-8d19-e140824dcd31"
      unitRef="usd">56700000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtMi0xLTEtNTg5Nzk_9289c09a-12b6-4714-ab6e-612cbb4f048c"
      unitRef="usd">202800000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtMy0xLTEtNTg5Nzk_aeb695a3-f99e-44a5-b595-5804b3c884c2"
      unitRef="usd">144600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtNi0xLTEtNTg5Nzk_6faab031-6173-49ec-9f01-96e54a614dc4"
      unitRef="usd">98900000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmI5MGQ4YjkwOTQ4YjRkNTZhMjU2ZWUwOTQ1ZTc4MGQ3L3RhYmxlcmFuZ2U6YjkwZDhiOTA5NDhiNGQ1NmEyNTZlZTA5NDVlNzgwZDdfMTAtNy0xLTEtNTg5Nzk_15fc38ed-b066-4f75-82b5-9efe681d70be"
      unitRef="usd">61000000.0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5c9296c20f324c8fafc1080799a70da3_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy00LTEtMS01ODk3OQ_14da197f-e543-44c5-bff7-a3598844500d"
      unitRef="usd">9700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2b4474a8a96541b39e3b1d4e792ff2c0_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy01LTEtMS01ODk3OQ_c53fb666-a9b4-46d4-940b-0fae693be27e"
      unitRef="usd">5600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="id20f8c33191c4815bf929abe5e50121a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy02LTEtMS01ODk3OQ_759e7500-89dd-44fb-bf80-c16dfc2c477a"
      unitRef="usd">14200000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i41a2e2ea84564d72a4afb25e8c4ec35c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfNy03LTEtMS01ODk3OQ_1fa28ffe-77d0-43cc-9ecc-60599dfa4c0f"
      unitRef="usd">6100000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="idb235bc6a0834cf8b1051570d9efcfd2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC00LTEtMS01ODk3OQ_7a5f4359-1637-44ad-a412-90b172cfe470"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0b19775d069f423880e9edef937484af_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC01LTEtMS01ODk3OQ_1c4fe6c5-9a53-4e7b-bb51-45421e0f47a4"
      unitRef="usd">-800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ifbdf89a5e09043f89d464a52f1f1cbcf_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC02LTEtMS01ODk3OQ_da1e3edf-376f-49b3-80fc-d346ef16cedb"
      unitRef="usd">-1100000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ia669f6d3e67f4786bbd8d4cfa62c4a11_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfOC03LTEtMS01ODk3OQ_0cf51808-af3e-4101-a6ed-28f5b0ef4c39"
      unitRef="usd">-1100000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib21734e807cd4e47b6955ff0fcbecc9c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTAtNC0xLTEtNTg5Nzk_e171c4c3-5df4-4598-a8cc-511a9a69f3f2"
      unitRef="usd">156300000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6cf147b8a161451fa1f8ea341adcecb0_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTAtNS0xLTEtNTg5Nzk_98e67450-e702-4211-a7d2-43d12f6d9f15"
      unitRef="usd">258600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="if8a1b50cf22c46cba7f94a3405c8b929_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTItMi0xLTEtNTg5Nzk_51f9ec4a-c5d4-4791-aca2-cbe228146e00"
      unitRef="usd">21700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i52d8935dcf644389a84187c0bf9ec7f2_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTItMy0xLTEtNTg5Nzk_5a0827b1-9b16-488c-9d93-00a4bd077ded"
      unitRef="usd">35600000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtMi0xLTEtNTg5Nzk_e5da1ae8-28db-4ecd-b0d5-6c64d01a23ad"
      unitRef="usd">21700000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtMy0xLTEtNTg5Nzk_2f32f952-12c2-4e3d-832d-45d811954a95"
      unitRef="usd">35600000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNC0xLTEtNTg5Nzk_a27bf3a2-71c0-422f-b857-58cbba060e78"
      unitRef="usd">165100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNS0xLTEtNTg5Nzk_e3e45a50-0983-46c7-bb45-e24c41ce7ea3"
      unitRef="usd">263400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNi0xLTEtNTg5Nzk_ae1bd591-232a-4c17-8214-6ce029f41736"
      unitRef="usd">13100000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNi0xLTEtNTg5Nzk_f9b543b1-a0b2-43a5-830b-28f1855153ee"
      unitRef="usd">13100000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjIwMmJjNWEwMDFjYTQwMDE5NWM4NzgxOTBhNmFlMDM1L3RhYmxlcmFuZ2U6MjAyYmM1YTAwMWNhNDAwMTk1Yzg3ODE5MGE2YWUwMzVfMTMtNy0xLTEtNTg5Nzk_f813d294-49b1-4fb9-9a66-9686a5f04c4b"
      unitRef="usd">5000000.0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfNDgzMA_5be172ef-8066-4ceb-acbc-2900ac8af3cc"
      unitRef="usd">22000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTI1NA_53626ca6-71a4-40f4-adba-5316694d30ca">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;1: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;2: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;3: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTI0Ng_28625908-2d77-4899-8b36-c624e5d4e700">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recurring fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale fixed income investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1b41955007d149708ebff22ad2acdb2b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNS0xLTEtMS01ODk3OQ_b48ab8be-64dc-4376-b273-92e5bad7f852"
      unitRef="usd">400000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i01bcaaa4b3194bcd9c8ab64e7e506f0f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNS03LTEtMS01ODk3OQ_67c65d32-f7e4-4cd0-acb4-8c32eb2e23cc"
      unitRef="usd">50900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic47baa2563274d178d24b9c707cec448_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNi0xLTEtMS01ODk3OQ_cf928877-d8a3-438b-ba56-8a7633b304ab"
      unitRef="usd">400000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic2c37287ee4c4f9baecb393bab99f75a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfNi03LTEtMS01ODk3OQ_361fddd7-c95a-4022-942d-77f1042a6a6f"
      unitRef="usd">50900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:TradingSecurities
      contextRef="i5a3013e3234d4648b00f091ea9483ca7_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOC0xLTEtMS01ODk3OQ_89f0a016-7743-48e5-ae3a-ed34e89a4870"
      unitRef="usd">47300000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i4740a19848394a6490ab4788151155ac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOC03LTEtMS01ODk3OQ_83e41551-7254-4056-a1cb-731583f12a70"
      unitRef="usd">50300000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ib7b8800864c446e3bfb4396ac7251eba_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOS0xLTEtMS01ODk3OQ_3156dad4-0107-471c-8b6a-b86bb3777a34"
      unitRef="usd">700000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i13cab697039642b0953eef067bf76e23_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfOS03LTEtMS01ODk3OQ_f5da12cc-e069-4d35-9888-ea3693c81781"
      unitRef="usd">700000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic47baa2563274d178d24b9c707cec448_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTAtMS0xLTEtNTg5Nzk_827b089e-c09b-418c-af54-6d15e4a64e60"
      unitRef="usd">48000000.0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic2c37287ee4c4f9baecb393bab99f75a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTAtNy0xLTEtNTg5Nzk_34fc90e6-d37a-4c52-9604-73c7e9096e16"
      unitRef="usd">51000000.0</us-gaap:TradingSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic5318b8966de4c9ab5c12c99f7de2b32_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTItMy0xLTEtNTg5Nzk_34703ac0-c560-4011-ab02-14c543db084a"
      unitRef="usd">15900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i677b7ff6d33c441eaf16aa67eb7dc18f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTItOS0xLTEtNTg5Nzk_c1a496f7-b678-4d56-88d4-f13a9ec5fc77"
      unitRef="usd">16600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i820b54ced26a43b8942c3d0dc474c2aa_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTMtMy0xLTEtNTg5Nzk_c4cbe3bd-833a-4ed9-ba51-9e1fd5e4f36b"
      unitRef="usd">13600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ffddd3ebd9249b282c2a947e3995e55_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTMtOS0xLTEtNTg5Nzk_8eb8dd84-e681-4608-bbc8-20bb87af6d10"
      unitRef="usd">14600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3240de2751ea4f6caf10457b795b3d54_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTQtMy0xLTEtNTg5Nzk_fdb8264c-59b5-4b21-b9f1-1f82b3337549"
      unitRef="usd">2500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47a9183eea87483492bb05c98ca32541_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTQtOS0xLTEtNTg5Nzk_22527daa-1bfc-4516-b732-334ad32ebd26"
      unitRef="usd">2000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ica31ae73f51947efba3f84f2f5e73f75_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTUtMy0xLTEtNTg5Nzk_c58429e9-8a2f-431f-803f-03a23eaa5b31"
      unitRef="usd">4100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4f6d283f86b4446cade80f58f4010940_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTUtOS0xLTEtNTg5Nzk_04042840-1973-437f-9b04-d8e746273093"
      unitRef="usd">4600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5c01cb8bf2d74226a4d1bb1d254e5e1d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTYtMy0xLTEtNTg5Nzk_ffa530e0-3920-4465-b5d0-3aad398a3cc0"
      unitRef="usd">500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20c1042f293c4a6cb388f7e3e3500abc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTYtOS0xLTEtNTg5Nzk_c4e73a00-1a11-475f-86ef-8e52ef6ddb89"
      unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb4b6849d2bc41cab8e20fa6106f5c67_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTctMy0xLTEtNTg5Nzk_c2b2761f-1cd0-4bfc-ac19-b4dbe14f4a27"
      unitRef="usd">36600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i64bab9ba75b1441cb4e430c740dd70d0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTctOS0xLTEtNTg5Nzk_ec0f1671-1834-4266-bca8-a4f696d3da8b"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i010e212468d14224aaf4661c0271995c_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTgtMy0xLTEtNTg5Nzk_2a333fce-3151-4993-8c0b-be367b46ad32"
      unitRef="usd">202800000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="idbb6f6a4865a4b13846c0311a8198fc1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMTgtOS0xLTEtNTg5Nzk_70dd63bd-0ac8-4d94-9eba-0c6458a89464"
      unitRef="usd">144600000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic47baa2563274d178d24b9c707cec448_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtMS0xLTEtNTg5Nzk_8fda7d3f-dbf8-42b5-a537-9cd6b92ca1e4"
      unitRef="usd">48400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id3a6d2ba35574c48b54a634add899b86_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtMy0xLTEtNTg5Nzk_f494dcfa-3e7e-465e-8235-78d5c93b0dc5"
      unitRef="usd">239400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic2c37287ee4c4f9baecb393bab99f75a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtNy0xLTEtNTg5Nzk_384e2751-abf5-44f0-92d1-06fa8016b12d"
      unitRef="usd">101900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i77480a5aa2164b569a9e91f030454ffb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjAtOS0xLTEtNTg5Nzk_a92f3e06-02ce-4e26-8579-b85c5baebed3"
      unitRef="usd">182800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i010e212468d14224aaf4661c0271995c_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjMtMy0xLTEtNTg5Nzk_29c13341-6360-486d-ba42-d97010b6d601"
      unitRef="usd">98900000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="idbb6f6a4865a4b13846c0311a8198fc1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjMtOS0xLTEtNTg5Nzk_dd693826-c4e4-4db1-8f65-4d1dc7976c41"
      unitRef="usd">61000000.0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i1194fb7125fd48feb4af6f6c94758641_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjQtNS0xLTEtNTg5Nzk_984e1a37-8e8f-4b26-86cf-211429ce33c4"
      unitRef="usd">198400000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjQtMTEtMS0xLTU4OTc5_84737019-6e41-4cb9-9f44-29150a846cf9"
      unitRef="usd">199700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id3a6d2ba35574c48b54a634add899b86_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtMy0xLTEtNTg5Nzk_5837d294-b5f0-48eb-ae8e-8d7e04c60918"
      unitRef="usd">98900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i77dc0798004d44c791a5bbb08b126c3e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtNS0xLTEtNTg5Nzk_0c462e3b-76bf-49b7-a3af-4d6935e8fb8f"
      unitRef="usd">198400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i77480a5aa2164b569a9e91f030454ffb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtOS0xLTEtNTg5Nzk_941d0c06-8803-40d7-b7a7-5257cd782646"
      unitRef="usd">61000000.0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iebdd0591acbe4bef9892e17e437e510c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOjg2ZWNlMWI5ZGIxYzQ0ZmQ5ZmJmMTg1NDdhNDIyYTFiL3RhYmxlcmFuZ2U6ODZlY2UxYjlkYjFjNDRmZDlmYmYxODU0N2E0MjJhMWJfMjUtMTEtMS0xLTU4OTc5_227eb6dd-a973-46ba-8d6c-d69e4d78dad4"
      unitRef="usd">199700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ic828aa0199d948a4a260f04156670656_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfODU2Mg_ded1a51c-0d12-4617-857e-fd99acf0857c"
      unitRef="number">0.080</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RleHRyZWdpb246OThlZTFmM2VjMjMwNDZmMTliMTU5YzMwYWQyNWE0YTRfOTI0MQ_f172b321-5930-4a95-b28a-9ac599d6689c">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the activity in the Company&#x2019;s fair value of contingent consideration from December&#160;31, 2021 to March&#160;31, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Portion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other current liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other long-term obligations in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icf8ebd1f9f2b43aea75b756394d24cc8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMS0xLTEtMS01ODk3OQ_19cc38be-b9dc-4cc9-9687-25a0b3705075"
      unitRef="usd">66700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i83bfda8fa6a3472ab6b18074c291d3ba_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMS0zLTEtMS01ODk3OQ_fa38e2d6-6194-4346-9193-514603c8a255"
      unitRef="usd">133000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMS01LTEtMS01ODk3OQ_84737019-6e41-4cb9-9f44-29150a846cf9"
      unitRef="usd">199700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMi0xLTEtMS01ODk3OQ_44290e85-9594-4ec9-8eb6-829304fa4d51"
      unitRef="usd">-15500000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMi0zLTEtMS01ODk3OQ_3fdfb97f-cd7a-42f6-a173-27bc7f79e584"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMi01LTEtMS01ODk3OQ_e98f9685-33c6-4e4b-aabe-3d86b88f3cf7"
      unitRef="usd">-15500000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMy0xLTEtMS01ODk3OQ_e7ac55bf-3533-4679-9faf-2821fab41cde"
      unitRef="usd">35000000.0</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMy0zLTEtMS01ODk3OQ_f206365b-dadb-41f1-ad0a-00f19dc764cb"
      unitRef="usd">-35000000.0</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfMy01LTEtMS01ODk3OQ_d3811fd2-e5a6-4e61-b28f-0b0e1168ba66"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <us-gaap:AccretionExpense
      contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNC0xLTEtMS01ODk3OQ_4a1b8895-9a85-4692-8c5d-bb1430c9133f"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNC0zLTEtMS01ODk3OQ_3fa38f1c-8f50-4ad9-afc8-54e5155e0c2e"
      unitRef="usd">1900000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNC01LTEtMS01ODk3OQ_91a6159a-8be0-4722-a702-2ca0b213c81c"
      unitRef="usd">1900000</us-gaap:AccretionExpense>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i36aa8b5622bd450f94b99b97444ac874_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNS0xLTEtMS01ODk3OQ_6f078ad5-d22c-4b4b-b79e-d823b234d90f"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i9b69b9f9a04a4edaa74c198eab9cd94d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNS0zLTEtMS01ODk3OQ_16e47fe8-8d48-47dc-9e17-b552c8be1c8d"
      unitRef="usd">12300000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNS01LTEtMS01ODk3OQ_85c8c0c9-8e09-4b7f-b9b0-3b7d0b020640"
      unitRef="usd">12300000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3e4d7d622da84b43bba3a6f1313667a9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNi0xLTEtMS01ODk3OQ_b4653449-fd99-4abd-9a03-9dd65d7081b4"
      unitRef="usd">86200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic5cf551f83c9439aa1d37ce9a597c5af_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNi0zLTEtMS01ODk3OQ_becf76e4-0565-4f33-b72e-3071fe5839ca"
      unitRef="usd">112200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF83OS9mcmFnOjk4ZWUxZjNlYzIzMDQ2ZjE5YjE1OWMzMGFkMjVhNGE0L3RhYmxlOmUxYzk3MTUyZmQ2MTQ4N2E4MzEwZjFiNWMxZjU1YzYxL3RhYmxlcmFuZ2U6ZTFjOTcxNTJmZDYxNDg3YTgzMTBmMWI1YzFmNTVjNjFfNi01LTEtMS01ODk3OQ_6c51a61f-7a36-4fba-b3b1-1ea3ef3c1281"
      unitRef="usd">198400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMTUzOTMxNjI4MDQ1MDM_eb2a2f26-0414-4d35-95c0-800ae5ce1d77">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had $655.4 million and $1.49 billion of short-term borrowings as of March&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfNDk_53a73b5b-5d7c-46eb-9816-8ce4276ea689"
      unitRef="usd">655400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfNTY_f6b5382f-6d11-4bc0-bfcf-d371d61c77c8"
      unitRef="usd">1490000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ia28510b5c71d4182aa49d69fb01fa474_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMS0xLTEtMS01ODk3OQ_c0cd1191-7f76-4837-a41b-0bb12b561cc4"
      unitRef="usd">328500000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ie18b5d9e71fd45c2b8cb4bb900be2c8a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMS0zLTEtMS01ODk3OQ_7087f320-dad5-4208-9fa8-66f266ec8d92"
      unitRef="usd">1173400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="if9efa78417d2452cb7a8ab1ecd2e2f9b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMi0xLTEtMS01ODk3OQ_007e8f45-fb9c-4afa-9ffa-e86b3fe33efa"
      unitRef="usd">325500000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i5878664ac9f14f6b85a0598e1613ce8f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfMi0zLTEtMS01ODk3OQ_5577a311-e222-4b82-add0-0976468c7c47"
      unitRef="usd">318500000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="idb3906df3ad546cd8e29117ea61b2a8d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNC0xLTEtMS01ODk3OQ_bb7d82f4-7f60-4506-adee-49f520cbe180"
      unitRef="usd">1400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i82800c514aa0452d855d2b15e4818734_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNC0zLTEtMS01ODk3OQ_d9513f65-e1e9-4189-881d-a40ace4a03ec"
      unitRef="usd">1100000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNS0xLTEtMS01ODk3OQ_2851a404-ee95-430a-9095-9101e419f8af"
      unitRef="usd">655400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmViMjhmOGU3ODg2MzRkOGY5YzI4YmJiNTM3MDQ5YjE1L3RhYmxlcmFuZ2U6ZWIyOGY4ZTc4ODYzNGQ4ZjljMjhiYmI1MzcwNDliMTVfNS0zLTEtMS01ODk3OQ_8924d811-c8b6-4d9f-95a3-0b6f7353574d"
      unitRef="usd">1493000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0d46a4c2ea764c4ea5d63935feab31f1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMTA5OTUxMTY0MDMyMw_5d7c5219-2938-4e08-b488-6fe846650128"
      unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjgyMg_2720e1d3-6737-428c-8b76-04a3cea34786">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;A summary of long-term debt is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;831.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,135.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,241.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,241.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2043 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2046 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; **&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; *&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEN Term Loan Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,762.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,717.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The fair value adjustment is being amortized to interest expense over the remaining term of the notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Mylan Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*** &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Viatris Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**** &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Upjohn Finance B.V.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i920805edb6bd4fc6b02db9ae904e4bce_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC0xLTEtMS02MTM5Mg_02745604-ef2e-473c-82dd-074456346ae8"
      unitRef="number">0.00816</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="i920805edb6bd4fc6b02db9ae904e4bce_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC0zLTEtMS02MTM5Mg_8d8fe292-d62b-45d1-860e-90a9c131de8d"
      unitRef="usd">831800000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="iacc4c1e487a74688ab81273067a97cf2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC01LTEtMS02MTM5Mg_eb430ce3-0fff-4964-ac95-3171b07a8cb2"
      unitRef="usd">856600000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i34906e61f9a74e3a9907c245d674475d_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS0xLTEtMS02MTM5Mg_c21ac891-04c8-4eb6-ae50-c8a6e5bd801f"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="i34906e61f9a74e3a9907c245d674475d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS0zLTEtMS02MTM5Mg_33b8e98e-a29c-4aca-9946-51fb6208f936"
      unitRef="usd">1001400000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i730b6b0ebf854761bfab2a3d7849fe20_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS01LTEtMS02MTM5Mg_2cecf390-d0df-44ef-b2b6-8cdc53f5d1be"
      unitRef="usd">1002900000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib033b18c10b54540877cb94c0a2c2d1b_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtMS0xLTEtNjM3NDY_ca665118-0291-4207-8e2a-48896c626215"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="ib033b18c10b54540877cb94c0a2c2d1b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtMy0xLTEtNjM3Mzc_db3fecac-ed2a-419f-a85b-45241de05848"
      unitRef="usd">762200000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i616a7760ff9a412f95e120d328a13496_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtNS0xLTEtNjM3Mzc_0d20540f-b0b3-45b8-bbdc-34836c5cd7cb"
      unitRef="usd">0</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="idb3906df3ad546cd8e29117ea61b2a8d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC0zLTEtMS01ODk3OQ_46864064-e8ec-4969-a990-7f527a965c6d"
      unitRef="usd">900000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i82800c514aa0452d855d2b15e4818734_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOC01LTEtMS01ODk3OQ_f748a09f-5a1a-401a-be94-f679cbd341fd"
      unitRef="usd">900000</us-gaap:DebtCurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ic62d942e80a44f328ced46abd8385b8f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS0zLTEtMS01ODk3OQ_5d14f4c6-456f-4286-8be0-7cf95baedf36"
      unitRef="usd">900000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i21352fc4b3034be49d25e0fe2cc81ea9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfOS01LTEtMS01ODk3OQ_c24ac254-4e42-4f96-a53c-29c190810a49"
      unitRef="usd">100000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtCurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtMy0xLTEtNTg5Nzk_8ef47949-136e-4fab-a864-fb05f59db110"
      unitRef="usd">2595400000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTAtNS0xLTEtNTg5Nzk_37d67222-ff87-4fc7-b7ca-cb000660c1c7"
      unitRef="usd">1860300000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i235e89926eb74f3d88770caa518d54ab_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTctMS0xLTEtNTg5Nzk_8bd9a7fd-5b0f-4791-99fd-62b33ed7041e"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i235e89926eb74f3d88770caa518d54ab_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTctMy0xLTEtNTg5Nzk_ec682339-4442-4aef-b036-8dd577af6fa8"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i77c67b48aac04b57a96558d5638e2069_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTctNS0xLTEtNTg5Nzk_d4147e6a-7963-4a23-a150-2bdb4e9bc587"
      unitRef="usd">766100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8760241a3c7746f88dfc82fd0dc38eb9_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTgtMS0xLTEtNTg5Nzk_2b6658a4-ac3a-4cd6-9970-8442fa406a3e"
      unitRef="number">0.04200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8760241a3c7746f88dfc82fd0dc38eb9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTgtMy0xLTEtNTg5Nzk_7e7edb77-0db9-4158-b02c-4cf7cea26c9a"
      unitRef="usd">499600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1c88993426de4bfa82c2af5b9e9ed5cf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTgtNS0xLTEtNTg5Nzk_0a72ff5d-15d7-4567-8e1e-c64a42727c82"
      unitRef="usd">499600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3495d968dabe49db8632cd8419777821_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTktMS0xLTEtNTg5Nzk_649007f3-5b31-44e4-8ac2-7713f2df8dba"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3495d968dabe49db8632cd8419777821_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTktMy0xLTEtNTg5Nzk_264d0fc7-a00a-4999-b898-96e267955dc6"
      unitRef="usd">1105700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if209dd52df884edca3b342ed0f29e0ca_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMTktNS0xLTEtNTg5Nzk_f004fb7b-5074-4dc6-8003-a8149db20090"
      unitRef="usd">1135800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i005465bb6d4141108265ad72c8d64c05_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjAtMS0xLTEtNTg5Nzk_6df1b9b9-57e5-4c6c-b209-a2671277d192"
      unitRef="number">0.01023</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1871f3ae6b044568aa7edef970da41e8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjAtMy0xLTEtNTg5Nzk_fbf08c59-00cb-4cd3-b106-4e7d4e34cb65"
      unitRef="usd">846500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i87954de7b4154d90921ac559950690e5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjAtNS0xLTEtNTg5Nzk_2e3fb3a6-d543-45b5-9f5f-8a937fa4eb19"
      unitRef="usd">871600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i410da26a1bdf4849ad61862472be13bd_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjEtMS0xLTEtNTg5Nzk_d365b8a1-12fa-44c6-b037-555911e83723"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i410da26a1bdf4849ad61862472be13bd_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjEtMy0xLTEtNTg5Nzk_25a6ab44-24c6-4944-9c2c-9a5490797010"
      unitRef="usd">552700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if4393b7ef55d44b491ed13b410ae5f95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjEtNS0xLTEtNTg5Nzk_a71c611d-6822-4e43-9269-2d588899afe1"
      unitRef="usd">567800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3a2f21b97703441394122c32e24bae16_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjItMS0xLTEtNTg5Nzk_b259d13e-9843-4d5c-8d97-5066c73a8dbe"
      unitRef="number">0.01650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3a2f21b97703441394122c32e24bae16_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjItMy0xLTEtNTg5Nzk_7f7c44ac-1b62-4624-868a-44b285b48589"
      unitRef="usd">762400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i59e61082e1f54d149a0319da03a3379f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjItNS0xLTEtNTg5Nzk_1cc79c47-ddaf-4d8c-8403-c5e6f948b6b5"
      unitRef="usd">763400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4a7f0dc2e5b0416aa4a0385ea9cf3510_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjMtMS0xLTEtNTg5Nzk_45046356-6f51-41fb-afc4-56cd47a63798"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4a7f0dc2e5b0416aa4a0385ea9cf3510_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjMtMy0xLTEtNTg5Nzk_910ae1a7-134e-4bb7-806c-4ddbb01ee3ee"
      unitRef="usd">2241900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i674842c707794f4b9c18faf16d310ee6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjMtNS0xLTEtNTg5Nzk_e6f5e9d7-b7b8-4de8-9972-e441e914776b"
      unitRef="usd">2241400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a34081d5ebc44a2b5346da3d6b8808e_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjQtMS0xLTEtNTg5Nzk_7a4a3651-37a8-4d54-868f-77f6e7bd5961"
      unitRef="number">0.01362</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i88e2860e30684408955db848202e3b35_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjQtMy0xLTEtNTg5Nzk_b6cc324d-16ab-4f51-9857-ba596e3657a4"
      unitRef="usd">984000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5a4808a45c314bcbb675ab9e037ae38d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjQtNS0xLTEtNTg5Nzk_83a10f4b-9ec2-44fd-843c-98b60a312c26"
      unitRef="usd">1013000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i724052a3d05f4c35a5c6a00a2fea921f_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjUtMS0xLTEtNTg5Nzk_53b1e480-8212-4545-85ff-e151bdbceff6"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3d84cd5ad0974a9989194bfb8e273bb0_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjUtMy0xLTEtNTg5Nzk_e05f98a8-c42b-4a75-a1be-41d1395be2d3"
      unitRef="usd">779400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0a475c2355f74134b164dcccd5dfb7d7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjUtNS0xLTEtNTg5Nzk_29027207-9c47-4947-ba4b-82912db44a8f"
      unitRef="usd">780800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icbb10749b14e419a92f4ae26723a62ac_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjYtMS0xLTEtNTg5Nzk_2313c9b4-8050-42b1-93b8-54d739dd2595"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icbb10749b14e419a92f4ae26723a62ac_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjYtMy0xLTEtNTg5Nzk_73a9af19-cd7f-4e30-b483-9434db97d39e"
      unitRef="usd">825000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iaaa95b408619484988378fae1c283bb0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjYtNS0xLTEtNTg5Nzk_8f0a5922-6c54-4c63-ad63-bae0ef8f0767"
      unitRef="usd">847400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1e4efee03b0b4da6844362cd1376dc49_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjctMS0xLTEtNTg5Nzk_f8fe2525-3f67-463a-8b32-4989a499d848"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icab334cf12f3428e832773ef37592e11_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjctMy0xLTEtNTg5Nzk_ba530ee7-6cbd-46f0-b88f-24b8f974bdfa"
      unitRef="usd">748800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifdcab6e29434459989a147cd7b7e7450_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjctNS0xLTEtNTg5Nzk_f0b77724-9fd1-4701-9892-35e7c48cb2b0"
      unitRef="usd">748700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f77a33b8832445ca8a138130657da67_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjgtMS0xLTEtNTg5Nzk_ffc536b8-e17c-4af2-97c9-5fec77496bf9"
      unitRef="number">0.02700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1f77a33b8832445ca8a138130657da67_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjgtMy0xLTEtNTg5Nzk_9bc08a28-98e3-4b69-9cb5-2e88e1537449"
      unitRef="usd">1518600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic9ec6ac3b5374b0a8f1f65dd3c2855cb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjgtNS0xLTEtNTg5Nzk_c1b2e25f-bb12-4092-a284-3c877438ccf5"
      unitRef="usd">1520500000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i39206c4f1d9c4866a802fcd055a7e2a1_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjktMS0xLTEtNTg5Nzk_33310e16-6764-4fca-93cc-c9b3c9356f2e"
      unitRef="number">0.01908</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i39206c4f1d9c4866a802fcd055a7e2a1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjktMy0xLTEtNTg5Nzk_101fbca4-21a2-46a2-9140-183e8392e717"
      unitRef="usd">1502800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i05c5629823074ba09faf3ca2ad8969a0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMjktNS0xLTEtNTg5Nzk_7ecb4d3c-e5f2-4afb-b5d2-cf2f338ba417"
      unitRef="usd">1546600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idb2326817a4c4b8aa31f1fcf83769a0a_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzAtMS0xLTEtNTg5Nzk_62d1f761-c7f6-4899-9525-dc33f4b1a98e"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="idb2326817a4c4b8aa31f1fcf83769a0a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzAtMy0xLTEtNTg5Nzk_31056043-1a61-4df3-97c5-38abe04ddf0a"
      unitRef="usd">1655400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3aed418e17ea4186b695f6810d200726_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzAtNS0xLTEtNTg5Nzk_51066dee-93d4-49b5-b071-c2d392446030"
      unitRef="usd">1657100000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i177681bbc11b40ee9f75db3045c19e95_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzEtMS0xLTEtNTg5Nzk_e019597e-fbd9-4948-96be-f48639ac14fc"
      unitRef="number">0.05400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i177681bbc11b40ee9f75db3045c19e95_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzEtMy0xLTEtNTg5Nzk_cde3fa14-907e-41bf-a810-28219afb53b4"
      unitRef="usd">497300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5606c2ba35cb4d71b8656f287034dcec_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzEtNS0xLTEtNTg5Nzk_e978dda8-19d6-42df-93ef-08b0b8ba3c4e"
      unitRef="usd">497300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i13bcb00848b642c88bfcc2a3c877ede2_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzItMS0xLTEtNTg5Nzk_54f264c9-93c1-4022-aca0-acee652630ae"
      unitRef="number">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i13bcb00848b642c88bfcc2a3c877ede2_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzItMy0xLTEtNTg5Nzk_dc937ceb-0376-45f0-8532-4ef4c909772e"
      unitRef="usd">999900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifc8c69e7703a44399519315b43924c3c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzItNS0xLTEtNTg5Nzk_363529cf-8295-41a6-8729-6feb184108fe"
      unitRef="usd">999900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia40f39ee6378480184a30bc13c9e3594_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzMtMS0xLTEtNTg5Nzk_945a1e95-758f-45f5-b75e-b18620e7c952"
      unitRef="number">0.05200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i992ae6748a1644e29dc32186549f45e4_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzMtMy0xLTEtNTg5Nzk_076dd40e-f90e-464e-b1a1-0615d99833f7"
      unitRef="usd">747800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ied7473c049234582bd30c2c495ac8ba9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzMtNS0xLTEtNTg5Nzk_cb0787b4-b9b7-4dd2-a070-28c084298ad3"
      unitRef="usd">747800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ad052255252472887637ab010a153d2_I20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzQtMS0xLTEtNTg5Nzk_a5185957-a5ef-4d66-8ca9-091838fa66eb"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5ad052255252472887637ab010a153d2_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzQtMy0xLTEtNTg5Nzk_43cfe275-f9da-40bf-92d7-84d62d27d9e5"
      unitRef="usd">2204000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaa54af0ed26448d9b6ab8f7c2c6167a5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzQtNS0xLTEtNTg5Nzk_7b0f72b2-dbe1-43e0-a877-070f3475cf63"
      unitRef="usd">2205100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i920805edb6bd4fc6b02db9ae904e4bce_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtMy0xLTEtNjE1MjU_1d4c57d3-bd34-4d8c-af11-c8f3136bcf22"
      unitRef="usd">328700000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iacc4c1e487a74688ab81273067a97cf2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtNS0xLTEtNjE1MjU_84897a0f-296a-437e-b768-8b877f8362e3"
      unitRef="usd">347600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8245ebc2dc2948b69c11fb33e05f36b6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzYtMy0xLTEtNTg5Nzk_3002a2e5-d327-483d-b131-20339192fec5"
      unitRef="usd">1900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idc759c1f2ebc440c8f306b8b1ca6b9f3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzYtNS0xLTEtNTg5Nzk_b2683d99-06d7-42e4-893e-80a6e2d0f7e6"
      unitRef="usd">1900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzctMy0xLTEtNTg5Nzk_62e33c4b-8c65-489f-893a-a09053d0b3d9"
      unitRef="usd">39900000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzctNS0xLTEtNTg5Nzk_40902220-e800-4acd-8788-5a6312b95863"
      unitRef="usd">42300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtMy0xLTEtNTg5Nzk_2ac6cd0b-7d75-406b-ac68-d6583f7b708f"
      unitRef="usd">18762500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOjgzOGYwOTFjNzE5MTQyNTZhMTU1YmZmMTIzZjY5N2ZjL3RhYmxlcmFuZ2U6ODM4ZjA5MWM3MTkxNDI1NmExNTViZmYxMjNmNjk3ZmNfMzgtNS0xLTEtNTg5Nzk_4dbb5c6f-aba5-4f10-a5c4-6828d7ead372"
      unitRef="usd">19717100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfNDEw_6e432a2b-34f3-4bba-b7d1-25040e50a42d"
      unitRef="usd">45000000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id07178dd71fc4b9d989a85d7e37587c8_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjQ0NQ_c54916d4-c9f4-4d3f-a6ac-53fc58f0a3a0"
      unitRef="usd">19490000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i05ca82ad60f24969bc24380087f4af1b_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjQ1Mg_16cd6202-43e0-46b5-acf5-5083445cd88f"
      unitRef="usd">22010000000.00</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RleHRyZWdpb246MGU4OWY4NTkwMmRhNGNkNGIwYjFiZTIxZTg2MmJjNDFfMjg0MQ_89b06283-e374-4a05-8a4b-3d45da959292">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2022 were as follows for each of the periods ending December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfMS0xLTEtMS01ODk3OQ_97802540-69c1-4694-9b3a-78ed97259057"
      unitRef="usd">1830000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfMi0xLTEtMS01ODk3OQ_b429e63b-5160-4d10-a4fa-8b0656513dc7"
      unitRef="usd">1250000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfMy0xLTEtMS01ODk3OQ_7e43cbc9-6b0f-40a4-97aa-6a108bb29c14"
      unitRef="usd">1937000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNC0xLTEtMS01ODk3OQ_5bec0145-7350-496d-97e5-0e0515786117"
      unitRef="usd">1303000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNS0xLTEtMS01ODk3OQ_2bf5498d-1d41-4270-a00e-3648400d1c27"
      unitRef="usd">2579000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNi0xLTEtMS01ODk3OQ_2eca096c-4476-4d7f-9eee-89c587605244"
      unitRef="usd">11854000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84Mi9mcmFnOjBlODlmODU5MDJkYTRjZDRiMGIxYmUyMWU4NjJiYzQxL3RhYmxlOmNiMmVmYWNmOTgwYTRiZTE4OTIzZjg4YzJkZWUzYmZkL3RhYmxlcmFuZ2U6Y2IyZWZhY2Y5ODBhNGJlMTg5MjNmODhjMmRlZTNiZmRfNy0xLTEtMS01ODk3OQ_f648acfa-3150-4b47-a43a-8b21b9f75371"
      unitRef="usd">20753000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RleHRyZWdpb246YmY5NWM2YWU5NDc5NDc5NDg3NDhkZWRjN2I5NjRiNDBfMjYx_1bbbb5de-a249-4dd8-8f26-eec925f8ca26">Comprehensive Loss&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, as reflected on the condensed consolidated balance sheets, is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss and prior service cost related to defined benefit plans, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in net investment hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,271.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,061.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,271.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,061.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(485.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(490.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,182.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,385.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RleHRyZWdpb246YmY5NWM2YWU5NDc5NDc5NDg3NDhkZWRjN2I5NjRiNDBfMjQ4_f5aeb5c8-21ed-413c-8bd9-86d2bedf32c0">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, as reflected on the condensed consolidated balance sheets, is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss and prior service cost related to defined benefit plans, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in net investment hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,271.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,061.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMi0xLTEtMS01ODk3OQ_799e393f-7f82-4fb3-9de9-9c6d046fe0f3"
      unitRef="usd">-1300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMi0zLTEtMS01ODk3OQ_f3a0fb9c-24f5-4bb5-a096-8806fde1a6d1"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMy0xLTEtMS01ODk3OQ_b4a491d2-549d-4cbf-b6a7-1ac58f01137a"
      unitRef="usd">29400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfMy0zLTEtMS01ODk3OQ_1e618b72-a3be-4772-bc9f-067f0cef15dd"
      unitRef="usd">-32200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i97cceb4d5127408091af840823fc721e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNC0xLTEtMS01ODk3OQ_7104f422-8721-4cf9-8b86-221702a0853d"
      unitRef="usd">9400000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i8bf7ecce65c9422f8f5f4fe13d646c1e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNC0zLTEtMS01ODk3OQ_f6926c51-f148-47eb-ad89-0241cf589969"
      unitRef="usd">9200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="i5a532fa1402b4fc68731b04ccee54724_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNS0xLTEtMS01ODk3OQ_4a5d5b8a-2069-4782-8135-824a8f33653c"
      unitRef="usd">173100000</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="i9319cb1e85a2470bbb378e5ce64d1b1f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNS0zLTEtMS01ODk3OQ_127863eb-26a5-46e2-bf64-07901eaddc42"
      unitRef="usd">16700000</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNi0xLTEtMS01ODk3OQ_b66156c7-f4eb-4a9f-b4ec-7a68b5d86b3b"
      unitRef="usd">-2271600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNi0zLTEtMS01ODk3OQ_ab32c992-fe19-4baa-bb83-905e6f3b5971"
      unitRef="usd">-1802400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNy0xLTEtMS01ODk3OQ_048114c8-2499-4833-a5ec-62e4e34afd5c"
      unitRef="usd">-2061000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjVkNWFkOGU4MjNkYjQyODdhYTA2NWRjMTc3MTc2MDM0L3RhYmxlcmFuZ2U6NWQ1YWQ4ZTgyM2RiNDI4N2FhMDY1ZGMxNzcxNzYwMzRfNy0zLTEtMS01ODk3OQ_c669d75d-c8d8-434c-ba3e-95612c2841a8"
      unitRef="usd">-1744300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RleHRyZWdpb246YmY5NWM2YWU5NDc5NDc5NDg3NDhkZWRjN2I5NjRiNDBfMjU0_940e9f16-fec8-40f6-8d37-072c72d48a45">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,271.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,061.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(485.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(490.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,182.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,385.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i8bf7ecce65c9422f8f5f4fe13d646c1e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy01LTEtMS01ODk3OQ_f6926c51-f148-47eb-ad89-0241cf589969"
      unitRef="usd">9200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="i9319cb1e85a2470bbb378e5ce64d1b1f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy03LTEtMS01ODk3OQ_127863eb-26a5-46e2-bf64-07901eaddc42"
      unitRef="usd">16700000</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy05LTEtMS01ODk3OQ_f3a0fb9c-24f5-4bb5-a096-8806fde1a6d1"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy0xMS0xLTEtNTg5Nzk_1e618b72-a3be-4772-bc9f-067f0cef15dd"
      unitRef="usd">-32200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy0xMy0xLTEtNTg5Nzk_ab32c992-fe19-4baa-bb83-905e6f3b5971"
      unitRef="usd">-1802400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMy0xNS0xLTEtNTg5Nzk_c669d75d-c8d8-434c-ba3e-95612c2841a8"
      unitRef="usd">-1744300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia55bbf8c4e19462595c29c8a377dea3e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC01LTEtMS01ODk3OQ_3a4f3611-ebc0-4aec-ac22-d7e237b1247f"
      unitRef="usd">13300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="if7f17a49b80d45fab66d262a44deaace_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC03LTEtMS01ODk3OQ_1dfa3c6c-f5b5-45ea-850a-8f725a9c79a1"
      unitRef="usd">201300000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC05LTEtMS01ODk3OQ_6039bbea-f024-4fe5-a429-b345934215b8"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id5e368b781a74d6686679790d4bff5a8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC0xMS0xLTEtNTg5Nzk_442dadc3-d326-4a45-839d-c8d02f94e7c5"
      unitRef="usd">-2700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia55ac01c2b07425bbe40921fb5981f21_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC0xMy0xLTEtNTg5Nzk_d70e1c24-e597-4062-9bdc-eff28440c5fb"
      unitRef="usd">-469200000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i067dee996df34e2f84a35524e9e8481c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNC0xNS0xLTEtNTg5Nzk_cd556da9-5c98-469c-9566-b80eb8291636"
      unitRef="usd">-259000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide8689d47bf04a43bf675d0763fad522_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNi0xLTEtMS01ODk3OQ_03f1304d-bfc5-4b2f-84f6-99e6b6154b95"
      unitRef="usd">-14200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4988c8f213a042118b4b5eaf9c7f1e82_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNi01LTEtMS01ODk3OQ_ae114512-b672-43de-a4b1-3443ed4ab743"
      unitRef="usd">-14200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib01b91695a1b4712b96033763cf44ccb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNi0xNS0xLTEtNTg5Nzk_48aa959b-d023-48b9-9650-571104e2518f"
      unitRef="usd">-14200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestExpense
      contextRef="i4771d8abfecc4e1e95bac68b8f627709_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNy0zLTEtMS01ODk3OQ_badefa94-59ab-4470-a643-ef6308be8f47"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0a0f1e83bb0d410fbdd5481b44ffd1f7_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNy01LTEtMS01ODk3OQ_dd3d1997-799d-4ed4-9798-61241530da5f"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i47a8319f4395450dbae6322e0e8646d3_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfNy0xNS0xLTEtNTg5Nzk_0b607117-723b-44e3-8cb9-1be4050af9f0"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ide368397434c48e59036b17de6b68663_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfOC0xMS0xLTEtNTg5Nzk_8be6eb86-b42f-4d27-afe5-20131ef591fc"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ic2ded494c0c74830993e23285344ef34_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfOC0xNS0xLTEtNTg5Nzk_9aff6804-8101-4713-8df2-029f7c02fddb"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="ib578d781d99c4f47885649d77583e23e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtNS0xLTEtNTg5Nzk_f37c9304-f45e-4c52-b01e-09d32d139a9f"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="if7f17a49b80d45fab66d262a44deaace_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtNy0xLTEtNTg5Nzk_1dfa3c6c-f5b5-45ea-850a-8f725a9c79a1"
      unitRef="usd">201300000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtOS0xLTEtNTg5Nzk_6039bbea-f024-4fe5-a429-b345934215b8"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtMTEtMS0xLTU4OTc5_9a604b8d-b1cc-44ac-b2a1-e7729573c4fa"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia55ac01c2b07425bbe40921fb5981f21_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtMTMtMS0xLTU4OTc5_d70e1c24-e597-4062-9bdc-eff28440c5fb"
      unitRef="usd">-469200000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTAtMTUtMS0xLTU4OTc5_c294e6f1-a34c-4ce5-a6f6-aec06836d8bd"
      unitRef="usd">-272000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia55bbf8c4e19462595c29c8a377dea3e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtNS0xLTEtNTg5Nzk_61446dcf-8bf7-4269-9cb7-4493be9fb146"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i879cd700e4194424af2d4d04eef590c5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtNy0xLTEtNTg5Nzk_a8a326ea-f099-42df-8a00-e54af591bea9"
      unitRef="usd">44900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i413aa6ce376641bdba0e00e871461952_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtOS0xLTEtNTg5Nzk_3a2263d0-c164-4794-a656-788517fea7c7"
      unitRef="usd">-400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i72e12d4aab9b464eb4d8ad17759e7f56_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtMTEtMS0xLTU4OTc5_c3cfd737-01ea-4200-81ee-5f6fabac272a"
      unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib31b0884d24244149616a8b8da8525b4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtMTMtMS0xLTU4OTc5_bcf845e7-81ea-4e88-9960-c42f44dff66c"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic2ded494c0c74830993e23285344ef34_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTEtMTUtMS0xLTU4OTc5_5a461c71-a815-4d5d-b21b-a882d6e061b6"
      unitRef="usd">44700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i97cceb4d5127408091af840823fc721e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtNS0xLTEtNTg5Nzk_7104f422-8721-4cf9-8b86-221702a0853d"
      unitRef="usd">9400000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="i5a532fa1402b4fc68731b04ccee54724_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtNy0xLTEtNTg5Nzk_4a5d5b8a-2069-4782-8135-824a8f33653c"
      unitRef="usd">173100000</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtOS0xLTEtNTg5Nzk_799e393f-7f82-4fb3-9de9-9c6d046fe0f3"
      unitRef="usd">-1300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtMTEtMS0xLTU4OTc5_b4a491d2-549d-4cbf-b6a7-1ac58f01137a"
      unitRef="usd">29400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtMTMtMS0xLTU4OTc5_b66156c7-f4eb-4a9f-b4ec-7a68b5d86b3b"
      unitRef="usd">-2271600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjg2MDhlYzFjNTRlMDRkMThiNDY2OWE2ZDIzZDY5YjgwL3RhYmxlcmFuZ2U6ODYwOGVjMWM1NGUwNGQxOGI0NjY5YTZkMjNkNjliODBfMTMtMTUtMS0xLTU4OTc5_048114c8-2499-4833-a5ec-62e4e34afd5c"
      unitRef="usd">-2061000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i058f357ea23c4c98b73c618d1d854722_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy01LTEtMS01ODk3OQ_023e40f0-6aad-408b-a6ff-e3b1f37f1d0b"
      unitRef="usd">-18000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i03493d8105474aeb862abf63b7ef74a6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy03LTEtMS01ODk3OQ_e2f4bc09-52f8-43f9-83f0-fb68f0ec6328"
      unitRef="usd">-353600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i78ad5902fd35439c8f4af1782d4c7515_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy05LTEtMS01ODk3OQ_7db08ccd-69f2-4b64-939f-cea1dfdea12a"
      unitRef="usd">1200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i31e0fdd1fab64cb898debb3cb62f7b63_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy0xMS0xLTEtNTg5Nzk_929a03a6-330c-4f00-b9ce-e3ead167c124"
      unitRef="usd">26100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ifb76b00d31784891b8cb395e638378b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy0xMy0xLTEtNTg5Nzk_a87c67a3-47a6-4864-bc04-709e9de790ba"
      unitRef="usd">-461500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bc0f9f8a1bf4a9a967c3233ef153a6d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMy0xNS0xLTEtNTg5Nzk_4a4332fb-7389-46d3-a620-555824100628"
      unitRef="usd">-858000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="idcbcb91759414078b56888757bdb9d8c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC01LTEtMS01ODk3OQ_cf510edf-5db8-42a9-ad50-e929b1f147c7"
      unitRef="usd">8300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i557fd976de2e4b8c83c710c96321b9ba_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC03LTEtMS01ODk3OQ_f862ea2a-84ad-467a-8fce-e85f89c58b31"
      unitRef="usd">227400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i2b30c4edf7ef407098a198c2ade53163_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC05LTEtMS01ODk3OQ_d92e9926-800c-4fe3-975b-cb26a135f73f"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8b05065a6c98419eb5b6caba576c82bf_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC0xMS0xLTEtNTg5Nzk_f3d5538f-d75c-4391-8f84-2f25e09b67b7"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="id5db4cd0e0a14bd7b8ad825332acc3a2_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC0xMy0xLTEtNTg5Nzk_20c5edbc-7e78-455d-bff3-797fe174c235"
      unitRef="usd">-721200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie72c892bc6534c14adab5d7152694449_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNC0xNS0xLTEtNTg5Nzk_5eaf0b00-1141-4167-ba42-aa4da4aa04ea"
      unitRef="usd">-485800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id851527d609c4cc481afc6dd44e8b9c8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNi0xLTEtMS01ODk3OQ_6f44224b-ec28-4195-9eeb-4649393717e6"
      unitRef="usd">-6100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id851527d609c4cc481afc6dd44e8b9c8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNi01LTEtMS01ODk3OQ_1195b523-10f6-4690-94be-cc94fb53dc89"
      unitRef="usd">-6100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefe2b30097f544b791322bb2f629e462_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNi0xNS0xLTEtNTg5Nzk_046a3605-2d5a-4b0d-8953-d7d8c4406ee6"
      unitRef="usd">-6100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestExpense
      contextRef="i13e37fd7655a489ca62fce5309929cdc_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNy0zLTEtMS01ODk3OQ_00ca6b46-189f-41c4-9c0d-115f932bd61e"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i13e37fd7655a489ca62fce5309929cdc_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNy01LTEtMS01ODk3OQ_26e850cc-1c5d-48a4-b247-687b76738ebe"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="idfeddcfa49be4a9f9ca7273bb0bc0b2d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfNy0xNS0xLTEtNTg5Nzk_6fb20e73-31cd-433b-a1f4-292b8093b1d4"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ife06d4353ee146d29a89e17a68a9eb78_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOC0xMS0xLTEtNTg5Nzk_b4ac3255-0796-4fd2-b04c-140a39ef1638"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ibac83a8acaf741ca954ebb93d7b9c302_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOC0xNS0xLTEtNTg5Nzk_a60f5b20-fb70-4150-b4b0-b5b6c6d8786c"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i0b458956e8dc417592a4e5054711af8b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOS0xMS0xLTEtNTg5Nzk_67069601-f4c4-4afd-b066-2ff6df46958d"
      unitRef="usd">-300000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ibac83a8acaf741ca954ebb93d7b9c302_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfOS0xNS0xLTEtNTg5Nzk_db57499e-2d60-4f9f-96ac-9d64ec2d397b"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="i6bf21bcb23a34c3498a8a496b6117bb3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtNS0xLTEtNTg5Nzk_8914bb21-ad23-4258-9ce2-fad8d9ed167b"
      unitRef="usd">3300000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="i59b28feb2f7d45d7b83dc9fca6123f83_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtNy0xLTEtNTg5Nzk_376afe5d-123f-4e23-9bb3-ccc562c20fb6"
      unitRef="usd">227400000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtOS0xLTEtNTg5Nzk_3b0a7ba5-9602-407b-b047-98cb539bb136"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ife06d4353ee146d29a89e17a68a9eb78_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtMTEtMS0xLTU4OTc5_9a95c142-56a3-4afc-8c28-bbb4691abb28"
      unitRef="usd">-800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="id5db4cd0e0a14bd7b8ad825332acc3a2_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtMTMtMS0xLTU4OTc5_20c5edbc-7e78-455d-bff3-797fe174c235"
      unitRef="usd">-721200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTAtMTUtMS0xLTU4OTc5_e95a98a1-f8d4-44b8-9266-de99d967f2e9"
      unitRef="usd">-490600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idcbcb91759414078b56888757bdb9d8c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtNS0xLTEtNTg5Nzk_8a195bf2-51b9-40d5-9582-1945165f14dc"
      unitRef="usd">800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i557fd976de2e4b8c83c710c96321b9ba_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtNy0xLTEtNTg5Nzk_28655b04-48c0-4a08-a6af-10cb24b62031"
      unitRef="usd">35100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2b30c4edf7ef407098a198c2ade53163_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtOS0xLTEtNTg5Nzk_7337bc2c-d54b-4087-9a11-1209d3a66f36"
      unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8b05065a6c98419eb5b6caba576c82bf_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtMTEtMS0xLTU4OTc5_66c4eb90-14b2-4a96-bf13-080dfa290c24"
      unitRef="usd">-1000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i156daef6d1e44bdbb6b3a817528d646d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtMTMtMS0xLTU4OTc5_c6b758f7-81bf-403e-a8c2-0e0379ad60c6"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie72c892bc6534c14adab5d7152694449_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTEtMTUtMS0xLTU4OTc5_d4e9ce75-bebd-47a1-9daf-3086f688912e"
      unitRef="usd">37000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ib366aa410a2f41b6a5c4c31aaf520612_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtNS0xLTEtNTg5Nzk_661a33d8-84f5-4573-bc4b-00b9f67c04d2"
      unitRef="usd">-15500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i69c1db3a5e434cf2b0bec2a19b9128b1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtNy0xLTEtNTg5Nzk_ea36044d-9c72-4bd6-9c2c-ccd13cf58b98"
      unitRef="usd">-161300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iae9a8abb5cdb4a0988a591e31a0ac4e6_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtOS0xLTEtNTg5Nzk_5e4d9423-905c-4881-bdaa-c6b7a8a03510"
      unitRef="usd">200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i7a0499bbe67f4f29816cc986f12548ee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtMTEtMS0xLTU4OTc5_48194189-eb2b-4141-9351-f34338f7624d"
      unitRef="usd">26300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia7c23dc951cc4e8989a77c2c56fbd5cc_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtMTMtMS0xLTU4OTc5_4b617cdb-455f-493b-86b0-414d0ad88dd3"
      unitRef="usd">-1182700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i84ae372e0d4640afaf6ca7d236588eca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF84OC9mcmFnOmJmOTVjNmFlOTQ3OTQ3OTQ4NzQ4ZGVkYzdiOTY0YjQwL3RhYmxlOjI5YzAyY2U4OGI0NjQ3ZDg5Y2VjMzM5NmU5MzYwZGRkL3RhYmxlcmFuZ2U6MjljMDJjZTg4YjQ2NDdkODljZWMzMzk2ZTkzNjBkZGRfMTMtMTUtMS0xLTU4OTc5_b12dd0a6-97d1-48de-b099-0d915355c4ab"
      unitRef="usd">-1385600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RleHRyZWdpb246MmEyMzQ4NDlkZWI1NGUwMWFlOGU0MTliY2Q1YzkwZTdfMzgyMw_a6d9517b-44e9-4975-8984-a88df65f4678">Segment Information&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#x2019;s ARV franchise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Intangible asset amortization expense and impairments of intangible assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;R&amp;amp;D expense;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Net charges or net gains for litigation settlements and other contingencies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the segments are the same as those described in Note 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in the 2021 Form 10-K, and Note 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in this Form 10-Q.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment Profitability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reportable Segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,285.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Globally managed research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlements &amp;amp; other contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction related and other special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(993.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(509.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RleHRyZWdpb246MmEyMzQ4NDlkZWI1NGUwMWFlOGU0MTliY2Q1YzkwZTdfMzgwOQ_94f50d93-2b66-428d-8a7f-782f3d39d8d8">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#x2019;s ARV franchise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Intangible asset amortization expense and impairments of intangible assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;R&amp;amp;D expense;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Net charges or net gains for litigation settlements and other contingencies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the segments are the same as those described in Note 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in the 2021 Form 10-K, and Note 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in this Form 10-Q.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RleHRyZWdpb246MmEyMzQ4NDlkZWI1NGUwMWFlOGU0MTliY2Q1YzkwZTdfMzgyMA_9bffa65b-363d-4ede-a72d-4f9e92762521">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment Profitability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reportable Segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,285.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Globally managed research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlements &amp;amp; other contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction related and other special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(993.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(509.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS0yLTEtMS01ODk3OQ_8f4ac8f8-036a-43c9-85a4-0baf7a7db283"
      unitRef="usd">2476100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS00LTEtMS01ODk3OQ_21506d4c-0871-4840-8325-931a2e9b8bf0"
      unitRef="usd">2571600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5e40a5cf74c543ebbe2e539fd71a5c2d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS02LTEtMS01ODk3OQ_26931815-e4d1-4fb0-9ccb-a0cfb76cf952"
      unitRef="usd">1211500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3da0c414e9c04b13bb617bb3182f3659_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNS04LTEtMS01ODk3OQ_8d8da47d-9440-4c69-9139-2d5e288b769f"
      unitRef="usd">1285400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi0yLTEtMS01ODk3OQ_ace86b96-3698-48da-839e-dbe070d359cd"
      unitRef="usd">573100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi00LTEtMS01ODk3OQ_777f02a0-3f91-41af-9620-9359ff8a9017"
      unitRef="usd">591900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0106616d59fa4c3baa1b76ddecd9fe83_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi02LTEtMS01ODk3OQ_7080db4f-a663-4c84-8c5b-8c301a712834"
      unitRef="usd">417700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3e111a91ddee4eff82f47a4137a80e7d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNi04LTEtMS01ODk3OQ_86d5c2ea-dd6e-4110-9632-7c29f2132e6a"
      unitRef="usd">404900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibde6978e33374457b942a44020cb10ac_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy0yLTEtMS01ODk3OQ_50c2e0b3-3d0e-4a3c-8511-d09f83a69998"
      unitRef="usd">423800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy00LTEtMS01ODk3OQ_9869fa50-7dfe-4ef8-b509-143f5e261422"
      unitRef="usd">481900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibde6978e33374457b942a44020cb10ac_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy02LTEtMS01ODk3OQ_b789105f-83a1-4ddf-b1c2-05fc42ebad1d"
      unitRef="usd">174300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4e7e132b30c04b4187e6bd5cbf2bc138_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfNy04LTEtMS01ODk3OQ_7c354fc7-b6cc-4df0-b962-d53440fbcd2e"
      unitRef="usd">184200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC0yLTEtMS01ODk3OQ_2f3049e6-00b3-4abc-abd5-2651fd1dfea9"
      unitRef="usd">705200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC00LTEtMS01ODk3OQ_1bf18e68-7e13-4793-9d9d-083bfac8da1f"
      unitRef="usd">754700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i26892e37395d4f3f8a626b7fefc4c90f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC02LTEtMS01ODk3OQ_32a287bc-0332-4584-a8f9-d6a8daa900d2"
      unitRef="usd">345300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7de14a444cf34f6780f7876dec4dc8f3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOC04LTEtMS01ODk3OQ_c10240ba-1d7c-469d-9788-8b5818ff6fca"
      unitRef="usd">337300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS0yLTEtMS01ODk3OQ_f5d9eaca-791a-4ae9-9f4c-8f6dc551ea53"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS00LTEtMS01ODk3OQ_08059515-2755-4688-85c2-a6820caa4c6b"
      unitRef="usd">4400100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf733ae3e5124ab199c7831a4facfe9e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS02LTEtMS01ODk3OQ_f4cb3b28-90c5-40cb-bd1b-a66d98f0b3a9"
      unitRef="usd">2148800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icf02807bb1474b44a231a8d6a3b86371_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfOS04LTEtMS01ODk3OQ_0d2440a7-f6d0-4d44-a0ae-aff4561d731c"
      unitRef="usd">2211800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTItNi0xLTEtNTg5Nzk_335727f8-f3d3-4f1b-bc17-748d1bb3139d"
      unitRef="usd">648100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTItOC0xLTEtNTg5Nzk_de0da4db-b12f-4eaf-b273-c4d1420010c8"
      unitRef="usd">684400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTMtNi0xLTEtNTg5Nzk_e3547d09-f02c-4ad9-acec-f782c254530d"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTMtOC0xLTEtNTg5Nzk_fc2f444c-2975-439e-878e-beccb913678b"
      unitRef="usd">83400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTQtNi0xLTEtNTg5Nzk_86c0d16d-4290-426f-aa9d-723bfdf0f925"
      unitRef="usd">142300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTQtOC0xLTEtNTg5Nzk_c36dd31c-abf5-4af5-9934-6306d8f27c03"
      unitRef="usd">184100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTUtNi0xLTEtNTg5Nzk_d429d997-8687-4a91-b5a4-290bcd5bef5d"
      unitRef="usd">-6200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTUtOC0xLTEtNTg5Nzk_46cc2f69-842a-4c8b-9da7-731c79562ee0"
      unitRef="usd">-22900000</us-gaap:GainLossRelatedToLitigationSettlement>
    <vtrs:OtherOneTimeNonoperatingExpense
      contextRef="i984782b1588948f9a9dc0da293d10e9a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTYtNi0xLTEtNTg5Nzk_3247c51f-0fe2-440a-bf9d-e8fa53f8ffe1"
      unitRef="usd">185600000</vtrs:OtherOneTimeNonoperatingExpense>
    <vtrs:OtherOneTimeNonoperatingExpense
      contextRef="ifa7571660234425ca582abda7db56793_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTYtOC0xLTEtNTg5Nzk_a07562fe-c866-462b-a1a3-30b8e9e26eeb"
      unitRef="usd">993400000</vtrs:OtherOneTimeNonoperatingExpense>
    <vtrs:Corporatecosts
      contextRef="i1dbf52cc348a44cba02d8ba438c2c120_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTctNi0xLTEtNTg5Nzk_f4615db1-4791-4096-87a1-7188b0da7d77"
      unitRef="usd">459200000</vtrs:Corporatecosts>
    <vtrs:Corporatecosts
      contextRef="i10246c296fdb4978908586b17cec13ad_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTctOC0xLTEtNTg5Nzk_660a3822-981a-4f3d-9f02-4c00ad81e90c"
      unitRef="usd">509800000</vtrs:Corporatecosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTgtNi0xLTEtNTg5Nzk_9d8ae75e-5d11-439f-a5ec-ac1dfb2d63f4"
      unitRef="usd">707400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5ec7dc21aa364c4b85b28702111e642a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85MS9mcmFnOjJhMjM0ODQ5ZGViNTRlMDFhZThlNDE5YmNkNWM5MGU3L3RhYmxlOjNmYzBkNDhkZTE3NDRkZjliNTg1NjY5YmY1MzEyOGQ2L3RhYmxlcmFuZ2U6M2ZjMGQ0OGRlMTc0NGRmOWI1ODU2NjliZjUzMTI4ZDZfMTgtOC0xLTEtNTg5Nzk_cf5f30ac-a89e-4cef-9d28-21dfcca60f4f"
      unitRef="usd">-266200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjIzOQ_83269d8b-e9a1-4744-9353-3b4ef768afe5">Restructuring&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Restructuring Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges for restructuring and ongoing cost reduction initiatives are recorded in the period the Company commits to a restructuring or cost reduction plan, or executes specific actions contemplated by the plan and all criteria for liability recognition have been met. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2021 to March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the three months ended March 31, 2022, total restructuring charges in Developed Markets, Emerging Markets, Greater China, JANZ, Emerging Markets and Corporate/Other were approximately $12.7 million, $2.6 million, $1.3 million, $0.1 million, and $0.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ia41f4e43848544a8b3cd335d5ac9237e_D20211001-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTA5Mg_bf667adf-1ee0-4c60-b108-f1eda9e1e02d"
      unitRef="usd">1400000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id1e5b4b8499b48638e60332fdcb0ebb0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTE0OA_1ed1461e-0761-4160-b1b9-b399dcd47d2f"
      unitRef="usd">450000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1
      contextRef="ib1452feb5e534b13a92ff4d8dc1fd100_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTMyOQ_fe04cb78-40f3-49b2-8073-3d7060acc9d6"
      unitRef="usd">950000000</us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjI0NQ_06ed6afc-bcdc-4ee7-b374-44a6b5c389ce">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2021 to March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the three months ended March 31, 2022, total restructuring charges in Developed Markets, Emerging Markets, Greater China, JANZ, Emerging Markets and Corporate/Other were approximately $12.7 million, $2.6 million, $1.3 million, $0.1 million, and $0.1 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="iea8b0cc4e1164b799a97e32fa53ec105_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMS0xLTEtMS01ODk3OQ_86d88041-e7d7-49d3-adf7-3bb1d0971241"
      unitRef="usd">292600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie81001995ccc476fb965e3e428336426_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMS0zLTEtMS01ODk3OQ_e96eafb8-812a-46e0-a12f-a99674fd41e1"
      unitRef="usd">4100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMS01LTEtMS01ODk3OQ_5019b163-d25d-4764-961f-6c0e5357a8a5"
      unitRef="usd">296700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMi0xLTEtMS01ODk3OQ_179ab792-8e9b-4750-a8dd-817db0b67863"
      unitRef="usd">7300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMi0zLTEtMS01ODk3OQ_ad699613-26fa-4c2a-ba53-a59401e29ee7"
      unitRef="usd">9500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfMi01LTEtMS01ODk3OQ_2b4c3c8a-a959-4c90-bb30-4b66911cfcb0"
      unitRef="usd">16800000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNC0xLTEtMS01ODk3OQ_3462988e-1878-41a8-a797-54a0170cf2d2"
      unitRef="usd">77600000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNC0zLTEtMS01ODk3OQ_879a4e6e-9e5c-447b-bbab-44cccc2013f9"
      unitRef="usd">6200000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNC01LTEtMS01ODk3OQ_2d9089a2-e51b-48b6-8c0f-2e8810b833e9"
      unitRef="usd">83800000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNS0xLTEtMS01ODk3OQ_74bfaec0-fd2b-45de-a01d-b7a133639230"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNS0zLTEtMS01ODk3OQ_107a730e-72d4-4354-9bd1-f360b65f910b"
      unitRef="usd">4200000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNS01LTEtMS01ODk3OQ_ae3714f9-6f99-4887-86fb-c32d95da0a51"
      unitRef="usd">4200000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i3117daa49ceb4cbfb76c102a6a8a13e6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNi0xLTEtMS01ODk3OQ_939df09e-4cc2-4674-b526-1a2ba76b7393"
      unitRef="usd">-2100000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i6588d37d8a6c4752b8f3ac16a12edff3_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNi0zLTEtMS01ODk3OQ_b2d8c550-0631-45f6-b712-05e02da789af"
      unitRef="usd">-100000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNi01LTEtMS01ODk3OQ_3f8cf6d3-127e-4f72-a873-a67fa6b99f41"
      unitRef="usd">-2200000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i434ad84a039c49a7b73a32c66eff9799_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNy0xLTEtMS01ODk3OQ_040defd8-412d-4c82-b19d-123f0cd9d333"
      unitRef="usd">220200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i939eb9ebbfc9436e9ef6a820918949ed_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNy0zLTEtMS01ODk3OQ_8d60aed8-50f2-4ddd-83a2-0432568f269a"
      unitRef="usd">3100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RhYmxlOjQ0NGZhMjI3Y2ZjZTRlMjliNTUyNmYyNGFiNDEyMWRkL3RhYmxlcmFuZ2U6NDQ0ZmEyMjdjZmNlNGUyOWI1NTI2ZjI0YWI0MTIxZGRfNy01LTEtMS01ODk3OQ_940f4eaf-0f2e-48a3-aa5f-370a30044ff7"
      unitRef="usd">223300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i16c59549d2424fa9a5594338ad75d06e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjA1Ng_193901fa-8844-4d22-86ea-908933ab4dc0"
      unitRef="usd">12700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i62ba8ffb1d38487795afa1ff0dfbc7e5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTY0OTI2NzQ0NDU2MA_f173888c-e025-44f0-a00b-f7d27a997e6e"
      unitRef="usd">2600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i66d5d176419d477fb97734cbf1fdb09e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjA2MA_fe7437b8-c7b0-4d5d-81d7-1f4203756194"
      unitRef="usd">1300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i47bf9ded0ef14ffc930218c5b349147d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMjA2NA_e747b591-e28f-42d4-9d74-b55183f9cc0a"
      unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6271454a81c6421fbe19f900527e1bbe_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85NC9mcmFnOjFhOTI2MzQ3MjNmZjRjMTc4ZGZkNzdkMDc0MzBiMjY1L3RleHRyZWdpb246MWE5MjYzNDcyM2ZmNGMxNzhkZmQ3N2QwNzQzMGIyNjVfMTY0OTI2NzQ0NDU4MQ_bc595ea2-b4ee-4c43-bfca-167e33999e45"
      unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85Ny9mcmFnOmU2MzRhNzAxYzU1NzQ1ODI5ZGNhYjUwZWZlMGFjZDg3L3RleHRyZWdpb246ZTYzNGE3MDFjNTU3NDU4MjlkY2FiNTBlZmUwYWNkODdfMjIyMw_42a6fc01-6309-4085-9623-fd4b750bff5a">Licensing and Other Partner Agreements&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically enter into licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple, high-value generic biologic compounds, insulin analog products and respiratory products, among other complex products. Under these agreements, we have future potential milestone payments and co-development expenses payable to third parties as part of our licensing, development and co-development programs. Payments under these agreements generally become due and are payable upon the satisfaction or achievement of certain developmental, regulatory or commercial milestones or as development expenses are incurred on defined projects. Milestone payment obligations are uncertain, including the prediction of timing and the occurrence of events triggering a future obligation and are not reflected as liabilities in the condensed consolidated balance sheets, except for obligations reflected as acquisition related contingent consideration. Refer to Note 10 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments and Risk Management&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion of contingent consideration. &lt;/span&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our potential maximum development milestones not accrued for at&#160;March&#160;31, 2022&#160;totaled approximately&#160;$338 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate that the amounts that may be paid through the end of 2022 to be approximately $10 million. These agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. The amounts disclosed do not include sales-based milestones or royalty or profit share obligations on future sales of product as the timing and amount of future sales levels and costs to produce products subject to these obligations is not reasonably estimable. These sales-based milestones or royalty or profit share obligations may be significant depending upon the level of commercial sales for each product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no significant changes to our licensing and other partner agreements as disclosed in our 2021 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="i4cd2df5979694abd9cfb33abc0ae4026_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85Ny9mcmFnOmU2MzRhNzAxYzU1NzQ1ODI5ZGNhYjUwZWZlMGFjZDg3L3RleHRyZWdpb246ZTYzNGE3MDFjNTU3NDU4MjlkY2FiNTBlZmUwYWNkODdfMTQxMg_ba993d1a-09c7-46e4-a3ee-4885d8b66827"
      unitRef="usd">338000000</vtrs:Developmentandsalesmilestonepayments>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="ib755013306ad4359a6aae01eb324d613_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF85Ny9mcmFnOmU2MzRhNzAxYzU1NzQ1ODI5ZGNhYjUwZWZlMGFjZDg3L3RleHRyZWdpb246ZTYzNGE3MDFjNTU3NDU4MjlkY2FiNTBlZmUwYWNkODdfMTUwNg_93f8b913-5afa-46d3-a431-c7af08590ae9"
      unitRef="usd">10000000</vtrs:Developmentandsalesmilestonepayments>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzQ1Nzc_224aac7b-038f-42f6-89ca-4a24136e1751">Income Taxes&lt;div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Examinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#x2019;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#x2019;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to ongoing IRS examinations. The years 2015 through 2019 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments or issued assessments to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law.  As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2020, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments for the years ended December 2009 to December 2019 and we have commenced litigation in the Australian Federal Court challenging that decision. A decision on our objection to the assessment for the year ended December 2020 is pending. The Company made a partial payment of $56.0&#160;million in 2021 and $5.2&#160;million in 2022 in order to stay potential interest and penalties resulting from this litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2015 concerning our tax position with respect to whether income earned by a Company entity not domiciled in France should be subject to French tax.  We have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. Some of these assessments remain in the audit phase where we are challenging them before the tax authorities while we are challenging some of the other assessments in the Indian tax courts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has recorded a net reserve for uncertain tax positions of $317.0&#160;million and $315.6&#160;million, including interest and penalties, in connection with its international audits at March 31, 2022 and December 31, 2021, respectively. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2020, with several state audits currently in progress. The Company&#x2019;s major international taxing jurisdictions remain open from 2012 through 2020.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Court Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#x2019;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS has appealed this decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Uncertainty in Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a&#160;50%&#160;likelihood of being sustained.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense
      contextRef="ib58c46b4f27f41a69c77fc95bcc936c7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMDk4ODk5_00fc4d4f-d65d-4f90-a852-3d50388a25aa"
      unitRef="usd">56000000</vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense>
    <vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense
      contextRef="i3c8958a092304f48b6c503090ac334f6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMDk4OTE0_29f9eb04-6d59-4ab6-9374-e3bc875efb54"
      unitRef="usd">5200000</vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense>
    <vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMTAwMzM2_09fe02fd-685b-4851-b426-395d9c127b60"
      unitRef="usd">317000000</vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties>
    <vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties
      contextRef="ic0f234c800024956b447083ed4d02c3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDAvZnJhZzozMTczNGYzZDkyNWI0Yzg2YjIxZjlkMGNiZTk4N2I0Yi90ZXh0cmVnaW9uOjMxNzM0ZjNkOTI1YjRjODZiMjFmOWQwY2JlOTg3YjRiXzExNTQ0ODcyMTAwMzUy_cb938d81-14b5-4447-b282-fe636c885234"
      unitRef="usd">315600000</vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i38aa3e44188c4557aa18bc19d33a2f00_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2NjQ5NTY_494135b6-8ffe-4428-9c8f-c4cd1a023790"
      unitRef="usd">264000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LitigationReserve
      contextRef="i3e4d7d622da84b43bba3a6f1313667a9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODU0NTQ_abc5b903-9fc0-4d59-8670-03d5e6a83991"
      unitRef="usd">269000000</us-gaap:LitigationReserve>
    <vtrs:Numberofstates
      contextRef="iaafdd9a3a724498080488d52b9b8e49a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzk2Nzk_1c2b1cd8-baf5-4064-9729-a517a2dc7fa4"
      unitRef="number">46</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="ifef39d3d08a74324abe20f3b54b78a71_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzk5Mzg_2253653b-e742-4368-940c-9fee1dba937d"
      unitRef="number">36</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i2cebc8f9c5ae49bab6671a9b180b170e_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwNzI4_3a34002b-43e3-460b-b387-7ff30dc489d8"
      unitRef="number">47</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="ic49cbe2fbefc424a92f99179077a1f8a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwODY1_13b8fb13-4e32-4196-b956-922c8a5cc626"
      unitRef="number">42</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="iaafdd9a3a724498080488d52b9b8e49a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2NzMwMTg_ff1313b2-dd95-4e28-a72e-8c5fa50b04a4"
      unitRef="state">46</vtrs:Numberofstates>
    <vtrs:Numberofcases
      contextRef="i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzE3NDg0_6e4215ec-739d-431c-ad1c-e074c2615495"
      unitRef="number">1000</vtrs:Numberofcases>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i4c504afee4fe48c49e1b8ec64187b6b1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODU0MTY_fea8df04-c541-40ce-babd-99b4dc6066a6"
      unitRef="usd">75300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement
      contextRef="i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzI4MDI1_3c0a325b-d6f1-42a3-a48c-83410b88c0b3"
      unitRef="increase">3</vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODUzODE_df945c8d-dcad-4790-9d33-6e878a563dfd"
      unitRef="usd">211800000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="id8a766f58ff5477781e10e45ea959330_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4OGQwYzc4YmZjMTQzZGJhZjNhYjllNWNkODVjM2FkL3NlYzoyODhkMGM3OGJmYzE0M2RiYWYzYWI5ZTVjZDg1YzNhZF8xMDMvZnJhZzo0NjhiNTY1YzIwNWE0YTBiYWFkNzBjNWY4MTdkOTQyZi90ZXh0cmVnaW9uOjQ2OGI1NjVjMjA1YTRhMGJhYWQ3MGM1ZjgxN2Q5NDJmXzEwOTk1MTE2ODUzNjM_b7a06f52-c4bf-44b0-aa87-526b2f015bdb"
      unitRef="usd">34800000</us-gaap:LossContingencyAccrualAtCarryingValue>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>101
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M F>K]\3BI[E/#KH^]?KHD":7S(Z>"O@80.>M<WAQXOB6QU?]!5!+ P04
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MD=%)8G3ROZ?B9=P]"F-^# TY<2U=,/C?XXHO)#IRRI:JD%H_" QB@3+!"GV
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MX&. R[*BR76U$KEV7I<#T%K(6F&P,O?*5@B4M2S"+!%>65EB=6/!AY#Y+\"
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M\6(V8B;<TL.+TXV_&6^TPSW;/Y:"8Z[1!JQOM7;]"QD8?BJY^1U02P,$%
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M.AT;_5)595)OFG>?"]]2(LS<I]:N*DL5'Q%-P9E,H_(A QON";^VI@CJ.&Z
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M4+L ^CY7RFXG;H/ZYS3\!5!+ P04    " ":@*E4'9E\B-@%  "H$   &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6S=6%MOVS84_BN$5PP-X,JVG%O3
M)$#2=%B&=0V:KGT8]D!+QQ81B51)*H[WZ_<=4O*M3KH.&S#L)9)(GN]\Y^K#
MG,Z-O7,%D1</5:G=6:_POCX9#%Q64"5=8FK2V)D:6TF/3SL;N-J2S(-050[2
MX?!P4$FE>^>G8>W&GI^:QI=*TXT5KJDJ:1>75)KY66_4ZQ;>JUGA>6%P?EK+
M&=V2_[6^L?@:+%%R59%VRFAA:7K6NQB=7.[S^7#@HZ*Y6WL7;,G$F#O^N,[/
M>D,F1"5EGA$D'O?TFLJ2@4#C<XO96ZIDP?7W#OV'8#MLF4A'KTWY2>6^..L=
M]T1.4]F4_KV9_TBM/0>,EYG2A;]B'L^.#WHB:YPW52L,!I72\2D?6C^L"1P/
M'Q%(6X$T\(Z* LLKZ>7YJ35S8?DTT/@EF!JD04YI#LJMM]A5D//G;Z352L^<
M>/ZS<6Y/U&3%.YLKC0B)VT):.AUXZ.'3@ZS%O(R8Z2.88_'6:%\X\4;GE&_*
M#\!O23+M2%ZF3P*^E381XU%?I,,T?0)OO#1Z'/#&7S/Z!M8&(\5O%Q/G+7+D
M]R?P]Y?X^P%__Q]UZK=C1NJ7TJE,T'*_7.Z[L*^<R$Q5-YYR,5F(7-TK4)D)
MC9+?EL*^+TC,0S+CO+PGB]H4NJDF #33B.D$ZMMYJ0-0WEA^L""T*I,GXDJ5
M0=]_B950.D/?<E$AKZ_D99XK[A*R[*!\(3TZ2E/FHH ^,2'2&_B62LEDO!&U
M\:2]DF7)AL!R-!KA* ,#KYB6A6ZD5X-NYEU?J&E0KZH:"<>>Z(22-IA0$=>>
M=*'TWJI)X^6D)*;Q44DL.'&MLT3P@4R661-92B>FID0+=B?B0V&)-FI4H,*R
M(I38\VN-/E.6< :8TD-&M5_769D&-NR%4N0_HT?R[TERB'R%EAP@"U/F9)WX
M94?@OQGDF1B_?)FD>#X?]8?CH^1P+U8)('/2!AU4>F/W3L2G[63:D4*C?CH:
M)@?\'![A^;5*>Y+N%L]A,AXSS6%R#(Z/U<O_T8L!Z<4D%**<2YL[D2:'XOOO
MCM-1^DI\,!Y5N"JCW8#C9+0$_'JS^?N!N5AK#-YD=QUCKE#P DK&JC?VY@25
MC[0B'VJOBK5'6[47:HJ1N:[Z H0CEC:>FU?9\'&E U!LGC*,-FA@7W2+E?&8
MW+ ,%>!;4YB"NHXXH4PVC@(@3:?8;%O>!#Y#1WNQ:DQO'EK];4#0';>(MPQ%
M1M9C&HP'VS@S6TQRD6[GIL*XP"2,ECICFW3TMD//S8/9H>U.&^ZL%?E$W#90
M2=M<X+(-NIT*2YA4'9HNSHX.D"IM9UL71&Z^W%YGEWUKM%;>+1<)>BR)US!:
MZH6HI0(_\;F1UI,MVQ\[P''@G@V34;H6+1/#V\J&HCAZY? CX1JN%Q9:RZRN
M>D/ZX26R&QU&=HEXQTL+<1"_^SNA+PU\Q52NE(4!!E604U:"S";K3+KB7Z+>
M1S(H$)\C#)Q[M5R$4L7^3XVFI4%<NQOE"A;@;&SX@3/Q9S4K.:_P,6D<ABCG
MHF,6(MWOW,+1B3:V&0ENT,D_SRPX;7P#>SI;':M=T[C+R(U =&:@1OALKAP&
MCZY2>>5+E_<#AR"84\T.;FJ<G\IV-Q87^XV[ E=&J2H5YX_=89VB2>L,0\FJ
MK/K+]M!'-&O%C=;2YP8DPF3"C!0>G>,(YTJ:;9WB5)_Q6&$PS0*;YV85YQJ=
MX\:"U9HG:951M,J GNU,B8/5;B? =*JX:DNZ1STOT_=P1_H"66,4R=@#C,B\
M=R!R'Y&-+XQ5?X1\OGI_?1,3@-^BQR4/1IN)A8A#S.#:I[(PUUE2^AX-GP_S
M0"<Q]=GUF&Z4AXM%'RM"V>6OV%]('O88M%?R;M5*U\934[<O05_D%(.G=I??
M.GBRZW(S6+L]5F1GX8[,<ACTXD5RN;J\AE_$V^?J>+S#H_W,,.DB::80'29'
MN/7:>"^.'][4X2XZ,1[.#:\%27B<#V!_:C!*MQ^L8/G/B?,_ 5!+ P04
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MZQ ] /&O9U2\&%2\$!4O_F $OUU:S/SQJT::-4,6+RI2;UW3:KM7)J!RUO=
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MU"-23?<9W;TXO?:?KG/M\ WFARL!(@QMP/I":[=[(07#;QF7?P=02P,$%
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MDQ:U.T#["Z7LQG !VMD]_0M02P,$%     @ FH"I5"RO: #\ @  ( @  !D
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M60#?%PK^&![8P.[,?/E?4$L#!!0    ( )J J51@!&I.B@4  $<1   9
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ME$BY+,/N,8<,ZQ"GKA 7$$,^QW#HYB5!'K&?45X*B:J1B6]HN$2UH%A1!^[
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M56=P,'%GI!M'2,W1DP^9_<;+;0YZZ5[AZ<4%.5R^Y]:S];\$L_+E>&M>_L6
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MSO"I>C2)X](UY=9J^LH)9Y>WN*$26[B2H<&N4I,[MA)HIHO$4@3GE[1[MHO
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MFST=Z*B= WU?*V6?'ER PU^$Y3]02P,$%     @ FH"I5**HH:)B P  5 <
M !D   !X;"]W;W)K<VAE971S+W-H965T,S0N>&ULC55M;]LX#/XKA*\8$B#G
M%R5-LBX)D&3=W0[85G3='7##<% <)A8J2YZD-,U^_5&RXV9=5\P?;%,B'SXD
M16JRU^;6%H@.[DNI[#0JG*LNDL3F!9;<QKI"13L;;4KN2#3;Q%8&^3H8E3)A
M:3I,2BY4-)N$M2LSF^B=DT+AE0&[*TMN#@N4>C^-LNBX<"VVA?,+R6Q2\2U^
M1/>INC(D)2W*6I2HK- *#&ZFT3R[6 R\?E#X6^#>GOR#CV2E]:T7WJZG4>H)
MH<3<>01.GSM<HI0>B&A\;3"CUJ4W//T_HK\)L5,L*VYQJ>4_8NV*:32.8(T;
MOI/N6N__Q":><X^7:VG#&_:U[H"4\YUUNFR,B4$I5/WE]TT>3@S&Z4\,6&/
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MZN'@.P_Y"!GZ<WYX>F#I#MZICYOV\$![/27SY4[C/UZK4.]5)=/R3\N!R.Y
MI#D0&3C06T6$,DJD\3O8IO(FM;[N;T](P,54Z7/;E<801GQ_&NS"]GI&=SVC
MUIZ=%>IT*RU#9+N&F%LM^>Y _/%:;E-%1R1$*>F(M-72$,81F3*SEF+7,V'M
MV7F>KA-Y[[W\U%S#9W%>QFF<1(5-WW#7>.A6W\ ')OF/5[C-[6J'0W\J>@J;
MPI"8AF:%@PXO VO?7LI,%O'<IFB H#'D6%,@38!':(HUL0*$\13W137$8<*&
MSML \!38^?0Z7L=57MA&"D )J&-1 3D!&R$JT\12P-108 IC@R@(@%+! YC*
MB]NHG-O&"5P)A&-)@3)!.$+24.>FS_5KWQ"&^)2;)47 )63GTNLOZLJ/O&^_
M"3CYWE:- $U0X%98!*Q!Z/'"MKE[%S8/.HJUU9$A3'3UW^\;P G9X?0QCE;%
M(<("4!!Q+"SP!MDK&+NPU$#64#MC36$X'((  D A.Z NU_$[F6UU]4XW5?[\
M5?:7<E"YM21  !G$'<L,#$+VXL8NL]#T$T)768]2#G20"\ L9&>6<J'RNE"%
MUX,G, ;68-^MLA@@A.TEC579-G=/6:IY@S:*=J,&2BT,Q,)V8ETNE_(^+PY0
MM>.W'!LN# 3"(RQ7F]M5E?,I[:MJB&)3&G9? R(#O;"=7K_G2;ZL#M 8F(,=
M&S$,^,$CK!C631;'4]^L7BNX(>5 P8%C^ &35DBERL-Z WVP8V-& $IDA#$C
MNN/B1"LA#%$LG(9^YS4PHT  :,0.M$]1$ET_-*] @$/$L4LCP"<RPJ6UN5W(
MTKY#([I#HWS(]9+.])$=9J=I7,7_'%"A$0 /<6S3"!")C+!IQ."_ JUT,$71
M05T!8,0.L$]1%AU0-A"@"W'LU APAXQP:FUN]UPE?E]3W:8I38?F$P%2U ZI
MBR]I7%8'G*L4@$(=VS0*L*$C;%J;NZ<JZ:E*=8]&_,Y,SGZ_@$S43J;?-FN9
M%/$!J@)4J&./1CN3S",\&M7-%\':#Y<A"K,A E!@$[6SZ4(-.<G7<N&]B8K/
MLBJ]?[T'Y\0I (8Z-F@4T$-'&#1JL%XH%+K*AC@R[-$HT(K::672^5'SY0Q
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MF[<W,EK(H@Y0GR_SO/JZ41]@]P#+R7]02P,$%     @ FH"I5!XV*)]3 P
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MEM;1FR7],%"[!#K?*F4/CMO)\1>4_0502P,$%     @ FH"I5##J5GC6!
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MCB&Y$ERO%+G@&63/\2ZR;R0$6PEGP4&'5U1V2.@?D\ +@A8^D\/P<T@;N'^
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MSBZ(WW8CW&W0-&%LE@9I",.RIE</K'<@>V4,;C>>8'A'\U]02P,$%     @
MFH"I5,1%I+ZJ P  :PP  !D   !X;"]W;W)K<VAE971S+W-H965T-#<N>&UL
MQ9?=C^(V$,#_%2NZASVI2S[XW!,@+7!55[IMT:ZN?:CZ8)*!6.?8J>W ]M0_
MOF,GA  AJD[5]0429SY^,^.,)].#5%]T"F#(6\:%GGFI,?D'W]=Q"AG5/9F#
MP"=;J3)J\%;M?)TKH(E3RK@?!<'(SR@3WGSJUM9J/I6%X4S 6A%=9!E5?RV
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MO3&F5Y63;7EC9.Z&PXTT.&JZRQ2_!D!9 7R^E=(<;ZR#^OMB_@]02P,$%
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M;^(P$/TK5M1#*[7Y A): 5(+K;;25HN*NGM8[<&$ :PZ<6H[0/_]CITTFY:
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M4-G@9=M93B3+BL[MF4G5!Q;#E6K5,=<&ZON",;F=Z&:P;OY'OP!02P,$%
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M58'4G#:\:7]B,NWA]:6FD1,FW9\=-6E0DU'4/W^63!U1!FHK#/!>XV:F.']
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M&O#?PQ'0!)%;LF%2LX1QJC1)I3);B2E3%Z!,X]AIM$QVG/NC:0^]>:P!,BR
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M<O\;U@&-K+]("EW^PKZV]1R("FUD6H.)0<JSZI\]UXEH ?SP ""H <%;P/
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M<$DR5]4;IIH8F9<]=RT-=?!RF-"[#Y4UH/V-E.9U8MMX\Y)<_ M02P,$%
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M+1PC6=E +_80DI7-/3[5EV1E-RA15252;2>Z#H1CRPFG>VA;PPF\8@\A?=G
M$+9:^CH23J^>6_>>GVAA*#X/!W3CR.GF;Y=?_R69!0<(P!E"VG(@5SO'2UME
M4_Y!0L=PQU[U2;Y69C-G7]AR''O<L)<<R/[.+]"UG!K%2C>J1*"R$B."Q._\
M(EU+,:XS-NMEK</;B9$#A3A#JUI.C5SEN%512V4EA@,,Y<@9BF6%CG0LAWLV
M=P@=RP&></K5L13=M]"Q'. 81\XQAP+2K7;E IVX0VA7+K".VY=VY39(4F95
MUFAA*#H/%.;**:P;4-]S-'*!K-PA]"H7J,3M2Z\J.Y;4&4RE)J+#P "NG &Z
M ?,@7<J%?.X.H4NYD,K=OG0IMUYN,K2J+M7"4'2>*["0)^Z.D&RM1;G  NX0
M6I0'V=SK2XLJ.^9WV&GUIH#<1G09",&3$T(WX+5_MLV#;.\-(2YYD+&]OL0E
MKT8FJGNV36TGN@[)WY,G_VY [$Q ]( $O"&4) _RNM>7DN35*$1,(-K#6&DG
MN@X4X<DIHAN,CQ$&/6 ";P@ER>-*\?I2DKQZ@4C3JW J[2IE?7Q=GUI)&DX.
MQ!I7GZ<-(4UAC:N+T]J)4T>45)4][R%49<\6AA7WN2HX[8 R..F4<$5MVB!5
M;1I7UJ:UJVNKGV9K3_OS;&=<W2\M[69;.U>P\YKNJV&-*W#3U#F^XR++<D1!
M-?*<O2)+E5DE)*YJ3I/G_ENZ%J)U1#- UV4FK2^ZL<85W6E#T #6N-(YK2\B
MV/:LN NL-*O40G,TH*COOO5??SFV0NWV(-S UTRW*)H^$MNR9^'$5)6K%$85
MMSE.4)1&_SU?,BS7:<I\W+Y](B!TCFY)]$!2^?QP1#%,^3-?_ZPH@#[D+2+;
MOH275-C[O-'*;%9G9MM-KXC ?%FTHBZZCY>);,=L^3H1S-=18SDC4-I*XCEU
M(7Y" </VDQ1;+G?C07(W7_:LJ'L^\NTHVVX%MJV^(&5K=,@K4B;<RZ+8R\!N
M?78'/T,A>:1]:&-V"RG=O%YK\R%/5L7[HQZ2/$^BXM<E\>E:80;T[X])DF\_
ML%=2[=YR=O%_4$L#!!0    ( )J J51A554YW@0  *H<   9    >&PO=V]R
M:W-H965T<R]S:&5E=#8R+GAM;+69[V_C)AC'_Q44W8M6NL7FAV/GE$9*V]OM
M3NI4M;M-VK07)":)51LR(,WUOQ]V4I/.QDDU_"8QF.?AR_/@CS%,=D(^J35C
M&OPH<JZN!FNM-Y^"0"W6K*!J*#:,FSM+(0NJ35&N K61C*:549$'* Q'04$S
M/IA.JKI[.9V(K<XSSNXE4-NBH/+EFN5B=S6 @]>*AVRUUF5%,)ULZ(H],OU]
M<R]-*:B]I%G!N,H$!Y(MKP8S^.DZJ@RJ%K]G;*>.KD$YE+D03V7A:WHU"$M%
M+&<+7;J@YN^9W; \+ST9'?\<G [J/DO#X^M7[S]7@S>#F5/%;D3^1Y;J]=4@
M&8"4+>DVUP]B]PL[#"@J_2U$KJI?L#NT#0=@L55:% =CHZ#(^/Z?_C@$XL@
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M@]:KI%#*; NKH1S4PK3]1?^V;Y-OFN;PX/TMOEJVS>ZKF[;WANX!:HQ&G&[
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M)@YS;^@=%^YH7FB[X">S'<GQ'O7#[E::F=^P9+1$KJC@('$[]Q;#R]78QKN
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M!X0#C%]7"]2[Z_]9Q3?1VGRXS8==V>C_\IWB+:C:,*'V$M#WV5II:?Z2'__
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M](247"(X5.9,KM 2CC:TXHM'6%,"S3@<5W./2>DN7; [\N?S'Z.)]D @SL+
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M=#<&\'LHA'ZY, _(MI>G_P!02P,$%     @ FH"I5%2]L7%1 P  W0L  !D
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M4)L;;/HY=7R)$L8_8=/$]@)(*F-5T8"I@H++^LU>&QUV ,2S'Q U@.@]8'
M$#> V#=:5^;;FC'+QD.M-J!=-+&YA=?&HZD;+IV+2ZOI*R><'5]SR63"F8!;
M::RNR"!K@,D4%MR\P)Q)\M(=0N<JRTA[N,]@AIJOF=/_#8I<L3G"5,F4;,;4
MK8P2/&66-DM+KR8P@_L2-7-&FATV US"->,:GIBH$&XP77&Y@@6*.C;GI3F&
MS@PMXX)67^!Q.8/.T3$<.>B<"^'"AJ$E:5R#8=+(,*EEB [($,-<29L;N*+:
MT[?XD"1M=8VVNDZB3PGG3'<A[I] U(NB/?5,_Q_>_Z2<N+4Y]GSQ ;[]CIW
M-[KGT+E3AL3\<4<@N"63S,]/4@[:E .?<G @Y2ZU^F K>;W 1*TD_T/_!D5>
M,2W)Z[W>U8G.?2(WEM;CJ-\]'X;K74$_!L6GW;,VJ.XAW+DI!>J5'R &$E5)
M6YO;GK8SZM)?S7?G$YI=]:CY1U,//K*.?EH# C.B['7/Z>;K>IC4&ZM*?Q^?
ME:7;[9<YS5_4+H"^9TK9[<8E:"?Z^"]02P,$%     @ FH"I5(0X[&W"!
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M8FU$(Z2C\=YJ?"M0STZNA&32$RR$F316KY A:X!)'^Z$>81K)I%,-PE'ET&
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M5I:6C3_F]'> VCG0^TPINS%<@.8/9O074$L#!!0    ( )J J539WG7R/08
M *LC   9    >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;,U:VV[;.!#]%<);
M+%J@L<6+?.DF 1JG00O4NT72=A^*?:!EVB8BB2Y)VPFP'[^DK(BR)3%V-P_*
M0WP;4F?F< YG*)UOA;Q72\8T>$CB5%UTEEJOWO5Z*EJRA*JN6+'4_#(7,J':
M?)2+GEI)1F?9H"3NH2#H]Q+*T\[E>?;=%WEY+M8ZYBG[(H%:)PF5CU<L%MN+
M#NP\?7'+%TMMO^A=GJ_H@MTQ_6WU19I/O6*6&4]8JKA(@63SB\Y[^&X<]NV
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MZ2*S^E.DLOCBBBJNP(_/Y@+@DV:)^L<##Q?P< :/-,#[\'/-]2-0]BH9FKJ
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MG4UI=&]B>%3E3YQ*DU96_L2).?%7_B?31ZH%/NJ&AP>UU3.<!ITD3M7)43V
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M9B//OT%9D">82J[])SJ7[PXBE)ZTD7D9;!GD3!3?]+EL1". X(X 4@80S[L
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M,9\@*$"5NEGX78*H;38%408V]$@/=;%FZ(![I # I6[@5K&#J^6 02HF>=R
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MP=S28X+&!]#^6FMW=/R\]L]3\0=02P,$%     @ FH"I5.)[E1HD @  QP0
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M9/#Y*@+37)O&(5V%R5MH<G,<S*U[:=#X +>_UJ[LK>.'N7N[RC]02P,$%
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MPVI_U^M(KH,9JI2!T[CLI3\)/Y[]#HK&'("5X_9@,$"4HT?4 0:3,4&QRW&
M"<[^3'B3.SV!(T6 XM3&!02X>@2\7_8'KO1:E@+K+F#$U5_+.MZ2>WU4YP)]
M7/SVZ\\%SKC;[DGMN_[<[G4H153G C7<_0.C'>XP!JXDZ'&Q,FOG D=</4?N
MO@LO^]OPS^$A9R0N8,+M(5)Q&S=UMU^->L5]+;<;MF"C<Y80R(JIT_(NL,/5
MLZ.3"^!3Y3G,)WPBI2P/(U9LW\#N>?KK E!<_^TMZX'[]_3N?Z_;FI[L-JVE
M6D4>>&1/[Y%W,M"[R2]XX+.]'GRV!S[;T_OL_6PKRWI9G4NNLF+*O*\'CMW3
M._8WG@&'1ZL>H,'KX8JM!\3P]('%?L:7_ I$9GQ),;7Q@2[>MCQ8?0<[%S=4
MB^=P>7R'[#5^V]'#75T/>.#I XQ=+J1[DBNQ*C/X@ )?CP*Y&=Z-V_4!)WX/
M>2(?O+Z_[0!DNP7];C+([&0UMQ3:% ^HX._XBX<?9.;#?:L/N/![R![YX-K]
M;=FC'2S<S1=)+*POM"D>N'Y?[_KOZY^$"QM4=ZV7/#K/*8MS6D8F=0"GM05X
M;[^'Q) /[MK_OSV[\'<ZNY"44B8Y_,:/_?08D>LLXKA[OA:S21RMOVJIWOR1
MQWA5.ND'REA"53_&]+N_$#3:.OK=DU+E\85I-'\>J&?6SE/]J"[NH%2K:31^
M.&CT0##Q8 @00,^P=[RJ7D1W5<NJ4GK4>+K"@N:S\K$6!8\G5BFK'D.P_G3]
M[(RK\H$1K<^OS8]!]0 ,:*9Z(,==F,\$ZQ(ZY4T:0Y$KRJM'7%1O6+8LG^'P
MF#&6+<J7<QI.:"X*\.^G6<9>WH@.UD\:N?P'4$L#!!0    ( )J J53EK^%X
MR0H  "9*   9    >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;,U<6V_;N!+^
M*T2P#RF0V"1U+]( L9+=#=!L@W9WS\/B/"@V;>M4EGPD.6D7Y\<?ZF(/99&4
MG#K6YJ&U95YFR.'W<69(7;TDZ==LR5B.OJVB./MPMLSS]?OQ.)LNV2K(1LF:
MQ?R7>9*N@IQ_31?C;)VR8%966D5CBK$]7@5A?'9]53Y[3*^ODDT>A3%[3%&V
M6:V"]/N$1<G+AS-RMGWP.5PL\^+!^/IJ'2S8%Y;_L7Y,^;?QKI59N&)Q%B8Q
M2MG\P]D->7]'B%'4*(O\&;*73/B,"EV>DN1K\>5^]N$,%R*QB$WSHHV __?,
M?!9%15-<D/_6K9[M.BTJBI^WK?]<:L^U>0HRYB?1O\)9OOQPYIZA&9L'FRC_
MG+S\RFJ-K**]:1)EY;_HI2Z+S]!TD^7)JJ[,)5B%<?5_\*T>":$";T=>@=85
MZ'X%4U'!J"L8?2N8=06S;P6KKE"J/JYT+P?N-LB#ZZLT>4%I49JW5GPH1[^L
MS<<KC M+^9*G_->0U\NO_63%+6Q93/TS0W=!&H?Q(D/GQ?,D9G&>H4]S]"E?
MLA0URWY,LNP=.K]E>1!&_-,E^N/++3K_Z1WZ"84Q>@BCB%M"=C7.N9A%9^-I
M+=*D$HDJ1#+00Q+GRPS=Q3,V:]8?<_5V.M*MCA.J;? A2$?((!>(8DHE\OC]
MJQ-)]5M]]5LVU5:_ZU\=:P;#V$VX4;9G*-J[F4XWJTT4Y&PFG=;[>)JL&#JO
MIO>OC[PZNL_9*ONWIG-SU[E9=FXJ.O^-0]\FYH@6A7_S_A<<R=!Y5/;$08-#
MU5=N34\10QF;;M(P#UEV@6)>*9FC//AV@9[8(HP+$RV>K%D:)C.9@552$%R*
M48#E\S4?NV>)Y-9.<JN7Y--D$9>R%U*S# 7Q#*VY&!Q\6?H<3AF:)EG.,;0:
MX3PI4(NW->.BQ_Q3CM91$#>TDBE0">,*\E]2;V3N=*@,KRKE"*4,.J)R1>V=
MHK9640Z_'%QCCCUIRN+I=Y2G7%ZN30GKL_]P2.)$D?>>"KNM"7$Q%71IB.GL
MQ'2T8HIFG)1F/&V8<3$]KS(=1R*O8YHC0RZONY/7[;2?+(B8% _=5I\F<5QA
M)BN8<EO3;9H8CXA<,F\GF:>5[#[.6<JXS;)O?/N1,9F 7DM 8MHM^:I2EEC*
M]N3"$0S\A ^!C&)>E5@AY1HLF="1LR>ZK!0>J807R)5HA?>70;Q@!1TVL*/$
MO5<BAU1'(H&+D;VO8[L4'KD*%2FH2+4J?E(NOB?&-[),A7!ULU9#9F??I.I2
M#<U,#PNZ-<4&%B1&A]67-/=[\ W=57:/SB?5.+^3BFNTEP!U!52HY6T7LSQ;
M!1X$>).\,7$R;FU:W*L%V%LG*L&!-LE@O-E'J2X>;6H%'$F.1)+=$DKXD5*'
M*"T<")(<FR&[A74D:Q;;"@(BP(U$3XZ_<'.N3.)C91U\%&^Y%,]!X45FFHTG
M 98CWNGWO11HC/:CL08'9-4:9M4JGH'&K]FY^+4$5G.K)9\;"A1&]10FPW>V
M<Q,K"*J1GFL7!5D6SL-IN1*Z.,"G;4;BD(K%/X5M4> GJN>G X'>IVW&4;(D
M!;JA>KKYD>GO6I8^;9/.);%&ED)H(!VJ)YV.98G^AS[OS3A*-J7</1?;7P]L
M]<12[0H#IJ'6  L<*('J*4%%=,V9+;:"Q=R&,?]2<@1:LMFB6-LE]16K9AFN
MN_Q#G[9IPU"1-07*H'K*.-F$\Y9:%,J!XB5(9QQJ8LZFTUP'^Q2HA;H#6 6P
M#M4[5UJWC[;=JDMBMMPJ63%;Y?49P$B&GI%..=D['S/EE5#V$JQULVL .1GD
M]+-K +<87=S2[3H;;3XAPN154]Q1J"F>$.G3DXYLAA_ 5?BB\)N;O0%;&.8
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MQ#'V-XVW=3'Q+ "Q5>Z@!SCM=1\F:L_V#^U0/.$:W@"Y6H+%BW:#7U'8BM"
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M;]"NP.X?E<)+XHY<]\.(/P!02P,$%     @ FH"I5/;G!%QR @  4 4  !D
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MM:,)#&9-3QX:'T#[I=9NZWB"X1'-_@!02P,$%     @ FH"I5&A<CDHE @
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M@MA"M]Z*Z_T21R/+$,40TSM1R9)#61:8A0IB"T',N]EBSJYJ;JWT=_^^^+?
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M_J"P1!F7!$D3K FT#LAU(/ Z(-B!0.R 9 <"LP.B'0C4#LAV(' [(-R!0.Z
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )J J52 2L/;[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )J
MJ5297)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ FH"I5*L-<J]R!0  !18  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )J
MJ52X#SYT$@4  *\2   8              " @;8-  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " ":@*E4SUQ,ABL$  #8#0  &
M        @('^$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ FH"I5)/@&Y74!0  RQ@  !@              ("!7Q<  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )J J51C=B >T $  (@#   8
M              " @6D=  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " ":@*E4<YJ1*(T%  !1&0  &               @(%O'P  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ FH"I5/,RCNA@!P
MXQT  !@              ("!,B4  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( )J J50S<.^*@04  '0-   8              " @<@L
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " ":@*E442[!
MQPH%  "U"P  &               @(%_,@  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ FH"I5*JM$WH?"@  Q!D  !D
M ("!OS<  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " ":
M@*E4J!D9!B@#  #A!@  &0              @($50@  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )J J50.LG*Y\@8  #81   9
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M970Q-BYX;6Q02P$"% ,4    " ":@*E4X-8/QFT%  "I$   &0
M    @('38   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M )J J50K6TVE!@D   \5   9              " @7=F  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ FH"I5 TAZ@-+!@  ,0X  !D
M             ("!M&\  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " ":@*E4=JM;6R@)  "&&   &0              @($V=@  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )J J50-2L_+!P8
M /$.   9              " @95_  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ FH"I5",-*IR-!P  7!$  !D              ("!
MTX4  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " ":@*E4
M=MMEL.$&  #7$   &0              @(&7C0  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( )J J52!<&!<Y@,  .T(   9
M      " @:^4  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ FH"I5#0MK6W; @  *08  !D              ("!S)@  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " ":@*E49\(L"#,'   )%0
M&0              @('>FP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( )J J531L/5;KP(  ,<%   9              " @4BC  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ FH"I5"RO: #\
M @  ( @  !D              ("!+J8  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " ":@*E4P((W;R\%  ".#0  &0
M@(%AJ0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( )J
MJ53R:00Q@ 8  'P3   9              " @<>N  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ FH"I5.#8H=M#!@  /P\  !D
M         ("!?K4  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " ":@*E48 1J3HH%  !'$0  &0              @('XNP  >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( )J J50%;BR,Y0,  "X(
M   9              " @;G!  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ FH"I5**HH:)B P  5 <  !D              ("!U<4
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " ":@*E4/M@G
MKTL"  !;!0  &0              @(%NR0  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( )J J50+R?FU7P(  ($%   9
M  " @?#+  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
MFH"I5'N%?*W.!P  S#(  !D              ("!ALX  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " ":@*E4'C8HGU,#  !;"0  &0
M            @(&+U@  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( )J J51AIQ/@R0(  ,<(   9              " @17:  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ FH"I5"TI'W>Y P
MS H  !D              ("!%=T  'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " ":@*E4!\LWD!8"  !]!   &0              @($%
MX0  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( )J J522
M&=JC( (  (X$   9              " @5+C  !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ FH"I5##J5GC6!   $10  !D
M     ("!J>4  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
M" ":@*E4HK<(:C(#  #K"P  &0              @(&VZ@  >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( )J J518-T::A0,  )@+   9
M              " @1_N  !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L!
M A0#%     @ FH"I5,SEH%-G @  4P4  !D              ("!V_$  'AL
M+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " ":@*E4Q$6DOJH#
M  !K#   &0              @(%Y]   >&PO=V]R:W-H965T<R]S:&5E=#0W
M+GAM;%!+ 0(4 Q0    ( )J J53XH+/6C0(  &@'   9              "
M@5KX  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ FH"I
M5,Y6@+MR @  3@8  !D              ("!'OL  'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " ":@*E4OIC=Y0@#  #4"   &0
M        @(''_0  >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( )J J52@^9S;/@,   @,   9              " @08! 0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ FH"I5)3MRK1A @  SP4
M !D              ("!>P0! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " ":@*E4D9'?"U8"  #+!0  &0              @($3!P$
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( )J J52_2F)6
M,P0  ',/   9              " @: ) 0!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ FH"I5"O9*XM& P  , H  !D
M ("!"@X! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " ":
M@*E4WR0AHJ<$   0$   &0              @(&'$0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( )J J50N&ZENH@(  $X'   9
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M970V,2YX;6Q02P$"% ,4    " ":@*E48555.=X$  "J'   &0
M    @(':+0$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M )J J50]&)+DR@,  & ,   9              " @>\R 0!X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ FH"I5"&PB@.C @  Y@8  !D
M             ("!\#8! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " ":@*E4/#[4G40"  "P!0  &0              @('*.0$ >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( )J J50HQNGW!08
M "4?   9              " @44\ 0!X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ FH"I5&?2@J<N!0  :A8  !D              ("!
M@4(! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " ":@*E4
M5+VQ<5$#  #="P  &0              @('F1P$ >&PO=V]R:W-H965T<R]S
M:&5E=#8X+GAM;%!+ 0(4 Q0    ( )J J502OD7PFP(  -T%   9
M      " @6Y+ 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%
M  @ FH"I5(0X[&W"!   ,!,  !D              ("!0$X! 'AL+W=O<FMS
M:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " ":@*E4H-7*R+H"  !L!@
M&0              @($Y4P$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+
M 0(4 Q0    ( )J J539WG7R/08  *LC   9              " @2I6 0!X
M;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ FH"I5#A&1UC)
M P  OPX  !D              ("!GEP! 'AL+W=O<FMS:&5E=',O<VAE970W
M,RYX;6Q02P$"% ,4    " ":@*E4'K3BC 4#  !."@  &0
M@(&>8 $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( )J
MJ52+'=S:T @  "PZ   9              " @=IC 0!X;"]W;W)K<VAE971S
M+W-H965T-S4N>&UL4$L! A0#%     @ FH"I5%Q7Y#HQ @  J@0  !D
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M=#@P+GAM;%!+ 0(4 Q0    ( )J J51),?G1B@4  .09   9
M  " @9N) 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @
MFH"I5-W7V5Y&!0  (QD  !D              ("!7(\! 'AL+W=O<FMS:&5E
M=',O<VAE970X,BYX;6Q02P$"% ,4    " ":@*E4RMQV8V4"  !%!@  &0
M            @('9E $ >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4
M Q0    ( )J J522&+Q6PP(  !P'   9              " @767 0!X;"]W
M;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ FH"I5-T^REHD @
MDP0  !D              ("!;YH! 'AL+W=O<FMS:&5E=',O<VAE970X-2YX
M;6Q02P$"% ,4    " ":@*E4GO]?RG,"   T!@  &0              @('*
MG $ >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( )J J52\
MP%HWT (   <)   9              " @72? 0!X;"]W;W)K<VAE971S+W-H
M965T.#<N>&UL4$L! A0#%     @ FH"I5"Z;[7T$ @  / 0  !D
M     ("!>Z(! 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4
M" ":@*E4]N<$7'("  !0!0  &0              @(&VI $ >&PO=V]R:W-H
M965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( )J J51H7(Y*)0(  !,%   9
M              " @5^G 0!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L!
M A0#%     @ FH"I5#'%/SE> P  1A4   T              ( !NZD! 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " ":@*E4EXJ[',     3 @  "P
M        @ %$K0$ 7W)E;',O+G)E;'-02P$"% ,4    " ":@*E4UA=R,Z,&
M  "(.P  #P              @ $MK@$ >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ FH"I5.;BI-"@ @  !34  !H              ( !_;0! 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ FH"I5,* #&LZ @
M:#,  !,              ( !U;<! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     &( 8@#E&@  0+H!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>397</ContextCount>
  <ElementCount>351</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>144</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements Of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements Of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements Of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements Of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements Of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1107116 - Statement - Collaboration and Licensing Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CollaborationandLicensingAgreements</Role>
      <ShortName>Collaboration and Licensing Agreements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Revenue Recognition and Accounts Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable</Role>
      <ShortName>Revenue Recognition and Accounts Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RecentAccountingPronouncements</Role>
      <ShortName>Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - Share-Based Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlan</Role>
      <ShortName>Share-Based Incentive Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122106 - Disclosure - Pensions and Other Postretirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionsandOtherPostretirementBenefits</Role>
      <ShortName>Pensions and Other Postretirement Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2137108 - Disclosure - Equity Method Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestments</Role>
      <ShortName>Equity Method Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2141109 - Disclosure - Earnings (Loss) per Ordinary Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShare</Role>
      <ShortName>Earnings (Loss) per Ordinary Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2171113 - Disclosure - Comprehensive Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarnings</Role>
      <ShortName>Comprehensive Earnings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2175114 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2180115 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2184117 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - General (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GeneralPolicies</Role>
      <ShortName>General (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RecentAccountingPronouncements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2276202 - Disclosure - Segment Information (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationPolicies</Role>
      <ShortName>Segment Information (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RecentAccountingPronouncements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Share-Based Incentive Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanTables</Role>
      <ShortName>Share-Based Incentive Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlan</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Pensions and Other Postretirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables</Role>
      <ShortName>Pensions and Other Postretirement Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/PensionsandOtherPostretirementBenefits</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponents</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2338306 - Disclosure - Equity Method Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsTables</Role>
      <ShortName>Equity Method Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2342307 - Disclosure - Earnings (Loss) per Ordinary Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShareTables</Role>
      <ShortName>Earnings (Loss) per Ordinary Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EarningsLossperOrdinaryShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2346308 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - Financial Instruments and Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</Role>
      <ShortName>Financial Instruments and Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2365310 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2372311 - Disclosure - Comprehensive Earnings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsTables</Role>
      <ShortName>Comprehensive Earnings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarnings</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2377312 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2381313 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Restructuring</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GeneralPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Variable Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2411406 - Disclosure - Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details</Role>
      <ShortName>Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Acquisitions and Other Transactions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails</Role>
      <ShortName>Share-Based Incentive Plan (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails</Role>
      <ShortName>Share-Based Incentive Plan (Stock Awards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2421412 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails</Role>
      <ShortName>Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Pension and Other Postretirement Benefit (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails</Role>
      <ShortName>Pension and Other Postretirement Benefit (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails</Role>
      <ShortName>Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails</Role>
      <ShortName>Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Balance Sheet Components (Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails</Role>
      <ShortName>Balance Sheet Components (Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails</Role>
      <ShortName>Balance Sheet Components (Property, Plant and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - Balance Sheet Components (Other Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails</Role>
      <ShortName>Balance Sheet Components (Other Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2433420 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails</Role>
      <ShortName>Balance Sheet Components (Trade Accounts Payable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components (Other Current Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2435422 - Disclosure - Balance Sheet Components (Other Long-term Obligations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails</Role>
      <ShortName>Balance Sheet Components (Other Long-term Obligations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2436423 - Disclosure - Balance Sheet Components - Assets and Liabilities Held For Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails</Role>
      <ShortName>Balance Sheet Components - Assets and Liabilities Held For Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Equity Method Investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails</Role>
      <ShortName>Equity Method Investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestmentsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2440425 - Disclosure - Equity Method Investments (Income Statement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails</Role>
      <ShortName>Equity Method Investments (Income Statement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestmentsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Earnings (Loss) per Ordinary Share (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails</Role>
      <ShortName>Earnings (Loss) per Ordinary Share (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EarningsLossperOrdinaryShareTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails</Role>
      <ShortName>Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EarningsLossperOrdinaryShareTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - Goodwill and Intangible Assets (Components of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Components of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2450431 - Disclosure - Goodwill and Intangible Assets (Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2451432 - Disclosure - Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2455434 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2456435 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2457436 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2460439 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2461440 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations, Derivatives Not Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations, Derivatives Not Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462441 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463442 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2466443 - Disclosure - Debt (Receivables, Securitization Facility and Commercial Paper) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails</Role>
      <ShortName>Debt (Receivables, Securitization Facility and Commercial Paper) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2467444 - Disclosure - Debt (Summary of Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails</Role>
      <ShortName>Debt (Summary of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2468445 - Disclosure - Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails</Role>
      <ShortName>Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2469446 - Disclosure - Debt (Fair Value) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtFairValueNarrativeDetails</Role>
      <ShortName>Debt (Fair Value) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2470447 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails</Role>
      <ShortName>Debt (Minimum Repayments on Outstanding Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2473448 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarningsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2474449 - Disclosure - Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails</Role>
      <ShortName>Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarningsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2479451 - Disclosure - Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails</Role>
      <ShortName>Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformationTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2482452 - Disclosure - Restructuring (Restructuring Charges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RestructuringRestructuringChargesDetails</Role>
      <ShortName>Restructuring (Restructuring Charges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RestructuringTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2483453 - Disclosure - Collaboration and Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails</Role>
      <ShortName>Collaboration and Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2485454 - Disclosure - Income Taxes Income Taxes Disclosure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails</Role>
      <ShortName>Income Taxes Income Taxes Disclosure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2488456 - Disclosure - Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails</Role>
      <ShortName>Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2492460 - Disclosure - Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails</Role>
      <ShortName>Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2493461 - Disclosure - Litigation (Drug Pricing Matters) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationDrugPricingMattersDetails</Role>
      <ShortName>Litigation (Drug Pricing Matters) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2496464 - Disclosure - Litigation (Product Liability) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails</Role>
      <ShortName>Litigation (Product Liability) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2497465 - Disclosure - Litigation (Intellectual Property) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails</Role>
      <ShortName>Litigation (Intellectual Property) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="vtrs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2498466 - Disclosure - Litigation (Other Litigation) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails</Role>
      <ShortName>Litigation (Other Litigation) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="vtrs-20220331.htm">vtrs-20220331.htm</File>
    <File>ex_311xvtrsx20220331.htm</File>
    <File>ex_312xvtrsx20220331.htm</File>
    <File>ex_32xvtrsx20220331.htm</File>
    <File>vtrs-20220331.xsd</File>
    <File>vtrs-20220331_cal.xml</File>
    <File>vtrs-20220331_def.xml</File>
    <File>vtrs-20220331_lab.xml</File>
    <File>vtrs-20220331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="986">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>107
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "vtrs-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 41,
   "contextCount": 397,
   "dts": {
    "calculationLink": {
     "local": [
      "vtrs-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vtrs-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "vtrs-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vtrs-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vtrs-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vtrs-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 813,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 1,
    "http://www.viatris.com/20220331": 1,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 7
   },
   "keyCustom": 34,
   "keyStandard": 317,
   "memberCustom": 70,
   "memberStandard": 70,
   "nsprefix": "vtrs",
   "nsuri": "http://www.viatris.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityAddressAddressLine1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.viatris.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityAddressAddressLine1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Revenue Recognition and Accounts Receivable",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable",
     "shortName": "Revenue Recognition and Accounts Receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Recent Accounting Pronouncements",
     "role": "http://www.viatris.com/role/RecentAccountingPronouncements",
     "shortName": "Recent Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - Share-Based Incentive Plan",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlan",
     "shortName": "Share-Based Incentive Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122106 - Disclosure - Pensions and Other Postretirement Benefits",
     "role": "http://www.viatris.com/role/PensionsandOtherPostretirementBenefits",
     "shortName": "Pensions and Other Postretirement Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Balance Sheet Components",
     "role": "http://www.viatris.com/role/BalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137108 - Disclosure - Equity Method Investments",
     "role": "http://www.viatris.com/role/EquityMethodInvestments",
     "shortName": "Equity Method Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141109 - Disclosure - Earnings (Loss) per Ordinary Share",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShare",
     "shortName": "Earnings (Loss) per Ordinary Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171113 - Disclosure - Comprehensive Earnings",
     "role": "http://www.viatris.com/role/ComprehensiveEarnings",
     "shortName": "Comprehensive Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2175114 - Disclosure - Segment Information",
     "role": "http://www.viatris.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2180115 - Disclosure - Restructuring",
     "role": "http://www.viatris.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements Of Operations",
     "role": "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "Condensed Consolidated Statements Of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2184117 - Disclosure - Income Taxes",
     "role": "http://www.viatris.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - General (Policies)",
     "role": "http://www.viatris.com/role/GeneralPolicies",
     "shortName": "General (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2276202 - Disclosure - Segment Information (Policies)",
     "role": "http://www.viatris.com/role/SegmentInformationPolicies",
     "shortName": "Segment Information (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables",
     "shortName": "Revenue Recognition and Accounts Receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Share-Based Incentive Plan (Tables)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
     "shortName": "Share-Based Incentive Plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Pensions and Other Postretirement Benefits (Tables)",
     "role": "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables",
     "shortName": "Pensions and Other Postretirement Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Balance Sheet Components (Tables)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338306 - Disclosure - Equity Method Investments (Tables)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsTables",
     "shortName": "Equity Method Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342307 - Disclosure - Earnings (Loss) per Ordinary Share (Tables)",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShareTables",
     "shortName": "Earnings (Loss) per Ordinary Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346308 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements Of Comprehensive Loss",
     "role": "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements Of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - Financial Instruments and Risk Management (Tables)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables",
     "shortName": "Financial Instruments and Risk Management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365310 - Disclosure - Debt (Tables)",
     "role": "http://www.viatris.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2372311 - Disclosure - Comprehensive Earnings (Tables)",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsTables",
     "shortName": "Comprehensive Earnings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2377312 - Disclosure - Segment Information (Tables)",
     "role": "http://www.viatris.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2381313 - Disclosure - Restructuring (Tables)",
     "role": "http://www.viatris.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "if11d265b55994603936bcc00f3604ac6_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - General (Details)",
     "role": "http://www.viatris.com/role/GeneralDetails",
     "shortName": "General (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "if11d265b55994603936bcc00f3604ac6_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails",
     "shortName": "Revenue Recognition and Accounts Receivable (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "iba711be447b3478c996341536356cdf5_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:RevenuefromContractwithCustomerGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Variable Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:RevenuefromContractwithCustomerGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
     "shortName": "Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411406 - Disclosure - Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)",
     "role": "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details",
     "shortName": "Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Acquisitions and Other Transactions (Narrative) (Details)",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
     "shortName": "Acquisitions and Other Transactions (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
     "shortName": "Acquisitions and Other Transactions (Purchase Price Allocations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
     "shortName": "Share-Based Incentive Plan (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails",
     "shortName": "Share-Based Incentive Plan (Stock Awards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ibd6d8a15669b44269a74dc8552c59bff_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421412 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails",
     "shortName": "Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ibd6d8a15669b44269a74dc8552c59bff_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Pension and Other Postretirement Benefit (Narrative) (Details)",
     "role": "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
     "shortName": "Pension and Other Postretirement Benefit (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "idf19978eee644aba94ea1363e7675424_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)",
     "role": "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
     "shortName": "Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "idf19978eee644aba94ea1363e7675424_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails",
     "shortName": "Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "if8dd750c9019453f8f3c004524321932_I20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Balance Sheet Components (Inventories) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails",
     "shortName": "Balance Sheet Components (Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
     "shortName": "Balance Sheet Components (Property, Plant and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - Balance Sheet Components (Other Assets) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
     "shortName": "Balance Sheet Components (Other Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433420 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails",
     "shortName": "Balance Sheet Components (Trade Accounts Payable) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
     "shortName": "Balance Sheet Components (Other Current Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LitigationReserveCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435422 - Disclosure - Balance Sheet Components (Other Long-term Obligations) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
     "shortName": "Balance Sheet Components (Other Long-term Obligations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436423 - Disclosure - Balance Sheet Components - Assets and Liabilities Held For Sale (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
     "shortName": "Balance Sheet Components - Assets and Liabilities Held For Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:EquityMethodInvestmentsSummarizedFinancialDataBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Equity Method Investments (Narrative) (Details)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails",
     "shortName": "Equity Method Investments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:EquityMethodInvestmentsSummarizedFinancialDataBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440425 - Disclosure - Equity Method Investments (Income Statement) (Details)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
     "shortName": "Equity Method Investments (Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i8a2b2960f44348c8a6f0ccf4632f9f95_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareDiluted",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Earnings (Loss) per Ordinary Share (Narrative) (Details)",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails",
     "shortName": "Earnings (Loss) per Ordinary Share (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Equity",
     "role": "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
     "shortName": "Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i0caf4a2fc4f44bb19d19a03b276d68f4_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails",
     "shortName": "Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i6a2086ac5d6c416b8cc71c7c9d2219a7_D20220331-20220331",
      "decimals": null,
      "lang": "en-US",
      "name": "vtrs:GoodwillImpairmentMeasurementInputTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - Goodwill and Intangible Assets (Components of Intangible Assets) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets (Components of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450431 - Disclosure - Goodwill and Intangible Assets (Amortization Expense) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets (Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451432 - Disclosure - Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
     "shortName": "Financial Instruments and Risk Management (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455434 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9fdb2ff01ac847c19778cd87d74222f1_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456435 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457436 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements Of Cash Flows",
     "role": "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements Of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460439 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "if8a1b50cf22c46cba7f94a3405c8b929_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461440 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations, Derivatives Not Designated as Hedging Instruments) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations, Derivatives Not Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462441 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
     "shortName": "Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic47baa2563274d178d24b9c707cec448_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463442 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
     "shortName": "Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466443 - Disclosure - Debt (Receivables, Securitization Facility and Commercial Paper) (Details)",
     "role": "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
     "shortName": "Debt (Receivables, Securitization Facility and Commercial Paper) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ia28510b5c71d4182aa49d69fb01fa474_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467444 - Disclosure - Debt (Summary of Long-Term Debt) (Details)",
     "role": "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
     "shortName": "Debt (Summary of Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468445 - Disclosure - Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
     "shortName": "Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "id07178dd71fc4b9d989a85d7e37587c8_I20220331",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469446 - Disclosure - Debt (Fair Value) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
     "shortName": "Debt (Fair Value) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "id07178dd71fc4b9d989a85d7e37587c8_I20220331",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470447 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)",
     "role": "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails",
     "shortName": "Debt (Minimum Repayments on Outstanding Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473448 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1107116 - Statement - Collaboration and Licensing Agreements",
     "role": "http://www.viatris.com/role/CollaborationandLicensingAgreements",
     "shortName": "Collaboration and Licensing Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474449 - Disclosure - Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
     "shortName": "Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i97cceb4d5127408091af840823fc721e_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479451 - Disclosure - Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)",
     "role": "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails",
     "shortName": "Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ibf733ae3e5124ab199c7831a4facfe9e_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "ic0f234c800024956b447083ed4d02c3e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482452 - Disclosure - Restructuring (Restructuring Charges) (Details)",
     "role": "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
     "shortName": "Restructuring (Restructuring Charges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i4cd2df5979694abd9cfb33abc0ae4026_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Developmentandsalesmilestonepayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483453 - Disclosure - Collaboration and Licensing Agreements (Details)",
     "role": "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
     "shortName": "Collaboration and Licensing Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i4cd2df5979694abd9cfb33abc0ae4026_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Developmentandsalesmilestonepayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2485454 - Disclosure - Income Taxes Income Taxes Disclosure (Details)",
     "role": "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
     "shortName": "Income Taxes Income Taxes Disclosure (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2488456 - Disclosure - Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
     "shortName": "Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i3e4d7d622da84b43bba3a6f1313667a9_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2492460 - Disclosure - Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)",
     "role": "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
     "shortName": "Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i3e4d7d622da84b43bba3a6f1313667a9_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "iaafdd9a3a724498080488d52b9b8e49a_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Numberofstates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2493461 - Disclosure - Litigation (Drug Pricing Matters) (Details)",
     "role": "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
     "shortName": "Litigation (Drug Pricing Matters) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "iaafdd9a3a724498080488d52b9b8e49a_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Numberofstates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i4c504afee4fe48c49e1b8ec64187b6b1_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2496464 - Disclosure - Litigation (Product Liability) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
     "shortName": "Litigation (Product Liability) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i4c504afee4fe48c49e1b8ec64187b6b1_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "increase",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2497465 - Disclosure - Litigation (Intellectual Property) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
     "shortName": "Litigation (Intellectual Property) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i4bf3415d8748400db65c623b551b0b4b_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "increase",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - General",
     "role": "http://www.viatris.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i9b232b0ef31e4e0a908fb784eea632aa_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Numberofcases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2498466 - Disclosure - Litigation (Other Litigation) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
     "shortName": "Litigation (Other Litigation) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20220331.htm",
      "contextRef": "i7e5e2a7d119d4b7e95d05c42a90b950b_I20220331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Numberofcases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 144,
   "tag": {
    "country_TR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TURKEY",
        "terseLabel": "TURKEY"
       }
      }
     },
     "localname": "TR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Ordinary Shares, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filler Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r164",
      "r358",
      "r363",
      "r371",
      "r629",
      "r630",
      "r635",
      "r636",
      "r740",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r164",
      "r358",
      "r363",
      "r371",
      "r629",
      "r630",
      "r635",
      "r636",
      "r740",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r164",
      "r211",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r237",
      "r241",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r366",
      "r368",
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r164",
      "r211",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r237",
      "r241",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r366",
      "r368",
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r87",
      "r89",
      "r162",
      "r163",
      "r377",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r376",
      "r408",
      "r523",
      "r529",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r756",
      "r806",
      "r809",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r376",
      "r408",
      "r523",
      "r529",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r756",
      "r806",
      "r809",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Company [Member]",
        "terseLabel": "Mylan",
        "verboseLabel": "Mylan N.V."
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r244",
      "r426",
      "r428",
      "r758",
      "r805",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r244",
      "r426",
      "r428",
      "r758",
      "r805",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r376",
      "r408",
      "r467",
      "r523",
      "r529",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r756",
      "r806",
      "r809",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r376",
      "r408",
      "r467",
      "r523",
      "r529",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r756",
      "r806",
      "r809",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r88",
      "r89",
      "r162",
      "r163",
      "r377",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r180",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r180",
      "r185",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r245",
      "r246",
      "r426",
      "r429",
      "r808",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r245",
      "r246",
      "r426",
      "r429",
      "r808",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r180",
      "r185",
      "r342",
      "r524",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r493",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Mylan Laboratories Limited"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Revenue Recognition And Accounts Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.",
        "label": "Legal Entity of Counterparty, Type [Axis]",
        "terseLabel": "Legal Entity of Counterparty, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current [Abstract]",
        "terseLabel": "Accounts Payable, Current [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableOtherCurrentAndNoncurrent": {
     "auth_ref": [
      "r775",
      "r798"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableTradeCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred and payable classified as other.",
        "label": "Accounts Payable, Other",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r33",
      "r65"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "totalLabel": "Accounts payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "auth_ref": [
      "r775",
      "r798"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableTradeCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Accounts Payable, Trade",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r25",
      "r46",
      "r250",
      "r251"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r319",
      "r320",
      "r324"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expense",
        "terseLabel": "Accretion expense"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r41",
      "r771",
      "r790"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r100",
      "r106",
      "r115",
      "r116",
      "r117",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Plan Items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r63",
      "r312"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "verboseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r95",
      "r106",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Gains and Losses on Derivatives"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r106",
      "r115",
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Gains and Losses on Marketable Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
        "periodEndLabel": "Net unrealized gain (loss) on marketable securities, net of tax, end of period",
        "periodStartLabel": "Net unrealized gain (loss) on marketable securities, net of tax, beginning of period",
        "terseLabel": "Net unrealized gain on marketable securities, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [
      "r95",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
        "periodEndLabel": "Net unrecognized gains (losses) on derivatives, net of tax, end of period",
        "periodStartLabel": "Net unrecognized gains (losses) on derivatives, net of tax, beginning of period",
        "verboseLabel": "Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r101",
      "r106",
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Net unrecognized losses and prior service cost related to defined benefit plans, net of tax",
        "negatedPeriodEndLabel": "Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r93",
      "r103",
      "r105",
      "r106",
      "r702"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Foreign currency translation adjustment, end of period",
        "periodStartLabel": "Foreign currency translation adjustment, beginning of period",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r49",
      "r103",
      "r105",
      "r106",
      "r793",
      "r817",
      "r821"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated other comprehensive loss, net of tax, end of period",
        "periodStartLabel": "Accumulated other comprehensive loss, net of tax, beginning of period",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r115",
      "r116",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r102",
      "r106",
      "r115",
      "r116",
      "r117",
      "r165",
      "r166",
      "r167",
      "r634",
      "r812",
      "r813",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r94",
      "r106",
      "r115",
      "r116",
      "r117",
      "r634",
      "r720",
      "r721",
      "r722",
      "r723",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r47",
      "r565",
      "r743"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r561",
      "r562",
      "r563",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r150",
      "r301"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "totalLabel": "Total intangible asset amortization expense (including impairment charges)"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).",
        "label": "Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net",
        "terseLabel": "Taxes related to the net share settlement of equity awards"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r531",
      "r533",
      "r566",
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r150",
      "r294",
      "r301"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AdjustmentForAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r260",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed Securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r157",
      "r219",
      "r232",
      "r239",
      "r267",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r369",
      "r371",
      "r372",
      "r629",
      "r635",
      "r705",
      "r741",
      "r743",
      "r769",
      "r789"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r27",
      "r29",
      "r82",
      "r157",
      "r267",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r369",
      "r371",
      "r372",
      "r629",
      "r635",
      "r705",
      "r741",
      "r743"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r693"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets at recurring fair value measurement"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": {
     "auth_ref": [
      "r307",
      "r743"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r18",
      "r21",
      "r315"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AustralianTaxationOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Australia.",
        "label": "Australian Taxation Office [Member]",
        "terseLabel": "Australian Taxation Office"
       }
      }
     },
     "localname": "AustralianTaxationOfficeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r256",
      "r259",
      "r278",
      "r774"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r534",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]",
        "verboseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r651",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting Policy"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r519",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r519",
      "r525",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r605",
      "r606"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r605",
      "r606"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business Combination, Acquisition Related Costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r615",
      "r616"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r614",
      "r617",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Other Transactions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r612"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "totalLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets (excluding inventories and net of cash acquired)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets": {
     "auth_ref": [
      "r609",
      "r610",
      "r717"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial assets (as defined) recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r609",
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "negatedLabel": "Long-term debt and other noncurrent obligations"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r609",
      "r610"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r60",
      "r152"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r146",
      "r152",
      "r154"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash \u2014 end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash \u2014 beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r146",
      "r718"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r679"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r621",
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration and Licensing Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r351",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Litigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r165",
      "r166",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Ordinary shares, nominal value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Ordinary shares, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r45",
      "r743"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r111",
      "r113",
      "r114",
      "r124",
      "r780",
      "r801"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r123",
      "r132",
      "r779",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "verboseLabel": "Comprehensive Earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarnings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidatedEntityExcludingVieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated entity, excluding variable interest entity (VIE) for which reporting entity is or is not primary beneficiary.",
        "label": "Consolidated Entity, Excluding VIE [Member]",
        "terseLabel": "Consolidated Entity"
       }
      }
     },
     "localname": "ConsolidatedEntityExcludingVieMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateAndOtherMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate and Other [Member]",
        "terseLabel": "Corporate and Other"
       }
      }
     },
     "localname": "CorporateAndOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bond Securities [Member]"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r241",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate / Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r127",
      "r758"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r390",
      "r397",
      "r398",
      "r400",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r156",
      "r164",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r403",
      "r404",
      "r405",
      "r406",
      "r731",
      "r770",
      "r772",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r42",
      "r401",
      "r772",
      "r788"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r388",
      "r403",
      "r404",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r72",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Stated percentage rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r73",
      "r156",
      "r164",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r403",
      "r404",
      "r405",
      "r406",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r73",
      "r156",
      "r164",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r399",
      "r403",
      "r404",
      "r405",
      "r406",
      "r411",
      "r412",
      "r413",
      "r414",
      "r728",
      "r729",
      "r731",
      "r732",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Available-for-sale fixed income investments"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r570",
      "r571"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r150",
      "r158",
      "r581",
      "r592",
      "r593",
      "r594"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax (benefit) expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r570",
      "r571"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "verboseLabel": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43",
      "r442",
      "r443",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Employee benefit liabilities"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r511",
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Estimated employer contributions in current year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r444",
      "r482",
      "r506",
      "r513",
      "r514"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r444",
      "r449",
      "r481",
      "r505",
      "r513",
      "r514"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r479",
      "r503",
      "r513",
      "r514"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r445",
      "r486",
      "r510"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Recognized net actuarial losses",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r447",
      "r480",
      "r504",
      "r513",
      "r514"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r150",
      "r214"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r642",
      "r643",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amount of derivative"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r85",
      "r86",
      "r89",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate swap derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r84",
      "r89",
      "r90",
      "r655",
      "r755"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r84",
      "r89",
      "r90",
      "r655",
      "r755"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r653"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivative, Gain (Loss) on Derivative, Net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r89",
      "r652",
      "r656",
      "r665",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instruments Risk [Axis]",
        "verboseLabel": "Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r649",
      "r652",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r649",
      "r652",
      "r665",
      "r670",
      "r671",
      "r674",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r662",
      "r669"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "verboseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": {
     "auth_ref": [
      "r663",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.",
        "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net",
        "terseLabel": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r664",
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "verboseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r641",
      "r644",
      "r645",
      "r649",
      "r650",
      "r658",
      "r665",
      "r672",
      "r673",
      "r677",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Intellectual Property"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Incentive Plan"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r308",
      "r309",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand, demand deposits with banks or financial institutions, and  other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.",
        "label": "Disposal Group, Including Discontinued Operation, Cash",
        "terseLabel": "Upfront payment subject to certain adjustments"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r310",
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r310",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r310",
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r15",
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Revenue of biosimilars portfolio"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r519",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r415",
      "r786"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Dividends, Common Stock, Cash"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Dividends payable (in dollars per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings (loss) per share attributable to Viatris Inc. shareholders"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r125",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r188",
      "r191",
      "r197",
      "r198",
      "r199",
      "r203",
      "r204",
      "r691",
      "r692",
      "r781",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)",
        "verboseLabel": "Basic earnings (loss) per share attributable to Viatris Inc. shareholders"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r125",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r191",
      "r197",
      "r198",
      "r199",
      "r203",
      "r204",
      "r691",
      "r692",
      "r781",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)",
        "verboseLabel": "Diluted earnings (loss) per ordinary share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per Share Policy"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r718"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "verboseLabel": "Effect on cash of changes in exchange rates"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOnFutureCashFlowsAmount": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The quantified amount of the future effect on cash flows.",
        "label": "Effect on Future Cash Flows, Amount",
        "terseLabel": "Effect on Future Cash Flows, Amount"
       }
      }
     },
     "localname": "EffectOnFutureCashFlowsAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and employee benefit liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation expense, net of estimated forfeitures"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock awards"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r115",
      "r116",
      "r117",
      "r165",
      "r166",
      "r167",
      "r172",
      "r182",
      "r184",
      "r206",
      "r273",
      "r410",
      "r415",
      "r561",
      "r562",
      "r563",
      "r585",
      "r586",
      "r690",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r725",
      "r812",
      "r813",
      "r814",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r61",
      "r220",
      "r263"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ExchangeTradedFundsMember": {
     "auth_ref": [
      "r468",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that follows an index, commodity or basket of assets that trades similar to a stock on an exchange.",
        "label": "Exchange Traded Funds [Member]",
        "terseLabel": "Exchange traded funds"
       }
      }
     },
     "localname": "ExchangeTradedFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r693",
      "r694",
      "r695",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r693",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r388",
      "r403",
      "r404",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r513",
      "r694",
      "r746",
      "r747",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging Relationships"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r388",
      "r468",
      "r470",
      "r475",
      "r513",
      "r694",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r388",
      "r403",
      "r404",
      "r468",
      "r470",
      "r475",
      "r513",
      "r694",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r388",
      "r403",
      "r404",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r513",
      "r694",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r388",
      "r403",
      "r404",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r513",
      "r746",
      "r747",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r701",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments Policy"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r651",
      "r658",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments and Risk Management"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible assets, estimated useful life, in years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r300"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Finite-lived Intangible Assets Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r295",
      "r297",
      "r300",
      "r304",
      "r759",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r300",
      "r766"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Finite-lived intangible assets, original cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r295",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets [Member]",
        "terseLabel": "Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r300",
      "r759"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net book value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign exchange derivative assets"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign exchange derivative liabilities"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r89",
      "r468",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency forward contracts",
        "verboseLabel": "Foreign currency borrowings and forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign exchange forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Gain (Loss) on Fair Value Hedges Recognized in Earnings"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r341"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "Litigation settlements and other contingencies, net",
        "terseLabel": "Litigation settlements and other contingencies, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r283",
      "r284",
      "r743",
      "r768"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodStartLabel": "Goodwill, net, beginning balance",
        "terseLabel": "Goodwill",
        "totalLabel": "Goodwill, net, ending balance",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r285",
      "r288"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Goodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Goodwill, gross, ending balance",
        "periodStartLabel": "Goodwill, gross, beginning balance"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r285",
      "r288"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Goodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedPeriodEndLabel": "Accumulated impairment losses, ending balance",
        "negatedPeriodStartLabel": "Accumulated impairment losses, beginning balance"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r286",
      "r287",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r126",
      "r157",
      "r219",
      "r231",
      "r235",
      "r238",
      "r241",
      "r267",
      "r358",
      "r359",
      "r360",
      "r363",
      "r364",
      "r365",
      "r367",
      "r369",
      "r371",
      "r372",
      "r705"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross loss",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r649",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r150",
      "r305"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AdjustmentForAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "negatedTerseLabel": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r121",
      "r219",
      "r231",
      "r235",
      "r238",
      "r241",
      "r767",
      "r778",
      "r783",
      "r803"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Operating and non-operating expense",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r122",
      "r150",
      "r216",
      "r263",
      "r777",
      "r799"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Loss from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r519",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r17",
      "r19",
      "r20",
      "r21",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r314",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r575",
      "r577",
      "r579",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r159",
      "r573",
      "r578",
      "r580",
      "r590",
      "r595",
      "r599",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r183",
      "r184",
      "r217",
      "r572",
      "r591",
      "r597",
      "r804"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax (benefit) provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other operating assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r199"
     ],
     "calculation": {
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross, excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r293",
      "r298"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net book value, excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r119",
      "r213",
      "r727",
      "r730",
      "r782"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r33",
      "r34",
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r52",
      "r280"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r24",
      "r80",
      "r743"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r54",
      "r280"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r53",
      "r280"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "verboseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalEntityTypeOfCounterpartyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of the other party participating in a financial transaction.",
        "label": "Legal Entity Type of Counterparty [Domain]",
        "terseLabel": "Legal Entity Type of Counterparty [Domain]"
       }
      }
     },
     "localname": "LegalEntityTypeOfCounterpartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Matters and Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Litigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r69",
      "r157",
      "r233",
      "r267",
      "r358",
      "r359",
      "r360",
      "r363",
      "r364",
      "r365",
      "r367",
      "r369",
      "r371",
      "r372",
      "r630",
      "r635",
      "r636",
      "r705",
      "r741",
      "r742"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r50",
      "r157",
      "r267",
      "r705",
      "r743",
      "r773",
      "r795"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r71",
      "r157",
      "r267",
      "r358",
      "r359",
      "r360",
      "r363",
      "r364",
      "r365",
      "r367",
      "r369",
      "r371",
      "r372",
      "r630",
      "r635",
      "r636",
      "r705",
      "r741",
      "r742",
      "r743"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r693"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r16",
      "r18",
      "r21",
      "r315"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-term Debt, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Tax related items, including contingencies"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCovenantTerms": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the conditions for borrowing under the credit facility including the nature of any restrictions.",
        "label": "Line of Credit Facility, Covenant Terms",
        "terseLabel": "Line of Credit Facility, Covenant Terms"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r75",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated litigation liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r75",
      "r341",
      "r350"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal and professional accruals, including litigation accruals"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r42",
      "r387",
      "r402",
      "r403",
      "r404",
      "r772",
      "r792"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt and other long-term obligations"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r164",
      "r355",
      "r392"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r164",
      "r355",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r164",
      "r355",
      "r392"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r164",
      "r355",
      "r392"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r164",
      "r355",
      "r392"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r164",
      "r355",
      "r392"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r73",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r349",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r349",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r341",
      "r344",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded",
        "verboseLabel": "Judgment issued"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r341",
      "r344",
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Damages to be paid"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Loss Contingency, Loss in Period"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r349",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of defendants named in a legal action.",
        "label": "Loss Contingency, Number of Defendants",
        "terseLabel": "Number of defendants"
       }
      }
     },
     "localname": "LossContingencyNumberOfDefendants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Reconciling items:"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputControlPremiumMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using amount above fair value that investor seeking to acquire control of entity will pay.",
        "label": "Measurement Input, Control Premium [Member]",
        "terseLabel": "Measurement Input, Control Premium"
       }
      }
     },
     "localname": "MeasurementInputControlPremiumMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputEbitdaMultipleMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple.",
        "label": "Measurement Input, EBITDA Multiple [Member]",
        "terseLabel": "Measurement Input, EBITDA Multiple"
       }
      }
     },
     "localname": "MeasurementInputEbitdaMultipleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue.",
        "label": "Measurement Input, Long-term Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Long-term Revenue Growth Rate"
       }
      }
     },
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r258",
      "r468",
      "r470",
      "r513",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by mortgage loans.",
        "label": "Collateralized Mortgage Backed Securities [Member]",
        "terseLabel": "Agency mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r146",
      "r148",
      "r151"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r188",
      "r189",
      "r196",
      "r199",
      "r219",
      "r231",
      "r235",
      "r238",
      "r241"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net earnings (loss) attributable to Viatris Inc. common shareholders",
        "totalLabel": "Net earnings (loss)",
        "verboseLabel": "Net earnings (loss)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r5",
      "r169",
      "r170",
      "r173",
      "r174",
      "r185",
      "r186",
      "r187",
      "r254",
      "r255",
      "r274",
      "r275",
      "r435",
      "r436",
      "r437",
      "r438",
      "r564",
      "r587",
      "r588",
      "r589",
      "r688",
      "r712",
      "r713",
      "r714",
      "r736",
      "r763",
      "r764",
      "r765",
      "r816",
      "r817",
      "r818",
      "r819",
      "r821",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RecentAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r168",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r179",
      "r185",
      "r203",
      "r252",
      "r253",
      "r270",
      "r271",
      "r272",
      "r273",
      "r276",
      "r277",
      "r357",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r565",
      "r583",
      "r584",
      "r585",
      "r586",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r689",
      "r690",
      "r691",
      "r692",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r715",
      "r716",
      "r735",
      "r760",
      "r761",
      "r762",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of Countries in which Entity Operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r219",
      "r231",
      "r235",
      "r238",
      "r241"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Earnings (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r733"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segment"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r22",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "General"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r32",
      "r33",
      "r34",
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r81",
      "r743"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r627",
      "r628",
      "r633"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized loss on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r103",
      "r107",
      "r108",
      "r487"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization of prior service costs",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r106",
      "r115",
      "r116",
      "r719",
      "r721",
      "r725"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive earnings (loss) before reclassifications, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r106",
      "r115",
      "r116",
      "r118",
      "r719",
      "r721",
      "r725"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r115",
      "r116",
      "r123",
      "r264",
      "r719",
      "r724",
      "r725",
      "r779",
      "r800"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other comprehensive loss, before tax",
        "totalLabel": "Other comprehensive loss, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r95",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r95",
      "r103",
      "r654",
      "r660",
      "r675"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent": {
     "auth_ref": [
      "r96",
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge, attributable to parent. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent",
        "netLabel": "Net unrecognized losses on derivatives in net investment hedging relationships, net of tax",
        "verboseLabel": "Net unrecognized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax",
        "terseLabel": "Net unrecognized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r93",
      "r103"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r110",
      "r113",
      "r115",
      "r116",
      "r118",
      "r123",
      "r410",
      "r719",
      "r724",
      "r725",
      "r779",
      "r800"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss, net of tax",
        "totalLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r101",
      "r103",
      "r487",
      "r513"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedNetLabel": "Change in unrecognized gain and prior service cost related to defined benefit plans",
        "negatedTerseLabel": "Change in unrecognized (loss) gain and prior service cost related to defined benefit plans",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r103",
      "r107",
      "r108",
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r104",
      "r115",
      "r123",
      "r572",
      "r596",
      "r598",
      "r719",
      "r722",
      "r725",
      "r779",
      "r800"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r95",
      "r103",
      "r678"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r261",
      "r279",
      "r468",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "verboseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r32",
      "r70",
      "r743"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Equity method investments, clean energy investments",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "terseLabel": "Other Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension plan, other postretirement plan, and supplemental retirement plan, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Other Pension, Postretirement and Supplemental Plans [Member]",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r323",
      "r324",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Exit Costs"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents and technologies"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r134",
      "r137"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Payments for product rights and other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r144",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payment"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedTerseLabel": "Payments of financing fees"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for financing costs associated with business combinations.",
        "label": "Payments of Merger Related Costs, Financing Activities",
        "negatedTerseLabel": "Contingent consideration payments"
       }
      }
     },
     "localname": "PaymentsOfMergerRelatedCostsFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisitions, net"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r257"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r467",
      "r469",
      "r475",
      "r492",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r513",
      "r515",
      "r516",
      "r517",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension and Other Postretirement Benefits Disclosure"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r534",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets [Abstract]",
        "terseLabel": "Prepaid Expense and Other Assets [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r27",
      "r58",
      "r59"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r26",
      "r28",
      "r281",
      "r282"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Pro Forma Weighted Average Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "ProFormaWeightedAverageSharesOutstandingDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r140",
      "r143"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other items, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Change in short-term borrowings, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfReceivables": {
     "auth_ref": [
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the proceeds from sale and collection of receivables during the period.",
        "label": "Proceeds from Sale and Collection of Receivables",
        "terseLabel": "Proceeds from sale and collection of receivables"
       }
      }
     },
     "localname": "ProceedsFromSaleAndCollectionOfReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from the sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from the sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Proceeds from Sale of Securities, Operating Activities",
        "terseLabel": "Proceeds from sale of terminated interest rate swaps"
       }
      }
     },
     "localname": "ProceedsFromSaleOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r138",
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other Revenues"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r21",
      "r109",
      "r112",
      "r117",
      "r145",
      "r157",
      "r171",
      "r183",
      "r184",
      "r219",
      "r231",
      "r235",
      "r238",
      "r241",
      "r267",
      "r358",
      "r359",
      "r360",
      "r363",
      "r364",
      "r365",
      "r367",
      "r369",
      "r371",
      "r372",
      "r627",
      "r631",
      "r632",
      "r638",
      "r639",
      "r692",
      "r705",
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r63",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r62",
      "r311"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r37",
      "r38",
      "r313",
      "r743",
      "r785",
      "r797"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r37",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r37",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r46",
      "r51",
      "r743",
      "r796",
      "r823"
     ],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Payments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Amount of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Reporting Unit, Amount of Fair Value in Excess of Carrying Amount"
       }
      }
     },
     "localname": "ReportingUnitAmountOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r569",
      "r757",
      "r838"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedLabel": "Research and development",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r36",
      "r152",
      "r154"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "terseLabel": "Issuance of restricted stock, net of shares withheld"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r322",
      "r324",
      "r327",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected cost remaining for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost Remaining",
        "terseLabel": "Restructuring and Related Cost, Expected Cost Remaining"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCostRemaining1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated",
        "terseLabel": "Restructuring and Related Cost, Expected Number of Positions Eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r323",
      "r326",
      "r333",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "negatedLabel": "Utilization"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r150",
      "r321",
      "r330",
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r323",
      "r324",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r324",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r41",
      "r324",
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r83",
      "r324",
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring Reserve, Noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r324",
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "terseLabel": "Restructuring Reserve, Settled without Cash"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r324",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r48",
      "r415",
      "r565",
      "r743",
      "r794",
      "r816",
      "r821"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r165",
      "r166",
      "r167",
      "r172",
      "r182",
      "r184",
      "r273",
      "r561",
      "r562",
      "r563",
      "r585",
      "r586",
      "r690",
      "r812",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r440",
      "r441",
      "r442",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r496",
      "r500",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r525",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r440",
      "r441",
      "r442",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r496",
      "r500",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r525",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r210",
      "r211",
      "r230",
      "r236",
      "r237",
      "r244",
      "r245",
      "r248",
      "r425",
      "r426",
      "r758"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Sales Revenue, Goods, Net",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition and Accounts Receivable"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Revenue Not from Contract with Customer"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition and Deferred Revenue [Abstract]",
        "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAndDeferredRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r120",
      "r157",
      "r210",
      "r211",
      "r230",
      "r236",
      "r237",
      "r244",
      "r245",
      "r248",
      "r267",
      "r358",
      "r359",
      "r360",
      "r363",
      "r364",
      "r365",
      "r367",
      "r369",
      "r371",
      "r372",
      "r705",
      "r783"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales [Member]"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r106",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Summary of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r499",
      "r500",
      "r501",
      "r502",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r652",
      "r665",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r17",
      "r19",
      "r20",
      "r21",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V."
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r191",
      "r195",
      "r197",
      "r199",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r21",
      "r157",
      "r266",
      "r267",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r693",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Financial Assets and Liabilities Carried at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r295",
      "r299",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r295",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Components of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r289",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r289",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "verboseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r35",
      "r55",
      "r56",
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Minimum Repayments on Outstanding Borrowings"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r63",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r333",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r328",
      "r329",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring - employee related"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r219",
      "r222",
      "r234",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r219",
      "r222",
      "r234",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Reconciliation of Segment Information to Total Consolidated Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r534",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r539",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Stock Awards Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock and Restricted Stock Unit Awards Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Expected Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r207",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241",
      "r248",
      "r326",
      "r335",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r207",
      "r208",
      "r209",
      "r219",
      "r223",
      "r235",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r247",
      "r248",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting Policy"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Series of Individually Immaterial Business Acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Stock option award vesting period, in years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of restricted stock awards, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Number of restricted stock awards, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of restricted stock awards, nonvested end of period",
        "periodStartLabel": "Number of restricted stock awards, nonvested beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted average grant-date fair value per share, nonvested end of period",
        "periodStartLabel": "Weighted average grant-date fair value per share, nonvested beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of restricted stock awards, released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Ordinary shares reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r541",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r532",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Stock option award expiration period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for stock awards exercisable, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for stock awards outstanding, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for stock awards vested and expected to vest, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r39",
      "r743",
      "r770",
      "r791"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term Debt [Abstract]",
        "terseLabel": "Short-term Debt [Abstract]"
       }
      }
     },
     "localname": "ShortTermBorrowingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r8",
      "r207",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241",
      "r248",
      "r289",
      "r316",
      "r326",
      "r335",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r78",
      "r115",
      "r116",
      "r117",
      "r165",
      "r166",
      "r167",
      "r172",
      "r182",
      "r184",
      "r206",
      "r273",
      "r410",
      "r415",
      "r561",
      "r562",
      "r563",
      "r585",
      "r586",
      "r690",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r725",
      "r812",
      "r813",
      "r814",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipsDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r206",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r44",
      "r45",
      "r410",
      "r415",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Share repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Viatris Inc. shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r116",
      "r157",
      "r165",
      "r166",
      "r167",
      "r172",
      "r182",
      "r267",
      "r273",
      "r415",
      "r561",
      "r562",
      "r563",
      "r585",
      "r586",
      "r625",
      "r626",
      "r637",
      "r690",
      "r705",
      "r719",
      "r720",
      "r725",
      "r813",
      "r814",
      "r849"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r726",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r726",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r726",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "verboseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r776"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r77",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r77",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "verboseLabel": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r323",
      "r324",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r161",
      "r468",
      "r513",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasuries"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Unamortized debt issuance expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Reduction due to lapse in statues"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemMember": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is abnormal and unrelated to ordinary and typical activities or is not reasonably expected to recur in the foreseeable future, or both.",
        "label": "Unusual or Infrequent Item, or Both [Member]",
        "terseLabel": "Unusual or Infrequent Item, or Both"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Unusual Risk or Uncertainty [Line Items]",
        "terseLabel": "Unusual Risk or Uncertainty [Line Items]"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the unusual risk or uncertainty and its financial impact or potential financial impact.",
        "label": "Unusual Risk or Uncertainty [Table]",
        "terseLabel": "Unusual Risk or Uncertainty [Table]"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Weighted Average Basic Shares Outstanding, Pro Forma",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r190",
      "r199"
     ],
     "calculation": {
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted",
        "totalLabel": "Total dilutive shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r188",
      "r199"
     ],
     "calculation": {
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic",
        "verboseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "vtrs_A2016SeniorRevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Senior Revolving Credit Facility [Member]",
        "label": "2016 Senior Revolving Credit Facility [Member]",
        "terseLabel": "2016 Revolving Credit Facility"
       }
      }
     },
     "localname": "A2016SeniorRevolvingCreditFacilityMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Euro Senior Notes [Member]",
        "label": "2020 Euro Senior Notes [Member]",
        "terseLabel": "2020 Euro Senior Notes"
       }
      }
     },
     "localname": "A2020EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020FloatingRateEuroNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Floating Rate Euro Notes",
        "label": "2020 Floating Rate Euro Notes [Member]",
        "terseLabel": "2020 Floating Rate Euro Notes"
       }
      }
     },
     "localname": "A2020FloatingRateEuroNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Restructuring Plan",
        "label": "2020 Restructuring Plan [Member]",
        "terseLabel": "2020 Restructuring Plan"
       }
      }
     },
     "localname": "A2020RestructuringPlanMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan",
        "label": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member]",
        "terseLabel": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2022EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Euro Senior Notes",
        "label": "2022 Euro Senior Notes [Member]",
        "terseLabel": "2022 Euro Senior Notes"
       }
      }
     },
     "localname": "A2022EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2024EuroSeniorNotes1023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Euro Senior Notes, 1.023%",
        "label": "2024 Euro Senior Notes, 1.023% [Member]",
        "terseLabel": "2024 Euro Senior Notes, 1.023%"
       }
      }
     },
     "localname": "A2024EuroSeniorNotes1023Member",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2024EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Euro Senior Notes [Member]",
        "label": "2024 Euro Senior Notes [Member]",
        "terseLabel": "2024 Euro Senior Notes"
       }
      }
     },
     "localname": "A2024EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2025EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Euro Senior Notes [Member]",
        "label": "2025 Euro Senior Notes [Member]",
        "terseLabel": "2.125% Euro Senior Notes due 2025"
       }
      }
     },
     "localname": "A2025EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Senior Notes",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2027EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Euro Senior Notes",
        "label": "2027 Euro Senior Notes [Member]",
        "terseLabel": "2027 Euro Senior Notes"
       }
      }
     },
     "localname": "A2027EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2027SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Senior Notes",
        "label": "2027 Senior Notes [Member]",
        "terseLabel": "2027 Senior Notes"
       }
      }
     },
     "localname": "A2027SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2028EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Euro Senior Notes [Member]",
        "label": "2028 Euro Senior Notes [Member]",
        "terseLabel": "2028 Euro Senior Notes"
       }
      }
     },
     "localname": "A2028EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member] [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes [Member]"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2030SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2030 Senior Notes",
        "label": "2030 Senior Notes [Member]",
        "terseLabel": "2030 Senior Notes"
       }
      }
     },
     "localname": "A2030SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2032EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2032 Euro Senior Notes",
        "label": "2032 Euro Senior Notes [Member]",
        "terseLabel": "2032 Euro Senior Notes"
       }
      }
     },
     "localname": "A2032EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2040SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2040 Senior Notes",
        "label": "2040 Senior Notes [Member]",
        "terseLabel": "2040 Senior Notes"
       }
      }
     },
     "localname": "A2040SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2048SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2048 Senior Notes [Member]",
        "label": "2048 Senior Notes [Member]",
        "terseLabel": "2048 Senior Notes [Member]"
       }
      }
     },
     "localname": "A2048SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2050SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2050 Senior Notes",
        "label": "2050 Senior Notes [Member]",
        "terseLabel": "2050 Senior Notes"
       }
      }
     },
     "localname": "A2050SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable facility maximum borrowing capacity.",
        "label": "Accounts Receivable Facility Maximum Borrowing Capacity",
        "terseLabel": "Accounts receivable securitization facility maximum borrowing capacity"
       }
      }
     },
     "localname": "AccountsReceivableFacilityMaximumBorrowingCapacity",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccruedSalesAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 2.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Sales Allowances",
        "label": "Accrued Sales Allowances",
        "negatedNetLabel": "Rebates, promotional programs and other sales allowances"
       }
      }
     },
     "localname": "AccruedSalesAllowances",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx",
        "label": "Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx",
        "terseLabel": "Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx"
       }
      }
     },
     "localname": "AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Anticompetitive Conduct with Generic Drugs [Member]",
        "label": "Amended Anticompetitive Conduct with Generic Drugs [Member]",
        "terseLabel": "Amended Anticompetitive Conduct with Generic Drugs [Member]"
       }
      }
     },
     "localname": "AmendedAnticompetitiveConductwithGenericDrugsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AmitizaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amitiza \u00ae",
        "label": "Amitiza \u00ae [Member]",
        "terseLabel": "Amitiza \u00ae"
       }
      }
     },
     "localname": "AmitizaMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]",
        "label": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]",
        "terseLabel": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]"
       }
      }
     },
     "localname": "AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AnticompetitiveConductwithGenericDrugsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticompetitive Conduct with Generic Drugs [Member]",
        "label": "Anticompetitive Conduct with Generic Drugs [Member]",
        "terseLabel": "Anticompetitive Conduct with Generic Drugs [Member]"
       }
      }
     },
     "localname": "AnticompetitiveConductwithGenericDrugsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AntitrustProceedingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Antitrust proceedings",
        "label": "Antitrust Proceedings [Member]",
        "terseLabel": "Antitrust Proceedings"
       }
      }
     },
     "localname": "AntitrustProceedingsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BalanceSheetComponentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance Sheet Components",
        "label": "Balance Sheet Components [Abstract]",
        "terseLabel": "Balance Sheet Components [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetComponentsAbstract",
     "nsuri": "http://www.viatris.com/20220331",
     "xbrltype": "stringItemType"
    },
    "vtrs_BioconBiologicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biocon Biologics",
        "label": "Biocon Biologics [Member]",
        "terseLabel": "Biocon Biologics"
       }
      }
     },
     "localname": "BioconBiologicsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BiosimilarsPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biosimilars Portfolio",
        "label": "Biosimilars Portfolio [Member]",
        "terseLabel": "Biosimilars Portfolio"
       }
      }
     },
     "localname": "BiosimilarsPortfolioMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brands",
        "label": "Brands [Member]",
        "terseLabel": "Brands"
       }
      }
     },
     "localname": "BrandsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BusinessCombinationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination [Abstract]",
        "label": "Business Combination [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAbstract",
     "nsuri": "http://www.viatris.com/20220331",
     "xbrltype": "stringItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Reclassifications",
        "label": "Business Combination, Contingent Consideration Arrangements, Reclassifications",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsReclassifications",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)",
        "terseLabel": "Fair value loss"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationLiabilityPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Liability Payments",
        "label": "Business Combination Contingent Consideration Liability Payments",
        "negatedTerseLabel": "Payments",
        "terseLabel": "Business Combination Contingent Consideration Liability Payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPayments",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "totalLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 1.0,
       "parentTag": "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 3.0,
       "parentTag": "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 2.0,
       "parentTag": "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CelebrexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celebrex \u00ae",
        "label": "Celebrex \u00ae [Member]",
        "terseLabel": "Celebrex \u00ae"
       }
      }
     },
     "localname": "CelebrexMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Changeinnoncashlitigationsettlementsnet": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncash litigation settlements, net",
        "label": "Change in noncash litigation settlements, net",
        "negatedTerseLabel": "Litigation settlements and other contingencies, net"
       }
      }
     },
     "localname": "Changeinnoncashlitigationsettlementsnet",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_Chargebacks": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 1.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chargebacks",
        "label": "Chargebacks",
        "negatedTerseLabel": "Chargebacks"
       }
      }
     },
     "localname": "Chargebacks",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CleanEnergyPartnershipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clean Energy Partnerships",
        "label": "Clean Energy Partnerships [Member]",
        "terseLabel": "Clean Energy Partnerships [Member]",
        "verboseLabel": "Clean energy investments"
       }
      }
     },
     "localname": "CleanEnergyPartnershipsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ComplexGXAndBiosimilarsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complex GX and Biosimilars",
        "label": "Complex GX and Biosimilars [Member]",
        "terseLabel": "Complex GX and Biosimilars"
       }
      }
     },
     "localname": "ComplexGXAndBiosimilarsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Corporatecosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate costs",
        "label": "Corporate costs",
        "terseLabel": "Corporate costs"
       }
      }
     },
     "localname": "Corporatecosts",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CreonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Creon \u00ae",
        "label": "Creon \u00ae [Member]",
        "terseLabel": "Creon \u00ae"
       }
      }
     },
     "localname": "CreonMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_CurrentPortionofLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Current Portion of Long-Term Debt [Member]",
        "terseLabel": "Current Portion of Long-Term Debt"
       }
      }
     },
     "localname": "CurrentPortionofLongTermDebtMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_DefinedBenefitPlansNumberofFrozenPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plans, Number of Frozen Plans",
        "label": "Defined Benefit Plans, Number of Frozen Plans",
        "terseLabel": "Defined Benefit Plans, Number of Frozen Plans"
       }
      }
     },
     "localname": "DefinedBenefitPlansNumberofFrozenPlans",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plans, estimated benefit payments, in current fiscal year",
        "label": "Defined benefit plans, estimated benefit payments, in current fiscal year",
        "terseLabel": "Defined benefit plans, estimated benefit payments, in current fiscal year"
       }
      }
     },
     "localname": "Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DevelopedMarketsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed Markets Segment",
        "label": "Developed Markets Segment [Member]",
        "terseLabel": "Developed Markets"
       }
      }
     },
     "localname": "DevelopedMarketsSegmentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Developmentandsalesmilestonepayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development and sales milestone payments",
        "label": "Development and sales milestone payments",
        "terseLabel": "Development and sales milestone payments"
       }
      }
     },
     "localname": "Developmentandsalesmilestonepayments",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High",
        "terseLabel": "Additional cash payments to be received"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationArrangementsRangeOfOutcomesHigh",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership",
        "terseLabel": "Percent ownership after transaction"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationConvertiblePreferredEquityPercentOwnership",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement",
        "label": "Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement",
        "terseLabel": "Term of transition services agreement"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsTermOfTransitionServicesAgreement",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vtrs_DymistaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dymista \u00ae",
        "label": "Dymista \u00ae [Member]",
        "terseLabel": "Dymista \u00ae"
       }
      }
     },
     "localname": "DymistaMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EUCommissionProceedingsCitalopramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EU Commission Proceedings Citalopram",
        "label": "EU Commission Proceedings Citalopram [Member]",
        "terseLabel": "European Union Commission Proceedings - Citalopram"
       }
      }
     },
     "localname": "EUCommissionProceedingsCitalopramMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EUCommissionProceedingsPerindorprilMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EU Commission Proceedings Perindorpril",
        "label": "EU Commission Proceedings Perindorpril [Member]",
        "terseLabel": "European Commission Proceedings - Perindorpril"
       }
      }
     },
     "localname": "EUCommissionProceedingsPerindorprilMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EffectiveIncomeTaxRateReconciliationCARESActAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, CARES Act, Amount",
        "label": "Effective Income Tax Rate Reconciliation, CARES Act, Amount",
        "terseLabel": "Expected reduction to tax expense by CARES Act"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCARESActAmount",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_EffexorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effexor \u00ae",
        "label": "Effexor \u00ae [Member]",
        "terseLabel": "Effexor \u00ae"
       }
      }
     },
     "localname": "EffexorMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EmergingMarketsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets Segment",
        "label": "Emerging Markets Segment [Member]",
        "terseLabel": "Emerging Markets"
       }
      }
     },
     "localname": "EmergingMarketsSegmentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EpiPenAutoInjectorCivilLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EpiPen Auto Injector Civil Litigation [Member]",
        "label": "EpiPen Auto Injector Civil Litigation [Member]",
        "terseLabel": "EpiPen Auto Injector Civil Litigation [Member]"
       }
      }
     },
     "localname": "EpiPenAutoInjectorCivilLitigationMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EpiPenAutoInjectorLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EpiPen Auto-Injector Litigation",
        "label": "EpiPen Auto-Injector Litigation [Member]",
        "terseLabel": "EpiPen Auto-Injector Litigation"
       }
      }
     },
     "localname": "EpiPenAutoInjectorLitigationMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EpiPenAutoInjectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EpiPen\u00ae Auto-Injectors",
        "label": "EpiPen\u00ae Auto-Injectors [Member]",
        "terseLabel": "EpiPen\u00ae Auto-Injectors"
       }
      }
     },
     "localname": "EpiPenAutoInjectorsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EpiPenIsraeliSecuritiesLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EpiPen Israeli Securities Litigation [Member]",
        "label": "EpiPen Israeli Securities Litigation [Member]",
        "terseLabel": "EpiPen Israeli Securities Litigation [Member]"
       }
      }
     },
     "localname": "EpiPenIsraeliSecuritiesLitigationMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EquityMethodInvestmentsSummarizedFinancialDataBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments Summarized Financial Data Basis",
        "label": "Equity Method Investments Summarized Financial Data Basis",
        "terseLabel": "Equity method investments summarized financial data basis"
       }
      }
     },
     "localname": "EquityMethodInvestmentsSummarizedFinancialDataBasis",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_EquivalentPricePercentageOfPrincipalAmountRedeemable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price equivalent at which long-term debt principal amount is redeemable prior to a specified date.",
        "label": "Equivalent Price Percentage Of Principal Amount Redeemable",
        "terseLabel": "Equivalent percentage of redeemed amount"
       }
      }
     },
     "localname": "EquivalentPricePercentageOfPrincipalAmountRedeemable",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_EuropeSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Europe Segment",
        "label": "Europe Segment [Member]",
        "terseLabel": "Greater China"
       }
      }
     },
     "localname": "EuropeSegmentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GenericsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generics",
        "label": "Generics [Member]",
        "terseLabel": "Generics"
       }
      }
     },
     "localname": "GenericsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GoodWillAfterAmortizationExpenseBeforeReclassification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Good will, After Amortization Expense, Before Reclassification",
        "label": "Good will, After Amortization Expense, Before Reclassification",
        "terseLabel": "Good will, After Amortization Expense, Before Reclassification"
       }
      }
     },
     "localname": "GoodWillAfterAmortizationExpenseBeforeReclassification",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_GoodwillImpairmentMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment, Measurement Input",
        "label": "Goodwill Impairment, Measurement Input",
        "negatedTerseLabel": "Goodwill Impairment, Measurement Input"
       }
      }
     },
     "localname": "GoodwillImpairmentMeasurementInput",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "vtrs_GoodwillImpairmentMeasurementInputTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment, Measurement Input, Term",
        "label": "Goodwill Impairment, Measurement Input, Term",
        "terseLabel": "Goodwill Impairment, Measurement Input, Term"
       }
      }
     },
     "localname": "GoodwillImpairmentMeasurementInputTerm",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vtrs_GreaterChinaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Greater China Segment",
        "label": "Greater China Segment [Member]",
        "terseLabel": "Greater China"
       }
      }
     },
     "localname": "GreaterChinaSegmentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Partial Payment Of Income Tax Expense",
        "label": "Income Tax Examination, Partial Payment Of Income Tax Expense",
        "terseLabel": "Income Tax Examination, Partial Payment Of Income Tax Expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_InfluvacMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Influvac \u00ae",
        "label": "Influvac \u00ae [Member]",
        "terseLabel": "Influvac \u00ae"
       }
      }
     },
     "localname": "InfluvacMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_IntangibleAssetsbyMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets by Major Class",
        "label": "Intangible Assets by Major Class [Line Items]",
        "terseLabel": "Intangible Assets by Major Class [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsbyMajorClassLineItems",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_JapanAustraliaAndNewZealandSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Japan, Australia and New Zealand Segment",
        "label": "Japan, Australia and New Zealand Segment [Member]",
        "terseLabel": "JANZ"
       }
      }
     },
     "localname": "JapanAustraliaAndNewZealandSegmentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LipitorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lipitor \u00ae",
        "label": "Lipitor \u00ae [Member]",
        "terseLabel": "Lipitor"
       }
      }
     },
     "localname": "LipitorMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LongTermIncentivePlan2003Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Incentive 2003 Plan.",
        "label": "Long Term Incentive Plan 2003 [Member]",
        "terseLabel": "Long-Term Incentive Plan 2003"
       }
      }
     },
     "localname": "LongTermIncentivePlan2003Member",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LyricaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lyrica \u00ae",
        "label": "Lyrica \u00ae [Member]",
        "terseLabel": "Lyrica \u00ae"
       }
      }
     },
     "localname": "LyricaMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputEstimatedTaxRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Estimated Tax Rate [Member]",
        "label": "Measurement Input, Estimated Tax Rate [Member]",
        "terseLabel": "Measurement Input, Estimated Tax Rate"
       }
      }
     },
     "localname": "MeasurementInputEstimatedTaxRateMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputIncreaseInDiscountRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Increase in Discount Rate",
        "label": "Measurement Input, Increase in Discount Rate [Member]",
        "terseLabel": "Measurement Input, Increase in Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputIncreaseInDiscountRateMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Reduction in Terminal Year Revenue Growth Rate",
        "label": "Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Reduction in Terminal Year Revenue Growth Rate"
       }
      }
     },
     "localname": "MeasurementInputReductionInTerminalYearRevenueGrowthRateMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Terminal Year Revenue Growth Rate",
        "label": "Measurement Input, Terminal Year Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Terminal Year Revenue Growth Rate"
       }
      }
     },
     "localname": "MeasurementInputTerminalYearRevenueGrowthRateMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Medicaidandothergovernmentalrebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 4.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and other governmental rebates",
        "label": "Medicaid and other governmental rebates",
        "negatedTerseLabel": "Medicaid and other governmental rebates"
       }
      }
     },
     "localname": "Medicaidandothergovernmentalrebates",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ModafinilAntitrustLitigationAndFtcInquiryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Modafinil Antitrust Litigation and FTC Inquiry.",
        "label": "Modafinil Antitrust Litigation and FTC Inquiry [Member]",
        "terseLabel": "Modafinil Antitrust Litigation and FTC Inquiry"
       }
      }
     },
     "localname": "ModafinilAntitrustLitigationAndFtcInquiryMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MultiDistrictLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multi District Litigation [Member]",
        "label": "Multi District Litigation [Member]",
        "terseLabel": "Multi District Litigation [Member]"
       }
      }
     },
     "localname": "MultiDistrictLitigationMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorthAmericaBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Brands [Member]",
        "label": "North America Brands [Member]",
        "terseLabel": "North America Brands"
       }
      }
     },
     "localname": "NorthAmericaBrandsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorthAmericaGenericsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Generics [Member]",
        "label": "North America Generics [Member]",
        "terseLabel": "North America Generics"
       }
      }
     },
     "localname": "NorthAmericaGenericsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorthAmericaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Segment",
        "label": "North America Segment [Member]",
        "terseLabel": "North America Segment"
       }
      }
     },
     "localname": "NorthAmericaSegmentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorvascMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Norvasc \u00ae",
        "label": "Norvasc \u00ae [Member]",
        "terseLabel": "Norvasc"
       }
      }
     },
     "localname": "NorvascMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NoteSecuritizationFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Securitization Facility [Member]",
        "label": "Note Securitization Facility [Member]",
        "terseLabel": "Note Securitization Facility"
       }
      }
     },
     "localname": "NoteSecuritizationFacilityMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NumberOfProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Products",
        "label": "Number Of Products",
        "terseLabel": "Number Of Products"
       }
      }
     },
     "localname": "NumberOfProducts",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of times damages may be increased in cases of willful infringement",
        "label": "Number of times damages may be increased in cases of willful infringement",
        "terseLabel": "Number of times damages may be increased in cases of willful infringement"
       }
      }
     },
     "localname": "NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofcases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of cases",
        "label": "Number of cases",
        "terseLabel": "Number of cases"
       }
      }
     },
     "localname": "Numberofcases",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofequitymethodinvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity method investments",
        "label": "Number of equity method investments",
        "terseLabel": "Number of equity method investments"
       }
      }
     },
     "localname": "Numberofequitymethodinvestments",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofstates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of states",
        "label": "Number of states",
        "terseLabel": "Number of states"
       }
      }
     },
     "localname": "Numberofstates",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_OtherCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other companies",
        "label": "Other Companies [Member]",
        "terseLabel": "Other drug manufacturers"
       }
      }
     },
     "localname": "OtherCompaniesMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherCurrentPortionofLongtermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Portion of Long-term Debt [Member]",
        "label": "Other Current Portion of Long-term Debt [Member]",
        "terseLabel": "Other Current Portion of Long-term Debt"
       }
      }
     },
     "localname": "OtherCurrentPortionofLongtermDebtMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other long term debt.",
        "label": "Other Long Term Debt [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebtMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Other [Member]",
        "verboseLabel": "Other Litigation"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherOneTimeNonoperatingExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other One-Time Nonoperating Expense",
        "label": "Other One-Time Nonoperating Expense",
        "negatedTerseLabel": "Other One-Time Nonoperating Expense"
       }
      }
     },
     "localname": "OtherOneTimeNonoperatingExpense",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_Otherlongtermassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other long-term assets",
        "label": "Other long-term assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "Otherlongtermassets",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_PaymentsforBusinessSeparation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Business Separation",
        "label": "Payments for Business Separation",
        "terseLabel": "Payments for Business Separation"
       }
      }
     },
     "localname": "PaymentsforBusinessSeparation",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent Of Consolidated Net Sales Impacted, High Inflationary Economy",
        "label": "Percent Of Consolidated Net Sales Impacted, High Inflationary Economy",
        "terseLabel": "Percent Of Net Sales Impacted, High Inflationary Economy"
       }
      }
     },
     "localname": "PercentOfConsolidatedNetSalesImpactedHighInflationaryEconomy",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_PercentOfTotalAssetsImpactedHighInflationaryEconomy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent Of Total Assets Impacted, High Inflationary Economy",
        "label": "Percent Of Total Assets Impacted, High Inflationary Economy",
        "terseLabel": "Percent Of Total Assets Impacted, High Inflationary Economy"
       }
      }
     },
     "localname": "PercentOfTotalAssetsImpactedHighInflationaryEconomy",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GeneralDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_PeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period [Axis]",
        "label": "Period [Axis]",
        "terseLabel": "Period [Axis]"
       }
      }
     },
     "localname": "PeriodAxis",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_PeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Period [Axis]",
        "label": "Period [Domain]",
        "terseLabel": "Period [Domain]"
       }
      }
     },
     "localname": "PeriodDomain",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_PfizerInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer, Inc. [Member]",
        "label": "Pfizer, Inc. [Member]",
        "terseLabel": "Pfizer, Inc."
       }
      }
     },
     "localname": "PfizerInc.Member",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability",
        "label": "Product Liability [Member]",
        "terseLabel": "Product Liability"
       }
      }
     },
     "localname": "ProductLiabilityMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ProgramNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Program Name",
        "label": "Program Name [Axis]",
        "terseLabel": "Program Name [Axis]"
       }
      }
     },
     "localname": "ProgramNameAxis",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ProgramNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Program Name",
        "label": "Program Name [Domain]",
        "terseLabel": "Program Name [Domain]"
       }
      }
     },
     "localname": "ProgramNameDomain",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ReceivablesFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables facility.",
        "label": "Receivables Facility [Member]",
        "terseLabel": "Receivables Facility"
       }
      }
     },
     "localname": "ReceivablesFacilityMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve for Uncertain Tax Positions, Including Interest And Penalties",
        "label": "Reserve for Uncertain Tax Positions, Including Interest And Penalties",
        "terseLabel": "Reserve for Uncertain Tax Positions, Including Interest And Penalties"
       }
      }
     },
     "localname": "ReserveForUncertainTaxPositionsIncludingInterestAndPenalties",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RestofWorldSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World Segment",
        "label": "Rest of World Segment [Member]",
        "terseLabel": "JANZ"
       }
      }
     },
     "localname": "RestofWorldSegmentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, Expected Number of Facilities to be Eliminated",
        "label": "Restructuring and Related Cost, Expected Number of Facilities to be Eliminated",
        "terseLabel": "Restructuring and Related Cost, Expected Number of Facilities to be Eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent",
        "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent",
        "terseLabel": "Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_RevenuefromContractwithCustomerGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Gross",
        "label": "Revenue from Contract with Customer, Gross",
        "terseLabel": "Gross sales"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerGross",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RevenuefromContractwithCustomerReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 3.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Returns",
        "label": "Revenue from Contract with Customer, Returns",
        "negatedLabel": "Returns"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerReturns",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_SalesRevenueGrosstonetadjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Revenue, Gross to net adjustments",
        "label": "Sales Revenue, Gross to net adjustments",
        "negatedTotalLabel": "Sales Revenue, Gross to net adjustments"
       }
      }
     },
     "localname": "SalesRevenueGrosstonetadjustments",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ScheduleOfIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule of Intangible Assets by Major Class [Table]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofActivityinContingentConsiderationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Activity in Contingent Consideration [Roll Forward]",
        "label": "Schedule of Activity in Contingent Consideration [Roll Forward]",
        "terseLabel": "Schedule of Activity in Contingent Consideration [Roll Forward]"
       }
      }
     },
     "localname": "ScheduleofActivityinContingentConsiderationRollForward",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]",
        "label": "Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block]",
        "terseLabel": "Schedule of Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Other Noncurrent Liabilities [Table]",
        "label": "Schedule of Other Noncurrent Liabilities [Line Items]",
        "terseLabel": "Schedule of Other Noncurrent Liabilities [Line Items]"
       }
      }
     },
     "localname": "ScheduleofOtherNoncurrentLiabilitiesLineItems",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofOtherNoncurrentLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Other Noncurrent Liabilities [Table]",
        "label": "Schedule of Other Noncurrent Liabilities [Table]",
        "terseLabel": "Schedule of Other Noncurrent Liabilities [Table]"
       }
      }
     },
     "localname": "ScheduleofOtherNoncurrentLiabilitiesTable",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofothercurrentliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of other current liabilities [Table]",
        "label": "Schedule of other current liabilities [Line Items]",
        "terseLabel": "Schedule of other current liabilities [Line Items]"
       }
      }
     },
     "localname": "ScheduleofothercurrentliabilitiesLineItems",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofothercurrentliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other current liabilities [Table]",
        "label": "Schedule of other current liabilities [Table]",
        "terseLabel": "Schedule of other current liabilities [Table]"
       }
      }
     },
     "localname": "ScheduleofothercurrentliabilitiesTable",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_SeniorNotes2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2021",
        "label": "Senior Notes 2021 [Member]",
        "terseLabel": "Senior Notes 2021"
       }
      }
     },
     "localname": "SeniorNotes2021Member",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotes2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2022",
        "label": "Senior Notes 2022 [Member]",
        "terseLabel": "Senior Notes 2022"
       }
      }
     },
     "localname": "SeniorNotes2022Member",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Two Thousand Eighteen - 2.6% [Member]",
        "label": "Senior Notes Two Thousand Eighteen - 2.6 Percent [Member]",
        "terseLabel": "2018 Senior Notes (2.600% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandEighteen2.6PercentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Two Thousand Eighteen - 3.0 Percent",
        "label": "Senior Notes Two Thousand Eighteen - 3.0 Percent [Member]",
        "terseLabel": "2018 Senior Notes (3.000% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandEighteen3.0PercentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortyEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SeniorNotesTwoThousandFortyEight [Member]",
        "label": "SeniorNotesTwoThousandFortyEight [Member]",
        "terseLabel": "2048 Senior Notes (5.200%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortyEightMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2046 Senior Note (5.250%)",
        "label": "SeniorNotesTwoThousandFortySix5.25Precent [Member]",
        "terseLabel": "2046 Senior Notes (5.250% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortySix5.25PrecentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand forty three",
        "label": "SeniorNotesTwoThousandFortyThree [Member]",
        "terseLabel": "2043 Senior Notes (5.400% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortyThreeMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Senior Notes (2.500%)",
        "label": "SeniorNotesTwoThousandNineteen2.50Precent [Member]",
        "terseLabel": "2019 Senior Notes (2.500% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandNineteen2.50PrecentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand nineteen",
        "label": "SeniorNotesTwoThousandNineteen [Member]",
        "terseLabel": "2019 Senior Notes (2.550% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandNineteenMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Two Thousand Twenty - 3.75 Percent",
        "label": "Senior Notes Two Thousand Twenty - 3.75 Percent [Member]",
        "terseLabel": "2020 Senior Notes (3.750% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwenty3.75PercentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SeniorNotesTwoThousandTwentyEight [Member]",
        "label": "SeniorNotesTwoThousandTwentyEight [Member]",
        "terseLabel": "SeniorNotesTwoThousandTwentyEight [Member]"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyEightMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Senior Notes 3.15%",
        "label": "SeniorNotesTwoThousandTwentyOne3.15Precent [Member]",
        "terseLabel": "2021 Senior Notes (3.150% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyOne3.15PrecentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2026 Senior Notes 3.950%",
        "label": "SeniorNotesTwoThousandTwentySix3.95Precent [Member]",
        "terseLabel": "2026 Senior Notes (3.950% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentySix3.95PrecentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand twenty three - 3.125 percent",
        "label": "SeniorNotesTwoThousandTwentyThree3.125Percent [Member]",
        "terseLabel": "2023 Senior Notes (3.125% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyThree3.125PercentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand twenty three - 4.2 percent",
        "label": "SeniorNotesTwoThousandTwentyThree4.2Percent [Member]",
        "terseLabel": "2023 Senior Notes (4.200% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyThree4.2PercentMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of stock-based awards exercised and restricted stock units converted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment",
        "label": "Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment",
        "terseLabel": "Issuance of restricted stock, net of shares withheld (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "vtrs_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TrailingFourQuartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trailing Four Quarters",
        "label": "Trailing Four Quarters [Member]",
        "terseLabel": "Trailing Four Quarters [Member]"
       }
      }
     },
     "localname": "TrailingFourQuartersMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Competition and Markets Authority Proceedings Paroxetine",
        "label": "U.K. Competition and Markets Authority Proceedings Paroxetine [Member]",
        "terseLabel": "U.K. Competition and Markets Authority Proceedings Paroxetine"
       }
      }
     },
     "localname": "U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_UpjohnInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upjohn Inc. [Member]",
        "label": "Upjohn Inc. [Member]",
        "terseLabel": "Upjohn Inc."
       }
      }
     },
     "localname": "UpjohnInc.Member",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VariableConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Consideration [Member]",
        "label": "Variable Consideration [Member]",
        "terseLabel": "Variable Consideration"
       }
      }
     },
     "localname": "VariableConsiderationMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ViagraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viagra \u00ae",
        "label": "Viagra \u00ae [Member]",
        "terseLabel": "Viagra \u00ae"
       }
      }
     },
     "localname": "ViagraMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_XalabrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xalabrands",
        "label": "Xalabrands [Member]",
        "terseLabel": "Xalabrands"
       }
      }
     },
     "localname": "XalabrandsMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_XanaxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xanax \u00ae",
        "label": "Xanax \u00ae [Member]",
        "terseLabel": "Xanax \u00ae"
       }
      }
     },
     "localname": "XanaxMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_YENTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "YEN Term Loan",
        "label": "YEN Term Loan [Member]",
        "terseLabel": "YEN Term Loan"
       }
      }
     },
     "localname": "YENTermLoanMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_YupelriMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yupelri \u00ae",
        "label": "Yupelri \u00ae [Member]",
        "terseLabel": "Yupelri \u00ae"
       }
      }
     },
     "localname": "YupelriMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ZoloftMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zoloft \u00ae",
        "label": "Zoloft \u00ae [Member]",
        "terseLabel": "Zoloft \u00ae"
       }
      }
     },
     "localname": "ZoloftMember",
     "nsuri": "http://www.viatris.com/20220331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=125520798&loc=SL114871939-224231"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123398962&loc=d3e400-110220"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=SL65897772-128472"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1),(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "825",
   "URI": "http://asc.fasb.org/topic&trid=2134543"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r839": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r840": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r841": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r842": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r843": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r844": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e526-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>108
<FILENAME>0001792044-22-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001792044-22-000017-xbrl.zip
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MO!'KJH 9H<9LED9\BX@%03"83\FC".7KQ4ZT$SL'9^<6A [/ZX.1!/3-5,(
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M(A&/:J5(R::T4( 4G"@7$AM2,@]ZJ'U84L(JK5BI>0APQ<G+^-0KRJ%!!7J
M+<YH)<+APY6)4T)QJV@#*E:.0'0Y:2H=L7G("Q>H/]  3C<P",>.,*E Y5<I
MNAQB+VPK&+&L"I@1:\QJ:<2W1)(@" ;SI7@4H3Q=["0;L;-S=JY!:/>\WAE)
M0-]$"0((=SC.$HMQ!W!14T"HX5;,(PA,*9XHK?R,ZL:F90G/(=@ACHN3R:;2
M&,GRKMI04=H".'*ASJ6IL2(8$-J+H<Q1OC3@A!%9$$Y)!*U3A$PX]02J^B9
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M15AWQPU6**,,A'>10!%*"0<@I&QZ:WB;Y)B/"9Q3DPE5RK8DMYHI'&HH)Y)
M9,O!N RJ6.J(X"2O2EE")%)!IY&TCJCSD^ ")XL5E[U#R<P^@/ABPL2T;I>+
M9RAQ6P0LBD5_H_# 9??6N_8&'KK73F&S'=1-NC@5A7&X;/CYC5<'.;:V.=3C
M Q=3 '%,MK?:![U-FK+]H"E;'>_I>C+T7.8C2'G>?EG)H!<3:"MF4+[K#DG^
M+*DDYG6D#!8/,-[!NPA:+VSOI+MW("X:ZJZ9YDB&G68+(.OTG#U4_U/8Q4)K
M,>F&$23VK<(9+<%).6S%B3O)8=]K#-IIU?@5UIB:C5](H@RL=E]@QA"800!P
MEH.@ )Q5W5IE=V<\.$SM5<7N&] JF:N*@'UOUU15$>8'A+<AOGL6/(UC1BJ%
M6$C8N@T D>%"D6[UT$NI*AB>=2FW4%BCWGUWICPW9LLFF,U?-+9:3KRX<'B!
MNW1HN&GHM%IY+O:LR-?IJFROZ>VW.FO%@1>NE3WFM@DWPO9ZTV6WO@W9A0W(
M* #[1:U9JPP*G*9P]^L&*+3(5OX>48V*6Z.\?"MA)%O!T4'X[W=Z9&#;WFKM
M]Y3]1&<G@]='PU/TZF(X&IT.K^XZ[<O",V]#L^E!%RG!:(JJ3#\3.W#R1,"=
M43@("4.O!-%PI9=?":SO!H]!3DFV>KO] 6"Q'KM4PU+)!D#M/,(%=C\&5Q5R
MY<6]%K\8A/=4_YL5VO@$O#XZ_W4X?(?.CZ[>GA[]?_X] MLUYG\0<H/.L2P9
M_@&V^0:GWPIW_P%@^>>GWPI:'SG]?'L7_>1TX(EHPC%<[RU?!&(^FU-/Q\J_
MOZG&$7*<'L@?A0BA*I9W #6> O73A$- D*Z=ALXI)%#ZV2KQSH&AQP3T"REN
MJ)E: ,5>(C"6Z4PIL*/8D-$YGP)/#W6R4G*J\H6#3>8:$E$@4!!JEJ&R@%],
MK$3I3]*F;Z\BAGP"]21C86;.R;V1(C48FY\7(!G*F23P;H%-11S=WP"P*\((
M5@2=BSGE;;8:K?UV.[06*C<LE@MM:@5<54$]3=W=P D*76"I*X)Z?]BU*>"U
MM;/I)9,'X^U"N/E^5Q*&S?UI9>"]>-=:]AHL3' ,+]Q2KS=9-TI=.SV??[I9
MOOVOPN'?4$L#!!0    ( )J J52]TJ]X>M$" $O!(0 1    =G1R<RTR,#(R
M,#,S,2YH=&WLO6MW4\?2+OK]_14<]CAG?WD=^E)]X\W*'EP,BVQL"':2!5_6
MJ.JNQI/(DI<D ^;7GVK9!@PD@42VYI2504#2O,_GJ5MW==7W_^?MX>C&:Y[.
MNLGX'S?U=^KFC?_SP_?_S];6O^X^>WSC_B0?'_)X?N/>E''.Y<:;;GYPX]?"
ML]]NU.GD\,:OD^EOW6O<VEH<<V]R=#+M7A[,;QAES"<;I[>I0J[D<,N91%L0
MV6VE6,-60)43:1.=M__]\G:&6'36?BL V2W(1FUAK''+4F2MG0E6PW^7VR;&
MHG*(5+,&6PBK14KL<HDN6RSML@=S>3IYPO'L]MM9]X^;!_/YT>U;M]Z\>?/=
M&_O=9/KREE%*W_K7SN.]?,"'N-6-9W,<9[YY=E3A#T>]I>GHNQGG[UY.7M^2
M#7*LT?^!\UW;YO+)WF=7\+=.-Y[O.IO.W^]7<4:+_>3'Q1FWE-ZR^GS743?^
M[<)]?WQ>>ZMM)IR]O]_N[7Q+;O'"$>>WW(UE;VZXWII/<3RKD^DAS@5W.95V
M6RI^=-D\.1[/IR=??O:SC8N[??_TG]WHV0O6*:5;BZT?W>.7G^B/;E!(H,R6
M-N]/,IN T>$/7LW9'F<'_/ZM-8Z<G_7U?'IQS]<=SJ?=[+L\.6PW893]\([:
MY;H_NH%/N-2]_;V=M?WHV<]W/YYMO40\^IPH9QL^)<OM$8Y?_N,FC[=^WKLI
MU&<L/WQ_R'.\T4ZPQ?\Y[E[_X^:]R7@N KVU?W(D-Y9/O_WCYIS?SF\MWL2M
M'_[KO_[K^WDW'_$/[75LG3_V][=.?_S^UNFI:5).?OB^=*]OS.8G(_['S=+-
MCD9X<GL\&;/<0/?V=MN1IZ<?NU)XO/@HVW=%JTR[?'K]M_-G7/]QLTMDK"'%
MU6H&5IA4K!0B,*.W!O'?]Q>WHN61/T QQL-V:>YN;X_E_D[NR>-,<?1H7/CM
M_^63FS>Z(J<N]I<3NC]Y_=@\>_W<[AR75]NO7SQ,KYZ\>@1/'O[TYOF[#,\/
M7[S:V?_IW8N'/QZ\>+5[\/S5:+3[Z^YO3^[_\FK'//CML=T=/7\W.7ER_^"W
MG8<[]LG#'P^?O]M6.^99]_S7Y^^>__K(O=C_Y=6+^R_U\W>[!R\>1/O8O#AY
M_FOV.Z_NV)W[/[[:>5<.=M[]]F;W?G:[#[?U\_V?8/?^3^]V7_TXVC4_V1?[
M.Z_+PP<=/?S9OSA\I'8?[KS;>?5<[>[_=B*?U<[AC]WSPQ]'+^Z75[O[9?3B
MU^VWSP]_.COF%[F6&[_8/SI\_NHG]?S=SLGNJY_TD_U'\OFGD^>+8W_Y;=?L
MZ%WSR^CY_H-.[E$]WM^>[^RIMX_W?X8G^]G]VV$ESMYO^1I$_[J2MJ@XOU70
M)IU"J<7 S1^4*,Z0C +X_M8%4"\3XSMBC$HS2 ]&^/+FC5,%(:=].[]=N[=<
MMBJ.FC+<@/['H-O/0$_DY&V3WTI5WCV ]5N"2[/-\@\'ZT)4-W]X<.?QWO85
MXGWN?SSH9AE'SQFG#^27V0;@/P,8/@/88PA*N;J5#/LM0$:1:N0M]#IG %!$
M[N8/#825X?M4SC\I&X2_"F'W&<(!G.$*9<N*GA81#KP5==5;CL6CKA A<;SY
MPT_Z"O&]=SR=7A#?[7&Y+X'$1=5=Y)>M0[GL@=B8C<G^4^C?[MQKL"_@UT_N
M_V:?_/1OC%"==W&+J&01;P"1[(:*2+8 &(RQY>8/VMRRWX2_-29X#C%7(+#*
MHX1IR9+*$HAI5O0'^)^YJ;?W#G#*=R5&*?<FAT<\GBU<^CM3\?!?<A/^NR<?
M=GF*)^VG.V]P6A9__<*S>3=^>:H:]&JYH7>Z=)@/'XR?',KO^X+GJT=F]]US
M\^3^3V[G_H/N^;M']OFK;;=[N',B(OGV^:NL']MG(_[GLY,7OY8C,N!?_+HK
MO-DQPA&[^^JY<.FW-SN_"L]>E6YG_S<CYW"[[QYTN^]^J3O[/[][LK_S5JYC
MA1/OY/N_LZH&3* M38A;H-%M$;+(N_<1!6=G3+[YPU/[_%M@CFC15?"I&@3-
MF"2<MLZKZG73'.D,9CB'V5MU#G.+$6[?%]=_,L/1P^GD^.C1.(^.BX FO[:K
M=.-C+D^.>+H ?K;/T\,G=;\%>%W[88^GK[O,LSLOI[S@PVI!-CM[9R"_^O'P
MQ?[HM]U?18C?R;_[SPYW[M\]>/+PE^[)_O.3G?V7;W?,C_+YYS>?@KQS^&+T
MY->?Y)P_O6O_[CY\_F;GX3:\D.L)F&^?W-]^]_Q0/N_?_03DG^WN_>?_9ET-
M6VVW?#%Q"U+SQD"YK03&L@85?*@"LOD<Y%L78ZTI5Q8-+*_W"R%B"\IOSQ8#
M'T*#&XL@_?9< L-_W)QUAT>C%KDN?CN8-I9<B :_>SL3??+]K8OG.+W^AXN>
MW<-L<CQ=?%N$S+?/J'<*\U^Q,.<GXD7(=_ZM*^U[[7AZ8W%#_,51D'N/_N_%
MX.73@W\X_^GBV8\6&NC\FT3VTWFS9 N/J47A2I\?]V';^]LL'^UJMZS^<(G3
M+>??SR]RZ\*+^N)["^S88"A:IP(4.+FB7 8C+Y"2$\W\J$>OZW0H9/Z%-W"^
MY>O>P/&X.WU\/IZ*25C8C?>/5[K7<EL?[[J0"IQ/IN<_'C+.CJ?\P]G8T.WM
MGY^=7^E\T_GW+Q[??KS/X\EA-_[2:<_P;W<U^Z/S7CC%K8MW_]%N7\2=R&+.
MP62CFKPD"LD"BCY $19YIC/<G8+>X>ZV%/Q-W$_?[<V_^N(_.]_Q0HM]F1P_
M[]W_FG-=0$=\[5"RT8C60P:*CDP,RFBMV8MP+K29/M=FNB?B>4&;Z:_79GII
MVBP64RNDH-%G*-[$&D2[1; .:N&D5F %SAZ?7S:?Y/1KD8N]/1IUN9OO\"')
M)4HG6T_G3F;3^>VGTTDYSO,GTS.GYL[;3LAZ[@F?;;TS+F>;G\P/>'IZIN]O
M??$"[U_>^_L8A'%"6]"DI-$X"YI40K+>@KSPR*B37X$8K F<5R6='VO(95C:
M/U&FO;2T+L02HBXI9:@08G0>4@G!1<OBAP] )YU3];Y@_5K"K]?\2.SN=#'F
M-GN(W?CQ9#:[>_)/+B\E7GO&H],0[: [NDCU>S@[>#":O#G;<1U5EDW:4? U
M>T:(M28K$5? 9(RFHG0=@,H:)MHK\3?8.I.QH$.O0%RV" HL!$(=K&S0UTBV
M=WG^:/R:9_-VX!H+.):0O=<D ! 8!B*O;#4)LTVEA.LDX"N ?"52WL9*+>0H
M*!A(SA- 4&*\"Q1ELECP%BMK;7H1A'T4*^LM;?[R&,E%J\8V.&\Q5(N0VFA!
MD4=7T6%P5LS:U8T2_56N[\T%_';,]G^.6W['Y/!H,FY\_\1F30X/)^.]^23_
MMGPF+VOXZN)0 :@4#*.EF "Q1!2.YB#VJ,;B8[DZ<JX)-,N3&HE8<U4N,-4B
M>B-$XRN#PIP\%@"[-M#<*64Q!X.CI]B51^-[>-3-<300F!Q%KV)5.B(#Y(I*
M=!RQ3FTT%,/Z2- SGHMQY[*-T[&8ZME \#'51@41:@Y-J5E4%@QY*A6 F-8'
MG_WI8NCA9$@ZKG).JF)U7@4)='4$6URIU9 .@<\\@W4 YT[.QX?'HY:^OAB@
M:_M-^:"=K?G/>7+( X%,^5"84_*E6F!3(Z!US@ GCA!U'E#0VF?L5A^J)IN\
M+S993024,!7EP0;Q0U(QJKCU _I2?<35 UJL3\:89&V6$#0AE:2LMLA:BP_#
M:?T O3+/<O7@&I]8HH(D>K@EZ03Q<%PM,4 *L2@>TCQ!;_S1U:.*5@&"9>>3
MR*PI(K.DLW'9L'71FK49.5E%#+B\490$J9:$VI6@0:><JO<"FY>?1,&&M#8P
M76D,N#Q\(@,IU_(XHOQ))*XJ0<6BHJHL4<?:X'-U,> 2P:E*@_@D$I$3.(D&
ME?9&2X">M0X8Z]J L^H8<'F0,58=)>S+*A3P6CP.*"$;6U2J+KK3*0VU!F'[
M58T:JZ6%YUBKKLY4XZ-X#-92<$ZS-5;%K#VHM8%F%1[#\F "[:P) =C5"A5T
M) W9V>I%#X82<6U@NE*/87GX6%%Q27'T:*R$4X@I8[+,3"TCI_JUP>?J/(;E
M@>,HJYIJ1$T5,&'R(8N&LUQ%JM"7M0%GU1[#\B!3&04J4UL.(Q#I5'1"9<D$
M7WRL<'60K>H-<# Y)D/9.PM9 THPW^)%9WP"@#2@S)\^LW?U^3Y1POZ4N")$
M#VU(3IE@8G2%J)41*NL']-6-FZ\$4(M8;(@UV6PA1J)"RBFD MDB1U@_0%<S
M;KZ:[+P:'.;L@L4,)&X?.-3)>!6B>.7Q="7;.F!Z=0E0RQIE""XFI=AP2 %,
MM2F7U!)G;8JLS7ENVAI LYH$J&7!A%!2U"G$G!/X:"F%"FR]B$_02M6U@>F*
M$Z"6A8_VVJ0<Q1\1K]-S:,O<J956L*+EM+9K@\]5)D M;? ;D&TPK IX4%BQ
M^HRA&.M=C)QQ;<!9=2B[/,AJ+"4XE9/2"9RML=JL%#@#UNAT-B?;ET75E_,&
MM"[&.W(NB<87>VP]97D'U7H%F/V <@U^'A_/CG'T9/IH7*?\GV,Y^I'0^2)W
M?V>G/^'KG]Y#6]S[7GH>\N3E%(\.NHRCTZN?%3B]O?_LTCSNJ\II>+^.=WS<
M;OQW*B<<R<?S$WQUK8/HQ9(E3K78"BYX]&P)(Z/#ZK0K ^+B>R[</9Z)GS&;
M[9V>XDR3GM8XXM<\FAQQV<'I;SP_WV495/SR.O/%5>].<5S6,L'&"'.2E\BO
MEMHJ&B%H,M6%6KTKZ(>DRKZ&/@\7%;2G]PZZ,6ZH\S>IDTSQ2LR@CAF<+YB<
M$E^[9,7%Y3*$1.AE8+=4?OZ(1SB^<SQKU9,[O#,NN_SF!>,(6WF+KZ'K()F4
MG%/.5^.K#F !T"6N'$Q)GJ*%(3#I6T#>/N3I8K'OQH0M@SV$06MB@$ 60LPI
M>=O2"[QU/I<ZA#S]:XN=KYPDF.3JM0?62 AM;30M4@\"K0%V+<X?\=N'_Q)E
M?K>;S+K#;H33*S4J?\UG'B2?'!J.Q2@'4("R:=%052J75LU,#Z*"6;_=V;]&
MYT%R"0)0LME#80NH7<H2)"F]F,FNN@ZA.DW_==/U='BK22TW-3G@U,I3HE>A
MF*#14%&(<0#4ZKW#>YTT5=),"HI%[Z#ZMGC<F:(BA:HPAR'0:0/F^W F%.V+
M;[6!%+")*>>2$ZG*+:09Q"K5/P'S(8];F?2-#WQ)!$HZ0*T5-&E S!@U!4I1
M^UB#I\V0[A7Q=Y#DR244RMJT/B-078Z 66<TUH/XPL$.@#P]U#[7U,M55958
M)?CF#$*I6%*@XK M$<84S0"XU'LO=YUUD7'LDCA#63D&Y1)1-%@LZ2(A><A#
MX,\U1J]AAB[7 -F!92(VXL&F6B3,==D,(3&AH7=O,IY-1EU9%'%M62^?Y'6=
MM50:OSS7"!NO]E+H)$3Q7@(CEUHBIR5$\6I],RTE58Y#<$QZX-4NF\V#I!(5
M]BE$MM8& ">Q$1AL'?I4)JUP"-/-O==,U]/C-3XFPS;8Y I46R-ZXRE4KAE:
MH<<!,*L?'N]&3[45L\WY-1I"J@H*MF(]$+&EZ<G'"'&(Z^ZN9VKG2E;V%1.-
MJL[D),8M$D?,G*FFK**AFE?1!6V 'M.UI YEZV.K>1I-AN1UBEXY%V/0*;!E
M-0#J;%([^\$D"=1LR9I1*6$28K0)"&+QK7QC&F0Q@+Z- :ZO'@H00<4L3D\Q
MPIY"1JE:D5I/;*O2$$S8M<4.M<[))T@Y&O"DT5?5AF\YH:98A]#IJ?_I4ZL9
M %Q-61F,JG!*3EQ9H)A2PNQJ;&M//4I\-  ^]=N=74V.S4JX!#:;T"8G74%
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M@4X&45YG=C&C=<X7KT%+T+<&)N_*\%N-_('SE@J1*P#!.%2>3':5LD2 8-9
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M)].]XZ.CT>(SCA8[W.?:C;G<Y;%\6,N%!XK Q>0\QY)!!Y<, COE(&B--=*
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M"W],2(D_[I32-4[BZ'XWRZ/)[%CB^[LG\N5H,L/1P^GD^&@FIQ@=M[&UMH]
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M08+Y$#)4[5!5\#JS!?3.I1YW /U;&G=1@ACSTM3^GU%E=S(N[]ERC5SI)8:
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MFJ40^2KN;&R-(DG;**&0LEICU"G6/(!1E@UEKEC+%(L2.A-:YP)DB.3$R[6
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MR%UQNO:EX%8I>%*J6-TJHR5-,9--CKUMO9LHKB-N5Y1X?2EXE4R9DI9 54(
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MI'GBU\_C].2\?GUJWJ]SVC[I'!MPNSEI3]%2)%7"1U"!).%,(QS6"(<C#,)
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M2[/V=?92@+\A1E[>>1,)5;]IZX<V*M\K7K53-KH:!(;;3A->2<BL>P;,GF%
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M;4Z@S[-6U[LSL/6VS2U3YH7I8Y8;EV0SUZKE _>EOJT)K;YS6NJ/&ME5F14
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M_8YX-TM2QV6S4 E4KXQQ7UB+?=O%^8\3J7KHX.HI&EDPJEZ.M!4^-%\[4'I
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MEHB0$:5X@!'G/W?-[NQ#'P+["\9PRXN53#N\7?S?+4"W/!.E;&X-SCB__#"
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M?I!$U!=<F##N!1S+N6BFU973A?N-G)R^4$[' [<9HP@*'V@;1@$MM A$OI(
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M/\18[,N0B41"@F/!$\Q%I*B,&97:BON)T-;PHE8^?+U+#<) Y(I? )[HM__
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MPP!HL!7: H@9"# ,)5)",AH9R8W"\.75/IQSXMDR^#57ESR-/75]:8*Q"GL
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M1M9!W:AU>[Q[EIKR,J5CQ*6OO%*8Z9#NI76D\6CO>N#!W<^R^%?:;CN 6A1
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MDM^84ONN_]P[:?ZTZ+XK7TO^:>8\5BZU?^&*^<6$TR$P(>R)BD#(F%;,,4:
M$RQ!*$,>8<B#T+='-R2*5BJCSG6E<\#TFFUD'# M&YC&8VB%1AZD@2GF)-3
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M2&0L0RX 3Q(&2!@2(.*  APJK7?)F% 9F .SD)#*Y%'9G^L!7LN(UW2 N(Z
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M)E:3W"]MQ?ZRN9#D'G!AMBIGDHP4! 1X8B*C1*68C/!4 RL+]C/DZ<\$%\_
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MI#( =Y9Z*ZFOKLS'C-US";*DI9HJ'DCBL1S/RH:X0!-)-$>=:98A1,1N^@Q
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MFX.FCQ#);K:(?6<>//1F5A53%5,54Q53%5,54Q53%5,5TPULUJ1Y,);[H*2
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MD6L; @TPOB0_<XMV_"HJ/294:D=%CVOCTV/8*7LDX/5E#KPD#SQ$"L3DZ F
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M0!-S,@.VIC,!?^^=%!F<1=D)\E:PO!98+N:Z\P)$8D$2QD))#"\\\89"2?M
M7?* ("?6-B2[ "Q;FA>^NI^>"+>J2-)N))FC75S3R+E.1$G+":XEJL0A&@(L
M>,YTM-[GM0WQ."K+K(*+ZL65N55G&G/6\>F@V^^7C;U![APW*K9BL4370,9
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MF@8<SGQK^ESZ[2O.HSQ.QI=_Y;+^W2/&->7"&#\_%F=_'@Z_U5 Y2,0/D_M
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M90L/MX7ZZ8^$J3 DZZPX:Q%7VB(3M0;3"!CF16C%@(Y0,T-[X,(6 (MFH0C
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MX@PE9:A@\FXP.:DYD*C&$.92E(+&B'.9D#7<(D6=]%X+0DV6,%8KY,4(&-]
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M !_"WM+(=30X\R&V+(A:IC,J(&^OK[5XA=RO'"!>-1.Z"A$5$YHS3$PR(<T
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M.J%2".#0VVR#(KW?S,R[#II:OW=7F_;#+G'YQ#=9TVSZ6RSZ:(J7)W/)L;T
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M"AQ+RGF,U #82+-4Y8EKJ*FAYEJH$=11YBTG'G/"O67$&A:43D)X&TT--8\
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M7>)RGC8Q+['^Y=SS?S%!P,EQYYC W(O("?R>,[2#4%Q$"4>=*(. YS ?U$'
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M#OBO _Y?3,!_;IO$N8XDI_=C*YU5"A-+3,*$N5#5O2:C@']":!WP_^@"R73
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M=ED)6#9>?0V> +*&*7OL'*G:A'$>HL&P#=P0ZBCF+"JGB**Y8:N4 &,FU$K
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M%2//LK;RK!H<QNJXU^KXUK%M5[;FG:J;ZM=?=H]@CJ?_^P]-B?J]7W6'@_[
M=O)F5MGA 5O>ZY[ 7_T*7JV_TADSX=1(4Y\.L0];; <Q5+9?=>*@:G6^QO[@
M"+:G.HSA(%8G\,8_KP6583],.SL9$5X:*X2)/&9SR8:(<T5>E1BGL>2D3&%(
M._[?F]./[\.QHUSN[1^V/^Z_/FI2F,?G)F#'QZ/F?KL%O _XT#SY\/ZOT]WW
MK_"'_3> !UMB;__=M^8^S.#[AY/F7Y^<,8I))E# ]46O"LC*2!!50L00N60!
MX(!1W5#78 &<]3;\U3C#A#E8[")/$7V?/'5MT)6:R64[<"Y[<)RK-W#$JS>M
M_A?@NHX]B/E\WW:%2T2-_7,LJ&)>6Q_X==#-/T;K[.5U]D_L<;]*O>Y1-8"G
M5_"!^O]6IZJA.;]P5&_#U!=[>8-LO]_UK1H23EJ#PYGXDUK?8D#U=S+>I'87
MI'_G8/1* (9M5#LSIC0XM(/J* +*](^!=U/+5];[#$\9R'RO!5]IV<KVXN1U
MF 1P?L:F9%N]ZJMM#R,LHO*V?Y@?>S("J7ZCVFJWX<D3/006UA_TAIG,_6K8
MAV%^O&9XXE&T_6$O ^'@XL/R^GKQN-L;8Z0?]GH9'&W6=/KU7,:OM%O6M=JM
M02MFJM3[!L (1R8_'GZK!6&]K\ZV;<?#KAS"7L#<7\,H%QXY6M)((OA#VSDX
M'_#B+B0 \C%]\C?R%IZO^DP.@/2.O?9I?C<3INHZ$*HV,WR_7C8(G/8PP*3@
M"6<[$[\=YVF/9C:]UQ<GEK]U>4[73*>594V*O;S!@T-0*@X.JZV]EZ_J><*;
MO>C;L*5P)NJI +6B[75J&75R&#MGP^9W!_&H:L&!]+#_DT\]#KQZ"=O3&CPR
MH.K%@V';PAF$W[ZVXDE_='[JI9X 7QW"M_O]?'9:@PPM'>"-%B@N(P#H'=M>
MS5+YH(0N_ *:37U _:"JH0_XK[)5UF,RHMC,B=W^!/]&/-,&QLX/R-.9&A:&
M.(Z]K%Z,6*7^C#WHQ7KK@3DO+J4U>GI_Z#Z/'Y]?O<A2>;@N<!!L=!MXO0?K
M& T[$YMJS2G+7WC.2]!Z+;#33SXXPOT)D[C3B_A<,_1!%_3G3D:94T"\_B O
MZ6PYSX";6J!UYN'RPT940!D$42^V:W3*[P%+Y:>F: >P=6/D/ND.VX"![0P%
M(W2;WDGXZZB5U<D)^DWF7)-_!*7_'6:$:1T=P9/S)X_M:;W"_F$]_,7E#, >
M.*A)4L6O<:3$ HK881M^!6$&G^U-1$E>\)E>>YEJ@"T@]_IYYM>)"!C-5F#K
MP+EQMM^Z*8!O^?P$>'+[M$;'+,!Z60>'&2>0$[5\&RGBX[W,JO98A-@#FZ=R
M47XTJFMY?LQF/-LR<-):^=@]KTD':_K]I!4&AQ-'P(5OC2$"GW_%.EC.<'#]
M5RZ89;X^<TN"D@M];>J]N/CS\"PQY1BP$KE>M%^033#9Y[9]8D_[&[]=!DQ
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M>JX77H[K&-W;/;]51LS5.B_7G+L%59%9N]'O=8;KL04W'+T4T%Z'4MMLQ0.
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M.UJLB.L)BF11[7$,7GN="Z [20P5U$@GL( S6KR,RT62:2\C(+I)SL0<VBH
M29A%3G./).6:2JEYL'YCTY"%>3"*Q%X8KWE*G*/,JZ0H" (@EF98DDB5(41X
M49R%R^6U:6>AT-Z$0"+BV%'$A3/(44V1M-;J$*2C/FUL"CFC@OBLS.V%)".N
M77C0=4Z[>_79_4BLS^T1>IP"7VABC&?.!##,35!.8A.E5R:00+70Q3Y?%@!=
M38>+426IA$+2) OVN5=(*T$0(<F *+$B>KT@^_Q&7/% R2ZWJO"QULQIF="8
MJ\AE\EQ1#3:C)\FK*"PC*9;HH"4RY[1-;PV0QW.+M*M5!$F1 <T.>25QTD$3
M'^0B;?J'O*\I\G/9\K,H\;=DTVF#V28=-;8:41=Y;E2KD,4"-/G(/,;9R1'T
M8@SF(D)7@3\?2(06_KPE?TX;V<EQS0.E8%J[' ;O!=*!&!0)QYKRX -0ZCZ,
M[!_XMPAM4+$RONYY+>W[N"F8,[[I"719G3^=<I%;\VA@&? W4JL"(29PIZ(1
M ><>J]9@9P1VQ>VP)$AN[F\-FI-6JOL'8O?[ET\&Q*;'QB)"G41<$8ZLDQ%)
M0KUS/&&N_<8F$*RA%QLGN:R&U 7F"LPMYHH')\JXUS ARHV0CG.%-8N!!TP]
MB\6!LTR8.[T,<S8Z:< L0,F8B#BW N6@)Y0-",>\UMS3C4W"^:)S-I8%<ZN2
M_E7@ML#M.FF5Q=B_+>3N3FF6,EGK,".@2BJ&N(D>F80),C(*;B4!>Y]O;)K%
M!9P6Q7)%N+H@W3HHE@7I;HUT4\HE$;E@40S(80DV=%(":>H$,C%%J4E0V,6-
M34D673Q@*4A7.U]_J_OS;4YZ8UYJBWFUR^G*MTYL=7(K[''/1-<=#NIFBG6'
MXM]^R7VU8__74<_MNI-[=Q375'5[XT['5?<XCGK'VG;.J:J3K.*W<;=X^-A9
MC_E>;OZ<&T]?WT1Q5B_5A^VA"(C5P/AV311%@XA[:**H&ICJA0\K&P+3,NH:
MC3I?9\:[]E"\P4?E=).B2?/3->Y3M%7W;,_=8O\80>"?8PA\$WWWH ,#A=PP
M]I7M=7+?^6LOHY[PWFSMO7Q5_;(;ZT_NVV^_5B!:KFO,^)3W;-RP&'8M];I'
MHWT#:=D].UW53:Y^[Y6SU[W]V/YA+\;J"#YWV*\BZ&2A.FO0-O]Y++OPI'9A
M3H9[W$UA?[[8U:/PI//D!'9'J/OHEIF=OH]P3>01KJG0:3W6]/CI5'HQ+J<7
MX^I->%T^639V.1N[\%H9M;=W"=FZY[Z'ZG6K8SN^9=O53J<_Z V/ +"S#[QZ
M:?N'U>MV]Z3ZOQ@.LJ?\36S72F3_L'5\;HDO=/JBH<4<*_C]N-MOY:D\[]5S
M^AI_SS888@TRPZ?M;#_F$4#')[_>S[SGV_8I-_^RHG-6JA-R&7TYHY=&R4MO
ME+QX])]S.[(GNF_;\9Y 7#:F,7S6-*['\!]#./MU-HK>A$J/+7)F_1IY_>\_
M-"7T]]+ZK9R8<F+*B5EVE)WPAAKI*4Z,<J^339Y@C94Q5N%@V:?M.IZ88(+F
M"RRN*Q*^[!X=]^)A[/1!NNUT?/<H9K=[MJRR897MJIB]\?G%%S&'"IW?@8[\
M]5MI$'O[]MOCB,K[O'/2//KWY]WWKTZ:VZ\_?]C_"_Y_)7;?-_GN]X-O>_LO
M#G>/7K>;VTTR'977_+QU^N&H23[L;YTTW^\>[F[#__M?8%X'; _&:/[QBGYX
M_^ZD^?WOM'N*\52R,>'!$J,2BH(SQ+D7R*6DD&7":,VYP#AL;)H9N<8%;PK>
M+!YO: [CY59;(P4GCIG(' D\*D-3HA[7>$,F>$,*WJPXWI IO/&")2>E1-8X
MGGO\<60X=@@G&Z5A+E(%MHPHS9 +WCP(W@30;+0'%#'$<TV$2Z#O6!=%%)A0
M8F^LWYQ[D"^XC2?8<C&2ZW6O>[3E_?!HV,YU(/=>[NQT!MT1.+U**?H\QG^Z
MO;R"W<>2V_IPP#-=]4@)$Q5H,TB;$$#120X4'8V1)S(D3SU7RN;4U@8MR%.0
MYP&0AQ-+(XU6<R%Y4-1RFQP547L>/1/^QII.09[50)[I>DXD6:IA6Y%2 2/.
MO$<FP@^)A3$A6>YQVMB4#;)"P+/0VE&K?@FR<RGMJ']BCY?2X&EIMQYGZQ^W
M>7I,EQ]GA'N<?2UNY_N]IT8&98O+%M]JBW^YB<'F*!/.2XLUXSYI1[ @0N%@
M8O(IT#D,MEQZ'WXKGJ+549OV7E[Q3"LK$F?"("*9RK6( K*<4&2P(XKZ%+G"
M&YMX1EV,*]'[A4L?FDN!1D8I$; TB5.F-8XFAI@,4UR#H3.'<5.X=!6Y=-J?
M2SQ/,9>H-5;D9F[*(><$05QP2B).7%F>N?1J6<3"I4OGTN1"TD"XB WF#'X-
M7'(K:"*)>.?3[65I\46L!KM.>T&#)9'%D!!3,B%N'$,:)X\"XS(F(GT,;F.3
MS/!%%'9=.KM:"=)4!A:E ES5TKF@ ^C 5E+/+2&W%ZJ%75>#7:==A]@G0336
MR"86$<^4M3(&1'42#L?$/3,KQ*X+"IU>Y79N\R2(Y"CBG<[7V!_DEV9GB3Q?
M1%SUO7:\*6,L9HPGY4J_DD_@NKU>74ZL7]E.6%!ZP;PI/X]392@.R;+%Z[_%
M-]!['26*\:BQ\H%'KG*-<I$2V"TN>F_\0F.0QPCV<@Q@^SU8XVB*6YU0_S62
MXEOA\W DX$'<[Z7B2KJ9LEL7"'UYN4!H)(IX4&F1"(DC+@SHO=I[) BQQH+M
MPU*N/B_DRK;R?O*L*GTBP*#:$DFX(,F2I*-EG-C@HW>+#=\MK/IPK/IVJA^.
MCE)Q@5%4F")."1BF*L!O+!":9#")B(U-*O3"&D445BV*2]GBXF49>5EVNX-J
M.V9O9G9#5K9_YF6Y\*GB8WDJ8SQM'TOW>%22_;[\*VL3R%@KBY,HQF=5)P[6
M,921/LU0QIO<6X-]X03VB5+/I7=6)</!RL#":V>H64S2#LB8<Q&SU1\+F!D7
M9.6BZZ8&Q<Z5!IM@*YKHN45>!+#]E0&#PEN*O(N4:L)EQ!@,"G+W1.2B[-Y3
MI0 :M&$B^"0Y9]I8S8E6'KM,6)7H8O)9"E/>)U-.=>P1%FNJ'$'&$8FXUAZ9
M8!C"V'(7L%(AAHU-MH!LW<*4ZV2!EBTN6URVN&SQ75U5,\UOVJ!B92SP:]I"
M= >V?8/RW]=U^RVM+DM'RPL:M'&4T1S6QTCD$5N#=7)*\QBM9-3>O!;%1!?>
MZYRUMJQ3(_KG79AV.I,.0D5;OI&VW+QBPD81++%1(ZJ#0SSZW.DR""2]Y $3
M2YD-MS)A5Z-A;P&K E87S7TPZH.GQ%HFN>=."T>URAUW292<VAN;^P6L[A6L
MIDQ[FAA-1E!$J*< 5BP@S6A 7 1-B!'<&G$KT[Z 50&KE0.KA6M6/PI+FIUP
MVB^Q1[>$KNDP04N52\Q2I(C'B%.:$$@?A83VSEDL<51Z8Y-(<>.*.@6["G:M
M''8M7-$JV/6 V#45-QE9Y,(*C+#1#''I%7*."Q0ID);XJ*)E8"-*UN %NPIV
MK3MV+5SO*HG*JP)L4\XO&XD+P@ =@:Z(>Z*0IH0CZ2.F)G&BF"Q'IQR=&4<G
M&2<X<P19['(&@15(,^QRDCO10A#!8@1]GLU0YXN,+#)RW67DPO7[ G2K G13
M/M>D"0O4\%QWAR">G$'&2HF,U-**A#/U<^\#O#ZP5E_P_S:P\+A)N/(RHK]I
MYKE/%_Y=CJ"&'Y/)'-G>0:LSV:P<:##>!I3A\SF3$TQM=0+PS7-$='UU_]#Q
MX_3V\>/DUWL)>I^+"I=WD^ &9WG[M@95T_;\X>@<,_*LRCK;LVIP&*OLB;"=
MTSILWP_Z\)H=5/;XN-?]!A WB.W3ZI_+U!MG%A7<[[Z(%Z'T?6MPV.KLG\3V
MU]B$Z1SV-W(N!LP?IO1M\+PS/$*A.T#C!ZT[E+;C_[TY_?@^'#O*Y=[^8?OC
M_NNC)H5Y?&Z>[&Y_/&KNMUO-_7?BP_?FR8?W?YT"W.(/^V_2[O;!]^;6)^$B
M430FI#'@'_?1(>N=1]1@;+VVB7F_L4GI#"BLX,RV\QGHINJX%]' ?JL3/0Z
M,OT*7O>Y/7/*[9D/Z^O#Z@2^4+E8]2[0JTH@^ZJMO9>OJA;(O"J.[Q6K,.SE
M++)\,#MPIJI!3=+JJ*9IXRG#"ET]6'D3X03TZX3 3+!V=^2NS$<C_YV/Q&^_
MM(%=?\W$'U\BYPI-9^2&#X<S=6EN^A+Z& G,UIW /^7N&]'W(C7O@YCG^U*/
M^+PU (KX'T<?UGI.#H^HZOB(JAEM?]B+6<._O+01:.Z"[M]K^04(R,LB\2Q
M8R^=I>=>L#7^ SJF/WUBDFUO?X?L@F1CDDIO)5+$@J*/$T<V.(L$(U(:'ACV
M=J2QM#K#&+:R?L!DLHEBQX*P.1+#Z63@V]X!%:Q7H"-$4!>.@0"PPW'C!P=W
M&H4R+#V\!7Q^2K_6I[35KS+,A(RVF6V/X4S&D9YWTAVVPU@X1T"J,>OF3^4^
MW)G18>JMO)@,6A5P.,CZ;J\ZMF#& &L/<IF/%'N7/]9N6==JMP:G&>SAG=H&
M D5R<%XB!!X*LCUV*MC!+S#FL<VXV(*= K"!F>4I')VS5Q5 %6U4.^.Q\J-;
M'=^##\1,S7ZK/ZAS<7,2KL\:;>_"#-+Y7EP8LO^LLA??.FS%7E:23ZM#"SN6
MYQ;[V;1J]4&3&>T7;%VW!^#^'0C5=4":K]GTJI\Z[%QXH=4Y'L(ZAGG78:KC
MIUY\6@V,@\->C)7K=6VHVO%K;,.<3@Y;_K"R\.D QZ[7<C$3"/2IYW.BIYP6
MCH(_A'"< T]GG]0<)4_E[_<L_&XTJ2EQR+/DWMC\,U-H9$*1Y_>3V3PG<_\U
M[.:R"S4C]ZM?AAU;E]B)X=>:X6K'T9BQ)@8=G"?KX=/]5GU@9S-8MIFFN;V?
MV7W"T"U0TJK]PSB;;PZR$E</? B3S1UMQOQRFIG@XO:-&61>A: <Z?L_TG2Y
M1WKO'#Q'!Q>-9-882;MU:0$XRIWJOY<._]7S/L\9GLKPOZ2N73J'XSGRVJ2\
MHM>?M,+@<.)ROO"M\;'%YU^QKM]M#P?7?^6"W\_'W!!J27H#%5-[<^'G8>\\
ML^8@(@?B]PNRN9/#<]L^L:?]C=\N,S%P\'APH6OK9WKUUZXQI=NL4?\L?2@S
M0KW3 >S17FW,/!]VLG)2VV#_LJLRE0HT [ 6_M&B6@?LE7;)$PZZJ4W,.A.%
M#UIX9L,GOK&Y7[,-Z&HOLZ'1R55'[.:UT/KP)VVV'?7WSM;^FYVWU<[NRT:U
MM;M=O7WWXNW.]L[6FYU7;W\F&+)%/96FMM3%[ (F];.4 Q*$7/XDY-]J;W]=
M(>F\C-+; ;PPJJ+TR[N.'896+;=13;S:*)G%@(!08Z-E9('7MMU/#9<;^5"*
M3%VX3&7+E:GO9I@D61&LS9*30S!P0!P.,G3TJDYW8HG!@;799K1?;:N=OSJ7
MQ@<&R@\4/G9#A>^*!VB)EO1.]E$"LH TRZ[I\WVX?'\R'(!RD>W"_-Z(20?1
M'W9:_QW&L1)^9+^UCN S]?> "!FR9U (C,G\K.E/SC(P:QLR5K!1684';:-6
M[Y_E@FPGL9VUGY%U#&(E_S;,")DM[=,*;&= GJK7ZG_).E0K/QA4I7Z_-@;@
M<>?KG*$M7<2B^_9VO?5@?@_;V=DU\7MMU4K=5B?\>:[3C7UQ8:_S)N;27$"K
M%[;?ZM?"<1\F]*+=]5^>GE<,[QY\HEI2 5N/:% *<6T,THY)Y"7E400>0:C-
M[^5BJ\.;YV)UK.=GYKF@Z%?>PDG(%0H'%P$L@^ %=W5KY!>KK]'[(V=+?JW;
MB1-/]\A1XT%R'P"\P8?.?3/6=;_&>7TS>>LN:S"P<?5SIZ()8 /;]K@?GT]^
M^3VT^L=M>_J\U:FWH?[2[U?OO:;N%VHZC=X^5[X;>*2 CRL#C)\\?KM1OS45
MXS!ZCZL&9_K:MW&#7/O>CX:5#<.O?_='H_[X/:;YVLQ5L-N-6N;Z>,[ /<U5
MS#?7F]4*64[@X[11?5W9E5G16F=K(F*>18VLR>4L:W;5DSJ"IYH$[]RA_,G:
M[\1V]/'(Q=YD,\BES5BK@SS_W?.H71T8(^, G/Z5%F.S:LM>%WTX(P!QM6E^
M\?9@40N?IP[RX]K :A[<*'LW>^]8V;M;[]T\//N$MZ>PY:+8<D&EZ%<DL6?V
MNL\<7-=%MMREZOS"CMFMVP:6299)/HE)KG4GF3FQZMQ#.W+:EYXP98PG.<9"
M>^2L5)'>V5ZXG+=5Q?\.6Z">W+X;U +QN8Q1QEC*& L2\S7G4]%0J\[YS6XG
MGDZB21*LZXK0O\G*U[S6PEQ+?#3%%(CCQ B!L0J$&X5U="E1:@.U/CCJ/NW,
MG_2[U0GYOU?G(N0L_F.[U??M;C9WUSV3=UP4X8!^?+_;;N9Q_]CY]N'[7_CC
MT5_BX]&_CYK[!V1W.QSN;N^<?MA_W9HNBK"W_;']@;[[!FOX\N'SZ\^[VV^.
M/FZWCSX<??BVM_T.[U*8]^=_'S;?_SM-JJ$UWV*RM_V%[?WUR7%MG78121X\
MXDQ)Y*ABR- HG TJ:4$W-O&-RZ'=!-/NTCCB#AI= :%U J';]=(HIZZ<NG+J
MRJE;KU-W X4+$^>MM=PQ8KCSP7B0YY)'%066":=:X2*$%H5K20H7FU*XI/)2
M!$914I$C[@/.I5<XTI[1Z&BD=>D5@1NF:%P%A8KL*Z>NG+H'/76+]-,SM>(G
MJ>ZD-RK9=<%5?ZVG?HXVC7-'EZQ)#\<;Z&*>*V<M%9)1Q0-1.E#NC%=8^>@Y
MU\7YM51=K'7%^>63H5HKA8*V#'&F'7)62*2MDHPYAKEU"W%^W90W[EMBSGOC
M\03Y_4X]6PN!"X$+@==(8E//%-4J1NYY,LY&[YAASCICDA*V>$^6++&GO2=,
MDA1"4,@;81$'=0H93@-2*A',J956IL5X3PK#KPW#%T0O!%XB@1<9WK,.@7U9
MP@U.JWY.0JB++-PNLF^\"_<7VKW @,XRR3+)]9_D(CV;ZQ"'^.J;/[2=@YC+
M#H=<VGA6*.)-Y.H:BLZ;-$*R#!,6&64\<,FUPSAA0Z(U7#-OU;SNRWW8;=BE
MMV?RH1@]-S!Z]EY><5-JD[#%1(*5PQGB.@ID([,H!L:C-I9KA3<VN6JP!1D]
M:ZKVKB%[WDFS+60J9"IDNIVPXXIC2XP&T6:XE=Q@Z[C2F@A"A+!^7L]?$79W
M%';3'C[-(@<*$*2HR T\A$26>(<4(T*S1*C-PD[@(NS6CCT+BA8R/;1#;1WL
MU&:=*3<J GHF1VYEI\X;T;9ZA^X&HMLIIS7&.G?KY3(REQQG1EH/$H-$9XN=
M^B"B^VHN&4AH&6S@"!.L$%?$(^VD14Y+YYA2RC*>PVG4XXML?N3<N?2@S$*F
M0J9'0Z:;Y%,S;YTT"H. X]1A(QBH65@JEY2,E!4S]8%DW;29FD2PA'J/(I8&
M\< $,EIK%"V3AGE-E"9%UJTC=Q80+60J>2(S\T3B=.1'2119:J)(D>IWD>K-
M_:TLT6LK=G?_0.Q^__))4^6P-A%Y;!SB1'MDD^!(!B)BOB>(,E^UZ@8N\:5/
MAK-7._RP$+@0N!!XY5)"BFR^JVS>/;TLFQE/WN H46#*(NX%149BCA3S*AIL
M9"1R8U.0(IN?$&<7Z"X$+KD?#T:-K4E/8)2Z/=0'>5:EUK>ZA:;O'N6VM%]C
M?W!T^WK/CSL"OTRR3'+5)OG4LD)>=GO'W9X=Q,IUGUX^R-*#NTH,WJ(-5L&(
M=MI(&<!D-=8)3ZC/QFJ(U#$ZKS/Y3+2_[O;>@F _MURWHQL4._:6=NS.H'G%
MCE6868^1%Q(CC@E!UF&*")BTG 6'-;<;FT0LK(9!8=N"KH5,A4SK1J8;"$&I
ME%,IR<"8YYQ$FXBT5JKH5/!$SUT&N0C!>Q*">U,7K9Y8;F12R$FE$0^YZIX.
M'"7"K(E>)*\4"$'9D$4(KAG;+AU=GUK^R+O&VT:UWZO[OSZ]S)&E!X*5>+T%
M"W--L1/<QT"EY0Q,6TX]"SAXKKBG=NX$GR+,[T68-Z]8M)Y[%YD+2#-F$8_!
MY#JZ!)E(4A"1)R8="'-V=V%>V+:@:R%3(=.:DNDF!2I2+G3*H@N&<N.HIB#Z
M#%>1&2.B$,6B7;(0G+9H=70Z!,U1E)H@+K%&SGF-0)EQ6MDD \$@!'D1@FO'
MMDM'UZ=V1[MU$#O^M#KJ]@8']B"BO, 8%I1X\F0.8/%\K:YX9Y3C$*D2)%J>
MI+>Y?KE03AGA6!"\V+A+%>]_7;%Q4W":2NZ1,$X@[BA!SB2"2-+4,<:4X&9C
MDS9$\5>O&=<6<"UD*F1:2@U&:XAF,5JMN&;<4.>P\$9[RZC@I)BX2Y:!TR8N
MI8*J8"TB+GG$!9'(*4818]R&W+XV4)EEX*(2< K7/AEP?6IWMEO]?AQ4B[%K
MBV.E^+]61::#Z"8V*I8$R<[JY"Q+FB>:1'Y1B6+7+E6FO[MZ=RLTIR8:I"U-
MB#.2D,8L(<PL9=%:X8!4F[Q!BM=ZS;BV@&LA4R'34JYN9: :Y)YTG'/I;8@:
M)Z$3QP0;CHM=NV09.&W78HXYU1PC8E3N ZX2,@YS%'147%+%L&%9!I:;VW7C
MVJ6#ZU.[N=T;',9>N9TM/J[5(]--6N%Y3+S3+M&@.,UAR($X1P(5/(I(0K%B
MERK!/UR]G4U6,!PQ8H9B!$J70$X$^-/:P(RVS'N<RS&7V]EUX]H"KH5,A4Q+
MD($4>P)F4:*&>6ZE=TSKI"*+3&!LW=P=\HH,O"<9>"6EED?%+ 8KUA*"N!()
M:1GA1Q0T)AF"TR;+0%YDX)IQ[=+!=9&WLVM2Z][.7^GN+I>VI5SC;39CC9QF
MCXW -VG4Y[B3FIM G>?$6Z<CQ<E*@F427L[=4+YH$/>B0?BK=\'4425)0L2#
M[<QSD)?UQ"#'@XN$)VZIVMAD"RC*41A^;1B^('HA<"'P.A/X)G6T>&YTX*P2
MCG"0V8Y'SK!7'(>@<"A7U\L6V=-&?_0X$:D((IIQQ*F4R'FK44XJ,S*P8+4#
MD:T;M(CL)\/PJXWHB[P27X>:^0"!\&>GBM_\H>T<1 #.7NNK';2^QLKF,/#2
M1F]1OJZ5 :?2T&,1V@@F.,)AX%('PBGEUB8N)?&8*F*,\/,Z$,8<^'+8Z^6Z
M B_A&?GI=0[&:]OJ_6W;P[C=ZOMVMS_LQ:*4W$@I.;CB1Z"6,99\1(P(@K@Q
M#&F/'7*12>6XS,EB&YM NX8NK9J>#.,79"\$+@1>9P+?0'0'YV22EFLI+'>$
M:2X]9H1838Q.?N[<[B*Z[U=T3_L3% Y!YE*>V/I<E]MP9**S"'O)A;;:<,ES
M%;,%!,,7QE\;QE]M9/^)0R&T^L=M>YJ/:OSQF2B?7,]/+B@\9:6]2..HE-I?
M5-E!U<L^]![,ODH@!JNO60Y61W4-^)BC4N[-[3<3LE9NN_YY?^M?;:B^2:X^
M5\Y:*B2CB@>B=*#<&:^P\M%SKN>.SZ@/9='&[JB-?=X:-*=KRJ9@56 )!9=
M&Z-.("N80L8'Z0SUED30QKB^>TSGFMWN%#0K:#9M<3(K W66":&XY]H);F4N
M3!6T,4[+@F8/CF;325K<\."312RJB+@4$6G*! +!([QA#@<O-C8I,P7."IP]
M2CA;[8OY<IC+8;XG2X-ZIJA6,8)D3L;9Z!T#Q+<N]RD6=NZPLB*;%R2;=Z>;
M$FM>5R-'UB6!.$\8&1H(PC)9C8ETA(:-38+)W;L2%S@K<+;><*84U]@*:RF1
MW EIK(F&),PP%SPE5^#LH>%L^AK+&II8Q!)AZL'4B%0B+91!3@LO0/RX&!C
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MUZG4R*4N9C>;3!FZ7IXAS\N+R'->V^[M.0;]\JYCP7"#]W^M4#6*M@;$G<6
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M!FO!K")&1^N,#X:'.5AZ49R<P['L .;T;?"\CEY&WV.O6SC\9AP^;8&Q%!)
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MQEWD)E 1<8K4>TVB-?/J)85-[^/J?<*FGG+KJ>"(1TX13T8B*YA'U'ABL":
ML2:SZ=6V54MATT7Z1JA88K6A.1GNI]5$5M5OLI#R&X\Q0>7&ZU]MB;"$?E@E
M*NN^[[SV#\3N]R^?=$Q<&6X083*";+ .62W!C'58)&&"(P1O;-)GPBR@3]9-
M^6+)_J>";P7?[JFM5<&W^[X@'.,;4T&JW%(^):T W[Q"3GF+O ,22HD]\2J'
MG6J)&VQ=\&VL(4\F,CG,O$:O571H/= 8%S9^JHO8Q9U?PUD^A:**N]T.\O=:
M6'%5RA*N]!BET%?9A)+Y4#(?2N9#R7SX<>8#92)J8ZB,3O'$@M9*86^M(#H(
M;DOFP[*M(7^>^3#Q]KA@K$H!"8<3XLH09 S\*:EC8,0JS$DLF0\E\^$^72BW
M@XVK+I3<DR>WY,GX ;:#+Y'6BX6.*4=Q]%)3Q@SB/%\BVIR_BYE$.@2AE$TR
M6;V*D=:%?Q=]Q:.\5(YK:SWF3M0QJ )85S(=*99SW_E?Q[^%3V_$I],.S\ )
M5U%:I(QDP*>4(4L$1M0%QZ-Q7FB5DYCDC.O^M<^'*+;F6EM.CS"6>Z;EI)7$
ME!/+O%)<)JU#\IJF@(,'$'6F6$Y+AM6#*Y83=5(*;7/E1V81]T&"Y:0PTJ -
M)<NQM P./V_0:SN#EUIE)0ODCED@MX*-HGG=%T1,64@JJAB<4@@'!V82$1HL
M).H!+)+RT5+IC06(,.;N96)+KM;J<BGQ6AO#.)4A<@=6,?74)N%,-#$(GXI]
M]*!<.FT?8:MH2B(@(H+*B0NY^ N)R$MN.554 :2N'I>6N[BQ?<0?2>>A<K\T
M3T%G$8S4P=:9)4Y+1GW0G!BEE*:D6$E+!M<O5ZPDR0W&*C$D'".YR"-'VGJ*
ME"(LT9!T<* "Y<S1.UM)Y7ZI^*>OJ^A\"]BXW?U2B=:](WY,F5!4\H!SC*[%
MV")0P@QRVFAD9*12&2&"KZL[$RP::C40I##Q?3!QHMB$(++(T#P&;YD#BRK"
MX: F8F_O:D05)EX<$T];6 ECGIQR2&#%$0>611ICAJPF&8\IQ@;73,S$2G7F
M*G=0C\S&*FUSYK"R,!9<"N=DOC@F!&LJA0V*>ATD]U@4*VNY /MYZZJ5%1)Q
MQADD5!2(>^D1H*I!%G0D0I4*Q-#<-P?3164T/1DKJWBYY_5R:T42LU$ZG'L*
M:VM5##$9A8/E).K;6%E%\[HI,$R93\DEK+TP"&/O\B4U0XY@B7A4@4?&O9-B
M8U-SD+NK 0R%-^_GGM@('J)RG,#_!IO<9TT(8P26!D=Q&^.I\.8->7/:*J*1
M)<>L1$'PNE*Q0":)A+0U3"7+HR,&>%.1<N^TBC:1>!PV4;EV^JE!Q FH,%1:
MXD+BFAL;)-&2<D5=),R5/J++QM975PRBP,""U98@0I-%/%<D=)@I)$#H$5!&
MF:(L7SN5M*9R[71?2M?M8*.$_=P71$S?+ DKK>,<T;I>J8'?C*<>&2NXP0KL
MUESG2@A:[I4>,Y<FS@QS*B8A N>.&Q(#<"<PKXTBF5N91H5+;\VETT:25<1+
M0@*2FM)<KI0A0Z5!- B=HRIMB@2X5*IR<;2:1M*ZVT?ERFB>P#Q+$R7.*(49
MYX093BCUC$;*G8U$%@MIR<"Z<\5"<E08$'01&9V]3T%XI(,!"PE+Z16S.M3=
MEQOR[H%YY<JHN*5G!^;="C:*6WJQP#"=M)24Y]QZ1)P$C0L,5J2ESDX41[5P
M7 MM1CTO%U7]MUP9K2!O"A-ECOV() D>"#<6,V("_+2,*7.KI*7"FS?DS6EK
MB'BOC.<*A6 3"&T-0IMCAKR(,AFNG70B\R9;*=XL5T9C:TBNOS54KHM^?EUD
M5<+A_V?OS9O:2)+_X;?2P7YC8R;"Q=21=7DVB&",[66?!69LO!/V/XXZ0;:0
M^$G"UZM_LEK"@"1L#@$":F-'%NKNZKKR4WEGX$EZ"DPY!PB:1B9G0Q:2T2H,
MW3&N;LT(0R I*"$545DR BQ[XG( (E6(H)W" \^4+'BV1BE5<]%-F8NN!!LU
MP.%.\&-*9K+%6L"<)DQ (N"])H:J@!Q:])ZRE$1*I68*!W;]\I_5FK2\1*PT
M&.!!4ZTM9/ V,)-=9BH*1E-2-4II>8AX6KA"$4HF&TLY$&^0=),I"9TX20 L
M609:*W],Q-<6KZJQ:?'BE7X8'GG5Y'2A7.-. #4LRN2+NI)[*4!%)Z+RQE"3
MJI1UQP#[UXR4I9&E%0H%+*%= 5C9:I8ST3JKI'V45K%B<A**+X?VZOY(656M
M?=%(").X430)J@P@@)0, MZ 0;!(PHMS@ANK6GNQP# E/GD5@N 0"8J]GD#1
MP5@CD1%S" D)(0.18V7-&EA=$EMTI<T;,3DYP)/;@0R"@0_>*RV=MXGB>9&$
MB5<S.561:7&$.RTR&>$813&7V!0X <B1&! !J=<KZ@3C@;?962@32T6ZU2+U
M762Z_])2-4G]5%C2'*A$B2E2F2$(Z610):$2S\E9SG(5ENX86M_,"$M2>);P
M/"2E? H!"9(8F3-)3#(??4 H5"6"25P_O7@U255M]GS_O&@@1.DBM1J<M<8R
M"SY[E*&T\/Y*)JG*<UT6&*;++B&&6^,,"<!16'):$L=\(L B$U;ZQ*-86=/:
M+I62NM+F@FF3.M R<"%EUL $>*8@AH#D&K/745?_O%N@S9F4#A99:DXU:9WT
MP$+18:!X9+AE/'H 9S+2IJ$U6FD9I2'S0 Q(U7ST4XDH>,^H!NL9)& 6I: ,
MKJ24Y<(I[D*5B.X87-_.%EP23 3K@1@J*4'FAQ$KO"$2HA8V1BZM7%"IVFH^
MJBKJN5S7U6"C1HO?%$1,QRX)9UUFEH2H,X$D*/%@!+$@('JKH[!X0!HNETH;
M7:ETP53JG$-!&*A1S);,*\8(;;)++'#S76]1<SK<%I7.6(TR==)R3E204++5
M"N(B?GB7:,IX52M=DE+J&L6TG%+2?1>0JL7HI_(12Y!R2E1XZB&ZXBPC% ^1
M":UB@%J0]JYA-<S(1XB<B4LNB<A*$U#"$>,%)WC^60?61@.F%*25-8BI6HQN
M2CYR7@@(F?$L@)MD!-=:I"PT'OB)7;O44N6\+@<1TXYV3@J:DD;.RT>$B(SR
MD3&9</ F6PT^9K>RIL$LE7ZZ4NFB<]Y%I%.5>!&+01:[KF.@46;V.FF053ZZ
M72J=+9?DM=8<B,V1$="TN,-:3H1,.H )GGLZIM)ERDQ9K4AC^4C0>R\?50O2
M122DK+43 L]/P1%%@S.."<,$55*CP*2KA'3'P+HW*R'E((7RAB2F P&7.;$Z
M6")S"EJ#53[;XE.GK^]35RU(53<]OTS2E6"C!CG<(FI,)W?P@1K'#3)A21#P
MRA(;O"0\&9.8%!K EB 'R<Q256JII+MHY89-0;D@?%ES3YW)+"L9HPC<2!E\
MC4^Z:]*=EJ0"\SQQF8GWQ8F>HA"%A Q$!(/GO3 A9-F2+J=+50"MVIHFLA1_
M(!YY-4KI(EG$+:<J0&;1!C!*.4-Y#I%*Z73B[ASE<96H;@U@/\Y(5$*4O$9,
M$:45$,C!$2M"(,%Z$:R0*O,VB[BE2Z)0OC\25=5F7S1*Z4JP4=FR6T2-*8F*
M499]<$ X<R7%.'Y8!I0P(Y+!Y4R:Z98MH[P:HAXRZ5(9I.+6<$%1HG+49I=%
M<-Q%8Y5U5S)$5=)=).E.2U0Z!0\H\9(D,R\J5$^\C)R$S+,0QCN8D"ZHZRM#
MJG5JX1(55.O40U-4S96EHN>"*\.T@P#>."=89CED(W0!5E=EJ;N%UF_K,[*4
MXI%EK1@).BL"QEIBBSM?#$)D\,Q9DTI\DZD5F:IUZH88LJO!1F7(;A$UIF0I
MP:A4% 1A#J$#8A;%IBV),,XG"C%FZ@I#IJ1<JG"*2KH++Z:6(C"3F$[(A!OE
ME94929E&3JGF5TH]7DEWD:0[+4M)1I6**1$K(A"P7A)/-9[_/ K+ 105=$RZ
M>I4M$>E6Z]1$EA+W7I:J5JF?^_EIC2CJ?6#, TW)9BVC%Q1D8#;9<S(&5TGJ
MUH#U^8PDE2BSTNI$LH^VI.$QQ"J/?X)1PKK ((>5->2':NZ\:I6Z*3^_*\%&
MC;&X*8B8$IM"3"([!L1277+G^4P<\LJ$&\ZLRUX*#RMK8/6J6 Z(J%1Z(RG'
M%56!>R=D,6MHYHTJ/@NF%*2.(84:"76K5#I3DLEJ$Z,SA-FH"/"8459*F5#C
MJ3>X; '2\E%IM35-Y*.S]6[OGWC45%/3100DX8.GU)3RT\"#,3Z'P%WK8YMB
MXE5 NF-<W9Q-+@Z9*PBV..LQ K@\Q 5'\2,E);D2U*4B(/%J:JJFIIL2D*X$
M&Y7UNBF(F!*08K!"A^0)%1I9+YDI,;)DDTD9@8-:K8MGK[7V^@5MJU5I>:DT
M!Q.431H%(@<@K)7,"B8]% M%$%5 NETJG1:0A!*2VY!+AG%)@#E%C.:6J)P\
M,\"HR4M(I=6 -!&0S+T7D*H!Z:?RD0.:A47&6FAD=BB2I1/4AY+,.@EIH<I'
M=PRK6S/RD07I6$)$U=+DPOQ(XK5,!#%5<9ITL)*W\E$U(%4#T@UQ7M9REY0&
MXY@"2-S&(#CN/PDV@TSGP$;EO&X*(J;D(ZI5C$ 3R18_0$%!!\<(54Q&:XT0
M69<D7;I&,#UD*DT1EU@$"I8+D(;[*&C@ :QTP7AGJWQTJU0ZDP#"4VVT!^*M
MUP1BY,117<R\@1K@UKBV6-J246DU((WE(UF#E1Z:AFFNA%0J3$K.I>22@^;&
M:)25G*>,.B9%K!:DNP;6OV8D)">9D59JXF1""2DJ14QPEE#+C##9*95\239.
M:RJ]:D&Z*>>=*\%&C7BX1=28$II A)RXEB@T14> ^DPLCYH8!! >N8XV23SX
MGW *M4+30R9=YR2X3%/D"L!$ZY7S)FN4G!13VLD:K'37I#N3^,'3K+GG)/K$
M"(A$B3-:$Y2FLBBEB+,28]*5#S%8:4R!O)6'+BQ7W041OGV^W12*:/[;QY>_
M<*'3[8R^WJBJMBJ2%J'NY=10F:)7/D(.RE,>O77)4DC@0[H:,U-![Q*@=RKU
M[X?G;.O#F_<L0I Z"N*C )1R3" N,T:"R8()Y4/F?&5-\.6JQ%!I<]'<2@@0
M6 *CG09E#/(JC&M!D5.Q&O? U;B52IN7HLWO#,F$-@T8JQW-A%N%LH30B7BM
M##$>V9)LA.()&1)D31YB'JI[PX[LC/;3X$;5(%4>6P#"&0XR^<!CX+8XY-K
M6/8"N7R9\9Q3U=A\BU@W6]=:4,H=3Y)$P34!(R+Q3#!25L0RRW,*LDVSNT2"
M5Z711>=F"EHB76:.A I "P]*E3>>!:>\S:*:FF^51J<5))XKI$MK"541:90G
M(,:*1 QU*O%(LTYJV6CTL2E'-E).N-MCDSL]UPLXA":G$\?;JAVYU=7XY1+@
MIY-,W.G(F(W@=;(R4AF .TN]E=1?E$%Y@W_V<0J^I=B:BX?#(]P(Z?F7P]0;
MI@J"EP+!V0*S1>@2 3PQ0<F2PS(7$'3$44NEB-0C0J)0-B\<X=>J*GD(A!IH
MY@*"P1YQL%)Y $V-2!$BY4&DBW(IE5 72JC3W H@07($3))PI0BX$(G1QA#I
ME& <(=44<P[P.8D5[H10%ZDWX7)5+SNG4IAT,BIVG(B[?UD5*#][SO<',0W(
M>":?"IS_V#_RW=0<3^#DAN)*5U9GV.]VXO>+/T7*I5NU_[LL$[_ "5KN(^0.
M6+WSY-SJ)7 #!K/)L<)=4 '9/**C1OZ/*D_P%T.BDD9D[9$5R"@$FR=:\855
MW%L<$=VQKJO":873Q5<M71!#7N'T%FV<QUQZ]%X&E8GS#N$T,TH<'H5$&6ZB
M3BX*S1%.[1/-%I<B^N[AM&7V?QLY?.EQW,2I$)4#-]CK]([[I^XB/H47&GQ_
MZG]G@SS.[2Q.YO$$C2-LA#H+P1^.AJ-._CK^J=.+2&%/"3.+'^,%HE[XE:->
M?G&_WDBHS@479KSM9S\W>\UH/S6Y,QB.FO]WY 8H7S7]W"#^T2?MI6?] ^SO
MUZ8(7IU>B1EI.I,PDF: ?S;#S^YPB# YQ &WE]VP<4UVG4'SR76/4K.?XEYJ
M\(&C[JBHESN]II=&S>&@C\05A^5U[A#_^H+X.$K=K\W_7<9'K%3G\#1EP1(D
MB@RQR5X;2 FE=N[<^XV6,V:T6 ;GL,AJ&M/_G'3KQ:!_\!J1>B>_3@CLN.1I
MN'.8<,@XAG7LUZ?VIP<-]MWT[U=?W_T=#ST'M?7R#>S\_1:V=S]^WCIXM;_]
M<OOC]LO-SV\_O.B\V]W\\FYWCV\=_.?#]L:+O+WQ_/-[E0!7@'LB()<B\=X1
MCR(,X9("39(ZX'%E#699W@8)H(M?5IO=LC=/=I*+!0Q*)%/3&38^E=WT7276
MC/HG.S.-=6)-'PFRW<:#=. ZO?) JT' /5=^[948NM6*5&?B\\[#BKO$KY,8
MMN8SXDMG.#S"%?=?FZVO7>S-9B_459R*LKP'R]A'Q@?/E"YB_O2*;J_^;_5W
MI,_/>'QTV]_?C-Q^LQ[^WU%G/!_-ZR-?%WY>>&US#Y;^9+W_UW&C <)Y7<HY
M2WG/UO+-X8?^?J]YT;H2I.8/).*I6._Q4;^-#P\ZX<P2GUXK<2+"K/W+#WY;
M.W=C3/H%92)G9_ES)X[VC_4#IYZ:["-Z\HCS*+,=C<Y_Y-3N*A'3:7!'(A:W
M4S-ZZG-_<)*S8"\1/TCN(W$9._O4=3^[K\.5W\Y2%9+4I'%IVKTX/?ISQYCS
M5<9HIH:HYQ%+.]/(0?<+KXU+@^)X&HPIXE]N6;K2[ ^*_/&/#C<FTJ!+JE8&
M(GJ7A?,VR1"-#,+%]["RMEO$]L)S/BNB2V\T_-=O[OPM??L[;=[85];^M[F^
M^VKS=;.Y_6RU6=_>:%Z_^>/UYL;F^JO-YZ]_AM0%WZ8,BG<ZF'&V#!01< EB
M$0UB^=;J:5JA=0Q9'==MVL0(!=N&S2]O>NXH=O#ZKPUI%Z_30Z2;1X#GGE6,
M'\_"++;=-G:LCYHM-PC[XQ-$L"=%SN>-Z\5F(X54TE"<N<3&*@"WMS=(>T76
M/R6+322HB7K@G_\PG.G?D:4[&@U'V&"1M%KIJCTAKB[?1ZI9*7B@60[@;;3&
M.B.C3D)+HX,YQ_*E?YP(XP6.XW]E&!<3W^TC$]^W/OQ%M_]Z'R18IB*08',)
M]1*9..4"D2(':3)UPI5B?'859EV7&C^6X=O-=9D%IS(XPUU4-'.PROK 01A*
MC<[@,O/GZ.;K@E]SP=G6WGNF0E0XO>-89E!>$A>R))(: 5".M&*JY'R5SBK6
MCQ?\2='T'::B($-:GU;A#(]Q8PY.I$$:WQ0;5Y21_8++"*8?6V5A)^ ]>= _
M:/R@_[%H*0>X_KA:@_;6]GP>MKNM;2ATW7#8R9VQ/O*_"3O3\*)Z')U5*>UW
MTJ! (O;T+*R?8507H',\NSM?A_T4CXIV<<N-CK6+^;0]J>49=O&=?W3[X>.C
MVX][=.NO]\9ZJK@1!-$> <A128P#3T0$&9V5EEN^TB0DVL/"-PV.TLI/I,8E
M.8BW<)^Z47_PM4$6O'-P=(!$<^B^CKF.$U5EOW>LI<3-C:R).^@?H<R%)'2:
M?+IG_*(*[<P[Y%NJ0%+(_6ZW_[G\.VB2"_O'!'F((^G'89/&C1[S XU@3R\H
ME;><SEGV#Z>W-5F=R%VMF0RGN>L.A^GI\9??8V=XV'5?GW9Z[62U#_U^MODY
MHG*[FN/+$\G%VE5-=1%>)HYQDQ=/Y)K55JZ9LOJ-KQFSRJPZ]S)=9>=>^U&S
M=E51N%"K/W'GNVHBNX5N[^]"4]O@T\X(7Q9^S'V/O64W>\=*_>&,K^3E!CN6
M(FYYN#\<W"Z>/MTS@[KM9(5WDXJ0\RN:T1^[+TYUM?FIJ\V,6?8T:W3",KWZ
M?FKNY#\''13@#UUWL[>-K]_]G+J?TA;V9?]A&VG''CD'VYVM@_\=O/U[^V!G
M=^\S/H-,U7/8:3UQ]N#MM_]\?/?WFV_8[X_3'CEO^28R:>_VW_*W<F?C#V3,
M_M/=VMV3Q1,'^_\!F;7NN]WMSKN#5_DXYR'^RW8V/HJ=O]Y;;2B70$F)D$:A
MP0*Q7CBB38I6<VFIU*5DNQ&+2E]V.\XVMUB,XX[P6YQ[$C_,F)UEAZVWR0UV
M/_<K6BT,K3HS:.6!VZ2$)Q*1AT L[H.0'3$H:4HEF8BA1:L%E/E;OE"?90<D
MN!(@/8I,!W<'2/N#=$&M:86D"T#2UQE(T@E$\,$2Y6DF0!TR4-HYHARCQGN.
M;!442++BVAG5EB]/PK)#DJP\TM)!THO^T: BTJ(0:?O9#"))GP)E((D6$IDD
MJR(B4I*$)BJ9U$8QUC))@C[F&O-WA$BJ,DG+ATB=3Y5'6APBS2J9N,\2K(F$
M16 $N$:QC=)$A *#VR:RP'5)M2WU \PEM=2(M+N?!JGU,:R<TA+ATGI9D0I-
M"X>F68T23\%1JP+!154$HL[$II2(L4$:K:CD4,0W]L1(>'C<TKW)<S=KI:W9
M!6IV@65&^[,>C,_<8/"UA)ZV/D 5T1>&Z+,*N8Q,I0O9$<&*^.M!$P>BV @X
M\S9K*30KHM@3_/:0$PS,"]9I]]-/8QZ,6;FTNUC[]]E:FV;*8^]&0K@N&$"
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MM5K5]GPGYZL[0$MCKM3JCZ])P6^DK[8Z:S]D9^TV-*(1[$D;5C[/B?D'([Q
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MMBF>63BRYE4:ZU^'^YW#X46\W"\R71?Q,'_0TUZ*O)QXP35C-[@ZNPN:742
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M>JML![?>;Q(&EC.46<&0O\KNN]G>J^ZV^4[@E< &J$5G_^T1/@W"9[(OX7L
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M"Z=#,R5L"THUB&!*6"1+2F]J  4ESU57$*,*3SM%E+_1\9;&[6J***IEA?+
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M_\5OL-2X0(Z#8)2D>5ROF5#W9<WGO!28V4#K[)C_AYXX_,5"+<R?N$U+)AR
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M\4JF&C<PR4RWHH6:DU.TDB_3NJ["97D^&U@O99Y7JPRT5(H<RVB S$0ZL)Z
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M\?.>[3&@-"MBWT7)=D)KWJH\$2FOAI)J7L AUE4FY+;K3'Q.!'7H6= <J*;
MDNF)6&FDI2IK87,(?\I'=550SR1%9KLQ>3]@L+1YD<YLF9UU%(2 ="F"I@=Z
M#"JU8=9FI)A!P[_((D%=2;TO1 <NJA7F9DA+FQS1VI3,58E-$=@646%?S=F7
MF'V<C0$;<TZ-#F"@Y\SDV1W !>B[N2K 5+E:%1D6!,5!"U6M,,Q!\RCLG*NO
M)^L8B?.:7X2M(B^6-39EV$9/I;*.![@GJ$4SWGC-K&W?A7SME,PR"C'!\.&M
M.(IU03U0,[ ;*9J&RTJ/17E)M66%YA*3P#7,_DI(6QLWYB@%Y4<*WK(&VKX@
MVQTV0J\:64&PM>3#>8QRLX/V"&:<E"-B[&X6.G#K5<10)?GP6V,U=2Q%Q7HP
MZ%XME9M/=4B=MKQJD;"]$YD7QCU):M=W+;4=TFO&A@8E$,B0H'A18YP/N#W8
M!M@.-PBN.BX4+:J"D(AF$%2;K$,>K4V"'EI-3<EQDS>LD1R:7888;:TU:0!X
MB2F5L&<4JU'2T9O?9@8)D;23U+C:-M<N4+.H8'?&10N9ZRD$2O.2FJ13];S(
MI;'9;,RX59)U$^XIK5U9X2=+:N1TDQ_04C: /$VB3F 518W;9J,%ZI V+4DT
M+66SOY4I2\0M8-T.Z,Y9^D'R :94_@9URVBS]ER#M4_26HVETBH=5O\?NJU]
MI\:GH8(A4J#>;',3'&PQ2GSIB;B 3;RF1YD?<B:S!95[,5^P2D8N<_H1V2@*
MA1D2(3 &[HC05B?P]6U)TM-ZV83K%_!%S3;23HIP]W@S_:1-0JV"B]L%.FV#
MP61L$,&R_FS0%ZO$7+".&TB/%;GBTJ6T$">,4,1!7)XWIR-X<8)S*;V;M[9(
MWEGH3<+)8JER0TC_3S?"'=*]::?@M"0Z?I H*TQC)8ZRPK@=]I?CD5[QBH:-
M\69!1%=YT\*2G\H'D/Y<Y]F0>1<#R!)W&CR%3Z=%!C=N0&:B9PNP1=5Y%Z7"
M-5LKD6[IIHJDEN"E&,N2XQ3R00.[ XM*.$,/*]+:0ZI#)J[4I=(T_#A^M :4
M"CT(RA10[83%M1/XPUDQ1RE3]9N'+X\929%55ZD8=,.WKN1K^D*3ZRH*=WT3
M>(9IOG4K!GO29.B?YK2]C:'SC3JMO)+HLNOPYYP]L!L->MSO(/-0HF+<6E*3
MB;^2C#LAT:<NBIA=LUXRO!W^R,3V'G,/1 >_X(:68]W/H$OBGA>(;U)]1#&F
M3BTK442/J'DH>APS#+(OZQGH@D_44_/HU?%+WGGX%^L,)&._[&0?B<%D":LM
M:I5*+M5T$EL;*Q+0OP;7+O59T%3N"#-.8^56@6-*]^XCDCN6,FK=&EG/*;J+
MK X?VNZNAE=7++1[A\]KEWAK781Y\WO!PSUL^3_&.%RNR1G;#B,/7=3/3,JX
M(D\R;+X>ROH2&U^^PF@I!_[??"BQ.2](6DP8*:7^6U!81_VWM2FMGY6D)8BQ
MRCVB2'+'#^:("*GQ;UTP88R*ON#!"8L_,W,=Z.^0T\V)D+]QE8711J9W#V,
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M[E"F%3+ M$V<L,=(?R+4HTJ99-C:@'_(I'!9$9EMK-1+U3U:BU9@U-MT7^+
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M"7O5<[HB?>:- 4N4WJR;;\EU"GY$5F/K:V %/J,SYSK/E);Y9"74LBBE\TA
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M)L0!/2I6'C)2O0Q@:.@YVW.:UI:"^7>>M?#-]]Y\[O5^&)_ */9H@U\!K>.
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M:.]L;Y7S*[[7GK3/@*6SQP&;1<:OX<*]W[S;TEM<TB[VL:,T>:X-;U+/[YP
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M8CM>8FS(/9/LS)\ T8N+>BYP0/S8CINPYEX,D@L' MR/F(+F!Q^8"_[QD5
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M$OZMI((M@D?)G!=Q^\T/= RBE"ITS. ;O.X'/"#+?B@^@G?W(F)!27;SAD8
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M"CX/\1"'W%+2.%,:VUZU6F9W-R:\(?_/G1KY?ZW>2DJA;LG_86J:;<@$F>&
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M&_*!6JN[#:M^;F5@:6CEY55,:I<5DPJPE&-73"I4W^GO=.T=>[XZHD[TB=Z
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M!-=6$C,'"T_1KE%*=];HVQ.SZ%BM!69A5?>I?Z_>V EP#K"^M]3$J\!BGJ2
M6]5--/#.\[,/TKN+PS[2!]'9D)G4MV8F:Y#T%!G+QY@EI,GS!)(L@6B>2O>9
MVC^3! /E%L6.]Q&2APR;\X@\9J=@_)#'6WW]C51LM:(WL^?*('&FE*.57"?<
MKV*34W@N^(I<^T\V3V'5D,'Z70R0IO(#=-<Q'G.2(K#6)_T<A[O,\'*&?_UE
MO=9KU>N_;#:]2"]]@WG=[YJ-S(+>X#>'+Y'&$PONKKX"X7'9LOC?8[49SE_L
M/W_O?;N[ONO=7?]Q107=X(LO\N^/U[>77[[?_GZ#Q=X^?/_]SOC:N_G'U9UQ
M<WW[CQ-D!*AAV'I@<HE;7$B#P E_5HR0,0-_J57?7T=LR@^QW3.-?^KA,!10
M\(4K__[(XZ847[#[V >'\U/C!@:EX:SWJT*J?!J*JQ: *%OG092-$R'*R^_?
M[FZ^?^$5%G_<?+^\^H@T>((4UP,E*PFUHJJ6Q&.3I*(PGF'^3BBC-BH7"Y.?
M'.RCMBJ(!8NTQY1=D.ZMQ8P?J@O;U2,;Q$28WS&A5+2+2C_S2>7)B6>2=M&R
MH;:GQ3J&#"4MC:,RZ)8M<:BX@50?M6S@(6<2250GDV1C?" M5O0)!",A@6CE
M.;9)#?$P?JM%BW;8P /36X^?9"CUJ\(D U,=(U"C1#NT)*V%:W)29\_"B2Q&
M3V08HY5 .:=)!F:B<%U(F7+YZ4;( ]%DD5J_8DJ9EK[U9PR4P$07<LK>%5F@
MJ"T2S%$/Q&0,5-CMT/?L/OSD.C_16J"L@LSSE=SUXVI2QJ.<>&D.6-I&Y8G5
ML<AU2W(;9=HC9@(! ))<1]*=>1X>=81[8)C1$VHO)%W9*1,0@SL/QM7-#R.<
M@RT\3:?C$6C\(3\XSDI<5ZV* (&_SI.L%^VP0JYP.[PK*#XADVAYYS!UBB(G
MF7(W C\>4Y\[,N&2'4MCFZ>#.EH6AGB'<Q:/<C?!;H9/8$J3/<VI?ET:-V42
M(BPX'!2ERV1#+<MK<:,$%IG*C-F>$5A%8WC=HWTC&M#!BL;&RFQ"E8BL&&<J
M,KH<T5TV?2IJ-7+M"^<@F!@3#1;#2)&,9BM1S0F>@9VDSR8)"9QG\ORC<"#=
M$8RWU\P6+ZI),VB!F\L=+]>T7EZXJ+L\7+2-XMC]I0PRO9P@TT$1-U]U_M&[
MN1,IH]=2P:>*%L;WN[]=W1C7WSY]O_D*YNWW;SN;0XW:>9A#UHF80U^N/O>^
M<#OHZN/UM\_+#:&"Z)&?J"-W4M$2FT('))3X!:G4)4"Z)84R#EL2&U;;.!;P
M\_?R1=U'W/.Z5JZBHGJ[#T0S5H0F;^(L%1QGJJEHH2PM&O(W05>2F>K_+(!'
MI=$\$Q;2,XO%*XQE+ U=EL:GWN7=]YO"\X^<.QOJUI^F'><9<*B@&R-[0,VL
MM<#$%O<X<KH(/P/&-ZT\C <(#=X T -8\3O>%GF>*7'=/JV*V1VSU6T^>PWJ
M3M>TJIL-FUL[I[5KB>/(GZW1MO?%9*J*R;1, _]7&$9#*[OZK[]=?[B^R_"2
M54V3:BN:)FU19GB7/C7/?NB[V34;E9S9S,9*,0[V.''Z3O3^Z L4EM<DBF;O
MWKY]>'@P89GFV+]_VPL&$^>>A6_9$'3!MT,[LM]:[6ZMVFB\A>5:5K=NU9JU
M6K79J38;;X>U5K->;0S98\TR)]'TE]]JII5CF:U'DZ+1^0)$K1I*/'2<V3P=
MHH>WBKD[?RARS] ^_<3Z00SBP:BUI><1TR+X-1]0!C\X_@#>AG]<?^P,0N.+
MN("$CZ0+RH\P;([#7G'$,0"X,LI^0QY:]!611.R\^8=X'";31TF"%+=7E_2X
M6E]'KH^7.P \F2&JP!@HUT'^]N=);03S/TL.4G*09^ @_"-P$/RC^I8]_F^M
M]G@?!>$CZG=6K6X]@GKW4W"3VOZ9R5$J:SHA51I088.Y,0:BM#W2AXD>PS#&
MFAIXF8W_@B4, ,AQX/#:-HO<H2:9@U*25;I4QO&<5S1_0SZ05J]W;+Y8<H%S
MX@) PW7+4D1<J];K0AN ?_>J#ARW(6$JR .$NBK K9=>N66#Y-)_O5J3X?A;
M.^C;'@O??']TV=SH#8A' *?4KO&78K<D.$YPM24$MU>1652"6\P6*0FN)+AG
M);A\>GN1U):?O[43-7:KK1=*C<<X4ZMJF=??;E/@/'U,O28WNO%?'VZ^&-=T
M<V7 C(_^($;O3(DZSX<ZMY=_.V/4N;,??<^?SH&]4?DE[-HXF+"I7:+0\Z'0
M9>_+RT*A2W'7$#]_<;R?>->O1*CG0ZB/5Y]> D)]9".JI5IBT5ZPZ$OOPTO
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MUXT'M-;))ENFU0%K]3&TSN'Q%@ZS%;GHJ[D\#2$KOO99BARU#IHNMMJR;W/
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MPQX1<M9(N':Q^SB=S28A>1$C BM8(K$<(@-);A\19506/NA.^F 7ZL;D5C6
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MQ9D4%&\%EZ(HO1H774/.&'S4Y@BYVJ9H7T&T/=V^@1Y44?&B&.+Z2JW,;#U
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MWDS&^2+-7D^6D;///@^G ^&BD5X[$-8(4,@R>!WHB_5%1[3,FXTN&.D%U]A
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M0!J-S#FNLW/'I+TUB4&ME;>-F!K$?2[R');#4M%X[<A=%+Q6B3"1[!SG'93
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M)N013,ANB=J@7',[09":"@ZO+TZJ%G7+P0/&&$"EP, 9(X"Y[%+(BJ7RU/;
M.X/\-NL.,NOV(UN#@M#-AWHQP>GCJTNR+$@C,LBB/2CG-41%KK'1*'()C"MG
MG^:4VVC\WV;C(6=C]Q3ML CU :YCA.'!2/)R?1:@4!6(3!>PMN1B$E/2M G@
M/-"]WU'JXG$^ZF2PA&@ 9<;*1P>Q]G!U/&5KLBGER5DIN]X8[:#!SH)SN0^2
M.1% *DMVL2"[V 5CP;,<4TE&)-'(@?L*RT#N%29R$)4?N@SD_5G"'DT6W#CP
MF JM'326Z- "E\:@)]E&'YN0]L0J5&S%A <K5&RCD:>2V[_)F+Y5J-@HZG\/
MLO21Y+^+II\*B[-4RCM%#KJN%:MU+2WD:AZZ%\[P:((6\BMG[U85*HZ.O-LH
MN %I[PM6?_ONCU7"-/=.9JLA6T463S)D\:2D(#-7K'.\,-.F$<F#L([PO**Y
MYL>MU+8V2+C+#)@WB[D:1GGN=+T9$WJ<#2<+PQM']([9JS"I_20^X1[)+3N]
M9_^\E?V'=RLEQ2325Z:184+E5?:<T?_SP$SQ/C$WV.F-^ZT4/U798%X^O'+Y
MI^&T.A$7$[SRD0Q/)7O)P7%O:\L:6FEYL#7-6$L>@RNYS7ZU$;R]JC+>?<-T
M<: S+K],QO_"T?RC@4F<)T>S#>M]E0I2@S.TUV0K?6&YB"C,8SS>XGW]+X;=
M$^%&&<8&8NZZ/N<28EQ /*]X:#T>?@RSJP\7>\!T.$H7DPE]5TA&X>P+ALF
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M%YJ;(CPYOC1139,$@LGPT[P"TF7EWNH7KSZ<K]H#$^*\]!LHY6I1UR0@TNX
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M;!/$\E1* 39BQC9R[[T4(">;2&E"4]M)T@9J##A1')2DA!4L<&X;GK(]B5*
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ME!XJ8#B0%QNH??#=W<-GA:7'>"Y*5MP9'RA"IX!=!5_U59&#U9Q9R7+AS5H
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M/4".K6YJ2Y+NH?5!SAKW8.@>Z._AZ^HY<!>X3>51/0$?1T#5C #=B3:8]TZ
M="%$KP--/E0JUX1T6366@9%"<6TIBY!MWNJ?!-F>$&V=*M?Z.*T!Q_X(5_5>
M<Z5KB&@1N0#+#8(RG .!2V!M$"6Z>A3?IDKS#S#&UQ<T==IL*(MOO2<;4G5
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M>SC_)&/7]\!;AH7S,IM_I3\\&%!TG'G:'4&D^G02;880-(5&(9=BE2BNT7W
MX$/YB6C;V,\-Y!</.F.L+'5[FS_-[R8A3B[)5[BX+:V6WT\_8+J>SVG[>!T6
MDYO#J_O!",NCRK4?I@RA5L*OSW4D@M$^QMH)1;DV!3L&'<9Y$G9L_[:0<JR&
ML'A@L-?U74'"CU\0K][5'T&>>OW]_E]8%J(-:5ED\/7W_\!<E>O_P,7D\_0F
M[%F>O_*LH@PF5%5*+7KA L3BR.2>!1&EU24W.L1N-J:QWH&W(^^)^/M4+F4>
MCV5YRF:]8B7:!)Z"'5 ,#<3L/5BM7?0T4S&UD=]NQG.LA^2G0I;9X$YK$*\^
M1G5[(M<%5],+EVW(CG.S,H3WGB3$ :8?DQJ*U1J\L8 .OI[F1PV>!P>R<.VT
MM=F$-C*3<2GQQ/W'F(SH8_$&3%@!POQJ<8OQ/M=9O?;+0A1!:Z'3L7983(Z6
MQE#(#,;SHF)*LDT-K@[@QH_CA_'DK*T;&IS8_3Z;YCN4MY!"TE'SR$%;66A&
M9 1G(X,8DG?2FZRPS2WJ!C!GPH1#S=QDC=AQ#'(747W FWJ2BR^3;\OE4OG,
M?/$:+*($I:,'KQ,'7H2WWF$2C8I<[X?W):8=V^D-CKHVP%K-R0[ Q@AZ'T,[
M3M0[AG\WQT #.:==6+P!H+-.)*84,'2T AN5P2E>@$>AA30916QS5SPR:YX(
MC$^*-'U\TD)QMEJW;Q'>[M4"30ZT)X/ G$!EG8"V:$&[-D<LJ+67;2I%;L9S
MM*CH4(=M.R;<W]H-8N)5C_@U4$9Q[KBHGI*U$ZL!;TJ!@,7Q@E;[W*8DPT8X
MY\* PVW=8!'X':_>3BE>6Y9*_Q%9DH(99SP81Y&[LDF 9PQ!2*YD]BR:U$8?
MN!W3N5!A(*MOC3]'UPC^'N;SY;9Z0$&B_3XTDFYP]P#7%(3.%QNUM,8)IZQU
M7F%,7B4B"8N"N6X*PD>?'"H)OK_WPI23#AS!QKK[H.?@E: PQQGK X_1K-<!
M'#S#?3>4;O"/^2PAYL6O-(<_AGJ9_+'>$B]OCM]_6\K'II]?)?KF\J\N3%9"
M*1]!UH,.95@]C1(99+#6E.AX\&W&WA/H,2_Z]V/*(Q%T0\\TB(E6TL0WLZ]Q
M<G,:L46,N-(F?%]OZG=A=(@VTQ"L6YI+6%K%4]WD=4Y).&T::4P& /_\"3>V
M!YL>62Z5,+_/*MIP>=/?[T+RQ+T@X^AH:BM1RR$HDR');+P,Z(1IDZ/MA/7\
MB3.<U1L<#;Z;33_7QL/_P'AUD;,0VFH)DJ6J6"&BNA(99)EX3*EH6B2;,. A
MBN?O\+UMVD X]C _Q-69U*?9:PK54WV2-"D3S/\UN?HRF7[Z"R__Q-]H3?NR
MN B&D@(3%6B9(RAM&$0F:/?T40;G@_*^S5ZS)^#GSYHQ/-6@?M"]&6YN5XRG
M/<QG <EY"ZI(A/K8"8(VA7'&7?%M+C_7@(RO 1QZM^AOSU.1ZVWJ<KT\\C8F
M24P6@1=>7SWJ C'EJI#DDFSE:2QM-!/;$!WK>O,@+S_1_'LO:S>(-G?T.N^"
MK.FUXW9LQ[EW',:''8AQ@ /&I0CGE">AH'D09>UQX62]P^"U.X+/A(S%TN8D
M96QJ/'&Y.#8S^MA]!$;\8[)8=E_]$*YP=;GAC-,B2,BV=C_Q] LES@6<=5R+
MR)A1;=283V,;/PH=RI-/$.1 -S0X4-MTZ5Z/NI=S0Z"@&*LV=#!F6=F71JV<
M@409M4[2H;:MCZ ?HSJ'6&,PJS<XRMBL [N=#%VP-8TX=J$[':W3?K[<2I*!
M'-'T*'0#1M0Y%%X[>ILZ0ZP1$.J[ZA)*09HE)MM6TNZQ2;*'M*D]1_K8?USY
M0M9)".4UU$H0M'9J#U$&!=HBUUXX:W4;]>XIR1>&\UUW!4,?PS>(-MY.KW!.
MP&K\\_&O\.T65<'D=!$*I%!5:!4S1.\$:%^*18_%BC8+Q68\9T2% 0S>8&5X
M.TVSKWA7X6"E05^NAIJ^CDY4'7G*]: _@8]!@RPHI'$Y%=7F,>H.4.<0<@YE
M\P:7*UN@W=*_"[BF(>=.>,>).0=S9C>2'.")\5:/56"L422A#,14Z_C4UVQ.
M<K?L[)I2U#77/A>:/!%U'H<E?1S0@!WOK[[@_)>_OY&-5D<L0900C/!@3*S5
MR'2"J).%J"SCTH@*MPDE'F,9/[08T%FS02W=Y# K7MTG6#?/J@LJXYT#8S,A
M<C*#BT9"8%$6$SWMF6U\_QC+.401!UJXR<7Y0T0/2L-VP=7XJ&HSLF,=4QWF
MN9U$.-#L30ZFMN!#$;@/UH'4KK+?\*KS"."<YR9GADRWB0_&I<.3!U+CL*&/
MM0=DP;)[PBMRA/KE>C[[B-/);/[[[ I7Q9XUDYHI+T&4Y$"QZ('60@XF%.DY
MCUF[M;NO+5U+MG_C&(<(0SAA-KP%!]SI[V"YS;!*Q&Q$Y."L5;7;D@!?4@!)
M#G L*90Y=7;LYF^<BV,'L&"+&<LVPTI><(&2%E:6)466,4$M_$:K$[KDI+$R
M//F(Z8EOG(MC![#@@->*=[#T9E@A*,F4XA3!Z B*?B7F44*2%-'0))YPO2C4
M#L=N_L:Y.'8 "PYX>G<'2VR&)8S(S,MZCU45^?0K^%@,Y/I.R"@CW7J3W1V.
MW?R-<W'L !8<,+/:NO5S)N0M-.64UT(4L)0L@O)5+6V% >,<]S$5$Y+<.X"Z
M_\ZY.'@@2SYV\M[-1>^@V<W<DQ3%>8L24-="O=HX<%P'B$0Z[:WF,NC.#M[\
MC7-Q[@ 6?.S8O1M_KF#)+8M*U,A2B05$1%%/?PR$2+N%3*:(Q+)STG9U[)9O
MG(ECA[#@8\<>UIIS&=_]>CE;/LNME[H5XD-P:%/Q%*43Z]*RP'8$%R)M'%9[
M[45A<;V6T*XX><>7SL3)PUGSL:O=0:[^/[_\7E^_O9N%Z2K0TRYRI-3,!JWK
M.#5M%4I#"L+YXG,6S'7R[:,??0[./,Q>C[WG#WZKOJ',WLW=FS2L)%L@"V=
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M!-$6&7WM6F1J!VPEA /'688D2_"%4PK2J-!A!W _,]^&]MUC>KE#Z?4$.L3
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M^&WLP:'/5/? ^T?XOMS=+M FE(IY0%2EUBY1$(T.E*EES9UT/*Z_]-NRMAT
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M6P>"JP"\Q((<112^[/"2BN/A<[K<-E YO:#M86J%,R%O!AU$.M91:?!%9]I
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M.U8I::6R!)%U 65$@9C(^$:K/(98!)E*7?3O25A';T:V(Z5#*Z('F&XB)@-
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MLG!'V&R=]JWB^O](8XR,M?F.=,440MRGO]P0=)-K<R_K6_&FO%Y>TMNWJ.T
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M'M11YEB.V9;$ QL#,[@'^QS17H[9UL"UX]QD"2BC<^IU D\Z*_0M"8(K*>1
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MY))G(EW>_^N?_G+W#N(__?=_^T__Z;_]7Q#^KU>?WX,W&5\]RF4)7N>2EE*
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MSX\"\"Q>^M/M=?"3.A==V.]KW8@[ [7 H))8_Z5E=N75,TC;LN45P(W%@5W
MZD!J[4CT3%5G&AN9@-I5/J:5"]>[D860Z;P)_'I^^YT_&+^;#WH@S"/IZR5K
MI&"(:0@1QA02&GHP"F,>)9PP))B-+7:N@:E95FL9P5I(8*2TXX&S(+:__WU
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MZ+$QKC^JO=Q1M3(.'@R=>LO"YV/H/AA\*VK"\#OXF0S=#2.YHPS3'6[>*]=
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M;^E('O*>+M[J)Y?/)O'91_7:&#4R?Z+:>&D2[YFTN8%>5$,J600182'$7I3
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MC:0>*@'4VN_Y#%;Z@U(#L*T3L,%@0E4"NG;<-*H'.$O_QZ@JT+53>JLVT%F
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M9^< E^ZPW',?!N2AM]G74E=YV#=RZ[^U7;PM$F)2+@Y9WM$!M$&B#FW:?Y'
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M@=T-F >Y$/4A%ETXNL1W[A<[0AD#[:'-BD9J4(D] QO!P:[D8"/Z;'=O;)"
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M\G4=#3GWN91AG% 8*.%!Q$T*510+2 5.$AZ32' G%QB+-J?&?(W(0-8R[Q;
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MD_;,) 38>G0##MVINVK?HUH!QF%"%T:-@^$Z/(5>;]KT5#L8G"<I>;BG!PH
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M E&<QI#E,H489QE-DI00Y37Y.]/.W)BJU1G<VADLG'\.5S<B&@"MD5DG!*A
M(<:S,(R@P7C<UC/(+YYU^+3RXOG+_4NFOEZNB_7C)W57V$<MUU;)<<$5QYG6
M)I 11$&DX\P$,BB"6&K*L8Q5PK5KZ=13#<R-!!H;P<[(6FC4O93J21#[!_X0
MT(P\XCU1\2JQVN=Z<*G5DP^=K.1JGTO[I5=[KPO[IF^SV9J=QM\4LUGS\L/R
MD[+JB,7R[B6KBNKWY8K; Y%VK_'M\F&SMIN52U'<%W7D\?*QOOW5/:NJ5E(X
MC^(4V^Q7E2-JDV$CFR4O(6(H3S%C6B+I$Q2,9>C<"*6V#]0&!BH]C]:E;O'(
M'#IJ[-U(GS[RCF3&!G#04&@T8R>-I<:&_&DP-GI[81^#1MK_@WYE)X]EH:JW
MR__Z6HBOS7>G.5*AJD6215G.5 2%B@E$*%>09H+ B-)$Y8D2S._8DUNS<R/J
M7;6(K=V@6(*_K.6@#8 ZV_T(W+$;W.AX>'!')M=!</4F73^8!J50QZ8G)40_
M.)[2F^?=@^4C?"Q7;ZR:YVM6+FLI,U5^MF7!?BGN-VLE%SE+,,OLVCJ2D9F<
MI@+2F$<P12C"&54QRKV(R]^$N9%8:Q9X84;8II)6LJ2II'9>!6NHSG"CKW$A
M'IG*3B4XU!+&H'8 =!Y803)0^V!7XVLO1DU]<$1P[(2(2V8\=YJ$(TP.R1.N
M3PH\]F$?90)&)6N1QV551X>W96G>Q7JQKWKYN+OF(WNL%P#M2:H/#_;*RMBF
M55'7@G^[;!28_DL5=U]M)=_OAJSOU.L?JA1%I3Z6A5"+E# 2T2B%9AJ/#(_R
M'!*:(A@1DK"89PFF7@O^4SLP-Q:N?8/<.@?V$0#[$ #^"/8O;&$ -0XWH$7B
M!NQA8>.F!HT;T.$!6D! APBH(?$\<C+U&^?VL9CS>S3RIV;.KY#_V99GZL=A
M#[],[<2TIV.>J8N.CL\\EQU7UCM\_<,:JUK1FH5&N4+4O$=8<EN^.=*0I8A
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M^_D.DUX&I/=XJ</MH2+@JW+=B8Y9L9]Z.5NB%&'!#0WE5JY;Y0(2F<8PTYG
M6.<4IUX:@B=;F5OX51NYKW_7Z'X%'#D_#:H;WUP-U<CL$H12@&YT#PH#*SR?
M:FEB+>8>9X]5D_LN#HU.:N7,Y=WORV+]49DWQ02I=^J#?L.*\@]VOU%OEZ]_
M"%55'_0K5I:/EI&^V>S?!<<QCTVX!S,FJ6$*G4":L\@01Q9G$<V1$E[52L)-
MF1N=;#T!UI4;L'.FEO(U[H#:'RN[WGA4IW&U/H'&*=_()[@?78.A*7IG]/AH
MS(X)B)NNQ73@4"K8G(FCJVMA.PZXKGYB:+KPKG)O)V8NXTS80[-08H(;55;"
M<0JQE)AJ005+Z>*[*OG*/47XJ!6?0;G?UIB)"%LC?5-_CS%TX[0K<1F9K/9+
MC8^A]=[C_<#YN\?M3)RQ>];1XQS=\Y<&+'#;5*[O[-ZPR<>R$&J?6<POEJ)X
M8/<-CWQ24JEO=09FCA55*M(P-\/>'@ZED* $P23&C"@>TXP[26H$6S"W<&KG
M W@X^&"7M<DVW](C8@KO&(<5];'A'IER]I"N[=\/D#YHL'6AC83 SHFQL?=8
MK1^[#Z;2.]I!_U#WA=IU#EN#O[X6XNO36@</VPYJ1@0HJG:0U$=RS9]7)5BO
M  /5@Q*%+LS8D6RMSJMN^>T37 -][RY"T(.GVV.XQN^#'8BK'N2?#VSB7O.Z
M?K7YB7>EJBN6O+(/5^4#*]>/>VHAFFI,,6<PR7%B)ON1%<&-$BB($BI#N0E*
MM6N:L'.K<_L0[5L9(MGB!WG_YV8T($?^Q 1@Z)5S[(W)U:G([BU.EJ'L#<)^
MXK+_S6%SW[>&V)KZ$$VQY5_+556967:CW/+K:B7_*N[O%S2*,AR3!.8L%28<
M1AB2A*1019P96"B*$J_ZYF[->E'/!(7/=U:W5<]OP)TU_ :HSG1PU]KN-WUV
M[ :W&?7PX(Y,1WNX=M74:YO!BZW5H#/[I^'FWGXX#3H==VQZTAFZ'QQ/)^V>
M=X<EJB79<0H12YG0AIT@T[9>NR0"$DTYY"E)5*0$RJCT250[T<;<0B!KY!6)
M:J=0=)A67X_-R#1R!$M@HMHI?/P2U:[$:;)$-=?7R#M1K0> 2XEJIVZ=-%&M
MQ_:GB6I]EP96C&OJ[%9?5K?"3$-+]1LK_Z;6=HKY68FV#.""<RYTK"6D&5$F
M',LXI'&>PCA..<\C'%&2^J6I.;7K] Y/FJ3VL0V2[4+DMZW%H-J:[%DNS@E]
MMRAL.$0G4CYO[;5+4ZW%8&<R^'P94O_*<3X0#5L[SJGE::O'^8!Q5#_.Z^8P
M:OI-L6I3UE/1M\N'S;HKE_E)?5?+C3(!WU_KKY_,H.].$#!)=29R*)%*(+)*
MFTSA%")!<JV3B,3"ZVBK9_MS"]KVS >U_5:\L5LX;GT C1/ >N''7+Z=X\9A
M(T(^,IOYHCU@,8,KP1N4YWQMF)3Q @%ZRGVACPE=,.M.AKXQ#KUJ=(W-#'<G
M;-P<#FVN^\)^*#,+7I?,M%$L6?E8E\5[;P R=QJP3$MWG<K((DTP1@F34 J4
M0T22%#(L-50F3,::,$PH]UME&\W6N2W-O6;ETIA7=>>_B^;,^-KZY+L4-UX'
M<TYC@C2#B@MN.UA"AJCY0NI,"2$89VZ'ZN;6P5,H/S0NM2<JEJLE7&U_HWX\
MJ&7E^<4<LY]=UVEGT7NC+^[NJ3< ^Q4 .U?!SM=NY+;7U^Y:F>M]][8B7T,N
M H_>"0.O'(]G[\3+S:,#?[Q&/7Z385'%7HJKB6"J=R9TN4^ZTK<DR13+,CMQ
M(A!%.8<D11'4:9+$-$\5IEZ'@7K:FAOIU[:!Q(_8^[!T(^:!$!J96'>9\C?-
M%,>6 V@ &V$VXX#)H#S7U]ZD/.7@^%.><;DEL #4MNIV)T7S8;G[W7NU7J@D
MC2+-%$Q%;-A"HM2P19S#6(E$1VF*A5^(>;'%N7'&SKC#FO*K)=C_D['<L\33
M1>C=R&500$>FF &P]"_BY(K/L.6:+K8Z;6$F5Q".2C YWQA&0/;$XP=]<#:Z
MS923.5<*(PU)GA-;>I)!GFD-TSS*(X4RJ5+D0SQG6YH;X=0'<%<:')[[#ZLC
M=QY>-W(9!+212240+V\BN8C%H 1ROK5)B>.BTT\)X_(-@<(&ZLZNR&X/]6U/
MA6$9\3P3&F819A!Q12#CJ0E0LBS1G#'*I5_9M3,-S8TF6CO![OBKPWDR/VC=
M.&((P$:FB""L_$4.+@ QK,[!N<:FE3JXX/*1VL&EZP.7.XIEL5;O3$0BG^0-
M_EXIO;E_5VBU2.(L%2@6,.$ZAB@3]@A>E$'.A$B(3!71N=>ZAT.C<R.-QF9X
M;XT&Q7'ZL:'MXENM+;2I?0#WQHD;>W+^4;'2<^?#J5<<5U &QGKLI90&YMI>
M\#0;^08T-@-K]( +*AX0#;NRXM+PM$LL'E <K;7XW.O'5G5]Q?)Q\>730N=:
M)7F>0"S2Q,JT9]#$*01&F+,L2G&28*=5E=TCY\8T7W[_]#]?_V\WPM@#II\.
MPMP=>_[1[ZGS0#YV[L0PK93X^6[U_=_;BYM1VOZC'J#UT-Q[U"0#[]CT;EB=
M^,O5)4/;K?F/JOS\E97J):L*<;N4OQ3W&_/EJ@O^?5$_UB^-97\S7WV641TS
MR$3$(4HB\Y-*,YAI$5.$8B*EUU<_T(ZY#<_:V'KKNS47;#,>'E0)/K0[5*#V
M#-RNUV7!-TWFYGH%?GLT#P/O?_[C_!GC03O1<2(R?M>,/4_9KTC:]8=QHNF&
M&W#<:TUU4F"= ;4WXQ0J#<%SK,JE7K8\5RG3$,!Z:IL&/2Z,:+NC577QJONF
M$,%2=HGQ;95H.W63_[UI:ZPN4IF@+&(<IE&DFLJ"+*8)S#(J2&3^IQ/E0[(!
M-LR-8-^L2E7<+4&M[+D4CV"]\\6/-$,ZQ(TP1X9Y9++LK+\!>_;7Y+@]Q;%S
M >SY,!Q#7@'@H.P88L>DS'@%4$]9\9I'A9P2-0];E^9)'\N54,H>/NW.\&54
M42XR N.4QA#Q)(5<( QQBG..$D4T8>XG1<^V,S=FVUH*]DSU.1%Y'M%^VAH0
MIY&IZ21$0:='SV/E<X)T$,PF.D6ZP^[!X?7R/$EZ$8C^TZ3G;Y_P1.E%'PY/
ME5Z^W(\5I2H6[1FPQSCA7XKUO5IDL=1IE$<02T4ATE)#CIB <:18',E((>RT
M67_JX7/CO]HH.T.+DQ?\I^X@XZ/;J#Z)7C_M78O)V,M?GG XC]@^OWM6QLQM
M=>#T=V1_A,V/]1@^^<!)!FZ?*]UH[;TF,+NOJ!Y6%;O_M5QM'MXN6^T,\UO1
MI"HKN<U4_EBJ!U;8BL1U\;I&<^-5/7=9+U3&)<XUAASS#*(XUI D7,(\RA4B
M6* 8>4WO!K)K;L30VMH='ZGJN<BJ+D#9S +7[3Z;9Z+@0+WH-B=\AKX9F: Z
MCT#M4ETOI=4 VO=J=W+D!G0=:?NO*2#:R0BUW@V8G3@LW,/F, YDV[29CL,"
M>I0/.?#C_>4=FTKROZGUUY5\N_RNJK52^YJ.#,LTY@Q2'FF(:"(@S9,,IH1H
MG9G9*DZHJZ9C?U-SH]_&0CM#N0G5<;R ;3^##HO8R*3H#Y:78*,;#E>K-%YH
M9C)I1C=W]_48'>^X5O3GMV*YL@%EO6OP=75OGE$M9)K@F* $VN/#9K)F,.6)
M2&&:TXAP)80T%-'J[7QQC^KZ6W5Z]P^U?KY,$;/MJ=2<.1L:K/ES$GRW*&P
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M>9?W&/-8,8U@3J2M[V2/BS!L2P?21,<IQCB.G:F_MZFY$?UU-48<H'5@\\$
M&YF[S]4Y"*'J?M!\M&&' F\J1=@S(/X\E/JK"Q[]FJ^]3YA0Z=7%DT-]5Z<[
MPM8%_DL5=U_72MY^-T^]4^\W]ID?=*T:7GW8K*NUH6X;N_.J/ORW2'@<:4E,
M$"TSPZE1I""G&8-"<!KGN8JU;X%I7Q-\WOYIBK)V'@#6N "JVG:PVAG_'W[+
M!-[=XK98,";4([/T%N/6=M 87RMB-&COV7\#?BGN-_;J/SM7!MQ\#T5QT&4$
M;R,F74P(A>CIDD+P<P(SXXOJ856Q^U]+,QW>%DZT]:]K"MXHV>IQK)9VI6,A
M::I$FE'(1!)!1 2"7$4$*ITR*F2NE?8KC^S7_MRBSM\?S)M@(H"'MC9)M>'_
MK<3:GO\4JERS8NE_K#:T:]P(<43 1^;#SG)0F[Y?YG/?>K U_Z9><!TP5SX,
MN6&3Y#UMF#8[/@R@H[3XP,=,7*"K_K\_5&4#U8]U:;YXD41($6DK*PO&(<((
M0ZJQA)3%:902(F+E-/T>P[BY4>?G]4K\#:P>ZHDGJVLZ?6\,;BL=WMC]IT?%
M2D_>'+1'W4CUN?II[#7>:ZMTW;3%NEH/P<?^$I;3E>OJP7T>A;M.&?C/4<*K
M!]K!BGGUM1&PIOH'*^OD^E,K6$)D.LIH!+$T_X=BED#*<0X9BY,D3IE.M%.9
METL-S8V>.U,/%[<\%@;[0'582QT(JI$9\C1*(>NH?7!YK*(.!-M$:ZBA\/FM
MI#I@TKN.VG?_=*NH#EX<K*&Z7!_ E;<&G&AOOZM]16/%(LI5#/-421/^IH8F
ME5)09T(@$9-(IDY%:GO:F!M#6B,/]F$]1OL9%!UX\7IL1J;$(UA"V/ ,/AY$
M>#U.DVWGN[Y&?JS7#T OX9VY=3JNZ[?]@.8N7!IZ^K%+>+6IK:__OJE+@:V_
MKN1.GZ1:X(ADN<H%3.P)$I1%F9GM:[M/A+E.:(X$H0%GDYP:=WJ1GZ',JQ6_
MJU/B56TW^%8;;F;R6\M]3TVZ](3;+'TX8*<Z56GM!2^LQ3\UJ#9&@\;J/?6B
M 9-%O5 :^."E2\L3'\3T ./X8*;/S6%,]?J'J&NA?BF95/+-9BF[;V6:94@(
MD4.5)+4$FH9<Y,20%>69%#'*M5<QA[,MS2TNZPP%Z]I2H*VI?JQS'E4WIAD$
MJY'990M38R2HK1SAX/9%+ ;ED/.M3<H;%YU^RA67;PC<WA!?E=S4%1;L2AI_
MNMCVR?!060@3'M3K\;=+^>0WOR\+JS=1Y[$_UH+77]2/]4OC[-\6,J>1%K&&
M)@B*(=(YA83(Q%!,$BE!XC2B7M7GQC1V;BSU?E5_ \S V_D FCT1*R-S]$OK
M6K.:7G5G1#R++8_Z*CCND\RD@R?<-]GNA^Q6M6\\NOQFV]EM\0-@'0:UQP.2
M]!0=,^S&RI@&3[O1,@'T1QLO4[09L+C8[.74*H\VH0BGV'Q;$-)F<HTQ9)@B
MF*"<:)DRQ!+W!<7=<^?V&6@L\Y+/?(J4PZ)AF/\CL^0 KGNL!X9!,-$:H!L4
M?NM_QP[WKOGM73[=.M^QC0=K>R?^'!8%U^RU$>M-62SO7AG*NU/5(I:8B8AA
M2&2J(.):04JB#,:Y3A.A<\;\4AE/-3(WNFG-\@L<3Z+G%O!=B\G(%'1@'K@$
MCG=4U>?]H-'0R88FC6+Z7'T:??1>&UCBKS !B7I7?+?'K]>FBXN=5N*>9$4K
MD?:_%2OK6NT+Q1-%49+ &./$<$ J(->Q@AG2YC=:J"2+_<YV!%KB,RBF.>)A
M7K7,LZ!>8">X4<D$P([,-HT'L'8!['QHU&%O:NW$>O:W[\X-L)Z VI4!R]Y=
MA^6P->T";9FV8-UU@!U5H[OR<8$DN2I5<;=\M=HLU^5CNZ =D10I9AA0XHR;
M>986D"*2PTA9[6X3"W'DM4UPJI&Y14&MC5:I"]QNUE]7I?=BVDDL'8GL2H3&
M9JE3X(RP+] 'P[ $<ZJA:=FCQ]4C:NB[-FS<ORO6Q5VWKJ/*[^K5IBS-I':1
M9BR-,-$PXBJ%B& S%T(J@SHG2<+S-%9<^HS]<PW-;?R_4W=6?G\IP4.YTJJR
MHF7V%T*4&W9?V8,'W=&B^ZU+VS_[$<59\-W(8@A(Q]Y(K-;%-YM@ G;&;F7P
M'V] :_%PS'$)DT'9XVQCDS+()9>?LLC%Z\.8Y%8(RTO51_98IY8V#]T>R2:1
MB'.<<"AE)B%*)8-$V_IK"F')*$E3OY2#_N;FQBJ=M: U=_OFNQS)#H';C4&&
M W%D'KD*/V\2<8-E4"JYT.2DA.+F_E-:<;SKVB)M]8;2(L%)BE*$8)I* I&-
M4RC".<0DQJE,220%#:N^=E"W>R[TL5?T_E*9>R?XW-CA"E!&I@,//*XH>W;@
M]4CUS)HVGJE0V6&-^K,5R*XI92]5L?BEW2AKMFQ>+^4O)B)<R(1S$L44QJFM
M62\)A51&"N8L4GDF,JNWZS*$S[8PNT'<&MF>= 7&3&#M=!O*YX'L'\R#P#/V
M</9%QGE07_3^Q+"NE/CY;O7]W\V]]8C^.[(_PN;'>AB??^HD _FB4]U0OGQA
MV-?X]^6F,K/=#^7;I2[5WS?F\6_7ZMLOJV^L6"XT1W&<)!@RP6QE5&$&=I(E
MD$9*1A'-18R5S[>YM[6Y#?+66 ,GV)D+K+TW]G<O5^NOX,_&=,]O>#_H;E_T
MP: <F1 &0='[R^^$SJ!Q0'^+DT8%3LX_C1'<;@HCF8_E2B@EZ_,1G]F]NEW*
M5ZO[>R7LRL4'_4D)9>(3$YE4"T83J?,X@8F6*42,&<;)N( ZQ2Q.,JX$]<K6
M<&]Z;O336=Z<"*J,[?52IMA:;Q7BRIW]?A3DT25N?#0.T".3TR'&GSN,7QU@
M_,D!8V^"\H=K4+;R:'Y2ZO*'Y2F/!3S!C]2J<FV%2ZO5?2'M<OCKY;J6_F^_
MWK&T]>(5A6F*B95F)H; 5 R3F'&.3>#$8Z?EC/YFYD96^Y:"SE3/Z.@"L/TT
M-!Q<(U-.(%+.!.,&1!^9F"?L$8GYUU,2N=#$)(3AYF9'#HY73RPM]Z$61=M7
M^_QDF.K-JK1_7&".LUC("&9$<(C2'$.J(@UCID0<BTCI'$\B,M=KYMR(:  M
ML];?FWW=7?"G]1FT3GM.]T9Z0=SBLN?O]I$)]9E[?#HQ.Z<.F8>L7;^I_QP"
M=TYP#R9UY]9:4"&1;P_WZL>O_\L$PB^+555\*^Y9N54/8)0H2A",&#/1JDPQ
M9!%3=H$OH3)/(Z*<IMN7FYK;AZ(U%OSZO^HIWYZ]7E4Q^L#M)^AA(1L]:CV'
M5E@QD3[8O(J)# 3?9,5$O%\ZWVHB#H!<J";2]X0IJXDX>/*DFHC+'0$4^OJ;
M*N\,(__&RK^I=?59W7W;UGA:)#D6$8EC*#47$&6YW?N,)63F9> 9DSR+G;9(
M+K8T-P+M; 6ML1[COQ=0!]8<"J:12?,I0J U-(0R>R'S8,RAH)N(,,]!.!!=
MNJ#1RY:]#YB.+%W\..!*IQN"-WL>5+E^M!6@UX:*K2#6@WWZ3D4$YXA)2BE4
M66J7-D@."8T0%#&A/!)*,+]MY<M-SHT\.XMOZKKTZSH:V%KMO9-S"6_G'9P!
M41Q_Y^8\@*-JJ+C#-/2.S:5FI]ZI<83AQ Z-ZYT!P=JOI6)F!+_Z6BS9X5>2
M1PG)I8G4TEPF$"&40DJ%ADQH3&))4N$1J9UM9FY,TQH*:DL] H[S.#H$:(.@
M,S*#' !S36AV'BF/N&P0Q"8*RDXB-U!$=A&'WG#L_-W3Q6(7/3@(Q"Y?'<"!
M>YO<;YBHSV>U;R2*"<\Q0A!G5LLXR3+(L=20YH8$!4<HR=UKQI]M9FX<N&<H
MZ"SU&.#GX72@PD% &ID*3^$3PH3G@?)@PD$ FX@)]X'3K;%#%0:^B$,O$YZ_
M>SHFO.C! 1->OOH:D??/YE6H-V#>6=3-2]%FE7 JXX13#47*#2$:!H0\81AF
M@BB6*()BSGVFHKVMS8T76^7QK;6@,S<PK[D?:K=9Z&  CLR95V 7J-5^ 9,1
M--K/M?@,VNP7G#^MR7[IIH#0ZC<E"\$*R99RM?ZJRKO5=U4NZT_-O5787*MJ
MD6<IHC1GD,8X-4$6,YPB"(8)C\P<-.,J$<*C8(1KNTZ#8_I:$9WE]1)-;3O8
M-QZTUGN$&2Y]X!"9#07I-'SS/#!ZQ&T#PSE1!'<MK'XQG0=&O=&=RW.FB_,\
MO#J(^'SN&W@OXKU:+Z(\94@B;44!,T/3$8&$11&,M%01,BR=<B\9B[[&YA;Y
M[9;/'[;+YZJS]P8LU5";$!;H!&N.49Y!G7(,44ZM^J+Y,A*,)8OB2"&;9+0R
MO3XQT-LF_R\!^LI]'D_XGG.'YP:\[T%NN#V=/4BFV<VQ#<YC'V?/=><=G/U[
MPAB[K?F^O&M%$:L%RR*F:,(AYB:01E&60!:G,32!=)KD29ZF4>;#'D<MS(TR
MOM@VP*HS$ZC63C^B. ;2C1VN@F=D2MC:!EY?PL2; L[Z/>BX/VYETL%^ULFG
M(_S\A8':A(:]#5'8_[S]]E":0*^NBM:N#NN,I&FJ8I@E6D*D>0SMX1<#'N-$
ML%PJZ;0KX=3:W$(Q:V7]<2OV3/44'^Q%UVW<#X;9R!RPA:O^8=_4$<1+G4 9
M5H>PM\5IQ0A=G#]2)'2ZZ;HB9RO=(ZS\9K/>E.J$O/*32E:"\EPH%D,<Q00B
M2JP@<FK8A\2,($*I,2&DJ-D0QLV-HDY*EG??X+#J9(/TH1NS/5?/C$R$G5M6
MHJ!7<KZZ 8UW)[MODGIC0T(_2GVQ00Q\EGIB0T)[KG[8H&V$EO9Y:$[+51_T
MN]7R[HLJO_VB^'J1,!X3@AE,TUQ )-(,<DX1C#)$F$HY4CCO-EO<F/Q<4P'[
M*V,O+K5V6@JX-Y9"\S'X!J2QU;?RSQEPW0CV*L"FRG!YV,/JW1:K7_JP"B@$
MU _$P,6 SC0V<4&@?I>/BP)=N#ZP/C8KEV:V6GU497V^=BN>G/$XY93D4*L$
M021E ED2<9@R)1&.A,HH]:O\<ZXIG[=]FM(^G:7@Q7U=6M[,Z4%E309LO2X+
MOEG77_[U"OQ1,/.+RH0.XN?FDJ^K>X.^;SWM<[T@<D68-N^P8)J:"7XB(6-I
M#K'0/$):(94QKR+E _3!)(%SUP/&T$: (%@D_"RV;AP]!&(C<W086/Z%RB\@
M,6R=\G.-35NF_(++1U7*+UT?1M)6AXOQ55DK$>]I(K3K5,K,NI.<,AAA;$A"
M*4/5D<Y@)C*6*B4D]YN1]S<W-ZHXL'9?N\2/)BY@[$86PR$W,F6<!6V$M4 W
M4 9ECPM-3LHA;NX_91+'NT(.Y?]]4V<(K[^NS)3TNZK6=53Y>?/M&RN+?RAI
MIJQL*0IV_PM;LY>LLL6F54(HD1B2/+*%D'($F4X$S/)4(IGD(J=.VGRA!LR-
M<QH7P+?:!U#LG #5U@N@.S> -'X ;AWQ.;@>T$_]+#4%^F.'.@WPC?E@SWZP
M<P!L/; "Z@R\G !X'R&!<3M@*GV!P3O"4X @',5^78* YTXH5Q#N]:&*P17/
M&3BA\-?23+$7:88RC1B#&<WM$6.F(:>$09H2G:>98)QG@Z04ULW-[7-R(=?M
MSMH\4+9; [=;-#L<B"-_%2YDO/W:B]]P.6\'L$R3]=8T.8^\MP/WG3/?#N\*
MW>/XKI8;52UBG G$I(8II@(B3!'D$DLH,\E)*HD4N?9)>>L>[$48DV6ZE:UU
MOGL6+5B",4)1@F&$LP@:V!2D.L]A0E*L8QUI[B9A>!58DQQBO@HFUZT<?^='
MW[JYX'? -LVADP-OR[0/GW@;YM"EXVV7)W\/S,ZUQS2ZFJ^%/:A;E'^P^XWZ
MI:C$_:K:E&J1(*WC3!AL.&40295#AE4&22:D2D2*N$I]QJ-#FW,;JK7)8,_F
M&V"M!K798&>W9T:O _ANHWQ@2$<F@*O1],\%=L=GV.Q@AW:GS1=V!^(H@]CC
MUC R:DNHO_XAOMIEQ5>K9;U)T>44"YK)-#*S,(DU1((KR$F2P2S/TYCC*$G3
MQ(>&>EN;&P&UQ@)15VX5CT W0M) M&9[1A']4.<Y25G$"8P(-A$8QQQ2DL:0
MQ7$<$2)Q9,)5KSWVP<">9J/]"&Z^*LO57_5FIIW$C8J^&^4/ANC(9-]!V1D*
M.DM'V-%QPF10@N]O<5)J=W+^*:F[W11X1,1,H.T#S:BQ8^A6B'+#[F_7KUA9
M/II?UA^/!=-<4QYAB#.>V'0_!BF7.8QQ+D6$&!>)5U44IU;G1N_6:+!G-6C-
M]CPUX@2X&[T,#N/(-..-H/_1$1]$ACU"XM3RM$=)?, X.E+B=7/ 5O*MW3]Y
MO2E7G]6R6)7O5VO5G9V*LB@AJ100,V57XB()::0YU(@*E<8I)LQ)'NI".W,C
M&&LHL):"QE10V^JQ^=@#J</F[C! C4PAIS$*D<WK <MC0W88T";:=_5\P?PV
M52\CT;MWVG/[=%NDEWTXV EUN/S9B]O]EPD=OZZ5O#63,G:G7O]0I2@J];$L
MA%H@Q$A"E((D(C%$+$\A42B%/$]9)@F.E?#*$)[([KD1]TC%T&Y !P)H40 =
M#*#&X=D*XO6^5&ZQZPQ?E9$_7;-[2YZSB)Y+G\VUJEZO[?^L9?9<.F3$NGM.
MS0?,,EYNJF*I[%3F&R^6M7T?R]7WHC(_L/NW2[TJO]6_?;LLUH69X BQVM2S
MGEK,\N%>K=6M_.]-D^3TB]*J+)7\PGXTQS 70B9IK&,"\SS5T)ZH@23-S&<T
M1CFC*M$)<OJ"3F'LW#Z;G;M@S]\;L.<QV'/Y!K1.@YW78.?V#=@Y?@,ZUX'Q
MO3V.[3$S&/N=<9B+S>A-&/FK^/_7E\!CCCFCEV&BB>H\7@J_^>]$O=0[B1[;
MANEFXA.A>3"=GZK-P"1HMMZ3ETJT1#$B$43(RJ@RH2$G.8%2I'$<L2PE//+*
M>=Y_^MP"A=:X>E=WK<37Y>I^=5?X)N4= N@V2PV&9>2O9H?(\-NS)ST>-A_Y
MH(5ITX]/.7>4;7SRHNO$LS[H,Z<FWAG&>;M6WZI%EB:1)EI!$7%N3^MSR&3,
MH*"IL!*^9I+AMQ;GW/3<AON^QM+YHT)_6OM![8#GH7Z/3G%<RQH%ZK&7HX9#
M.5BARAVP4?2G')I_%G4I=UC.:4=Y/,&/V*0J%J]-S+-^?%6G7:T_J0>K0;6\
MLV4_-M5"(:$I3B@DO"[MHSBD%&4P%RS3F*6,4Z<,P$L-S8VT&EM!:RS86@L:
M<]T8ZB*Z_7PT)&8CLT\H7,Y4XXK%"6*IE/CY;O7]W\TC:D[Y.[(_PN;'FD@N
M/GP2VG!UL2,)Y^N'48.R)S_%[E.JD49QKE*(J#U>E<<YI#J+8(:1B'(B,8F\
MY(;[FYL=/1S)[-S41YK%C=WR,3/.;ZLE>'7/JLHN9XC[C5T4!U_^6C6_[#[-
MX4'/A=YQ"W2&PWQL>ID0[JNUD$ZC.*HBTI,FGU47Z;3[E]21SMQUQ0DK*XCW
M68E-69^<:)<),IW'J39!#-.18:V8*$@RED":TCA*4QXA[)7Y>K:EN1%6;6C
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M-O)Z!=;L!U!M[6.;@65= ,8'G](J_EWCL/PS+N C\]?6^.:\HZI/-=;$=>C
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MSK8V[8;%):>/=B8NWA!&(=OD=GM@ZGYESU#MYI-9RHB.: Q5+FW%]41!RHB
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M)5%,0.,"J'T +XS)4?2O0*PV#ZNEXV9V2"_T,]?(V([-7ON(VC*PG>V@,QY
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M%&R^B[E;[6*O<ISG&,4QQ)Q0B/)80")R8?Z)<2YR@K+$J11*4*FF1E%MI>[
M@5I5T8>V8G8?OE-MWW*K?R1=F'EVW(*//7M#[[!'FCC_/7-(H,-NB8-(-NZ.
M-R28)QO:H _O1_7VE* :Y$&)KXOB7QM5-ZV9R42G5*<11(FT=5FY@@SE#"*6
MB!S;[-F4^;#WI8&F1L@[.<']\W.Y9.)K]3GOI/;L<7059S?V#('>T/O@FX'S
MIKIKJ 1EKXN#C4I(UU0^YIBKU_>CC>:X?+6CICIW?S53.DJ(3C&,LT@:HR])
M(:.9^:?*12QYAC&B/3)!+XWG=_8R6M;GYUT?#0WT5F"@E>^IVT68W5CC)M3&
M88TV4CLAJUB+@)F:UW (RA,7!QN5)ZZI?,P35Z_OX0Y_.U=L\6ZARL>7SZQ<
MF[]49XJ-IY.J-.%,$IC(5!@K(X\AR6,,<Q(+I#5F<>+4K/[Z4%,S,2IA02TM
M:(O;QWM\!63$I& )@C'%AHX39N@XD3E,<I62E"$42<<PO[ PCQ,-40.M:J#W
M1]V.).P K\.I13#(!B;B$5]*CS..8.B-=.AQ$<5 !R!.>'2>B'0_8;PC$B=-
M#LY,W.[HV=:<%645,/?FY>>"\6)>K%_>SMFJSE1':41BSEGENH0($PZY,D:M
MPB32G(F$4*]^29VC36VUVDD(*A%[%0+HAM?-F T&VL!$ZHF7?^MP%QS"=@GO
M'''<AN NRI_T_G:ZJ1]QO-D4<]LBL5G:<(P5IR*&$IL],.+"%JKD$>1Y)D4N
M1"QRK^/6P\=/C1JVTOF1P1%D;E]_?R &_MRW@ETWD[R_]/,Z!_VTCX88]5L^
MK][QQWOAJCX=P9^+SVIQOUDO/RS^6PF#_=8@Y4HP&0OSP:8L,7\H!7F""-0)
MQB3C$B7*R=?=/<S4OMY:T"9NR<H+=P+[]*"^B*K#YB@(5@-_X!TP]>K9?1$O
MGQ[=(7 ;JR=WC]?,LQ'W-32Z&V]?O'O$1MO7-#ALK'WUZIYET&RBT9OC1*-6
M1MR;E_TEC</P_@]6RG?_VE0MWFPEW]J+:$-U'[ZRQ:?G*I7@)_.(]>K#HDY2
M^H<J'K^NE;S_IDKVJ*I?_LC6:F>GS=*$)"+3*<REH!#9A!"6FUV7Q+',)$TB
M'A&_A*#)Z#8]+]E69,!JF<&C%1I*VSE1&['!-RNW;8<%5A:BN_H")3V+P4UE
M!EP+STU%W@FMA>V,V38J[;19P%_.9]9:;.Y C0YHP0/J9)6U 0@T"-V!&B.;
MIE2C= =VKVD#5'T)L% !BQ6HP I8=V]J\Q^VQM]DM!NWGN!DU+ZPW9F>@/UL
MB3HU9U^)D1D>$>K7KTK9 O_[3.=]G;/5FQ?SC^?EBLU_*I>;9R.JS>0Q6S][
MS7*Q+A8;)3^99:A.3ZQ<AWF$,IJ@#&91'D&DM()4I1Q&6,6I^4T4::\2B^.(
M/;6=X%8!4&D /II+>[EY1YITM_5[>E,Y\.+<8Q:]%\5Q00VZXHTD^JC+V;C3
M<;Q6C3QZWSX&V\S0UMKX<;G^4:V*QX4-"+M?_:U.?6]=\!,K%C:O]*-:SPC3
M"8D0AUA$"B)B_L8)I3".8VY6G2Q&"?)98VZ6:'++QTZA [/>J 3V.@&V HU6
M[:N,I5]5J&B2THUVOCT1;IW>A&I->)3!-%?(3*\BD&-$(4%)1B(E=8RXGZ]A
MU D>QT?PYYYB-X-AU&D;VA889[YZ],P(A''@1AJW2C5R=XU ()ZVW CUX)X.
M:/%5R<U<?=+;ROWWHJYR98V!-R^M?[VMC(5',[[-G"ED8S$\J._K-P:K?\YB
MF:<BT6:Z(V7/]!(,.<>V;J[ E&F2499Z=>T()]O4UN^M:C8&>ZL<:&MG77JM
M?U?I;HV&X$!%\/L#X^9!5E50Z>K;,23@&^#HYGV=>1W:4?LJ4^KO8PT/?E@O
M:4#YQO5SA@?VQ%,YP! ]B^56/:!V^<A2T$2A+(.2YAE$.,HA8XK"W"X(&$<)
MBGU+VQX,,#WK_/[77]\]_.I9=/80-#>R[ _$P'Q7"S9(/O5YG</64CT<8MS*
MIV?5.ZE3>OZJ'E%86[)XNWSBQ:+B@<_E\IMA"NLJ^K#0R_*I^ND'6\:4S>^%
ML!4M*I/3EEJ>J[7:5^_Z:;F4?Q3S^4S&F=9IPJ!-6X8(H11RR6/(%,XRJ7(=
M8^T<PC6,C%,S^W9V04O-.]!2%+0TM?4 *UW!7EFPU_:N51/0[!\;C3W"H@9Z
M+1QBT%Y_L@?FQO\7YMDC=N[UYWNDP+M7G'>_^+UA9Z0S^&^@H<>+'!P6NX.P
MPX&'ZF?[_[Q</#ZH\NE'Q=>_L/6F-$.KU1?UO,MG_EP6"U$\6PG_2['RP;P/
M:L9IE&&"$F,D4)O1E0M($-)0R8PF+,5")LAOC]!/D.GM)<PW@OQV$CVGP&W'
M,3RL Z^^5@%H-0!6A3O0*/%R!ZRTH!(WW&;E-KB";FIZBC+JYN<VN(XW23<^
MK1\!;GGTP],S*THE#>MNGC9SZZRO?V2'MN[Y&<^8ICG.8<QE#)&*<YO%J@T%
M2D."E#!.=Z59ZB"Q7]>L="RU[RR&TZ=Y6+'E6)@!W0A[J4&Q$[LIH6]+G3\6
MBX6UC'@=Z^!'E.Y3I82.$9(2FK]$$&4XAC15!*:<4'NPD8L('4[5NX6<RD1M
M17FU:5(+.<(<N:U?8>$>9\G:RFSV!(W4=Z -^5YP8"4/MWIY@Q5TP7(??=0U
MRAN4XV7)_P$CIP\U <I_5RM[PKR0[[X_*V$K=2WMCSYMUJLUJS[IHZ#E=]]5
M*8J5,JNJ4+,,)U10E,)(:@(1Q0S2G$10*)I0)+$6N5>8UNNJ,S5G88#,CUUN
M1XU,51UPBPU8+ZL?FZOV^)S)^=AB!"J01DI "O-^.AY'_VG>NJ%/L/]4+]QX
MV45!YWD:*45A5/ISY!$%G;Y@R4-AI>IG/I@=L]D^L+EM86@VR7/K-URKIVUV
M/"8DEHJ;C2MF*411:I=WSB&)F422(95JIW*!;L--;?EM20D**^9_^JU]5\!U
M6YO"03;TVJ$>JW6@C5HEZ0!%6MQ "4JT5X8<E0C=U#\F*L>[IEW&8(9B'0D[
M14JF'"(98<@12J 0::(B*N(L\SQ$&$OTZ1T[?-S8F;?ABN:I:[.<6"-L5378
M9E;!U<2K#DRLJ,"4R/C5:@9,P%KO.6W3L,M]A?]S6. ]I^2U$O4#'0\9H_[#
MPACQCP6?JSJ:;Y^6N8^93R.A,D0$9,Q60F,H@E03!"/S\RA!+$:,^2UI?@),
M;V':RE]Y#_8:@%J%?H<+CI/A=\(0'N"1CAG.(POVPH/?!TD^Z ?<($<.CB*\
MRKF#'SR7#A\\G]*/[#ZJ/_9!1Y_+Y<+\5=3MDCZ5;[]:9OZP:%]1G<;/597A
M,HL$HBDQ\X0ESB'2"8:4"0ECEF0X)JF2V,O#<),T4W- M*("?[6^(&N2@]^>
MJR)A]ONM];&V5^O*G4I-$I%G,MAMT^G&GJ--TL!D.O#\>)-K$%R#<NUM$HU*
MO4' .V;B, ]]G:/AE@>Z=A3,",IQHJ2&2'#S!XH22+DRUBK-J2W9D%#E59(_
MN(13(_"0YVD'1V:UNN,>Q9Z^#^.<KMXTR]/WL_2:X-&//B].PC2\)A>E_'.X
M1ZZ!'/K,\?) ?>L]\?7>N5+5BQ,49Q'!RICSMH!3QBFD)&%0"]N).I8DXEZ&
M_>D04R-[*V'+7=JKF-\9(-U(]C9X!F9)3V1Z%+BYI'S@BC4GPXQ<@N:2FJ<U
M92Y>V>\#-S3S5-1]W.X7<E=:0!3JK!.-8<:(#7CG/#*[>D$SR$ABN(#@C/$4
M13R-_#R:?@),SZ-Y(+$?)WAB[\87P^$Y,)>T!*_WV&W1A_=?]L,M* UYBC J
M1?6#YYB^>CZEYS99E>:YG_0'8PY]*^2&S><O'YZ>FF")<V56MJU#6*X4Y0+B
MW!@W*&7*D%R$H<YH+K-<YI1[M9WJ*\C4[*!:#QM5T-8$[%4Y7QS)<S/;=]8<
M]ZPCS,7@\5B]IF& :*U;P0R[Q>PKS+@[R1LA.]DPWOJ\'D5G&K?FZHL2JOAF
M'9KOF:CZ /["OA=/FZ<WR[)<_F&;7C/S#IN?SQ(EHCA&*8PUPA#EN81$QS:Q
M1!&612C55#@7E/$??VI,NM4 E#L5P$J)*L?UW[6?23<J@:=:)\"W2@'1:.51
M**3'E'7SZ0@3,<X9SPKLI0=;\4$C/]@I -Z. KI'Y95AP1^IJLJY#\'AS?]K
MH%HI_3'LK(/2X['CU3CIK_-!_9(;'M.W-^Q)P90+E1!W;6E_4<QN*.Q[_&'Q
MO%G/4DHB37(!92PRB)*,0B8X@8(RG*:$)!A)OX:R-\LTM:7I?)VC2_5,[\!.
ML3O04@U4NOEVLKU]@MTV 2-/V\ +V2@SUJ/=;C", _?HO5VND1O[!@/RM!MP
MN$?W(_7WQ:)8JY^+;^HDH*W9UIN5->7*9I[+V,:1B<C6EDJ@U"HF$LLDQUZ4
M?77$J1%R+3"L)+XU9/8ZW&X$&A3$@>FQ&[\!O"+.X 3EM>NCCLI:SB <<Y+[
MC<',R!OJ[AU6X"[98J5562HYB[4@69IKJ'5.#&VA&%+"8L@(05F2*L;R;+9>
MKMF\MZ4Y@-A>W+<3?FS3)D31S<.J_"T(;K99AWB;>INUK_R.O(KE^SJO1P@#
M><#9&MJ&'D+TUS:S!YP.!TM\R-&#+9TVY?QQ4?S;+-;2#%SH@NV6Z^K0H:PJ
M8&RW#X5:F=]MGNS:_LU<ORQ?9@E6F1(H@R3B""(E."2I)E HE6>*93S+LAM]
M,K=+.;5-P58P[YB38>:P]_HT[LR\RG*T5Q&T==SN/[9:5C$O+3U!HZA=MAI5
M!UU[PLW$T$M- $E?>V4)![;#0A)PL-O6C=8IM%G<WMLEK;6R[0/=4$Z32.4Q
M1,CV$$W3%#+%<IAG,I$*49DD7LWF/,>?&M>?B^:HK%Q0J="V<?NM!:[SXL?R
M Z ]%G]?!WK0/FX]$1R$=UUE>!5&]03H$E?Z/F; 2.M=![$XBC@560X12Z2Q
MBHU!S)0QDB,4H9@G$>&Q4P>F7J-/C0'=0X.O=RP+,#=N/#@8X@.S8$BPAXG"
M'K1[G)\$TXO!OM9[KM]#;NU W-00_**>EV7MM=CQZYN7YI=UH0%!<H(9QS C
M2D#$4P1I)%.8,!2E4J,TX;1?IV%G&:9&?^WVL_MBC(T6ARY.FY':7-&K2$2?
M&7.CPX'G86!2'&8*;NCPZPWB0)U\W>5XI8Z]WD!=[LSK_ZA^M%F5,/MH%-V4
MI7ED:V->/7V_(8OR5":(8,@S9G;+$1*0)-00)I:<8141E7AQI>O 4R/(NGSA
M7O"V'\V/_YRA=R.](0 =F.FZL!QTU^N+55!"<QY\5!;SA>28NKSOOX&O;+V"
M4GU5BU7Q356'4LIV07FC#$>J!_9]AG(I!)<8QBA.S8X6V8994029%&E.&4$9
MH3X1$4ZC3BV@H?ZZ1%OJJM&2[89E109K]KT'8UT%/T]I1&-"H,YQ!E&>:$A%
M9/Y "<E20A--O*+HPH,_VC(Q/O@>:T5(2$=9* X$KL,I%/C!ROR7':P/';#V
M6R9<80J_1EP=>?P%PA6,LZN#\\W]EH;?%IO5ALV_%*M_?BI_,SJ5:U8LUB_U
MSC'3,:**4IADJ6$EQ#GD-.(P12C-C36+$K\N%)VC38V-&F&!E=9@"EKR]MN[
M=V/M1D+!$!R8?&X!SYMRG$ )2C7=(XY*,4[*'U.+VTW]*.5SJ9Y943756:S4
MV]JTG1'&,<FR'$J:,8BD,7"(3A44R$81*24C&?E0R=E1ID8AC9! U5)Z[G7/
M ^G&$S?#,S _;)%I!+P#C8CA2*$3@:!D<'ZD44F@4]GCC[_[XIYUZ(H5>WPL
M;6/<8KGXI+^H;VJQ44=.&2KC)!<L@ZF-(D36E& IQI"DU)" EN9_W*LTG<NH
M4R.%0Z&MP[H1V[-@G1/B;FP1',>!V>,BA(,ZP+Q0"EO_SFGD<4OB^8!Q4B7/
MZ^9^C.3=GOZ]V6#-$DPY12B#FA()48P2R)G"4.M4IAE+2))AO_IYO>3P^=;&
M*:-GWLS,CZ#Z38 ;80T.ZL $9N6'5@%@-;@#C0XO=\ *"ZRTX7CK)K""\E@_
M24;EM9O .N:YVQ[6C_=VIY^_+8KU_9/-0OFDW[.B_#N;;]2'Q;OO0JW,R&]9
M6;Z8R^I+9H@HC9-80(VX#6K+5!W6D68BP7&62B*9CVG63XRIV6K[$ *KQAVH
MI;0&AU4%5+K8+A.U-O;G6WV:2_THL^?<N7'F\#,R,&D.-QG>E'H;ED$YM:<H
MHY+J;7 =L^J-3YM:F]6/R\6WJA/UE^5\_GY9VIMF:8)SE*<$HE1IB")-(4'4
MYJ@CB564Q4QXI5B,*_[4:'R\IIP[-+:-)*J -/O8%?C=(@0:B'SC_L9]_=Q6
ME.F^5 .O1'^J]VE"[5^[IG4:[4SZJ?#GZ'5RT_2,UQ"V4XJ1%^_ZF_NDZR_N
M?K/^NBQMHN8L9E$N*8J@R*2"2#-BUN=,0I&R!!%-<TZ]CK."2SBU)?A3*8L%
M*U_ JB8O\_^JM!6?]+($Q6JU8>;E'VE-O#BK R][(>9J^BO;R3JU5W0":]2U
M.9C&,G11RC_'2G,-Y&"+R=6!^H8P+(52<O7>0-+VUOUJ'K_>.O1FL4J2+,<*
MYBS+())Y"DF>YS#-,$Y3)C.NO*+[G4:=&J_O.ZVNK)AP;9W:NX+0QH)=*$\G
MF!OXKF$0@2$=/"RBEA?8CQ'\L!?9T.E?P*][A*W<(6,E/& *'#OA,O+(L10>
M8)S&5OC<W*.W0\UX2RT,%:YF@A-.,B5AG.08HBABD$<9,@LS4SI2-$^P4T#%
MZ:.GQC-[JZ(2SZ/*_R%BW;QQ&PX#DT,H"#QZ&/2&8J3V!*Z0^'4=.*MU9T.!
MPSO&ZQ5P5M*#-@#GK^A!//^'/;/%_<;FG<\+=K^0']4?_U<Q,QVR2:UL*A03
M(5F<*0%CI<S6.,K,UC@U[$2D)A0+*A%*G#G)==2IT=7_N?_X?ST^4&=P'>AK
M",@&9K9*Y#NP$[JJ:V'$!HW<^X3M:\6@;X#6@Q:'@'@DQG2%.A"5^B+5R;+.
M#QN/@'WU.^!F[YM[T/8V.WZIE];/VF2:SH\R36<8YYQ$5,$H,>8CHFD,>1I'
MD*@HB810""&G\ ^/,:=&V>T2$LLZ$[')L)Z?9%C[$)#C##@P>WA<A_8FOBZD
M'HP>'MJ1^#P,Q'ZD[@=6)Z4[/FH\0O?3[8#./6_MYYI\*)DL%H^_-LT(S7:.
M1BA.4F-J*X(U1%QHV\0@@3K!$@N1*)5[I8Z?C# UHFZ.SE<[ ?W\BZ<(NOD2
M;\)E8**U7B6PE^P.-,+>5>9= UC[]^__#C]^".= O(A-4&?AZ2BC.@8O*GGL
M!+Q\8<_D*C.[^P/SH^!/%1&<"//Y$T83B!3+(,<R@C$F42XRHI,X]BG;T368
M%Q.,4*WCP8[AF3;5A:4;$81":&!.J'(,UOL<@Y_*Y2J A\P'A;!)4%T#CIO[
MY*#Z2<J3RSW]Z.&GY5+^4<SG[0"^A":"9K:'9I;%MI%F#HGF&$J1QS)+9"ZT
M4S_GCC&F9A9L1;PISO(<EFZL<"-" Y.!+SC>=-"A?E 6.#?.J!]_AZ+'WWS7
MI2&2>[X7JYE,A$X3F4"6* D1Q0HR8P] @7F*XU1J'7M9_R<C3.TS/\P" ;];
M&3T_\E,4W3[QF[ 9^ /W@^7&A)>6Z@/FLMA17C%-I:5D=P9*^\)^GW7=ZV.7
MPK*O\SR+19XG+,D@BU-MRZ90R%.D(<F0HDPCKHGR^;POCC2US[PR[0&K>_"P
MM>T_ORE+^WYKF^SUK4KV>MHWN_5C@,N NS%!$!@'9H1:QKMV<MQ>SG#,<!6*
MH QQ>;11F>*JTL>,<?V&GOV9MT]LU0YM6D#+3[:S4/W1O&&K8O7;8LEMT+7U
M0E:]H6WCH84P=S4EDG=-I-_.S8?WX_*)%8N91HJD:2P@88) %$<44ELE%%%.
M&8FERHE7)MK@$D^-R5K?'W_9-W<'E<C@]UIH3PMF^&EWX\%)3>; ?'KC//JW
MJ1X+V[!MK@>7>MPVV6--PDF;[=$&[EE>I]6-;B%_72_%/[\NY^;^57W:,--$
MQCIA*<1*:ILA%=G:H0)JEA+&",D36^O+W2]];<!)^J8/#F'M48RJ9/4LI',-
M:C>N#@G@T*[K(]3>=:/F7Q''$8JPQ6^N#3ING1M'"$Y*VKC>=T.I^GLARHUJ
M-[S<%K]$G/!8$@P)X0JB5"NS';:=)R.5(R)0SB*OKFO=PTW-DJRD[5$ _3*>
M;LP1#J6!>:/.H&\D;3?&&*"^J!LHX0N<7QYR_,KF5]4_6]+\^EV]:Y ^+U=L
M_E.YW#S_3<WE^V7Y*YNK3V7]&V,XZ3<O]B<?EVN[ Z]ZJQE)/CTWK=A732AP
M%I&42$*@2F+K=9.)V?UF"4P0UBGFQK))O;QNP22;&B-M%0.59G? Z@;ULH3F
M9\K6_=[J9\/3;-JP^;$M:K$&;2W!7DWO&JB!9MSQY/\UYG%@S@P^A=>#]/M4
M7@V+>^CJK(&D&[N":UA0SU1Y#3S 0-4_5I?2RYN*).^^JU(4*[7ZL/BLRF(I
M_Z&*QZ]K)>^_&4$?U?;WG\M"J)F*8ZDUIY#'*K/QF S2B""8:JPBF=LZBWX-
M,D<5?VHKC$M!BM65BA2[:DH[)&R^>HW%'=BB 1HX=E>!"I# -4G"OFMNR]9T
MWZ"!U[;IOCSA"YX,,H?C5D,)J\*T2J4,,CW>=52&D:)/6II:%,O2K/MJ]?#'
M\N'K<K-B"VL@K%_>V1&W.9DDITFN)&01SJV_Q^821P)BE/&4"TT4=_+W>(PY
MM04PB1 !M>B@DAW\@/]J1/B/O_@D3+G!W;V<# 3BT&O %8'[Y!2[OKT>^6?!
M81TK_^QF>#USS[R ZLX]<WO4B+EG7KH=YI[YW=J#L>\-@/C=IERVAFK><Q&;
M+8T--H^UME5H,(%<" F5SJG9 R&N/"H^7!YG<LS\USC!_P&LK(<$+3<*6"T\
M&*4#70=2#H/9P$1L93P#5@_Z[0#+@W+#@#82S?8%SX]<KT/22:@=MX]'HM=U
M."!.A\O[)NV5Q3?S5GQ3/Q<+]6&MGE8SPJE6B*9081L3$6$&28((Q#&3<9[+
M*,K\SA5.QY@:2>Y%!+];(4$EI6>XVSDL'3WVMR$TM._=$YP>27H7U0^<FW<Z
MSL@I>1<5/<W$NWQIWZP<F]<G;'^?Q>.7NK!Q.X&,1BJ)S+L *:$"HBRAD*52
M0LD8-B92PI/,*X3VRGA3HX #<4$C[TU9>M< =^.&@# .S!,W(=@CU\<)E\"9
M/]UCCIP'Y 3 :5:0VVT](_V7I2H>%W6HA'AYNURL2R;656+!N40615/)M<1F
M%T891-;@8)'AH#1F2%."4A)CK[A]O_&G1D*-^$!]%W7%8KE?>^LL(\\(?,_I
M<*.D 4$>F**V^&Y%!UO9[T E_>!Y2#VA"QO\[BG#N*'L_0 Z"4SO^9B>9_=-
M3:5/N@H=:P+%ZFRJHU;'F<@$9[F&F"7&RLHC!6G*4TCC)">IBA(4>367=A]Z
M:EQWU%R]CJ&N8R,;+>IOTI/R/.;"\5QZ$(2'/D]H%5P[A^F@+:C]$0M[@NL^
M_+BGK]ZPG)R<^C^A'Z%]6(CEDWI@W]]6T4Z/ED/K:H4Q5Y%,N((Y1KDQV 2&
M/%(4BHBC1.,H1C+SX:^+(TV-KFI!@9$4M$3U*PMY'5XW2@H"VL ,U!,O;[*Y
MBD50;KD\VJA4<E7I8^:X?D/?J,56QX@'\XPF,1<)F61:1E (DADSAQH+!T49
M9"DA.%<)U=S/S#D_SM1(XJCWR1VPHO;,GKX$K:/5<CM@0YLH_;#J$9/6B43@
MX+'S8XT<Y=6I\&DX5O?E =)<#/O,-[;8Y-GXZ0^+M7DO"D-&M24S2S,5)PKG
MD/$\MC9&##G&'&92<J&E3)/(JRS<#;),C6#V\C7^H!ZMJVZ9&L?SK'$ '_K<
MZRCG9*?(A9P2>\5N=JYL76]++ND'Z7#I))[RO%X"23_@.E-&>CZR'ZN^8^7"
M-JS[K,HJ0G;ORXB40$P(#BFF'"**$.3<S)S(B4*4$XJ55X6]BR--C1&W@H(?
M?EZN5G\!!GFP:^-:B>['CI<A=N.^(, -S&P[S(R0-49F7S:$)^@J&$$YZ?)H
MHS+.5:6/^>3Z#;<4[/ND/?AJIGA*4):9[5K$#8\8(C&,DF)($XTR@21+48]2
M?EXR3(UA&H_I5S6O^T#;E-,^A?S\)L*-;0:&=W(65FBSZ@;\!J@8Z"?'*]02
M[ 74^2J#_1[5LUY+_9S%X_:LZ9ZOJO/ 6:9SI'A,(8V%@"A.)21)2F"."14"
MY;'.L]DW5?*E<[&62V/Y?'?M$8?[_':B M7(^I^>=5LNXNK&7D&P&IBC]B#M
M#BI_WXH9T%*Z"D78&BT71QNW/,LUI4\JLUR]H:>E)(1M<6 >7'<*MU6CWI7E
MLGR[+$LEJJS#W;N=*YXIJA%DJ0V4Y-A81T)G,!6)I.9744Z1EXGD,?CD;*.=
M[* 1OBZ%9L4'+?E=OIG;9\;19AH([X&)*"34_G92#\S"&D@^ HQK&?6 YL0D
MZO,,/ZI;E>O9+\6B>-H\;>M'*<VTHAFD)+,M6&1LK* T@23.!*5(44&<NFF>
M/'EJ)-4(YT8\ISAUL\I-V@],&8U< 1.P+FK;];&;FUH?NOG7\4=^^M11ON"+
MRFP_S\L7] ZK*15;J1]5_=\/BRJ.9V?5O&7/Q9K-/ZKUC$L1,8$)E-K@A%)"
M($<XA3%.N(H%C;-(S!;JD:V5=#,SW =W>H-I_0:W11C0"*]"V)8[4WS;<<&L
M?_-V_43OLS"/&7$S+@*C/%JL3B4L^&$K]E]L^9@:]?T&Z'Z/^D'5RH\=J/>)
MY_$$,'2 C^OP8T?\>,)R)@3(]PD]$O!M:NJVI>2_*]_->R:JJM[;W&>&6*RI
MAJFBU.R>\A@R+A2,M< TCG.FL]PY#?_::%.S1*R\X%!@L)78([7\*LC=7!4<
MNH'IJ0NU/IGYU]]1]_S\D#".E*5_&YQ^N?JN\'1F[%]]R'AY^Z[Z'&3O.]_4
ML[.F;9GZN5SJ8CW+*,F)3#74%;O&(H<DBG*8,L0U3=*,<.33SZ#U;"\N':%U
M024:>*YD\VR?V0),T)3$5"H8T5R;33 7D.>*0H+3#$N4,L:<EJ-; 1NC]6@%
MV+RKO^Y5N-R,X)X@#+R,U/I_[GYA_%N*GNH:MI5HZ_GCMA ]5>RD=>B92WH&
M-FFMQ/J3?M<DOGXQF\I/B[=L]=7^OVW:\(W-;6G *GVY$&;+:7]QOY"'/VA=
M.6,Z3172&60XM98FYN9O<083HG N<\24]#S;&T#*Z9T*UDH"8Q0((ZI-(!.-
MN[EH)2:;/8/RY)$AYMB-CUYYW@;FM>V$:;#5#U@%[0Q:H>^J/T%+]CNP5ZO^
MI=W2'_^L=4/ @+#A9B)L*-D <HX;A#8<T"?A:P,.%:QHZ\,?YKD'=2\3BKC0
MRL9ZR,@L#RJ#A%3U)TC,N8C,KYTBW7P&G9I)>%7L<'5'3R? P4DQ *P#D_&K
M(GIS*=>;D'W56JY>"(<HYGH1JA[57$^?]=KE7"]JYU#/]?*]-S=Q/%>S)C%F
M?&Q#^(Q-'T,D6 ()C3*H&$_2/",B3[TZ670/-S4&?U\LV$(4M@NYL>$^+A=Z
M]X.#,QJ_NC9]YL'-% ^'[L!$/@RPMS2!'*L^T)4A7ZL!I$?U'\>[>J:\J[GY
M[>-/:J%*-C=6[+U\*A:%#<ZQ=;J:R,29UC*B.(Z@R+@Q+TG&(>5<PR@A"3)0
M)"CS]#ZX#3P]AT(C]QUXK"6O/BAV(+MG9KS;#+@14GA4![<P&SA_:L%Y*/0V
M5#E@$KT72F%SZMV&'C?%W@N.DXQ[O[O[T=3G<BF4DJOW1OBJGYDV/Y$;84?8
MYMD3(A25"&9Q+"%"R% 4P12R)$\SE.8D2KWZU%X?<FK6TU9B8*<8K+\J4/<3
MU+VJ+3I [L9)88$<F(\.,?RUP6\O</"<+7=T@O*0P["C<I [#,?\XW'G+?VQ
MJR<9PUDT9<JV4?H:B5QDF,&<TQ2BC&K(L8RA4CC3,<((D<B_/?:%T:;&.$WS
MYZ9VQU[>W@D2W5B[\4TP! >FFEO Z]DZ^PHH W3.OC3B*S3.OJ+\^;[9UV[J
MX=+_L-#SS3<F&C<G1Q'1/$>&0'*SM8IH;DP6\T>:(X+C)%89=BH:?>;94Z.+
MK73@?_Z/.$?_V\-G?(29@[.]/Q(#?_9'(/3QH!^AX>$H[X_*2/YPUU?$S^E]
M7NU.W_;1+>.YL,_+>N"IOG!)N$X:#R5;K.9U)\N%K)E0_O=FM;9OP"PFF N:
M(!M@QFTHBH L90S2G*>(FCU82KS*(7I+,#5>VQ9B%]M"[.N]]+=WV>B>##>;
M:%"(!R;,LYTX[D!+_%:Q[;T&PS;G< )O\'8=W5*\>@,/)Y!<6GJX/>B&[9WM
MW5NJKVJQ,KO&NKRL+<#U1FGS:7]18LY6JT(7HA*A^?$#^S[3B8XQ2A'DL<TZ
M)>9O+,HL*4K,M?F3NS7+#2',U%BQ_B!%6QF@=O7-YE5],UX)#\ICI>ZVOUFS
M[SUVD'VGTV.#.<(DC;+_/- #-'6NZ^ISNTDX46?WFX>.Z>FW1[T1U_!;V+X"
MC;_#O1&ZLQO@6Y_9CY/?;%;%0JU6]^)?FV)5V&=_5N:U-]N/1_5)_WUI4_P^
M+ R+F<6BOJI4<B82SJDR')S0U+8C(1ARD@O(>:PIB\W?_9J^]1-C:CR\U0*T
MU+@#>T6L@[M6!>QT 5ME_,BWY[RYT>[PLS$PX0XS$=XT>QN.00FVIRBC4NMM
M<!V3ZHU/ZY7#7*Z_WC^ITI#T&V-'RVW?9L8%2Q-D+-;85G[27$&""(5*4(QX
MI+E [H['2Z-,C0PK.4$C**@E]4JVO0"F@T<R!$0#,]0Y=/KE)%^ R2L7^7:X
M1LM![@.;;^YQ-QQ7<HXOW#QFKG&W_$<YQE<N[AE[NUP\;GM#_,+650JS6GU1
MS^S%OB4K>W1<+$3QS.8?%O]E]JKOS2LRBR3+&4D9S'$DC569,4ABK&'$,TJP
M$!$5PB_VK9<</N_].*%PMHV[9]!MKPEP,P\'!W5@[K7RPX=] YE&AY<[8(4%
M5MJ @;BW@!4V/K>7)..&[=X"UDDT[TT/ZQD]USS[8=D8E%LK5*T^JO4G726P
M;3=C3.8,XRR'E"8:HC17D.-,0)5EA@4S@E.JMK6Z'CS"Z3QD</HJ#TMV/8Q@
M.U:)I%673ULXG>TM^#ZUNKSFQ(T!@T,\4LA=(S98+[>[7;"7O"K(97?&%?KA
M=\-]0 L;B><CP+@Q>3V@.8G.Z_.,WF6/-T^;><4&K?.BW3E1LP4QW*803V.8
MQ$29;6^*(!51!"-!-4IRG$4Y\2QX[##LU/;!)[W#V\>I#H>HM\R &YN%QW5@
M'FL)#$[@W<L-[M?KLN";==6RV'#>9U9'_07;+_9#,'2!8Y>AQRYM[ ''F:+&
M/G?W[#-HC,)]:E>['Y9M5!QIF# 10U0=.*,D@5QHK62,"8N]CIDOC#,UDK)B
M>G8#O "@&^4$@&5@CK$2MC(S!VIT=06'L*WW+HPU;EN];H5/6N9=N?R&0)2#
MZ)=FO=18BR2)$#0<D$%DR  2AAA44C"S-6,LSKV.-2\--+7/OPY0>/>]6(.W
MRY5O_M)%.-VX( 1( Y-!C<]A>%QX*^(:$.$C+LX--GXT18?*9R,ENJ[O6RIB
MH<P.R>R,BJWIS!$V2SUF,$ZH,00X89!FDL$D08D4/!<Q\VIH=SK$U$C 2EAM
M_RL9/0^C.I!T="K?A,_0'F-/:'J4:[BD?> 2#2?#C%R6X9*:IZ48+E[9N[%X
M8T68QRZ?;*ITM:_XHJJ=1K7L55TTW["5DCMGRLZNY2F)2,Y32$F:0"2P@EQE
M&/(HI8@H'FG&_,ZF;I1H>J=4E;"PDM:&-QII;:#C9W.-=Z/QFZ;*<0LR'OP#
MLU.-.Z]P;^0$]V5I:^I5?Q]HZQ(&O]#=Q6^2:>P.XR$ /--E/,AC^U:YV97V
MVAI2'&N49QRJS"8R<<7,JTH2F$LF*8^21,>9CR%U,L+4[*A:0%!)Z%N@YA@\
M-RJ["9*AR:F%Q@"&TT75 ]>2.1YEY+(Q%Y0\K1!SZ<)^7_.N"M:'Q?-FO?I9
M?5/S=%L'5?-4)A1#'>,<(BURR##',$]DQC%-$\:EGT'4,=KTC)U*.I#Z?>!=
M>+I]ZH$P&OBCWQ>WL\VYK:!WH %L  YPP"0H&W2--RHO."A^S! NM]Q\*-R5
MSW+_C15S>R#W?EG:(C+;!B=JM3_AJ<ZK;998)B46W)X;YTI#L\V*S?9+2IAE
MB.,H)3267O[8 62<FO5A8S@VBU*Q>?%OLQ]X9,7"5G1_8N4_57T0NMII4P73
M6+^&=^[?$).=B$A)R0@DJ<X@PHF$1!-N=M@XBR523(A\]JS*8BE_7;-R_:>8
M\F-YQYWX)O?39?YMHN%CL; YH_8GM=RO_U+(%&>YX HF&:(0H=R\'HIALYF@
MA&(D4410\U*\6SAVM)S$*[&5=L(OA%K(*;T*;@;2*T_NP(;5_:>W'^ZJL&7P
M:VO6=MI O2RAK45XUXJ#N0-,FZ4G; KQ@#@/%1\33,[7"J8)#71'Y$WPH?IT
MY!!?E=S,U5(OK31-8;!6XUY[2/!AK9Y6,V26"!G3!!*4)6:92"CD"4\ABA(M
MJ=F)QFZAAI[C3LWXVTIN:7M9%X5H*MVUI >_5\=9E0)>W23<IZ.;J@<$>6AG
MUD3P]6G8,0C.(Z7[M9&L4@$<)^#!LE.P/A[>"':W\G!_W(C=/+QU/&SHX7][
M[U-<]OA8VDP4\^)]TE_4-[78J/V7@6,<95P)&&5$0J118A8"I:'Y42)%GG%"
MA5?\YI4!I[8"',IK/Y-&XAZLY RZ\X%K,"@'YOD;4>QSENH$3>C#TNY!QSX-
M=8+@S'&GVWT]Z^.P5;'ZI(UEO-PL;,6(S\MY(5[J/_<A!S8V5"N$(,<80Y1(
M!2G*$,0TP4R)3,4">=7#<1IV:N1326V_EKW<H!;9L[B-&^ANM!,>RH')YPR*
M=PV,X/?FOX-$=/@A%;8\C=O0XY:C\8+CI/R,W]V#GKGL7&A(\RRG2$(6:[--
MUK&$A' ,8\[3G$F2FKVRWYFMIP33.\=MYY(MS]11].][[CLI4:8(EHS!G-JJ
M%YQ38ZU2 1G+S=Q$C"$6#W;N,>TS#9?)>9U#C-WL<2UPCLS7I!-D5G[,8DAD
M1"&*>))IG:,\5@,=4$SY\,%_YH8_;1CF)&&*IP0M\!UJCS9I_Z]Q/# %U_^D
MW?J!7/8WNN.E*F;OC!6S?GGWI,I'VX2L7/ZQ_FI'8XN7680HRU-&K"&!# D*
M9./BC5T18YQK'!%&G>(TKHPSM?U.+2K8R@IJ84$CK1N'78.VFZL" C8P)_7$
MRIEX')$X0S K)?[ZN/SVO\P3*F[Y%[)_A?5?*T*Y]NQ1B,-1P2U!N%[>XUQN
M6UC$/(H7B\KO\KE<?BM6YB^VEI)>ED_53S\LBG7!YOL]4$5(SW.U5ON3PG:9
MIIF6,C9D@F%&I;&AJIJ9$C&H>9[A5!.%/%KT#"?GU(AH5^^VI>H=:"D+6MK:
MD,Q*W[:;9J_Q8>3 8:TTC].L 5\2A]/%:4S]T(ZB_Z=FW>/,<QJS/](9Z:N_
M!7ZGJ<//3>?IZX##CW=:.SR&!Z>[(PS7^S3X>;EB<V/9;)[?'C1(N/]>K&9<
MYTE*E&T78VP()",&F:(4)IPRF5MS(LX]#X.[QIN:5; 5%U3R@D.!P>]69/^3
MX$[ G0^"0\$X_#EP?P3[G *[X!+Z$+ASS+'/@%T .',$['2;O\_C[?*;*G=-
M<7&6&!Z)(DAC9<M3BQQRE@J882%2266JF!.=G#QY:L11">?=6?@4L.N^B]XP
M#/SA.R/@Y9\XJVUOC\3ATT;S09Q5HNUU.']!SWK*Y?*]M2[^H8K'KVLE[\VC
MV:.J\M=7GS;KU9HMI#$T?BSF&_/KF?D\E<Q%#'G"4HA$;'ME9HE9\76"H@2)
M5'LUS/0<?VH?<B,6^*%8@%4E\U\\:R=[XN]F  R(ZL"\8"0'E>A@*SMHA >U
M]* E_AUH% A80[D?<F'+*'O*,&XEY7X G113[OF8T1IC[LXR,8V1SC2%.F?*
M;'0R#DF6IS!-52J(S/,LCP?NBSG55-B;VBXZ'(H&GTLW]AQIA@9FTJ$G9XR>
MF(.>7M\BS]0[8EX[U0[QR'Y4_% JMMJ4+[^NE^*?-=W/4(85CI6A6$8$1!&+
M;+/+!,;&H$29DHK%RB]J[LPHTXN,VPH)5E;*N\: ]&/#LW#&BJ0ZSF"<1\KF
MZB60Q2F#/--13FF6L$SXQ[O=".EX,6UOF/FG4/UM\G.8FK5?B2PR:W^,I-GW
MI!A2@1#$N4@1QE3$1/I&H05!=/A(LT'P=%N);T1HX!5V]_W^6G^_OW9_O]X+
M9H?V01?"<^.,NL!U*'J\<'5=VF]!^FVQ66W8_$NQ^N>G\C<C;[EFQ6+]\O,N
M^RI*D:"<8,BR)(*(&P(@2::ARC!*,*-1HKQ\'E='G)J=WP@,K,0&6]"2^8:L
MM^O NY%$4#@'IHR;D?0F$6=T@E+*]5%')1AG$([IQOW&GM4\OR[+]?:P=O_B
M$RERDFMBX)4I1)3%D.,H@II0FF)CT6'E5]+S[#!3HYE*2KC>QD/<0"T78'7C
MD]O!&IA$>N'D7_BS$X:PU3_/#S5N"=!.=4_J@'9?W3,5]K2A^COSM_7+KHGZ
MA]5JH^2GTO[75F#XN+%U!3_IVA"J?SMC)$U1PF.(!24081N4P3,"I12<1(A0
ME7MU6 HCUM3(9A?5U5+K#M2*@:UFH);=KM1;W>Y K9UUCUTQ^(><9#<J&W_J
M!J:^$6;-/ZLW*,AALW[#B#9N5G!0.$^RAL,^O1_1-R44/B[7[XWZ;Y>+ZB3_
M'\7ZZ]O-:KU\4N4,,2*$(7"89"F#2.0(DBB3D">(1HAE&9->>\[K0TZ-H+<%
M08S(P+XE8"LT^*.P>2V-V'[LZX"\&[.&Q7-@UKP52F]*=$<G*-TY##LJE;G#
M<$Q3'G>&/1'?E1[4RW)UH?1@?4#TP+Y_-D:PC0%L=8%]6-8]8&<LT;%.%8*8
M:[.%Y8Q!GG*SH\U5A(E(B<)>=:*&%GAJ]'=47-:F<U^L*AOF #W8U-]VROX:
M$_KZ1_&G!69;]6</DD::0_L'F]+?J'^A#_/P1_>AYVJ4\_U@0D\B""#T%+A&
M"@0?MV?\:M->Z?WRL&OE#&FD,R5S&*69@"A1#-(HSB'-$THT(2G+Z&QAJYHI
M^> 1KWIA/">VH37;G(PZ'/.\9:NOX+F6V3,P]1*P;NQ^$TXCA9HV(E9U3P^$
M#!A.>@6&L'&CEP8;-T#TBLHGD:#7KN]'#(:RGI:+ZIBXZ?]#D,HC\]5#E8D<
M(J8T)-C8IAIE*(N1U@GW.E0Y&6%J)F0M8!V=X/?QGX(G4\8HY@K*A%M_1!Q#
MAHB&L6"4);GDF J_$*V;X!LG0.N7VXWM4R3=^/,F= 8FSO9[-4"WJ8NJ!R7+
MTU%&9<F+2A[3X^4+>V[\GU7)=JG#5<#G+"%IG&,FH<BB#!J[B4 NS-9=2\4U
M5CFE.9JMEVLV=]RKGX[AQ8V[D89[A]^QTA:Q6VT;ME1NL64M]W+ANZ,^@ZGC
M)O@VI(;>MVZE.]RM!MQ77E8_[%;PS#CC[MXN*WJRX>JXM$^/CWW'RH<_E@]?
MEYL56\AW5=:-6J1_C3ZKTG:2;E8G(:-48)3 3$<)1-PL\02E&8P3KG(<H913
M]_I ?F-/S7Q*HIB @^ZJ/QB1H^@_@%ANGI<+QRC8/K/031X#8SLPJ1P@:D0'
M6]G!5G@ @9$?- I<MS!NAMNGV\=@L(]4S<87_E ]/GKAUMWGP^^1(_;ZZ*7K
M8;^/?H_H6>5%E<4W\]I9UY[=@%?;\9]8L;!KSQ<EEH\+>P;Q85&O2!\62FLE
M[/5;O]Y"WC_9BC3OOHOY1BII#ZW>;2^RQ^T/9F=OEK2/:CWCJ>11E%/(B6U7
M'@L,69YR2+A"@F61C#*OEJ.C2C^U-6JO/&AI?P=^JGH15M8:V&, S ]K%&R9
MJAT.NV,$RP(U%&"+16T8'Z !&CBJ+$'/\C:COFEN)OADWY^!U^'IOCK^=7U>
M8PK#5@D:58-Q:PZ]QN2<5#!Z%2%N]-#\K)A90)H>7R]OZYY?LUA)F6%;=R6)
M.40,*;-#BRFD2FFL54X9H5Z!%9W#36W!V[LDYE;<75<ZSP8X5S#V=-[<C-QH
M?IQ*TCNPD_4.--(.X-/I1&48]\[Y(5_'T].I_D6G3_==?8_"YN:?R[+BO_NR
M-*^&L@3X8[$2\^5J4ZI]RR<2)U3(+(,:R=CF.6>0XYS#-*,B$T(R)KVL<X^Q
MIT8U+=$; ^?G0M@0"/,=W3^6JM+#^SC(?2I<#XH& 7CP(Z26U* E-MC+#7X?
MI E7#\ "'SRYCS_RD90W,*>'5?Z/Z,=I[XM%L39$^<T:;6LS3L'GZGZU4NN5
ML=.,R?;OZK-]]_W9?+'JOQ0K'_Y8SG*%4)YG$<PCVTLHBJP5Q1"4#$<D3R+%
MD5<7P5Y23(WGS'N*_%BL'_AN?#8XI ,S6RT_K!0 >PU I<(=L'*+JJI=2YD[
M8/6PWMAP-'<3CD$)KY\DHU+?36 =D^!M#^MQQ/=+51*C(MH/B^?-^HN2&U&7
M"[<IJL6"S>TH34Y!W:7D"UNKYO0CR3*1T%1"H5-E3#XE("5F0\F%V6::S:;Y
MCY/)%T"6J5%C2QM0J7,'=@I9C]A6I?K[W:;9-)UWK%H>9U8WSJ+#D>%X<S,P
MQ]X\+7W.%&^<'X\SQO'F::0SQ^$^([]#R## =AY*WCC$>(>48; X.+0,],A^
M&X*_*6E[</VH5L7CHM6A(DOR3.((RCQ)((HYAS23%"J<9IE"1&OF%?1[?IBI
MK5N-E* E9J]V%!= =;/D;X=JX&6D!TK>9G@W"$'M[ M#C6I(=ZM[;"E?N7K0
MEMWOEZ4RH]8>5O'R4++%:E[+L,M?VM> EC%7BN:04*PA4CF%A @"XYQ&(L)Q
M+/RR\0>0<6H4U,@.1",\6.^E!VPG_B!]B+WF-LK3C*8)@R36$MJZ"Y#S%$.,
M,Z1B'&'-V6#=P8>:X?&JK3K.\WB-P[TFGR4IQA0C&-$4F;VO-0\(CJ$PAIU0
M49R0G W47'S8J1^^+*SSQ _?=]QKRMV,EU>>Q($M'\_^Y=NIWJH)6GH>Y*:_
M8J/S/C/Q&LW0O>2<8L/T/D#W;*K>:ZB^A3A9J=ZPE9)6%B-([:<A&D>9C@44
M6BJ(DBR&U&PHH19$$JFQ(L2KEM[Y8:9FNU520F[%!&TY?8MPGH74C7]O!VI@
M"FUCU*0PM\^Q#1>:K\YFWS=^_I"%.;N@"5R8\^Q0(Q?F[%+WM#!GY]5]Z[6U
M\M+O%_*+JJCKWL;^53G!Y\(W<IZ11$D$TRA1MH:OV5=$D80RS:R=*5E$F%\%
M-W\AID8L;E46PLV!&]<,C>S 3'0@?A6GU"@ ]AH,'U9S"XB!B\#U$&3DLG#]
MH3HM%'?#LP(TA3;&VGQ3-VI;&?77Q<(6S]SF47]8?#-KX;+<!=9F$:*(Q@G$
M68HA0AF"7//_G[UW;7(<Q[($_PK,VJPGR\Q1PP=( MN?/%[9,1L9X9L16;5C
M^4&&IP>[%*(7)8\,[U^_ $E)E$NB  BD,VO'IB?+PYTD[CT@#U[WGJLY$D6<
M)2K*D!LI7F'+W+AQ:Y^SQ,0U_6%'D!.A/#)/'M::-FDLG2.@[PG8N6*NZ)P9
M(4PZ *;CU:EVM.?E:EC[ 3=8W]KSD9ZAV7J%H%G;_(^1(?Y.ER:F^';SFM;U
MD[;A;W3Y*!>*IJ0HT@@6B<(0*7/\4 @!<Z7GD205@BLG+4VK5N?&CXV4F9G=
M-*LJN;?;,0+;"G$[7@R.X\@,N(.P^:%G\@V@&["U&C1F!PRX=D$I;*BU5<O3
M!EF[@'$47NUT<S"QD'=5O7GZ7/[(_IID=[7L"R>D6-*4YU"RAI@X@C1# C*:
M%7E1T#RCUZJ%G&U\;OR41"A_)A=B; XH%W*^'X;I:FQTQ]YIL[4\G%+(P!M_
MK51($,0GBMM[_DIOW^@ "E#7(.2A"G+^F2\M"W+16PM=D,O/"%"KM_L E.!)
MBF,%::$'7!3+'&*21%#_D I"&&<Q=IF+GFAC;LQ^6.?SBMJG3@J05P(S,BD?
M8C*""N2 ^^,5/WT))<@!1P>+GP;YPGLG5FL]L_Q8K>C^-\UY*VTB>-?=JUOP
M**8XP;#@(H&()"G$-,MA(M(\(5$4%3QV"H1S:W]NS- WOUE8:0=@SP/0=P'\
M_J;Z1LN58PRN:Q?9L<N(P(^]B#V;.MQHT/3^W4:V;+[2%3B\Z6)'N >I^,$9
M-@#%T89I@TO\ #H*'/%\S'7%!;Y43;FP6M[51B)V\W2GW\B-;M^LPA_,)0LA
M%2=8$:A46D D&(*,,0*SB/%",81IDFS+#=A1HWWC5A_G8>V!T??J'LH-70)I
M8A]$N7ET+I/H +T=X06&<^(2!9L*=&:#K=TWH+'\IJ&]G?'A2Q?8 S9*,0.+
MYE^DO($]+.<*'C@\X8H:7ULMF5*NMX=^A<Q1K#(!F5)*<U6*(4T3"4F!(E44
M.,NBW$W+_TQ++E_2-(K^[92@#5G>[,2C_$IHG4 VCPL6R3R&G*4$HA29NMU4
M0IQGO,B1I+F;MF4 7*>8!G?U5[_)S=?** 5^EVULYOH&\*74TR^YDO7]4_\O
M8?"VH_X *([,\^UKV3-Q#%VN813"E]XZT=;T%;/..WRRT-7 Y7X<;(YDFEW:
M+Y)_797_?)1-!F4B.)*\R&!$60R-JCHD7 @890C%C*LH14XGNJ>;F1M/[*P$
MMP\/=45Y>QJYL]DK1_4,PG;4<#UN(S/#M9 YT\0P(D%9XDQ3DY+$L+O/.>+"
MU7X4T>.<!95Q)/*<ZFD#%A 1E.FY0Y3#C% B649(EA.72BR]9SN1P0056+Z8
M-ORG8'W4[+YU3RQ&_L _6 #@_!&?<#7HE]M__J2?ZPG'GG^CIRZ90F/NH_RQ
M^?*'7'Z7OU2KS=?U(A*4X51AB!5+(<(X@B12"#*>T *A))6Q<EMF76?0_%9C
M^NU*QU2>.^H2.Z*8#N:1N>4*+;I/JX 18&$ ?4%1NB.39JQ.=PZ^ZV3JSCXU
M9+IE?W?_U=/^FF['[/8/6HM/#\W^_L_ZRLWZ_>JNR2K_NVPJHXA;S5OT7K[]
M(6M>KN5=77*Y8'$:2QXG9DY5F$2L M*(%3"328XCRE6*H^MS.$>Q?6X+N'.)
MH>#@()0]@9/9D0:"&]"!< -:&(S^5PO$#=A" 3HLP!8,T* 1(OUTG%?,;ER9
MZ8LS\B TTW<F4-KMJ+TW02[O./;/($%XU(ZQRSH>UP2?\&[^58K'I:Q4EQ_X
M5*Y>-RDN]]H>_=.Z%%V>RZ_5<OFNJHV)"Y4RI)A$,.,9@RC.4DAP0?6+)A1.
MLESEF97ZU14VS&X@[+PP:B=;/PPK[3T!!ZZ WXTSH//&*4#9K\^&1Z2)>F+L
MD67NG> 2+#YZ9TQ57W*D3G&,++\*SN$ <[]'3QAG?I7OA^'FUSW*;VWX7$;V
MBWY,>VB6([UP4RD466I4&',&<2$S&.4QCB*<)P);91M=:FAN@\V1?#(PEGH=
MEIW%UFX%$P*QD0<%/["<5P.7D @Z=3_;V*3S[$LN/Y\47[S>C1[6]69A&*=:
MEJ)-Q=[(;^OFY964I"C63)#%<62( >EE9$Y@RB2/:)1G,K,BAO--S(T2#JP$
MC9E.?#  YC 3A(%H9 [P0,>: "X#,/3IZ[M[G[W^U_-/?N#QDWSLE]W;?N86
M5WHL45_7LEIUF0PTS3A&"$%4%#%$$<DAY5D".1$<F52S)+$*DGG^X-E]S,8T
M\.__%A?H/QP6)7VH+)9[G@",_:GV?/?)W^V#X+#<\@1CHC64U0OAMB ZX?#@
M*J=__71+EQ-6'JQ'3OW]BMCH,[*C=^873<G?YJJ[:KVIY:9LIS*OY$JJ<F-B
MM==[%=)74E6U-/+"F"54Y2*&>@*2F[D(A8R1#*991*1 HF"9VB:"?'&,!![!
M7JNW_S!WY,L4E/C5[)R:?8/'5;TO0O[3LBE+?F]*E)LPN(?:I*:O9?V]Y!)P
M[3BH.^V[306$=GRE?V0M!.#!8. 1>#S&:Q(IJA3E%.HEK9ZR8IE"%G$.!::X
M8!BQG$GG2/&7>C^FK/]\0JWZI];5OP#C[ UXTW5[YUF3)G,#J-+FF8+V2[I>
MEZKDQ^K5K'%Z4+UZ8BY)59[RB$ 5<P(1RKB> *44*IQ$&2\R4Z%MRR4?I65E
M@ADQR=;FR7GD7X! [#9LYD +(\\@7Y@1_/(P1NR2\(D<8Q@[?2;(B)"?3"49
MLSVW.:^0Y>+M:E-NGFZ%T)_>^K7^\5/]I?ICM1 )B>*T*&#*1:J'F)A#DB(,
M)9,LD@E),;<29!UH8VY3B-9,T-EY XRE&D=@;+4C]R% AWDY$$PC4ZH70M9$
M:('!"0Y;2_[7^^K[_]1W-_3U3V1^A.V/#6<-/7<2NK%P;,L4-I=Z[)Z]?2@U
MO]P^;JKWJ_^27./_NOQ>+C^4F_*^&=VZG9(L5EEDU JDY'KUP50$B< 9S/)8
MD83'2E(K&1>71F=' XW9P-@-MH:#QG*P-]UG2\JV$RSV[$: =FSJ>&E4'38!
M1T!WH@W"0"B[;2$ZPC6XO6C[K.FV'AV].]B6=+W7YURDS4:^,X'YU:I2'ZK5
MO2FJ^T:RK31E+$14)%C ",<,HH3ED(D\AU+%!<ZCJ"@B^SKNE]N;&Y]W%H/.
M9!-_9(R&QFI@S'8Y5;B,MLV)2U ,QSZ(N02?U^G,91Q=#FV"XCD158<ZO['V
M??A8Y_)C)CSML?;I\!#(_C;/Y*0NZNV3LJQ3]X6R9:_J4,0DYBR1$(N,0I06
M'-*8&$$PKC!FC'"*W!(_K[3(Y;.8)O/S4@%*XX-CNL^5G6:WGSIA1XS,]X=Q
MN@[E0,'OC4]@E"I2@? -FSASI4W3)L.$ ? HP2708WWK[VTW2,W.Z#X>F$>R
M*(@TB9U*3WB1@D3I"6^415A(PA.:.XG1GFYF;O/<O97-.89_+/ 95.V(\'JL
M1N8W'Y@\BMX-H1"XK-W)IB8N7#?D[G%INL&K_:C@%=7/XO+S5RDW'ZKVR*YY
M;?,4YS'!$51ZO0M1P3%D>NX+):5II 3-,Y:XD,&YAN9&!YV=H#$4;"WU(H2S
MV'))<ZED 9.<%!!)9:0CF81%$DL3[Y03%;E-:$.@.\U,=0I\[2@W!&8CDZX?
M6,ZT>PF)H,1[MK%)J?>2R\_)]^+UGO7JCF=[IAC)?ADE4IZ*/.<PHI%>^Y)<
M0893!/.,$)GRF.6Q=*.*2TW.CS(.%T]O:;TJ5_>N9>HN 6W'&2'!&WL#<F#)
MV10?&J=NL2U"80O376ITVIITEA <E:.SO<_CO.,VT:NX7K6C;K<X3XL,Y9Q#
MQF4C11!!(CF!$@M>1'&:8XJLSSA.MS&W"9XQ\J"NG,/^^QD4+<XNKL=F9+HX
M@L7G?.(,/@YG$M?C-%DM-]O7R.U@8AB P<.(,[=.=P Q;/O!H<.%2Z\]:/C\
MM:HWVT.,9N],4YU>5T4IASG+,401BR'14RE8Z,66%#Q)%'63+1MH;&Z<U]^<
M;JR%F_TQ9&.QX])K$&G7K?_K\)MP7]\5NBNVZ\]C,M)>_(D&7VBC_;SKYW?1
M!^[QHY+W*]W-<KWIY!H7FBHH1@)!@7 "$4XEQ'&F8)'E&49Q(7CLQ![/GC\W
MPMB:UU8<6CM*!3X'SXX0KH!D9 [8H?'V AK.'_P9GX-^X\_;F/2S/N/@\R_Y
MW&4>*YU7C^MR92* JV^L7#6SP+NZ^EZ:+ &Z?+]25?VMS:]?E9N2+F\YKQX;
M"9YFR?6PE!NYSQ5HSN0^:E_;((E6SW618JY8SA,H:)Q#1'@.<9ZF,"9%&F5Q
MD0HEK)=-$Q@\-WK9N@QZ/M^ GM>@Y_8-Z!P'>\_!WO6;@PRC]KA][W^KS>RR
MQIOB_;%8,,[LK1A[H_O_YR^$PPIY9B_&1,OM^;P@;LOY"7MK<&]@"CNFVVB8
M$-6#78LIV_4L?E,9ZSI%05[*]:NGC]34"_VD]K]^:D_XE4RB3 G($8D@HGIQ
M0W)40)'$4E F.(N=3OCMFY[;=,18#GHV@M9NKT-IAPZP6Q:- ^O(X[DGHNZ%
M>9S!"5NWQ[[Y:<OZ.,-R5/7'_0G>L8C4B ELCW5[\9!&9H"7FP6/8QG'2015
MGF8098)!DA*L*2M5&2M23/+4[0S\<J/S.P7?V@RDUP&X!<YV?!06NY%Y: ?:
MUEKP4S\XNS/X+T$C&"W1"1W->*G9J2,;+6$X$>5H>Z>[WND^@_ U74L30OFF
M^J:;6U"<)!DQ>SD%28V&%(4L(1GD6)&$X2+'D94D_U CLYOU[#-;C:%=1&]K
MJX/LZ5E,A^DD%%)C3V2>@701'R?ATTL 7"U]>K:!R<1/+[G8ES^]>.T5Q;'8
M0#61KI@(>UY,Y.V/A[)58V_KB"Q(EA4YD3G,,5$0\5C/1! O(,YSC)7$/"NL
MPF6"6S8W;OF\J?@_0-448P'46&Q.DCJ3P4-7:ZA<@2<]FW'-3 O6G98'U2_1
M26.?:EL4D;I00VKO75<[*G!IJ)"(AR_\%,2ZZ<LZA03U9-&FH WXT7WWZ/4G
M]8NL[V7]:RM ^+I:;];ORA75R]G5?5=_PU0[SIG #%$"&5,4(F&6ER1-(26I
MC 7+49K%'@JSCF98D<,+",?NR\SP@S(S#YU[;MSMVC=V##T&U-/P\-9R$UW4
MV@XZXT%C_0W8V0_V#H1C6D_D@O*IJPV3LJ8G0,^YT?<QGA/>C7YX<\*@FHG8
MUVJI;UZ__>>C$4ACZTU-^6:19WG!BCR#L9!Z,EMD K)"IK!0TM!AG*B<.$UF
M;5J=WT2U,[J)[^N9_3] :SCX?6NZ:XBD52=83D%#0SOV]#($JN[31A>4PDX)
MK5J>=KKG L;15,[I9C^2:A_VB]Q\K<3[U7?9GHFN]QE9.&4I2?6\#.=1 A'*
M*:0)(3#7;U]29*E,,ZMR);8-SHV:NB^E-1CT+';CH8LXVU%02/1&9I^SP(TJ
MM6(+4%#BN=CHI)QC"\%SNK&^SU>G^5VYE/5KS6GW5?VT$%&DXCQ)(8]0 5$:
M$TBPIIC('"A2)#&+K&*YSSQ_=CS2J@]K&Y=&B:BSTE69^1#"8<X( ,S8%+'#
MQ 82#RGFDXY?*<-\^,R))9A/.G0LOWSZ,H\P[C?RNUQ6#U+\0NM_R,WZL[PW
MI-!E%,HD*62L%,RX1!!%"8),Y1+B+*&Y2(D@Q+Z$]F!3<_N:=\:"SEJ'2-9A
M3(>_Z;!(C?QY'X$$.DM]DEJ'47.(W V&WD0QMV=1#!0;:X7'8%3K\!.FBT>U
M\N0@DM3NCFO38-_(NORNWQ(C)Z 7;<U+L_Z9EBL3WO5^U5OF=9M0='DGZR:*
M53N]7R(H7D1%EL50B$A")-(4DB(O(,NS+%,B2QER6HH%MW!N+/U6*<F;W8^]
M@Z#G(:A68/-5FA!)81*>!-B7_M3_V+G=; Q_>N@VW;TE/$.]!Y:[52_9NZ./
M+*>Z\P88IZ85] R,[4AIQ:&L?*%<Y, @GT]@#MV0W\CQV^<O=5-E_.FSY(]U
M<Q:QG><41'\<DL"8%GK&K81F?QSE4$0YEUDA4NP6^G*^J;EQ^6]__?Q7T!D[
M=/CFBJ@=F8;!:616_.WS%J GL#<S8,$,>S2"\MA <Y,2TF6WGS.+Q1T>B_)?
M*D%5N2J7MV:Q7S^N-_N0O=N5>+?A[U?_?"SKIVW%<<I8QC6N(D>Y6:9CB(7(
M]:J=)BI#E,>%?5TDQ\;G1B,[\\'._GYQ&5,]\]V7UZ#SP6%]ZMHI%NO\$:$>
MF8G<4/;9#G"%VV&#8$38)]HR<(/_KX$V$CQQ&]Q:<'WF=)L-GMX>;#_X/L.G
MTI)<2E;+']WGP'!,F-&5CG+!($I3"JF0&!)!<IFA2":XL*^J=/#LN3'^UCKP
M[_\6%^@_7.K\'&)FP=C^2(Q,R,] \*IZ=(B&2X4C;U0FXDO;5\2QN-%)MX<+
M&1W>,F'1HI.V'A8H.GV)GPIJ@H_U*3G*>)I1 :4R>NPJ32&+3-'>3""JBAA'
M;BJH)]J8&S<9(T/(?9Z"TX*NK@=I9-H:$Q\W.=0K<9I,#O4<7J'+9@Y#<DD@
M]=2MDPJD#MC^7"!UZ%*__;V/\H^]),E=7:WTC[P]:-"SOM=?3:;&^OVJ?TVY
MXN7#4O;BQ522%KD@,<Q5I-E2( 99(O5_5)86.&%I$CN5"0IAU-SH5?O4UQXZ
M],IM!S%(G]GM-4[=$R-S>*\#/F_TTI/68@U^>S!';,U*M'7(9"$>=%7GTDCZ
M^"$Q#KK7&<2P27=%0T+Y?/\TZ+/]R%H_NY9FU-[*J/)$I+&(!40R)1 12B&C
M*M&SUASIU8-(1$Q=B/=Y W,CT9U]?BJT1_C9D> UJ(Q/:!T@P85HSWD=E&*.
M&IF4+LZY^/S3/WN=KY*TD&:K;2,_E-^E>*^GXJO[DBUEJ_?V]@=?/@I-(#]7
ME?BC7"X7F- <)3R!G-,<(I1A2#,N8*QBD21I&G&[U:BO 7.C@?<K^%!7W(@_
MZL=*W0%?F^%;M"%4@P%I87K$CCC&Q'ED8MF;#I?&=K WOI/#!#_M[ =;!P+*
M)OEB%U@HV]&(B96T_2 ZEMKV?(YG-K[Y=*58O],.-;EDGQI1$-V.K'FYEF+!
MXDA@4XDCP3(U>5X<8I;G9O>-T%2@"*?*A>\NMC@W@ML:#$RGZ[E.:Z:)_%OW
M9%1<,^TOXF[':D'1')G&#H%L-6@Z<\'.WH#)\[;0A$V7O]CJM GRMB <I<1;
MW^BST:_79$9P5\_C3$R=";-]Y)L_RLW7-]6/)_[$]8WR/_7_T(U\(Y?T28I?
MY5+2M>S]_1>]ZOOZ)&I]S<_+\J'\[U+(7^3&!-V9&#SQ-UG3!_JM7&[W=64L
M1(XS&$>17J1EB$"2* 33(E,LRZ4DV"JO[,4\F!LQ/L, ="  @P+HN0DZ'$ '
M!.B0N#FXJ ?&#=C! 7=X-)/*'2)>^_TO\=;9G+;,_%T:>]G\?UXC"_)R.)2:
M^>LTT9'7O%\KQT.U%^S2X2.[ES!LP@/!%\3]\+CQ)0WQ6UF^.[^(??7T"_VO
MJGZ]I.MU([7/\B3+XXSKR7260R1%"FF"<AAQ@I%21LG3*8'-H>VY3:I:T^&'
M,_L\[ DT]H/& :\2""X=8[<('0GND><=09%V7IUZ8!9TG>K2_J0K5@]@GJ]=
M?1[A*^7V7'[I_:K;H+NKZB9<=[.I2_:X,3F'7RI33J9:;30>RZ;J3%M6;R%)
M3)C@!50H91 I$ZZ19BF4-$]RA(20(E]LJ@U=VO%?&+.<J'%GW'@?[!?3!I"-
M/ZYB;T&Z27=&CF2.(:$IABBE"C(A$$19GL8L8CD6\:)53_Z\H?5FKIWUW,3Q
MNNP579H$R!?IK2@O5![G.4QS3G1O20IQG!0PSE"N<H$SM.NMMRLQ[[[:&OBO
MV5-VLXSIL1]Y G)*>='4QML>Y'5>@;Y;8%.!0\? UK.02HTAD0XLY1C$M(FU
M'D/">2P&&?3I[AINM]_D2I@-G7=+>K_0XZ!229[IJ4R20I30'+*HB"#5DYA<
M)@6.E544U-&3Y[90VQD'C'7V>FV'< U3WU4@C+UM:^>_DSC;25^]9=D.GS:9
M(-M))_I2;*<ON/[\_OUZ_6C&\$_J0[6Z_R+K;V\DVRQP(?4E10X+_9,)3F20
MY)C"A C&69101IPV5RXW.;=/]?#@N>QL-B?X2VTUU"9\ T+;[7^$?P9Z]S/\
MZP&=]!#_?0_+#SLLWPQA>=4Y_C \HQWDGVGVQ4[RAV$8.LJ_<.>5@O;M_,/4
M%ZE632RVV4,LHB3A&*=0$*9G!(2DD&4YA3)/.4F*1*8Y]A*R/]7:W*BG$SO>
M&^FU93L,L.WR*1!L(Q.,,V+^0O1#2(PC0'^RQ9<1GA]R_JS@_.!-GJ)6JT=-
M2<M/]?N5JN4_'_5CW^O&NG-OLX"04N50Q4A!E)$$8IIAR%/%<:YY)$]S)UVK
MH=;F1AZ=L1I.L#<7&'MOS.]>59NOCG)7@UC;\4@P!$?F$0OPQE# LD$GK C6
M8(O3ZF#9.'\DA65UD^<9-"WKO]'EHWQ3KOFR6C_J%VQ7VT6EJ*")T;S*:6+J
M5B-(B%XF131)1932G/#,Z=!YH+&Y,8NQ%33&@IZUWL5T!G&V/$,.A-[8A\;>
MP+F?$%L@$O9(>*C!:<^ +5P_.O2UN<<[U7-;Y/JCW&QE/\URZHU<E_<K\X=/
M]?^C6:Q43^7J_C5=?WVWK/[X3RGN=[(2!8D8)U3"+.*QR:- D(J<0,9C$14T
MC9$0CNFA5QLU-UHR7JR;4#KCBVQTF/?2JXXI%D%ZS8Z\INZ+L;=V]^X [<^!
M>G*S[6/L!\8!T'IP=$1U1VLK.7^?1-A@2(=.GKW>L*D3;H-!>2))-]RS_4A;
M#P/T_KZ6K6K>)_6K_"Y7C[(1_UX@$DO.-!FK+$XABDU2&TUS6"2(9UBH-!6)
M"QD/-38WDCVTU>S<=M9VRNB.<[]!G.WH,Q1Z(].B/W#.-&>#2%#Z&FQP4EJR
M<?TYW5C=XZL/H!^E.^M)\]B",$&CR,00)3&#B$8%)!GG,.51AI*(4I**Q7=9
ML\H^^W__>)=7O=_(>&_\UCIG7?4#U&+*4YH6!,K(H"92"4F<QE!R541,":6H
M4W2C+V93Q"B&0<R.-GUQ&)DF=V;=F,EC2!&"8W<#"PST&IA8/.#8M6-A@!/7
M7%N!J*MK]*M\,*%")ARHJ5EA6/354_?'7LE76J#(E'SE7'(3VZ.7L%&NH!1<
M)$1&2O+4K\Z0DQUSFU#]*DTWE\MR-R_8EC/KN6%616T \T$IH=X5OM6#W/K0
M\K!P_)X9F86V'O2[8^=$'_8;D^FQJS\W26T@+TQ'J@#D9LL+U?GQ NQ\-1^_
MQWER[5=:RU=T+84Y-96K=2OB7M=&HLXTI%O<77)'G\RO;O^@M>CT%G[6%V[6
M[U=W31SX(D.2X<04W$X2,P.-8\BPC$VT91RE(BLD<E+W#&O>W)BY,1TRVE9P
MV_L'>@XVGW_ONLY)T'AYLQ4HN0&MIT:.LO6UF=T8=GE7U4J6&[/?[$CA85\-
M2V9_L0X?F_#GTM?N \,H71)VO AKXK3#R"CP'HTNX[1RY;EWF_1XNQ(?2LKT
M#+6M,V4*3TGQ:?6KJ3U5ZP%07_"Q6M7;?VH;R_6'<B7-0?QZ(3#)5<8R*&1D
M:LO1#-(8%9"E/$X8BU&,G4ZN@EHWMR%G?T!\L\TD;LZS]AZ"K8OF=&OG9'-5
MWTW0^ E^-YXV82O.>=Y!7P+'4_RINW:R8_\)>]4_8B D^N.$& 2Q\&5B$D*"
M>S:((6@C?H-(&^OYB]Q\K839?%IOMOK:_ZLJ5YN_Z7\<Q/E0%?-(Z@4)*G &
M49IA2 A*((U$IN(T(IE@+L.$8_MS&PBZ..;6?M!SH.&$Q@6P]<$[\,JUC^Q8
M?$3D1^;IT* [4[ G=$%)UM6&26G4$Z#G1.G[& ^QRK>_Z1G]MW*]UM/T+I5&
M4^WZ=;FAR^JAIMOP:8)1BFF"(1,FSR5).*0R)]!LRZ "Y2R-K:;)+HW.CO0>
MZ^I!TA7X;666WGL?0,\) ,'>#P?A/=N.&":YL> =F]E^.X?FWF@?-4-;4!T$
M"$< =R+-0!N0 TGZ.8(TJ,)G^ZSIA/,<O3O0NG.]UX/27SVN]21YO=8-L7+5
MO%2OJZ9.C'['S/E<J1_T? -GK6?=1C:J5"5O_K9>R)RF&36S78$UY1=(0!:E
M">0849%CC/+8ZD TI%%S&Q*.#'0@IU#]9#$BO #Z(X\86X] SZ4;L'<*''C5
MWR9?WX Y])K#D/,"O3?1D#11+[H-7H'A'AS<0K4UW> 7&)V#P3'TL]T&SW6]
M,6H"1GOV4_U9UM]++IL4=(53U4CAI1(KB"*&38E>"DDN$:%ISA)EE4MWKH&Y
M#6J=C<VN0F>F4V+_62"'1ZH0\(P\ZG@@8\T]E]P?VD71]_9V4/2_GN^>G'WX
M),1QR;4M"5R\SF<V7%;K\ENYI/7:*(:I:EE6W:HORI"@<5K  K/8!#P3\TG'
MD!>RR+EDB!56Q7\NM#.WS[MG*=B9ZC(#.H^HS50T"$YCSRY/0>2S 3& E<L$
M, AF4\WIG%XOQZG912"&9UOG;Y]P G71A\,YT>7+_4[ /FV^RMJ$<]3RJ]13
MJ^_R_8I7WV23RU;5LKQ?O7ZL:[GB3U_T9&M->3/Q6HGF7\MV&B;^Z['=G/XH
M-Y_4%_IC(7DDBZA((4M2/5E*"P5)'$=01)CP/"^H($[)9^.8.3=.;KP$!VZ"
MUL\N-?4&=,Z"K;>@YVXS(>DY#/8>[Z*[M-=NQV\CO2!VIW0OW^TC#S$OW./.
M9W_C=DC0(\*13)WT)'%<N)\?.([<VI7">Q]V<5I,Q#)1F,."< &18 KB%)O<
MNX0E,<9"4.FEMO=AKA%W.PNOB)4[ :0="5\'S\@$ZHB,OY#>D?/CJ.=]>)G(
MK_-NGM7).[[2[P,_L=UGLLWN5^5_2_%>Z)9*5=)==9-;_L_'LI;B,&Y,_TVO
M:D1+3YOV2B.LAXG0\T]&3!GS&.40QS&'-$EX@E'!1.:D"CR:I7.CF\XX0+O"
MVW)7>+O<Y_XV<X]5.\?@1BR%=OZ>+\H]<?_;T=LL>O5%SLGV;H*^G]OHWZVG
M1V' G;,W8/N>M#>$(]W1NR0H=X]G[:1#P.B@/Q])QF_0;T#Z56YT.V:(N],?
MT1?]D#?5-UJN%@G&,I6$0Q6K"**4"8@E*: D>E2)%,NCW*JZ\J6&YC8<[.T$
MQE!@+ 6_M[8Z3D+/8FO'U2$0&YEJ_<!RILA+2 1EN+.-34I0EUQ^SB\7K_<X
M1_K?;S\:0?D/%5UU&_@Y82DM)(8\,YEC28HA12*'O-"K4U0D#$56ZLVG'S\W
M*M & F,A,"8ZG( <XV9Q2'05&B-_Y@= ^)P)'2/B<!1T%3(3G0#9O2IN)S]G
M_1X\\#F^:[ISGK,6'QSOG+_*4\WU.RV79NKTKJH_TZ7\;+*GFOF2*86Q_]<B
M4@5E7!.70+G04QJ>0%H4'*9(,HGBA-&4."FV6C8\-U[;V0U55<.UMARL=\8Z
M:K+:8F\WY1D#T9&YT1@&]I;=@&-T ZJE.N(35A'5MO%I54\=(3E2-G6]WU.]
M5#]L+V2]UZP7(DTC*2')(E,.(U.02B1@7"#,<QKCQ*ZZWG S<R.@YIO9F^F=
M+7D&5#NNN1ZJ*9C%#25W7=)!$,(JDIYN:EHMTD%WCU1(AZ_V6%&]_DKK>\DH
M_\=Z@?(<)U&<PZB0#"+..22"9##+$ZYR?6\:%XN5D4"5XHOEDJKW?*L7F;0O
M\E$K(^ZV[RUT6#_T<;-82[G",,WW?+WK#HLF3P@F6B[90.&V6#KA[^ RJ7_]
M= ND$U8>+(U._=V[CNB#K#=/9C=H<[L2)K_ZH94M,IM#36QZ2B*B(A;#!$5$
M,Q#1DX\XPI F+.=Z7J)G(DY;O!9MSFTFLC7YIMF_;*/<=V;?=/N9'@7^;."W
MFZ8$!G5DCFMJAGXHOTL!ONC?E[L3MN!%_QQP"5U&]&*[4]<1M07B1"%1ZUO]
M:.AU53]4M9Y<?*Q6G1!GMP&H5S91DFO*0205$"6$0)QIN"F+8I47/";*27OX
M;$MSHYR=H>!_@B8(S8U9SB-JQR=!<!I[IK2U\<9H;<&=F&_PZC,7P0A*'>=;
MFY0P+CK]G"8NW^!=T>6A6M/ESW7U^/!^U87=F!57DP'Y*,6GAR[YL2L L4CR
MG"F42,A3BC1U9 R2B'*8Q055+&&2)DXU_MQ-F!N=;$N65 JP7AK*@UN6TQ5=
M8KG;,BK08^_$=,:#QOH;L+,?]!T .P]NMH5D@A:0\<0O=%D95S.F+C;C"=.)
M$C2^3[HB.>GM#R,U*[L177(B9"P*F$B>FA*#$I(\$IKMXH3$(M-TE[F5ISEN
MQ.4SFZ9(39LF(ELC/?)W#C&THZ?K<!F9?EI .NM&F 6==SY\CLIA,]/GEYQT
M\V1NR.DK?:/LUIOZD6\>C:CGZVIM%EOZ=[+^+C_L99D)PU&D3!4 O1A"M$@A
MP9A"*F*ETB+#$B&WB+O+C<YO-M.S&1BCFRV9SNPK$D*L>L".*T+C.C)[A(#4
M(V+/'J/ T7L6#4\<R6</Q7%4G\.]GAO%)OFM26QK6.].-U+O8@E?R954Y6:]
M/P7K%8]"A5)1P2#%+(=(:;K"&$LH4D915& I$K?=8T]#YD9AG1_-1]:.W(>N
M@*TOO;-=Q\UEWRZSW'&>H"-&Y[QCM'\?I0C4M6"%W9OV-6;:#>LK(3O:Q;[V
M>;Z%1'DMZ5J^D>W_OE_=<EX]KC;K._ID HJ^U%3(!54\*U0605:D>@TG!888
M"?U/G.&,JTQEF9.*NEVS<R/%K8W@H372M9:F%=1V]!8>P)');&LP^&EK\E],
M):,=I)W9-Z Q/&1]3A>@ E?NM&IZXIJ>+G <5_MTNOO:.J#;=+,FCVQ=-AJ!
MKYYZ_VK+>4>)2@E.(QCCN( HH@DD)%:P0!FAF>X<5&"_ J!V!LR-IOI%)G=I
MI'T7FN*2O5_XE5AW[B<[9AL3_9$Y+CSP5Y3S=$-OI#J>ED:\4 %/-XC.5^YT
M?,Z5U=/TDTTLRFNCG=J$X$@]"T.(29ARJ2=G2A208#U7PT+F0DJ61\2)_\ZV
M-#>B:V-R&O.\XIO.0VI'54& &IF3'##RK^QUSO]QJG0=M?8R%;?..7VV>M;9
M&]SECC]SN:)U61F-)T[7V^ 9DM,4J11!G,@<HAQSB#DRJ[:$$X&S5,56F:WG
MFY@;!6RM;$77C)WV4L=G0!S^]L- ,_)'OS4LX#';9;^OUCD^\_C)E(Z'W>MK
M'5^XTC/*D*Z_OEM6?_RG%/?R9UJNC(C;E^J5W.ND2_'W<O.U7'WY0RZ_RU^J
MU>;K>D$)+42LT>01T1^]X 6D,>.08Q5%L<A91IRTU3SMF!LSW-42;NB/1N]H
MJ3V0:U,#LY$]4MH[\-6XMP:;"C )ZIYKP+P5X/;3Z[>@7.D_2UJOFFH[Y4H_
M[,<&;!JOP;?&;<>X1\\^MIN/3-!S(Q.7\0 8%T#C S!.=+*:74_U70%_-+Z
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M9!H8!16'@(@KT9DH L(1);? AP$(!B,=3MTW76C#@-4'L0Q#U_G-A?02R @
MW)F ?2'%JZ??UE*\7W7U2E;WMUP3:)NZ*%"<Q2K!D&<*0:00@T06>KD9*Q9G
M$<Y94;BD%]DW[<1^$Z0@:<M;B9.'SG8C.%AM[09T9[C;?,FA+^QF3^,@/#*)
M&G ;@9*['K@_&<M!N?H+V!D/;B_#[#S%<D<LZ(3+H?E)IU_NL#R?C'D\P7,O
M[6M5;[YH>GQ5U77UAY$46J0\DEDL&"RB0L_..$L@H5A AF/&5!;%RBZD8Z"-
MN4W0&A/;\97MC'3<[#J!I.4FUG7XC+TYM8?&5&T/N+MTWNVPNT8GVIEV-^B\
MHT>[/ .7>B8[]W>+3'ZUV3#:;Q)]V-=(RE@62QI!5>B5F%Z!Y9#B*(=Z]B)2
MC2R7N5,@IFW#<Z.";=7'+E^]B=W6YI_:$K^B:))UM]A1R!A@C\PKSAO=-EB[
MIW4[ A<V\=NV\6E3PQTA.4H>=[W_VE- ,RQ].3P]RC.6,QXC& M*(8IY!%F>
M%3"6,=;S&9$H&;F%; PU-[^(C<^/W[[1^LD<*#5UX[]<'+[=,78]H;L.MPF/
MX(RA$YVKG<=DI(.S$PV^T,G8>=?/'WT-W'.E?GVG0W.@/_.+I*:JD?ADM&L>
M:U,H3E_PL5K5VW^^HNMRW=:1D%%$*4LD9"E3>M%$."1<2%@4#.,<BQR3PDOO
M_EK+YC:_,HZ!QC/0N=%D03<R5JWMS1R@[XQ?*9!P?6O'="_28R/3XKZSKNH?
M?Q'_4%B.(_I_M74O4R0@%*AGBPH$:\ W8H%MWJ],?4]#+>TW3(GDF8@H5#%A
M$"&.(5-Q! L1\8Q%B8@Y=0M4.&IC;DS;G]-\V)T?-;.;O>5K/W(]!;$=35X)
MW(3SP"LP\PA6.(M*X!B%XW8F#DTXZ^AQ1,+Y2SV)H5P_5&NZ_+FN'A_>K_CR
M46C>,04L&^&51\U.[0Y[M6K.#CL)O#1FG&*DP4QS#I'B2L_R(CW+DXCF/.$X
MS:TJF%QGQMSHI3V8]E$6].P&2WX9'=R1*6CK &@\N $['T#?";#SXJ:KA1Q:
M\? Z(,.REI\ITQ+;57 =<=]U3[M"L7&_4[<VIY"M^.J"LRQ/4T2,P+8I29Y2
M2(N$0(P*BE06IVF1.HLUGFQJGC17[TWU$&D\C:D=GX5!:F3.:D'J6=ED"^R4
MI0-K,@ZB$5Z.\71STRLQ#KI]4H1Q^ [/BE!5_5!IYI';JN!=RF["!!*()C 7
MJM ,4<2:')" 0N59'N%$Y,)I@76FG;G1P\[,9E>D,=2Q^M(9/.W8(0!*(U/#
M"8 "YD-;XA"V[-&9MJ8M:S3L\%'9H@N7^W'!WV5Y_W4CQ>UW/1>YEQ\?S3,_
MJ<]?J7Z#/CUNUAO=Y]W.#E_P7"J9QPQF-$X@BB6&%,M($P:*]0J*IAE%+@SA
MU/K<>*,QRHTIW-!6.$MDKOE84$7T4C5CD(J<P5CQ'#%&LBAQ/ (=#>]ISD2W
MY@/:V@_6C>&@VEL^9G_8\?EH&(_,\CMP.\-!:[G91FMM!SWC;\#PV^_,_EZH
M!1T3W"R8=*3P N?Y^.'W$+]1Y6U7V_).ULWSWY3+1]WT0F D6!+G>OPH] PS
MU__!-!(0$TZ9BKE(I5--T3/MS&VDZ,P"/Y4K\-OG-T"O^UOJ^HL;79V#U:!*
M,Y1 AK(((IQ)2(E L$!<DBA+%6*. T4 8*<9$K;0[JJI_K1L]*,-Q/J-+5<F
MAJ;!.@S4=F-  /A&9ONMA4";V/+[#>BL#$?J%V (2M_GVIJ4J"\X_)R2+UWN
M&5;7RLEMU5F%5#R.$,22F41-2B C(H(1R3),,RYBX73R<?#TN1%M9]S:,W_[
M$#F[3]T;C[&/0:VA< ]^.^5RV&BW@Q:F#6\[Y=Q1/-O)BWQ#'52YDN*57.D?
M-D;O];.LOY=<OJ[6FP5/XE@I$^J099G1;$PAB[&$:9+00N*84VQ5)]BJM?E]
MSHUI@&O;7(,;AD"U/(8,!=78IXVMG: S%!A+;\ 6N]=#V'D$.5A@$CC<8:C%
MB0,?+)P_#H&PN<F/.DRQC=>[@C-/;^@WO;!;W]%2-#%<BXSG*4L8A['$)H$Y
MEA +06"BUV R*E(1<Z?MN@OMS8T^.OM,#1DFP8,VTXU$+L%K1R,!01N92(RE
MH&>J7A%T"!IK;]HHTG!<8@E,4#:YU.:D?&()P'-&L;WM6JVH7K3<OK(/7]+U
MNE2E%.^T/[></WY[;*K]?'K]_OW*E)PP=>+>*B5-?K.\JVH3X/!1;A:4B"+%
M2D*4Q!@BGBB(XY3!A*213 5%G&.W38JQ3)WA+L=>;JGGZ@TXK)BU=QB8EPWT
M7 ;:9U!JI[MRBS=@YS?H'/=0!QSM7;&=H+U\_X\^MWOICK]"M&N<7AE)\"NP
ML2\D%C8.Y.>%QD9JSW/CBRY-DD(3>\&52&.L8B@D3R$J4CWUS16#"LLD5RF2
M-(Z=MKWVSY[;-+<QS;$XV2G(+/>[_( 8>[?+#@/WK:YC;\-N=/6>/^TVU[%C
M1YM<)R[Q4 _\?^F*_NA>L0+1*.&*0$(D@RC52U.2<P%QFN1)&BM.(JNO\OF#
MY_9)-J:!?_^WN$#_X:"&UX=J^&N\!H"1/\6^[SXE$_L@.$@!>H(QD02@U0OA
M)OQWPN%!P;_^]=,)_9VP\D#@[]3?KU63^%6:20G?/'89BET]6K/AUJ4#IR8;
M" MNBE?G$.520A(5#$:<:E(2!$GD-CNP;WMN5-5/ESLPO@GVW)9A;NSWRS-T
MZ1?+*<@X:(\]10D(]!5Z%=:0C21?<;G]%U*SL ;FO+B%_2,\M2[*5;F1'_2:
M2>AUE'ZY2OW,+E/[FUE%_7<SC'4U.IZ)O:2\B-,T)WI%1(GFO(A#&K,8)CS+
MB$8.98G38< UQLR-!%M?X-(X _;>= EYH._/Q=(TX7O.CA6GZH^1:=*C*T95
M^@D!:UCIBFL,FE:M(@!T1P(5(9[IQ[[/V_LH-V]_=&F=/U>5^*-<+A>4YPFF
M:0&Y,,5T45) B@F&&:5$Q2@56>P4;F73Z-S8M/?5MKGE-V#E>K1@!39#.":)
M2"#G1B,N33C$LD PDQA'*,YRGCL)= <'>P)I[M-@ U95_P#?6]D?N?4!W'=.
MC- 7=H-4:(1''HR.QI_FK 3\M+,9;(T^'\GM/.*X8!1T9+%J>-(1Q 6*YR.%
MT[V^B;3?'FKY58\TS5&(.=70K7Q27^B/!4YPJG"4PHA%"40THI"J@IA: @3S
MB'-&(A=N&FAK;I1T8.KSR'S7U-KS"-LQ3B#<1B::0\A:,[OSW99R*@6TQ3?@
M=K.I2_:X:2:\FPJTE71#9N%>A"MP)N[Y]B;.QKWH^'%&[N5;//.GOCTLJR<I
M/TN3K*7M[_;#HT+EJ1'WCF2,("*\@-BLX1E3.-?,DF+EM(8_T\[<)I1;,P]W
MR1P3>LY :L<B 8 :F4%V&.U,'.$X] (,81-ZSK0U;4+/L,-'"3T7+O>N;;[?
M5C1E>>OO<JM D\8D%0D7,,LC"9%H"C<R FF2ZH41RG#!F0LC#+0U-U8X,-6Y
MQO991.T((1!.(Y/"X3E#9^8(FCX6:(2NK7VVO:DK:U]R_$1=[8NW!.")P^,'
MLQ_&]<_;K.^[:MW4Q5B_79;?RI6Y;,%HE.2IGE?(6 F(),.0B8S#C#&1$TYI
MDCDE9U]GSJS9YNC([@9L7>K))NR\ GNWKN I]Q[UH+)1^VE2M@O?1=?1HC>R
MXS&GNTDO1Z[>\ WRK_]3/2+AFASO5W1M&OMFSB>:HXK;6L\4[QL)_5=/^TON
MZ)/YU>T?M!:?'EHK?LB:EVNY?K^ZDW59B2]F,^?]:J,]69>\U>U>B;?_?"PW
M3[W(W$8MZLM7NNJ>\S>-@#D^:1]R>/\B14Q@G.<F4C;6$\HX@BRA N9I@FB!
M$E1D5E40_C0>SVV@V5G7;M\;EEIO*OX//:\W)2&I@6<-9(>,:'BN-N]TV7!;
M<RUX7)6;-=#?F5Z'6(\Z?YHNLPF._#/X,:.QL\$"-F" /F"@AQAX]03ZUW6H
M@0:V&] Y;,;9#CKP?@5:OV]  Q_8O]QM_1!3EJV%\$"<O=48-"CNG]H"V7_D
MLX?]J[WD#L&O?P9_7%[VB:)R_Y5?>K=@XC_3"S08Y?RG<&2Z\.L_!1RGXL+_
M5(9["[_(NC8/-R='7^B/7JD=DP0KBTA&E"0P87D*$:<9Q"A5,",1%X03FJK"
M-6%ZL$47AIXJ[[DU&)3MB>B&_@#+SN8G9T680;3M]DH"(CCRA&X'77>8K&T%
M/6.#)_U:X1):&6:PS:FU86P .*$.8W7;%=4@/FH'VNWE@U)>S>$GBE#!)**F
MFE8&D9)&85B#34F:*98@D1+WFA ##<YMK=U.N9:[*E$56Y;WS4CC4R-B"&D[
M>@F)W\C\TD*WM[5/+B.</-LB$[YVQ%"CTU>0L(#@9!T)F_NNS;L[$0]C(IB>
M93/H%XL5,<J@RED,420%)"(6,$F5(KF@!8N=JM0[MC\W"C)&5ZMF 5BI;@UX
M& UF?/!-N;/K$CMR&A'HD;EJ(+INHBK13HB-E'EG9\,+9=\Y 70^ \_M,7Z$
M]^IQ7:[D>GW+]>*Q/2!J?JREW&KN1CPE2$20I)1IBF,(LAS'D*"8$L;R)*+*
MA>(NMC@W4ML:#'H6WX"MS9[JO)=QM^.QH&B.S%S7 NE,6=;@!"6IRZU.2DO6
M(#PG(OL;KZ,>37/,G$?KY_\J>76_*O];KR&%GD64JJ3[C+BV;7%8QEG_[?&;
M%'=U]2#KS9.1)-UT6V$/9@]LD7.4B)1',$^X7AI&F8(LPQAB3G%11%F6H\2'
MOD:U>FX4N#7T!CP84YMC6KDUUH_XQNUU-_*<35].1< ]AV_ WF70]WF7I-QY
MW71Z?UW<.7X#]F]'X_Q-<^7;BZ^'-YU/TEVC# GC6OXBP\HDG7%N:)JF<8_H
MJ%O](A1O'^OJLUR55?VQVNPVSP23,>4LAY@*#!&)8\AH3B$QZO<JBIG*(^N8
MI//MS&T(,88"8REH306-K0YA#@.06D30A %J9'X^C9&/[MC0^V<?B1$&M(GB
M'QQ?,+>0@LM(#![D#]P^W?'Y91\.#JTM+O<]*GZH)2^;UT'_O)3-RF(E^I(7
MBUP)B7/&8"J8GK8S$NL9NT@@*V01\4QQ197K>?'E9N=X:+RWNIE7T9ZYKH?&
M%KC;GAR'Q7+TX^.]N3=@9W"#YZT-GAY'R/8 !3Y'MFAXXL-D>RB.3Y0=[O5C
MHU\D73_6313.^]7#X\84(]#NW>E?E8_?NC&3*A%QR0C,&(XU&T4$4HQR&).L
MB'.I.$^)RR:"3:-SF\#U; :-T3>@,QMT=KO1D17P=G04&LZ1Z>@RDB.<.;M@
M%)21K!J>E)%<H'C.2$[W>BP<M]DZ7TK]_G354'ZA3Z_,^4\M37S@^]5K_3_K
M3^KOY7*I'I?O5\HD_S0F+7B:<"5I B6*];1)I)&>-BFJ5YB)2D1*DJ*PBH$)
M8,O<^&N?)[<Q_@#1E0/Z1I],1:5RZY/^"7#CE;GTC]8O_;N]8P[+L"M[TV)=
M.UT?C4R*?\+N<5A)3]=-$ZVVQ^\NMP5Z&( '%_%7-C'=0C\,%@>; 8$>>6U0
MUCM:UFVT>[NO>["?VPW-XI/9"WZLZZ[\^_/X()7BE!&9049B 5'*,T@R%D.:
MX*S(DH0(E+CM+ 2U;WY;$._*%5WI1=AR>R+T_"#H-=7.F .B#3  N"2PC=/%
M=JN&%^NVD4?2OC;[OC]NSO7>UC]0K<#.0]"X.%$\64#X1XHV"V'A"\6B!03W
M?*1:R$;\QHA^82X3=GHB=FZ[EY/I 2 5 A98+XQ0DG.]1(H3J*2(,=/_I@5U
MXW_KMN?'[0?%]8*$Z]IW1)RG0A+)H301TR@2!#+."BA8DA418S+%PF53;91N
MF&)E>FO*&I[6PO2LA&;?"79#Y2C0CCP,7H6J\VCFC%#0D<J^]4E'(6=0GH\P
M[@^8HA;)K])$/PJS'GI7KCE=_F])ZT6>\P2+7,&,Y@0B36&0QBJ!^M=IPK*\
M4+GCN!+ JOF-.&9=/6:YD=.=8T=S$P,^,@%VQ4<^G"P^TA,0Z[MFH@$[KYKE
M0^,7,(Z]5!&2091?L!;):;MF7))D$,CK*I,,/]JW0$F[L?1&MO_[?O5^]5V/
MW56MEQ0+S)(4DXC !",C2)\R2"414)C)?<*%8$0N5O+>C!QV9#O8GM573=JO
MNM_J>!]WSSC7^A=#N-KQY/58357QHK4/_+2U]"]F/]H&.X]"%Q:8!*YP,=3B
MQ*4M+)P_KFEA<Y./-&&W+U&I\]G"'\J5?+^1W]8+PE+,TQ1!E1>:2IBD$.=Y
M"FFB1!+A.%<N&H$N3<]M'=K?.!S.B#<N@,8'EZ!4MWZQ./P<#>T)=VA?'F@7
M:;:Q )_HU+*/)U!5#>Q[(E014W\<AZ7"G)XXH6:7CZ>'XEE>3QBU[/+NH"F2
M.,KR/(%1H6>@*!,",J'_D]*,%ZDDA"5TA-++<Y5_.-2LAD!NRWC4K?6CU%KV
M/O4+#O'(HX9=G>6Q#^N<4'N)LLLO?>#F!)!G^>5 AV;F89^4J1]GCNP^R_I[
MR>7Z<[44BR1C:1))!2G/<XABK"?$1*0P5HBIB.$XBJ7;;N;YQN:W26EL;;2J
MZ=)U?3V J1U!A<%I9"[: M28V7#1UE!@+ U9PNT2&H$KN)UM;N(";I?</J[?
M=O$.;V5//;L2K^1*_[ Q6;+;G>-WCYJ=9%<FJFXBH<U9FQ&<.[T++UG,<8(H
MS!26$$F$(&59!G,F(T*9BE,:NTR7PIDVMYG4V_6F_-:,[=T<JC;Z]WLGFK#*
M;IGR-+0[/W:7VG':RW34R!S8.04ZKQKQ@]ZQ2NL9V+H&#GR;XIPE/.BA%4]#
MF3>U.&I@6$_HJ(9N(6@-KEN^*;^W$@I,7T#Y9D$)3@M.,22Y[FE$60HQX1$L
MLIA+G$1%G%IMHCJW/#?B/K](V]L.?M]:[QC68]\?=K0\"LHOM@IV SA4_:OS
M8$U1ZNI$ZW.H:G4>%,L"5@,/N$(]^D3XT&^K6M*ED8WY6=.G"7?\M'HCZ_([
MU0;HUNMRK0U[TYC7RN:_DJJJC;KU(F*%R!E/]4P6%_H_7-,?UW/:/&:(I8@(
M)9W$7T>P<6[T>"K&]%F!\+VWP+B[E3:M5J#G,^B<!JW7NX(BK''<Z,-[2%X'
M?CWL./B%.WUDMIY!?_NI<X_3(^$%O0/;.;T&^#A GY0-'ZDIMP%)R'+Q=K4I
M-T^O]>*]-F5<A/SQ?\NG!>4)XRK)(<,J-<)@&:11(2&)]/"">)9%*;(93LZV
M,+?!H#42=%:"QDR@[;2C[O- #A-O$'A&IDUG9*Q)[J+W)RAJ+?E?[ZOO_U/?
MV[#3/Y'Y$;8_-I1T_JF3$,I%I[9T</E"O]GE75T)/8G=;[PV?+,57%,JCZ,"
M0:$(UVMC3*#)0(4\$RG&0NK_.JV-AQJ;VR?>CO^_RN]R]>AZDC((JMWD*A14
M(W_NG9G]<Y2;+APE?*:*#29!YRF##4XZX;!Q_?G,P>H>'X70;Z6)HNY>9Q43
MFD4BA9$4"42(<8A59#1"*26(H8)1*X&IXT?/C1$ZX\"__UM<H/]PD;0\ &SX
M^[\.AI&_]D,$O-0]#Z!P$?3TA62B^#S+E\-1N_.4T\-RG0=W3*C0><K20U'.
MDU=X9UCH%=!GW:=M#4JJNX++SU^E-&QW*T0C^4^7;\HU7U8FA7O]ZDG_XZ%:
MT^7/=?7XL-:/6#X*LT+2UU1Z8J5'>?'I0=9MV;$/^R!KK&A$4P&)-',@43"]
MMLD%S#+,<\F*@N1.M=DFM'UN!-IMG^Q\OP&=]Z!QOQ6UW $ >@@ ]@2V&( 6
M!%."MX,!]'$ >R \@I!?X@VSFQ#.]+T9><29YROCDV(S=>>%3MB9S/ZITW^F
M[I@3R423F^ 98[ZI^#^^5DM]QWI;L;EK^,YD5E:KOFC!E\H$O+<BD_JA]^]7
M>HR1Z\WNI)>H+(TP*F"$$P$1P6:,Y1F4+*94(IX4.'>4LPIJX/R".UN?'&/1
MPW::W6#U<ATQ\GC4=^Q_@-:U_K#2>7>DWG'H(-AZ.,IQ_SC@APV(#VOBM/'R
MH\![%$X_3BM^Q&].EUXWX\J]7/&#%+Q($%K(B$*1%)K$J>YKEE &$Q+A.(DH
M25.GY='YIN:VFC&6@@-3KUAO#"!LQ[AA<!N9/7TA<Z; RV@$I;.!YB:EILMN
M/Z<9BSL\=HC?R.]R636EJ/0"K4E%^5;J_VRJE7R@3^;WZP7E),TIC6&L"(*(
M<P%I)"C$L8QR/2,D"<;6&\<V+<Z-0'HV-^O8QFJP,QML[7;87K4"WF(#.C2<
M(_/*2R'IL'\=&M&)MK6O1M9MP]L%I<%]<*L'3;<][N+7P:ZYTXTO7\SV=(I[
MM;K_(NMO;R3;+ K%"\'U>I_F661"A3 DD4I@07(JI$Q$+IWFBY-:/[<19*2J
MJ*>%)&Z @0)JO[X! \;+%<^]_);9S9EG^^Z,/%S.\[5YT:*ZUMTWV^*ZESWX
MTQ;9M>Z<,8OMVAMQ19I'[]'[]A:(22GB0H^9DIL0&T$@3G(%.9(T5S''$J5N
M&^7G&YO?IG<;3;;<D4C%EN5]>[#AD2EQ&F&[\2(,:B.3>PO7 0'O[0R<:C"(
M1?B,@=/-31_X/^CVR?C]X3M\U0W8YOW*Y*!]:TAINU]84$23A$20)#PS"5X$
MDI@S&$N9\4P@A6+I)E5PLIVYS86-F6!OYQ5[L>> M2.) '"-OEOB@91'#O\@
M#H$3\D^W-7%V_:##QZGRPY>[Y^9\J:DY'OK\](U5RP4OL!$L(5!DK("(90CJ
M%R.!+")IG!&69L1J>_7HR7/[\#OC0&N=?0;.(5S#'_=5((S\.5OZ[Y1G<])7
M[_R:PZ=-EE=STHE^/LWI"WQ'XVWJ7;N66%#""RYD!%FB!U^4Q\K4B"&04Y0H
MQ3.9V^7$G6M@;I_A+J2AIAL)UG_0!R!V)@/:V.PZ#C^#U'8 ]@=J])%W!TAC
M6\C1]K33@8?99XU,/+Z>=O%X8#USW77;X\WFP+J)Q5O?U=6[JOY&N^RP14(*
M0EEA"G.E,418K](98@G4*W-<9(JEB4A\-K4'VIS;Y[_;4^S9? .TT:"Q>IM(
MY[=I/(2]VU9O($2GVJ#U!--[*]4"GE$V0(?:?9%M2PL@SFTVVMSJ62FPXF43
ML$'77]\MJS_^4XI[^;HM,Z7I;JL#<*OT!V]D/ H44Y6E.8PB*2%*\PAB@BB,
M,I+%)(E8S)U47AS;GQM%F;)J-\ 8#XSUH#%?_V+G0%_%XP90XX:['HMK)]GQ
MUXC0C\QEP5%W+W#GAUW8,G>.-DQ;[,X/H*.2=YZ/N486Z^A$9E<J5;(<91Q2
MEE"(].P,LEQE,$I0Q&B6D0@K=X&K,ZW-C>@ZZ:)3M2"\:G(.0\UYP91,%,P1
M$A#%.8;,U$:-)<NBE.G9;YYYG$Z% 'O* ZKMT?=R;W!(E!U.J$(@-\DAE=<;
MZBF*=0&3$>2MSK7X D)5%YP_+3EUZ2;/'+*OM):OZ-K4 _AF2O U)[FW=:U?
MCS;_[6E_R5T;X7;[!ZW%IX=F1OTWN=XT)_1;8=DOE?G5I\?-VD3(E:O[CX^M
M+H40/)*Q7H1S3,VA>0P9%0BB'(M4<2KR+',J<#*1X7,;3!JG-'3KIEK'WG/0
M<]WDVO:OZ]P'C?\WH$/@!K08-!%$.['I3=7\6E^U1^(&M%@X9KI-]6K9<?$<
M7YB1:7V6[XI[_MS$'1<VLVXJXZ?-N9NX2XZR\:9N_PK5\](\OTD?_!M=/LK&
MKO7[]?I1BH]R\TGII=??R\U7DUNHVUTO:!)1B?74G2:QGK]CHN?O4J^7"*4Y
MU[\B-'7:O/8Q8FZ#GK&T49FH%*AW_H"U<>@&K&1;8J=Q"OQA_) #E6/"=97=
MP#-V!XP\B.S-!Y];O!L/;MI18PU:)\#'MA.T'Z#O2&#5=$\8PPNHNQHRO9:Z
M)U0G9=5]G^61J_B\2#A[^H7^5U6_7M)U+PE712+2I*A@@G$&4:3_0S+%88XQ
MEWE&,:=6I_GV3<Z.$G=&;S,"]$2NL1LTAOM6?+7#?YCYQD%U9)Y[64 =4A>#
M SM1[N(E@ /E+#K!,YBT:/>DZ;(6G3P[2%MTNS-L70QSQO"KY*:I4I6\G:F+
M_WI<;\P[]TZ[:(ZD[LPM^@\KT3SGKM*CCMR4=3N;W]<O6K^K:CWD; \O]C42
M<)%'>9QGD&=<3YLSHUZ4$ II%K.XX%D>"Z>*<"_KSMQ&&XOJ"Z>+F!T<)C['
M#>R! ^9=!^WA9.C2&Q.]@5Q&$8UX"C%+,W/&A2".4@1C7#":TR@G2;)8R7M3
ME>9?YATD[3O8=VOTDYV#MU#2>F7FG."G9?N2U<]?,GK\DKV] 0\M.LV&5M4\
M]^$ (/T6MN_Q@X'HIJGQ;A::]\T+W;75O:F;/]F;ZG)X->NW;S:E9R8EOV!U
M:*;MR4E*UDSDTBRJVTS;?;:%<":VRF^R:JH;_U$NC5[G>KU(<J[T_W%8Y"S1
M<T>&(8EQ!K'^780R%!6$+AZ:HCV?-[3>V(W>!VVXT-GSEL9CMJV)-^#>&&G8
MY[Y<F?$4L%;WU&U<.X0U3E1!]+0'QEQ)B$Q].YJ)#$99CF.EL!(TZF!]N[*<
M$ET)ZK:="2&5S7E""#SMAFUOA$8>1?? -):%&]U..AQTL#EL85+N/^G<<RH^
M?9''YNN'\J'48'<Q3BG-4HZR%.::_S0MZB^9*9G".(XY4CS+9$RM-UD/'CVW
MY6UGG,.NWB%2%MNAWOZ/_%EV=EU10^00"H>-3&]()MJP/(0FT/;D2:<'MR$/
M[YANN_&DI0?;BJ>O\-6TW4NW])1 J$H)BA(),<G,IHJBD&*D8,1YG"2QGJ85
M5FG3P\W,CH]VZBK"6=GK#)!VDX?KX1F;K@[$JV[ VQ];J>]M].HOU)2 'HSW
M]="O'8(EL';MR:8FUJT=<O=8LW;P:L^X5/Y5BL>E_*2VDYLO1AAJ82J;9GKZ
M 9'".43"1,?D*H8*)1C%.>%IXA9&>KJ=N1'"UDP38K$U%/S>F.J8/' .6#M^
M" #7R 3AA91[3.(P#F%#",^T-6W$W[##1P%Z%R[W6)N\?2COY.K]NJ9R67Z6
MO"/Y#_J_K?S8M@"BP"J77).#D<%'(B40<V[6+Z10&4J0Q)'UJL6RT;G116LV
MZ.P&>\/!WG*?J;YM'UBLAT9 =F1F>6E0'596(X [T9HK#,AN2S)'M 87:[;/
MFFX9Y^C=P0+/]5Z_N=YOJ\?U(UU^JM^O5"W_^:C?,A.0<ONC7"^*3-$H,9%]
MHB 0)22&1/,[Y*E>&,89HY@YJ><-M#4W$N],U5""O;%-_-F-^=VK:O,5_&X,
M=YP!#L%M-PL,!.+(?!T /^=YH04R0>>&0^U-.C^T</SY'-'F%H]YXJ]R+>OO
M\EU5_Z8MKS>T7'VA/^ZJ3@)D5[9I5Y-I)33'T:4AMD6"B@(QD<&,Z94E2C(.
M"<TS2%B44:S)GA!F/7F\QI*YD5'G2Q,&L_.FB?;?^=.ON[93'],^@9U3#I.B
MJWK18OHY5=^,S'%_JFYQF,!.U3T3S6K'[2:WV6X(: >GP%<U,-V\. 0.!Y/E
M( ^\(HN?7<Z'9&?R(=_^D#4OUV:+YN^RO/]JDB._RYK>RU_E-^V'MMI4)3.E
M"_6(;39[XX4LF%(%RJ%*39XBHAC2C,<P*9(B9X(D%$6.Y6*G]\*%*Z91+^DL
M!O769,#W-H/FY,.P2)/Z"*CQ?@WDWO$;H(GE2=+:4>WD)=X@RRWG>;\58V]G
M!TSA?]M_3;98@.T+MT,#].  !H_ J?POTY?AL_HG]F/Z!/^7Z:B3N?XO9(K?
M\G-3/W)S!KVZUT/\KW)I,B->5^O-5FR@U1;XI-Y1WDGY?*E>R;?+\ILIBB/%
M0J\U"YFA&"+*L3G'(!"C6$*5Z9^+O,#43BLGE$$S7(SN76HR.#JG@/'J9B]0
MTCIFC@+WKAG5$B;!WCNWY<_5G6NW.)VRR\9?H_YY>\MMS3IEKTVW=)VB]YS7
ML*&@OK24O;J=25>TH5!YOK -]MPPQ=BZ6*];MF[&[462LUA%>O')F$P@2E0,
M*9(QS!*L_T 8Y<0J4MFRO;F-AR=JC&VCX7[?VNRC,3J N-W:+2".(P]2UT%X
M=;FV,\",6K/M>9LO6KCM# "7JK>=N\UCXMX\N@NUR J2%?I%@0FB2/.)1)!%
M6003SKA"$D4D4G9[6\\?/;\-I^V;OSW2=YA@]2&SF-9ZPC#)E^\1M]/WWF&:
MZ(G"1-.]0!.T$TX.3K3ZUT\W83IAY<'$Y]3?_28P=W6ERHW)8%V0+$6IR@DD
M/,HA2O4RG\2(PKB@!6$91C2U.F(^?O3<IB5&$FXYE.IW"2J[288? ".SBO']
MF4; _GSOKJK;/=S-IB[9XZ:IZZV72B9ZWFQ%5<ME_Q@PW+3C&*J@,XS>XR>=
M3!R[]7S><.(*7TG/P\SV3X^;3^J6\[:L@A3GLN+?5&:O44\L.%,D22$51011
MQ"FDBN>0$<$04XSA.'43][S&G+D1QI%$1O78B$KV' (#8AR_MUXYKG2N[%$[
MCIJNGT;?S!NWBSQD04,@&U@@]"J3)I8*#0'?L6AHD*=ZK.)>U70EMD4Z8DX5
M0HSJ6181$!4(09I1"?6_"A31*,?$2DKYZ,ES(\[6-H>URP%,%DLW7^='9J/6
M+)_%VP$ #JLW7R F6KY=>!'<%G&G?!U<Q1W<,-TR[I2=!^NXDQ?XS?]>5ZMV
M,UQWX_N5GE;>Z^[;OD=,)%P4@NC9G30A49A#AB,.,1<4,YPH%CMI4 XU-C<*
MZMMJ8I >.FO=)F.#\-I-M4*!-C)U/<=K:^@(%9=L$ DZ 1IL<-+IC8WKSR<O
M5O=XL@==?S7__^T_'\OO=*G'@_5>7]W\H3E=Z_^B=^5""41S@01,:<8A$GHF
MPWA>0)%QSG,JDIQD[C)E5]GD\D%-)VMFC+P!W-2XE'M;F\/K7O6(YN___F\X
MB9/_Z F?Z<5,:ZDC<UW5M2)!120S!%,>*8@(3B"FNG^++"$\2Q 7(G>52INX
M8\>75O/H5FG475^B0Z7DO. )AC$SZX\<I_I;%11F@L94BK3(.5MLJ@U=SJPS
M]S;-H2.G[#++Z<54'3'V_*/I@Z8.<,] (U.[ZX#FCVW$S^'O>C<$G*6$ #;L
M-.8JBZ:=YX0 [V@B%.2AONNL;]^J55-RYH[6GVH];=!M--5G[F3=!/PN9)(C
MFNFN8Q'1@V86<T@SC&"F4,X*1$3L5E38HLWYK;J,R=O"3-IJD]G<VMV6:0+:
M\C8YP'4A=AG_+(YXDN,8<E0@L]R5D*89A53_.V,9SA66;AE @7M@H@"*6I0K
M6C]U!<ANP*HR46]+\-W8'1YVVV5P4"A'7PU?_QY[K(NM(0J\/+[<[L2K9&L@
MCA?+]K?ZC02=M'Y/$_Q-N>;+:OU8RP^[^DF2QG$<17I93'(!42HPI!%AFIHD
M+AA+!"Z<=$*L6IW;:'"J"@'8V^U1P<JM$^R8*3BT(W-3$%2=R<D)I:#T9-?R
MI 3E!,9SBG*[V8^D?I'4/,Z<\+Q?/3QNWK)R(^@OC\M-^;"4W?YUD1*4*:F@
MBC#3\]6$FK0N!M,D)PA'0A$[93J71N=&43V;06/T#7C[ZOV7-[=@:[<;,5D!
M;\=+H>$<F98N(SG"48(+1D%)R:KA23G)!8KGE.1TKQ\CM87^GJ=M<%[$F4H%
MI,0LV1)%])*-"JC7<7K.E!8D8[G;DNUD._-;I&V3.6AC[O_E1C*GL;1CE:OQ
M&9E&6OO&S789Q" H39QN:5)>&'3V.1$,7^PI!F.68(9:/JDVJNIV)4[$6NW>
MXX))*E/*8928;/,<:4[("PYC4M",)5F:8N(DJ>W6_MQF*#OSS<'1Z2!&SYPZ
MUXZQ(Y@1X1Z9>H(@[:Y!XH=76/T01QNFU?[P ^A(M\/S,=X)-EQ*L3;UY3H1
M$%,ZK@DT?5>NZ(J;W&6^*;\W>8,+9>JZ29'KSN$91"PO(%4HAH)ISE-II%C!
M';-P7-J?&^FU(=NE60G?F#*GSBD[3N#;$=N(D(Y,;%O+V[J>/VV--\)=?^FB
MXW<.@+T'0?-\?* +G0SD9,/4&4,^ )U(*_)ZC!_'Z2?J+_2#ID[QO*![6R 0
M\YAQE:40%UD,$9<%9)GDD%&$98HH88JYK>XN-3F_A5YK,5P:DT&YL[E;^!GE
MY_*^.9WCU4!FG1_^=KP6$M.1B:P#L[$5[(T%VT5CX$J.ML@$Y:F+C4Y*3+80
M/&<BZ_L\<FJVXBZ:[<0CWZP7*24)C2()-:-HGBFXA$RP!%)$(LY('B61?6'(
MYT^?V]2HTS7ZI,#60H<TDR/HABGB:D!&YH.P6#BDW5R#R42I-P[8N*7AG/-]
M,!7GZ*;ITG'.V7N0DG/VHFO+Q0T085."ZHO\L7FE;?W'HD DUO]/PB+)<X@P
MHWJVQ!FDF&1%4619II> ;@+&[E;,;P)EUNC5JEFO5.IXT/>M-F??+Y;;7N-B
M/?;65Z]*W? DJZM=!XP7H'%CE#)VSB".5.+.WHX7*G_G#-3YTGCNC_+/.C*;
M;X<!NN]H63=Q6OMHB$64%40D>B;'(LKUQ"Y!>NW()$Q$G!64%HA1Q^-!Z[9G
M2(3/\A/<<Q'L0+?CNU& ')GE=@D$QVD&QO NLG-O>MAD B>T@B<.V+4^>9*
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MNWEHKCI?2[J1'V3U]Z=5'15?W;^G3PM]5&E'0&4)3!(L.,@*?<:"4BG 4HP
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M@\QK2!=8IN N"!"T%F76'"5ODRTZG-9.IM"?*8$YE-+Z2&#>L/^UUQ%Q1GO
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M5Z!.;K71228:=?8[^PB>?N;3G9)M&$WY'0!_GQD@*H3DK2?9ZDQ605>K($G
M29!G*U$3R_]G!,^9D7/$")Y#U#CVMGQO>DR@K8EQVD4"K7,2CE%U#@V%62)F
M\EZ<#EKLM2U_?R-X#M+;DR-X#A%B![;IR1->S46L$X7 1D$&/Y<$/B4$W)[O
MDA/#VIP(G=S3K)^Y=0.GZ(]33D= &Z**[/FVQ\+N,I@A?KU%#AP-"4(X!$="
M@"2=DJ;8K,O9+F$/PU)WV> C4=>PD/!X"/S!UL+7VA=6%',Z4_P7I* ]S 0(
MGNG:K"<7E!9=XZEI@[+373JZOS5PG.K_8/A_O"12)2V3]@J\RQ*4MQR<< 9,
MSME'*5DP_7=E.JU@=IQ;1;VLCV&@\0=;+]^NP,<8T*50QX,G^F)(<YY;VE$-
MPR*R5<;]5[FM,<XEIE[6S[!0&3O=,6S)\;4(8E(ZJ2 AER)JQ3%"*#D1O-%;
MGT0L>;_NS&WHZ[AIWS$P[T63'6P*UW2[G$5V0@,+]1C(.@$Q!0Y:*.^%,=&F
M-D<A!V%LG*L[IYC2HP3\Q[)R+W8<O N?KR)MC\QKY4 *[DD6I5"DK1)]6[(V
M3+B0]LL1-R:TXZYVG=B]TW3;@0$<TM6Y+XR@N>')$?>ZA@C)D3!RE* =*\D9
MI2/*[KW@XY;%.,WT>O%Z3X/"'VQ=;%S^KUV-=P)1)065;*P3 4,M81$0',^0
M9!&,6VGD^=J>#LM:Q[WX>ED?IT/BC^4C[020HO:Z=H9-OM#F258!@M !F"\A
MFZ(XRV-T(CKD0&F<!GZ=N$-'J/%X'"_68=:=K=])P$L7?/ <4N&.). D1!WK
M2O9H"_&0]=DZ39S(2\\-!'LQYT=H?43<MV@^]E4DNT/E2;0<LT,'12G2C7>!
M'#YG($:6?3#!6V0CV/+[E/;<YK 3NWZB>O]@_OSS>]-))E$DU!8-2</7>O2Z
MXYE@Z4M&RU*27+0=7-F&KY[;+O9B^T]$P^%KPV_7QAPO:G?[[E;'M\?W.!=9
MB:5 RJ9>0E02O.(!2&-6:ZMR]OU'OL-,>AJIPV,O:V=8K/S!MID;.;2;QJ6D
M:(V)#(1$ 8J3;(*/C@24N8X1G43=_>IYF+>>FS_VLF0&0,4?*W7T<"K-"J&D
M50C2F@A*V0 QD(^*+#FGE1'6CI%).CY?.E+;QDX"D-.5_ ?;'![<.2>1QZ!L
M[=RG<JK=!#5$SR0PS!Z%"D[;_M-.#[+6<P_'7K:&TS'1:S!R@N5X;%[=A!FM
M,3@!)B@&2AB*SP++4$+R*B%9E-*F;?QY^-MOP?PA3JG'1L<?[ CC[IRP9+Q-
M#!5IB]4.":S>PS29K$A4(3.)^>Z-U@XWE6/&Q?'_VF?4I^#@CW6ZL17 5>8[
M<\5RO8?*0HJU:%N!TYS4Y=#X(ETP=Z]*GO&0^I S#?%_SJJ/4NIWVO/Z;_-P
MF:?KS96>S9BTZP7^!E>79(\;-K_>^]WGZ()]G"!.;(?]A(5>77<_-LB#5"X#
M]R: JMVN?-T;M=,E!"63Q+/=/EV-UD.;H[,N>@M"1C(0%,I#R#:"1T9V(W.T
MK,T4S^^CA_;@2#JYC_8A"NLH#W.W9Z_DVEFFR*/)QH"RLH 7]$5:DZ/3(F7>
M=O5]WWVT#T+!GGVT#U%)I\BZW8 5HU"B=C)A@9,3'6J>7BD-Z%)66@G%6=O9
M*M]9'^V# '!P'^U#M#'VJ<F]SH7HLMDT@=9UO*,RS% H)A3P9%+R6J7HO^FW
M==0 LI'6GFS^>(@(^S0O7\,J,K!%92_ VMH37!E%894ND+1P5OS_[+UIDU-)
MDB[\B]PL]N4C4,NM:Q1@0/?8O%_28O$ W4XD1LJDB_[UKX>4^WHDG= )98V-
M334%5!Y?'O=PC_ E9RR-2TYWGC/5S^3BD8^PW933)]#N[W17R0BE)# IZHPV
M%B%HQ\&EY%1RAL=TL*TC=XGKSH/MB(0M=I[OHI;.D79[C7LA;^R4IHRFUO\H
M7CQ$SC44DU1$U-$,F\(^*MYND=CQM*56J-M=17UB[Y*O7\-R/IM_67W Y:>O
M)/[7835+)R6D6) 3?SGS>CQ0,$IT@77.*ENLM_)@+N])2CN>:S0R$L=3V'$!
M\I?9Z?D9YI-D5 Q>9%"E,!)G21!-]) 38]G8B+[Q*_9P6CL>%G0@4.ZBM Y@
M>6=A^]JTUORLWI^?K<["/!.3ESR?9,.2UCR"$[4HBR4&#J4!9(6YS&IA?)L;
MCJW(['BDSSY@;*>J#G!X2?<=)N_Q=VEFM3TIF9K(I5KYI.L]@20>#2_:AEQ<
M-&VV1VU):,>C?_;!8DMU=?H$>QEZU+%OJ19;_, Z-W&7%]7'?M08#Z2#R!SI
MO?.7V2J=+E;GR_7,^&_?<;ZZ*$LYK16#;Q:KL]6:GECI^1!^UK?YZW<LGPSG
MGHNZ1[%NQ:[#\;)UH"4/46-*G+59Z; ?W?NZNL%??WWSZY])9Z_IQ_SK1+A<
M4F 4[L98=R>I -Y)<O0\9F<9.KP[8>K08GN8\&DO;@Z(U;O.\I *W]EYD@./
MB\.[S_7=[$YE*4__P(:N]"&2^W"H0244.2!DC'5U:-VB$+R'DKE6H03A2YOP
M?%J'>OT4<*VQFU1\.B,K>O]]4T212(UUT4E5XK6)9>L91<MD8M9:4"@]69<J
M@$D&&844WK099K8_[4?M5K=![..E+ =1^XB>=32HQ[L\?T02["R1Y-?<OYKG
M.[_SC_GL[#%I.,]Y=C)#C"'5I8P" E,1M)->H5*9W>VK:V,$HW(U[<5]/^8Q
M'52.*Y][%Y:U8^0'[E$Q._1'-PQ2GF:CDW"%)V4T)W>0L8"*W$"P-@%7SA3'
M'&>Z34U>W^'**]+<_,MZ0^KJ]<][B<&K?X=EWI0TR)1"\"%"D5Z"4M%!E#Y
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M]7\>,!3O<HIU_I;,@9(H34%LU#F 5]EBR#:Z1F-^GR2KTPO]D= UGD8Z@->
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ME#N:K,!G:4 H%I./3DCCGY-QPPTB=ZQN+;WK[LVW=Q_CO&(E9<M!)!5J-Z<
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M 0OY8TQA=78Y:@V%,R@46"FK\=3K7DH&@>LBHU?HF"JC(^4V#5/.1AQ%L0]
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M*H<L(F\S=&U+0O?UFX]\[MIZ/Y,"7M-_\:\3G;CTJEJ"<;P6=!=P43LP28;
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M@0%)<F%0E]_6,!M"W<1%$X>Y[1]=31U [X]YQO(X7[_^E4[/ZPK4RPG0)\1
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MH28EF#J8G(NU'E.;X:M]E)6W@LY6<CW"8U*B+MJC 99KP7M4M?2=.T"='8;
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MB?'J(0RY>?E;4!GO'!B;B8<ZK\M%(R&P*(N)GFQU&^2\I*67&O,8 ?]1<N[
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MC@"BQ<0:[0#%!W9 F*A"T3D "3B (H<)?. .N->2$Z-*RE[<VIZ*MUU?[R>
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M.S!E+[FX6^>-*@?O%"13,WQ8,L1,0G)T?*60J#5K,W%]&T73.E)C:/N[ #I
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MW2]?A]5L=7>=ZJ)=%F"2RZ"4K](K&BPOG(N<0F[D)(_&0H=70 /DOLA938*
M#KR=U^&2K!9^^(3X-!2.G@5>ZC1XFRL?=6P[M_1+HQS*;(3V;1+QVRB:%I@3
M 6310%N=HNY^I7TTR)T KJ*J2Q81@F49M!$V*RDUXZ?#70_YJG%TO@>0#E!
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M&*\^5$$^KF&+D*.)1+XGEQP4<Z;*2(-&%R(=)H>F55_W2VHZ"6YZ0M_12NL
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M9MZ59R?J0MI@%),9BA<1E'<!O*!@K(1BHU/"9-EJE.KWJ3O_]-#89G D37:
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M"[Y#\-P>KNR48X8K<+).26:ROM?2":+/>CUM08AR$OCTX.L>K^?O .< H7<
MG??X=7'Y=3;_XPU]>W;US(@BNFB0F]LV""$U!(L)F,%B9"DH;)L-4CO)Z@M(
MA^A]T4H)'2#JB7U^>S]S3F:7K>9TT[,:6J*T]&^E@$^V8 Q:$T_M(^^W@T90
M-MN(=YKDS6'"G]IE?I72XOIF?-!M '!_'FXRFO==[V_"%_J3JV\71='QDH9\
MQ\Q(8H@:*K]@R 6TEI@4\;M/40[\=D=1^('J7IQ.]AU8IZ<M8^NYF!^(EI#?
MS1\7Y?F%BM(Y3EZ!";6%K,Y<<\(;X$:DY-!ZI=HX3_M2V%&\?QSRFJJF \A5
MZ;PKSZ[V;<>)DXQR] 5,'=Z@/.'#>54@!.-345K3<6OCLP^@LJ-<PCC0:Z:B
M#N"WX;78141&\B@9K"MUP@^QX%E,D$4TEN=4I&B36-A S,1EM/'!=*S .WX=
M_.'Z\^>P_+9X\L;^R/>_.W_F6"]\]R>\[? 5;ZPM@3' H!CAH"[R-98!+[QH
MB8[K_9H9#O(JVHQH>KBR;\(7-,X&KZL;J.JN8KJG Q+R VHO EW<2K2IDFT@
M9OJG3T=B8+>/-%S@/=U'3XO.FIPW6R18D3BH'!)X[3C8(JP+J7#.VKRO/+RU
MXT1/Y@Y0\GX='0,DWB-L;O-N='EZO>Z*9,Z DL10B*PN!<Q<%A$REL:N3$]9
M[A%4O6='QQ"Y]P ?G,\6RUHUO-LCE'AV/F<&I?#JQF.L:ZHL6,E-DM4A:S5)
MXSDIG4'F$ 4_!\U1TNX +ANK11ZS3R(**%[7DC+% T'7.3_2V<BXL\FV<=X.
M+L>>Z"GN\5?4T?+N$#-WYRCJ;+,P@*IRP>HH/&ELS>EK*P*&J-J\HCN;*NP@
M/>]7A1TB] Z@\])>:L-XBMZ ]*&6$XT EPP'X;.1RJ243*-R65^WTQCZ_>[E
M-$384Y?'UM,O'F<Q[OJ=; PQ,@2!F$!93N>'%P5U5:(7+LOX/*6W:ZK(RP],
M>]^,"(/1I#CIM-(U%YN&H#QCB%F?>9$.<G%U1V9&""%)B.@5DYH3PLU>L/C^
MMZ:M"HR-D)%EV\$ELV%F$T\Y9%>'6N@Z!],G#4'( HPYI1QY;<KO];3NR%S=
M]$]NQ_9GCY1U=VAY-%N%6QZDJ[,/Q'J@<VVQ=;8 2E]$CEERFT^ F8XGH0W2
M]+Z3T(:(O0L?98\)724Q;K)W=-O6$U8WVGM.+ KOA//2*I;T_C[+V4Y"&Z3:
M0R:A#9'SU-AYY)U__'/Q\=/B>A7F^:?9'Y^N$.?B'^9W7";B]VX;N&%&TVD#
MIB(#%0M=[70I Q>1&ZN\Y'F_W97#OMM3]F4,)#64>M^ DO]@3UGC6;!2%W75
MMXZ@N*"SXIB"DI75N2XS>%Z^/ A0S[_;D_O3'E!'2;U/0/TVF^/-6='L]R4^
MXDT6*X/E%((0)>0.J PN\@R)%=2%*^OC?O,^!WYXVL::4T%J'+GWC:F[-!4%
MG$(F!9DI8D@K!RXDA&@P(!?!N.?C#PX"T@#T-'ON=6KT'"#AJ2'SBO3*?KY<
MA+K,KS;&_G2]7#S.:@:2A<,DR8BF!"IYXD/6)]2HD7OTB>>T%UR^]Z5IWU*,
M#Y51)=L%3"H#+]/>41;'ZW,BK[B_&7(;)-9:KQ<V,ZZ*WR]EO/T;>T'#GADT
MCI?FU*#8; P__DE2^B;_8?53YTPQYTV@R-&GNC7):4'2<I$PKYWFS(;\/$LX
MZ-[9\MF]H./.!SKM9-XSFM[-4?Z#ZZ>>F<YH>(P"D-?EE#EZ<#PK",2;)]D6
MAON]UQKZY;TPY7\,3!TM^9YA]9%@4=D3SXX-8YY)YAT=FTBF-YH,46L'24?T
M-@H,8K]RUP$?WR^[R'X,=(VA@.X!IOXAGG+G#+KH60'GZ]QGY0($QS($;[A.
MQA3KV3CP>O[I_<!U1KGKML*?&EK53U2;_40A:KLMTR!*HA/BZO ;%^J;_N2E
ME8S[LE\Z:/LW]@/+&:6G1Q)G#ZC0F]G@4D91AQ05L]Y(F10X1NY?9 1ZIGC"
MJ/9&Q>9O[(>*,\HQCR3.J5&QRQ)^F/TE_^&?.7$N899*UMGP]0&1"[+N8;>@
MT1/>8U06CTDH;__R?@@Z^Y3R2**?&E?U>+C-Q\.+;'T-)TTH)+!L* *PIH[0
MLU%QGHNW^Z<&-W]C/ZR<40)Y)'%.C8I=D%^7Y^Z0SKC.+'FP6=94>'$D,93
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M60N0JT?7NJG/R;CF0F6=4VYS#8ZZM_I$K0DM8K:1=-,!YGY?+A)B7OU,4OQ
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M?%7(S;WG-$N=,Q>I+LI-=6*5!(>)K@DG39:&R<@F-YU/*)Y^'-1T"#U<=5V
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M"1F-5>($3^6>FHY\WSE1= CO.]!";_'+KL..^7'G..]K447*&D#8DJ]"Z6W
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MNT'D+>LXG Z+T\NJ^R?SY\T6_TF?\1/R><_VO[B@7UOG7@L6'%&<//Y+IGV
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M,S,Q+FAT;5!+ 0(4 Q0    ( )J J51:Y)51Z@<  *<A   8
M  "  2((  !E>%\S,3)X=G1R<W@R,#(R,#,S,2YH=&U02P$"% ,4    " ":
M@*E4W3$QEK4%  "P&   %P              @ %"$   97A?,S)X=G1R<W@R
M,#(R,#,S,2YH=&U02P$"% ,4    " ":@*E4O=*O>'K1 @!+P2$ $0
M        @ $L%@  =G1R<RTR,#(R,#,S,2YH=&U02P$"% ,4    " ":@*E4
MB?VSLE(?  #Y:@$ $0              @ '5YP( =G1R<RTR,#(R,#,S,2YX
M<V102P$"% ,4    " ":@*E4"_-V340H  !%G $ %0              @ %6
M!P, =G1R<RTR,#(R,#,S,5]C86PN>&UL4$L! A0#%     @ FH"I5+AP&?UE
M\   I T+ !4              ( !S2\# '9T<G,M,C R,C S,S%?9&5F+GAM
M;%!+ 0(4 Q0    ( )J J52TP"BSH($! 'U%$  5              "  64@
M! !V=')S+3(P,C(P,S,Q7VQA8BYX;6Q02P$"% ,4    " ":@*E4='[Y7'DD
M 0"/Q T %0              @ $XH@4 =G1R<RTR,#(R,#,S,5]P<F4N>&UL
64$L%!@     )  D 6P(  .3&!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
